paper_id,tokens,norm_sents
3ab5bac23479ddada58d37cb139d5033bc9bfeaa,k þ active transport plasma membrane passive diffusion h þ electrochemical gradient þ atpase simple passive gap junction membrane transport þ k na þ nobel prize primary active semi permeable solute movement transport system activation energy chemical gradient diffusion simple electron transport osmotic pressure prize chemistry side membrane vesicular membrane þ gradient additional energy biological membrane diffusion carrier diffusion diffusion diffusion solute electrical gradient free glucose l state membrane hydrophobic pinocytosis phagocytosis potassium channel secondary active water soluble atp synthesis cell membrane co transport diffusion active electrical potential energy form energy solute extra cellular fluorescent dye free energy gel state group translocation integral membrane lactose uptake lipid bilayer membrane cell membrane lipid membrane solute movement solute oxidative phosphorylation permeable membrane ph gradient receptor endocytosis solute concentration solute electrochemical solute membrane state permeability transport co water permeability water small þ transport active symport anti fungal atp production body temperature cardiac glucoside cell plasma chemical energy clathrin essential cm water complex membrane concentration concentration concentration gradient constant temperature cross membrane cytoplasms adjacent dg ¼ diffusion coefficient diffusion rate diffusion water dimensional structure dj electrical drive movement e g electrical energy endocytosis rme endocytosis uptake energy change energy chemical energy diffusion energy source,"['life membrane ability level aqueous membrane', 'membrane cell', 'transport complex membrane', 'membrane topic chapter', 'biological membrane semi permeable meaning permeable water impermeable various solution', 'important concept unequal transmembrane distribution hence permeability water work chapter', 'biological membrane accomplish semi permeability', 'barrier solute movement membrane hydrophobic core thin å thick layer', 'inherent permeability core membrane', 'bilayer permeability', 'lipid impermeable', 'figure membrane permeability variety common', 'note log scale solute permeability cm ¼ cm water ¼ â cm', 'þ cm water â cm', 'range', 'example luvs dppc pc sharp phase transition temperature c gel state permeability low', 'packed liquid state l liquid crystalline state permeability high', 'maximum permeability l state', 'luvs gel state approach l start form gel state', 'l gel increase permeability', 'maximum amount gel l state porous domain', 'permeability', 'temperature luvs pass l state permeability single component l state', 'maximum permeability', 'tendency region concentration concentration physiologist adolf fick figure', 'work fick diffusion', 'free solution diffusion', 'fick tubes water', 'fick law diffusion diffusion rate ¼ àda dc dx ¼ diffusion coefficient ds ¼ sectional area diffusion dc solute concentration gradient diffusion region concentration concentration relationship solute molecular weight diffusion coefficient table', 'large low diffusion small', 'diffusion rate particular solute physiological', 'theoretical limit enzymatic reaction rate size cell', 'solute center bacterial cell plasma membrane', 'reason typical chapter', 'size cantaloupe cell earth today egg', 'dinosaur american museum natural history new york size basketball', 'egg function store nutrition embryo size many normal cell', 'osmosis special type diffusion diffusion water semipermeable membrane', 'water membrane potential gradient', 'introduction high low potential figure', '', 'osmotic pressure force prevent water movement semi permeable membrane', 'net water movement potential zero', 'early application basic pioneering work hemolysis red blood hewson chapter', 'mlvs multilamellar perfect hypotonic hypertonic chapter', 'liposome absorbance due light simple spectrophotometer', 'osmosis many common inexpensive process', 'permeable', 'deviation ideality reflection coefficient', 'ideal semi permeable membrane solute impermeable ¼', 'solute permeable permeability equal water ¼', 'biological excellent semi permeable', 'movement basic passive diffusion active transport', 'passive diffusion additional energy source solute electrochemical concentration gradient equilibrium membrane', 'passive diffusion simple passive diffusion solute membrane lipid bilayer passive diffusion solute specific diffusion solute specific', 'active transport additional energy form atp nonequilibrium net accumulation uptake solute side membrane', 'basic simple passive diffusion diffusion active transport figure', 'countless different membrane transport process', 'representative', 'figure osmotic pressure', 'water u shaped tube tube semi permeable membrane size water solute', 'addition solute tube right arm water right high water potential low', 'column water tube solute extra weight column osmotic pressure solute', 'pump osmotic pressure whereupon solution columns right tube', 'pump pressure height osmotic pressure', 'small amount solute filter perfect', 'simple passive diffusion energy cross bilayer membrane', 'order cross membrane solute hydration diffuse membrane regain opposite side', 'step energy lose hydration', 'table relationship proportional number eoh homologous series activation energy diffusion', 'number glycerol erythritol activation energy diffusion', 'activation energy energy hydration', 'water diffusion fit model', 'water permeability high', 'several account high membrane permeability water', 'water small', '', 'due size water small statistical', 'statistical simultaneous lateral movement adjacent see lipid chapter', '', 'water lamellar membrane g', 'micelle cubic h ii phase', '', 'high water permeability defect e g', 'surface integral boundary membrane', '', 'conduct', '', 'specific water', 'membrane simple passive diffusion water small', 'large simple passive diffusion cross membrane', 'diffusion carrier diffusion simple passive diffusion dependent inherent energy solute gradient', 'additional energy solute final solute distribution equilibrium membrane', 'diffusion simple diffusion specific membrane integral solute membrane passage', 'basic', 'diffusion menton saturation carrier active site', 'diffusion solute exquisite precision similar glucose l glucose exhibit saturation', 'figure simple passive diffusion diffusion', 'figure scale facilitated diffusion simple passive diffusion', 'studied example diffusion carrier glucose transporter glut', 'activation energy simple passive diffusion glycol glycerol erythritol table activation energy', 'large discrepancy presence glucose diffusion carrier', 'figure mode action', 'abundant small intestine', 'example', 'integral membrane membrane region', 'typical membrane transport mechanism', 'glucose site causing conformational change transport glucose inner side membrane internal aqueous solution figure', 'organisms wide variety ion potassium', 'basic potassium protein related heterotetramer', 'potassium channel distinctive pore loop structure top channel responsible potassium selectivity', 'selectivity filter loop', 'selectivity hydration potassium ion', 'structure diameter water central potassium membrane', 'dimensional structure important integral membrane protein x ray crystallography figure seminal accomplishment field membrane', 'work rod rockefeller university figure nobel prize chemistry', 'potassium channel work structure non water soluble impossible', 'mackinnon work structure potassium channel molecular mechanism', 'blueprint determining structure membrane stimulated interest field', 'þ parallel action k þ', 'diffusion cation ion electrochemical gradient', 'excitable na þ responsible diffusion phase action', 'þ nerve conduction', 'basic þ voltage ligand', 'þ channel selectivity filter na þ', 'þ flow part channel å wide', 'large allow passage single attached water', 'k þ squeeze channel selective na þ', 'particular interest potent biological ttx saxitoxin stx injured many', 'þ extra cellular side', 'tetrodotoxin ttx fish porcupine fish ocean sunfish triggerfish', 'ttx potent neurotoxin figure þ effect k þ', 'puffer fish second poisonous vertebrate world golden poison frog', 'world fish delicacy business slight error fatal', 'puffer puffer soup known antidote', 'saxitoxin saxitoxin stx neurotoxin marine shellfish toxic algal red tide', 'saxitoxin figure dimensional structure potassium channel', 'clear center structure single k þ center channel', '', 'membrane transport potent natural figure single contaminated mussel enough stx kill', 'stx toxicity keen eye united military toxin designation tz', 'force solute movement simple passive diffusion free energy change dg', 'free energy change solute concentration right side membrane solute concentration side membrane r gas constant temperature k z charge solute f faraday dj electrical potential solute movement dg ¼', 'negative solute movement right favorable', 'positive solute movement right unfavorable left right direction energy solute right equation chemical gradient transmembrane electrical gradient dj', 'net movement solute combination solute chemical gradient electrical gradient inherent cell', 'solute charge z ¼ case right hand part equation zfdj', 'final equilibrium distribution glucose membrane internal glucose concentration equal external glucose concentration independent dj electrical potential', 'equilibrium solute situation solute k þ', 'net dg chemical gradient electrical gradient dj', 'dj', 'þ concentration cell outside chemical gradient unfavorable k þ dj direction negative interior sufficient magnitude drive k þ uptake chemical gradient', 'water system', 'water biological numerous', 'water permeability rapid movement water', 'predicted water leaky n peter agre figure johns university specific membrane water pore', 'accomplishment agre nobel prize chemistry rod mackinnon work characteristic living formation maintenance transmembrane water', 'large k þ important', 'typical cell interior mm k þ mm þ cell mm k þ mm living negative interior uneven distribution ionic na þ k þ', 'chemical electrical equilibrium active transport', 'active transport form energy atp drive movement electrochemical gradient non equilibrium distribution solute membrane', 'number non exclusive overlapping describe different active transport', 'figure', 'primary active transport direct active transport uniport', 'energy pump solute electrochemical gradient', 'studied example primary active transport plasma membrane k þ atpase', 'familiar active transport redox h þ gradient system h þ gradient system photosynthetic thylakoid acid h þ pump epithelial lining stomach', 'basic primary active transport table', '', 'crucial active transport protein membrane bound k þ atpase', 'single enzyme third human energy expenditure pacemaker metabolism', 'result k þ atpase', 'skou figure nobel prize chemistry', 'case biochemistry serendipitous discovery natural product instrumental unraveling enzyme mechanism action', 'compound ouabain cardiac glucoside poison tip somali figure', 'fact name ouabain somali word waabaayo arrow poison', 'ripe certain african potent kill hippopotamus single arrow', 'discovery treat atrial fibrillation congestive heart failure', 'replaced digoxin lipophilic cardiac glucoside', 'several important þ k þ atpase mechanism action', 'include', 'þ k þ atpase example primary active transport active antiport', '', 'þ k þ atpase ouabain cardiac glycoside', '', 'ouabain outer surface k þ atpase þ transport cell', '', 'þ', '', 'k þ', '', 'atp aspartic acid enzyme', '', 'phosphorylation þ transport', '', 'dephosphorylation k þ transport', '', 'dephosphorylation ouabain', '', 'þ cell k þ', '', 'þ k þ atpase electrogenic', 'mechanism k þ atpase forth conformational', 'bind na þ k þ conformation', 'conformation change', 'bind bind k þ þ outside k þ þ', 'hydrolysis p k þ atpase original conformation þ na þ inside', 'ouabain step', 'mechanism k þ atpase secondary active transport secondary active transport co transport separate', 'energy dependent movement ion e g', 'h þ k þ electrochemical gradient ion membrane', 'gradient movement solute direction symport opposite direction antiport figure', 'movement ion electrochemical gradient diffusion', 'purpose cotransport use energy electrochemical gradient drive movement solute gradient', 'example symport sodium glucose transport intestinal epithelium', 'energy downhill membrane movement transport glucose apical membrane uphill gradient sugar bloodstream opposite side cell', 'secondary active symport system lactose uptake e figure', 'lactose uptake þ gradient bacterial electron transport system', 'free energy equation transport dg ¼ rt ln þ zfdj h þ motive force dj membrane electrical potential figure transport system', 'uptake lactose movement h þ electrochemical gradient', 'example active transport co transport active symport', 'r gas constant temperature k solute charge faraday dph ph gradient force h þ proton motive force dm hþ uptake', 'note ability lactose combination electrical gradient ph gradient', 'lactose uptake h þ movement possible lactose gradient e', 'dj large', 'importance vectorial metabolism', 'water soluble substrate product directionality', 'mitchell many integral membrane unique orientation', 'substrate product direction', 'enzymatic conversion vectorial unidirectional', 'mitchell basic concept famous chemiosmotic mechanism atp synthesis oxidative phosphorylation', 'idea mitchell nobel prize chemistry', 'vectorial metabolism describe several membrane transport', 'example glucose cell external source sucrose free glucose', 'vectorial membrane reaction membrane sucrase external sucrose internal glucose þ direct transport free glucose transport system', 'mitchell type vectorial transport group translocation example phosphotransferase system saul roseman', 'active transport system energy intracellular phosphoenol pyruvate extracellular', 'glucose mannose fructose cellobiose', 'system plasma membrane cytosolic', 'energy drive system dg hydrolysis kj mol', 'high energy group enzyme bucket glucose pep ei hpr eiia eiib eiic', 'sequence detail figure', 'hpr stable protein high energy p ei enzyme eiia', 'eiia specific glucose eiib membrane glucose eiic', 'membrane cell free glucose', 'free glucose cell glycolysis', 'group translocation solute different form membrane', 'term ionophore ion bearer', 'small lipid soluble microbial origin function conduct', 'diffusion electrochemical gradient', 'basic mobile', 'stationary many membrane', 'mobile ion side membrane membrane bilayer release ion side', 'ion time', 'representative k þ ionophore valinomycin proton synthetic crown ionophore nystatin figure', 'valinomycin cyclic peptide figure', 'examination unit dodeca depsipeptide amino acid peptide amino alcohol ester', 'molecule alternate nitrogen', 'valinomycin l valine hence name hydroxyvaleric acid l lactic acid', 'circular structure macrocyclic molecule carbonyl face structure chelate single k þ', 'outside surface valinomycin hydrophobic side valine l hydroxyvaleric acid', 'polar interior valinomycin k þ', 'constant k þ valinomycin valinomycin', 'high selectivity valinomycin k þ', 'valinomycin membrane lipid bilayer k þ membrane electrochemical gradient', 'valinomycin potassium ionophore bernard early', 'valinomycin antibiotic k þ uptake h þ', 'many valinomycin essential electrochemical tremendous metabolic upheaval many', 'reason antibiotic ionophore', 'several animal feed growth', 'potent agent severe acute respiratory syndrome coronavirus severe form pneumonia', 'dnp classic uncoupler oxidative phosphorylation', 'synthetic lipid soluble proton ionophore proton bioenergetic mitochondrial inner thylakoid bacterial plasma', 'uncoupler therefore h þ diffusion carrier', 'role dnp oxidative phosphorylation essential component support peter mitchell chemiosmotic hypothesis', 'electron movement nadh farh mitochondrial electron transport system considerable amount electrical energy membrane ph gradient', 'movement h þ membrane electrochemical gradient channel f atpase f type primary active transport system atp synthesis', 'dnp short þ gradient pass f atpase electron transport energy source h þ gradient atp synthesis', 'presence dnp electron transport rate atp production', 'energy chemical energy excess heat', 'combination medical application dnp treat obesity', 'addition dnp • patient weak due low atp', '• breathing due electron transport rescue atp production', '• metabolic rate', '• body temperature due inability trap electrical energy chemical energy form atp', '• body weight due respiration burning fat', 'successful weight loss drug', 'early dnp diet drug tainter stanford university united weight loss drug year use', 'dnp side effect death', 'fatality lack dangerous body temperature hyperthermia', 'kg dnp lethal', 'general use dnp united fat', 'crown family synthetic similar function natural product valinomycin', 'crown pederson figure dupont', 'work nobel prize chemistry', 'crown cyclic several', 'common crown ch n n ¼ tetramer n ¼ pentamer n hexamer', 'crown x total number number', 'term crown shape molecule', 'crown form specific number', 'example high affinity k þ li þ', 'crown figure', 'valinomycin exterior ring hydrophobic crown membrane lipid bilayer cation', 'possible tailor crown different variety phase transfer', 'crown catalyze membrane hydrophobic interior', 'nystatin channel ionophore membrane', 'rapid diffusion various', 'b natamycin anti fungal agent', 'fungi presence normal animal difficult challenge cell', 'figure', 'permission', 'different present variety bacterial amenable', 'fungi', 'fungal plasma dominant sterol ergosterol animal sterol cholesterol chapter', 'nystatin fungi presence animal', 'present sufficient k þ leakage death fungus', 'nystatin polyene anti fungal ionophore effective many candida', 'major use nystatin prophylaxis fungal', 'gap structural feature many animal plasma', 'similar', 'gap chapter figure', 'gap primitive type intercellular communication membrane passage small amino migration large nucleic', 'gap cytoplasms adjacent non selective', 'adjacent nm', 'small gap term gap junction', 'gap select membrane', 'early injecting fluorescent dye movement adjacent fluorescence microscope', 'yellow become fluorescent dye choice gap junction fluorescein', 'dye cell', 'time spread adjacent plasma membrane', 'gap', 'size fluorescent dye upper size limit dye diffusion', 'molecular weight cross cell', 'gap cytoplasms adjacent structure figure', 'gap junction', 'associated adjacent cell plasma gap junction', 'connexon gap junction channel', 'gap junction aligned', 'connexin diameter hollow center diameter', 'gap adjacent constant electrical chemical communication', 'particular importance rapid transmission small second triphosphate ip', 'gap', 'possible dilemma', 'single cell deleterious', 'membrane transport spread entire liver', 'important function', 'extracellular intracellular cell intracellular', 'gap junction intracellular spread damage', 'gap important cardiac muscle electrical contraction', 'number human neurodegenerative deafness', 'several large', 'receptor endocytosis rme phagocytosis pinocytosis exocytosis membrane large many', 'receptor endocytosis rme clathrin dependent endocytosis involvement membrane protein clathrin membrane internalized cell', 'clathrin major role formation clathrin', 'clathrin barbara pearse become clear clathrin essential biology', 'clathrin essential component small endocytosis export many', 'small primary mechanism specific internalization eukaryotic', 'figure gap junction', 'connexon cell unite form gap junction', 'rme specific receptor membrane figure', 'growth serum cholesterol transferrin iron bacterial', 'receptor complex membrane patch membrane pit', 'receptor ligand clathrin adaptor protein dynamin', 'membrane surface area minor membrane', 'collection curve section membrane form coated vesicle', 'clathrin dynamin recycle plasma membrane uncoated vesicle free early endosome', 'early late lysosome digestion', 'rme fast process', 'invagination vesicle formation min', 'single fibloblast cell minute', 'example rme great deal attention essential role human health proper level cholesterol body', 'process uptake cholesterol ldl lead hypercholesterolemia cardiovascular disease', 'rme role cholesterol metabolism michael brown joseph goldstein figure similar transport long time pinocytosis phagocytosis', 'involve non specific uptake endocytosis many water', 'membrane transport large whole', 'pinocytosis greek cell membrane invaginating volume extra cellular fluid anything water soluble', 'phagocytosis greek cell membrane large insoluble', 'pinocytosis form endocytosis small', 'process small intestine absorption fat', 'endocytosis cell membrane extra cellular material pouch internalized vesicle figure', 'pinocytosis phagocytosis', 'lysosome whereupon vesicle', 'pinocytosis considerable investment cellular energy form many efficient endocytosis', 'sharp contrast rme pinocytosis non specific', 'pinocytosis recent discovery transport', 'discovery lewis', 'phagocytosis type endocytosis uptake large solid', 'whole contrast pinocytosis phagocytosis figure surface bind solid', 'figure phagocytosis', 'phagocytosis routine process amoeba protozoa use food', 'specialized white blood cell', 'pinocytosis phagocytosis intracellular solid lysosome digestion', 'phagocytosis figure phagocytosis type endocytosis uptake large solid', 'major mechanism immune system', 'fact early system discover phagocytosis', 'work nobel prize medicine paul ehrlich', 'exocytosis process excrete waste large cell opposite endocytosis', 'exocytosis secretory transport', 'exocytosis intracellular plasma membrane release aqueous outside time vesicular membrane hydrophobic plasma membrane figure', 'steady state composition plasma membrane endocytosis exocytosis', 'resultant process plasma membrane', 'example pancreatic secretory amount membrane equal whole surface cell min', 'plasma membrane min', 'plasma membrane fusion exocytosis life', 'dock plasma membrane process nm', 'complex molecular prepare fusion', 'process vesicle fusion release aqueous compartment snare chapter', 'process exocytosis • surface plasma membrane size vesicular membrane', 'important cell', 'secretory vesicle cytoplasm figure exocytosis', 'intra cellular secretory plasma membrane water soluble membrane material plasma membrane', '• material inside vesicle cell exterior', 'included vesicle intracellular', '• vesicular membrane part membrane', 'correct protein orientation vesicular membrane essential', 'side protein inside vesicle fusion outside plasma membrane fusion', '• special type exocytosis kiss run', 'brief contact plasma membrane release return cytoplasm empty', 'fusion vesicular membrane plasma membrane', 'plasma membrane morphological feature late stage apoptosis cell death', 'bleb irregular bulge plasma membrane cell localized cytoskeleton plasma membrane', 'bulge blebs parent plasma membrane part cytoplasm', 'clear figure plasma membrane apoptotic cell integrity essential', 'blebbing normal cell cell locomotion cell division', 'solute movement essential feature life', 'many thin å membrane hydrophobic barrier', 'transport passive diffusion active transport', 'biological membrane semi permeable permeable water osmosis impermeable form transporter', 'passive diffusion simple energy inherent solute electrochemical gradient membrane', 'contrast active transport additional energy e', 'atp non equilibrium net', 'membrane transport accumulation solute', 'passive transport simple diffusion', 'active transport many complex', 'active transport primary active transport uniport secondary active transport co transport antiport group translocation', 'multitude transport gap receptor endocytosis phagocytosis pinocytosis exocytosis apoptotic membrane blebbing', 'last chapter book chapter biological membrane structure drug delivery', 'bad dietary fatty fatty good fatty acid fatty acid docosahexaenoic acid impact human health']"
dec3bae21563da31f703012a5a4920e0e854ae4c,et al brsv antigen brsv speci®c brsv infection danish dairy herd b igm iga respiratory disease half life anti brsv control antigen speci®c igm brsv danish day infection detection brsv igm response kimman al lung lavage nasal swabs observation period respiratory syncytial syncytial virus uttenthal et al preparation anti bovine body temperature bovine coronavirus calf week control calf coronavirus infection coronavirus lung der poel igm anti infection herd lung lavage¯uid maternal immunity natural infection outbreak respiratory present calf prevalence brsv rectal temperature time infection van der affected brsv al belknap antigen nasal b half belknap et bovine anti bovine viral breathing frequency bvd virus calf brsv calf igm corona virus dilution serum disease march elisa uttenthal enzootic pneumonia experimental brsv experimental design free brsv herd c herd prevalence human respiratory iga igm iga response infected calf infection brsv infection igm isotype speci®c kimman et larsen al larsen et life brsv ml ml month old pid pid poel et post infection preparation larsen presence pre present study rabbit serum reinfection kimman response present response reinfection seroprevalence brsv serum control serum human serum twofold titre herd titre ®rst tjùrnehùj al value serum virus bovine virus brsv virus dako week observation weekly blood,"['speci®c antibody different respiratory syncytial virus brsv experimental brsv infection', 'increase speci®c igm infection brsv', 'igm titre transient positive present time', 'iga ê', 'uttenthal', 'front matter science b v', 'pii herd prevalence brsv', 'test free brsv', 'level', 'production brsv infection', 'blood young stock maternal immunity', 'transferred half life brsv', 'outbreak enzootic pneumonia brsv', 'herd acute brsv weekly blood clinical', 'serum danish dairy', 'presence widespread high veterinary microbiology bovine respiratory syncytial virus brsv pneumovirus family paramyxoviridae', 'industrialised production van der poel al uttenthal al baker et al', 'young stock brsv infection severe pneumonia morbidity mortality baker al blom', 'virus combination mycoplasma kimman tegtmeier al brown et al', 'respiratory disease brsv winter summer season severe van der poel et al', 'maternal colostrum protect infection high maternal immunity severity disease kimman al', 'maternal suppress serum experimental natural infection seropositive et al diagnosis brsv serological', 'order study pathogenesis brsv ef®cacy model tjùrnehùj al preparation larsen al severe respiratory single inoculation', 'aim present study antibody colostrum fed', 'half life maternal seroprevalence brsv danish dairy test', 'male jersey closed isolation contact', 'experimental free persistent infection bovine viral diarrhea virus bvdv challenge bitsch ronsholt', 'brsv inoculation tjùrnehùj al preparation larsen et al', 'brie¯y ®ve age unpassaged lung lavage¯uid infected calf brsv larsen et al', 'brsv inoculum tissue culture infectious virus millilitre', 'inoculum single aerosol ml ml phosphate saline pbs intratracheal inoculation ml ml pbs', 'calf mock brsv free lung lavage¯uid healthy calf', 'inoculum free bvd virus', 'clinical rectal temperature daily', 'control calf brsv exsanguation post infection day', 'pid', 'blood jugular vein week observation period', 'nasal nacl subsequent presence viral', 'dairy herd b history recurrent enzootic pneumonia presence adult dairy population blood month winter season', 'serum analysed igm iga', 'sera tested corona virus', '', 'herd september february', 'addition ®ve pasture calves old', 'september age', 'herd b old ®rst blood sampled', 'part concurrent project al preparation danish dairy presence clinical respiratory disease', 'validate isotype speci®c brsv infection', 'clinical detection brsv antigen lung lavage', 'lung lavage nonsedated uttenthal et al', 'investigate prevalence brsv danish dairy blood healthy brsv speci®c igm', 'health laboratory danish dairy board sera danish national program eradication bvd virus houe', 'identity anonymous bovine viral diarrhoea pi', 'test panel serum young', 'brsv speci®c igm iga titrated elisa kimman et al', '', 'murine monoclonal id lelystad anti bovine anti bovine anti bovine iga antibovine igm', 'brie¯y igm iga anti brsv immunocapture elisas', 'microtitre maxisorp mab bovine igm iga sodiumbicarbonate buffer ph', 'sera twofold dilution pbs ph w v tween h', 'antigen poly glycol peg brsv danish ®eld strain larsen al cell primary foetal calf lung parallel control antigen uninfected cell', 'brsv antigen upper row control antigen', 'biotin rabbit serum human respiratory syncytial virus dako denmark followed horseradish peroxidase hrp avidin dako', 'enzymatic reaction ortho phenylen diamine opd kem tek denmark manufacturer h', 'detection brsv speci®c indirect elisas', 'microtitre rabbit serum human respiratory syncytial virus dako', 'control antigen immunocapture elisa', 'serum twofold serum dilution serum control antigen', 'mabs hrp rabbit anti mouse dako', 'opd substrate enzyme', 'optimal dilution checkerboard', 'reagent volume ml', 'deionized water tween', 'h', 'doublebeam elisa reader nm', 'eliminate value serum control antigen od value serum brsv antigen odpos', 'odposàodneg positive', 'titre reciprocal dilution serum positive score', 'isotype standard positive serum infected calf', 'coronavirus indirect elisa uttenthal et al', 'serum twofold', 'serum tcid danish strain brsv h', 'mixture duplicate continous calf foetal lung passage', 'micro day inoculation', 'cytopathogenic effect cpe determined reciprocal growth cytopathogenic brsv', 'presence brsv virus bovine coronavirus lung lavage material nasal swabs antigen elisa uttenthal et al', 'general speci®c igm post infection iga present calf igm', 'reaction dependent preinoculation titre seronegative pid lasted', 'response present calf pid', 'brsv antigen infected test high preinoculation nasal', 'consumption colostrum various', 'time infection old control calf', 'day infection test typical respiratory e', 'respiratory rate ocular', 'pid predominant disease', '®ve rectal temperature day duration', 'brsv antigen nasal successive day infection', '', '', 'virus bovine coronavirus nasal swabs lung lavage', 'control calf show respiratory body temperature rise', 'brsv antigen nasal swabs brsv antibody serum calf', 'igm response present day infection', 'calf inoculation', 'antibody level suppress response clinical course infection calf fever respiratory frequency', 'calf speci®c fig', '', 'body temperature antibody activity month old experimental primary infection brsv', 'nasal daily day detection brsv antigen v', 'titre inoculation seroconversion day', 'calf typical increased breathing frequency fever', 'calf seronegative prior infection', 'infection body temperature increase igm pid iga pid pid', 'igm iga negative pid pid', 'high observation period', 'calf time infection infection', 'calf respiratory pyretic', 'brsv antigen consecutive pid', 'igm iga calf', 'calf titre day infection', 'igm day period detection limit', '', 'colostrum feeding mean serum anti brsv titre herd', '®rst detection level february age fig', '', 'iga ®rst', 'parallel speci®c disappearance', 'similar brsv anti corona virus titre ®rst january increase virus', 'coronavirus infection enteric respiratoric respiratory herd january', 'contrast veterinarian acute outbreak respiratory disease march', 'presence active brsv infection herd intensive observation period', 'iga igm july', 'initial mean titre herd b', 'calf igm november calf old', 'enough serum perform iga isotype positive sera', 'december outbreak respiratory disease', 'blood speci®c increase brsv', 'igm anti brsv january', 'iga', 'speci®c february', 'herd b virus december', 'january titre level primary sample herd', 'coronavirus respiratory disease december', 'sera herd b half life brsv speci®c b half life sera december brsv herd', 'half life corona similar', 'speci®c time point bovine coronavirus infection unknown halflife till december fig', '', 'herd c outbreak respiratory disease march', 'old titre ®rst blood relation outbreak', 'seronegative', 'clinical pyrexia rectal temperature depression serous nasal breathing frequency', 'pneumonia', 'brsv coronavirus lung diseased table', 'speci®c igm serum', 'affected brsv positive week', 'brsv speci®c present week week sampling', 'present calf week', 'calf week observation period', 'age active response week', 'high affected calf week', 'addition low week calf', 'week low ®ve', 'table antibody igm iga natural infection herd c respiratory disease week', 'weekly blood sera denmark', 'total blood herd presence speci®c', 'igm anti brsv', 'anti brsv seropositive animal', 'individual present igg', 'brsv', 'isotype speci®c sera cross reactivity', 'different antibody response brsv infection experimental design capable inducing severe clinical disease similar affected brsv kimman al', 'inoculated infected brsv nasal swabs several', 'time infection igm response whereas presence prior inoculation igm', 'excretion brsv antigen development clinical presence pre', 'transferred colostrum development presence high immunity prevent virus clinical lung al belknap et al', 'immune brsv independent age calf contrast age critical duration igm response kimman al', 'present study suppressive effect depend presence pre brsv speci®c age', 'experimental igm prolonged period accordance al', '', 'contrast', 'serological infected antibody et al discrepancy experimental design e', 'latter design sparse clinical', 'appearance iga rare', '®ve iga response', 'prolonged iga response reinfection kimman et al', 'agammaglobulinemic receive passive immunity milk ®rst h birth mcguire et al belknap et al', 'level high young recurrent herd b', 'maternal immunity isotype igm', 'initial identical new infection herd', 'coronavirus natural infection', 'half coronavirus identical half life', '®gure brsv al', 'serological evidence coronavirus infection present herd b', 'herd coronavirus lung lavage¯uid', 'enteric unknown', 'respiratory several viral uttenthal et al martin al al', 'blood assessment seroprevalence brsv denmark february incidence igm', 'van der poel et al', 'positive igm year round tofour month old', 'igm present infection', 'sera test sample', 'iga positive due duration isotype iga contrast igm response reinfection kimman al', 'detection brsv speci®c iga igm contrast bovine virus infection graham et al', 'study ®eld sera infection igm anti virus iga sera', 'sample free brsv speci®c igg brsv common danish dairy', 'different study bulk milk june december paton al similar high herd prevalence uk denmark', 'speci®c', 'presence animal limited number negative positive', 'age speci®c animal detailed comparison age possible', 'conclusion present report antibody severe experimental brsv infection comparable effected', '®eld study high prevalence brsv danish dairy']"
5daceb492bad28a61fc43c4be83a164042d8c430,author funder copyright holder holder preprint peer author preprint peer biorxiv preprint doi biorxiv available copyright cc nd international license license available nd international rv infection hyper phosphorylation preprint copyright rv replication cell line guinea pig pig serum replication competent stable transfectant terminal tail alexa fluor c terminal competent viroplasms free water hierarchical phosphorylation impaired phosphorylation infection rrvs mechanism hyper mechanism hyperphosphorylation molecular mechanism negative rrv non structural phosphorylation cascade pivotal role post translational recombinant rv rescue recombinant reverse system role rv rotavirus rv rrv stable serum guinea tractable reverse transfectant cell translational modification v v ability assemble able investigate activator fig additional structural additional viral additional viroplasmic address role advantage tractable airyscan objective anti guinea anti mouse antibody alexa antibody pig antifade mountant application rg approach first assemble capable assemble pivotal assemble round assemble unknown assembly crucial assembly maturation assembly replication available phosphate b l buffer dpbs buffer mm capable recruit cascade hereafter cascade paradigm catenin ser cell culture cell prolong™ cell table cell wt cellular kinase characterise several citrate free click rna co expression co infection codon position common mechanism competent viral complete removal complex hyperphosphorylation complex phosphorylation composition number confocal setup crucial role crucial step culture medium,"['rotavirus rv round cytoplasmic viral assemble unknown', 'rv infection hyperphosphorylation phosphorylation single serine residue', 'role post translational modification formation impact virus replication obscure', 'investigated role rv infection advantage tractable reverse system', 'cell line generate characterise several recombinant', 'demonstrate rrv unable assemble pivotal role rotavirus replication', 'number impaired phosphorylation interrogate function post translational modification assembly replication competent viroplasms', 'rrv mutant impaired viral replication ability assemble round', 'investigated mechanism hyper phosphorylation rv infection negative rrv stable transfectant cell wt deletion', 'hyper phosphorylation crucial step shaped key role terminal tail formation replication competent viral', 'complex phosphorylation cascade paradigm functional viral', '', 'cc nd international license available copyright holder preprint peer author funder', '', 'doi biorxiv preprint importance rotavirus rv rna genome virus progeny cytoplasmic', 'non structural protein complex hyperphosphorylation process rv infection formation virus', 'formation rv replication due lack tractable reverse system', 'show novel application rg system stable cell line rescue', 'approach first direct evidence pivotal role protein replication', 'recombinant rv light molecular mechanism hyperphosphorylation infection involvement assembly maturation replication competent viroplasms', 'rescue recombinant rv strain rrv wt μl transfection reagent mirus microgram dna plasmid', 'mixture μg rescue', 'μg μg', 'cc nd international license available copyright holder preprint peer author funder', '', 'doi biorxiv preprint transfected increase rescue efficiency', 'rescue recombinant rrvs immunofluorescence µ slide gmbh munich germany antibody pig serum guinea pig serum guinea pig serum monoclonal antibody alexa fluor anti mouse life anti guinea pig life', 'mm uridine eu cell culture medium incorporated manufacturer protocol click rna alexa fluor kit thermo fisher scientific', 'cell prolong™ diamond antifade mountant dapi thermo scientific', 'confocal setup zeiss airyscan objective zen lite software', 'nuclease free dulbecco phosphate saline buffer dpbs min room temperature', 'dpbs v v ethanol rnase free water hour prior hybridization', 'min hybridization buffer mm nacl mm trisodium citrate free water v v mm vanadyl ribonucleoside complex', 'equimolar mixture dna target region gene segment simian rotavirus genbank acc', 'direct demonstration role rv replication knock rrv generated reverse', 'rescue strain stop codon position cell line fig', '', 'essential rv replication', 'rrvs impaired phosphorylation address role hyperphosphorylation number rrvs impact phosphorylation', 'rrv mutation table copyright holder preprint peer author funder', '', 'doi biorxiv preprint cellular kinase phosphorylation', 'fusion', 'lack phosphorylation affect', 'mutant additional viroplasmic mutant fig', 'left panel', 'observed immature electron dense due', 'cc nd international license available copyright holder preprint peer author funder', '', 'doi biorxiv preprint rna composition number available phosphate uo procedure', 'role phosphorylation viral rna production genome replication', 'mechanism hyper phosphorylation model hierarchical hyperphosphorylation viroplasms step mechanism initial interaction ii phosphorylation', 'step place iii hyper phosphorylation phosphorylation long c terminal tail', 'phosphorylation mechanism rv infection number phosphorylation negative rrv stable transfectant cell table', 'presence deletion mutant failed form', 'co expression unable trigger phosphorylation cascade hereafter e g', 'co infection rrvs table fig', '', 'mutant unable induce phosphorylation infection rrvs c terminal tail', 'result activator fig', '', 'replicate spherical', '', 'non structural viroplasm assembly crucial role scaffold additional viral', 'assemble capable recruit additional structural', 'complete removal rv replication', 'modified reverse mutant stable transfectant able investigate molecular mechanism hyperphosphorylation', 'mutant', 'cc nd international license available copyright holder preprint peer author funder', 'copyright holder preprint peer author funder', '', 'doi biorxiv preprint hierarchical phosphorylation common mechanism many cellular', 'mammalian hierarchical phosphorylation β catenin ser hyperphosphorylation glycogen copyright holder preprint peer author funder', '', 'doi biorxiv preprint copyright holder preprint peer author funder', '', 'doi biorxiv preprint copyright holder preprint peer author funder', '', 'doi biorxiv preprint copyright holder preprint peer author funder', '', 'doi biorxiv preprint copyright holder preprint peer author funder', '', 'doi biorxiv preprint figure', 'cc nd international license available copyright holder preprint peer author funder', '', 'doi biorxiv preprint ta b l e', 'cc nd international license available copyright holder preprint peer author funder', '', 'doi biorxiv preprint']"
5237c45681cad45eb4e6c51317e32c0e9b638c08,et al vector borne land use tick borne vectorial capacity mosquito borne vector host climate change host ratio culex spp host abundance public health rosà et biodiversity loss borne encephalitis incubation period infection hazard rodent density transmission vector wildlife zoonotic al al approach health borne sensitive deer density e g emergence wildlife encephalitis virus extrinsic incubation gray al human population important role jaenson al larval density long term nile virus parasite interaction reservoir host virus tbev virus transmission abundance behaviour abundance distribution abundance infection al rosà al tonteri al vector anthropogenic interaction avšič županc bakhvalova al behaviour reservoir borne disease borne infection borne pathogen borne tick change important change land community composition density larval density tick density urban dilution effect disease emergence distribution abundance due example eastern europe effect hypothesis emergence vector europe asia general vector global change health framework host choice host community host interaction host mortality host preference host vector human influence infection prevalence infection rate interaction vector interaction wildlife jaenson et knap avšič labuda al last decade level complexity levi et levine et low density mainland europe marini et medlock et mortality rate mosquito rate multidisciplinary approach north america pathogen transmission period rate population growth randolph et,"['anthropocene context land use biodiversity important anthropogenic interaction wildlife zoonotic emergence', 'transmission vector borne sensitive due complexity cycle transmission interaction vector macroparasite reservoir many wildlife vertebrate', 'scope paper effect major anthropogenic vectorial capacity tick mosquito borne', 'present vector borne tick borne encephalitis virus tbev nile virus wnv', 'variation vector host critical intensity pathogen transmission infection hazard', 'vector borne disease hazard global change long term multidisciplinary approach health framework', 'human population growth economical transformation climate change habitat reduction fragmentation land use modification', 'organism macroscopical microscopical scale host parasite interaction global emergence wildlife zoonotic et al aguirre', 'human impact last many unprecedented effect size rate change', 'snow ice sea level risen', 'human influence climate system incontrovertible recent anthropogenic history', 'carbon dioxide last record', 'particular surface long term average period ecmwf copernicus climate change service report', 'recent climate widespread human natural emergence wildlife zoonotic', 'climate change land use change important emergence wildlife zoonosis loh al al guo et al', 'recent human cover earth surface wild', 'empirical analysis global human population distribution land use global map eighteen anthropogenic', 'classification earth ice free land show evidence alteration light mobile hunter complete replacement pre human residence land use', 'majority populated urbanized terrestrial net primary production new human ecosystem interaction low density urban vast high density low density agriculture new ramankutty', 'land use change important driver climate change biodiversity loss socio economic exploitation', 'consequence sixth mass extinction event anthropogenic et al', 'loss biodiversity critical problem first place valuable ecosystem', 'body evidence current anthropogenic extinction rapidest earth', 'fact comparable previous mass', 'example vertebrate vertebrate last last population strong variation et al', 'biodiversity loss driver wildlife disease emergence dantas civitello al ostfeld levi et al level quality available many disease different possibility validate model empirical', 'relationship biodiversity loss disease emergence dilution effect hypothesis', 'vector borne lyme disease nile virus illness north america represent theory ostfeld levine et al', 'dilution effect hypothesis diverse ecological disease spread several', 'diversity loss harm', 'contentious debate hypothesis infect et al ruyts et al', 'understand ecology emergence vector borne critical focus vectorial capacity important elucidate complex interplay novel control kramer', 'paramount component parameter vector host ratio dependent host abundance behaviour well host choice', 'paper recent research work last decade european context ecology transmission tick borne encephalitis virus tbev nile virus wnv', 'zoonotic wildlife borne major public health pathogen abundance diversity human animal morbidity mortality', 'continuous discovery new new epidemiological due example invasion new habitat vector constant intensified surveillance', 'general vector borne infectious', 'burden tropical subtropical mosquitoborne', 'major yellow fever health', 'disease leishmaniosis vector borne', 'temperate hemisphere wildlife challenge mosquito borne infection', 'general vector borne last semenza suk', 'europe lyme borreliosis lb tick borne encephalitis tbe average number', 'tick borne public health concern rickettsiosis crimean congo hemorrhagic fever', 'mosquito borne concern viral infection wnv usutu virus usuv chikungunya virus chikv', 'dengue virus plasmodium spp', 'potential threat sporadic autochthonous local circulation basin', 'similar trend usa borne tick borne incidence tick borne sporadic domestic invasive mosquito borne et al', 'transmission vector borne sensitive anthropogenic interaction principal vector many vertebrate host transmit infection competent', 'host interaction vectorial capacity rise infection hazard disease incidence', 'vectorial capacity crucial predicting hazard emergence vector borne', 'index exploration control mosquito borne adaptation mosquito tick borne reservoir host particular attention', 'general vectorial capacity dynamic relationship infectious disease vertebrate', 'physiological genetic susceptibility infection ability transmit relevant ecological behavioural host preference host abundance eldridge edman', 'case borne vc measure mosquito population capacity infectious agent new susceptible population', 'integrate biotic abiotic', 'enable clearer understanding impact transmission mosquito borne pathogen kramer ciota', 'vectorial capacity number host perfect vector efficiency case smith mckenzie mcmillan al vector host ratio e', 'number female host mosquito rate e', 'number vector unit time average vector life span n length extrinsic incubation period', 'r number infected host susceptible population number mosquito b c transmission efficiency vector host host vector host infectious period smith mckenzie', 'concept r case number infective tick bite susceptible host randolph et al', 'case indication size r tick host ratio h host mortality rate host incubation period β transmission efficiency μ tick survival duration host infectivity unit time randolph et al', 'relationship r vc derive measure tick borne infection vectorial capacity vc vc simplification tick borne complex biological transmission life nymphs mosquito borne straightforward hartemink al rosà et al', 'addition pathogen transmission several transovarial infected female tick transstadial tick stage next systemic infectious vertebrate host uninfected tick non systemic transmission e', 'uninfected susceptible immune vertebrate group', 'particular co transmission efficient transmission route tbev labuda al al randolph', 'broad range various level complexity scale', 'instance global phenomena climate land use occurrence possibility vector borne pathogen circulate al', 'local scale variation climatic longevity behaviour reservoir host abundance competence modulate pathogen infection rate', 'fact vector borne interaction vector reservoir host abundance host community composition due example intensive land use wildlife management artificial feeding exert dramatic effect hazard host vector abundance infection prevalence', 'specific wildlife pathogen maintenance role host risk target host community composition al levi et al levine et al', 'assessment meta community structure esser et approach public health evaluate infectious', 'individual scale genetic vector competence emami et al', 'microbiome composition pathogen survival transmission analyzed minard et al', 'anthropogenic parasite interaction infection hazard', 'pathogenic', 'include tick borne encephalitis virus tbev wnv powassan virus powv usutu virus usuv virus zikv', 'distribution e g', 'tbev virus kyasanur disease virus', 'human pathogenicity misdiagnosed e g', 'usuv cadar et al grottola et al', 'broad number review research anthropogenic various vectorial capacity computation number viral', 'wnv', 'public health challenge europe asia', 'neurological zoonotic infection various degree severity tbev european tbev eur siberian tbev sib eastern tbev fe et al', 'tick bite ingestion raw milk milk dorko al', 'g', 'time clinical', 'hard persulcatus dermacentor reticulatus haemaphysalis concinna europe', 'tbev eur variant central north eastern europe dobler et al', 'recent new transmission case isolation tbev sib subtype tick new foci emergence jääskeläinen et al', 'exophilic hard tick complex acari ixodidae', 'host tick catholic medium large domestic livestock immature parasitizing small mediumsized addition large gray al', 'host vulnerable desiccation relative humidity prolonged', 'individual several suitable habitat stagedependent larvae gray et al', 'tbev wild enzootic cycle', 'tbev carry virus life', 'virus nymphs adult account virus transmission et al', 'mainland europe labuda al al', 'tick feeding infective transport route virus co viraemia', 'act transient', 'tbev virus susceptibility tbev', 'high viraemia major role transmission tbev', 'example northern red vole bank vole reservoir prolonged viraemia vertical virus transmission bakhvalova al bakhvalova al tonteri al tonteri et al', 'extent infected consequence different transmission natural condition investigation jaenson al', 'peculiarity transmission cycle vectorial capacity tbev exogenous anthropogenic essential vector host ratio vector survival host mortality rate', 'large scale land use geographic range survival rate seasonal questing activity tbe hazard gray al gray al knap et al tagliapietra al medlock et al kilpatrick randolph daniel al', 'mainland europe climate critical role persistence tbev transmission co mechanism seasonality particular synchronicity randolph al rosà et al', 'land use sufficient explain ricinus temporal spatial variation hazard randolph medlock et al', 'fact tick distribution abundance infection rate tbev affected exogenous host abundance distribution', 'example widespread ecological small home range max', 'rodent dramatic anthropogenic pressure alter hansson henttonen rowe terry', 'large variation survival abundance tick feeding host availability immature stage infection prevalence gern et al', 'relationship tick demography rodent density complex', 'negative effect rodent density larval intensity host kiffner al study increase total number larvae year rodent density rosà et al', 'total larval density rodent density nymphs effect', 'explanatory variable nymph density larval density previous year discrete nature tick demography rosà et al', 'contrast large wild domestic important role tick spatial temporal distribution tbe foci infection hazard knap avšič županc jaenson et jaenson et al', 'european continent ungulate distribution abundance last', 'decline due second world war negative trend', 'economic due traditional agriculture abandonment climate change expansion e g', 'lindner al see', 'conservation wildlife harvest management kerstin et al constant solid growth ungulate abundance distribution al', 'deer density affect local tick abundance hence important role tick borne', 'number evaluation effect deer density tick change scale observed increase gilbert al decrease al', 'empirical study several case control approach deterministic framework tbev occurrence decrease threshold value deer density tick burden', 'important aspect underlined spatial scale different probability contact different', 'today ungulate conservation distribution status global level local overabundance urbanized city extreme discontinuous distribution fragmentation major', 'dispersal migration', 'result move average tucker et al', 'movement ecological process heterogeneous al intense variation spatio temporal distribution g fragmentation g change vegetation productivity phenology pettorelli al climatic g al animal movement distribution profound hazard', 'tick borne tbev dependent movement top density distribution persist new', 'space use movement al', 'tick cycle movement different host presence common habitat', 'overabundance secondary deer tick availability correlate occurrence knap avšič županc local tbev emergence tick removal competent', 'fact increased infection risk co occurrence abundance favourable climatic economic exposure last randolph jaenson al jaenson al', 'research disentangle movement space use different borne transmission tbev understand scale transmission potential dilution interact new knowledge tick host choice virus transmission different', 'wnv neurotropic mosquito borne virus flavivirus japanese virus serogroup widespread distribution world', 'wnv wide variety bird natural reservoir virus', 'wnv affect range vertebrate', 'pathogenic dead end viraemia high virus new vector pérez ramírez et al', 'main genetic', 'europe asia oceania kunjin america', 'africa central eastern europe southern europe', 'viral different world different', 'pathogenicity phylogenetic lineage geographic origin recent european african wnv virulent differ pathotype profile prototype strain perez ramirez et al', 'wnv significant burden public health europe last decade southern part continent', 'human asymptomatic severe neurological', 'phylogenetic several european virus introduced migratory africa paz semenza', 'several competent wnv transmission culex complex central role virus circulation seasonal', 'vector host ratio culex spp mosquito avian', 'climatic mosquito density temperature key role biological mosquito life cycle', 'fact warmer culex spp immature development al mosquito longevity ciota al andreadis et al', 'assess possible impact temperature change culex spp abundance', 'instance southern europe year decrease culex spp adult survival summer time increase population size marini et al northern peak vector abundance al', 'temperature increase extend active season different comrie rosà et al', 'urbanization land use human mosquito', 'culex spp agricultural urban al ferraguti et johnson al zittra al trawinski mackay diuk wasser al peak larval density urban heat island effect townroe callaghan', 'climate change avian al', 'instance american southern warm present northern zuckerberg northern european bird local climate jiguet al', 'addition migratory potvin al wnv unaffected al', 'land use human influence bird bowler al vector host ratio', 'vectorial capacity extrinsic incubation period rate temperature', 'fact extrinsic incubation period rate warmer al et al', 'mosquito express opportunistic behaviour cadena al farajollahi al remark mosquito rate avian density heterogeneity sensitive environmental', 'essential understand ecology wnv', 'fact population level transmission competent incompetent al marini et al', 'analysis host preference abundance behaviour reservoir competence kilpatrick et al', 'demonstrated american robin turdus migratorius unexpected super spreader north america', 'europe first time al', 'clear feeding preference common blackbird turdus merula wild potential important role epidemiology northern italy', 'addition mosquitoes activity season july october abundance blackbird cx', 'l', 'eurasian magpie pica pica human wnv seasonal spill human domestic animal', 'great human population growth change land use biodiversity loss act parasite interaction emergence number wildlife zoonotic last', 'zoonotic spillover complex phenomenon several ecological epidemiological behavioural pathogen exposure human susceptibility infection zoonotic hierarchical series spillover', 'interact space time ability predict prevent spillover al', 'vector borne sensitive anthropogenic transmission complex non linear process several al', 'proper hazard precise knowledge various level complexity pathogen', 'information integration available', 'rapidity environmental condition similar speed way wildlife assessment vector borne hazard', 'era broad array innovative enable host global scale', 'turn big interpretation integrated interdisciplinary approach health perspective vayssier al ezenwa et al kosoy kosoy', 'multi host ecology complex empirical analytical vital development effective control research', 'much attention simpler life global urgency influenza severe acute respiratory syndrome', 'vector chronic protozoan studied', 'progress new generation pathogen life host scientific smith al cross transmission', 'high number transmission vector borne complexity transmission vector borne disease global change scenario development predictive intensification research understanding host interaction wildlife alter vectorial capacity establishment long term multidisciplinary approach health framework', 'study original consideration journal', 'final manuscript submission', 'conflict interest']"
63aed9fa99e7df7846c24993fbf4d7aebb4d957a,et al spinal cord growth factor mixed phenotype type astrocyte adult cns terminal pulse astrocyte phenotype glial cell normal adult tissue wpi type mixed absence gc anti gc cell surface cell type cns tissue color immunofluorescence demyelinated tissue dubois dalcq exogenous growth fbs dme g ml gc gfap mixed oligodendrocyte oligodendrocyte astrocyte optic nerve proliferation lineage proportion type see fig wk age wpi fig adult mice age control bfgf igf cns myelin control mice course demyelination demyelination wpi efficient remyelination ffrench constant functional recovery g c gfap type growth differentiation infected mice isolation medium jordan et lineage adult lineage cns lineage type mitotic potential ng mi percentage lineage ph thymidine present study raft et silver nucleus solution h tris buffer vitro system acidic protein adult rat adult spinal alter ratio anti gfap antigenic lineage antigenic phenotype aranella herndon astrocyte progenitor astrocyte type bansal al basic fgf basic protein bfgf ng bsa sodium buffer solution cancer research cell isolation cell pulse centrifuge sorvall ciliary neurotrophic cluster silver cns demyelination constant raft contrast cell cord mice cord tissue coronavirus murine course disease culture milieu dalcq armstrong demyelination remyelination development remyelination div autoradiography div type dme mg e phase early course early phase,"['disease dr friedrich current address brookdale mice intracranial injection coronavirus murine hepatitis virus strain functional recovery efficient cns myelin repair', 'study biological repair process glial spinal young adult mice demyelination remyelination', 'color immunofluorescence antigenic phenotype mitotic potential individual glial', 'galactocerebroside glial fibrillary acidic protein type astrocyte progenitor antibody', 'tissue several first total number lin cage second population proportion mixed oligodendrocyteastrocyte phenotype third cell lineage enhanced proliferation', 'proliferation pdgf basic fibroblast growth factor insulin growth factor igf medium', 'bfgf igf influence fate lineage tissue', 'basic fgf percentage galactocerebroside', 'contrast igf relative proportion', 'lineage adult phenotypic plasticity mitotic potential response episode demyelination', 'efficient remyelination demyelinating disease', 'damage myelin sheaths electrical axonal', 'myelin human cns perier gregoire al', 'multiple sclerosis prolonged neurological dysfunction', 'contrast efficient remyelination functional recovery certain experimental demyelination ludwin', 'model infecting mice coronavirus murine hepatitis virus development multiple cns et al jordan et al', 'coronavirus glial early phase disease cns jordan et al', 'infected mice exhibit clinical demyelin ation first week post infection wpi', 'wpi focal demyelination present cns prominent spinal cord', 'remyelination functional recovery', 'model analyze regeneration cns myelin', 'myelination cns interaction several glial raine wood bunge raft', 'vitro optic nerve newborn rat bipotential progenitbr cell rise oligodendrocyte type astrocyte progenitor cell', 'type express present surface progenitor', 'localization function type vivo clear present time', 'type astrocyte type astrocyte type glial precursor distinct progenitor raft et al', 'type secrete growth proliferation migration differentiation raft dubois dalcq armstrong', 'maturation extensive cns myelin paine', 'perinodal type excitable adjacent myelin ffrench constant raft ffrench constant et al', 'role efficient saltatory conduction nerve electrical insulator perinodal astrocytic various impulse propagation ritchie black waxman', 'normal adult cns mccarthy leblond', 'vitro mitosis exogenous growth successful', 'adult cns proliferate wood bunge', 'addition progenitor adult rat optic nerve capable vitro absence ability differentiate ffrench constant raft wolswijk noble', 'evidence regeneration lineage cns', 'widespread cns demyelination periphery able elaborate myelinating achieve efficient remyelination', 'proliferation precursor demyelination necessary facilitate remyelination', 'electron microscopic autoradiographic tissue mitosis several herndon et al aranella herndon ludwin bakker', 'recent vivo analysis autoradiography progenitor express early course demyelination coronavirus infection demyelination et al', 'present study vitro system remyelination process', 'threecolor immunofluorescence autoradiography identify specific glial cell', 'system analyze proliferative capacity phenotypic plasticity differentiation potential various glial key role cns remyelination', 'female mice prior exposure frederick cancer research facility md', 'age mouse ci line balb c sturman al', 'age inoculation dosage proportion mice relative incidence acute mortality', 'wpi mice methoxyflurane', 'glial cell isolation spinal infected mice neurological dysfunction woyciechowska al spinal cord tissue age control mice', 'spinal dissociated procedure miller et al', '', 'tissue trypsin collagenase mem incubation trypsin edta solution trypsin free dna soybean trypsin inhibitor dnase bsa fbs dme ml ml pipette', 'tube isolation medium mm u ml penicillin g ml strep tomycin gentamycin hbss calcium magnesium ph spun min rpm centrifuge sorvall newton ct', 'supernatant pelleted ml isolation medium', 'glial red blood percoll gradient hirayama al al', 'gradient ultracentrifuge beckman alto angle rotor spun rpm min', 'glial cell layer region myelin cap red blood tube isolation medium spun centrifuge sorvall div', 'supernatant pelleted pl spinal cord fbs dme mg liter l glutamine g liter v glucose g ml gentamycin mm sodium pyruvate', 'cell suspension plastic dish extracellular matrix accurate chemical scientific corp westbury ny', 'h enhance attachment ml fbs dme solution', 'vitro die fbs medium dme mg liter l glutamine g liter v glucose insulin g ml transferrin nm selenium nm triiodothyronine g ml gentamycin mm sodium pyruvate eccleston silberberg', 'low serum medium enhance growth relative', 'l die paraformaldehyde mem', 'terminal pulse ci new england nuclear boston', 'vivo mice ci g body h death see fig', '', 'vitro ci ml culture h fixation fig', 'b', 'growth bovine bfgf ng mi r mn human pdgf ng mi b chain heterodimer r human insulin growth factor igf ng mi amgen', 'growth factor culture dish div fbs medium see', 'terminal pulse die see fig', 'immunocytochemistry lineage color immnnofluorescence simultaneous visualization reactivity gc glial fibrlllary acidic protein gfap antibody', 'anti gc monoclonal b ranscht la jolia cancer research foundation jolla gc antigen cell surface ranscht al bansal al', 'rabbit polyclonal anti gfap r pruss merrill dow oh react intermediate filament', 'mouse monoclonal igm', 'sommer southern general hospital glasgow scotland sommer schachner sulfatide seminolipid unidentified antigen bansal al', 'anti gc hybridoma fbs dme', 'mixed mem solution gelatin bsa sodium mem hepos fixed visualized rhodamine goat antimouse igm g mi jackson immunoresearch grove pa', 'anti gc goat anti mouse tzg ml biotech orangeburg ny', 'secondary mem solution h glacial acetic acid ethanol min internal cellular', 'mem buffer', 'polyclonal rabbit anti gfap tris buffer solution gelatin bsa sodium tris buffer overnight biotinylated donkey anti rabbit igg tris buffer solution h amersham chemical co arlington streptavidin acid ml tris solution h molecular inc eugene khallhn etal', 'atter final fixation paraformaldeh coverslipped solution tris ph glycerol autoradiography see', 'immunostained epifluorescence zeiss photoscopo rhodamine fluorescein coumarin fluorescence', 'absence cross reaction color immunofluorescence protocol turn primary unchanged', 'omission primary secondary affect', 'presence mixed oligodendrocyte astrocyte phenotype second set prirnary', 'described combination rat mab gfap lee al fluorescein rabbit polyclonal antiserum gc laboratory procedure al coumarin', 'segment spinal cord sterile razor glial cell isolation', 'overnight immersion glutaraldehyde paraformaldehyde phosphate buffer', 'tissue buffer postfixed osmium tetmxide h graded propylene epon resin', 'transverse toluidine blue', 'cultured vivo vitro post', 'graded air kodak nuclear track emulsion developed kodak fixer', 'several', 'glial cell population color immunofluorescence simultaneous visualization different fluorescein coumarin', 'expression cell surface anti gc raft al intracellular gfap classified biguami al rafter al', 'type type cell surface antibody trotter schachner', 'adult cns absence gc gfap wolswijk noble', 'particular cell oligodendrocyte gc gfap type astrocyt¢ gfap gc progenitor g c gfap mixed oligodendrocyte astrocyte phenotype cell gc gfap type astrocyte gfap gc', 'paper term type astrocyte denote gfap g c antigenic phenotype specific localization function vivo', 'glial cultured parallel spinal age control mice several viral inoculation', 'various glial lineage type mixed phenotype small proportion total', 'number lineage counted culture fig', '', 'number similar control experimental tissue wpi fig', 'demyelination see fig', 'b', 'demyelination vacuolation wpi see fig', 'c lineage much abundant tissue fig', '', 'remyelination wpi fig', 'number lineage lesioned tissue fig', '', 'possible cns inflammation vacuolation dissociation tissue yield', 'versus cns cell cell type', 'flat gfap type', 'type prevalent tissue', 'div dense accurate quantitation initial type population fig', '', 'type assayed incorporation fig', 'b', 'flat presumed due absence gc gfap present p', 'ameboid appearance presence phagocytic debris giulian rieske et al', 'microglial resident mi blood available', 'simplicity phenotype paper', 'rare tissue', 'contrast number diseased tissue period demyelination wpi', 'schwann antibody receptor nerve growth factor chandler et al schwann rat sciatic nerve express receptor yasuda al distefano johnson', 'control spinal wpi', 'schwarm', '', 'relative different', 'relative proportion type gfap g c div defined medium fbs', '', 'neonatal rat optic nerve fbs induce development substantial number type astrocyteg raft et al', 'spinal cord tissue wpi predominant cell type div fig', '', 'percentage population type tissue', 'div type prevalent', 'time point progenitor lineage population', 'remarkable feature tissue presence mixed oligodendrocyte astrocyte phenotype control', '', 'gc surface intracellular gfap fig', '', 'mixed phenotype gfap different combination different', 'certain growth effect fate lineage development mcmorris al gene expression dubois dalcq', 'treatment growth antigenic lineage isolated course demyelination remyelination fig', '', 'tissue exogenous igf proportion type bfgf relative number', 'alter ratio type agreement observation pdgf timely differentiation type cns tissue raft et al', 'previous vivo study disease lineage terminal pulse frozen sec et al', 'mitotic potential lineage cns prepared spinal normal infected mice vivo terminal pulse table', 'active dna synthesis div autoradiography triple label immunocytochemistry fig', '', 'proportion lineage low control normal mice wk age wk age', 'contrast proportion lineage type mixed phenotype thymidine infected tissue early phase disease wpi wk age time widespread demyelination wpi wk age', 'next proliferative capacity vitro table', 'case proliferation vitro sh thymidine culture medium div autoradiography fluorochrome immunocytochemistry fig', 'b', 'percentage lineage vitro ph thymidine ninefold diseased mice wpi age control mice threefold wpi table', '', 'type', '', 'mixed phenotype terminal pulse', 'type percentage tissue significant wpi control figure', 'cell mixed oligodendrocyteastrocyte phenotype demyelinated tissue grown culture color immunofluorescence', 'cell surface membrane mab gc fluorescein', 'b intracellular polyclonal antiserum coumarin', 'cell visualized rhodamine', 'bar ttm', 'p paired test', 'lineage cell type mixed phenotype ph thymidine demyelinated tissue', 'percentage single group significant proliferative response tissue wpi control p tailed test', 'proliferative response lineage', 'pdgf igf bfgf proliferation neonatal progenitor rat cns dubois dalcq assayed mitogenic effect growth adult spinal cord see protocol fig', '', 'growth factor wpi effect particular growth factor course disease', 'tissue none growth significant increase percentage lineage ph thymidine terminal pulse p difference', 'preliminary control treatment pdgf igf bfgf enhance proliferation lineage normal adult mice', 'exogenous growth phenotype expression fig', 'enhance proliferation lineage', 'present vitro study growth differentiation glial cns mice course demyelination remy figure', 'relative abundance type spinal cord inoculated', 'number type described fig', '', 'defined proportion type demyelination wpi', 'addition bfgf ng nd div type astrocyte phenotype relative number gc', 'treatment igf ng ml proportion express oligodendrocyte phenotype', 'exogenous pdgf ng ml alter ratio type astxo', 'variability parallel timepoint inoculated time virus', 'value ratio cell entire dish', 'total set', 'estimate variability nonmatched type similar exogenous growth', 'outside confidence interval variability exogenous growth', 'fig', 'b', 'value percentage total lineage type mixed phenotype hlthymidine autoradiographic silver nucleus average', 'significance paired test', 'cns tissue growth differentiation lineage vitro several polypeptide growth brain review raft dubois dalcq armstrong', 'pdgf proliferation progenitor premature differentiation vitro raff al', 'figure', 'type astroeyte demyelinated tissue wpi fig', 'presence surface rhodamine intracellular expression gfap b coumarin absence gc antibody fluoreseein', 'cluster silver nucleus cell pulse', 'e phase contrast cell', 'bar fgf mitogenic lineage silberberg noble et al', 'fgf epidermal growth factor inhibit expression myelin al', 'igf proliferation lineage precursor mcmorris dubois daicq', 'related ciliary neurotrophic factor present optic nerve transient expression gfap progenitor vitro lillien et al', 'growth effect lineage adult cns tissue clear', 'human normal adult brain proliferate response treatment several growth pdgf fgf epidermal growth factor interleukin al', 'present study bfgf igf induce mitosis lineage adult mice incorporation', 'factor neuroblastoma mitogenic cultured adult rat brain hunter al', 'normal adult lineage capable exposed adequate stimulus', 'stimulus cns demyelination lineage spinal cord mice increased proliferation vivo godfraind present', 'growth antigenic lineage cns', 'basic fgf percentage lineage gc whereas igf proportion type', 'bfgf igf phenotype expression cns development remyelination', 'proliferation mature immature several electron microscopic autoradiographic experimental demyelination adult cns herndon al ludwin aranella herndon raine et al', 'vivo coronavirus induced demyelination mice situ hybridization analyze expression myelin presence cell type specific oligodendrocytes et al godfraind et al', 'myelin basic protein mrna abundant development remyelination jordan et al', 'recapitulation molecular characteristic development responsible remyelination disease', 'triple label immunocytochemistry progenitor frozen spinal cord mice godfraind al', 'early course disease figure', 'adult progenitor demyelinated tissue wpi fig', 'reactivity antibody rhodamine absence gc b fluorescein c coumarin', 'cluster silver nucleus cell pulse', 'e phase contrast cell', 'numerous microglial present culture', 'bar demyelination stage et al', 'present study demonstrate mitotic activity lineage vivo demyelination', 'proliferation active culture milieu vivo persist vitro', 'nature signal proliferation unknown', 'reactive mitogenic response trauma giulian giulian et al', 'microglial present spinal cord much prevalent tissue possible lineage due culture milieu', 'addition soluble axolemmal mitogenic cns chen lineage demyelination', 'denuded proliferation lineage response specific growth', 'previous adult spinal cord gc myelin basic protein divide presence bunge', 'gc', 'major source', 'type mixed oligodendrocyte astrocyte phenotype response demyelination', 'astrocyte several vivo tissue bunge al carrollet al godfralnd al paine', 'ciliary neurotrophic factor transient gfap expression neonatal much abundant cns tissue nieto sampedro al mixed phenotype vivo', 'presence phenotypic degree plasticity possible differentiation', 'mixed phenotype intermediate bipotential stage differentiation state transdifferentiation astrocyte oligodendrocyte', 'mechanism mixed phenotype additional number available remyelination', 'vitro system glial normal adult cns design future new pathway', 'similar vitro system adult human cns dorn al human oligodendrocyte lineage', 'study growth differentiation cell remyelination elaboration remyelination human demyelinating']"
120be7888e94409082f16c372c818d66e558d33e,lung biopsy oral prednisolone community pneumonia fibrinous pneumonia lung injury positive tuberculosis ppd skin skin test spot negative test positive test spot tuberculosis antibody acute lung afop rare alveolar damage antibody test biopsy pnlb blood cell case report cell count connective tissue consistent afop diagnosis afop examination massive exudation organization fibrin pneumonia fibrinous exudation histologic examination histologic pattern informed consent intermittent fever massive fibrinous mg day mg l nontuberculous mycobacterial organization alveolar patchy distribution pneumonia afop pneumonia patchy pneumonia tuberculosis possibility tuberculosis prednisolone mg prior admission rare histologic reactive protein right calf sweet syndrome treatment patient white blood actual clinical acute fibrinous acute onset acute subacute addition diagnosis addition similar admission enhanced admission laboratory admission penicillin admission vital affiliated hospital afop antibiotic afop controversial afop histopathologic afop independent afop lung afop nonspecific afop patient afop show afop transbronchial afop uncommon age range air diffuse al cincotta al literature al traditional ali acute alveolar fibrin alveolar infiltrate alveolar neutrophilic american thoracic antibiotic resistance antibiotic therapy antibiotic treatment antibody editor antibody profile approval diagnostic aspect right association sweet asymptomatic stable attention risk auscultation breath autoimmune antibody auxiliary examination available review beasley et bilateral diffuse bilateral distribution bilateral patchy biopsy consistent biopsy method,"['rationale acute fibrinous pneumonia afop uncommon type acute lung injury infection connective tissue drug exposure hematologic', 'patient female intermittent fever dry cough', 'chest tomography scan multiple bilateral patchy', 'ppd skin test positive tuberculosis antibody test spot negative', 'histologic examination massive fibrinous exudation organization alveolar neutrophilic consistent afop', 'patient prednisolone therapy', 'radiograph improvement symptom improvement fever respiratory week oral prednisolone treatment', 'treatment patient asymptomatic stable disease quality life', 'unique pathologic liable community pneumonia ortuberculosis', 'ineffective good response glucocorticoid therapy', 'fibrinous pneumonia ali acute lung injury dad alveolar damage ep eosinophil pneumonia h e hematoxylin eosin nontuberculous mycobacterial pneumonia', 'fibrinous pneumonia afop rare type interstitial lung disease intra alveolar fibrin pneumonia patchy distribution', 'beasley et al', 'clinical afop nonspecific diagnosis histopathology', 'present female auxiliary examination typical community pneumonia tuberculosis nontuberculous mycobacterial', 'histopathologic examination percutaneous needle lung biopsy pnlb pattern afop', 'female october chief intermittent fever cough', 'prior admission penicillin local clinic tangible improvement', 'july painful round nonulcerative red aspect right calf', 'cyclophosphamide period time gradual withdrawal', 'history hysterectomy', 'admission vital temperature pulse rate respiratory rate blood pressure mm hg oxygen saturation room air', 'auscultation breath', 'physical examination unremarkable', 'laboratory white blood cell count â l c reactive protein mg l erythrocyte sedimentation rate mg l serum procalcitonin ng l', 'ppd skin test positive tuberculosis antibody editor n', 'special approval diagnostic treatment matter routine', 'informed consent participate patient', 'informed consent publication case report', 'copy consent available review editor journal', 'relevant information support manuscript', 'test spot negative', 'autoimmune antibody profile tumor normal', 'chest radiography multiple patchy mediastinal lymph', 'b', 'drug resistant pneumonia high prevalence antibiotic resistance china', 'broad spectrum moxifloxacin imipenem voriconazole blood culture galactomannan gm', 'treatment patient clinical status remission fever body temperature ppd skin test positive tuberculosis antibody test spot negative possibility tuberculosis ct pnlb day', 'affiliated hospital university medical school pathologic assessment', 'histologic examination massive fibrinous exudation organization alveolar infiltrate consistent afop', 'ziehl stain gomori methenamine silver negative fig', '', 'clinical pathologic', 'day patient treatment methylprednisolone mg day', 'day general condition', 'patient day oral prednisolone daily', 'radiograph fig', 'f dramatic improvement complete resolution pulmonary dosage oral prednisolone mg daily', 'clinical condition stable recurrence respiratory oral prednisolone mg day', 'clinical oral prednisolone', 'several disease drug reaction environmental exposure connective tissue disease lung transplantation', 'difficult clinical specific afop', 'patient history personal history unremarkable', 'laboratory admission enhanced inflammatory white blood cell count reactive protein procalcitonin infection factor case', 'patient prior admission laboratory detect admission', 'histologic pattern similar diffuse alveolar damage dad cryptic organic pneumonia cop eosinophilic pneumonia distinct histopathology', 'course acute subacute clinical mode onset', 'severe afop show clinical course similar poor prognosis', 'subacute similarity cop respect clinical treatment efficacy prognosis', 'hwang al cincotta al traditional dad manifestation lung injury late manifestation', 'afop independent disease entity variant dad', 'rare histologic pattern idiopathic interstitial pneumonias american thoracic society european respiratory society', 'large age range age', 'main clinical respiratory distress tightness', 'common radiologic patchy peripheral bilateral distribution lung', 'ct solitary nodule air diffuse lung', 'addition similar lung interstitial pneumonia pulmonary infectious pneumonia', 'definitive diagnosis afop histopathologic evaluation', 'tissue histopathology intraalveolar fibrin form fibrin pneumonia patchy distribution', 'histologic diagnosis afop transbronchial lung biopsy pnlb thoracoscopic lung biopsy open lung biopsy', 'large biopsy method lung biopsy consistent actual clinical situation patient tolerance specific location lung', 'optimal treatment afop controversial', 'kuza al literature', 'found common successful treatment modality uniform', 'therapeutic disease', 'acute onset good prognosis', 'case report symptomatic improvement antibiotic treatment possible role management entity', 'diagnosis idiopathic afop lung consolidation exclusion granulomas', 'infectious prior administration', 'afop patient tuberculosis inherent tuberculosis severe bilateral diffuse military tuberculosis use', 'addition diagnosis sweet syndrome clinical right calf effect hormone therapy lack skin biopsy', 'literature review association sweet syndrome ntmis possibility', 'case patient small methylprednisolone possibility tuberculosis ntmis long term necessary', 'attention risk diffuse miliary tuberculosis recurrence disease hormone reduction discontinuation', 'afop rare histologic subtype enough attention', 'community pneumonia tuberculosis possibility afop antibiotic therapy ineffective', 'yw jl lz cz manuscript literature', 'yw yl qw manuscript prepared', 'cz study design coordination manuscript important content', 'final manuscript']"
fbb13d5bcfe0597fc854533fa1637fd4c415bb5a,beau r ciliary activity pathogenic ibv cross protection gene sequence protection challenge chimaeric gene amino acid log cd rt pcr challenge pathogenic post infection sequence analysis virus isolation day post qrt pcr allantoic fluid different serotype gene gene group group ibv strain loss ciliary paci bsphi pathogenic strain post challenge previous work primary inoculation tracheal group activity ciliostasis clinical virus cytoplasmic tail degree cross ectodomain region group fig group pathogenic heterologous serotype homologous protection induce protective infection group nasal discharge protection heterologous replicase gene sequence gene strain ibv acid sequence bird day cd pathogenic challenge group control group different serogroup free medium full length gene apathogenic gpt gene group ciliary group log group primary heterologous protection homologous challenge ibv beaudette ibv cdna ibv different ibv glycoprotein ibv ibv ibv rna ibv vaccine infect tocs level ciliostasis massachusetts serotype mock group mock mock part experiment presence virus protection different r gene retention ciliary rna qrt sequence ibv signal sequence total rna viral rna virus present able induce able replicate accession number acid beau acid difference activity day activity trachea amino level analysis different analysis group analysis ibv apathogenic ibv apathogenic virus average ciliostasis backbone beau beaudette glycoprotein beaudette sequence beaur ds,"['replacement spike gene apathogenic ibv strain beau r pathogenic strain serotype apathogenic virus protection challenge', 'recombinant ibv genetic backbone beau r spike protein pathogenic ibv different serogroup beaudette', 'similar previous clinical gene pathogenic virus confer pathogenicity ribv', 'protection homologous protection protection challenge wild type virus clinical rna qrt pcr fact virus challenged ibv', 'heterologous protection challenge level', 'previous ectodomain protein precise effective way candidate ibv', 'avian infectious bronchitis virus ibv gammacoronavirus family coronaviridae order aetiological agent acute contagious poultry disease infectious bronchitis ib', 'ibv infectious pathogen domestic fowl epithelial respiratory tract ib nasal discharge tracheal ciliostasis', 'ibv respiratory tract responsible major economic poultry result poor weight gain egg production', 'addition renal disease nephropathogenic', 'cell cytoplasm contain unsegmented single positivesense rna genome kb', 'structural small membrane protein integral membrane protein nucleocapsid protein n genomic rna', 'coronavirus glycoprotein type glycoprotein endoplasmic reticulum form coronavirus virion observable electron microscopy', 'protein virion covalent responsible binding target cell receptor fusion viral cellular major role infection susceptible', 'coronavirus signal sequence synthesis ectodomain present outside virion particle transmembrane region responsible protein lipid bilayer virion particle cytoplasmic tail', 'ibv glycoprotein amino amino n terminal subunit protein amino cterminal subunit protein', 'subunit subunit c terminal cytoplasmic tail', 'subunit receptor binding activity protein', 'ectodomain region subunit fusion region heptad repeat oligomerisation protein entry susceptible', 'ibv reverse system replacement ectodomain ibv beaudette glycoprotein region pathogenic ibv confer virulence beau r result ribv tissue tropism', 'clinical disease challenge ibv beau r challenge', 'able induce protective response homologous challenge r unable induce protective response', 'beau r molecular clone beaudette isolate ibv several hen loss virulence implicated loss immunogenicity', 'work infectious virus tracheal infection r vaccine strain ibv', 'genome isogenic beau r fact able homologous challenge beaudette able replicate possibility inability beaudette virus serotype due fact virus replicate chicken due immunogenic mis match beaudette massachusetts serotype', 'replication ibv ibv harderian gland induction immunity ibv able replicate tissue', 'possible protein beaudette combination glycoprotein block protection beau r', 'paper describe use ibv reverse system investigate role ibv glycoprotein protection', 'ribv ectodomain region beaudette glycoprotein gene corresponding sequence ibv pathogenic strain ibv different serogroup beaudette important problem poultry industry', 'animal experimental strict accordance uk home office licence regulated uk scientific', 'iah home office experimental animal house iah ethical review committee iah poultry production unit', 'pathogenic ibv strain study gift intervet uk ltd specific pathogen free spf rhode island red rir hen production unit primary chick kidney ck refractory growth ibv', 'pathogenic strain ibv adaptation ck', 'vaccinia titrated vero whilst large isolation infected', 'tracheal organ prepared spf rir chicken embryos', 'infectivity tocs median ciliostatic cd', 'sequence chimaeric gene transmembrane domain ibv gene sequence genbank accession number cytoplasmic domain beau r genbank accession number described fig', '', 'gene sequence rt pcr rna allantoic fluid ibv paci bsphi restriction', 'chimaeric gene paci bsphi present respective', '', 'paci site nucleotide proximal gene initiation codon distal gene transcriptional regulatory sequence bsphi site nucleotide end transmembrane domain', 'brief paci bsphi cdna fragment sequence', 'vector paci bsphi sequence insertion paci bsphi cdna fig', '', 'plasmid replicase gene beau r chimaeric gene gene gene beau r fig', '', 'rt pcr variety gene sequence beaudette sequence gene sequence staden sequence software', 'sequence ibv genome recombinant vaccinia virus rvv vv beaur ds complete beau r genome minus sequence', 'homologous recombination transient dominant selection system tds', 'brief vero confluent vv beaur ds moi h mg presence lipofectin invitrogen', 'resultant guanine xanthine phosphoribosyltransferase positive gpt rvvs plaque purification vero presence mg mycophenolic acid mpa mg xanthine mg ml hypoxanthine', 'next mpa resistant gpt rvvs plaque absence selection medium', 'process second recombination event loss gpt gene generation rvvs ibv cdna original sequence beaur full length cdna', 'pcr amplification dna rvvs confirm absence gpt gene specific determine presence chimaeric gene sequence gene', 'recombinant vvs gpt negative pcr size gene sequence sequence analysis different chimaeric gene confirm gene ibv genomic cdna', 'rvv full length ibv cdna genomic background beau r sequence gene sequence work', 'dna rescue ribvs ck', 'cell lysate ml transfected ck infect spf embryos', 'embryos h overnight', 'allantoic fluid ep spf embryos resultant ribv subsequent', 'rna allantoic fluid rneasyh method qiagen amplification part gene rt ready tm rt pcr identity ribv sequence analysis', 'stock eggs final titre cd ml subsequent vivo', 'virus prepared rir tocs stock cd log cd log cd volume ml', 'n spf rir vivo analysis ribv', 'negative pressure temperature hepa isolation group separate room', 'conjunctival eye drop intranasal log cd free n medium', 'serumfree medium', 'post infection log cd total ml ibv ibv mock mock mock challenged conjunctival intranasal', 'clinical determine pathogenicity sound similar sneeze tracheal bronchi chick dyspoena nasal discharge watery ciliary activity trachea', 'clinical period', 'presence tracheal watery', 'group challenge assessment ciliary activity', 'different level ciliostasis tracheal section light microscopy', 'part rnalaterh ambion rna extraction virus isolation', 'rna extraction trachea rnalaterh rna lysis buffer disruption homogenisation tissuelyser ii qiagen min hz', 'total rna rneasyh kit qiagen manufacturer real time rt pcr gc catgttgtcactgtctattg taqmanh probe g probe caccaccagaa cctgtcacctc tam tracheal pbs freeze tissuelyser ii qiagen', 'tracheal infect tocs', 'tracheal mock group day', 'tocs tracheal suspension', 'infection h ml medium incubated ciliary activity', 'compare ciliary activity analysis post hoc dunnett multiple comparison test graphpad prism version graphpad software inc', 'generation genomic backbone beau r gene sequence analysis ibv gene nucleotide insertion beau r gene sequence total amino acid extra amino glycoprotein fig', '', 'amino acid difference cytoplasmic beau r', 'overall primary translation amino beau r identity identity', 'chimaeric gene signal sequence ectodomain transmembrane ibv cytoplasmic tail beau r', 'last gene cytoplasmic domain maintain interaction protein terminal domain beaudette', 'transmembrane amino acid difference r beau r', 'plasmid chimaeric gene used produce full length ibv cdna complete genomic sequence beau r chimaeric gene vaccinia virus genome tds method', 'beau r ds receiver sequence donor sequence fig', '', 'tds dna rvvs cdna', 'analysis pcr gpt specific loss gpt gene second tds recombination event rvvs', 'ibv rvv presence sequence region gene', 'rvvs sequence analysis different chimaeric gene gene sequence ibv ibv beaudette genomic sequence gene sequence', 'rvvs contain sequence chimaeric gene rvv chosen work', 'recovery infectious ribv chimaeric glycoprotein dna ck provide rna polymerase co rvv dna pci', 'ck supernatant infect fresh ck', 'infection supernatant rt pcr', 'several rescue pcr ribv present p donor gene refractory growth ck', 'embryos cell lysate p ck', 'allantoic fluid h post infection total rna analysed rt pcr', 'rt pcr positive specific indicative infectious ribv', 'sequence analysis region replicase gene region gene gene ibv', 'allantoic fluid stock ribv subsequent', 'order test pathogenicity ribv able induce protective immune response challenge pathogenic number single experiment test', 'first part experiment determine clinical ibv infection ibv', 'second part challenge ribv homologous protection', 'part experiment infection pathogenic control clinical pathogenicity part experiment', 'addition heterologous different serotype pathogenic ibv', 'beaudette belong serogroup massachusetts fig', 'part protein sequence similar way beaudette sequence', 'previous offer protection serogroup', 'order test pathogenicity eye drop log cd', 'ml serum free medium', 'clinical nasal discharge postinoculation', 'low min bird day infection group bird day infection group clinical', 'contrast pathogenic clinical ibv post infection fig', '', 'replacement beau r gene gene pathogenicity virus', 'primary inoculation group log cd pathogenic ibv group log cd pathogenic ibv group mock serum free medium', 'previous control primary inoculation group log cd pathogenic ibv mock mock group free medium', 'clinical daily group postinfection', 'addition post infection group ciliary activity presence ibv', 'group primary inoculum pathogenic clinical', 'postchallenge fig', 'score observed post challenge fig', '', 'tracheal bird nasal discharge', 'min bird group day post challenge group pathogenic fig', 'group fig', 'clinical observed homologous protection', 'control mock clinical fig', 'b', 'consistent clinical mock group pathogenic ibv ciliary day inoculation', 'group primary inoculation ribv ciliary activity day inoculation', 'contrast group pathogenic ibv level ciliary activity ciliostasis day fig', '', 'group primary inoculation ribv pathogenic ibv high retention ciliary activity day post infection group fig', '', 'group ciliary activity prior infection protection challenge pathogenic', 'group heterologous serotype pathogenic ibv maximum bird min day post challenge group fig', '', 'group post challenge', 'previous work caused snicking day post infection wheezing day post infection avirulent ibv', 'experimental level cross protection analysis clinical', 'day post challenge figure', 'comparison amino acid ibv r', 'clustalx genedoc multiple sequence alignment editor utility version', 'amino black represent identical amino acid sequence amino', 'transition ibv glycoprotein arrow signal sequence position junction position tm domain position cytoplasmic tail position', 'ectodomain amino composed amino group ciliary activity ciliostasis group', 'poor degree cross protection analysis ciliary activity', 'summary clinical virus clinical group', 'contrast extent', 'clinical ciliostasis pathogenicity strong degree protection primary inoculation challenge homologous pathogenic protection pathogenic belonging heterologous serotype', 'overall able protect homologous challenge pathogenic cross protection heterologous serotype ibv', 'detection ibv order virus challenge pathogenic ibv tracheal section infected infect tocs', 'tracheal pathogenic ibv used infect tocs growth potential virus result loss ciliary activity loss ciliary activity ciliostasis indicative ibv present tracheal sample infected bird', 'significant difference ciliary activity control group pathogenic ibv fig', '', 'average ciliostasis tocs infection tracheal group group average ciliostasis level group fig', '', 'observation virus low virus present tracheas indicative induction protective immunity cross protection', 'check presence rna tracheal epithelial challenge pathogenic ibv total rna epithelial pcr', 'analysis group ibv rna present table', 'subsequent sequence analysis ibv rna present pathogenic ibv', 'exception bird ibv tracheas group table', 'consistent clinical activity infected trachea infected protection subsequent challenge pathogenic ibv', 'ibv rna group table indicative cross protection', 'sequence analysis rt pcr product sample', 'result virus isolation infectious ibv tocs infection tracheal group', 'ribv glycoprotein ectodomain pathogenic ibv strain genomic context apathogenic strain ibv beau r serotype', 'cellular tropism apathogenic clinical', 'increased protection beau r challenge virus ectodomain region protein important protective immunity ibv infection therefore region detail effective ibv vaccine development', 'extend work ectodomain region beaudette gene sequence pathogenic ibv different serotype serotype', 'virus ibv serotype france', 'uk ibv serotype found common pathogen many western late', 'availability vaccine serotype recent serogroup prevalent european presence important concern poultry many different', 'ribv eggs tocs able infectious virus ck tropism donor strain beau r refractory replication ck evidence protein major determinant tropism host range', 'previous work gene beaudette ibv strain serotype', 'recombinant ibv vitro host range', 'similar apathogenic previous observation gene pathogenic strain different serotype sufficient confer pathogenicity', 'consistent pathogenicity chimaeric ibv replicase gene apathogenic ibv beaudette genome pathogenic strain chimaeric virus pathogenic pathogenicity replicase gene', 'work ibv major massachusetts serotype vaccine poor protection challenge virus', 'amino acid beau r differ', 'subunit immune ability induce protective amino acid beau r', 'similar protection protection challenge', 'measure pathogenicity observation clinical ciliary activity trachea presence virus rna qrt pcr isolation tracheal', 'clinical prior inoculation protection challenge', 'analysis group significant retention ciliary activity low ciliary activity tracheal group', 'observation qrt pcr analysis rna trachea', 'chicken positive detection viral rna trachea challenge group', 'reduction tocs potential virus present tracheal group group', 'comparison ciliostasis tracheal group group overall level ciliostasis group level presence virus', 'degree cross protection different ibv low acid', 'gene apathogenic beau r massachusetts serotype serotype apathogenic virus protection pathogenic virus different serotype', 'serotype glycoprotein irrespective genotype ibv strain', 'challenge ciliostasis observation clinical pcr virus isolation low level protection heterologous different', 'previous work hodgson al', 'virus beau r level ciliostasis high', 'ibv sequence amino level differing', 'subunit differ amino level', 'cross protection different poor cross protection different', 'ibv vaccine protect challenge retention ciliary activity heterologous brazilian', 'protection challenge loss ciliary activity clinical virus isolation wee', 'addition ibv vaccine protection challenge belgium french french', 'heterologous protection heterologous serotype difference', 'vaccination jp ii genotype basis sequence spike protein protection challenge classified different genotype respiratory ciliostasis virus isolation tracheal swabs', 'control group group group previous group kept rnalaterh', 'disruption homogenisation rna used template ibv specific qrt pcr', 'trachea different day control group bird day assessment', 'triplicate taqman machine', 'amplification sds software', 'qrt pcr method manuscript sensitivity maximum sensitivity', 'degree cross protection virus isolation analysis viral rna qrt pcr', 'vaccination degree cross protection challenge reduced clinical virus isolation detection viral rna extensive loss ciliary activity', 'previous work beau r', 'work marquardt al', 'virus ciliostasis heterologous challenge', 'reveal presence virus amount virus present low', 'heterologous vaccination protection reduced clinical absence detectable virus trachea whilst time induced protection heterologous challenge loss ciliary activity ciliostasis', 'retention tracheal ciliary activity assess cross protection', 'marquardt et al', 'argue use criterion correlate protection', 'importance intact respiratory epithelium field laboratory', 'partial cross protection clinical virus recovery performed laboratory animal insufficient protect economic field', 'damage respiratory epithelium observation ciliostasis pathogenic g', 'e present additional pathology', 'previous work ribv heterologous glycoprotein ibv recipient virus beau r amino acid sequence', 'work expression heterologous glycoprotein different serogroup acid sequence beau r homologous protection challenge pathogenic', 'addition clinical detection virus rna isolation virus heterologous protection experimental ibv isolate different serotype']"
d6da8802866acb6cd35ee1c4a0ec6c64d06b8345,migration invasion cell migration present study expression bcc bcc cell sigma aldrich aldrich merck human cancer invasion bcc merck kgaa previous study current study emt process fisher scientific invitrogen thermo prostate cancer scientific inc thermo fisher bcc tissue protein expression addition knockdown anti rabbit basal cell bcc normal cell proliferation e cadherin epithelial mesenchymal inhibited migration invasion fig knockdown inhibited lung cancer medical university overexpressed bcc rabbit igg role bcc study activation activation inhibitory adjacent non agg cag arginine protein b pathway benchmark system cadherin vimentin cancer aberrant cancer metastasis cell carcinoma cell line cell lung chain reaction committee medical contrast overexpression crystal violet decreased expression different cancer downregulation pathway emt bcc emt progress expression knockdown fbs sigma gag ttg gene protein general hospital goat anti hrp goat human skin immunofluorescence assay incubation h inhibited bcc invasion emt invasion metastasis kinase b md usa mesenchymal transition mrna expression non tumor normal basal normal tissue overexpression inhibited pathway bcc phosphate saline phosphoinositide kinase polymerase chain potential therapeutic progress bcc progression bcc quantitative polymerase reverse transcription role emt serine arginine sex region sirna vector skin cancer squamous cell study committee study knockdown target bcc tca agg tissue normal transfection expression transition emt,"['basal cell carcinoma bcc common type human skin cancer aberrant activation hedgehog', 'previous evidence sex region box tumor metastasis', 'expression role bcc unknown', 'aim current study analyze possible mechanism progression bcc', 'reverse transcription quantitative polymerase chain reaction', 'transwell determine migration invasion bcc', 'immunofluorescence role serine arginine protein phosphoinositide kinase b pathway bcc', 'overexpressed bcc', 'addition knockdown inhibited migration invasion bcc epithelial mesenchymal transition emt progress bcc', 'expression downregulation akt expression', 'transfection pathway activation inhibitory migration invasion emt progress bcc', 'conclusion target bcc therapy pathway', 'basal cell carcinoma common human skin cancer aberrant expression hedgehog pathway', 'epidemiological exposure radiation various atomic bomb interventional', 'uv common cause bcc general population numerous possible pathogenesis bc dna damage certain cell', 'various regulatory chronological progression bcc investigation', 'sex region sry box member sry high mobility group family involved human carcinogenesis several', 'distinct different tumor', 'previous development certain cancer osteosarcomas colorectal cancer glioblastomas prostate cancer breast cancer ovarian cancer inhibitory gastric cancer squamous cell lung cancer', 'tumor gene human cancer', 'addition multivariate analysis expression factor cancer', 'regulatory potential elusive bcc', 'previous study epithelial mesenchymal transition emt implicated invasion metastasis various human cancer', 'addition inhibition serine arginine protein kinase prostate cancer progression modulation alternative splicing', 'phosphoinositide kinase b pathway signal transduction tumor', 'present study role invasion metastasis bcc regulatory effect pathway', 'clinical', 'total male female bcc adjacent non tumor department dermatology second hospital tianjin medical university china', 'pathological diagnosis bcc mean age world health organization', 'history cancer history present study', 'bcc embedded paraffin', 'none chemotherapy radiotherapy prior tumor resection', 'informed consent', 'study committee medical university general hospital', 'cell culture', 'bcc normal adjacent non tumor', 'dulbecco eagle medium dmem sigma aldrich merck kgaa germany fetal bovine serum fbs sigma aldrich merck kgaa u ml penicillin µg ml streptomycin sodium pyruvate l glutamine co', 'immunohistochemical ihc analysis', 'bcc normal tissue deparaffinized xylene ethanol', 'endogenous peroxidase activity hydrogen min room temperature expression', 'briefly tumor specific primary cambridge usa h', 'tumor monoclonal horseradish peroxidase hrp goat anti rabbit igg antibody origene china', 'ventana benchmark system examination protein expression tumor az usa', 'percentage positive staining magnification', 'rna extraction quantitative polymerase chain reaction qpcr', 'total cellular rna bcc normal rneasy mini kit qiagen gaithersburg md usa manufacturer protocol µg total rna reverse cdna high capacity reverse transcription product code', 'next mrna expression determination µg cdna qpcr iq sybr green supermix bio rad', 'invitrogen thermo fisher scientific inc waltham usa gag ttg tca agg cag reverse gag ttg tca agg cag β agt caa cgg att tgg reverse ctt ctc cat ggt cgt', 'pcr amplification denaturation primer sec primer extension sec', 'relative expression δδcq method', 'fold change relative normal target mrna expression β control group', 'western blotting', 'bcc lysis buffer protease inhibitor sigma aldrich merck x g min', 'sds', 'subsequent blocking milk h primary dilution akt e cadherin vimentin fibronectin β actin abcam', 'monoclonal hrp goat anti rabbit igg secondary h', 'ventana benchmark system tucson usa protein expression', 'small rna sirna transfection', 'bcc h', 'next medium opti mem invitrogen thermo fisher scientific inc h', 'sirna gene genepharma co ltd shanghai china cag uac aac ucc aug utg guu cgg ugg uca sirna vector control guc uca uug atg aca', 'total pmol sirna cultured bcc µl lipofectamine rnaimax reagent invitrogen thermo fisher scientific inc', 'incubation h analysis', 'lentivirus production cell transduction', 'packaging plasmid envelope plasmid invitrogen thermo fisher scientific inc', 'pwpxl vector pvector vector bcc lipofectamine invitrogen thermo fisher scientific inc', 'incubation h investigate effect gene depletion proliferation migration invasion western blot', 'cell proliferation', 'bcc pvector sirna vector vector', 'incubation medium w v crystal violet sigma aldrich merck kgaa', 'cell image pro version software bethesda md usa', 'cell migration invasion analysis', 'bcc bcc mg sigma aldrich merck kgaa h', 'migration invasion bcc serum free dmem upper chamber density chamber fbs sigma aldrich merck kgaa', 'transwell size µm emd millipore billerica uncoated evaluate cell migration invasion', 'h bcc chamber paraformaldehyde min crystal violet dye sigma aldrich merck kgaa min', 'light microscope olympus olympus corporation', 'immunofluorescence assay', 'immunofluorescence', 'brief ly bcc', 'bcc phosphate saline paraformaldehyde sigma aldrich min', 'phosphate saline triton min', 'indicated cadherin vimentin fibronectin abcam', 'fluorescein isothiocyanate donkey anti rabbit igg polyclonal immunoresearch grove pa usa h', 'microscope leica b leica gmbh wetzlar germany', 'statistical analysis', 'mean ± standard deviation independent', 'spss software version corp armonk ny usa graphpad prism version graphpad software inc la jolla way analysis variance tukey multiple comparison post hoc', 'indicate significant', 'expression bcc', 'bcc tissue bcc cell analyze expression', 'overexpressed bcc tissue normal basal tissue ihc staining fig', '', 'fig', 'expression upregulated bcc tissue normal tissue', 'gene protein expression bcc cell normal basal cell line fig', '', 'expression', 'cell migration invasion vitro', 'role bcc analyzed', 'knockdown transfection expression overexpression transfection upregulated expression bcc fig', 'b', 'overexpression cell migration invasion fig', 'inhibited migration invasion bcc', 'f', 'expression bcc cell migration invasion', 'previous study emt process critical regulator progression cancer metastasis', 'bcc', 'overexpression bcc cell proliferation inhibited bcc cell proliferation fig', 'b', 'addition knockdown upregulated expression epithelial marker e cadherin mesenchymal fibronectin bcc', 'contrast overexpression reverse emt process', '', 'immunofluorescence assay overexpression epithelial mesenchymal marker expression', 'f', 'expression proliferation bcc', 'previous study associated human cancer metastasis', 'elucidate potential molecular expression bcc', 'transfection expression knockdown inhibited expression bcc', 'b', 'addition knockdown result reduction cell migration invasion fig', '', 'overexpression inhibited migration invasion bcc control fig', 'f', 'knockdown emt increased e cadherin fibronectin fig', '', 'contrast overexpression inhibited emt bcc', '', 'direct target emt bcc', 'previous study activation metastasis human cancer', 'present study association bcc', 'fig', 'decreased expression bcc', 'knockdown decreased expression bcc whereas overexpression fig', '', 'activation inhibitory cell migration invasion fig', 'f', 'knockdown cell invasion pathway', 'several expression human cancer normal ovarian prostate cancer', 'present study expression bcc overexpressed bcc', 'expression associated lymph node distant invasion colon cancer tumorigenesis', 'current study bcc cell migration invasion emt pathway', 'association expression progression several human cancer functional potential bcc', 'role controversial different cancer', 'present study upregulated bcc', 'gene protein expression translational efficiency sox bcc tissue', 'yang al promoted migration invasion laryngeal cancer matrix target rapamycin pathway', 'overexpression overall survival squamous cell lung cancer adjuvant radiotherapy', 'present study knockdown inhibited bcc cell migration invasion downregulation pathway', 'dysregulated different cancer', 'inhibition potential therapeutic strategy prostate cancer therapy', 'previous study critical role emt process human glioblastoma', 'current study potential target expression knockdown bcc', 'addition downregulation emt process bcc inhibition migration invasion', 'downregulation pathway', 'reduced expression suppression metastasis', 'previous study activation', 'numerous activation development progression human cancer invasion cancer', 'current study knockdown downregulated pathway bcc', 'crucial role emt process proliferation invasion lung cancer', 'paclitaxel resistance prostate cancer cell line pathway', 'current study activation cell migration invasion', 'pathway role migration invasion bcc', 'conclusion present study pivotal role bcc cell migration invasion potential therapeutic target bcc', 'applicable', 'funding', 'study available author reasonable request', 'zl yj present study', 'jh present study', 'present study committee medical university general hospital', 'study consent publication']"
221e5c964d0af38a0a1744714dae695e3fdd75f5,type ifn et al antiviral landscape single cell viral replication gene expression iav infection disease severity wnv infection antiviral response e g transcriptional profiling viral pathogenesis bulk cell denv infection host response human disease suthar et viral infection weight loss al suthar collaborative cross genetic diversity iav pathogenesis ifn production molecular signature viral load al al al shalek analysis antiviral antiviral type asymptomatic symptomatic disease outcome drop seq enterocyte hi hemorrhagic fever human viral ifn transcription innate immune lethal infection model human murine rv pro inflammatory rlr type rv infection shalek al specific antiviral susceptible mice system whole transcript expression viral tropism whole cell whole tissue activation dependent al human al peng allelic variant antiviral immunity biologic validation bulk intestine cc mice cc model cell analysis cell level cell population cell resolution cell specific cell type cell whole comprehensive analysis conventional antiviral development novel discovery novel disease human early responder ebov infection enhanced viral enterocyte lo expression single fatal molecular ferris al genetic influence genetic loci heterologous rv hi population high viral host influence human denv human population ifn induction ifn response immune viral immunity disease influenza virus iterative process lethal disease linkage disequilibrium load enrichment long range low high,"['host antiviral viral infection form dynamic complex web antiviral landscape', 'conventional antiviral reductionist assess function single limited subset', 'holistic approach entire system whole individual', 'biology unbiased comprehensive analysis antiviral landscape discovery emergent conventional', 'antiviral landscape hierarchy complexity whole organism level single', 'review discuss biology understand antiviral landscape', 'organismal level collaborative cross invaluable genetic resource genetic diversity antiviral response', 'whole tissue bulk cell critical tool comprehensive analysis antiviral cellular complexity', 'new single cell analysis individual bulk cell population overall antiviral landscape', 'pathogen recognition series orchestrated dynamic immune rapid generation antiviral specific', 'central function viral replication spread uninfected viral clearance', 'conventional antiviral mechanism action single related set experimental perturbation', 'antiviral host response narrow viewpoint', 'holistic comprehensive host response viral infection', 'major biological system whole powerful tool thorough analysis antiviral response', 'unique feature level ability emergent system whole individual system', 'type approach computational network predictive refined iterative process', 'latter step biological validation integral component biology investigation suthar pulendran', 'use level guides conventional novel host', 'scope biology organism tissue cell distinct complementary host response fig', '', 'beneficial use term antiviral landscape represent entire defense response process viral infection clearance', 'review recent biology unravel antiviral response transcriptional profiling heterogeneous cell single', 'epidemiological clinical host immunity disease severity response viral infection', 'nile virus wnv single polymorphisms snps strong risk susceptibility disease severity glass et al', 'genetic risk hepatitis c virus venegas al human immunodeficiency virus vannberg et al influenza virus juno al human viral', 'human genetic variable environmental genomic difficulty causal genetic variant complex trait', 'mouse tractable viral pathogenesis', 'initial development refinement biology simple classic inbred urokinase pathway coronavirus lung injury pathogenesis', 'mouse tractable viral pathogenesis complex genetic influence disease symptomatic infection', 'overcome diverse collaborative cross cc recombinant ri mouse panel identify characterize dissect genetic g', 'gene diverse relevant al kelada al kovacs et al al patel et al philip al rogala al sun et svenson al zombeck al susceptibility fungal bacterial shusterman al viral al ferris al josset al peng al peng al xiong al', 'cc multi parental ri panel mouse classic laboratory major mus musculus castaneus small genome minor allele distinct locus collaborative cross keane al', 'generation cc long range linkage disequilibrium population risk spurious genotype plague', 'population structure collaborative cross flint eskin', 'removal long range linkage disequilibrium gene emergence extreme epistatic development novel spontaneous colitis rogala al hemorrhagic disease al', 'cc mimics complexity genetic diversity human natural opposed extreme abrogation genetic lead outcome', 'cc important gap mouse human disease useful resource basic pathogenesis platform antiviral vaccine development', 'host influence influenza virus iav pathogenesis correlative unable show direct causal rare human population cheng al ciancanelli al horby al lee al', 'model impact genetic diversity viral pathogenesis iav infection ferris al', 'infected panel different incipient cc mice precc iav', 'diverse range phenotypic emergent present infected founder high viral replication low weight loss inflammation significant weight loss lack viral replication', 'transcriptional profiling several phenotypic disease weight loss airway inflammation transcriptional immune inflammatory direct relationship disease severity genetic variation host response', 'major strength cc model ability phenotypic specific genetic loci quantitative trait locus qtl mapping', 'gene expression e g', 'qpcr genetic genomic dna e g', 'snps rna transcript expression genomic sequence variation regulation gene expression', 'paper several disease iav infection antiviral effector gene potent activity iav', 'genomic sequencing biology utilized novel antiviral response iterative process experimentation computational modeling', 'single cell differentiate bystander cell specific antiviral response', 'cc founder discovery novel allelic variant protection virus weight loss ability inhibit viral replication', 'eqtl analysis several related inflammatory immune cc mice novel allelic variant decreased potential explanation weight loss iav infection', 'several disease known antiviral unidentified genetic influence iav infection outcome', 'group reactive transcriptional dependent genetic specific loci particular unique transcriptional different', 'implementation model pathogenic nonpathogenic influenza potential drive discovery novel host iav pathogenesis potential therapeutic', 'diversity infection iav infection unique common feature human viral', 'infection flavivirus nile virus wnv present asymptomatic symptomatic severity mild febrile illness severe encephalitis death graham al marion al suthar et al', 'contrast human disease predominant model wnv infection utilized mice neuroinvasive disease daffis al al suthar et al', 'et al cohort mice wnv infection human disease clinical asymptomatic symptomatic', 'asymptomatic group presence absence immune system involvement central nervous system cns former emergent disease outcome', 'anal ysis innate immune correlation ifnˇ expression symptomatic disease role genetic diversity gene disease outcome bigham et al', 'diverse adaptive immune cns regulatory cc asymptomatic disease complexity host immune regulation', 'symptomatic wnv infection understood work cc mouse divergent infection asymptomatic symptomatic define uncharacterized host wnv pathogenesis', 'mouse ebola virus ebov lethal mice fail hemorrhagic fever syndrome human disease', 'lack small animal model ebov hemorrhagic fever major obstacle understanding ebov pathogenesis antiviral', 'feldmann michael understand impact host pathogenesis rasmussen et al', 'mouse ebov infection diverse complete protection lethal disease resistant mice hemorrhagic fever pathology death susceptible', 'spectrum disease human population ebov west africa bah al schieffelin et potential cc model human infection', 'virologic comparison representative susceptible resistant cc line similar genomic rna significant increase production infectious virus susceptible mice', 'widespread infection susceptible mice', 'contrast mice restricted infection endothelial kupffer', 'transcriptional profiling susceptible enrichment vascular integrity endothelial activation inflammation', 'particular regulatory network endothelial kinase tek regulator coagulation correlate disease severity susceptible mice diminished expression network relative naïve mice resistant mice expression', 'tek allele tek divergent divergent phenotypic co gene divergent mouse', 'define relevance tek genetic loci disease severity human ebov infection', 'work utility novel new viral pathogenesis small animal', 'wnv broad range cell suthar', 'spleen primary permissive tissue visceral organ stage wnv infection nonpermissive infection suthar et al', 'rig receptor rlr mitochondrial antiviral protein mavs type interferon ifn receptor ifnar critical protection infection al al suthar et al suthar et al', 'understand viral tropism suthar al wt mavs ifnar mavs ifnar double knock mice wnv permissive spleen non permissive liver', 'approach molecular rlr type ifn dissect individual antiviral immunity wnv infection', 'network analysis rlr type ifn trigger strong antiviral immune viral replication liver', 'infected enriched natural killer nk cell protective role nk wnv infection', 'biologic validation expansion activation hepatic nk wnv infection rlr type ifn dependent manner role cell viral tropism liver', 'study antiviral landscape wnv infection critical ifn tissue permissiveness infection role nk viral tropism liver', 'immune competent different virus iav disease severity e g', 'seasonal severe e g', '', 'host influence development divergent disease understood', 'clarify immunity disease severity iav infection ron germain group top approach whole cell infected time course non lethal strain iav sub lethal lethal al', 'whole lung similar activation antiviral type ifn infection', 'contrast unique molecular signature lethal infection increased enrichment group pro inflammatory g', 'neutrophil chemotaxis nfb tnf', 'fatal molecular signature decreased enrichment gene pulmonary homeostasis repair consistent lung pathology severe infection', 'integration whole organ immune cell lung microenvironment induction antiviral type ifn', 'contrast pro inflammatory gene fatal molecular signature', 'consistent observation lung infiltration lethal infection partial neutrophil depletion dose dependent enhancement survival', 'analysis whole lung immunohistochemistry predominate source chemotatic neutrophil influx', 'virologic analysis similar viral replication lethal non lethal infection former enhanced viral spread lung', 'integrated approach lethal disease outcome enhanced viral spread early pro inflammatory response lung neutrophils trigger inflammatory feed circuit promote pathologic neutrophil infiltration fatal pulmonary damage', 'mice useful iav pathogenesis model distant non human nhps model human disease bouvier lowen', 'understand host severe iav infection kawaoka group rhesus clinical mild severe disease human et al', 'model human iav pathogenesis expensive difficult manipulate', 'overcome capture antiviral landscape bronchial brush', 'several similar co expression mild severe infection', 'enrichment subset viral potential virus dependent transcriptional', 'gene immunerelated inflammatory cytokine production antiviral', 'severe disease diverge mild disease weak activation early infection strong activation infection', 'support model early viral control uncontrolled viral replication immune activation', 'use biology tissue cell pathogenic role excessive inflammation determinant severe iav infection murine nhp pathogenesis', 'model similar transcriptomic reconstructed iav power biology illuminate antiviral landscape cilloniz al kash et al', 'recent transcriptional profiling monocyte dendritic infection seasonal pandemic uncovered molecular signature blood symptomatic asymptomatic iav infection hartmann et al', 'utility biology identify disease specific molecular clinical relevance', 'dengue virus denv mosquito borne flavivirus responsible', 'dendritic target viral replication balsitis al cerny al little early innate immune response human denv infection', 'inherent lack manipulability human mechanistic difficult perform', 'et al overcame whole blood antiviral landscape acute denv infection', 'pbmcs infected denv distinct transcriptional healthy denv seronegative', 'gene expression distinct viral load independent disease severity', 'analysis top high viral load enrichment inflammatory innate immune viral load innate', 'top low viral load enrichment stress response target plasmablast differentiation', 'cell level transcriptional immune revealed expansion intermediate denv infection', 'ex vivo denv infection healthy human generation intermediate potent ability drive plasmablast differentiation antibody production secretion april', 'prominent plasmablast expansion human denv infection wrammert al intriguing role intermediate development humoral immunity denv', 'high throughput genomic invaluable antiviral recent', 'novel viral pathogenesis immune whole cell gene expression bystander', 'conventional limitation comparison low high mois recombinant reporter gene e g', 'fluorescent protein enrich infected rna infected et al', 'historical utility introduction experimental g', 'use infection high virus', 'recent technological nucleic acid amplification high resolution gene expression analysis single cell level qpcr e g', 'fluidigm biomark hd rnaseq e g', 'illumina hiseq', 'development novel droplet', 'drop seq macosko al increase ease affordability single cell', 'characterize heterogeneity gene expression individual context embryonic development shin al cancer miyamoto al immunology meredith al shalek al shalek al underutilized study virus host', 'previous antiviral bulk dc heterogeneity present homogenous cell population', 'determine individual overall antiviral landscape regev group bone marrow dcs bmdcs prototypical pathogen molecular strong activation isolated single shalek al shalek et al', 'individual bimodal transcript expression immune', 'divergence cellular gene expression developmental stage bmdcs differential activation dependent regulatory', 'observed hour period small early responder antiviral type ifn production first stimulation', 'late cell communication type ifn activate antiviral activation type ifn early responder', 'individual single antiviral landscape work extend viral infection infected', 'bimodal expression question population level small importance', 'rotavirus rv severe diarrheal disease infection absorptive villous small intestine high intact type ifn response sen et al', 'rv suppress type ifn response exact mechanisms viral evasion vivo infection unclear', 'rotavirus immunity harry greenberg group viral host gene expression single naïve murine rotavirus mice', 'transcriptional heterogeneity enterocyte lo enterocyte hi low high expression enterocyte', 'enterocyte hi population high ifn small subset responsible homeostatic ifn healthy gut', 'rotavirus enterocyte hi population decreased type ifn expression trigger type ifn production enterocyte lo population consistent ability rotavirus type ifn induction', 'type ifn transcription gene expression bulk intestine cell type ifn transcription rv infection hematopoietic', 'inhibition dependent transcription rv infection rv nfb activation prevent type ifn production', 'context whole organism − − mice deficient type ii ifn infected murine simian rv heterologous strain efficient replication type ifn deficiency', 'heterologous rv infection nfb activation bulk intestine murine rv equivalent activation dependent', 'type ifn transcription heterologous rv murine rv prevent type ifn induction promote viral replication', 'single cell transcriptional profiling murine rv transcription type ifn viral replication type ifn production intestinal hematopoietic', 'work understand antiviral bystander context relevant human viral primary', 'implementation single cell analysis potential identify novel response transcript expression infected whole tissue bulk cell', 'critical determine sensitivity detect viral rna replication reliable discrimination', 'maintain holistic view single cell integration bulk cell whole tissue organism level complete view antiviral landscape level complexity', 'recent development droplet single cell rnaseq platform e', 'drop seq invaluable tool tissue cellular level', 'example drop seq profile host response specific cell spleen single cell resolution', 'comparison transcriptional profiling bulk cell whole cell specific antiviral landscape response bulk', 'protein expression single cell resolution yu al recent technological single cell chip seq rotem integrated individual epigenetic transcript protein', 'conventional instrumental understanding virus host new holistic necessary appreciate entire scope antiviral response', 'integration biology chart antiviral landscape transcriptomic proteomic metabolomic epigenetic single cell predictive antiviral response', 'importance integration observation notable discordance transcript protein antigen specific hukelmann al', 'utility biology notable challenge extraction meaningful information extensive data', 'implementation current novel computation identify prioritize top candidate hypothesis generation', 'critical next step experimental refinement predictive process biologic validation', 'application biology dissection antiviral difficult study cell primary human clinical cell type specific antiviral', 'biology potential redefine field medicine treatment vaccination host hood tian', 'summary implementation biology essential understanding viral pathogenesis antiviral immunity novel therapeutic vaccination']"
97ab5bad794553f1af287d9ee88c0113e1ba80ed,saudi arabia ∘ c region saudi c min detection respiratory jazan province province saudi ∘ min human respiratory human rv invitrogen usa january winter l rna min ∘ mixture ∘ respiratory age rt pcr usa l viral infection volume l winter season winter time age table arabian peninsula association viral buffer l c use cause artis coinfection uncommon detection rate due several extension ∘ flu human flu prevalent flua hrsv healthcare center healthcare symptomatic hold ∘ hrsv b hrv flu human rhinovirus infection clinical infiniti analyzer infiniti rvp multiplex reaction non human non saudis nose lethargy overall prevalence pattern saudi pcr multiplex polymerase invitrogen presentation healthcare prevalence respiratory public health reaction buffer reaction mixture represent major respiratory healthcare respiratory syncytial respiratory tract rhinovirus hrv rna arna rvp assay several respiratory significant association southwestern province southwestern region study dual surveillance respiratory symptomatic january syncytial virus taq polymerase uncommon study undertook surveillance viral prevalence viral rna virus age virus hrsv virus hrv abdulaziz university ability examine accurate identification acute pneumonia acute respiratory addition flu additional risk age actual age age age due age group age hrv age infected age presentation age range age winter aid epidemiological alagaili geographical alahsa taif alkaline phosphatase,"['undertook surveillance respiratory healthcare symptomatic january winter time', 'nasal respiratory rt pcr multiplex microarray', 'total positive viral infection', '', 'human rhinovirus hrv pathogen non human flu human respiratory syncytial virus hrsv', 'age hrv flu prevalent age', 'moreover coinfection uncommon study dual due several', 'dual age', 'study cov common southwestern region saudi arabia high diversity prevalence common respiratory', 'study importance contribution surveillance infection control', 'acute respiratory tract represent major global cause morbidity mortality', 'age due respiratory', 'respiratory major cause artis prevalence transmission several geographic demographic environmental', 'lack easy cheap diagnostic nonspecific large number possibility mixed timely accurate identification causative viral', 'human respiratory human respiratory syncytial virus hrsv influenza flu human rhinovirus hrv enterovirus ev human coronavirus hcov human parainfluenza human human', 'several respiratory east respiratory syndrome coronavirus avian influenza several world', 'saudi etiology uncharacterized due several', 'previous annual hajj pilgrimage viral', 'second several viral prevalence artis saudi arabia specific viral', 'third city riyadh capital saudi arabia number country', 'recent emergence saudi arabia spread high mortality serious public health economic concern', 'lineage c betacoronavirus betacovs asymptomatic mild upper respiratory tract infection severe acute pneumonia occasional systemic infection multiorgan failure', 'saudi arabia arabian peninsula europe', 'arabian peninsula', 'frequent sporadic multiple hospital several alahsa taif jeddah riyadh', 'jazan province southwestern part saudi arabia north', 'second populated province saudi arabia density', 'barley report prevalence respiratory region country', 'several surveillance several seroprevalence jazan province serological evidence circulation region', 'consistent overall prevalence pattern saudi arabia single case province', 'undertook surveillance respiratory healthcare symptomatic january winter time southwestern region saudi arabia', 'total healthcare province saudi november january winter time', 'nasopharyngeal symptomatic healthcare', 'male female', 'virus transport ∘ special infectious unit fahd medical research center abdulaziz university jeddah saudi arabia', 'ethical approval jazan university ethical committee juec', 'clinical information laboratory informed consent adult', 'order control extraction ice l rna arna hepatitis c virus genotype l sample internal control', 'rna extraction qiaamp viral rna mini kit qiagen germany manufacturer final elution volume l rna ∘ c use', 'viral rna reverse superscript iii strand synthesis supermix kit invitrogen usa', 'reaction mixture l random buffer l rna arna total volume l mixture ∘ c min pcr block ∘ l reaction buffer l enzyme mix mixture ∘ c min ∘ min', 'reaction mixture ∘ c min inactivate ∘ c use', 'infiniti rvp assay infiniti analyzer respiratory', 'cdna pcr multiplex reaction l ready use amplification mixture dntps multiplex reaction buffer usa l platinum taq polymerase invitrogen usa l cdna', 'cycling cycle ∘ min denaturation ∘ sec ∘ c extension ∘ min', 'reaction final extension ∘ min hold ∘ c pcr dntps pcr l shrimp alkaline phosphatase sap l exonuclease exo ge life usa l titanium taq polymerase invitrogen usa pcr product mixture min ∘ c min ∘ final hold ∘ c infiniti analyzer rvp assay auto usa manufacturer', 'briefly primer extension reaction detection usa fluorescent fluorescent product hybridization amplified virology dna microarray', 'analyzed', 'positive ratio virus signal signal threshold manufacturer software', 'rna upstream e gene upe detection real time rt pcr lightcycler roche germany final volume l negative template control positive', '', 'statistical package social science software spss ibm crop armonk ny usa', 'descriptive continuous nonparametric mann whitney test kruskal wallis test', 'categorical exact test test evaluate difference', 'tailed probability value significant', 'mean standard deviation necessary', 'positive table', 'saudis whereas non saudis positive', 'prevalence positive similar gender ethnicity', 'detection female saudis non saudis', 'significant effect detection respiratory', 'table presentation healthcare detection rate respiratory age', 'respiratory age infected', 'viral detection rate healthcare', 'age presentation healthcare age actual', 'marked detection different healthcare region', 'table healthcare center healthcare center number', 'profile', 'study rt pcr', 'consistent current prevalence circulation pattern saudi arabia negative lack nasal carriage region saudi arabia', 'next variety respiratory infiniti rvp microarray', 'table infected single respiratory virus', 'hand respiratory', 'flua hrsv b hadv', 'frequent virus hrv coinfected coinfected table', 'flua hadv hrsv hrsv b ev', 'human rv hadv common coinfection flua coinfection', 'due unique combination respiratory table', 'human rv virus age age group table', 'male virus age table', 'overall clinical noninfected table significant association positive detection viral nose lethargy healthcare', 'small number limited ability examine association viral infection clinical significant association nasal congestion single dual table', 'present study clinical symptomatic suspected artis southwestern province saudi arabia respiratory', 'several respiratory evidence study population previous region', 'noteworthy alagaili geographical circulation dromedary saudi arabia evidence jazan province', 'viral prevalence similar age', 'positive', '', 'rate infection rate riyadh province southern region saudi arabia figure', 'difference previous hospitalized age', 'contrast primary healthcare wider age range consistent decrease detection respiratory age table', 'proportion age', 'human rv non human', 'hand detection respiratory ev hmpva identified', 'hrv flu prevalent detectable age', 'contrast rsv', 'hrv important cause artis addition flu winter season', 'overall prevalence respiratory previous respiratory arabia', 'hmpva proximity jazan province', 'required additional risk', 'coinfection uncommon study dual infection consistent recent study turkey', 'likely due methodological', 'common virus hrv hadv flua hrsv', 'hrsv hadv', 'non', 'single time', 'dual common young age', 'viral frequent hospitalized impact clear several disease severity risk hospitalization', 'understand clinical impact', 'detection respiratory', 'virology positive current study large community region suitable future surveillance', 'similarity clinical infected respiratory bacterial hurdle diagnosis clinical presentation', 'association viral infection clinical nose lethargy overall array specific due small size', 'short period winter season viral', 'rapid molecular diagnostic microarray pcr aid epidemiological characterization circulating', 'conclusion southwestern province saudi diverse hrv represent major pathogen age winter season', 'infrequent region saudi arabia limited number dromedary host direct contact', 'multiplex herein spectrum diversity respiratory effective control public health', 'work importance surveillance epidemiology respiratory appropriate control']"
e035002c8135dab46801a3fc8a43b87240dbef8d,urban area j j hong kong outbreak probability transmission rate case study city j map representation risk threshold computational approach large number number country predictive power probability outbreak additional file agreement empirical cumulative number different stochastic meta population outbreak country outbreak likelihood population model probability infection resolution scale air travel airline network code gray color code computational model disease propagation e g emergence epidemic figure represent global spread gray low index patient infection country low outbreak number compartment occurrence outbreak origin infection overlap function probability red red high reproductive number sir model specific disease stochastic meta stochastic model transmission model able transmit actual number acute respiratory agreement official agreement previous analysis cumulative analysis epidemic area j area population area resolution average time binomial distribution canada urban commercial airline compartment e compartmental model compartmentalization additional conditional occurrence connection time correct red country conditional country country data epidemic define probability detection case diagram transmission different initial different outbreak discrete nature disease follow disease parameter disease study distribution probability early stage epidemic likely equal time equal μ evolution disease figure map flow diagram function θ global epidemic global scale good agreement h r health care high outbreak infection quantitative infectious average j infection,"['global spread severe acute respiratory syndrome importance long range transportation', 'introduction extensive transportation important step order epidemic realism', 'general stochastic meta population model actual travel census urban', 'model probabilistic country', 'level predictability model related appearance robust epidemic probable disease', 'order assess predictive power model case study global spread', 'disease parameter initial model evaluated empirical', 'outbreak likelihood specific epidemic', 'simulation agreement empirical data epidemic', 'computational approach integration range mobility demographic epidemic predictive power', 'computational strategy general tool analysis forecast global spreading definition containment catastrophic', 'outbreak severe acute respiratory syndrome serious public health threat international community', 'rapid spread initial outbreak great concern potential ability virus large number coordinated effort containment', 'pointed mobility commercial airline major disease propagation global scale', 'spatiotemporal human global analysis epidemic outbreaks example airline network structure world', 'article present stochastic meta population model extension deterministic modeling approach global epidemic diffusion study spread complete international air transport association commercial airline traffic database urban information', 'disease free adjustable model', 'toolkit specific stochastic nature process risk analysis assess reliability epidemic', 'particular predictive power model emergence epidemic propagation complex transportation network', 'case study assess model effectiveness accuracy real', 'model kong outbreak way consistent global nature meta population model impact infectious city', 'temporal geographic pattern disease toolkit epidemic empirical', 'global stochastic meta population model epidemic transmission', 'approach spirit deterministic global spread infectious successive stochastic compartmental model evolution urban area air travel', 'air travel database model', 'commercial globe total worldwide traffic', 'airport corresponding urban area population mixed disease', 'population several census specific', 'model stochastic account discrete nature compartment', 'transmission model urban area compartmentalization specific disease study', 'instance case simple susceptible recovered sir model population j city j susceptible infectious n j j j r j j j r j represent number time order discrete nature stochastic evolution infection describe disease propagation urban area binomial multinomial', 'infection contagion process e g', 'generation new infectious transmission disease infectious transition compartment e', 'infectious', 'class assumed susceptible city j contact infectious individual rate βi j j β transmission rate disease', 'number new city j binomial distribution probability βi j δt j number time scale interval', 'second class transition process number compartment e g', 'sir model city j j → j rate μ binomial distribution probability rate transition previous example μ number number compartment time previous example j', 'basic sir model compartmentalization additional account possibility compartment able transmit infection due e g', 'non perfect isolation', 'case section infection specific disease study latency hospitalization patient isolation fatality rate', 'figure schematic representation compartmentalization case study stochastic discrete evolution specific compartmentalization additional file', 'compartmental model urban area compartmental urban travel stochastic operator number compartment urban area urban area j', 'number x city city j integer random variable x potential probability ij w ij j w ij traffic connection time scale n urban area population', 'city connection time define stochastic multinomial distribution', 'addition', 'detailed mathematical description coupling', 'model stochastic individual compartmental', 'model realization initial different', 'context comparison single realization model real evolution disease', 'mere comparison number country several actual number poor indicator reliability prediction', 'many average large number variety', 'crucial distinguish country degree resolution urban area outbreak number latter', 'reason define analysis scenarios forecast real world comparison', 'likelihood experience outbreak different stochastic epidemic initial probability infection country', 'different stochastic define probability outbreak country fraction positive number country', 'identification infection quantitative measure outbreak probability', 'quantitative analysis cumulative number country conditional occurrence outbreak country', 'outbreak likelihood magnitude analysis level single urban', 'section present example available resolution scale', 'high potential value forecasting perspective infectious necessity accuracy epidemic various stochastic present process', 'present computational approach meaningful stochastic initial similar intensity time evolution', 'airline network structure model different con flow diagram transmission model figure flow diagram transmission model', 'population city different susceptible latent l infectious h r die h dead r', 'infectious able transmit infection large percentage health care', 'actual efficiency hospital isolation reduction transmission rate β factor r β β early stage epidemic hong kong', 'infectiousness h r h equal assumption model', 'susceptible latent class', 'contagious asymptomatic epidemiologic clinical diagnostic canada', 'infectious average time ε mean latency period', 'individual infectious average time equal μ clinical hospital', 'hospital travel', 'average spent hospital admission death recovery equal μ μ r', 'average death rate', 'large number huge amount possible different available infection spread world', 'principle set epidemic different initial poor predictive power computational model', 'contrast airline network topology predictability disease evolution heterogeneity passenger volume various specific diffusion high traffic', 'degree predictability connectivity traffic initial', 'order measure stochastic variability computational model specific disease follow consider overlap function θ similarity different outbreak initial', 'overlap function different outbreak evolution time number active j urban area j infection', 'outbreak initial vector j th component probability active individual city j time π j j ∑ l l', 'compute statistical similarity different affinity', 'normalized measure invariant rescaling constant factor', 'introduce similarity epidemic prevalence j j ℵ ℵ ∑ j j world population', 'overlap function θ overlap θ equal time epidemic share common city equal time identical', 'outbreak predictable likely similar high value function', 'view strong inherent infection process movement presence appreciable overlap possible presence robust mechanism disease propagation emergence epidemic', 'preferential epidemic likely spread', 'origin large traffic volume year air travel', 'order pinpoint presence epidemic identical initial simulate different subject different stochastic time evolution epidemic urban area main text', 'propagation country travel infection country level', 'outbreak realization possible identify country country origin infection construct graph virus propagation latent infectious j c outbreak country c directed link weight equal', 'origin infection multiple interested path disease geographical region', 'significant number weighted network direction link direction virus diffusion number observed n', 'country sum order define probability infection flow', 'network epidemic directed probability threshold order major epidemic spread', 'information country possible infection quantitative estimation probability infection origin', 'information crucial importance development assessment preparation single', 'travel medical entry place epidemic analysis identification epidemic', 'concrete example previous approach analyze specific case study', 'several mathematical see', 'many localized generic hospital specific small role global travel', 'particular key epidemiological local', 'scale empirical', 'boundary region consideration possible region', 'use global computational model previous section simulate synthetic outbreak worldwide scale empirical real world occurrence', 'compartmentalization disease parameter model previous', 'worth compartmentalization figure authoritative due information social specific structure heterogeneity full understanding disease', 'constant evolution disease hospitalization rate μ transmission rate table', 'correspond implementation hong kong containment transmission rate', 'reasonable consider certain reaction time delay place country detection case implementation transmission rate national scale', 'report intervention delay week', 'additional file immediate reaction delay delay', 'initial available evidence early assume index patient case detected mainland china hong kong february', 'kong february index patient l initial latent', 'effective consideration super multiple transmission index patient', 'complete time frame study july date last daily update world health organization cumulative number probable', 'transmission rate β initial number baseline epidemiological initial', 'model procedure main text', 'successive μ model prompter identification subsequent isolation infectious', 'step function factor f transmission parameter β effective reproductive number r respect early stage hong kong', 'effective reduction reproductive number due application control', 'spond relative variation square value minimum offset optimal value', 'value reproductive number r agreement previous', 'different initial super substantial', 'figure represent map color code gray low outbreak probability red high probability outbreak', 'quantitative indication risk country presence infectious disease containment', 'point development appropriate intervention risk', 'geographical appreciable likelihood outbreak', 'particular many east asia display large probability outbreak vicinity initial seed', 'fact western america outbreaks role large air traffic propagation', 'figure resolution scale e', 'level urban expected situation canada', 'worth large number country significant probability actual vancouver', 'proceed comparison empirical group risk threshold outbreak occurrence probability', 'norisk probability risk threshold', 'situation country risk', 'set risk threshold', 'small threshold alter', 'particular show additional file case risk threshold', 'risk threshold', 'threshold significant threshold valuable information risk country outbreak probability unreasonable', 'figure represent comparison july numerical date risk threshold', 'report july cross final summary laboratory worldwide map representation likelihood stochastic model figure map representation likelihood stochastic model', 'color code gray low outbreak probability red high outbreak probability', 'prob', 'outbreak different', 'figure red agreement empirical full color risk infected report correct prediction outbreak pattern official classify risk', 'class agreement green', 'map good agreement official updates worldwide spread high success rate infected uninfected', 'total number world able', 'risk probable sweden kuwait ireland romania risk official update case table', 'model correct classification', 'additional analysis agreement empirical whole duration maximal error wrong classification', 'quantitative analysis cumulative number country conditional occurrence outbreak country empirical', 'number figure box plot median empirical red', 'last report analysis probability outbreak', 'map representation outbreak likelihood canada urban area resolution scale figure map representation outbreak likelihood canada urban area resolution scale', 'urban color code gray low outbreak probability red high outbreak probability', 'canada', 'risk possible test empirical cumulative number conditional presence outbreak', 'panel empirical model', 'final report model able provide actual number error statistical', 'agreement initial kong', 'worth note risk show conditional outbreak agreement empirical inset panel', 'c correspond outside model', 'category thailand republic korea report empirical', 'sight error model large c figure large real occurrence worth predicted ballpark total country population order several', 'table data risk infection', 'japan large number numerical median', 'number small median equal', 'table empirical quantitative evidence agreement previous air crucial ingredient propagation global scale', 'additional file report magnitude case delay reduction transmission rate detection case country', 'possible observe accuracy large singapore', 'delay impact extent outbreak certain', 'important stress likely different country local health infrastructure', 'figure representation comparison numerical', 'risk probability outbreak n different stochastic noise', 'red represent agreement official correct red correct red order test predictability inherent model case case study figure section function time', 'average value confidence interval', 'overlap value equal stochastic share initial time', 'θ time window strong computational reproducibility synthetic', 'simulated disease follow similar evolution realization process', 'previous section origin reproducibility emergence epidemic', 'preferential epidemic likely spread', 'order identify path virus initial', 'hong follow propagation virus identify infected country country j infection probability origin infection country', 'figure epidemic thickness probability infection', 'country case infection kong italy taiwan', 'spain exception second level infection seed receive infection european bottom left panel figure', 'surprising case airport hub hong kong worth figure represent distribution country probability infecting country', 'case different infected city epidemic nontrivial informative deployment monitoring control', 'computational predictive power present case study subject introduction much detail computational scheme', 'taiwan prominent example quantitative magnitude outbreak', 'model many likely responsible simulation official', 'population heterogeneity frequency related wealth distribution', 'specific relative single health care specific control etc', 'account stochastic model', 'transmissibility infected compartment', 'account effective way occurrence outbreak diversity initial stage transmission', 'contrast model integration heterogeneity way different peculiar feature virus', 'inclusion transportation likely impact contiguous geographical', 'profile figure profile', 'worth empirical evolution', 'taiwan instance anomalous outbreak explosion temporary failure infection containment single hospital', 'situation mainland reproducible due lack available information actual initial', 'reported figure numerical hong kong able country', 'fact impact south east asian vietnam airline large traffic china', 'computational approach scale epidemic model level', 'good agreement historical data epidemic transportation census basic analysis disease global level', 'detailed version model interplay different transportation information specific country compartmentalization susceptibility heterogeneity infectiousness improvement posteriori analysis epidemic', 'case new emergent global epidemic computational approach possible epidemic evolution', 'initial unknown map representation epidemic map representation epidemic', 'paths virus transmission infection hong kong', 'thickness probability path probability filtered sake simplicity', 'different black paths transmit virus seed hong kong infected gray first level', 'malaysia singapore disease spread computational approach short time exploration wide range basic initial extensive case likelihood decision', 'general encouraging present level large scale computational useful predictive tool assess risk management preparedness future space time']"
885c77c8535ecc8f77c5debd1f4d5291cc9ff1ec,et al pennisi al al pennisi al al solano gallego gallego et l infantum al basso al maia maia al al solano brianti al basso al al brianti al dedola al pimenta dedola al pennisi et pimenta et antibody level bardagi al al fileccia al rüfenacht bardagi et bone marrow clinical disease clinical fel foglia manzillo gallego al laruelle magalon magalon toga migliazzo al robert et rüfenacht al sanchez robert spada al vector borne adaptive immune al attipa al caracappa al chatzis al et al hervás al laruelle al metzdorf al p al richter al saridomichelakis al sobrinho allopurinol monotherapy attipa al basso et blood parasitemia blood pcr borne co canl fel chatzis al chronic course clinical leishmaniosis clinical status co infection common clinical course disease current knowledge disease et disease high fel fiv feline disease feline infection fileccia maia genetic background genetic susceptibility grevot al hervás al high antibody high blood ifn γ immune response infantum clinical infantum infection infection development information fel knowledge fel leishmania braziliensis leishmania infantum low high lymph node maia et manzillo et mattos al mild disease non endemic non vectorial p brianti pcr positive recent information richter al sensitivity specificity severe clinical simões mattos,"['leishmania infantum li vector borne zoonotic disease phlebotomine sand main reservoir host parasite solano gallego et al', 'fact majority clinical mild disease sustain survival parasite cold active', 'huge amount − understand leishmaniosis early accurate diagnosis manage disease prevent infection', 'feline leishmaniosis fel li feline disease fact endemic nonendemic et al richter al pennisi al maia al basso al pimenta et al', 'level medical care « emergence » availability sensitive diagnostic progress parasite host vector al', 'recent information fel evidence past aim review current knowledge fel', 'infected leishmania spp', 'infantum old world central south america', 'leishmania infantum mediterranean spain portugal france greece turkey cyprus iran brazil pennisi al al attipa al metzdorf et al', 'zymodeme zymodeme mediterranean area pennisi al al', 'l infantum antibody molecular prevalence rare pennisi et al', 'sporadic rare occurrence canl fel non endemic consequence companion gallego al pennisi cleare al svobodova al richter al rüfenacht al et al', 'leishmania new world leishmania amazonensis leishmania braziliensis leishmania mexicana leishmania venezuelensis solano gallego al pennisi et al', 'leishmania tropica leishmania major skin mucocutaneous', 'latter et al paşa et al', 'sand fly transmission important way transmission leishmania several habit sand feline infection gonzález et al pennisi et al', 'non vectorial transmission responsible autochtonous endemic gallego et al karkamo al similar information fel lacking', 'blood transfusion source infection', 'endemic healthy healthy positive blood pcr pennisi al al al attipa et al akhtardanesh et al brianti al diakou al metzdorf al al', 'susceptibility progressive infection development clinical adaptive immune response immune exhaustion predominant helper response solano gallego al al', 'similar pattern humoral cell adaptive immune response l infantum', 'fact study fourth produce l infantum specific ifnγ ex vivo blood antibody level non producer', 'sick severe clinical disease high blood parasitemia antibody level lack specific ifn γ production vivo whole blood solano gallego et al', 'infantum clinical disease high blood parasitemia low high antibody relationship antibody titer severity disease specific ifn γ production bardagi al basso al p brianti al dedola al maia al pennisi al pennisi al pimenta et al', 'longitudinal progression disease antibody canl foglia manzillo et al maroli et al', 'fel clinical improvement l infantum therapy significant reduction antibody level canine mild moderate disease et al solano gallego et al', 'duration incubation variable canl non endemic lasting et al rüfenacht al solano gallego et al', 'complex genetic background susceptibility resistance wide dynamic clinical spectrum canl subclinical infection self mild disease severe progressive illness solano gallego et al', 'balearic immunological pattern resistant autochthonous ibizan clinical leishmaniosis solano gallego et al', 'sanchez robert et al', 'polymorphism carrier family member gene natural resistance macrophage protein gene specific haplotype distribution ibizan haplotype disease sanchez robert et al', 'boxer endemic area specific susceptibility severe disease healthy old resistant clinical leishmaniosis analysis single polymorphisms genetic component disease quilez al sanchez robert et al', 'genetic susceptibility disease prevalence al', 'immunosenescence progressive chronic course disease peak disease et day', 'age range fel wide mature old diagnosis age al basso et al britti al hervás al al', 'pedegree present genetic susceptibility disease', 'genetic background clinical status elucidate susceptibility somatic phenotype domestic shorthair silvestris domesticus undergone natural selection endemic', 'age fel datum support chronic course disease', 'vector borne co g', 'ehrlichia canis hepatozoon canis influence parasite burden progression canl tabar et al', 'retroviral coronavirus toxoplasma vector borne co pcr positive l infantum attipa al ayllón al pennisi al pennisi al pennisi al al sherry al sobrinho al solano gallego spada spada al al', 'significant association feline immunodeficiency virus fiv l infantum positivity pennisi al sobrinho et spada al', 'review fel fiv feline leukemia virus felv prevalence fiv coinfection co infection positive bardagi et al basso al brianti al al caracappa et al coelho al dalmau al dedola al fileccia grevot al hervás al ibba laruelle magalon toga richter et al rüfenacht al al verneuil al', 'fel fiv negative immune immunosuppressive mellitus bardagi et al basso al caracappa al laruelle magalon toga al immuno competence half clinical', 'face great number field prospective prospective study available immune pathogenesis fel', 'time post infection follow duration study infantum et al', 'study infection specific et al', 'recent experimental study intradermal inoculation stray felv leishmania braziliensis simões mattos al', 'latter study dissemination primary site infection development multifocal skin', 'ulceration spontaneous healing several size skin', 'selfcure skin persistence subsequent recurrence simões mattos al', 'l infantum fel canl', 'case recent information common clinical pathological fel bardagi et al basso al brianti al dedola al maia al pennisi al pennisi al pimenta et al', 'misrepresentation clinical fel presence parasite skin lymph bone marrow oral mucosa stomach large bowel kidney nasal exudate lung eye pennisi', 'frequent severe clinical underestimating clinical relevance fel', 'canl skin mucocutaneous common reason veterinary consultation physical examination bardagi al basso al brianti al dedola al maia al pennisi al pennisi al saridomichelakis', 'diverse macroscopic skin', 'ocular leishmaniosis reason al pietro al pennisi pennisi al pimenta et al', 'clinical canl fel frequency table', 'leishmania infected feline bone marrow skin mucosal eye al basso et al p brianti al fileccia maia al pennisi al pennisi al pimenta et al', 'cytological useful information pathogenesis diagnosis invasive', 'lymphoid hyperplasia common lymph node cytological pattern l infantum pcr positive feline lymph irrespective clinical status titer fiv co infection perillo al solano gallego miró', 'histological evaluation dog cat granulomatous inflammation fel described et al fileccia maia al migliazzo al al', 'useful detect feline skin squamous cell carcinoma pemphigus eosinophilic granuloma grevot al laruelle magalon toga table frequency clinical clinicopathological di pietro et al pennisi al saridomichelakis gallego et al', 'rüfenacht et al', 'immunohistochemistry feline heterologous canine rabbit hyperimmune serum monoclonal antibody primary antibody migliazzo al al', 'molecular dna used fel diagnosis pennisi al solano gallego et al', 'feline epidemiological edta blood positivity rate area et al', 'limited available bone marrow noninvasive conjunctival oral swabs benassi al brianti al al pennisi et al', 'skin mucosal marrow lymph node sick high parasite quantitative real time pcr migliazzo al', 'culture research time feline et al pratlong et al', 'antibody detection research clinical ifat dat western blot wb al', 'cut dilution similar clinical fel low high antibody level bardagi al basso al brianti al dedola al maia al pennisi al pennisi al pennisi al pimenta et al', 'excluded basis negative serological test ifat elisa dat wb foglia manzillo al al solano gallego et al', 'diagnostic performance elisa ifat wb sensitivity specificity et al', 'serological molecular time foglia manzillo et al pennisi al solano gallego et al', 'lack consistency serology molecular different sensitivity specificity many different', 'treatment clinical fel label common clinical cure et al basso al brianti al dedola al maia al pennisi al pennisi al pimenta al solano gallego et al', 'safety controlled adverse treatment renal disease possible clinical recurrence therapy pennisi et al', 'long term oral administration allopurinol monotherapy maintenance treatment course subcutaneous antimoniate', 'allopurinol monotherapy acute kidney injury therapy', 'domperidone allopurinol miltefosine case bardagi al dedola al maia et al', 'propylene glycol miltefosine oral formulation treatment canl milteforan™ heinz body formation life span red blood latter adverse effect case christopher et al maia et al', 'life expectancy clinical good several diagnosis concurrent pennisi et al', 'retrospective evaluation therapy retroviral coinfection', 'individual risk l infantum clinical disease pennisi al', 'moreover protection feline health strategy regional control l infantum infection', 'fact perniciosus lutzomyia proven infantum single sick cat fel da silva al al', 'important information infectivity sand healthy relevant percentage antibody positive negligible endemic et al et al chatzis al chatzis al fatollahzadeh al magalhães junior al maia al maia al martín sánchez al mendonça al millán al al pennisi et al pennisi al sarkari spada al al', 'prospective epidemiological role additional reservoir', 'sand toxic et al solano gallego et al', 'pyrethroid formulation able incidence l infantum infection', 'current knowledge blood detection blood pcr advisable measure non vectorial transmission et al feline infection cat disease l infantum endemic many', 'consolidated evidence knowledge fel available important', 'fact infancy stage knowledge transmission immunopathogenesis development management prevention feline disease therapy', 'case fel minimal part part']"
44a856d7636e82ed2fe46a0790866df52373b4ce,incubation period respiratory tract medical care gram stain shortness breath air travel diagnosis clinical et al productive cough travel travel upper respiratory antibiotic treatment chapter • chest film clinical recognition disease chronic etiologic diagnosis inhalation anthrax large proportion lung disease respiratory chapter respiratory illness respiratory syndrome risk factor specific etiologic tract infection treatment supportive abrupt onset abscess formation active infection active tb acute febrile acute respiratory adult pneumococcal air borne amoxicillin clavulanic anti diphtheria anti influenza atypical pneumonia avian influenza bacterial pharyngitis bacterial pneumonia central asian chronic lung clavulanic acid clinical presentation common respiratory condition severe cough shortness cough thoracic date anti dimorphic fungus direct contact disease high doxycycline amoxicillin dry cough empiric treatment european group evidence association exposure history factor transmission fatal outcome fatality rate febrile illness fever respiratory free living gram negative group legionella h influenzae health problem hemisphere winter high fever human avian ill medical illness cough increase titer infection upper influenza virus international travel lobar consolidation long term low income major risk mortality rate non specific person person person year plague foci pneumococcal disease pneumococcal vaccination public health pulmonary involvement rapid antigen rapid diagnostic responsible pneumonia risk infection risk tuberculosis second phase severe acute skin test,"['respiratory life health problem', 'risk certain respiratory tract due travel close influenza legionella tuberculosis due unique exposure travel plague q fever coccidioidomycosis', 'travel related respiratory importation secondary transmission global severe acute respiratory syndrome outbreak influenza tuberculosis', 'chapter causative clinical management rtis', 'steffen et al', 'monthly incidence acute febrile rtis', 'analysis rti third infectious', 'rate equivalent person year incidence common respiratory usa person year', 'difference attributable reporting large proportion rtis mild require hospital care', 'incidence rti similar developed', 'classic study incidence different travel america oceania caribbean', 'literature large proportion respiratory illness', 'comparison difficult likely diverse diagnostic true epidemiologic', '', 'attack', 'large database ill surveillance system freedman frequency respiratory ill caribbean southeast asia', 'analysis respiratory medical care systemic febrile diarrhea dermatologic chronic diarrhea non diarrheal gastrointestinal', 'database leder ill medical care geosentinel respiratory illness', 'series respiratory infection upper rti non specific pharyngitis', 'rtis tract infection pneumonia bronchitis', 'travel travel travel hemisphere winter likelihood influenza respiratory tract cohort', 'brien et al', 'group sick tertiary hospital australia traveled asian second accounting', 'series tract rtis distributed bacterial pneumonia influenza', 'bacterial pneumonia common', 'quarter upper tract due group streptococcus', 'multicenter hospital study italy respiratory chapter • respiratory syndrome third pneumonia', 'tb responsible pneumonia', 'malaria underlying disease', 'recent analysis geosentinel ill international travel ill medical care major diarrheal process dermatologic disorder systemic febrile illness respiratory disorder', 'upper respiratory tract disease acute otitis majority syndrome', 'geosentinel surveillance system likely present upper respiratory tract infection travel', 'travel travel travel hemisphere winter respiratory tract infection upper tract disease cohort male gender twofold risk female gender', 'air travel major risk factor transmission rti high exchange rate air laminar pattern air active flight close proximity person infectious result infection', 'prolonged period air cabin flight air flow risk infection', 'pressure oxygen airline high', 'respiratory intestinal common diagnosis medical care board cruise risk legionellosis influenza pneumococcal disease', 'susceptibility cruise ship respiratory contaminated ventilator spas common fomite contact e g salad age underlying physical condition', 'small elderly chronic tracheobronchial cardiopulmonary risk severe clinical rtis', 'spread streptococci direct person person contact large', 'ground infectious person', 'tiny droplet nuclei µm diameter viable air pass narrow', 'lead infection large number outbreaks disease exposed', 'tuberculosis way', 'influenza', 'legionellosis respiratory disease unique chain transmission', 'bacterium water free living ameba water', 'legionella whirlpools', 'transmission', 'example decision rti', 'syndromic management algorithm differentiate upper respiratory tract probable causative guide treatment', 'assist identify respiratory chapter • pneumonia available', 'sputum gram stain simple quick inexpensive procedure helpfulness specific etiologic diagnosis uncertain', 'utility sputum culture unclear procedure insensitive half sputum contamination third', 'advantage routine sputum gram stain culture rare tuberculosis melioidosis', 'cause pneumonia basis specific clinical radiographic laboratory parameter antibiotic therapy', 'treatment effective pneumoniae responsible agent atypical pneumonia pneumoniae c pneumoniae legionella', 'travel exposure history table diagnostic example differential immunocompromised broad', 'pneumonia pulmonary traveler specific table', 'require specific treatment', 'practical rhinorrhea headache fever shortness breath define rti', 'upper respiratory tract', 'isolated coryzal syndrome medical consultation', 'additional diagnostic treatment supportive', 'diagnosis laryngitis clinical treatment supportive', 'diagnosis pharyngitis clinical important identify group streptococcal infection lessen likelihood subsequent sequelae glomerulonephritis rheumatic fever', 'bacterial pharyngitis severe pharyngeal pain fever grayish yellow exudate cervical lymph', 'clinical unreliable identify bacterial pharyngitis tonsillitis typical presentation', 'rapid antigen detection available specificity sensitivity seek medical care pharyngitis young streptococcal disease', 'need bacterial culture rapid test negative', 'treatment course penicillin amoxicillin treat pharyngitis due', 'rare cause pharyngitis fatal outcome', 'thick gray pharyngeal tracheal membrane attempted removal', 'diagnosis clinical recognition culture isolation toxigenic strain corynebacterium diphtheriae', 'mainstay therapy diphtheria antitoxin antibiotic treatment penicillin', 'vaccination risk travel pharyngeal diphtheria', 'otitis sinusitis air travel secondary barotrauma', 'viral bacterial common empiric treatment combination supportive care hydration', 'antibiotic pneumoniae infection', 'upper rtis peritonsillar retropharyngeal abscess formation', 'treatment mechanical drainage', 'clinical suggestive pneumonia productive cough thoracic pain shortness breath', 'examination pulmonary crepitation adventitial', 'chest imaging define pulmonary involvement', 'pulmonary cavitation pneumothorax empyema formation', 'many collect nasopharyngeal swabs severe rtis pneumonia rapid antigen assess common respiratory influenza parainfluenza respiratory syncytial virus adenovirus metapneumonia virus', 'majority evidence pneumonia infection proportion due high systematic antibacterial treatment viral screen', 'chest film helpful specific etiologic diagnosis lobar consolidation cavitation large pleural bacterial cause', 'pneumococcal disease abrupt onset fever cough rapid respiration lobar consolidation chest film', 'atypical pneumonias pneumoniae pneumoniae gradual onset progressive dry productive chest film normal peripheral white blood cell', 'overall clinical presentation specific etiologic diagnosis effective causative agent european group legionella network report legionella likely incubation period geographic location source transmission', 'group disease center cluster', 'international global regional surveillance geosentinel tropnet eurotravnet play pivotal role early detection public warning travel', 'international health imposed public health outbreaks example influenza animal travel arrival departure quarantine spread respiratory', 'public health threat paradigm infection risk international travel role global rapid lethal spread pathogenic rti', 'november guangdong province southern china mysterious contagious pneumonia', 'severe atypical pneumonia prevalent healthcare', 'condition spread china march world health organization global alert outbreak condition severe acute respiratory syndrome', 'outbreak single bangkok hotel number subsequent spread', 'july fatality rate', 'global public response', 'april single case worldwide', 'novel coronavirus distinct', 'virus animal food introduction human person person inhalation aerosol transmission large viral', 'healthcare', 'incubation period median', 'prodrome headache myalgia fatigue day non productive cough shortness breath', 'non specific', 'gastrointestinal diarrhea', 'series toronto x ray normal admission', 'unilateral bilateral', 'multifocal', 'laboratory extent thrombocytopenia hospitalization many hypocalcemia hypomagnesemia hypokalemia hypophosphatemia', 'prevention rtis traveler behavioral hand avoidance close contact sick vaccination chemoprophylaxis example anti influenza medication outbreak table', 'influenza pertussis pneumococcal hib preventable', 'date anti influenza anti diphtheria anti pertussis example tetanus anti diphtheria acellular pertussis vaccine', 'date anti h influenzae b immunization hib pediatric pneumococcal polyvalent vaccine', 'travel indication adult pneumococcal vaccination age certain date adult pneumococcal vaccination', 'date immunization influenza', 'control legionellosis application safe water international tourist', 'proper disinfection filtration storage source water avoidance dead maintenance spas periodic replacement likely amplify disseminate organism', 'early recognition important management individual legionellosis', 'legionella sporadic', 'endemic legionellosis responsible pneumonia incidence age fraction', 'cdc hospitalized united infection', 'european group legionella infection', 'total', 'travel europe', 'scheme new cluster travel spain', 'tourist', 'mediterranean region europe origin outbreaks area risk identification cluster associated hotel bangkok', 'transmission air borne source infection environment', 'incubation period recent large outbreak incubation', 'clinical spectrum wide subclinical lethal', 'overt picture legionellosis lobar pneumonia abrupt onset high fever severe headache confusion', 'patchy present', 'mortality diagnosis antibiotic treatment', 'diagnosis detection antigen urine l pneumophila type', 'culture', 'treatment empiric treatment choice', 'co trimoxazole effective', 'number respiratory travel resource', 'melioidosis gram negative rod', 'north south equator diagnosis case definition possible contact history fever respiratory', 'available use routine viral rna detection epidemic', 'treatment supportive', 'corticosteroid therapy antiviral drug little certainty efficacy', 'spite receiving mortality rate median', 'mortality rate elderly comorbid chronic lung disease', 'pathogenic influenza virus endemic avian asia related', 'several human high case fatality rate', 'human', 'avian influenza virus poultry asia northeast africa', 'june indonesia human avian flu', 'egypt fatal indonesia', 'large virus excreted infected', 'transmission direct contact', 'avoid contact dead disease', 'human human transmission sporadic limited close', 'virus mutate transmissible human community new pandemic influenza', 'human avian influenza severe pneumonia fatal', 'evidence antiviral duration viral replication survival', 'influenza sporadic common', 'type virus involvement large proportion population risk explosive nature', 'influenza outbreak alaska yukon territory', 'influenza common infection hajj hajj season', 'influenza limited disease high morbidity responsible lethal', 'hallmark clinical presentation influenza febrile illness cough', 'dry cough', 'pneumonia frequent complication direct viral involvement bacterial suprainfection pneumoniae h influenzae group staphylococcus aureus', 'otitis serious', 'severe chronic heart', 'diagnosis clinical', 'rapid diagnostic antigen', 'viral isolation method reference antibody significant rural africa eastern europe south central contact soil animal described', 'inhalation anthrax notable absence pulmonary infiltrate chest presence extensive mediastinal lymphadenopathy pleural severe shortness breath toxemia sense doom', 'incubation period germinate exposure', 'pathogenesis toxin responsible hemorrhage edema necrosis', 'specific mild fever malaise productive cough', 'period patient condition second phase high fever respiratory distress cyanosis subcutaneous edema neck thorax', 'crepitant evident auscultation', 'inhalation anthrax fatal short time onset second phase mediastinal death', 'diagnosis inhalation anthrax difficult epidemic', 'direct examination gram stain sputum positive', 'serologic elisa test available significant increase titer convalescent', 'useful bacteriologic test case suspicion blood culture b anthracis', 'treatment inhalation early possible carbapenem penicillin doxycycline fluoroquinolone ciprofloxacin', 'ancillary treatment sustain vascular volume cardiac pulmonary renal essential', 'plague yersinia pestis gram negative coccobacillus', 'disease increase number india gradual expansion low endemicity', 'affected african democratic republic congo madagascar mozambique uganda republic tanzania', 'central asian region active plague foci central asian desert kazakhstan turkmenistan uzbekistan', 'plague foci autonomous incidence', 'permanent plague americas native rodent flea brazil ecuador peru usa', 'indian epidemic total pneumonic bubonic period travel trade disruption severe economic', 'plague endemic example epidemic india', 'rodent risk infection', 'septicemia event case air borne transmission pneumonic plague rare', 'plague febrile endemic', 'presence suspicious', 'bacterium standard bacteriologic culture blood bubo', 'gram stain negative coccobacilli polymorphonuclear', 'rapid diagnostic direct immunofluorescence test presumptive identification pestis antigen interest rapid management vast majority southeast asia northern australia', 'bacterium free living soil water infected inhalation direct contact', 'melioidosis risk wet season water', 'b pseudomallei frequent affected asian tsunami', 'melioidosis endemic', 'risk clinical disease chronic alcoholism chronic lung disease chronic renal disease', 'cellulitis abscess formation pneumonia septicemia frequent', 'lung involvement acute pneumonia chronic granulomatous lung disease tuberculosis', 'diagnosis pulmonary melioidosis difficult', 'endemic endemic', 'diagnosis gram stain culture respiratory blood', 'presumptive diagnosis melioidosis positive iha elisa serology appropriate clinical setting', 'iha active infection asymptomatic endemic', 'current therapy imipenem trimethoprim sulfamethoxazole doxycycline amoxicillin clavulanic acid period', 'maintenance therapy trimethoprimsulfamethoxazole doxycycline amoxicillin clavulanic acid necessary', 'vaccine melioidosis available role chemoprophylaxis', 'pulmonary involvement leptospirosis rare dry cough cough blood sputum', 'leptospirosis due several spirochetal bacterium leptospira zoonosis', 'transmission accidental contact water soil urine animal rodent', 'adventure group pulmonary hemorrhage frequency', 'clinical manifestation leptospirosis asymptomatic infection fulminant disease', 'severe renal failure mortality untreated', 'pulmonary fatal outcome extensive edema alveolar', 'radiologic', 'diagnosis isolation blood urine', 'diagnosis clinical recognition serology', 'prevention leptospirosis difficult tropical disease high risk', 'prevention rodent human important', 'human vaccine use tetracycline chemoprophylaxis mg week available', 'cutaneous disease form human anthrax', 'pulmonary anthrax common caused inhalation bacillus anthracis', 'anthrax risk respiratory chapter • influenza', 'confirmation disease urine antigen comparison acute convalescent phase serum', 'fungal sensitive fluconazole itraconazole amphotericin', 'tuberculosis tb infection cause human morbidity mortality', 'travel increase risk tuberculosis resource healthcare service work', 'infected mycobacterium tuberculosis become ill e disease latent tb infection basis skin test interferon γ', 'evidence association travel risk ltbi', 'lobato probability positive tuberculin skin test history travel', 'et al', 'risk tuberculosis infection long term asia latin america year', 'rate similar native risk', 'abubakar et al', 'first evidence uk travel high infection independent risk factor ltbi', 'effect vaccination', 'recent systematic review tuberculin skin tst conversion surrogate ltbi cumulative incidence ltbi long term median local many', 'tb risk worker cumulative duration travel total time tb endemic', 'air travel major risk factor transmission tuberculosis exposure infectious traveler plane active infection', 'risk tb transmission little epidemiologic importance', 'active tb ltbi medical care site born low income high income region birth visit born highincome low income common tourist', 'evidence association actual travel active tb ltbi sparse', 'report health tb present list mortality american', 'jung incidence rate person active person peace corps', 'general population al', 'suspicion disease', 'serologic passive hemoagglutination enzyme immunosorbent assay available', 'fourfold increase titer single titer presumptive evidence plague culture negative', 'antibiotic treatment basis clinical suspicion streptomycin gentamicin doxycycline chloramphenicol', 'pulmonary present particular risk human contagiousness organism', 'doxycycline mg daily family index standard maximum plague incubation period', 'paragonimiasis lung', 'infected ingestion raw crabs crayfish', 'infection se asia thailand china taiwan america africa asia', 'disease rare', 'incubation period several exposure', 'disease chronic bronchopneumonic process productive cough thoracic pain low grade fever', 'extensive inflammation cavity formation infection nodular lung bloody sputum', 'acute paragonimiasis present pneumothorax lung tissue', 'diagnosis clinical recognition detection sputum', 'treatment praziquantel', 'prevention raw crayfish crabs', 'coccidioidomycosis histoplasmosis fungal respiratory route respiratory system', 'coccidioidomycosis inhalation dimorphic fungus dust soil', 'pathogen present semi arid', 'symptomatic disease c immitis syndrome', 'radiologic hilar pleural involvement', 'outbreak coccidioidomycosis church group mexico average incubation period pain present cough', 'diagnosis serological', 'histoplasmosis infection soil dimorphic fungus histoplasma capsulatum', 'agent ubiquitous diffusion tropical', 'acute histoplasmosis', 'disease condition severe systemic disease immunocompromised', 'outbreak histoplasmosis college acapulco acute febrile respiratory illness cough shortness breath chest pain headache', 'chest x ray patchy interstitial pneumonia', 'diagnosis difficult disease differential diagnosis unrecognized bacterial bronchitis prevention state infectious tb postpone air travel', 'epidemiologic infectious exposure duration', 'high tb endemic behavioral provide healthcare use respiratory probable tuberculosis post travel assess ltbi evaluation tuberculosis compatible disease fig', '', 'vaccine bcg available protective adult population', 'respiratory third frequent health problem international', 'incidence majority', 'due cosmopolitan tropical', 'rti significance', 'primary vehicle spread influenza globe critical global spread new', 'effective antiinfluenza influenza immunization hand cough sneeze hygiene', 'date prevent rtis pneumococcal diphtheria pertussis', 'ill rti characterize illness tract rti travel itinerary exposure history clinical incubation period host specific']"
7b00b9f04112c671d8c31227d31b3fea7ca10c7e,drug discovery molecular target reporter gene reporter mice reporter system high throughput β gal alkaline phosphatase animal reporter cell animal extracellular reporter reporter protein target approach age related approach drug development cr drug development drug screening medium blood powerful tool pro longevity time course animal drug biological activity biological research blood stream cell reporter charge device chloramphenicol acetyltransferase crisp mice culture medium enzymatic activity extra cellular firefly luciferin fluorescent protein gene expression gfp green green fluorescent high sensitivity identification cr intracellular reporter metridia longa mice crisp promoter enhancer protein reporter reporter activity reporter animal reporter construct sea pansy sensitivity luciferase single molecular unmet medical β galactosidase academic field academic rare academic research academic sector accelerate early access biological accomplish promising acetyl coa acetyltransferase cat acetyltransferase β activation external activation functional activation reproductive activation specific activity candidate activity cr activity detect activity expression activity growth activity inactivation activity mammalian activity metabolism activity molecular activity property activity putative activity receptor activity reporter adapt activity addition culture addition exogenous addition food addition pro advantage require advantageous single aequorea victoria ageassociated progression agent platform alternative phenotypic analysis putative analytical biological animal enable animal model animal welfare anti agent applicable activity applicable c application drug,"['recent drug discovery utilized high throughput large chemical activity molecular', 'molecular target approach drug pharmaceutical biotechnology knowledge available protein structure computer simulation', 'molecular target approach structure target physiological', 'approach drug discovery identification novel', 'alternative phenotypic pathway approach drug discovery popularity academic sector', 'approach opportunity promising drug novel information biological', 'reporter powerful tool phenotypic compound', 'various reporter secreted enable hit', 'cell animal enable simultaneous evaluation drug metabolism toxicity biological activity', 'drug access biological efficacy risk side', 'article review reporter available phenotypic drug discovery', 'drug development high throughput reporter mice age related biological research', 'powerful various biological activation specific transcription', 'reporter construct promoter enhancer transcription gene activity expression assay system', 'promoter region transcription response stimulation upstream receptor receptor independent cascade', 'transcription factor promoter reporter gene subsequent reporter protein expression response pathway activation external drug', 'important exogenous protein reporter gene unique enzymatic activity property endogenous', 'activity reporter protein assayed photometry colorimetry fluorometry', 'detection bioluminescence chemiluminescence fluorescence become signal detection sensitivity ease use', 'detection equipment charge device ccd development convenient reporter drug screening', 'major intracellular extracellular', 'intracellular reporter gene', 'hand extracellular reporter medium blood stream', 'intra extracellular reporter gene protein activity', 'time course experimentation medium blood research', 'report suitable high throughput small molecule drug', 'determine concentration biological activity growth', 'measuring organism recombinant gold standard target activity', 'present review basic reporter emphasis application drug screening', 'chloramphenicol acetyltransferase cat reporter protein', 'cat bacterial enzyme specific detection system', 'cat reaction acetyl coa chloramphenicol form coa', 'difficult adapt activity detect', 'β galactosidase β gal bacterial lacz gene intracellular reporter gene', 'number detection substrate', 'β gal endogenous enzymatic activity mammalian', 'important distinguish endogenous exogenous reporter system', 'ph assay mixture endogenous enzyme activity', 'utility β gal', 'luciferase several firefly sea pansy', 'firefly luciferase oxidation firefly luciferin short flash light', 'sensitivity luciferase cat', 'high sensitivity luciferase bioluminescence β gal', 'various luciferase available long half life linear', 'enzyme dual luciferase reporter system sea pansy luciferase cell', 'different response stimulus', 'reporter green fluorescent protein gfp live', 'gfp jellyfish aequorea victoria', 'excitation uv light gfp green light emission maximum nm', 'intensity light engineering fluorophore region protein', 'reporter distinct advantage require cell permeabilization addition exogenous', 'suitable drug', 'recent gfp detection response small subcellular level', 'gfp suitable reporter transcriptional activation functional protein translocation cell response various', 'alkaline phosphatase seap reporter system investigate activity putative promoter enhancer', 'reporter several important high sensitivity specificity vitro vivo', 'seap terminal mutant membrane placental alkaline phosphatase', 'removal domain secretion enzyme culture medium blood stream', 'expression gene chemiluminometry', 'form alkaline phosphatase heat stable activity inactivation endogenous alkaline', 'easy distinguish exogenous endogenous seap activity', 'seap luciferase reaction incubation substrate firefly luciferin phosphate', 'product first reaction luciferin substrate luciferase', 'assay protocol sensitivity reporter system application', 'secreted form luciferase useful reporter', 'luciferase marine copepod metridia longa unique secretary suitable extracellular reporter', 'al', 'substrate specificity metridia luciferase metluc suitability use reporter gene expression', 'common seap monitoring gene expression time course reporter', 'seap metluc available commercial dual reporter system drug research', 'reporter suitable multi parameter phenotype drug', 'contrast single molecular target approach cell reporter complexity living organism', 'screen small', 'drug discovery assays', 'instance isolation single particular molecular target optimization medicinal chemistry', 'cell black box', '', 'drug molecular target approach phenotypic accelerate early phase drug development', 'fact cell false molecular target many potential biological pathway interest', 'molecular target generate effect undesirable side harmful', 'context paradigm shift drug discovery academic field important accomplish promising candidate isolation drug discovery pipeline throughput', 'many large pharmaceutical open innovation research collaboration profit research', 'academic research cell reporter primary drug screening', 'research living complex', 'animal reporter reporter mice powerful tool identification drug', 'knowledge luc estrogen responsive element luciferase gene mouse first example reporter animal drug development several reporter mice', 'luc model unique reporter animal drug discovery estrogen', 'model applicable activity', 'validation animal model important reporter activity receptor activation', 'luc mouse existence unliganded activation', 'animal reporter new physiology target', 'reporter mice differential er activation reproductive non reproductive', 'reporter mice useful biological research', 'precise toxicology mouse model metabolism model reporter mice', 'high provision animal welfare', 'table summarizes', 'suitable b applicable c applicable', 'time course suitable extra cellular intra cellular', 'vivo system detect luciferase gfp', 'tissue specific transgenic mouse detect specific tissue expression extra cellular', 'chemiluminescence sensitive fluorescence', 'cat chloramphenicol acetyltransferase β gal β galactosidase gfp green fluorescent protein alkaline phosphatase metluc metridia longa luciferase high throughput ccd charge device', 'calorie restriction cr many', 'identification cr mimetic enable therapeutic retardation various age related metabolic syndrome neurodegenerative', 'development cr fulfill unmet medical', 'approach development cr novel approach potential cr', 'purpose cell mouse system extracellular reporter', 'microarray analysis putative regulatory pro longevity dwarfism response', 'dfcr cell animal reporter system crisp cr anti agent platform', 'dfcr lived unidentified transcriptional sequence longevity delay age', 'reporter construct transgenic mice crisp mice increased reporter activity cr unpublished', 'hence reporter mimetic pro longevity drug', 'luc mice crisp mice novel longevity target', 'activity candidate addition culture medium mice addition food water', 'addition pro longevity method negative', 'respect crisp advantageous single molecular target screening', 'step screen primary crisp identify secondary screen verify activity metabolism toxicology crisp powerful tool promising novel drug', 'current reporter assay high throughput chemical', 'isolation candidate dependent choice reporter protein construction efficient cell animal', 'identification cr attractive development anti', 'cr ageassociated progression various refractory', 'pharmaceutical incentive develop', 'academic rare phenotypic cell animal reporter', 'candidate cr show beneficial similar cr cr great potential solve unmet medical rare common age related', 'bioassay protein reporter review biosensor analytical biological important drug discovery', 'development cr important approach future drug discovery']"
2494819e609831c7fb593af07a94e5c40d799f6c,tourism development plan implementation deviated implementation tourism planning general manager master planning private investment qualified staff economic development master plan park general social cultural anhui province china tourism cultural economic human resource imbalance development implementation plan long term practical experience actual implementation approach tourism background survey case study cause gpi detailed planning direct quotation eco system implementation process implementation stage inaccurate anticipation local economic local opera national nature nature reserve process implementation recreation area site planning survey analysis action plan administrative structure al shepherd analysis planner anticipation future anticipation planner approval ministry area place bamboo lake basic tourism big bang central government central local chinese central community involvement control land cooper et depth interview detailed action development master development priority development process divergence planner early stage effective implementation et al examination basic examination implementation experience practitioner failure tourism flaws master foreseeable future framework research function area future performance general manger government policy gpi disparity gpi examination guniujiang tourism help new implement plan implementation ggtdmp implementation guniujiang implementation number implementation tourism inadequate background initial implementation insufficient land interview park investment imbalance invite help lack detailed lack practical lack qualified land park land usage market demand market development park plan pearce plan,"['tourism literature phenomenon ubiquitous planning exercise', 'gap implementation approach tourism development', 'phenomenon rare china tourism important country economy', 'paper research gap chinese context order offer possible', 'case study examination implementation guniujiang tourism development master plan', 'major flaws master planning planner inadequate background survey analysis planner inaccurate anticipation planner lack practical experience practitioner divergence planner private investment imbalance development', 'r crucial successful tourism development management planning principle tourism development regional national inskeep world tourism organization hereafter wto', 'possible plan first place', 'implementation process plan purpose cooper gilbert fletcher wanhill gunn inskeep mcintosh goeldner ritchie shepherd veal', 'plan planned', 'practice fact balance idealism society pragmatism private sector investment', 'situation implementation hereafter gpi failure tourism', 'instance failure tourism development analytical control land usage cooper et al shepherd failure central planning lack community involvement tosun central local', 'gpi ironic telling paper mcvey government dust perfunctory bureaucratic exercise gunn p theoretical exercise baidal p', 'phenomenon gpi rare china tourism planning', 'tourism summit workshop conference tourism management effective implementation tourism weak china', 'zhishang huahua qiangshang paper hung wall planning jargon chinese edition paper exercise', 'wei former director planning department national tourism administration hereafter cnta china tourism level come end present form lack', 'due continuous growth tourism economy zhang zhang number country', 'wei criticism china see high rate plan abortion poor implementation public private', 'major purpose research paper identify gpi specific chinese provide', 'literature tourism little indepth study gpi', 'much plan initial implementation little consideration pearce p', 'observed phenomenon gpi community involvement control land usage cooper et al shepherd mismatch central local sancho shortage funding resource plan inskeep uncontrollable environment inskeep shepherd wto', 'indirect empirical evidence', 'obvious significance research attempt supplement inadequacy tourism planning literature gpi', 'research recent involvement planning exercise tourism development national nature reserve hereafter gnnr', 'gnnr shitai county china anhui province fig', '', 'study implementation guniujiang tourism development master plan ggtdmp cf', 'shenzhen shenlanke company private investor national park reserve', 'area sixth acreage become tourist attraction adjacent famous national mountain resort huangshan anhui province bearing name national geological park hereafter gngp', 'major reason case ggtdmp tourism undertaken china inland', 'prosperous coastal china social cultural economic development chinese central government policy give development priority coastal', 'order catch coastal exploit abundant natural development', 'tourism important field exploitation', 'province various tourism local economic development', 'ggtdmp', 'inland development subject rate abortion due developed social cultural economic research', 'specific begin conceptualization gpi theoretical framework research', 'definition future certain inskeep implementation plan', 'gpi disparity discontinuity', 'gpi examination basic tourism planning process fig', 'major preparation plan implementation', 'whole process phase plan preparation', 'study preparation determination analysis synthesis plan formulation', 'ultimate purpose form plan implementation', 'phase plan implementation last', 'carry various action specified', 'second monitoring reformulation assess prepared feedback plan implementation', 'examination basic tourism process break continuity tourism process implementation stage', 'gpi disparity original actual implementation', 'disparity whole part deviated implementation plan implementation', 'conceptualization major research study process ggtdmp', 'extent', 'park course', 'seek study site observation depth interview', 'step approach reference pearce plan methodology fig', '', 'first step sort key implementation research documentary study representative practice plan', 'result guide investigation', 'second step assess implementation comparison actual implementation site observation park relevant business performance', 'implementation key deviated implementation implemented', 'third step depth interview plan', 'ten total staff represent key managerial familiar content plan implementation', 'last step interview park plan perspective specific social cultural contexts anhui province', 'review gpi table', 'review process reference gunn wto service human resource management environment management', 'step plan implementation gpi examination implementation ggtdmp detect gpi implementation process implementation', 'table', 'assessment depth general manger department staff primary ggtdmp see table', '', 'opinion implementation', '', 'kind', '', 'adapt practice', 'site implementation drawn table', 'direct bearing plan implementation process', 'park selective level difficulty certain item', 'trouble discard item implementation list', 'implementation step', 'tourism reported specific implementation', 'gpi question', 'development exercise private cnta tourism planning performance', 'result serious implement plan', 'lack detailed action plan cause gpi', 'possibility cause relevant plan', 'case cnta rule examination cf', 'general rule tourism planning cnta', 'rule master planning set policy recommendation tourism area order purpose building main image scope development land', 'addition part main purpose', 'construction task master planning', 'indispensable step process planning', 'ggtdmp master level bearing content raise water level dam lake cf', 'shenzhen shenlanke company sufficient', 'sufficient content avoid park implement plan', '', 'hand master planning inevitable big bang similar', 'broad brush planning feasible plan action', 'hand park master plan enough tourism project gnnr', 'neglect need planning park', 'common single project various wto true case china', 'tourism university capable master theoretical basis capable detailed site planning', 'tourism planning wisdom disciplinary expertise', 'university specific field', 'multi disciplinary order accomplish tourism planning', 'china collaboration cooperation university hard specific', 'result insufficient background survey analysis early stage planning blame failure ggtdmp', 'lack demand tea service incompatible local traditional tea culture various indicate implementation size platform large inappropriate scenery deviated implementation stage mulian local opera available deviated implementation pole deviated implementation tourism anticipated figure plan implemented deviated implementation present homepage form e commerce implementation administrative structure different implementation number staff much anticipated plan deviated implementation hotel town high fiscal cost ground base plan lake traditional local opera show mulian fresh air enjoyment club battery', 'applicability studied implementation', 'implementation practical', 'master planning shot big bang nature clear cut specific background', 'result anticipation future performance', 'pearce plan absolute future', 'meeting various unpredictable true medium long term', 'nature impact relevant outset complete accuracy', 'plan foreseeable future', 'obvious inaccurate anticipation future performance gpi annual tourist structure human resource demand', 'actual tourist arrival figure much table ggtdmp direct quotation lack market demand performance quotation cup tea', 'majority young tea', 'chinese black tea installed quotation business tourist stable quotation usable land park scarce due rough steep terrain', 'need platform lake quotation size small', 'use platform performance stage stand square', 'platform beautiful quotation square hillside steep', 'possibility landslide', 'see bamboos prevent possible landside rainy season', 'grown quotation performance bad', 'interesting', 'costume makeup performance quotation', 'local opera', 'difficult performance dialect', 'need performance popular quotation good environment qualified staff quotation bamboo order place park bamboo lake', 'want move function area place quotation expert consultation dam harmony landscape', 'specific quotation construction difficult lake water deep', 'thought pavilion lake impossible', 'june july day destroy quotation truck moment', 'general manager carry', 'limited budget battery unsuitable road steep quotation small average width quotation insufficient land park building', 'solution cut', 'approval ministry order time quotation promotional plan invite help new quotation complete wordy impress potential quotation major targeted market development quotation traditional promotion city', 'effective', 'install commerce homepage need', 'investment quotation planned administrative structure economic', 'early stage park development many serous problem lack qualified staff', 'stay quotation many skilled staff', 'young average age', 'stand slow life pace loneliness tranquility natural environment', 'low salary reason', 'recreational staff bar playground order life interesting quotation quotation easy dig ground time square anticipated see table administrative qualified staff total ggtdmp workforce park', 'worth outbreak severe acute respiratory syndrome tourist year', 'circumstance difficult predict time plan endorsed', 'result practical experience', 'case park promotional', 'interview park general manger dissatisfaction satisfied design invite help new direct quotation research interview', 'manager appear wordy unattractive', 'phenomenon practical experience park promotion marketing', 'china tourism development university professional', 'practical business knowledge relevant plan', 'result divergence big obstacle implementation', 'look recreation area cause gpi divergence', 'recreation area bamboo wood part wood', 'park general manager idea', 'argument park green bamboo lake scenery', 'recreation area place park', 'detailed planning matter park general manager planner interpreter actual job implementation assistance business', 'similar divergence implement', 'result private investment', 'eco system gngp', 'park urgent matter obvious attitude due time direct quotation interview', 'attitude eco system private investment park', 'recent number private zhejiang province invest tourism', 'hand investment development capital anhui province local economic development tourism', 'hand private investment', 'private local economic development environment protection profit', 'true private investment gngp', 'interview general manager businessman main job money', 'view important planning initiate project generate quick', 'result due imbalance development', 'gpi reality gngp qualified staff', 'park general manager human resource manager poor performance lack help trained staff dilemma choice location function area lack detailed action plan water deep construction steep battery small construction insufficient land supply time procedure approval ministry promotional unattractive market development lack economic practical unnecessary lack qualified staff loss direct difficulty workforce run park', 'direct cause gpi withdrawal qualified staff park', 'park human resource manager young lonely life park', 'part big picture', 'investigation current imbalance development park coastal', 'anhui gngp social cultural economic development inland province', 'matter fact experienced depopulation workforce chinese central government policy development priority coastal', 'article research implementation master plan national nature reserve china', 'study actual implementation', 'half', 'park various physical construction unstable market demand loss managerial staff insufficient implementation', 'major planner inadequate background survey analysis planner inaccurate anticipation planner lack practical experience practitioner divergence planner private investment imbalance development', 'park impact gpi', 'park general manager basic knowledge planning prevent', 'false concept master plan enough', 'difference master detailed planning', 'help prevent wrong inappropriate type planning', 'park acting planner', 'past practice park park detailed planning', 'long run overall strategy sustainability tourism development reserve planning expertise experience', 'park right compensate flaws master planning', 'initial implementation ggtdmp find', 'essential park site planning detailed next phase', 'park assistance relevant valid term reference hereafter tor', 'sure real choose competent', 'tor help unqualified planning project outset', 'park interactive relationship present future', 'process ggtdmp park', 'planning stage eliminate legitimized plan implementation stage', 'studied case instance plannerpractitioner plan', 'result plan reformulation crucial feasible effective implementation plan materialize similar inskeep wto yuksel bramwell yuksel', 'park plan', 'difficult situation customer relationship management dynamic planner practitioner tie', 'necessary training committee appoint necessary team supervise implementation', 'park short term long term development process', 'park national nature reserve eco system fragile sensitive human', 'short term economic high environmental detrimental park', 'time ultimate task countermeasure gpi', 'aware risk logic fallacy unit analysis ambitious seek general china cope gpi basis single case study', 'believe gpi research somehow insightful policy', 'first implication see study approach china moment date', 'china centralized economy kind top planning approach government decade approach unfeasible long term', 'possible countermeasure wto integrate master nation region destination site planning priority development', 'help concrete action process implementation', 'second implication professionalism management', 'case study implementation number inadequate qualification experience planner', 'possible countermeasure nation wide qualification control system guarantee quality planning', 'system planner certified service', 'third implication mechanism facilitate bilateral planner practitioner tie', 'project tourism planner close contact implementation', 'create win situation planner learn practice gain valuable experience planning client incremental consultation guarantee appropriate plan implementation', 'last multi scenario method unforeseeable situation plan implementation', 'method conduct study social cultural economic environmental implementation plan different development foreseeable future', 'sum research neglected planning problem gap planning implementation', 'critical eye specific case tourism china intend deny approach tourism development', 'aim help quality tourism insightful workable exercise china', 'theoretical framework research useful plan relevant', 'phenomenon', 'particular mid long term examination plan context china', 'kind examination help planning real powerful tool ability realize al', 'gpi effect tourism development', 'easy job study avoid gpi environment prearranged p', 'implementation visionary', 'unpredictable future tourism development', 'public criticism plan approach tourism development crucial role future help tourism development process']"
59e339e8a09eb0b00c603cbd5867d8edabc2151d,rt lamp real time dengue virus qrt pcr reaction mixture et al hnb dye naked eye single tube detection limit genotype ii ii iii isothermal amplification number true sensitivity rt true number viral rna amplification lamp color change detection dengue kit μl lamp reaction loop isothermal ncr gene reverse transcription rt pcr sky blue step rt time turbidimeter university malaya x prevalence alternative dengue amplification dengue asian cosmopolitan centre ummc change violet clinical sensitivity co ltd colorimetric detection cosmopolitan genotype cost effective culture supernatant day day den dhf dengue specific denv infection denv rna detection denv diagnosis dengue diagnostic tool dna amplification dna isothermal early diagnosis easy use efficiency dna extracted culture f loop field pcr genesig real genotype iia healthy donor high efficiency iia iib iii asian iii sub isothermal lamp kit qiagen lamp alternative lamp amplification lamp detection loop b loop f loopamp real ltd japan malaya medical medical centre molecular diagnostic notomi et number false parida et pcr denv pcr elisa pcr machine pcr table pcr time plasmid dna positive reaction positive rt predictive value primer single primer μm qiagen germany reaction color require rt rna serum sensitive specific sensitivity specificity sensitivity x simplicity high specificity rt,"['dengue isolation virus serology molecular diagnostic', 'several commercial dengue affordability performance', 'hence loop isothermal amplification lamp ideal resource limited', 'serum healthy dengue infection', 'rna serum reverse transcription ncr gene', 'turbidity meter real time assay', 'sensitivity specificity rt lamp pcr elisa', 'rt sensitive detection limit rna', 'dengue virus rna positive rt lamp none negative', 'optimization rt lamp simple reliable test denv prevalent', 'dramatic global spread frequency magnitude epidemic dengue dengue hemorrhagic fever den dhf critical effective surveillance prevention control', 'dhf endemic conduct adequate surveillance burden possess adequate control vaccine prevention', 'lack available affordable sensitive specific diagnostic primary hurdle den dhf surveillance resource', 'early diagnosis dengue critical patient management administration ineffective triage febrile appropriate health care', 'prospect specific antiviral therapy future early diagnosis crucial identification receive proper care', 'prompt diagnosis index vector control community transmission', 'available diagnostic dengue diagnosis dengue endemic available igm igg elisas', 'dengue specific denv capture anti dengue specific present serum', 'serology inconsistent detection appropriate collection false positive due presence previous', 'virus isolation acute phase serum plasma presence mosquito cell line gold standard disadvantage approach available', 'isolation dengue virus clinical cell culture approach unsuccessful fastidious nature virus low level transient viremia disease process', 'due ability molecular diagnostic information reverse transcription rt pcr pcr nucleic acid sequence amplification real time pcr diagnose dengue virus', 'requirement maintain expensive thermal gel electrophoresis utilization', 'simplicity high efficiency dna isothermal lamp alternative dengue virus field pcr time require rt pcr machine', 'loop isothermal amplification lamp notomi et al', 'sensitive easy use time diagnostic method', 'lamp h isothermal simple water approach suitable field work', 'method distinct dna nonspecific binding specificity', 'lamp major equipment ideal diagnostic tool use', 'use reaction detection dengue virus parida et al', 'rt lamp reverse transcription sensitive positive dengue specificity', 'cost effective multiplex rt lamp method dengue virus single tube', 'addition hydroxynaphthol blue hnb dye colorimetric detection isothermal amplification reaction', 'attractive lamp hnb dye test naked eye', 'approach sensitive simple turkey coronavirus association virus isolation', 'study approval ummc medical committee committee irb reference number', 'total serum denv infection university malaya medical centre ummc kuala lumpur', 'clinical part standard patient care', 'laboratory routine diagnosis serological dengue igm capture sd dengue igg capture standard diagnosis inc korea evaluation rt lamp study', 'viral rna virus culture genesig real time qrt pcr denv detection primerdesign ltd uk', 'retrospective study patient study specific reference patient identity', 'healthy department parasitology faculty medicine university malaya', 'volunteer healthy blood consent healthy donor study', 'genomic viral rna μl patient serum qiaamp viral rna mini kit qiagen germany', 'rna qiaspin columns final volume μl elution buffer used', 'serotype specific rt lamp amplification dengue primer explorer software noncoding region genbank accession number western pacific new guinea table', 'loop f loop b', 'rt loopamp rna amplification kit eiken chemical co japan', 'briefly reaction mixture μm fip bip primer μm loop f loop b primer μm primer μl reaction mixture rm kit μl enzyme mixture em kit μl sterile deionize water florescent detection reagent fd kit μl template rna', 'single tube rt lamp primer single reaction mixture', 'reaction mixture loopamp real time turbidimeter teramecs co ltd japan', 'prevent cross contamination different different work template preparation reaction mixture preparation dna amplification', 'duplicate', 'real time amplification dengue rt lamp loopamp real time turbidimeter teramecs co ltd japan', 'reaction positive turbidity min nm', 'time turbidity sample threshold time tt', 'hnb dye sigma usa distilled water mm prepare stock solution', 'μm hnb dye μl reaction mixture lamp fd reagent', 'turbidity rt lamp naked eye', 'positive reaction color change violet sky blue', 'top pcr μl lamp reaction mixture pcr min extension sensitivity assessment target region ncr gene serotype use lamp reaction', 'target dna sequence lamp pgem vector promega usa', 'plasmid dna purification qiaprep miniprep kit qiagen germany', 'ncr gene confirm target', 'positive control plasmid determine minimum copy number detection limit target gene sequence detectable lamp', 'standard curve lamp serial dna sterile water', 'denv rna extracted culture supernatant genotype ii iii asian cosmopolitan genotype ii iii sub genotype iia iib', 'sensitivity rt lamp panel viral extracted culture supernatant', 'viral rna genesig real time qrt pcr denv specificity lamp genotype ii iii asian cosmopolitan genotype ii iii sub genotype iia iib', 'university malaya medical centre ummc diagnostic virology laboratory repository related common region japanese encephalitis virus jev chikungunya virus chikv sindbis virus sinv condition', 'specificity test lamp duplicate', 'clinical sensitivity specificity rt lamp suspected dengue healthy donor serum', 'sensitivity number true number true number false specificity number true number true number false', 'positive predictive value ppv negative predictive value average dengue prevalence malaysia', 'ppv sensitivity x prevalence sensitivity x prevalence x specificity x prevalence specificity x', 'composite diagnosis sample pcr elisa rt lamp result reference', 'primer single tube step rt system rapid detection dengue', 'lamp reaction plasmid dna template determine optimal reaction', 'amplification typical ladder multiple', 'rt amplification naked eye inspection addition dye real time turbidimeter', 'positive reaction color change violet sky blue fig', 'temperature optimal time positivity naked eye real time loopamp realtime turbidimeter denv denv serotype fig', 'positive color sky blue turbidity reference virus none control color change', 'sensitivity rt lamp detection detection limit rt low ten', 'total positive rt lamp', 'elisas qrt pcr positive table', 'clinical sensitivity rt lamp qrt pcr table', 'loop isothermal amplification lamp novel dna amplification method notomi et al', 'diagnostic', 'lamp easy use convenient cost effective minimal equipment water', 'diagnostic tool several viral bacterial parasitic', 'parida et al', 'step rt lamp detection dengue separate', 'li et al', 'single tube reaction system detection denv infection rt lamp amplification c prm gene gene denv inter serotype', 'rt lamp ability detect denv small clinical sample size', 'teoh et al', 'single tube reverse rt lamp untranslated region utr detection denv dengue', 'sensitivity rt lamp', 'present study step rt capable dengue', 'addition real time monitoring present lamp test study hnb dye detection naked eye min amplification step', 'amplification time rt rt lamp', 'rt study sensitive specific qrt pcr table', 'date illness ranged day day', 'denv viral day day denv rna serum', 'viral equivalent rna detection limit qrt pcr', 'possible false negative qrt pcr', 'simplicity high efficiency dna isothermal lamp alternative dengue virus field pcr time require rt pcr machine', 'advantage lamp assay colorimetric detection positive positive negative observed color eye', 'study rt lamp potential alternative molecular diagnosis routine dengue virus endemic', 'useful monitoring efficacy dengue control eradication']"
432a9661e8c0a00f31e4e276a808a0a47860bbb5,cov infection hematologic malignancy respiratory virus hsct hematologic rhv env respiratory tract possible proven cov respiratory infection respiratory respiratory rhv respiratory viral malignancy hsct cov hematologic positive cov role cov viral infection allogeneic hsct bal sample infection similar new radiographic np bal possible lrtd similar respiratory tract disease unique infection virus panel acute chronic admission hospital autologous hsct bronchoalveolar lavage cell transplant clinical impact confirmation additional coronavirus cov cov lrtd cov positive disease respiratory due respiratory episode infection group covs group ii hematopoietic stem hsct acute hsct possible identification cov identification respiratory impact coronavirus impact cov impact respiratory incidence cov infection hospital infection host infection hsct infection initial infection likely lrtd due majority cov malignancy respiratory new pulmonary nosocomial acquisition pcr panel positive positive positive respiratory proven cov proven respiratory radiographic infection respiratory table retrospective review sample new stem cell transplant hsct unique episode virus np virus rhv accounting positive accounting relative acquisition month acquisition requirement acquisition respiratory acute pulmonary additional feasible additional prospective address impact adenovirus adv administration purpose admission respiratory adv hematologic adv methicillin age cov allogeneic autologous allogeneic hematopoietic american clinical analysis bronchoalveolar analysis cov anemia mastocytosis antibacterial therapy antibacterial use aplastic anemia assay distinguish assay food,"['background respiratory little known clinical impact coronavirus cov infection hematopoietic stem cell transplant hsct hematologic', 'role cov respiratory tract hsct hematologic malignancy', 'study design retrospective review infection polymerase chain reaction pcr nasopharyngeal bronchoalveolar lavage fluid', 'infection hsct hematologic malignancy clinical respiratory', 'identified n n positive respiratory virus n', 'hsct hematologic malignancy', 'unique infection enterovirus rhv env infection common', 'group march', 'cov infection upper respiratory tract similar respiratory', 'possible proven respiratory tract disease common respiratory rhv env', 'hsct hematologic malignancy respiratory viral infection likely progress respiratory tract disease respiratory', 'clinical significance respiratory respiratory syncytial virus rsv parainfluenza pivs human metapneumovirus hmpv rhinovirus rhv adenovirus adv hematologic autologous allogeneic hematopoietic stem cell transplant hsct', 'address impact coronavirus cov infection', 'respiratory tract disease lrtd due cov case report level retrospective analysis bronchoalveolar lavage bal hsct acute pulmonary process cov sample', 'prospective surveillance study hsct single center course year high cumulative incidence cov infection first allogeneic hsct case cov respiratory tract sample', 'series impact respiratory viral assessed clinical impact cov hematologic', 'high frequency infection relative paucity information impact cov hematologic retrospective review cov year period order role cov respiratory tract', 'nasopharyngeal np bal outpatient inpatient respiratory virus june july health science university ohsu study', 'demographic clinical information patient positive cov respiratory part multiplex pcr panel obtained medical chart review', 'patient hematologic malignancy treatment type leukemia lymphoma multiple myeloma aplastic anemia mastocytosis myelodysplastic syndrome amyloidosis', 'underwent autologous hsct cord blood transplant cbt classified disease necessitating transplant', 'multiplex respiratory virus pcr panel xtag rvp luminex manufacturer', 'assay distinguish rhv enterovirus env analysis', 'cov pcr rvp kit clinical college american clinical laboratory improvement regulatory molecular lab', 'unique episode infection initial identification respiratory virus np bal sample', 'respiratory virus multiple consecutive patient interim negative test representative prolonged single unique episode infection', 'mortality respiratory virus infection death due respiratory failure identification cause respiratory virus', 'respiratory virus inpatient infection new inpatient ward', 'possible proven identification respiratory virus np sample possible lrtd bal sample new pulmonary', 'comparison categorical viral exact test', 'total np bal general hospital inpatient outpatient limited hsct hematologic malignancy', 'unique infection positive respiratory virus table', 'cov third common virus rhv env accounting positive', 'bal positive positive', 'unique infection hematologic malignancy hsct patient table', 'cov hematologic malignancy hsct', 'infection hsct hematologic malignancy population winter march fig', '', 'malignancy hsct positive cov majority group n group ii n', 'cov positive positive cov rhv rsv hmpv rsv adv', 'order define role cov respiratory tract hematologic limited clinical analysis cov co respiratory table', 'cov underlying hematologic malignancy undergone allogeneic autologous hsct', 'clinical cov infection infection respiratory rsv rhv env patient population', 'median age cov similar respiratory', 'cov hmpv rhv env trend rsv', 'cov infection hospital', 'inpatient hsct oncology ward day period january march', 'indicative epidemiological link unable', 'surveillance part infection control program time period nosocomial acquisition respiratory virus rhv influenza personal communication dr lynne strasfeld', 'outpatient admission hospital evaluation new pulmonary', 'requirement hospitalization cov infection different infection respiratory', 'similar respiratory majority uri congestion sore throat', 'evidence lrtd cough new radiographic infection trend hypoxemia well', 'allogeneic hsct possible cov lrtd identification cov np new radiographic infection respiratory rhv env', 'none underwent bronchoscopy', 'allogeneic hsct identification cov bal sample new radiographic', 'adv methicillin resistant staphylococcus aureus bal contribution cov unclear', 'incidence possible proven cov infection respiratory rhv env', 'possible proven day hsct acute chronic graft versus host disease gvhd', 'third episode proven third cov positive bal table patient undergone hsct hematologic malignancy case', 'mortality attributable cov infection', 'complement expand role cov infection host', 'group hsct hematologic malignancy respiratory viral infection diagnostic testing', 'population cov infection similar uri nosocomial acquisition requirement hospital admission respiratory', 'cov infection possible proven respiratory rhv env', 'frequency detection cov study consistent previous cov detection respiratory', 'true prevalence cov infection screen asymptomatic prevalence infection due detection asymptomatic', 'important note true rate influenza infection initial test choice institution influenza specific pcr respiratory virus panel study', 'accounting relative frequency cov influenza respiratory', 'hematologic malignancy hsct majority positive cov respiratory', 'bias likely tested respiratory symptomatic importance', 'female predominant gender distribution infected cov knowledge', 'frequency respiratory general population due exposure responsible burden cov infection similar pattern respiratory', 'confirmation additional', 'majority cov hematologic malignancy hsct group', 'group covs infection host group several series case', 'contrast general pediatric patient majority cov group ii', 'group covs differ mechanism virus entry host cell degree genetic variability pathogenicity', 'cov', 'incidence cov various patient necessary insight fundamental biological group', 'similar previous rate low different respiratory', 'caution bronchoscopy many virus upper sample institution', 'possible lrtd disease respiratory rhv env rate possible lrtd due respiratory consistent literature', 'performed time diagnosis respiratory viral infection likely evidence respiratory tract illness', 'possible proven cov hsct possible proven lrtd infection respiratory hsct hematologic malignancy', 'acute chronic gvhd', 'findings cov virulent respiratory immune suppression hsct order progress lrtd', 'low number cov lrtd study meaningful risk factor assessment additional feasible', 'lrtd cov infection relevant', 'hospital infection hospital acquisition month span', 'cov infected empiric course antibacterial therapy', 'cov part respiratory virus panel institution study period cov medical record assay food drug administration purpose', 'theory negative respiratory virus panel result frequent admission hospital medical evaluation antibacterial use nosocomial transmission', 'cov infection similar infection respiratory table overall impact respiratory viral utilization medical', 'conclusion hematologic suspicion respiratory viral infection lrtd respiratory rhv env', 'retrospective nature work confirmation additional prospective']"
d80ebadc0c335da9a5c4fffa527690bf146e934d,rt siba rt pcr rsv b detection rsv rsv rsv siba rsv reverse transcription detection time siba rt rsv np sensitivity rt amount time bio rad np swab pcr rsv performance rt rapid detection analytical sensitivity detect rsv respiratory tract rsv rna rsv rt target region target specific b rna diagnosis rsv nucleic acid rsv positive sensitivity specificity siba rapid time detect total amount acid amplification chain reaction comparison rt compatible rapid high sensitivity invasion amplification pcr detection point care polymerase chain reaction rt respiratory syncytial rsv clinical rt rsv sample processing siba comparison strand invasion syncytial virus transcription polymerase transcription strand viral rna accurate diagnosis amplification method amplification reaction amplification rt average amount common respiratory complexity preparation concentration nm conclusion rt constant temperature crude sample discovery life ease use evaluate performance important role internal control iowa black isothermal nucleic kit qiagen method total mini kit nasopharyngeal swab negative rsv np negative np siba pcr radts positive rsv preparation total processing method qiaamp viral rad qpcr radts important radts radts rapid sample reaction tube reaction volume region rsv reverse transcriptase rna mini rna template rsv binaxnow rsv high rsv nasopharyngeal rsv point rsv reaction rsv similar sample rna siba compatible,"['background respiratory syncytial virus rsv common respiratory tract young elderly', 'accurate diagnosis respiratory tract patient care unnecessary', 'rapid nucleic acid detection rsv high sensitivity rt pcr', 'evaluated reverse transcription isothermal nucleic acid amplification method reverse transcription strand invasion amplification rt siba rapid detection rsv', 'rt good sensitivity rna reverse transcription polymerase chain reaction h performance rt siba rsv nasopharyngeal swab', 'rt sensitivity specificity', 'conclusion rt siba require purified rna rapid detection rsv compatible rapid', 'complexity preparation total amount time detect rsv clinical', 'rt rsv tool prompt management infection respiratory syncytial virus rsv cause respiratory tract high morbidity mortality', 'rsv acute respiratory tract infection young', 'year rsv account respiratory rsv age', 'rsv member paramyxoviridae family negative sense rna genetic material', 'major rsv b surface genetic variation', 'rsv circulate epidemic', 'accurate diagnosis rsv important role management treatment distinguish rsv viral bacterial respiratory tract clinical presentation', 'diagnosis crucial role inappropriate use risk antimicrobial resistance', 'nucleic acid amplification reverse transcription polymerase chain reaction rt pcr detect rsv sensitive rapid antigen detection', 'superior sensitivity rt pcr radts radts important diagnostic tool point care due turnaround time ease use', 'specialised training sophisticated costly instrumentation perform rt pcr', 'large central', 'study naat rsv similar time detection radts high sensitivity rt pcr', 'diagnostic time isothermal reverse transcription strand invasion amplification rt detection rsv', 'rt siba rna cdna reverse transcriptase isothermal reaction', 'siba utilize recombinase single stranded invasion io separation target duplex', 'generation single target template bound target specific action polymerase', 'dependent strand separation subsequent polymerase dependent extension target exponential amplification isothermal', 'total nasopharyngeal np swab discovery life discovery life', 'positive negative n rsv binaxnow rsv rapid immunoassay test usa', 'evaluate performance rt siba comparison rt pcr detection rsv', 'viral rna qiaamp viral rna mini kit qiagen germany manufacturer', 'μl rna rt siba rt pcr rsv', 'np swab quick crude protocol rna purification', 'end μl np swab μl lysis triton mm magnesium acetate sigma aldrich usa μl crude lysate rt siba reaction', 'preparation rsv rna purified rsv atcc rsv b atcc american type culture collection lgc germany viral qiaamp viral rna mini kit qiagen manufacturer', 'rna genesig® rsv rt pcr kit primer design™ ltd uk', 'kit rsv rna pre copy', 'generate standard rsv rna rsv b rna', 'rt pcr bio rad qpcr instrument bio rad', 'rsv rna analytical sensitivity rt siba comparison rt pcr detection rsv', 'assay detect human rsv b', 'rsv virus pathogen resource national center biotechnology information database', 'assay region rsv n protein gene', 'assay target region rsv rsv b', 'rsv rsv b share homology target region', 'set target region', 'reverse primer probe', 'use multiple improved detection rsv rsv b reaction tube', 'rt detect bacteriophage', 'target specific', 'rsv reaction tube', 'internal control inhibition', 'rt siba siba® reagent kit orion diagnostica oy finland addition reverse transcriptase promega uk', 'reverse concentration nm', 'rsv rsv b', 'rsv concentration nm', 'rt siba rsv table', 'total sigma aldrich reaction', 'uvsx concentration mg ml', 'total μl sample rna template total reaction volume μl', 'rt siba green dilution', 'min fluorescence bio rad cfx bio rad', 'curve profile amplification reaction specific', 'performance rt rt pcr detection rsv rsv b', 'rt siba rt pcr time', 'μl sample rna template total rt pcr reaction volume μl', '', 'rt pcr express qpcr supermix thermo fisher scientific usa', 'thermal program min min bio rad qpcr equipment bio rad', 'analytical sensitivity rt siba comparison rt pcr analytical sensitivity rt siba rsv rt pcr rsv', 'siba rt pcr rsv independent serial rsv reaction', 'dilution', 'rt siba target specific green', 'internal control assess sample inhibition', 'rsv probe rox iowa black fq quencher iowa black rq quencher', 'rt pcr target specific probe specific detection rsv rsv b', 'fig', 'table', 'rt siba rt pcr rna control dilution', 'average amount time positive corresponding cycle ct pcr table', 'rt siba constant temperature thermal cycling', 'hence rt siba min', 'rt siba rsv rsv b', 'ct rsv b rna', 'average amount time positive pcr due initial reverse transcription step instrument ramp time', 'rsv rt siba rt pcr', 'analytical specificity rt siba rsv subsequent curve analysis presence single specific amplicon performance rt siba detection rsv np swab', 'total np negative rsv positive rsv binaxnow test', 'total rna evaluate performance rt siba rt pcr rsv', 'table', 'rt siba rt pcr rsv rsv np positive rsv', 'amplification reaction rt siba np negative rsv', 'rt siba rsv rsv positive min detection time rt pcr rsv h detection time advantage rt siba rt pcr', 'possibility step rapid lysis np rna', 'complexity preparation total amount time detect rsv clinical', 'table', 'rsv rsv positive np siba crude sample lysis method', 'detection rsv rt clinical commercial extraction clinical rapid sample processing method', 'difference final amount rna present reaction', 'rsv np nasopharyngeal rsv respiratory syncytial virus rt pcr reverse transcription polymerase chain reaction rt siba reverse transcription strand invasion amplification utm universal transport medium viral transport medium negative np siba', 'min rapid preparation protocol whereas purification rna np min', 'crude sample processing protocol siba shorten total amount time detect rsv np', 'study alternative naat rt siba rapid detection rsv np swab', 'method useful detection', 'siba isothermal nucleic acid amplification method dependent target specific dna duplex', 'inclusion reverse transcription siba siba rapid detection rna', 'siba low constant temperature therefore require complex instrumentation contrast rt pcr', 'siba compatible complex point care', 'portable specialised interpret', 'study rt siba qpcr device convenience multiple reaction', 'rt rsv rsv b', 'rt siba rsv similar analytical sensitivity specificity pcr method detection rsv', 'rt rsv b rna min', 'detection time rsv b target region complementary', 'siba tolerate nucleotide target region detection time rsv b rna', 'detection time rt siba rsv rt pcr h rt siba rsv specific manner cross common respiratory', 'performance rt siba rsv np swab', 'rt siba rsv np rsv positive rt pcr', 'number np rt siba sensitivity specificity', 'method compatible rapid sample processing method total amount time detect rsv clinical', 'detection siba similar radts', 'radts detect min', 'sensitive rt pcr', 'superior sensitivity rt pcr radts radts important role diagnosis rsv point ofcare due rapid detection time ease use', 'rt siba detection time rapid high analytical sensitivity similar rt pcr', 'conclusion rt siba rapid detection rsv high sensitivity specificity rsv rna', 'method total detection time diagnosis rsv nasopharyngeal swab', 'rt siba compatible rapid portable device useful molecular rapid diagnosis rsv point care']"
866751c51397d3b80b2b7f1735947c8c5096da2f,new world prevention control clinical disease experimental infection world monkeys infection common intranuclear inclusion clothing face common susceptible electron microscopy gbv b infection new protective clothing vaccinia virus animal animal animal model biologic identification chronic hepatitis cowpox virus diagnosis typical disease virus ebv infection electron microscopic experimental ebv gross pathology incubation period infection meningoencephalitis influenza virus interstitial pneumonia isolation molecular lymphoproliferative disease molecular biologic morbidity mortality nasal discharge natural host natural infection nonhuman primate old world rna virus secondary bacterial simplex virus typical histologic vesiculation ulceration virus isolation virus strain world monkey zoonotic agent able infect absence visible acidophilic apoptotic acute hepatitis acute respiratory adenovirus infection apoptotic councilman b infection belong genus burkitt lymphoma callitrichid hepatitis callitrichine herpesvirus causative role cause human cell infiltration common animal common marmoset cotton top differential diagnosis direct contact disease natural disease occur disease similar disease spread evidence syncytial experimental gbv face risk family flaviviridae fecaleoral route gamma herpesvirus gb agent gbv c gross congestion hemorrhagic fever hepatitis several hepatitis virus herpesvirus herpesvirus herpesvirus infection herpesvirus related high morbidity histologic electron host range infection disease infection fatal inflammatory cell intranuclear intracytoplasmic le bn lymphocryptovirus infection lymphoma development major cause marmoset colony marmoset lymphocryptovirus measure nm,"['kerstin mätz martina bleyer german primate center pathology unit göttingen germany etiology', 'family herpesviridae beta gammaherpesvirinae', 'family typical dna complex dna genome icosahedral capsid', 'adapted natural able persist latent form', 'potential cross severe zoonotic susceptible', 'common important simplex virus callitrichine herpesvirus lymphocryptovirus gammaherpesvirinae', 'clinical', 'susceptible human virus', 'original host reservoir hsv', 'natural host cause mild facial gingivostomatitis keratitis inapparent', 'lifelong infection simplex virus viral latency sensory', 'immunocompromised fatal encephalitis systemic disease occur', 'immunity stress disease virus activated suppression latency transcript gene', 'stage virus absence visible', 'oral conjunctival infection meningoencephalitis whereas genital neonatal infection infection', 'susceptible', 'transmission monkeys vice versa high morbidity mortality common', 'evidence presence virulence', 'spontaneous wild black ear penicillata natural park brazil young pet jacchus private common marmoset colony germany', 'herpesvirus infection close association family', 'epizootiology', 'likely source transmission close contact oral herpesvirus infection', 'disease spread contact saliva contaminated', 'animal able infect example food mouth mouth hand offspring', 'colony disease spread direct contact aerogenous transmission', 'pathology', 'infection fatal febrile disease typical mucous', 'clinical extent severity gross', 'infected severe apathy anorexia weakness salivation serous nasal discharge moribund die', 'death first', 'rare persistent infection serologic examination', 'gross pathology variable extent oral genital mucous mucocutaneous confluent covered fibrinonecrotic exudate fig', '', 'severe lymphadenopathy regional lymph', 'hemorrhage organ disease', 'severe cerebral cortex', 'histopathologic severe vesiculation ulceration squamous mucous tongue acantholysis parakeratosis coagulation necrosis polykaryocytosis', 'necrotic foci submucosa surface epithelium fig', '', 'epithelial ulcer degeneration necrosis', 'typical intranuclear inclusion key morphologic infection', 'epithelial', 'intranuclear clear halo red blue feulgen', 'presence hsv antigen immunohistochemistry commercial simplex antigen', 'nonsuppurative meningoencephalitis frequent hsv infected fig', '', 'intranuclear inclusion glial', 'widespread distribution virus immunohistochemistry fig', '', 'transmission electron microscopy large cytoplasm intercellular', '', 'intranuclear measure nm extranuclear diameter mm', 'similar gross histologic', 'diagnosis', 'diagnosis histologic immunohistologic electron microscopic demonstration classic intranuclear inclusion', 'commercial hsv detection immunohistochemistry cross reactive', 'definitive diagnosis virus isolation detection viral molecular', 'prevention control', 'treatment available application antiviral early disease', 'natural reservoir host virus contact', 'infected absence visible', 'use appropriate personal protective clothing face', 'etiology', 'saimiriine herpesvirus herpesvirus tamarinus alpha herpesvirus many simplex virus infection new world monkeys', 'reservoir', 'clinical', 'squirrel virus clinical disease', 'rare mild oral ulceration infection', 'persistence virus sensory', 'virus reactivation oral', 'susceptible acute lethal disease', 'incubation period infection inflammation various', 'clinical vesiculation ulceration oral mucous', 'pathology', 'addition vesiculation ulceration oral mucous gross ulceration hemorrhage alimentary tract', 'initial intraepidermal progress full thickness necrosis', 'adnexal sebaceous hair', 'giant reveal intranuclear inclusion', 'inflammation spleen kidney adrenal gland lung', 'contrast virus infection meningoencephalitis minimal', 'meningoencephalitis criterion distinguish herpesvirus', 'prevention control', 'prevention separation susceptible reservoir lagothrix', 'past live vaccine vaccination vaccinated vaccine', 'simian new world old world monkey', 'cmvs host range infection healthy mature host asymptomatic', 'cmvs typical opportunistic infection disease apparent immunodeficient', 'marmoset herpesvirus associated disease', 'etiology', 'nonhuman infected specific gamma genus lymphocryptovirus', 'distinct simian', 'related human herpesvirus epsteinebarr virus ebv', 'ebv indigenous', 'infected lifelong latent asymptomatic', 'certain infectious mononucleosis', 'association infection tumor development', 'context ebv pathogenesis burkitt lymphoma cell lymphoma nasopharyngeal carcinoma oral hairy leukoplacia non lymphoma', 'general infection disease natural host', 'immunosuppression infection nonnatural rapid lymphoproliferation lymphomatous disease', 'spontaneous disease ebv infection common demonstration serum susceptible', 'experimental ebv infection common seroconversion definite evidence lymphoproliferative disease lymphoma', 'epizootiology', 'positive early antigen virus capsid antigen nuclear antigen low number', 'experimental ebv infection resemble common useful model potential development ebv neoplasia', 'cotton top ebv virus different manner fatal lymphoproliferative disease human burkitt lymphoma', 'white labiatus lymphoma experimental ebv inoculation', 'etiology', 'common marmoset lymphocryptovirus callitrichine herpesvirus', 'virus lymphoproliferative disease b cell intestinal tract lymph causative role oncogenic potential virus definitive proof', 'several individual infection laboratory', 'typical lymphocryptovirus complex genome', 'sequence overall homology genome primitive lymphocryptovirus', 'epizootiology', 'wild caught captive seropositive virus', 'seroprevalence marmoset lymphocryptovirus infection ubiquitous infection ebv lymphocryptovirus infection old world', 'overt clinical disease', 'affected weight loss inappetence diarrhea', 'pathology', 'intestinal obstruction due intraabdominal', 'nonspecific neutrophilia shift', 'gross pathology mesenteric lymph', 'digestive tract mucosa', 'lymph node architecture heterogeneous neoplastic round b', 'small reactive neoplastic', 'similar colonic mucosa lamina propria submucosa muscularis serosa', 'small intestine fig', '', 'neoplastic cellular liver kidney lung', 'development spontaneous healthy immunocompetent lymphomagenesis', 'causative role development gastrointestinal carcinomas unlikely', 'diagnosis prevention control', 'serologic available diagnose latent', 'possibility isolate free herpesvirus', 'zoonotic potential', 'etiology', 'saimiriine herpesvirus herpesvirus saimiri hvs gamma herpesvirus related herpesvirus', 'lymphotropic virus squirrel sciureus cause disease', 'squirrel hvs', 'transmission horizontal infection saliva life', 'virus sensory', 'neoplastic oncogenic', 'clinical', 'disease natural host experimental transmission hvs common susceptible new world monkeys fatal acute lymphoproliferative disorder', 'clinical outcome experimental virus strain', 'different hva c basis dna sequence divergence terminus l dna', 'oncogenic marmoset peripheral blood cell new world primate', 'experimental infection different disease virus strain host', 'time span infection lymphoma development survival time', 'aggressive extensive necrosis replacement normal tissue structure', 'survival progressive lymphoma development leukemia', 'pathology', 'gross pathology enlarged peripheral visceral lymph', 'characteristic hemorrhagic peyer', 'basic histologic lymphoblastic organ', 'discrete neoplastic infiltrative invasive growth', 'neoplastic pleomorphic round large', 'leukemia present', 'neoplastic', 'prevention control', 'experimental disease', 'accidental natural transmission squirrel possible', 'squirrel mixed', 'zoonotic potential', 'ateline herpesvirus athv herpesvirus gamma herpesvirus related hvs', 'virus spider', 'lead clinical disease', 'athv similar pathogenic saimiri new world primate', 'survival time experimental infection hvs', 'identical', 'etiology', 'large brick ovoid enveloped dna', 'different opv family yatapox virus monkey tumor virus yaba disease virus occur new world monkeys', 'important pathogen opvs varv causative agent smallpox', 'contrast vaccinia virus vacv cowpox virus cpxv broad host range able infect cattle nonhuman', 'vaccinia virus orthopoxvirus smallpox vaccination', 'vaccinia virus ankara mva vaccinia virus elstree vacv le bn classical smallpox eradication', 'mva different nonhuman primate animal recombinant', 'common typical vaccine take site intradermal injection vacv le bn multipuncture method standard', '', 'focal poxlike skin lesion infectious vaccination skin', 'specific igm igg day day vaccination', 'day postvaccination', 'epizoology', 'common susceptible cowpox virus cpxv orthopoxvirus endemic', 'virus europe central asia endemic wild bank glareolus wood mice apodemus sylvaticus', 'domestic infected contact potential responsible majority human cpxv', 'cpxv variety zoo old world monkeys', 'clinical', 'infection skin local infection site inoculation', 'infection fatal clinical disease occur immunodeficient susceptible', 'cowpox sporadic environmental viral burden pathogenetic potential virus', 'common natural experimental infection severe vesicular hemorrhagic dermal facial skin fig', 'scrotum labia palmar plantar', 'orthopoxvirus infection new world monkey cowpox virus calpox virus isolated natural disease outbreak', 'induced disease similar natural infection', 'pathology', 'vesicular skin acanthosis vesiculation hemorrhage necrosis typical orthopoxvirus inclusion epithelial syncytia formation basal', 'andc', 'lymph hyperplastic reveal necrosis spleen', 'disease course fatal', 'similar common yatapoxvirus', 'diagnosis', 'diagnosis typical histologic electron microscopic isolation molecular biologic identification', '', 'natural infection common influenza virus susceptible experimental infection pandemic influenza virus influenza influenza', 'animal animal transmission influenza virus strain', 'human flu nasal discharge breathing loss appetite', 'total protein bronchoalveolar lavage fluid lung damage', 'gross pulmonary multifocal hemorrhage edema consolidation', 'detailed description microscopic common available', 'etiology', 'belong genus family adenoviridae', 'dna mild moderate respiratory enteric disease', 'many cell culture healthy subclinical persistent common nhp', 'clinical', 'clinical disease due natural adenovirus infection common evidence latent infection observation human adenovirus detection adenovirus captive common central europe', 'experimental infection common monkey adenovirus tmadv novel adenovirus acute respiratory illness fatal hepatitis pneumonia titi productive infection clinical inoculation specific antibody detection virus nasal swabs postinoculation', 'pathology', 'pathological mild bronchitis atypical nodular hyperplasia liver enterocolitis', 'typical basophilic intranuclear consistent active adenovirus infection', 'diagnosis', 'diagnosis typical histologic electron microscopic isolation molecular biologic identification', 'prevention control', 'adenovirus zoonotic agent evidence cross transmission care', 'protective clothing face risk transmission', 'etiology', 'relevance belong genus betacoronavirus family coronaviridae', 'common severe acute respiratory syndrome coronavirus middle east respiratory syndrome coronavirus disease similar useful animal model pathogenic coronavirus', 'intratracheal inoculation cov urbani strain mild clinical disease increase rectal temperature watery diarrhea dyspnea infection', 'multifocal pulmonary atelectasis consolidation tracheobronchial lymphadenopathy', 'predominant histological lesion multifocal interstitial pneumonia syncytial type pneumocyte hyperplasia edema lymphocytic bronchiolitis', 'tracheobronchial lymph parafollicular lymphocytic hyperplasia histiocytosis subcapsular', 'extrapulmonary lymphocytic hepatitis single cell necrosis mild diffuse colitis mild multifocal lymphocytic myocarditis', 'common inoculated strain moderate severe respiratory disease increased respiratory mouth decreased activity presence oral frothy hemorrhagic discharge', 'transient decrease body temperature', 'radiographic imaging severe bilateral interstitial infiltration', 'major gross multifocal consolidation dark red discoloration', 'show multifocal moderate severe acute bronchointerstitial pneumonia type pneumocyte hyperplasia consolidation pulmonary fibrin', 'coronavirus microscopy common enterocolitis', 'petal measure nm', 'zoonotic', 'etiology', 'single rna family parainfluenza virus respiratory disease common', 'virus result direct contact inhalation likely represent stress', 'clinical disease upper respiratory tract disease severe systemic illness death infant', 'clinical', 'clinical ocular serous purulent discharge dyspnea depression anorexia', 'pathology', 'gross congestion consolidation alveolar edema', 'main histological acute interstitial pneumonia variable degree evidence syncytial intranuclear intracytoplasmic inclusion', 'diagnostic direct electron microscopy nasal swab lung immunofluorescence lung tissue serological detection', 'prevention control', 'natural infection treatment symptomatic prevent secondary bacterial', 'available nhps', 'protective clothing face risk transmission', 'etiology', 'morbillivirus family serious high morbidity mortality marmoset', 'spread main source infection', 'exhibit inconsistent organotropism infected respiratory tract skin common disease manifestation', 'clinical', 'several nwm monkey gastrointestinal tract hemorrhagic diarrhea predominant infected common characteristic pneumonia', 'common infection apparent lethargy facial edema nasal discharge exanthema', 'death h first clinical', 'pathology', 'characteristic histopathological interstitial pneumonia hyperemic alveolar', 'syncytial epithelial eosinophilic intracytoplasmic intranuclear inclusion disease obligatory absent skin', 'secondary bacterial infection bronchopneumonia', 'syncytial inclusion different lymph spleen colon', 'maculopapular skin focal hyperemia', 'experimental intracerebral inoculation encephalitis similar subacute panencephalitis', 'immunosuppressive clinical picture secondary opportunistic viral bacterial', 'diagnosis', 'diagnostic etiology detection seroconversion virus isolation immunohistochemical demonstration viral antigen tissue', 'treatment supportive therapy secondary bacterial', 'prevention control', 'tolerability commercial common literature', 'zoonotic risk naive protective clothing face', 'etiology', 'paramyxovirus saguinus variant single outbreak infectious gastroenteritis marmoset colony new england primate research center', 'virus infect cotton top common clinical diarrhea dehydration rapid progression death', 'gross congestion hemorrhage gastrointestinal mucosa enlargement lymphoid spleen', 'predominant microscopic lesion ulcerative typhlocolitis evidence syncytial epithelium', 'intranuclear intracytoplasmic multinucleated', 'syncytial pancreatic duct epithelium pancreatic acini hepatic kidney endometrial epithelium', 'histologic cholangitis necrosis germinal spleen peyer', 'virus fecaleoral route', 'origin infection unknown', 'preventive curative treatment available', 'etiology', 'callitrichid hepatitis acute fatal infection new world callitrichid hepatitis virus', 'virus rna virus related lymphocytic choriomeningitis virus lcmv house mouse mus major reservoir', 'lcmv cause human disease self influenza illness disease progress acute meningitis', 'several hepatitis captive united feeding neonatal mice lcmv', 'outbreak germany transmission wild mice', 'general transmission contact ingestion', 'clinical', 'clinical dyspnea weakness jaundice', 'serum', 'clinical', 'coagulopathy', 'pathology', 'hepatosplenomegaly pleural pericardial subcutaneous intramuscular characteristic', 'random hepatocellular degeneration spotty necrosis mononuclear inflammatory cell infiltration liver', 'lcmv antigen demonstrable foci', 'round acidophilic apoptotic councilman present fig', '', 'free kupffer', 'necrotic spleen lymph adrenal intestine', 'nonsuppurative meningitis encephalitis liver', '', 'extrahepatic liver', 'electron microscopy enveloped virus rough endoplasmic reticulum golgi complex', 'experimental infection possible identical clinical pathological', 'prevention control', 'contact essential avoid rodent borne disease', 'zoonotic agent disease', 'seroconversion disease', 'etiology', 'hepatitis virus hav major cause acute viral hepatitis several nonhuman primate', 'common indicated serologic', 'virus small rna virus hepatovirus family picornaviridae', 'transmission fecaleoral route', 'clinical', 'clinical uncommon seroconversion elevation clinical infection', 'past common animal model disease', 'infected oral route intragastric infection direct inoculation virus liver', 'infected acute hepatitis infection virus day', 'pathology', 'target organ viral replication', 'hav antigen detectable primary site virus replication', 'hav late incubation period excretion hav liver bile', 'end incubation period initial increase serum liver', 'characteristic histopathologic sinusoidal piecemeal necrosis periportal parenchymal mononuclear inflammatory cell infiltration detectable acute phase maximum transaminase appearance hav', 'time empty virus electron microscopy cytoplasmic', 'convalescent phase regeneration hepatic tissue transaminase baseline', 'hav zoonotic agent infected human infection', 'chronic carrier', 'etiology', 'major cause human hepatitis hepatitis b virus hbv orthohepadnavirus', 'transmission blood saliva', 'hbv cause persistent chronic hepatitis hepatocellular carcinomas', 'virus', 'natural new world', 'etiology', 'hepatitis small enveloped rna virus chronic hepatitis', 'hcv member genus hepacivirus family flaviviridae', 'hcv natural disease nonhuman experimental infection several nonhuman primate', 'susceptible represent important animal model chronic hepatitis', 'contrast gb agent number new world monkeys gbv enzootic viral several nwp common gbv b gbv c blood borne man', 'gb agent related', 'single positive sense rna family hcv', 'several gbv circulate wild new world monkeys', 'clinical disease gbv c infection diagnosis rt pcr plasma serum', 'contrast gbv b acute hepatitis several new world', 'common susceptible experimental gbv b infection characteristic acute nonsuppurative hepatitis infiltration b first primary infection', 'experimental gbv b infection surrogate model hcv infection investigation pathogenetic antiviral drug development', 'etiology', 'yellow fever yellow fever virus yfv flavivirus family flaviviridae viral infection new world monkeys', 'disease haemagogus', 'yfv endemic south america disease wild', 'howler', 'coincide human geographic vicinity', 'common endemic', 'infected succumb disease death week infection', 'gross specific fever jaundice', 'liver hepatocellular necrosis fatty change hemorrhage', 'acidophilic apoptotic councilman', 'disease problem wild living differential diagnosis endemic endemic', 'experimental infection common susceptible rna bunyaviridae arenaviridae filoviridae hemorrhagic', 'common animal arenaviridae argentine hemorrhagic fever junin virus filovirus hemorrhagic fever ebola marburg virus', 'etiology', 'family rhabdoviridae diverse group', 'cause morbidity mortality nonhuman', 'disease several new world monkey common', 'endemic nonhuman infected natural habitat represent important', 'several human contact wild cuffed common region brazil', 'specific rhabdovirus strain', 'epizootiology', 'nonhuman contact reservoir inadvertent host', 'virus spread animal animal animal human', 'infection vaccination virus', 'incubation time', 'initial replication site inoculation spread virus brain peripheral', 'brain virus', 'clinical widespread dissemination virus', 'clinical', 'infection meningoencephalitis clinical furious paralytic self mutilation irritability paralysis', 'disease start', 'pathology nonsuppurative encephalitis formation glial neuronal degeneration', 'eosinophilic intracytoplasmatic negri pathognomonic', 'diagnosis', 'diagnosis typical histologic virus isolation molecular biologic identification', 'diagnosis fluorescent antibody test specific antibody', 'differential diagnosis case cause encephalitis particular infection', 'prevention control', 'significant zoonotic threat care', 'vaccination preventative health care', 'vaccination nonhuman indoor outdoor enzootic advisable', 'use']"
a742cd09cb64555da961669c914e0f1527aea4fc,visna virus density gradient cell membrane et al virus cell electron dense electron microscopy harter choppin harter et cell fusion cesium chloride choroid plexus dense core gradient centrifugation sigurdsson al virus infection al becker becker al cell sheet electron microscopic harter al host cell infection harter infective virus morgan al osmium tetroxide peripheral coat plexus scp prepared electron present communication refractile spindle single osmiophilic virus viral acetate lead acheson tamm acid rna acridine orange addition glutaraldehyde additional membrane adsorption maintenance agent sigurdsson al acheson al infection al sigurdsson al stuart albumin bsa alteration host altered host american cell amphotericin b antigen cytoplasm appearance intact appearance refractile armour pharmaceutical atmosphere carbon attached prepared avian infectious az harter b atmosphere bablanian et become detached become result beneath outer bovine pancreatic bovine plasma bovine trachea brain spinal bronchitis virus bsa similar bud cell budding process buds singie buds surface buffer edta buoyant density carbon dioxide carcinoma leukemia case herpesvirus case oncogenic cell harter cell number cell plastic cell surface cell type cell tyrode cellular cytoplasm center hamre central core central matrix centrifugation bovine centrifugation cesium characteristic cytopathic chloride density chloride infective chloride large choppin harter citrate rca co kankakee coat cytoplasm coat mp,"['virus progressive neurological disease sheep subacute inflammation demyelination brain spinal cord sigurdsson al sigurdsson palsson', 'disease paralysis death', 'introduction virus first manifestation disease hence term slow virus describe visna agent sigurdsson sigurdsson al', 'visna virus primary tissue choroid plexus scp sigurdsson al', 'virus continuous line embryonic bovine trachea ebtr', 'infected characteristic cytopathic appearance refractile spindle development large giant long stellate degeneration cell sheet', 'virus latent period', 'ensuing virus cell sheet extensive degeneration infection harter et al', 'visna virus antigen cytoplasm inclusion giant late course infection harter az harter et az', 'acridine orange collect cytoplasm visna thormar harter et al', 'incorporation radioactive uridine thymidine virus viral nucleic acid rna harter al', 'previous electron microscopic study virus replication scp infected', 'intracellular viral virus cell membrane', 'present communication ultrastructural visna virus virus density gradient centrifugation', 'cell', 'scp prepared choroid plexus domestic hampshire suffolk harter choppin', 'ebtr american cell type culture collection', 'lamb choroid plexus scp drs', '', 'takemoto l sturman national health', 'cell plastic eagle medium bablanian et al infection', 'ebtr plastic petri cell', 'low rapid cell fusion degeneration virus cell harter choppin', 'adsorption maintenance medium heat lamb serum pg ml amphotericin b atmosphere carbon dioxide', 'infection supernatant bovine plasma albumin bsa', 'fraction armour pharmaceutical co kankakee illinois', 'material quick frozen infectivity', 'attached prepared electron microscopy', 'control medium bsa similar manner', 'monolayer plastic multiplicity tcid cell', 'seventytwo inoculation prepared electron microscopy', 'virus', 'viral infectivity observation eytopathic choppin', 'density gradient purification virus', 'low speed centrifugation bovine pancreatic deoxyribonuclease ribonuclease cesium chloride density gradient manner harter et al', 'material diluted phosphate buffer edta g electron microscopy', 'preparation electron microscopy', 'scp ebtr cell tyrode addition glutaraldehyde plastic centrifuged', 'pellet min glutaraldehyde postfixed min osmium tetroxide embedded epoxy resin epon', 'scp hour osmium tetroxide min', 'latter fixation preparation density gradient microscopy', 'virus uranyl acetate lead citrate rca electron microscope', 'electron microscopic control fibroblastic similar ultrastructural', 'large prominent chromatin', 'normal appearance intact cristae endoplasmic reticulum numerous', 'viruslike', 'light microscope first indication visna virus infection development refractile spindle', 'infection numerous large long slender fig', '', 'prominent microscopy crescent cell membrane extracellular distinct', '', 'cell number cytopathic infective virus table', 'crescent size l diameter single osmiophilic membrane', '', 'coat thin electrondense membranous structure rnp thick', 'many material cellular cytoplasm visible', 'majority process formation cell surface become detached free extracellular central core fig', '', 'second type extracellular particle spherical elliptical size diameter mp', 'single osmiophilic core diameter external limiting membrane density', 'additional membrane electron dense core', '', '', 'rare intracytoplasmic dense core single membrane peripheral coat cytoplasm', 'diameter peripheral coat mp', 'density gradient potassium tartrate cesium chloride infective visna virus buoyant density g ml harter choppin harter al', 'thin virus isopycnic gradient centrifugation cesium chloride large number single multiple', '', 'identical dense infected cell', 'purified virus fraction density gradient centrifugation', 'presence extracellular question visna virion', 'electron dense resemble size morphology visna virus cell', 'many density gradient maximal infective virus impression infective agent', 'intracellular visna virus', 'crystalline intracytoplasmic incomplete mature virus rna morgan al acheson tamm stuart fogh morgan al stuart plisser', 'specific stage development virus', 'visna virus viral infrequency documentation hypothesis difficult', 'noted dense bud cell membrane', 'crescent dense', 'present communication lend support extensive study reveal transitional', 'transition rapid intermediary escape notice', 'dense cytoplasmic density gradient unlikely infectious represent helper virus', 'host cell membrane become result viral infection resemble envelope buds', 'similar phenomenon case herpesvirus paper al', 'latter study altered host contact surface membrane uninfected fusion similar fusion envelope time entry al', 'interest connection visna virus cell fusion harter choppin', 'mechanism cell fusion analogous', 'buds surface visna virus resemble surface mouse mammary carcinoma leukemia double walled cell membrane thormar', 'current microscopy budding process visna virus infection case oncogenic rna', 'immature spherical mammary tumor virus', 'dense central matrix development murine leukemia deharven dalton et dalton ziegel', 'interest avian infectious bronchitis virus ibv human pathogen strain electron dense core translucent center hamre al becker al', 'infective unclear', 'resemble present study', 'buds singie electron dense layer beneath outer membrane visna virus infection cytoplasmic infected et al becker al', 'infection specific structural alteration host cell membrane determined']"
86bd9005ed7a8aa7f895a9d0769b8dd8e4990e06,substitution rate structural gene host range non structural transmission route mammalian rna cell tropism range genome viral substitution genome architecture r r route acute mutation rate rna virus significant predictor persistent infection specific host ancova base dn ds nucleotide substitution rate variation rate viral acute infection epithelial target fecal oral gene substitution mean substitution oral respiratory structural non target cell virus evolution acute persistent different cell generation time long term cell transmission gene dataset neural target regression base respiratory transmission substitution target term substitution vertical transmission analysis r base epithelial base neural base target family specific gene rate genome length genome sense genomic architecture infection family infection host infection order model significant order specific predictor variable r model respiratory vertical significant viral substitution structural target fecal target respiratory target transmission length genome mutation base nonstructural gene rate predictor sense genome significant substitution structural different substitution mammalian substitution study tropism significant ancova analysis ancova structural architecture ecology available genbank bayesian coalescent control rate determination r different viral epithelial significant genetic diversity genome segmentation influenza virus log scale mode host predictor confidence relationship substitution reliable mutation rna viral scale mean second ancova selection variation significant rate standardized confidence structural nonstructural structural structural,"['high virus evolution replication error prone rna dependent rna', 'long term substitution correlate well mutation selection', 'substitution rate variation virus ecology intrinsic genomic', 'nucleotide substitution rate mammalian rna comparable dataset substitution structural different structural', 'ancova ecological cell transmission route host range infection duration genomic length genome sense genome segmentation', 'target significant viral substitution epithelial significant', 'tailed epithelial neurotropic structural structural', 'strong evidence mammalian rna turnover proliferative epithelial', 'viral generation epithelial infecting different cell', 'cell tropism key factor viral evolvability', 'rna responsible disproportionate number human influenza ebola hemorrhagic fever hantavirus pulmonary syndrome middle east respiratory syndrome place tremendous health economic world', 'rotavirus age', 'rotavirus medical treatment societal year', 'implementation many intervention result evolutionary', 'viral evolutionary certain capacity new host virulence resistance', 'understanding rna prediction pathogenic epidemiological potential', 'high substitution feature rna virus evolution genomic ecological', 'strength direction selection variation substitution', 'general selection selection structural relationship selection long term viral substitution', 'high virus evolution replication error prone rna dependent rna nucleotide substitution span correlate viral mutation', 'substitution high fidelity dna comparable high substitution', 'polymerase error rate explain substitution rate variation rna', 'mutation rate viral replication frequency rate', 'replication variety related viral genomic architecture ecology', 'example weak negative viral genome lengths substitution enhanced replication mutation', 'different transmission infection generation time variation year synonymous substitution rna virus structural', 'modern survey mammalian rna virus evolution substitution structural non structural bayesian coalescent', 'related virus genomic architecture genome length genome sense genome virus ecology e target cell transmission mode host range infection acute persistent', 'viral substitution ds mutation generation', 'recombination role viral evolutionary substitution rate potential analysis', 'broad analysis able demonstrate cell tropism impact viral generation time greatest influence mammalian rna virus evolution', 'review literature bayesian nucleotide substitution rate structural different mammalian rna viral bayesian non structural gene different viral non structural table', 'novel bayesian substitution structural different viral novel bayesian non structural different viral table', 'nucleotide site year ns structural structural table', 'plotting variable mean substitution rate similar structural structural ns transmission route', 'viral substitution target cell route type host range figure', 'substitution viral genomic architecture genome sense strandedness figure genome segmentation figure viral genome length figure', 'apparent genomic linear relationship substitution coefficient determination r ns r', 'dn ds study single likelihood ancestor slac method structural gene dn ds non structural gene dn ds total table', 'ancova structural non structural gene cell transmission route infection mode host range genome length genome sense genome segmentation predict nucleotide substitution mammalian rna', 'many categorical different variable base', 'ancova coefficient determination r r substitution rate variability predictor study', 'residual potential structural gene potential non structural gene amenable general linear model', 'regardless base significant transformed substitution structural non structural tropism significant predictor variable type iii sum ss structural non structural gene', 'epithelial significant predictor structural gene base table figure sole significant predictor substitution non structural gene dataset p table figure', 'high correlation viral structural gene substitution rate non structural gene rate r', 'possible calculate non structural similar structural gene dataset', 'potential bias multiple single viral strain control rate', 'multiple substitution calculated average log substitution rate sole substitution rate analysis', 'distributed figure r r full r ns r r', 'control consistent full dataset epithelial significant substitution rate figure', 'rna human treatment control difficult', 'dna much fidelity rna dna', 'tremendous variation evolutionary different rna variation mutation', 'present survey mammalian rna virus comprehensive comparison different genomic architecture ecology', 'cell tropism significant predictor long term mammalian rna virus evolution', 'instance epithelial', 'mechanistic insight respiratory gastrointestinal difficult control', 'black bar mean level variable mean substitution rate', 'table', 'figure', 'nucleotide substitution genomic mammalian rna', 'log scale mean substitution rate log site year different genomic sense strandedness genome genome', 'show structural non structural', 'black bar mean level mean substitution rate', 'line fit e f determination r linear regression lengths vs substitution structural gene dataset non structural gene dataset', 'table', 'high correlation structural nonstructural gene final set ancova combined dataset', 'identical structural gene table', 'exception addition cell tropism type iii ss analysis transmission route significant predictor variable p significant cell tropism', 'addition different cell transmission arthropod significant rate predictor table', 'substitution rate variability predictor variable dependent predictor collinearity', 'exception persistent infection variable endothelial target cell variable ancova structural gene rate rate dataset significant collinearity variance inflation', 'non structural gene rate many different predictor', 'subsequent individual variable collinearity', 'due consistent structural nonstructural gene rate dataset independent', 'target significant series tailed confirm cell viral substitution', 'epithelial structural gene substitution target endothelial table', 'epithelial nonstructural gene substitution target table', 'control rate viral', 'systemic wide variety cell', 'leukocyte target cell category rate variation target cell', 'transmission arthropod significant rate predictor ancova combined epithelial cell tropism fecal oral respiratory transmission significant variation substitution different transmission', 'series transmitted fecal oral respiratory route substitution arthropod', 'different cell transmission', 'fecal oral respiratory epithelial substitution cell figure', 'neurotropic substitution target cell figure', 'linear viral substitution evolutionary', 'reliable mutation base infectious cycle available different study poliovirus hepatitis virus influenza virus influenza b virus', 'mutation base strand replication available study poliovirus influenza virus', 'mutation ancova analysis r r r model significant predictor confidence', 'ancova base epithelial target fecal oral respiratory transmission route acute persistent infection host range genome architecture', 'second ancova base neural target transmission route persistent infection order specific host range genome architecture', 'third ancova base target respiratory vertical transmission route acute infection family specific host range genome architecture', 'ancova analysis r r r model significant predictor variable standardized confidence', 'ancova base epithelial target fecal oral respiratory transmission route acute persistent infection host range genome architecture', 'second ancova base neural target transmission route acute infection order specific host range genome architecture', 'third ancova base target respiratory vertical transmission route acute infection family specific host range genome architecture', 'substitution rate p r p mutation base infection mutation base replication', 'significant substitution ds p r p limited structural gene non structural gene', 'ancova epithelial cell tropism neurotropism significant viral substitution rate', 'cell turnover mammalian determine host turnover rate viral generation time', 'model sanjuán long term substitution rate mutation rate transient deleterious able estimate generation reliable mutation rate', 'model k ame bmg b h g genome length g generation time h harmonic mean selection coefficient influenza virus influenza b virus poliovirus target epithelial generation c virus', 'limited dataset quantitative evidence link cell tropism generation time', 'average generation lead replication year year substitution', 'variety intrinsic ecological tempo virus evolution rate genetic diversity viral', 'genomic rate variation weak negative correlation genome lengths substitution ssrna dsrna', 'significant relationship genomic', 'limited ecological comprehensive analysis cell tropism key factor mammalian rna viral substitution', 'persistent acute', 'exception latent retro dna scope study difficult classify persistent', 'duration persistence vary persistent viral acute phase acute phase e many acute', 'possible significant association infection substitution rate', 'endothelial infecting persistent', 'persistent level tropism endothelial persistent infection variable', 'infection duration substitution rate variation baltimore evidence mammalian rna virus substitution study', 'transmission mode host range viral substitution', 'plant animal arthropod transmission infect diverse transmission', 'ancova implicated transmission route significant substitution rate predictor significant relationship substitution rate host range', 'genomic ecological independent', 'example neurotropic second common cell tropism table', 'observation vector borne consistent', 'cell tropism significant factor cell neurotropism', 'previous phylogenetic sister taxa similar evolution', 'virus variable due high colinearity', 'virus significant colinearity structural gene dataset', 'non colinear tropism predictor viral substitution', 'nonstructural gene dataset hand significant collinearity predictor', 'ns dataset statistical power', 'possible expand mammalian rna virus ns dataset time novel rate number reliable available genbank', 'dataset identical dataset target consistent predictor', 'many likely influence nucleotide substitution cell tropism significant predictor mammalian rna virus substitution rate', 'cell tropism viral substitution suggested ecological', 'infection different host different selection', 'possible cell tropism rate genetic diversity viral mutation generation', 'variation strength direction selection determinant viral substitution', 'positive selection variation short term substitution selection dominate', 'variation strength selection due', 'instance unique evolutionary host diversity', 'previous selection non dn ds structural', 'dn ds nonstructural non', 'significant correlation dn ds substitution detectable selection variation substitution mammalian rna', 'date link cell tropism selection', 'evolution dna evolution rna high mutation', 'weak negative lengths viral substitution relationship mutation rate substitution rate mutation', 'spontaneous mutation longterm substitution relationship certain mutation rate threshold site infectious cycle end mutation rate range rna', 'surprising significant correlation substitution available reliable mutation rate', 'recent study retrovirus infection different cell lead mutation rate evidence mutation rate cell tropism', 'mutation rate variation different cell substitution epithelial mammalian rna', 'selection mutation virus substitution rate variation result variation replication', 'replication generation explain variety virus ecology substitution rate', 'example phase infection persistent infection latent phase replicate', 'alternative differential selection argument transmission mode viral substitution generation g horizontal transmission vertical transmission', 'dna generation tropism rna virus generation time obvious rna cellular replication machinery', 'evidence rna viral genome replication dependent host cell proliferation synthesis much', 'example hepatitis c virus genome replication due available viral protein synthesis nuclear translation initiation available cytoplasm cell division', 'similar dependence cell proliferation viral replication efficiency number', 'model sanjuán epithelial generation virus epithelial', 'possible mechanistic basis target body intestinal respiratory epithelial substitution low', 'statistical evidence cell tropism mammalian rna virus evolution likely influence virus generation time', 'new perspective difficult create effective epithelial tissue rotavirus enterovirus', 'viral evolution result genetic diversity epidemiological fitness substitution epithelial infecting evolvability potential emergence novel host', 'long term substitution mammalian rna literature focus structural gene major antigenic site non structural', 'rdrp dsrna structural virion different selection structural immune system', 'variable substitution due time dna rate', 'non incidental dead end', 'individual viral aggregated multiple analysis', 'single gene full multiple gene', 'order minimize rate g number taxa temporal range portion gene subtle methodological bayesian coalescent taxa isolated minimum range analyzed gene', 'bayesian coalescent viral evolution range date range taxa', 'determine phylogenetic relationship substitution entire evolutionary history taxa', 'long term substitution', 'genomic architecture ecology substitution', 'included multiple available single study multiple single rate', 'dn ds available', 'substitution novel beast rate sequence available genbank browser', 'structural non structural isolation available genbank literature se al', 'information lab analysis', 'final conservative', 'recombination lead estimation substitution recombination different gene conv bootscan maxchi chimaera siscan rdp', 'recombinant algorithms analysis', 'dryad', 'determine fit model nucleotide substitution dataset aic', 'long term substitution beast', 'dataset effective sampling size', 'different clock uncorrelated lognormal different demographic exponential bayesian skyline', 'fitting clock demographic model combination dataset bayes tracer', 'independent replicable control analysis dataset outcome analysis', 'single likelihood ancestor slac maximum likelihood method available hyphy package datamonkey web server evaluate strength selection pressure', 'order determine substitution mammalian rna spss log mean substitution variable predictor cell transmission route infection acute persistent host range genome length genome sense genome', 'variable different base chosen base level influence', 'collinearity variance inflation indicating redundancy', 'separate ancova structural non structural gene', 'multiple viral additional substitution rate virus', 'multiple virus used average rate', 'tailed additional measure significant directional variation log mean different categorical variable significant rate predictor bonferroni correction multiple', 'additional control rate virus', 'dn ds mutation rate available study available variable corresponding mean substitution rate spearman rank correlation dn ds pearson correlation coefficient mutation', 'structural non structural gene rate pearson correlation coefficient', 'correlation spss', 'table', 'tiff figure control', 'point observation ancova rate viral', 'b show first analysis c show second analysis e show third analysis', 'residual interval red virus table', 'tiff figure viral substitution', 'standardized confidence different predictor structural nonstructural right gene substitution rate viral', 'b show first analysis c show second analysis e show third analysis', '', 'dark correspond significant substitution rate epithelial leukocyte hepatocyte epithelial target leukocyte epithelial target c neural epithelial target e neural target f gray', 'table nucleotide substitution study', 'table dataset analysis information novel substitution study', 'table', 'nucleotide substitution general time reversible gtr tamura nei trn transition tim transversion tvm transversion equal unequal kishino yano hky gamma distribution rate heterogeneity g', 'table significant viral structural gene substitution rate viral', 'multiple regression analysis r r r model significant predictor confidence', 'first regression base epithelial target fecal oral respiratory transmission route acute persistent infection host range genome architecture', 'second regression base neural target transmission route persistent infection order specific host range genome architecture', 'third regression base target respiratory vertical transmission route acute infection family specific host range genome architecture', 'table significant viral non structural gene substitution rate viral', 'multiple regression analysis r r r model significant predictor confidence', 'first regression base epithelial target fecal oral respiratory transmission route acute persistent infection host range genome architecture', 'significant analysis', 'second regression base neural target transmission route acute infection order specific host range genome architecture', 'significant analysis', 'third regression base target respiratory vertical transmission route acute infection family specific host range genome architecture', 'docx table significant viral substitution study', 'ancova analysis r r r model significant predictor variable standardized confidence', 'ancova base epithelial target fecal oral respiratory transmission route acute persistent infection host range genome architecture', 'second ancova base neural target transmission route acute infection order specific host range genome architecture', 'third ancova base target respiratory vertical transmission route acute infection family specific host range genome architecture', 'docx table structural gene substitution rate variation different cell', 'control substitution rate viral', 'significance cell column log scale mean substitution target cell top row value test', 'statistical significance bonferroni account multiple', 'n endothelial l epithelial', 'table non structural gene substitution rate variation different cell', 'control substitution rate viral', 'significance cell column log scale mean substitution target cell top row value test', 'statistical significance bonferroni account multiple', 'n h epithelial', 'docx author']"
9f5b88ccb461ad00982bfad6778331faf6840982,influenza virus bat influenza amino acid figure panel appendix table different bat avian influenza brazil peru close genetic exact test high viral influenza surface peru brazil protein figure reverse transcription viral diversity abundance lituratus acid avian acid brazil acid hl acid influenza acid na active site activity different acute respiratory ambiental paraná ambiente dos america figure analogous febrile ancestry positive ancient influenza artibeus planirostris available virological avian specific basic pb basis morphological bat artibeus bat cellular bat figure bat lilium bat peru bat positive bat preliminary bat virus batborne rna biologic activity biomedical science body temperature brasileiro meio brazil appendix brazil nucleotide brazil strain brazil surprising c putative capable zoonotic cell susceptible cellular receptor chimeric vesicular cleavage site coding sequence coexistence viral combined genomic committee biomedical common ancestry common intensive comparable batborne comparable evolutionary comparable level comparison full consistent detection consistent genetic consistent high consistent qualitative critical amino cycle metabolism daily cycle definite host definite influenza detection rate detection site different exact different polymerase discovered bat disease avian distance km distinct bat distribution bat divergence influenza divergent avian diversity high diversity subject dos recursos eating bat emergence new entry brazil epidemiology southern evolutionary avian factor common febrile response fecal shedding,"['nfluenza major human disease avian', 'influenza genome reassortment intermediate emergence new capable zoonotic', 'major zoonotic', 'influenza discovered bat lilium little yellow bat artibeus planirostris flat fruit eating bat', 'bat influenza divergent avian influenza ha neuraminidase ancient influenza', 'consistent genetic divergence influenza surface lack typical hemagglutination neuraminidase terminology hl neuraminidase nl bat influenza surface', 'individual bat influenza genomic pivotal', 'planirostris bat peru definite host', 'investigate bat influenza virus epidemiology southern brazil', 'study individual table', 'mist necropsied identified basis morphological field', 'intestine available virological', 'instituto brasileiro meio ambiente dos recursos naturais instituto ambiental paraná committee biomedical science university são paulo', 'intestine sensitive reactive nested reverse transcription different polymerase basic pb gene lituratus table', 'low overall influenza virus detection rate study different exact test previous p p', 'low influenza virus infection consistent high seroprevalence different bat preliminary investigation seasonal variation bat influenza virus comparable batborne rna', 'sanger pcr close genetic relatedness brazil strain peru', 'virus positive intestine strain specific quantitative real time reverse transcription rt pcr appendix table', 'high × × rna tissue', 'high intestinal consistent qualitative study intestinal tropism potential fecal shedding environment', 'full sequence viral bat virus genbank accession', 'appendix table', 'nt combined genomic', 'nonsynonymous amino acid na table figure panel b', 'recent common ancestry positive consistent detection site', 'comparison full coding sequence novel high sequence identity brazil nucleotide identity genomic table', 'genomic relatedness peru brazil surprising time span geographic distance km different bat positive study previous study', 'critical amino acid influenza virus replication entry brazil peru ha monobasic cleavage site motif piketr glf', 'thermodynamic modeling amino acid brazil peru tridimensional structure hl nl putative receptor site hl protein figure panel c putative active site nl protein figure panel', 'result preservation biologic activity different bat cellular receptor bat influenza sialic acid avian influenza', 'amino acid hl peru bat influenza virus respective nl exact test low rate nonsynonymous bat influenza virus reminiscent strong purifying selection hemagglutinin avian specific influenza virus', 'finding comparable evolutionary avian', 'definite influenza virus', 'lituratus peru represent distinct bat', 'distribution bat figure panel virus exchange', 'phylogenetic close genetic relationship peru brazil appendix table lack reassortment available', 'host comparable level host rna', 'zoonotic potential unclear cell susceptible infection chimeric vesicular stomatitis virus', 'abundance lituratus latin america figure high viral diversity high profile zoonotic', 'pathogenic reservoir', 'severe acute respiratory syndrome marburg hendra', 'high viral diversity subject speculation', 'hypothesis flight factor common intensive selective force coexistence viral daily cycle metabolism body temperature analogous febrile response', 'visit website listen']"
82195d353c088d65c8cc9ce1b903889a755b9879,et al national research research council sprague dawley car bacillus respiratory tract sendai virus percy barthold ad libitum life cycle clinical disease bacillus infection embryo transfer stock strain direct contact laboratory animal small intestine athymic nude direct examination h bilis mycoplasma pulmonis upper respiratory bennett vickery gram negative h diminuta helicobacter spp litter size p aeruginosa rat virus rcv sda altman goodman cesarean section chronic progressive clostridium piliforme disease status host range incidence sprague pathogen status rat colony alveolar histiocytosis blood agar cecum colon cervical lymph corynebacterium kutscheri crassicauda infestation cuniculi infection dawley wistar direct life fecal oral fox et fox laird helicobacter infection hematoxylin eosin immune system incidence severity infection rat islet cell kutscheri infection laboratory rat lang lang mammary gland mesenteric lymph natural ingredient p rcv pasteurella pneumotropica pleural surface pneumonia virus polyplax spinulosa rcv p relative ad renal pelvis rouleau et section embryo serological evidence teratology association tyzzer disease vegetative form virus mice barrier commercial bilis h bivin et caloric intake caseous necrosis central nervous cesarian section colon rectum cycle h dietary restriction differential diagnosis drinking water duncan et e g enterococcus spp fecal flotation female sprague female wistar fox lee g duodenalis genetic drift giardia muris,"['j philipeaux adrenalectomy albino', 'united', 'pivotal development rat research h h donaldson much define early laboratory', 'second mouse mammal biomedical behavioral research', 'short gestation short life docile behavior ready availability health genetic responsible importance rat laboratory animal', 'standard toxicological teratological carcinogenesis pharmaceutical industry governmental', 'use behavioral neurological nutritional endocrinology today', 'size rat surgical organ transplantation vascular', 'number inbred inbred rat important repertoire disease table', 'commercial inbred past decade high percentage united several', 'many small regional multiple united', 'bar health status genetic integrity laboratory available', 'meet care use laboratory national research council', 'wall ceiling floor effective sanitation resistant damage normal use manipulation equipment', 'environment room controlled animal limit design', 'humidity room range f relative humidity appropriate', 'hour temperature humidity animal component electronic environmental management system useful detecting environmental', 'practice many general ventilation fresh air sufficient compensate heat load generation', 'stable photoperiod necessary avoid behavior food weight gain', 'cycle hr light hr dark', 'susceptible phototoxic retinopathy', 'sufficient evidence indicate light intensity cage level prevent retinopathy national research council', 'prevention control infectious location size environmental housing room', 'transfer potential impact infectious group', 'instance appropriate sized room cubicle space necessary separate pathogen status immunological status vendor protocol investigator', 'incorporation class flexible wall help specific pathogen status period time', 'stress noise rat distant mechanical cage noise national research council', 'amount cage space group function animal weight specific physiological protocol animal national research council', 'experimental need solid bottom wire bottom', 'help pododermatitis wire national research council solidbottom environmental enrichment', 'solid bottom polypropylene', 'former plastic damage translucency observation', 'various contact appropriate g hardwood ground cellulose', 'solid bottom frequency week', 'frequent cycle cage density low perinatal frequent cycle cage density high pathophysiological e g', 'detailed description appropriate sanitation rodent housing laboratory animal management national research council', 'section summary morphophysiological rat reader', 'comprehensive section', 'small thick length body contrast r rattus body', 'hair short hair former sparse', 'hair growth young cyclic period period', 'female pairs pectoral abdominal region greene', 'body growth dependent stock strain source', 'outbred dawley wistar rat', 'exophthalmic injury trauma anesthesia', 'cornea visible', 'harderian gland orbit lacrimal cornea', 'harderian gland excessive chromodacryorrhea animal e g malnutrition dehydration disease environmental', 'reddish secretion crust useful indicator illness husbandry problem moore', 'orbital venous medial aspect orbit useful site blood collection animal', 'accepted color vision recent study color vision koolhass', 'olfactory strong behavior rat', 'male social status kinship olfactory', 'alarm', 'hearing frequency range hz khz khz sensitive range', 'high frequency sensitivity hearing capability', 'high frequency sensitivity khz dam sexual aggressive behavior koolhass', 'skull nasal premaxillary maxillary zygoma palatine lacrimal frontal parietal squamosal periotic capsule tympanic bulla mandible auditory single vomer greene', 'ethmoid basisphenoid presphenoid occipital interparietal hyoid', 'vertebral column cervical thoracic lumbar sacral caudal vertebrae', 'ventral dorsal ossified true costal', 'humerus ulna radius similar mammalian', 'carpus', 'pelvis ossa coxae articulate sacral vertebrae', 'femur tibia fibula tibia', 'tarsus greene', 'dental formula rat pm', '', 'due gingivitis congenital malocclusion nonfunctional spiral elonga tion palate food intake', 'salivary consist parotid submandibular sublingual', 'parotid serous caudal border mandible clavicle', 'submandibular mixed caudal border inlet', 'sublingual mucous rostral pole submandibular', 'multilocular adipose tissue brown fat gland ventral lateral confused salivary', 'figure location salivary cervical lymph tissue greene', 'stomach cardiac portion nonglandular corpus pyloric portion glandular', 'ridge curvature stomach ridge', 'responsible inability rat vomit', 'small intestine cm jejunum cm ileum cm', 'comma cecum prominent mass lymphoid tissue apical portion', 'colon colon prominent oblique mucosal longitudinal mucosa', 'lobes median deep fissure hepatic ligament lateral large caudate small', 'rat gallbladder bile form common bile duct mm pyloric sphincter', 'differentiated adjacent adipose tissue darker color firm consistency', 'numerous excretory large empty common bile duct bivin et al', 'figure abdominal thoracic viscera situ greene', 'rat maxillary recess sinus maxillary bone lateral lamina ethmoid bone', 'recess lateral nasal gland steno gland watery product rostral end nasal turbinate', 'secretion viscosity mucous layer nasal epithelium', 'lung single right lung cranial middle accessory caudal lobes', 'pulmonary vein cardiac muscle wall contiguous heart', 'rat supply bronchial musculature bronchoconstriction vagal tone bivin et al', 'male rat number developed accessory sex', '', 'paired bulbourethral cowper base penis open dorsal surface urethral flexure', 'abdominal cavity large seminal gland dorsocranial coagulation gland ventral dorsolateral', 'female rat bicornate uterus uterine distinct uteri', 'right kidney craniad cranial edge vertebra caudal edge level', 'kidney unipapillate rat useful kidney', 'rat model nephron transport vivo micropuncture system presence superficial renal cortex', 'greene', 'brain large olfactory bulbs smooth cerebrum parafloccular lie deep periotic capsule skull', 'hypophysis optic base brain thin hollow stalk infundibulum', 'ventricular system similar', 'spinal cord fourth lumbar vertebra ilium terminale level tail third caudal', 'heart midline thorax apex diaphragm lateral', 'heart thoracic wall third fifth ribs useful site cardiac blood collection', 'blood supply atria rat extracoronary internal mammary subclavian', 'many normal specific group source stock strain', 'age pathogen status sample collection husbandry colony important dameron al perez et al', 'physiological clinical chemistry hematological iii iv', 'adequate available commercial', 'refinement diet available', 'natural ingredient', 'type research natural ingredient diet agricultural', 'class diet open formula diet information amount ingredient available formula diet information confidential producer', 'nutrient composition natural ingredient batch various g relative weather storage', 'certified natural ingredient toxicological good laboratory practice glp maximum list g heavy study', 'nutrient variable defined single nutrient nutrient class e g casein sugar starch vegetable oil cellulose formulation', 'diet', 'downside class bivin et al', '', 'expensive palatable', 'defined g specific amino essential fatty', 'costly lack palatability national research council', 'table v nutrient national research council', 'ad libitum', 'numerous demonstrate long term carcinogenesis toxicological longevity incidence relative ad libitum food amount', 'sprague dawley wistar increased variability carcinogenicity safety assessment usefulness assessment keenan et al', 'instance wistar ad libitum age significant incidence lung mammary pancreatic islet cell pituitary ad libitum', 'overall incidence malignant group ad libitum group feed group longevity', 'reduction chronic inflammation fibrosis heart acute inflammation prostate radiculoneuropathy acinal hyperplasia mammary gland feed limited al', 'rat vagina birth compact epithelium vaginal plate del vecchio', 'cornify age open age', 'persistence vaginal plate occasional cause infertility', 'puberty sexual maturity ability viable young full body size weight', 'stock strain', 'puberty age rat fox laird considerable variation', 'barthold report vickery report', 'et al', 'report', 'estrus puberty full reproductive competency occur rat al', 'wistar b h age et al', 'estrous cycle analyte', 'proestrus uterus fluid peripubertal rat condition hydrometra', 'ovulation hr estrus peluso light cycle', 'viable hr laird', 'age russell', 'sperm age fertility puberty age sperm production maximal age russell', 'histologic examination young rat degenerate prior age indicative poor efficiency early al', 'male sexual behavior erythrocyte x age stock strain matuszczyk al smith et al', 'serum testosterone responsible age related behavior phenomenon', 'coitus dark light portion dark cycle early portion et al', 'multiple pelvic vickery precede first ejaculation second', 'cmcv mean corpuscular volume dmchc mean corpuscular hemoglobin contact series ejaculatory latency refractory period dewsbury', 'single ejaculation likely impregnate female', 'multiple series refractory successive', 'coitus detection vaginal smear observation vaginal plug pale coagulum seminiferous fluid visible vagina direct observation sexual behavior', 'implantation blastocyst endometrium fertilization process completion peluso al', 'parturition time coitus occur early vickery baker', 'pregnant time coitus gestational length pregnant', 'several determine rat estrus useful production pregnant', 'specific behavior ear head lordosis swayback posture pelvic area blandau et al', 'vulva vaginal wall dry estrus moist pink appearance metestrus diestrus', 'due cornification vaginal epithelium estrus baker', 'vaginal epithelium cytologic examination vaginal luque', 'estrus epithelial bennett vickery', 'vaginal cytology lead electrical impedance vagina estrus', 'precise method estrus detection koto al b device impedance meter electrical probe vagina', 'pregnancy difficult detect early gestation conception outbred rat inbred', 'careful palpation detect accurate gestation', 'gestation mammary gland nipple development evident bennett vickery', 'inbred trios male cage', 'commercial economy', 'pregnant separate parturition cannibalism abandonment', 'number husbandry population laboratory', 'lack seasonal variation estrous ovarian function estrous cycle light', 'continuous light cause persistent estrus cystic formation corpora lutea fox laird', 'chronic exposure low intensity light dark cycle result vaginal opening ovarian atrophy al fox laird', 'caloric restriction decrease ad libitum caloric intake cessation estrous sexual maturation fox laird', 'high ambient male infertility pucak al irreversible degeneration seminiferous epithelium', 'damage young exposure low female building activity continue lactation bennett vickery', 'material available necessary material purpose', 'clear mucoid fluid', 'labor female cage', 'behavior progress female lie cage floor', 'female birth canal', 'parturition litter size', 'nursing', 'litter size stock source maternal age', 'effect maternal age', 'wistar bh age et al', 'second litter bennett vickery', 'age litter size decreased pregnancy rate age', 'loss pregnancy wastage function age mattheij wastage age', 'wastage due preimplantation early postimplantation mortality', 'contrast decremental litter size maternal behavior virgin age gonzalez deis', 'addition maternal fetal wastage', 'increase fetal wastage due earthquake dams gestation difference number live fetal incidence al', 'possibility similar fetal loss stage gestation peer literature', 'strenuous maternal exercise e treadmill result size fetal weight mottola et al', 'dystocia rare', 'cannibalism indicator maternal stress', 'rat altricial nidicolous hairless poorly short ear baker', 'inverse relationship fetal birth weight litter size romero et al', 'phenomenon significant reproductive toxicologist tendency test substance cause fetal weight fetal loss', 'birth weight weight age', 'age al', 'external acoustic open age', 'cochlea organ corti immature birth adult morphology time', 'first able hear age able vocalize time birth feldman', 'age molar molar age molar brown leininger', 'birth equivalent human fetus', 'open age retina mature age final anterior chamber age weisse', 'trunk birth touch guard english munger', 'age', 'maternal antibody yolk sac utero laliberte et al', 'antibody intestinal mucosa maternal colostrum milk rat', 'transfer low maximal day gut closure complete martin et al', 'sex mature direct observation perineal region', 'scrotum preputial opening', 'penis visible urethral papilla female', 'addition distance genital opening anogenital distance male female', 'sex discrimination difficult prepubertal possible', 'comparative evaluation reveal neonatal anogenital distance female distinction subtle', 'technique sex determination preblastocyst embryos utsumi et al', 'male embryos development presence antibody hy antigen development antibody', 'contrast embryos presence hy antibody female pups', 'age early', 'prior capable urination maternal stimulation weaning obstructive urinary tract disease', 'synchronization estrus rat administration mg drinking water ethanol liter water fresh daily intramuscular injection iu pregnant mare serum baker', 'synchronization estrus production large pregnant impedance meter practical', 'synchronization estrus prepare transfer', 'mature hormone hormone agonist rouleau et al', 'vaginal cytology', 'artificial insemination ai rapid coagulation electroejaculation due seminal vickery', 'fertility', 'sperm twice male rat', 'sperm proximal portion cauda epididymidis fertility middle caudal akhondi', 'sperm uterus estrous al', 'essential step success ai induction pseudopregnancy recipient female prior vasectomized male mechanical stimulation electrical stimulation cervix bennett vickery rouleau et al', 'embryo transfer alternative cesarean rederivation order eliminate', 'embryo transfer investigate specific due uterine environment contrast genetic gomez sanchez rouleau et al', 'embryo collection cryopreservation', 'embryo transfer embryos', 'embryos phosphate saline pbs bovine serum albumin bsa trypsin', 'trypsin', 'embryos pbs bsa fetal calf serum uterus oviduct pseudopregnant recipient kubisch gomez sanchez rouleau et al', 'nonsurgical implantation embryos cervix otoscope bennett vickery wide use', 'vitro fertilization ivf rat research tool development colony management tool gaddum rosse et al vanderhyden et al', 'form ivf microinjection individual used mice rescue motile spermatozoa tanemura al songsasen leibo', 'common', 'cryopreservation technique widespread mice tada et al', 'cryopreservation efficient method potential live mice available', 'serve fail safe measure contaminated', 'addition murine reproductive embryos test culture human ivf meyer al', 'embryos cell cryopreservation sperm leibo tanemura et al', 'cryopreservation sperm', 'little space many laboratory animal medicine texts previous edition volume behavior laboratory experimental design disease status', 'unfortunate unavoidable lack rat behavior important aspect laboratory animal science contrary true', 'many normal behavior scientific use biomedical research specific', 'behavior relevant experimental design disease status broad normal behavior', '', 'laboratory many docility', 'strain', 'sprague dawley sd lewis brown', 'frequent gentle increase docility whereas infrequent fear', 'gentle occupational injury animal stress', 'induced stress lead behavioral valiaho shalev et al', 'vocalization ultrasonic range khz brudzynski al brudzynski chiu brudzynski ociepa', 'stress induced vocalization difficult range', 'additional interesting fact rat vocalization illustrative importance rat behavior rat ultrasonic range signal capable hearing feldman', 'active night feed day active al', 'circadian rhythm relevant broad range behavioral', 'example pain flick test', 'female tail flick response middle dark period metestrus martinez gomez et al', 'vary percentage', 'fecal output volume intestinal absorption', 'effect iron absorption tidehag et al', '', 'general likely fight male mice norm many toxicology safety assessment', 'temporary single housing female wistar han group housing glucose observed et al', 'clear change glucose due generic response change environment result food consumption', 'report transportation stress blood glucose wistar wu et al clear blood glucose normal', 'afforded choice solid large al blom et manser et preferred housing', 'part environmental enrichment program inanimate wooden chmiel noonan', 'deleterious', 'streptococcosis disease infection streptococcus several opportunistic clinical disease', 'streptococcus hemolytic streptococcus historic concern rat various group opportunistic infection', 'addition enterococcus spp streptococcus spp', 'pneumonia pneumoniae streptococcosis', 'term streptococcosis streptococcal infection', 'streptococcus pneumoniae present today low significance laboratory national research council', 'natural host pneumoniae', 'streptococcus pneumoniae aerosol minor role', 'disease due pneumoniae infection asymptomatic', 'asymptomatic', 'numerous exist disease infection pathogenic et al', 'infection human nonhuman suppurative inflammation upper respiratory tract lung cause bronchopneumonia kohn barthold fibrinosuppurative pleuritis', 'affected bacteremic fibrinopurulent inflammation serous g peritoneum synovium', 'pneumoniae infection na sopharyngeal culture blood agar', 'differentiation pneumoniae hemolytic streptococci optochin inhibition test', 'optochin inhibition pneumoniae hemolytic streptococci', 'occurrence nonpathogenic et al isolation pneumoniae problem present colony diagnosis isolation pneumoniae asymptomatic colony health threat', 'action pneumoniae indicated presence characteristic detection pathogenic', 'streptococci present many disease', 'streptococci lancefield', 'exclusion necessary practical', 'streptococcal enteropathy due nonhemolytic hemolytic lancefield group enterococcus hirae e faecium e', 'streptococcal enteropathy disease', 'affected diarrhea soft stool yellow pasty', 'mortality high', 'small intestine gram positive cocci', 'disease enterococci pathogenic potential', 'ability pathogenic', 'control streptococcus spp', 'enterococcus spp', 'problematic ubiquitous present high percentage human population del vecchio', 'enterococcus spp', 'autochthonous savage', 'streptococci aseptic microisolator technique use low incidence disease additional time expense housing', 'pseudotuberculosis corynebacterium kutscheri infect guinea last bacteriological evidence', 'silent suzuki et al amao et al', 'nonspecific clinical fur posture dyspnea mucopurulent ocular nasal lameness', 'death', 'infected latent submaxillary cervical lymph nasopharynx middle preputial', 'latent clinical variety immunosuppression host', 'include poor husbandry malnutrition intercurrent irradiation treatment immunosuppressive brownstein', 'persistent mycoplasmosis disease frequent', 'transmission direct contact oronasal exposure', 'due septic emboli capillary network lung liver kidney synovium', 'lung rat', 'gross kutscheri infection consist solitary multiple kidney skin', 'suppurative inflammation preputial gland tympanic bullae', 'gross', 'interstitial inflammation lung due hematogenous lung bronchi suppurative exudate', 'caseous necrosis prominent epithelioid giant abscessation', 'large caseous necrosis liver', 'septic embolic glomerulitis pyelonephritis', 'caseous necrosis tissue', 'definitive diagnosis bacteriologic culture fox et al', 'site culture submandibular cervical lymph', 'oral cavity cecum colon rectum organism', 'microscopic evaluation characteristic positive tissue stain impression stain', 'possible histopathology bacteriology', 'disease provocation stress activate latent kutscheri pneumocystis carinii clostridium piliforme', 'adequate culture need stress', 'serology detection c kutscheri infection immunocompetent al', 'serologic serologic complex false false positive culture', 'differential diagnosis presence multiple streptococcosis streptobacillosis mycoplasmosis pulmonary car bacillus infection pulmonary miscellaneous', 'mycoplasmosis car bacillus infection', 'tyzzer disease tyzzer japanese mice tyzzer clostridium piliforme duncan et bacillus piliformis', 'host range protean numerous rodent nonhuman human skelton al', 'clostridium piliforme infection silent motzel riley hansen et al', 'overt disease rats young', 'clinical nonspecific lethargy emaciation fur acute death clinical', 'diarrhea mucus blood', 'rat tyzzer disease albeit low incidence hansen et al', 'clostridium piliforme rats fecal oral contamination', 'resistant desiccation', 'delicate vegetative form', 'c piliforme vegetative form mucosal epithelial gut lymphoid tissue peyer duncan et al', 'multiple pale foci pinpoint necrosis visible surface liver', 'megaloileitis flaccid hyperemic ileummmay present fig', '', 'hyperemia edema hemorrhage ulceration part intestine terminal ileum cecum colon', 'secondary intestinal involvement mesenteric lymph hyperemic edematous', 'heart pale epicardium', 'myocardial necrosis due tyzzer disease pale linear heart apex', 'characteristic ileum cecum colon heart', 'intestinal tract enteritis typhlitis colitis', 'coagulative necrosis liver hallmark lesion moderate leukocytic infiltrate neutrophils mononuclear periphery', 'acute mineralization time', 'heart myocardial degeneration necrosis minority mixed leukocytic infiltrate dystrophic calcification', 'histopathologic evaluation diagnostic characteristic bacilli tyzzer duncan et al', 'vegetative form organism filamentous bacillus tm wide fig', '', 'bacilli intracellular numerous jumbled array pickup stick parallel arrangement shape cell', 'vegetative form visible hematoxylin eosin special necessary warthin starry silver giemsa methylene blue', 'gram negative c piliforme poorly gram', 'liver', 'intestine normal gut mucosal mucosal epithelial evaluation', 'observed cardiac intestine', 'differential hepatitis rat bacterial septicemias corynebacterium kutscheri infection rat virus', 'diagnosis clinical disease demonstration organism tissue', 'tissue rapid diagnosis suspicious liver useful', 'colony latent infection problematic', 'serologic rapid simple motzel riley subject false difficult context', 'disease provocation stress latent follow test serologic positive', 'doubt efficacy stress chemical immunosuppression cyclophosphamide boivin et al histopathologic evaluation', 'doubt test piliforme infection therefore susceptible activation latent infection', 'sentinel soiled bedding specificity false susceptible piliforme motzel riley franklin al', 'interference clostridium piliforme research morbidity mortality coagulation van andel et al', 'pasteurella pneumotropica gram negative coccobacillus', 'blood agar hemolysis smooth gray translucent car ter', 'numerous mammalian low significance immunocompetent national research council ld', 'pasteurella pneumotropica high prevalence nasopharynx cecum vagina uterus conjunctiva routine monitoring national research council', 'vast majority asymptomatic rare metritis mastitis percy barthold', 'suppurative inflammation', 'control agent necessary immunocompetent rarity pneumotropica induced disease', 'treatment enrofloxacin goelz et al', 'rederivation cesarean section embryo transfer agent sul tandosa al', 'antibiotic treatment infected prior cesarean section major rodent vendor c clifford unpublished pneumotropica present uterus', 'probability successful elimination p pneumotropica cesarean section uteri offspring culture positive uterus', 'strict isolation e mixed breeding colony negative p pneumotropica', 'pasteurella pneumotropica significant degree multiply environment', 'colony free agent little risk reinfection introduction incursion', 'salmonellosis disease salmonella', 'taxonomic classification subdivision controversial much taxonomy subject change chapter', 'clarity communication useful refer salmonellas likely encounter enteritidis percy minor', 'salmonella enteritidis', 'vary pathogenicity geographic distribution serovar classification epizootiologic significance', 'discussion treat enteritidis single entity', 'salmonellosis nonexistent laboratory united infection prevalent many wild potential introduction', 'clinical infection rare hunched posture fur lethargy weight loss conjunctivitis', 'soft diarrhea', 'salmonella enteritidis ingestion feed bedding water', 'incursion wild feral laboratory facility risk', 'addition salmonellosis anthropozoonosis wray infection source agent', 'subclinical gross microscopic', 'clinical disease evidence gastrointestinal involvement septicemia mural thickening mucosal', 'enteric edema lamina propria leukocyte infiltration reactive hyperplasia crypt epithelial', 'lymphoid hyperplasia focal necrosis neutrophil infiltration peyer spleen mesenteric lymph', 'septicemic spleen fibrin present liver spleen lymph barthold', 'salmonellosis diagnosed culture mesenteric lymph spleen blood', 'material enrichment selective growth medium', 'symptomatic culture positive colony incidence asymptomatic', 'detection enteritidis repeated significant', 'probability national research council confidence positive true prevalence positive', 'differential diarrheal disease tyzzer disease rotavirus infection enterococcal enteropathy cryptosporidiosis water', 'salmonellosis rigorous control food bedding', 'good personal hygiene source salmonella enteric colony', 'colony', 'strict quarantine small group practical prior rederivation embryo transfer cesarian section', 'flexible film semirigid isolator', 'treatment chronic carrier state potential zoonotic disease', 'enteritidis research zoonotic potential risk', 'research mice national research council', 'pseudomoniasis clinical disease pseudomonas aeruginosa gram negative bacillus order family pseudomonadaceae', 'motile aerobic oxidase positive distributed water soil sewage skin gastrointestinal tract many', 'part common commensal domestic laboratory gilligan', 'near ubiquity p aeruginosa implicated disease specific severe host defense deficient functional', 'athymic nude mice subject high incidence pseudomoniasis treated myelosuppressive', 'general pseudomoniasis low significance national research council l treated radiomimetic percy barthold', 'particular pseudomoniasis consequence infection jugular', 'septicemia', 'necropsy vegetative valvular endocarditis multifocal hemorrhagic pneumonia', 'fibrin emboli gram negative heart lung', 'pseudomoniasis cultural identification organism', 'caution observed morbidity mortality ubiquitous p aeruginosa', 'pseudomonas grow blood agar isolation selective pseudomonas isolation agar agar', 'use selective healthy low common cecum nasopharynx', 'exclusion p aeruginosa research national research council', 'appropriate exclusion gnotobiotic sterilization water sterilization', '', 'possible contamination human skin wet surface', 'control p aeruginosa infection system', 'group metabolic activity dense glycocalyx', 'resistant chlorine resistant free al', 'chlorination ppm acidification colonization mice p aeruginosa eliminate infection', 'rederivation cesarian section embryo transfer p aeruginosa colony', 'treatment gentamycin animal drinking water gm liter eliminate infection mice practical large', 'cause rat bite fever moniliformis historic interest', 'zoonotic agent nonexistent modern laboratory brief mention serious infection anderson al wullenweber', 'agent gram negative pleomorphic bacillus sheep blood agar trypticase soy agar horse serum savage', 'streptobacillus moniliformis commensal wild nasopharynx middle ear respiratory tract', 'present blood urine bite', 'organism nonpathogenic', 'clinical incubation period fever vomit arthralgia rash', 'disease mortality low', 'laboratory culture blood nasopharyngeal swabs streptobacillus moniliformis colony organism', 'wild moniliformis detection laboratory rat colony exposure wild', 'several helicobacter spp', 'natural last', 'helicobacter muridarum first lee', 'trogontum intestinal helicobacter al h bilis large bowel immunodeficient', 'organisms ultrastructural morphologic appearance h heilmannii h bizzozeroni stomach wild al', 'laboratory microaerophilic negative straight', 'coccoid h bilis h pylori fox et al', 'pathogenic potential h pylori human gastritis work confirm similar pathogenicity rodent', 'koch h hepaticus causative agent enterocolitis hepatitis mice fox al experimental reproduction disease natural infection spp', '', 'athymic nude h bilis similar immunodeficient mice h bilis h hepaticus proliferative ulcerative typhlitis colitis proctitis causal role', 'immunocompetent laboratory helicobacter', 'transmission helicobacter', 'mice horizontal transmission bedding fecal oral transmission', 'fecal oral transmission probable', 'host range rat helicobacter', 'h bilis additional report eaton', 'helicobacter muridarum', 'host range h trogontum', 'many helicobacter able wide range mammalian', 'due natural helicobacter infection small series male athymic nude age h bilis al', 'gross focal diffuse cecal wall normal colon rectum', 'cystic mesenteric lymph', 'typhlitis similar colon rectum', 'crypt epithelium hyperplastic cytoplasmic basophilia goblet', 'lamina', 'mucosal erosion ulceration', 'many intraperitoneal injection x h bilis saline', 'infection helicobacter lifelong', 'infection colonization disease', 'helicobacter muridarum h trogonturn h muridarum cause lymphocytic gastritis mice loss parietal cell mass gastric ph', 'key pathogenic pylori urease cytotoxin vaca presence pathogenicity island', 'helicobacter spp', 'bilis h trogontum h muridarum urease positive fox lee', 'virulence', 'helicobacter infection prime differential diagnosis proliferative large bowel', 'spontaneous chronic ulcerative colitis athymic nude pass', 'unable culture helicobacter spp', 'affected molecular', 'diagnosis helicobacter infection laboratory polymerase chain reaction pcr fox lee', 'common approach use genusspecific capable helicobacter spp well specific single follow initial amplification restriction endonuclease digestion gel separation digestion product banding characteristic various', 'fecal cecal mucosal tissue', 'helicobacter spp variety', 'culture large rich site', 'fox et al', 'recommend passage cecal filter culture brucella agar vancomycin polymyxin suppress growth unwanted fox lee', 'general easy exclude animal specific environment', 'uncertainty full host range rat possibility transmission difficult', 'usual source infection helicobacter infection contaminated laboratory', 'indication transmission feed water', 'colony treatment small possible', 'several antibiotic successful mice', 'oral gavage several day incorporation diet', 'triple therapy combination tetracycline metronidazole bismuth oral gavage day effective orcutt', 'elimination infection large likely effective practical single rat viable helicobacter reinfection entire colony', 'research due infection helicobacter spp', '', 'car bacillus respiratory bacillus genus bacillus', 'group fact motile visible motility flavobacterium flexispira rrna cundiff et al', 'final identification', 'car bacillus mice common laboratory zwieten al mackenzie et al waggie al griffith et al', 'asymptomatic nonspecific clinical loss dyspnea', 'transmission direct contact', 'significant role natural transmission car bacillus transmit infection', 'airborne exposure important transmission itoh et al', 'car infection gross translucent gray cystic dilated mucus pleural surface itoh al', 'coinfection mycoplasma pulmonis suppurative bronchiopneumonia', 'hyperplastic peribronchial peribronchiolar mononuclear cell itoh al', 'thin basophilic layer surface epithelium hematoxylin eosin impression basophilic normal specific definitive diagnostic feature', 'warthin starry methenamine silver filamentous cilia respiratory epithelium nasal cavity', '', 'upper respiratory tract course infection tract histologic car bacillus infection', 'car bacillus infection murine respiratory mycoplasmosis pneumonia due streptococcus pneumoniae corynebacterium kutscheri etc', '', 'detection car bacillus infection suspicion coinfection van zwieten al mackenzie et al fig', '', 'car bacillus infection serologic immunosorbent assay elisa immunofluorescence ifa matsushita et al shoji al lukas et al', 'false positive positive steiner stain tracheal mucosal histopathology use special', 'infection cundiff many detect car bacillus infection', 'infection lifelong retrievable tracheal lavage al', 'car bacillus pcr cundiff al important confirmatory test positive serologic', 'pcr positive serologic conversion nasal swabs nonterminal procedure franklin al', 'car bacillus infection exclusion', 'effective treatment', 'alternative elimination rederivation entire infected direct contact transmission advantage', 'individual serology negative pcr positive positive rat test', 'infection aerosol possible control spread infection', 'expense labor possible failure value', 'interference car bacillus research unknown', 'interference ciliary function', 'car bacillus respiratory response documented scientific literature', 'et nutritional e disease tvedten al', 'mycoplasma virulence davidson al', 'environmental intracage ammonia temperature humidity etc', 'schoeb et al', 'mycoplasma pulmonis dysfunction loss cilia kohn fig', 'likely cause accumulation opportunistic bacterial transport ova infertility', 'mycoplasma pulmonis host cell al toxic nonspecific naot al', 'latter proliferation autoreactive host victim immune system', 'mycoplasma pulmonis host immune upper respiratory tract persistent progressive', 'exact mechanism pulmonis host immune system unknown', 'murine respiratory mycoplasmosis mrm chronic respiratory disease mycoplasma pulmonis kohn kirk lindsey al', 'clinical infection silent young', 'clinical nonspecific referable respiratory auditory involvement ocular nasal head tilt', 'middle ear involvement tail', 'reproductive efficiency leader al', 'mycoplasma pulmonis direct contact aerosol utero transmission', 'venereal transmission possible', 'disease outcome complex interaction host pathogen environment', 'host age strain davis cassell immune status lymphoreticular function presence intercurrent virus schoeb fig', '', 'electron micrograph bronchial epithelial cell', 'numerous pulmonis cell surface cytopathology', 'gross percy barthold order frequency suppurative rhinitis otitis laryngitis tracheitis upper respiratory tract', 'lung suppurative bronchopneumonia atelectasis bronchiectasis widespread bronchiectatic appearance cobblestone lung endstage disease', 'classic lesion mrm rare recent', 'arthritis', 'genital tract resorbed suppurative salpingitis', 'van andel et respiratory tract suppurative exudate hyperplasia squamous metaplasia mucosal epithelium striking hyperplasia bronchial lymphoid tissue balt', 'respiratory tract pseudoglandular hyperplasia nasal epithelium chronic peribronchial alveolar type ii', 'car bacillus secondary bacterial pneumonias accompany mrm', 'female genital tract mycoplasmosis suppurative oophoritis salpingitis hydrosalpingitis chronic suppurative endometritis pyometra', 'differential bacterial pneumonias corynebacterium kutscheri infection streptococcosis cilia respiratory car bacillus infection mycotic pneumonia', 'viral mistaken intercurrent common sendai virus pneumonia virus mice', 'diagnosis mycoplasmosis individual rat cultural isolation exudate upper respiratory tract', 'surveillance', 'pathology gross examination histopathology diagnostic guidance definitive', 'mycoplasma pulmonis research immune system respiratory system reproductive system primary early mortality al et al lindsey al lindsey al', 'haemobartonella muris gram negative bacterium order family anaplasmataceae ristic kreier', 'family parasite grown vitro', 'clinical latent infection immunosuppression splenec tomy national research council', 'due destruction weight loss hemoglobinuria pallor dyspnea', 'clinical pathology anemia reticulocytosis coagulation plasma serum igm', 'h muris spiny rat louse polyplax spinulosa rare modern laboratory animal hemobartonellosis rare national research council lb', 'potential biological route introduction rat', 'addition agent vector extant north america low level threat', 'necropsy case active splenomegaly', 'blood likely active', 'hemobartonellosis lice rat colony anemia hemoglobinuria', 'diagnosis detection coccoid elongate rod dumbbell surface', 'hemobartonellosis polyplax spinulosa biologic colony', 'disease colony rederivation embryo transfer cesarian section treatment antirickettsial small kreier', 'hemobartonellosis research virtue parasitism', 'half life function mononuclear phagocyte system increase rejection transplantable research blood borne parasitic trypanosomiasis', 'sendai virus rna virus genus paramyxovirus comprised homologous national research council', 'sendai virus disease mice asymptomatic disease sendai virus', 'clinical virus production litter retarded growth young', 'clinical respiratory makino et al', 'lewis sendai virus lymph upper respiratory tract initial major site antibody production', 'development serum immunoglobulin g igg clearance respiratory tract infection recovery viral infection liang al', 'coinfection respiratory pulmonis flexibacter sp', 'car bacillus pasteurella pneumotropica pneumonia virus mice pvm severity clinical disease pulmonary williford al carthew', 'sendai virus prevalent commercial mice today barrier commercial', 'commercial institutional naive', 'sendai virus contagious transmission respiratory tract aerosol direct contact', 'exposure initial tropism upper respiratory tract characterized focal diffuse necrosis epithelial leukocytic infiltrate plasma', 'hyperplastic suppurative bronchitis focal alveolitis', 'alveolar septa hypercellular alveolar', 'viral replication bronchial epithelial type type ii alveolar', 'perivascular peribronchial lymphocytic plasmacytic infiltrate acute phase infection burek al percy barthold', 'experimental infection lesion severity severe brown lew sorden castleman al', 'due low prevalence clinical diagnosis detection demonstration typical respiratory tract', 'elisa test choice diagnosis sendai virus', 'comparison complement fixation cf hemagglutination inhibition hai elisa sensitive detection early antibody sendai virus detection small antibody et al', 'prevention sendai virus introduction colony pathogen status source serological', 'regular periodic serologic help control infection rodent housing', 'mouse rat antibody production map rap transplantable biological transmission sendai virus infected recipient', 'pcr presence sendai virus viral sensitive', 'sendai virus rat colony immunocompetent antibody infected', 'antibody naive pregnant preweanling breeding virus colony al', 'addition research respiratory tract virus immunological g severity adjuvant arthritis garlinghouse van hoosier cell thymocytotoxic autoantibody takeichi et al', 'prototype rat coronavirus rcv p sialodacryoadenitis virus rcv sda', 'addition coronavirus p rcv sda', 'rcv p rcv sda distinct clinical al', 'clinical pathogenicity histological variable similar rcv p rcv sda neutralization group new rcv isolate useful pathogenic potential compton et al', 'infection rcv sda rcv p comparison clinical', 'antigenic p rcv sda significant allow crossinfection virus', 'important point clinical perspective virus prototype offer significant cross protection virus strain viral recurrence clinical percy barthold jacoby bihun percy kojima et al', 'rat asymptomatic transient clinical sialodacryoadenitis tissue salivary lacrimal harderian respiratory epithelium', 'distinctive clinical disease virus', 'breeding endemic mature infection clinical disease nonimmune ocular conjunctivitis', 'transient week', 'second type clinical picture sudden onset clinical naive adult infected', 'cervical fig', '', 'edematous pale submaxillary gland arrow cervical lymph', 'courtesy dr robert jacoby', 'due inflammation edema submaxillary salivary', 'nasal ocular photophobia corneal', 'last', 'megaloglobus jacoby al', 'rat contagious transfer susceptible direct contact regina et al', 'virus present target week exposure time antibody infection self', 'immunity lifelong', 'experimental susceptible reinfection early initial infection able transfer infection naive contact', 'severity minimal associated primary et weir et al', 'pathogenicity rat et al carthew slinger', 'histological sialodacryoadenitis sda salivary lacrimal coagulation necrosis ductal acinar epithelial acute squamous reparative period infection', 'mixed leukocyte infiltrate', 'regeneration epithelial postinfection', 'focal additional several harderian', 'microscopic rhinitis tracheitis focal bronchitis acute stage disease mononuclear polymorphonuclear cell infiltration hyperplastic respiratory epithelia loss focal alveolitis', 'respiratory tract abate percy barthold', 'diagnosis sda serological elisa method histological examination harderian submaxillary parotid salivary national research council', 'disease subclinical typical salivary gland harderian gland', 'differential mycoplasma sendai virus pneumonia virus mice pvm chromodacryorrhea percy barthold', 'transfer contagious naive entry facility pathogen status vendor effective quarantine program', 'control infection colony facility fact virus week', 'virus', 'rat coronavirus colony entry susceptible room suspension breeding removal', 'rapidity virus determine period time susceptible breeding resumed', 'period jacoby et al', 'suspension method continue sda define subset breeding colony seropositive relocate breeding separate room original colony late gestation kill original colony brammer et al', 'research sda reflect lacrimal salivary eye vomeronasal organ respiratory epithelium percy barthold', 'long term ocular research linked period active infection reparative period', 'period food cervical swelling', 'single dna active host', 'kilham rat virus rv toolan virus rat parvovirus rpv', 'transplantable tumor rv tumor cell line', 'rat sera presence parvovirus rv', 'virus parvovirus opv rat parvovirus rpv', 'clinical rv infection serological evidence infection preweanling', 'litter size fetal neonatal death', 'subclinical hemorrhage necrosis brain young adult al', 'ability rv cross placenta virus strain dose time gestation', 'resistance lethal infection postpartum week jacoby al gaertner al', 'serological high prevalence antibody virus clinical disease virus national research council b', 'pathogenesis rpv definition rpv subclinical weisbroth al', 'rat virus urine milk aerosol direct contact', 'rv bedding stored room temperature capable seroconversion', 'transmit rv long seroconversion frequency persistent infection natural straindependent gaertner', 'experimental inoculation rv neonatal duration infectivity cage', 'duration viral recovery infectivity et al jacoby et al', 'study recoverable tissue explant newborn al', 'persistent antigenic evidence rv lymphoid vascular muscle renal tubular epithelium gaertner al jacoby et al', 'correlation age rv pathogenicity complement target phase division productive infection', 'immune status host significant outcome rv infection', 'rat virus athymic severe persistent infection euthymic et al', 'diagnosis rv rpv virus sera elisa ifa rv h l recombinant antigen', 'positive response delineate rat parvovirus antibody antibody rodent parvovirus present', 'positive elisa ifa sera hemagglutination inhibition hai rv', 'negative hai positive rpv al', 'pcr rpv rapid specific sensitive viral dna tissue al environment w r personal communication', 'research rv tropism active cell', 'rat virus modulate immune function tropism cell mckisic et al', 'rat virus infection diabetesresistant rat macrophage autoimmune al', 'effect rv immune system rat strain dependent natural killer cell activity', 'natural killer cell cytotoxicity brown wistar furth al', 'research unknown', 'pneumonia virus mice pvm family paramyxoviridae', 'contrary virus name serological evidence infectivity mice guinea', 'prevalence seropositive rat exceed today serological evidence pvm infection', 'diagnosis elisa hai national research council', 'virus cause clinical disease multifocal nonsuppurative vasculitis interstitial pneumonitis necrosis prominent acute phase disease', 'several', 'virus significant copathogen respiratory pulmonis cross potential concern percy barthold', 'diarrhea virus identical distinct group eiden et al', 'disease infectious diarrhea infant al', 'infant liquid erythema perianal skin', 'pathology infection small intestinal villous atrophy villous epithelial necrosis syncytial cell formation', 'agent diarrhea enzyme immunoassay inhibition prevalent', 'human infant al vonderfecht et al', 'nonexperimental infectivity', 'rna hantavirus family bunyviridae', 'natural reservoirs virus genus specific rodent', 'hantavirus chronic subclinical virus', 'significant zoonotic', 'rattus natural host seoul hantavirus hemorrhagic fever renal syndrome hfrs', 'hantavirus wild several', 'report evidence human infection rat hantavirus al', 'cotton hispidus hantavirus hantavirus pulmonary syndrome florida hutchinson al', 'transmission hantavirus laboratory laboratory japan belgium united kingdom desmyter al lloyd', 'multiple hemorrhagic fever renal syndrome', 'lymphohistiocytic lung attributable virus etiology barrier commercial breeding', 'multiple small gray tan foci pleural surface lung', 'mild moderate multifocal histiocytic alveolitis perivascular cuffing', 'severe', 'bacteriological pcr car bacillus suggest', 'viral etiology inoculation lung tissue bacteriologic cytopathic tissue culture riley franklin slaoui al c clifford personal communication', 'several rodent serological evidence infection rat negligible clinical pathological importance', 'adenovirus mouse encephalomyelitis virus reovirus parainfluenza virus endogenous barthold national research council barthold', 'protozoa little consequence laboratory recent national research council barthold', 'several', 'spontaneous disease due enteric protozoa laboratory', 'second parenteral rare laboratory', 'third universal use high quality heat disinfection use', 'fresh', 'protozoa potential significance rodent encephalitozoon enteric muris giardia muris disease alter immune mice', 'encephalitozoon cuniculi microsporidian parasite wide variety mammalian lagomorphs', 'poonacha al reetz', 'encephalitozoonosis common conventional rabbit pig', 'ingestion inhalation urine wilson', 'vertical transmission foxes mice et al liu et al', 'resistance infection infection dependent cell function strain dependent liu et niederkorn et al', 'athymic nude mice athymic nude susceptible lethal infection euthymic', 'encephalitozoon transplantable', 'clinical gross cuniculi infection', 'histopathologic examination cuniculi infection granulomatous meningoencephalitis brain spinal cord', 'interstitial nephritis similar', 'adjacent', 'hematoxylin eosin positive', 'diagnosis e cuniculi infection serology al', 'efficient method high prevalence gannon', 'serologic positive serologic second method assay positive', 'histopathologic observation organism definitive', 'primary histopathologic differential diagnosis e cuniculi infection', 'encephalitozoon cuniculi gm hematoxylin eosin', 'toxoplasma gondii gm gram stain wilson', 'encephalitozoonosis purchasing free encephalitozoon', 'effective treatment', 'research cuniculi factor histopathologic evaluation central nervous system part study zubaidy', 'toxoplasmosis zoonotic disease toxoplasma gondii', 'toxoplasmosis subclinical', 'definitive host domestic cat', 'many intermediate', 'transmission ingestion cat', 'ingestion intermediate transmit infection mode transmission rat colony', 'infected', 'order rat colony infected gondii cat', 'result little current significance research toxoplasmosis geographic et al', 'numerous enteric laboratory significance', 'life cycle entamoeba direct flynn levine fecal oral transmission', 'form present gastroinestinal tract', 'reproduction asexual resistant cyst kunstyr', 'spironucleus muris glandular small tine osborne wagner', 'ageinfection similar mice age susceptible infection', 'transmission muris schagemann et al', 'isolate infective immunocompetent athymic nude mice', '', 'resistant drying room temperature ph day hr kunstyr ammerpohl', 'spironucleus muris infection examination wet duodenal', 'phase contrast microscopy helpful', 'identification size • gm characteristic motion', 'wet fecal', 'measure gm characteristic pattern kunstyr', 'giardia spp', 'ancient yu al yu et al', 'giardia mycoplasma al et al tai et al', 'giardia muris wide variety mammalian mice', 'recent evidence g muris g duodenalis sharma mayrhofer', 'conclusion zoonotic potential g duodenalis human pathogen host specificity incomplete', 'giardia muris isolated mice example infection al', 'attach surface intestinal epithelial flat suction disk levine', 'attachment surface membrane lectin occur point parasite surface disk inge et al', 'liquid infective year craft', 'clinical disease g muris', 'experimental infection g lamblia g duodenalis secretion specific immunoglobulin bile loftness al sharma mayrhofer', 'giardiasis spironucleosis', '• gm levine characteristic piriform teardrop shape broad anterior tapering posterior end levine', 'slight curvature ventral side motion multiple flagella impart motion national research council', 'dual nuclei prominent', 'small dark median visible posterior nuclei', 'fecal fecal flotation', 'entamoeba muris nonpathogenic commensal amoeba national research council levine', 'tm length wet mount colon feed', '', 'control intestinal similar', 'rederivation cesarean section embryo transfer effective', 'animal disinfected chlorine dioxide suitable sproul prior repopulation introduction', 'room exposure rodent', 'infection introduction', 'include examination age e', 'treatment infection intestinal limited success', 'metronidazole flagyl dimetridazole national research council drinking water ineffective environment', 'success giardia spp metronidazole', 'metronidazole carcinogenic goldman', 'oxyuriasis muris tetra pteraioccur laboratory rat', 'continued occurrence dramatic progress viral bacterial due persistence environment low degree attention', 'syphacia muris common oxyurid rat national research council owen', 'syphacia mice rat housed room mice', 'syphacia spp', 'direct life cycle completion flynn', 'transmission horizontal ingestion', 'viable room anus colon infective hr', 'small intestine', 'larvae mature cecum', 'mor phology similar muris male tail proportion body width flynn', 'muris x tm obvelata x tm', 'addition flat side muris side', 'aspicularis tetraptera ingestion persistent environment flynn', 'direct life cycle syphacia requiring', 'syphacia aspicularis anus', 'adult tetraptera alae present anterior end body', 'size muris x bm symmetrical', 'gross rare flynn histologic oxyuriasis', 'diagnosis oxyuriasis direct examination cecum colon low magnification stereomicroscope', 'sensitive complete direct examination large bowel time', 'examination', 'perianal tape test effective syphacia fecal flotation effective tetraptera', 'oxyurid sensitive direct examination bowel adult helminths et al klement et al', 'oxyuriasis individual huerkamp klement et al zenner hasslinger wiethe', 'source original infestation prevent reinfestation', 'ivermectin effective environment', 'oxyuriasis rederivation', 'proper adherence modern room technology hasslinger wiethe', 'numerous research', 'interfere adjuvant arthritis pearson taylor growth rate intestinal electrolyte transport lubcke al', 'ii', 'trichurid nematode rat flynn', 'widespread rare cesarean section embryo transfer', 'adult live urinary bladder free mucosa flynn antonakopoulos al cornish et al', 'vagina uterus', 'pass urine', 'transmission crassicauda ingestion dam', 'stomach larvae wall pass peritoneal cavity bloodstream reach', 'larvae lodge', 'reach kidney bladder survive develop maturity', 'entire life cycle present urine age', 'infestation crassicauda persistent inapparent flynn', 'number barthold present bladder cause mild uroepithelial hyperplasia zubaidy antonakopoulos et al', 'renal pelvis mild pyelitis pyelonephritis', 'infestation live urine examination filter medium', 'diagnosis direct examination bladder wall histopathology electron microscopy microscopic examination cryostat acridine orange cornish et al', 'last reliable practical routine large scale screening', 'treatment crassicauda infestation single dose ivermectin summa et al', 'followup infestation reinfection', 'colony free parasite little chance reintroduction colony', 'research crassicauda infestation scientific literature proliferative urothelium unsuitable research urinary system cohen al', 'early speculation possible etiologic role crassicauda infestation bladder famous study high diet homburger', 'proliferative crassicauda infestation identical early carcinogenesis chemical n methylnitrosourea mnu pauli et al', 'adult laboratory nana h diminuta', 'primary consequence nana zoonotic direct life cycle h diminuta indirect life cycle intermediate host zoonotic', 'rare laboratory', 'hymenolepis nana small intestine', 'ability parasitize h nana significance little damage national research council', 'hymenolepis nana vary', 'slender mm wide', 'scolex', 'mature many oval colorless visible polar', 'inner envelope', 'host', 'direct life cycle hsu hatch small intestine', 'cysticercoid larvae', 'larvae reenter mucosa', 'additional mature', '', 'infection immunity autoinfection', 'autoinfection eggs small intestine develop high worm', 'indirect life cycle grain molitor obscurus canis xenopsylla cheopis serve intermediate', 'definitive intermediate host', 'hymenolepis diminuta similar host range mice', 'hymenolepis diminuta h mm wide', 'scolex h diminuta unarmedmit', 'diminuta x tm polar', 'life cycle h diminuta indirect similar indirect life cycle h nana', 'hymenolepis h diminuta pathogenic severe growth weight loss impaction death literature hsu recent potential', 'jueco infection common geographic subclinical', 'human long autoinfection', 'infection detection adult direct examination small intestine observation fecal flotation histopatho logic detection cysticercoid small intestine hsu', 'infection common young immunity older', 'hymenolepis h diminuta infection purchase clean adequate disinfection barrier room insect control exclusion wild national research council', 'treatment infected zoonotic disease', 'indirect interference research hymenolepiasis', 'addition adult larvae taenia taeniaformis cysticercus fasciolaris', 'several', 'presence cyst scolex strobila bladder hsu wescott', 'nonpathogenic cyst development hepatic sarcomas similar induction sarcomas rat variety foreign goodman', 'definitive host cat detection cysticercus evidence environment unsterilized cat', 'control simple', 'numerous wild plagiorchis muris p philippinensis p javensis', 'zoonotic hong et none significant laboratory', 'radfordia ensifera ectoparasite laboratory animal environment affinis myobia musculi pelage', 'acariasis mite infestation persist environment', '', 'infestation result pruritus self excoriation secondary bacterial infection', 'mice acariasis mitotic activity skin immunologic amyloidosis', 'acariasis direct examination microscope flynn', 'alternative dead clear glass plastic container overnight examined black background', 'control acariasis similar parasitic meta zoa acariasis individual et al', 'source original infestation prevent reinfestation', 'ivermectin effective environment', 'infestation rederivation proper adherence modern room technology weisbroth', 'pediculosis laboratory rat rare spinulosa flynn owen', 'polyplax spinulosa mm long', '', 'female', 'distinct operculum row operculated end', 'pneumatic mechanism air body use pressure force open operculum owen', 'young yellow brown similar', '', 'environmental', 'entire life cycle', '', 'transmission direct contact hsu', 'pediculosis inapparent unthrifty pruritic', 'polyplax spinulosa vector haemobartonella muris national research council', 'diagnosis direct examination pelt', 'time infestation p spinulosa blood haemobartonella muris', 'pediculosis introducing free condition', 'treat hsu valuable significant intercurrent', 'fungal associated predisposing immunocompetence', 'report fifth wistar study chronic rhinitis aspergillus fumigatus rehm et al', 'factor virus infection', 'clinical nasal exudation yellowish friable material present nasal severe nasal', 'fumigatus rhinitis naso', 'bronchial abscess hyphae multiple rat', 'tracheobronchial aspergillosis aged rat concomitant large granular cell leukemia', 'immunodeficiency due leukemia involved multifocal transmural necrotic bronchi hubbs et al', 'pneumocystis carinii dna base ribosomal al', 'agent present immunocompetent laboratory pneumonitis', 'immunocompromised rat model p carinii pneumonitis', 'agent airborne transmission conventional barrier commercial', 'diagnosis infection immunocompetent least treatment corticosteroid cyclophosphamide elicit detectable level infection', 'special silver demonstrate fungal', 'polymerase chain reaction pcr detect p carinii infection rat week treatment feldman et al', 'pneumocystis carinii life cycle distinct gm precyst gm cyst gm gm national research council', 'histopathology multifocal alveolar interstitial perivascular severe pulmonary consolidation eosinophilic alveolar exudation severe interstitial fibrosis gv solas', 'control disease treatment trimethoprim sulfamethoxazole', 'al', 'induced rhinitis immunosuppression', 'corncob hardwood bedding determine source aspergillus infection material', 'range fungal gram corncob', 'genera acremonium penicillium aspergillus fusarium scolobasidium negligible hardwood bedding', 'use corncob bedding eliminate fungal contamination bedding', 'dermatomycosis ringworm due trichophyton wild laboratory', 'laboratory many', 'dermatomycosis patchy hair loss scurfy erythematous papular pustular', 'investigator meat desirable trait investigator poison', 'stock strain laboratory rat specific genetic', 'common albinism behavioral docility willingness captivity certain tumor', 'overt metabolic obesity zucker rat bb rat hypertension shr fawn dahl valuable biomedical research spontaneous appearance research', 'subtle strain related responsiveness brown lewis particular research', 'recent genetic manipulation development metabolic disease model critical human', 'scope chapter catalog innumerable genetic strain related laboratory consult large electronic national library medicine specific current information particular', 'addition characterized spontaneous genetic variation degree genetic drift', 'inbred molecular fragment length difficult assess degree outbred interindividual variation intercolony', 'source vary time sufficient exchange', 'genetic drift careful adherence specific line systematic exchange multiple', 'inevitability genetic drift large role environmental husbandry dietary experimental apparent', 'extraneous major impact expression genetic', 'example modification lesion prevalence impact ad libitum incidence progressive renal disease keenan et al', 'frank dietary several', 'high quality commercial universal use', 'second fat soluble vitamin manufacture vitamin many', 'heat moisture vitamin particular lysine vitamin vitamin e riboflavin thiamin', 'storage similar', 'addition maintenance adult protein fat optimal growth young successful reproduction', 'clinical evidence dietary insufficiency decreased reproductive performance litter loss poor growth hair coat', 'severe specific rare', 'occur squamous salivary hypovitaminosis hemorrhage hypovitaminosis k embryonic death testicular degeneration hypovitaminosis nutritional disease susceptibility severity', 'addition feed total specific size hardness', 'example feeding diet result incidence malocclusion', 'limit number health suboptimal care management experimental', 'common', 'sanitation animal cage bedding water feed experimental equipment critical', 'high moisture content rapid growth incidence urinary tract skin', 'softwood aromatic hepatic microsomal sublimated phase bedding manufacture', 'airborne enter spread facility air', 'quality disinfectant', 'management consideration human', 'transmit streptococcus spp staphylococcus spp escherichia coli klebsiella spp pseudomonas spp campylobacter spp', 'addition serologic cross many', 'sensitive temperature humidity noise light room activity environment', 'low humidity relative humidity high temperature condition ringtail', 'experimental reproduction ringtail pathogenesis condition', 'ringtail condition young formation prominent annular', 'distal necrotic', 'condition bite normal subtle age', 'range many ultrasonic range', 'low audible noise noise acceptable', 'susceptible retinal degeneration ambient light lux semple rowland dawson', 'result room light national research council', 'note floor actual light individual various light', 'exposure high light lux day necrosis harderian al', 'addition exposure constant light anestrus section', 'exposure contamination dark phase light cycle light low interfere growth metabolism al', 'traumatic uncommon rat', 'wire bottom pododermatitis long term caging', 'wire grid rat foot become wire grid severe edema injury foot leg', 'recover anesthesia wire bottom cage', 'group housing likely result traumatic due', 'ulcerative dermatitis staphylococcus aureus trauma scratching fox et al wagner', 'report al skin commercial vendor hypothesis specific staphylococcus phage host susceptibility', 'adynamic ileus leading death subsequent intraperitoneal administration chloral hydrate', 'clinical several lethargy anorexia abdominal distension', 'prominent dilatation jejunum ileum cecum', 'usual anesthetic dose chloral hydrate mg kg concentration drug dosage correlated induction ileus fleischman al', 'prevalence neoplastic disease rat defined large scale carcinogenic toxicological', 'stock strain specific prevalence mackenzie garner goodman al goodman al', 'overall prevalence neoplasia specific tumor genetic variation environmental laboratory diagnostic garner altman goodman', 'age important mammary many testicular old barthold', 'table vi incidence dawley', 'environmental diet important factor tumor prevalence', 'reduction food intake overall tumor incidence male female wistar pituitary mammary gland', 'study morris tumor incidence sprague dawley ad libitum life food age', 'food prevalence', 'proportion group multiple tumor', 'group food day persistent reduction food ad libiturn diet', 'environmental influence prevalence disease status particular report', 'tumor risk effect infectious preneo lang lang', 'plastic small barthold', 'mammary gland', 'sprague dawley female low incidence lang lang', 'mammary fibroadenomas carcinomas', '', 'mammary tissue point neck inguinal area large size become ulcerated', 'gross examination movable subcutaneous firm', 'acinar epithelial inter intralobular connective tissue altman goodman percy barthold', 'interstitial cell', 'discrete soft yellow brown hemorrhage', 'leydig cell apparent', 'solid organoid pattern', 'cell polyhedral granular cytoplasm hyperchromatic nuclei scanty cytoplasm altman goodman percy barthold', 'incidence interstitial cell low', 'pituitary dawley wistar barthold', 'pituitary chromophobe adenomas', 'carcinomas frequency prevalence classification', 'incidence incidence sprague dawley', 'prevalence pituitary female sprague dawley', 'diet restriction incidence pituitary', 'chromophobe size diameter', 'soft dark red due prominent hemorrhagic', '', 'circumscribed size compress adjacent brain tissue induce hydrocephalus', 'consist large polygonal prominent vesicular eosinophilic cytoplasm', 'architecture arranged vascular altman goodman', 'female sprague dawley lang lang', 'islet cell single multiple reddish brown', 'islet cell carcinomas capsular invasion', 'rare altman goodman', 'large granular lumphocytic leukemia major cause death', 'incidence coleman al goodman al', 'initial site malignancy spleen', 'neoplastic transplantable', 'leukemia mice leukemia retrovirus', 'diagnosis clinical anemia jaundice loss laboratory leukocyte', 'adrenal system lang lang cortical adenoma incidence male female sprague dawley pheochromocytoma incidence stock', 'incidence sprague dawley table vi', 'pancreatic islet cell common', 'incidence male diffuse infiltration malignant various barthold', 'sprague dawley rat low', 'lymphoreticular histiocytic sarcoma incidence sprague dawley myelomonocytic leukemia bn bi', 'scope chapter catalog congenital', 'incidence influenced administration mutagenic teratogenic strain age mother disease status human terminology', 'susceptible wide variety genetic valuable', 'spontaneous urinary tract heart central nervous system', 'range unintentional side', 'animal resource investigate due scientific scrutiny background information specific prior research laboratory animal', 'large reproductive available middle atlantic reproduction teratology association midwest teratology association example', 'hydronephrosis congenital unilateral bilateral dilation renal pelvis', 'single dominant gene gunn rat polygenic sprague dawley rat van winkle et al', 'right kidney left', 'severity hydronephrosis vary slight dilation renal pelvis severe dilation kidney transparent cystic structure', 'ureter', 'normal renal pelvis young caution identifying hydronephrosis maronpot', 'hydronephrosis pyelonephritis material pelvis polycystic renal papillary necrosis', 'culture histopathology site distinguish', 'congenital cardiovascular system ventricular atrial septal endocardial cushion various great', 'overall incidence cardiac colony sprague dawley al', 'common anomaly central nervous system rat dilation cerebral sprague dawley atlantic reproduction teratology association midwest teratology association', 'variety rat various wistar macpherson', 'wistar investigation audiogenic cairasco et al', 'congenital ocular common', 'albino pigmented tapetum development retinal atrophy', 'corneal mineralization subline bruner al yoshitomi boorman', 'deposition calcium visible stained basophilic interface corneal epithelium stroma', 'ocular laboratory retinal degeneration osseous cartilaginous metaplasia sclera colobomas', 'several tract laboratory transverse vaginal septum female wistar sprague dawley brown al', 'affected sterile septum complete subfertile septum spermatozoa uterus', 'pseudohermaphroditism male pseudohermaphroditism testicular feminization e present external female', 'affected xy express default feminine phenotype', 'mutant characteristic allison et al observed', 'testicular rat defect lack androgen due point mutation similar', 'brown high incidence granulomatous pulmonary inflammation incidence age', 'brown rats affected', 'affected brown lung', 'lung parenchyma granulomas giant', 'foreign material fungi visible demonstrated light special', 'laboratory subject wide range neoplastic nonneoplastic age', 'use carcinogenicity geriatric rat particular significance laboratory animal professional', 'type incidence severity stock strain rat infectious disease status experimental manipulation husbandry dietary restriction', 'common nonneoplastic consult scientific literature excellent additional information particular stock strain', 'neoplastic separate section chapter', 'chronic progressive nephropathy cpn important age related disease rat kidneys common death', 'chronic progressive nephrosis old rat nephropathy', 'condition common appellation', 'gross age cortical surface', 'cortical interstitial fibrosis removal renal capsule cortical parenchyma', 'severe year age cortical surface irregular pallor', 'glomerular thickened basement capillary layer bowman membrane segmental glomerulosclerosis short goldstein', 'disease numerous medulla proteinaceous', 'secondary hyperparathyroidism subsequent renal functional compromise widespread dystrophic mineralization', 'etiopathogenesis understood multifactorial', 'several major barthold percy barthold', 'incidence', 'genetic predisposition development cpn', 'sprague dawley high wistar long incidence', 'difficult ito interpret geographic variation different wistar europe sprague dawley united housing diet strainrelated change', 'example many incidence cpn european cage result feed consumption weight gain relative single housing', 'second gender factor development cpn', 'male incidence age severity', 'third diet critical factor factor management', 'clear moderate dietary restriction incidence severity cpn age relative ad libitum', 'mechanism renal blood flow glomerular filtration rate gumprecht et al', 'glomerular hypertrophy macromolecule filtration mesangial damage glomerulosclerosis protein leakage', 'mechanism reduction caloric intake relative ad libitum incidence severity female severity cpn male survival al', 'nephrocalcinosis deposition calcium renal tissue variety additional reflect localization mineral cortex medulla', 'contrast cpn common common female', 'addition gender incidence age strain young old', 'incidence incidence sprague dawley wistar', 'high incidence bdix', 'incidence severity nephrocalcinosis several dietary high high phosphorus low calcium phosphorus low magnesium percy barthold', 'clear dietary key factor background incidence nephrocalcinosis', 'short goldstein mineral deposition corticomedullary junction recta thin', 'chronic myocardial disease major cause death male multiple sprague dawley ad libitum keenan et al', 'condition cardiomyopathy chronic progressive cardiomyopathy early age', 'heart pale visible', 'weight heart degree damage histologic examination', 'lewis necrosis myocardial interstitial infiltration mononuclear', 'course disease fibrosis', 'large reactive nuclei', 'myocardial papillary interventricular septum', 'chronic progressive nephropathy incidence chronic progressive cardiomyopathy age moderate dietary restriction e reduction total caloric intake relative ad libitum al', 'pelage geriatric laboratory concern', 'common change loss hair', 'stock strain common brown', 'old albino appearance sebum skin', 'tail increase number age year english munger', 'continue prominent yellowed time', 'yellowish material adjacent ear black time oxidation bacterial action', 'addition male pigmented foci skin shisa', 'skin normal color', 'dorsum tail perineum', 'scale formation gonadectomy', 'nature pigment unclear lipid amino', 'alveolar histiocytosis common incidental finding lung many', 'alveolar histiocytosis visible white pale tan foci visible pleural surface', 'foci pleural surface lung', 'subpleural adjacent terminal bronchiole contain large pale foamy', 'cholesterol dense slight infiltration adjacent response proinflammatory', 'alveolar histiocytosis mistaken viral pneumonias seronegative lymphoid infiltrate macrophage aggregation', 'cause alveolar histiocytosis infectious']"
9182c40a4be4e5849c1bcf4a0fbe20e5ca86e168,science diplomacy health care joint russian rise poverty vaccine science achievable goal addition leishmaniasis addition regional akin global alcohol tobacco approach valuable arbovirus echinococcosis bank russian bilateral presidential bpc carnegie carnegie endowment catastrophic infectious century joint change human coalition epidemic collapse health commission included compelling joint conflict eastern consequence poverty consumption use control noncommunicable cooperation dual cooperation eradication dagestan russia diplomacy legacy diplomacy oral diplomacy panacea disease achievable disease leishmaniasis drug resistant dual track due collapse due oil ease today east north east respiratory eastern crimea economic recession economy recession editorial russian emergence leishmaniasis emergence several endowment international epidemic preparedness eradication control europe rise example infectious extraordinary meld factor rise feasible test financing new focus hiv foreign scientific fund tuberculosis funding organization global eradication global financing global fund goal nonprofit health major health pih help global high co high multi hiv prevention human southern humanitarian life important short include middle included joint infectious postconflict infectious war information file initiative new innovative wnv institute similar international funding international peace joint cooperation joint humanitarian joint soviet joint vaccine last rise late century leishmaniasis dagestan leishmaniasis middle leishmaniasis tropical libya tropical likely nation major focus majority east malaria scientific many infectious maternal health,"['late century joint soviet russian health major focus hiv prevention prevention tuberculosis tb', 'bilateral presidential commission included joint cooperation eradication control noncommunicable alcohol tobacco consumption use mobile phone technology maternal health care', 'bpc carnegie endowment international peace public private task force', 'important short compelling joint vaccine science diplomacy oral polio vaccine global eradication', 'war ease today russian', 'russia extraordinary meld scientific world major', 'last rise emergence several catastrophic infectious', 'include middle east respiratory syndrome virus name', 'help global financing new coalition epidemic preparedness international funding organization akin global fund tuberculosis malaria', 'russia special risk many infectious postconflict due collapse health care', 'example infectious war libya tropical disease leishmaniasis middle', 'russian federation', 'time new similar emergence leishmaniasis dagestan russia republic region conflict eastern crimea', 'addition regional factor rise tropical poverty', 'rise poverty russia', 'world bank russian economy recession russian population poverty', 'economic recession part due oil represent russia export', 'consequence poverty change human southern europe rise poverty neglected', 'addition leishmaniasis tropical vivax nile virus wnv arbovirus echinococcosis', 'russia high multi drug resistant mdr tb likely nation high co', 'nonprofit organization health pih mdr control', 'feasible test innovative wnv tb plasmodium vivax malaria scientific effort', 'joint russian initiative new disease achievable goal nonprofit sabin vaccine institute similar muslim majority east north', 'joint russian cooperation dual track record foreign scientific', 'vaccine science diplomacy panacea approach valuable joint humanitarian life', 'information file', 'russian translation editorial russian united science diplomacy legacy', 'pdf']"
1b3f6e0bc46bcf400a5372320e5fda56a21f5686,viral meningitis cell count aseptic meningitis bacterial meningitis csf cell enteroviral disease enteroviral infection lumbar puncture meningitis bacterial prognosis cause puncture csf simplex virus acyclovir available additional culture admission possibility amount information antibiotic therapy antibody deficient antibody titer assessment exclude assistance meningitis atypical examination atypical severe available compassionate available enteroviral available treat aware child bacteria negative bacterial disease bacterial section bleach gallon bleach solution blood cell blood rectal brain involvement care contact care provider careful assessment cause specific chain reaction child care child hearing chlorine household chronic enteroviral clinical additional clinical presentation cns focal code unspecified common presenting common year compassionate release considerable assistance consistent diagnostic contact bleach control observation count count count culture count wbc count white csf aseptic csf high csf normal culture mycobacteria culture negative cup chlorine cytopathology tumor day antibody deficient chronic definition viral developmental evaluation diagnosis lumbar diagnosis unclear differential diagnosis disease e disease efficacy disease neurology disease toxicity e antibody early shift efficacy intravenous enteroviral meningitis enterovirus positive enterovirus simplex evaluation age examination cytopathology exclude meningitis fall year family member fecal oral first life focal weakness formal developmental foundation large fungal protozoal gallon water gamma globulin globulin agammaglobulinemic glucose level good prognosis gram stain,"['definition viral meningitis inflammation many different', 'aseptic meningitis code unspecified viral meningitis common year', 'temperate summer fall year round tropical subtropical', 'spread person person fecal oral route respiratory', 'incubation period', 'meningitis', 'brain involvement perform lumbar puncture csf cell count white blood cell count count wbc predominance early shift mononuclear predominance glucose level normal csf normal gram stain negative bacteria negative blood rectal nasopharyngeal viral', 'serum day antibody titer', 'history clinical additional culture mycobacteria fungal protozoal infection', 'atypical examination cytopathology tumor', 'enterovirus simplex virus polymerase chain reaction pcr', 'least culture negative csf aseptic meningitis enterovirus positive pcr', 'identification specific viral pathogen possible many consistent diagnostic', 'risk reye hospital admission possibility treatable bacterial disease toxicity hydration pain control observation specific antibiotic therapy available enteroviral disease efficacy intravenous gamma globulin agammaglobulinemic', 'acyclovir available treat meningitis simplex virus', 'bacterial meningitis bacterial section diagnosis unclear', '', 'toxic csf high wbc young patient atypical severe clinical presentation', 'pleconaril available compassionate release enteroviral disease e antibody deficient chronic enteroviral infection', 'prognosis cause', 'enteroviral meningitis recover', 'ten percent cns focal weakness obtundation coma', 'first life risk language development', 'formal developmental evaluation age', 'viral meningitis primary care provider', 'subspecialty consultation', 'pediatric infectious disease neurology common presenting headache irritability careful assessment exclude meningitis young infant', 'diagnosis lumbar puncture csf cell count culture', 'parenteral treat viral meningitis bacterial meningitis differential diagnosis', 'wash', 'child care contact bleach solution', 'use cup chlorine household bleach gallon water', 'good prognosis cause specific true enteroviral infection', 'low risk neurologic sequelae', 'aware child hearing neurodevelopmental status', 'meningitis foundation large amount information web site considerable assistance meningitis family member meningitis']"
e1d098eb2a103cbeb58cb9deed56b4d908d07ae0,pmeo dapy silica gel amino acid bis pom hsv vzv vzv hcmv acid phosphoramidate g mmol antiviral activity bis poc ethanol water ethyl acetate ml mmol phosphonic acid r f room temperature acetate acetone acetone ethanol anti herpesvirus bis amino column silica methanol chloroform mixture h pom prodrug simplex virus system ethyl yield mg â ml alkoxyalkyl acid bis amidate bis hexadecylamido carbonyloxymethyl poc chloroform elution column methanol compound concentration cytomegalovirus hcmv embryonic lung ester prodrug gel ml hcmv ec herpesvirus activity human cytomegalovirus human embryonic lung hel mg mmol mixture residue mono pom oral bioavailability parental drug ph p phosphoramidate prodrug plaque formation poc alkoxyalkyl pom ester potent selective reaction mixture toluene â vaccinia virus absolute meoh acid residue active parental active table activity rna activity selectivity adefovir dipivoxil aldrithiol g amide group amino ester avance iii bis trimethylsilyl bruker avance ccid virus chromatographic separation chromatography silica colorless syrup cyclic form cytopathicity plaque cytostatic concentration dapy active diisopropyl ester dmf ml ec mm elution column elution ph ester bis ester cyclic ester potent ester r free phosphonic g pyridine gradient methanol green monkey h mixture h room hexadecylamido l hexadecyloxyethyl ester influenza b introduction poc kidney mdck l alaninate,"['new pmeo dapy prepared pro moiety carbonyloxymethyl poc alkoxyalkyl acid', 'activity vitro different virus', 'none activity rna active simplex virus hsv varicella zoster virus vzv human cytomegalovirus hcmv', 'bis poc bis amino acid phosphoramidate dapy herpesvirus replication parent compound selectivity vzv dapy', 'mono octadecyl ester potent selective prodrug hsv vzv hcmv ec marginal anti herpesvirus activity', 'bis hexadecylamido l tyrosyl bis pom anti herpesvirus selective mono octadecyl ester prodrug', 'acyclic anps great importance due broad spectrum biological antiviral cytostatic immunomodulatory antiparasitic', 'available treatment human cytomegalovirus cmv retinitis adefovir prodrug form adefovir dipivoxil treatment hepatitis b hbv tenofovir tenofovir disoproxil fumarate new prodrug form tenofovir taf treatment hiv hbv', 'hand last thirty systematic investigation anps attractive advanced stage preclinical clinical', 'antiretroviral purine acyclic base moiety c open aza deaza phosphonomethoxy ethyl', 'common structural attribute anps polar character presence phosphonic acid residue responsible unfavourable pharmacological low permeability low oral bioavailability', 'overcome problem transformation free acyclic nucleoside', 'work focus interesting anp example open ring anps group antiviral potential diverse prodrug', 'open anps phosphonomethoxy group aliphatic part position oxygen atom', 'open imidazole ring', 'antiviral activity identical parent enantiomeric specificity', 'dapy r pmpo dapy pmeo dapy fig', 'efficient hbv', 'number antiretroviral available market investigation new advisable several emergence resistance none able eradicate hiv infection vaccination available early development new drug necessary due longtime process vitro laboratory clinical final approval', 'additional reason focus open pmeo dapy type r pmpa tenofovir reverse transcriptase rt mutant r pmpa rt thymidine analog', 'pmeo dapy active immunocompromised hiv', 'development anps laboratory order search new epigenetic similar', 'none new criterion new class antiviral various ester cyclic form fig', '', 'selectivity', 'prodrug hexadecyloxyethyl ester cyclic form potent anti dna virus selectivity activity vs toxicity order', 'simplex virus hsv', 'varicella zoster virus vzv hcmv', 'disadvantage metabolic profile bound instability alkaline physiological ph', 'stability various anps stability derivative e', '', 'fact antiviral activity marginal free phosphonic acid form compound', 'fact many transformation appropriate', 'moreover activity spectrum activity transformation', 'typical dna viral octadecyloxyethyl ode potent selective inhibitor hepatitis virus replication cidofovir hexadecyloxyethyl ester brincidofovir efficacy rna viral ebola virus', 'fact lipid moiety brincidofovir vitro antiviral activity virus', 'compound ethoxy pyrimidine procedure literature', 'briefly base alkylation diisopropyl mixture appropriate oand n diisopropyl phosphonoethoxy methyl isomer diisopropyl ester bromotrimethylsilane', 'synthesis low solubility pmeo dapy synthesize biodegradable ester pom isopropoxycarbonyl oxymethyl poc acid phosphoramidate prodrug scheme', 'pivaloyloxymethylation reaction phosphonic acid chloromethyl pivalate n n base', 'reaction give mixture bis pom', 'chromatographic separation acceptable', 'alternative reaction g', 'reaction dioxane dbu', 'introduction poc different various dbu diisopropylethylamine', 'way bis poc derivative transformation free pmeo dapy tetrabutylammonium salt pocchloride dioxane', 'bis amino acid phosphoramidate prodrug direct pmeo dapy ethyl lalaninate pyridine treatment premixed solution triphenylphosphine dipyridyl disulfide aldrithiol', 'synthetic carbonyloxymethyl poc alkoxyalkyl acid', 'introduction poc pom action appropriate alkyl chloride n dimethylformamide e', 'transformation adefovir adefovir dipivoxil scheme', 'contrary adefovir reactivity solubility appropriate modest formation', 'pivaloyloxymethylation pom derivative main reaction product', 'amino acid method jansa phosphonate dialkyl', 'diisopropyl diethyl common deprotection bromotrimethylsilane bis trimethylsilyl final phosphonic', 'principle method utilization intermediary bis trimethylsilyl ester reaction dithiodipyridine triphenylphosphine amino ester bis laborious free phosphonic', 'selection amino acid diethyl alanine lphenylalanine optimal pharmacokinetic profile', 'case diethyl ester l phenylalanine scheme', 'preparation pom poc desired symmetrical bis amidate prodrug mono amidate small amount mono methyl ester', 'compound chromatographic separation mono prodrug system high percentage methanol', 'type prodrugs', 'concept phospholipid lysophosphatidylcholine lpc', 'lpc natural uptake pathway small intestine reach target tissue oral bioavailability', 'important compound family ester cidofovir brincidofovir iii clinical adenovirus', 'compound experimental drug smallpox ebolavirus', 'previous alkoxyalkylester approach hpmpdap search new bioavailable anti poxvirus synthesis fig', '', 'synthesis pme azac first tetrabutylammonium salt hexadecyloxypropyl mixture diester monoester', 'monoester predominant steric', 'small product isolated scheme', 'last type study amino ester esterification phosphonic acid residue free hydroxyl group appropriate hydroxy amino serine valine tyrosine', 'concept mckenna group oral bioavailability hpmpc hpmpa', 'pharmacokinetic various amino acid dipeptide tyrosine single amino acid favorable promoiety prodrug plasma stability', 'enzymatic stability tyrosine promoiety replacement carboxyl ester alkyl amide group', 'increase bioavailability antiviral activity long lipophilic alkyl chain incorporated tyrosine amide group', 'comprehensive review synthesis sar tyrosine n alkyl anp', 'synthesize symmetrical bis tyrosine prodrug carboxylic function hexadecylamido group scheme', 'compound alkylation sodium salt whole aliphatic moiety e', 'boc bis hexadecylamido ltyrosyl ester chloride boc', 'tyrosine synthon multistep synthesis diisopropyl chloride common building block synthesis diverse pme', 'isopropyl first action bromotrimethylsilane hydrolysis', 'intermediary phosphonic acid reaction oxalyl chloride dmf phosphorodichlori date reaction boc hexadecyl tyrosine presence triethylamine good preparative yield', 'tyrosine amide precursor n boc l tyrosine standard procedure edc n hydroxybenzotriazole hobt ch alkylated l tyrosine e g', 'octyl octadecyl', 'tested antiviral human cytomegalovirus hcmv varicellazoster virus wild type thymidine kinase deficient tk à simplex virus wild type tk à simplex virus vaccinia virus vesicular stomatitis human embryonic lung hel virus respiratory syncytial virus human cervix carcinoma hela reovirus sindbis virus coxsackie virus punta toro virus green monkey kidney vero corona virus feline kidney crfk influenza b influenza b kidney mdck', 'none displayed activity rna several active table', 'pmeo dapy amino acid phosphoramidate active hsv vzv hcmv', 'bis poc active compound hsv vzv effective hcmv', 'active parental drug pmeo dapy activity hcmv ec mm mm versus mm compound', 'antiviral potency augmentation cc cytostatic concentration dapy', 'consequence selectivity index ratio cc ec selectivity si', 'hsv vzv replication si si pmeo dapy e', 'hsv vzv', 'pivaloyloxymethylation pmeo dapy synthesis bis pom mono pom strategy result improvement anti herpesvirus activity', 'mono pom prodrug potency selectivity identical pmeo dapy bis pom prodrug active pmeo dapy cytostatic decreased selectivity parental drug', 'carbonyloxymethyl pom compound improved activity parent activity', 'bis pom prodrug replication hsv vzv hcmv ec range', 'amongst alkoxyalkyl octadecyloxytheyl ester prodrug antiherpesvirus octadecyloxyethyl ester active table antiviral cytotoxic human embryonic lung hel', 'compound bis pom ester prodrug weak activity vaccinia virus ec mm selectivity table', 'pmeo dapy', 'bis poc ester bis amino acid phosphoramidate prodrug low virus activity selectivity', 'carbonyloxymethyl poc alkoxyalkyl acid pmeo dapy weak marginal activity', 'mono octadecyloxyethyl ester potent selective inhibitor', 'hsv vzv hcmv', 'bis hexadecylamido l tyrosyl bis pom anti herpesvirus activity selectivity mono prodrug', 'bis poc bis amino acid phosphoramidate dapy active parental drug hsv vzv hcmv selectivity hsv vzv hcmv', 'otherwise kpa pa analytical tlc silica gel f merck kgaa darmstadt germany chromatographic text', 'column chromatography silica gel lm fluka', 'h c p nmr spectra bruker avance iii cryoprobe mhz h mhz c', 'p spectra bruker avance iii spectrometer ig', '', 'general scheme assignment nmr', 'decomposition system ethyl acetate acetone ethanol water bis pom derivative', 'elution column methanol mono pom prodrug', 'yield mg colorless syrup', 'methanolic solution tetrabutylammonium hydroxide ml suspension mg absolute meoh ml suspension ultrasonic bath dissolution', 'clear solution residue dioxane â ml', 'dry dioxane ml poc chloride ml mmol mixture h reaction course tlc methanol chloroform', 'mixture room temperature', 'residue water chloroform ml organic layer', 'residue silica gel gradient methanol chloroform', 'yield white amorphous', 'solution mg mmol ethyl l alaninate g triethylamine pyridine ml solution', 'triphenylphosphine g mmol aldrithiol g mmol pyridine mmol solution solution', 'whole reaction mixture h room temperature', 'toluene column silica gel ml system methanol chloroform elution triphenylphosphine mercaptopyridine gradient methanol chloroform', 'crude sirupy product g l alaninate chromatography silica gel system acetateacetone ethanol water', 'mixture mg mmol g mmol poc cl ml mmol dmf ml room temperature', 'mixture residue toluene â ml silica gel column ethyl acetate elution rest poc cl system ethyl acetate acetone ethanol water diester r f monoester r f', 'yield mg white', 'reaction mg mmol pomàcl ml mmol', 'chromatography system ethyl acetate acetone ethanol water bis pom ester r pom ester r f', '', 'bis pivaloyloxymethyl ester yield mg colorless syrup refrigerator', 'crude product mg form dicyclohexylmorpholinocarboxamidine salt column dowex ml eluted water', 'uv fraction give sodium salt yield white solid', 'diisopropyl ester g mmol ml bromotrimethylsilane ml mmol room temperature h mixture residue toluene â ml', 'mixture diethyl l phenylalanine hydrochloride g pyridine triethylamine ml argon', 'mixture min', 'solution ph p g mmol aldrithiol g pyridine ml reaction mixture h room temperature', 'toluene â ml column silica gel flash chromatography chloroform elution ph p', 'additional elution gradient meoh chloroform elution ph p pyridine thiol', 'bis amidate system meoh chloroform', 'product dried vacuo', 'elution bis amidate column methanol', 'uv eluate small amount silica gel ml column silica gel broad short column ml', 'elution system ethyl acetate acetone ethanol water monoamidate prodrug r f yield mg white', 'solution bu n oh à thf ml mmol stirred suspension g absolute meoh ml', 'min solution residue dmf', 'dry dmf ml ode br g mmol reaction mixture h mixture residue chloroform water organic layer magnesium sulphate', 'residue column silica gel ml system chcl give crude f r f', 'purification see', 'elution column methanol crude monoester purification', 'cytomegalovirus hcmv davis vaccinia virus lederle strain respiratory syncytial virus rsv strain vesicular stomatitis virus vsv coxsackie parainfluenza influenza virus virus b sindbis punta toro', 'antiviral inhibition virus cytopathicity plaque formation human embryonic lung hel green monkey vero human epithelial hela madin darby canine kidney mdck', 'confluent cell ccid virus ccid virus dose infect cell plaque presence test', 'viral cytopathicity plaque formation completion control virus cell test', 'antiviral activity ec compound concentration virus induced cytopathogenicity viral plaque formation', 'cytostatic activity inhibition cell growth', 'hel rate â proliferate h medium different', 'incubation number coulter counter', 'cytostatic concentration cc compound concentration cell proliferation relative number untreated', 'cc graphic number percentage control function concentration test', 'selectivity index compound cc ratio', 'cytotoxicity test minimum cytotoxic concentration mcc compound concentration detectable alteration cell morphology']"
def2c6aa475f309fa8a2c450c71410fd316c5cdf,rpoifn ␥ poifn ␥ ifn ␥ ␥ w ␥ protein et al antiviral activity w rpoifn ␥ gene commercial rpoifn ␥ cdna amino acid landrance duroc activity rpoifn ␥ commercial activity poifn recombinant protein antiproliferation activity dose dependent duroc hybrid petpifn ␥ plaque inhibition ± ± acid sequence antiproliferative effect dependent manner human ifn porcine peripheral protein variant sequence poifn snps poifn ␥ l ␥ poifn duroc landrance expression vector hybrid landrance maldi tof novel snps polymorphism poifn protein sequence region ifn tof ms ␥ fig acid replacement activity ifn activity ␥ affinity chromatography anti poifn antibody dilution antisense primer bottle dolphin cdna fragment cdna missense cdna sequence conclusion novel duroc poifn exon poifn extension • flight mass functional snp fusion peptide fusion rpoifn g ml gene al gene nucleotide inhibition assay kit invitrogen landrance breed macrophage monocyte malu et mammalian ifn mass spectra mature poifn mature protein mean number ms analysis nitric oxide nucleotide al optimal induction peptide mass plaque formation pnpp solution polyclonal antibody porcine ifn primer pmole protein antiviral protein p protein plaque prv dose respiratory syndrome rt pcr sense primer snp region son malu study poifn swine fever tag protein time flight various ␥ w petpifn,"['interferon ␥ ifn ␥ cdna sequence porcine landrance duroc hybrid landrance', 'single nucleotide porcine ifn ␥ poifn ␥ c sequence landrance duroc hybrid position g landrance breed', 'protein', 'poifn ␥ cdnas duroc poifn ␥ w landrance duroc hybrid poifn ␥ prokaryotic expression vector express recombinant poifn ␥ w rpoifn ␥ w rpoifn ␥ protein', 'identity protein desorption ionization time flight mass spectrometry maldi tof ms', 'recombinant', 'recombinant protein comparable antiproliferation nitric oxide induction porcine peripheral antiviral activity rpoifn ␥ w protein p rpoifn ␥ protein plaque inhibition prv', '␥ w rpoifn ␥ protein prv assay ± ±', 'conclusion novel snps poifn ␥ cdna missense', 'antiviral activity poifn ␥ protein', 'first report functional snp region ifn ␥', 'future imperative determine replacement ifn ␥ association', 'interferon gamma ifn ␥ pleiotropic cytokine natural killer nk', 'member type ii ifn ifn ␥ antiviral activity charley et al samuel immune immunoregulatory tumor cell differentiation author', 'tel', 'fax', 'e mail address h chiou', 'expression major histocompatibility complex mhc macrophage monocyte antiproliferative effect normal tumor isotype switch b et al farrar schreiber fromm ehrlich et al al', 'isolation human ifn ␥ cdna gene devos al gray et al ullrich al cdna porcine ifn ␥ poifn ␥ charley', 'cdna sequence', 'sequence poifn ␥ gene aligned human ifn ␥ gene deduce intron structure et al little known polymorphism poifn ␥ gene cdna', 'human population several polymorphic exon human ␥ gene iwasaki al tiroch et al', 'intron human ifn ␥ gene affect production ifn ␥ pravica et al pravica al manifestation iga nephropathy schena et al infection susceptibility parvovirus kerr al severe acute respiratory syndrome coronavirus chong et al', 'explored polymorphic region ifn ␥ gene protein activity', 'study specific aim functional polymorphism region poifn ␥ gene', 'reverse transcription polymerase chain reaction rt pcr cdna duroc landrance duroc hybrid landrance', 'amino acid poifn ␥ gene al identify polymorphic', 'poifn vector rpoifn ␥', 'plaque inhibition assay antiviral activity rpoifn ␥ protein', '␥ antiproliferative effect nitric oxide production porcine', 'anticoagulant blood mm edta duroc landrance duroc hybrid landrance scrofa', 'histopaque sigma st louis mo usa • fetal bovine serum fbs', 'g ml concanavalin con sigma h', 'messenger rna mrna con mrna isolation kit invitrogen rockville md usa', 'total g g oligo dt primer reverse cdnas amv reverse transcriptase', 'pcr l reaction volume pcr buffer dntps mm cdna template ng sense primer pmole antisense primer pmole taq dna polymerase u', 'denaturation step • pcr denaturation • primer • c min extension • min final extension • min', 'sequence poifn ␥ gene al sense primer antisense primer amplification region', 'pcr poifn ␥ cdna fragment gel electrophoresis vector ta kit invitrogen', 'dna fragment mature poifn ␥ protein ncoi xhoi restriction pcr expression vector', 'resultant petpifn ␥ series escherichia coli strain', 'cdna study genbank accession ␥ w poifn ␥ poifn ␥ l', 'alignment ifn ␥ cdna dnastar software clustal w program dnastar madison usa', 'alignment amino acid ␥ various bioedit software ibis', 'e petpifn ␥ variant grown • medium ampicillin g ml', 'recombinant protein expression mm isopropyl ␤ thiogalactopyranoside iptg od', 'aliquot bacterial culture different time optimal induction', 'optimal induction bacterial pellet centrifugation volume original culture buffer mm imidazole nacl mm tris hcl ph', 'sonicator rpoifn ␥ protein affinity chromatography nickelchelate column invitrogen', 'bacterial recombinant sds page', 'electrophoresis nitrocellulose nc', 'membrane solution fat dry milk normal serum pbs min rabbit anti poifn ␥ polyclonal antibody dilution solution r mn usa h room temperature', 'saline tween pbst membrane alkaline phosphatase goat anti rabbit igg antibody dilution', 'pbst color detection', 'maldi tof ms analysis lin et al', 'briefly gel rpoifn ␥ coomassie blue digestion', 'bruker ultraflex time flight mass spectrometer laser sample scout source bruker germany maldi mass spectra reflectron mode', 'peptide comprehensive nonredundant protein sequence database ncbinr mascot program al protein identification', 'kidney atcc manassas va usa × rpmi fbs', 'adhesion rpoifn ␥ protein variant study commercial rpoifn ␥ protein r', 'pbs prv × pfu • unabsorbed virus methylcellulose', 'methanol min crystal violet plaque', 'percentage plaque formation inhibition mean number − mean number sample × number', 'concentration rpoifn ␥ inhibition', '', 'grown medium control various ␥ protein variant h • c h p nitrophenyl phosphate pnpp solution measure acid phosphatase activity', 'pnpp solution et al', 'reaction n naoh final concentration', 'color development nm quant spectrophotometer bio tek vt usa', 'adherent porcine peripheral various fbs h supernatant culture', 'nitrite nitrate medium production nitric colorimetric kit biovision mountain view', 'statistical graphpad prism version software graphpad software san diego', 'way', 'specific poifn ␥ ␥ cdna rt pcr', 'poifn ␥ cdna fragment bp cerretti al ovine equine curran al bottle dolphin human devos et al murine gray goeddel ifn ␥', 'fig', 'poifn ␥ share amino identity bovine identity identity equine identity bottle dolphin identity ␥ human identity murine identity ifn ␥', 'mammalian ifn ␥ fig', '', '␣ helical structure human ifn ␥ ealick et al', 'open reading frame orf poifn ␥ gene amino acid signal peptide sequence mature protein sequence al', 'mature protein sequence poifn ␥ w poifn ␥ cdna expression vector bacterial expression ␥ w petpifn ␥', 'induction iptg e coli petpifn ␥ w petpifn ␥ recombinant protein kda molecular mass mature poifn ␥ kda n terminal tag kda', 'iptg induction recombinant protein maximum amount anti poifn ␥ polyclonal antibody', 'recombinant protein nickel chelate affinity chromatography fig', '', 'recombinant protein trypsin maldi tof ms analysis', 'mass spectra trypsin rpoifn ␥ w rpoifn ␥ protein poifn ␥ thioredoxin fusion tag', 'table mass corresponding amino acid sequence poifn ␥ trypsin cleavage protein', 'da peptide mass amino acid sequence ffeifkdnqaiqr spectrum rpoifn ␥ w fig', 'table', 'hand peptide mass da rpoifn ␥ spectrum ffeifkdnqair', 'table', 'antiviral activity rpoifn ␥ w rpoifn ␥ protein plaque inhibition', 'fig', 'protein able inhibit plaque formation prv dose dependent manner p', 'antivi ral activity rpoifn ␥ protein rpoifn ␥ commercial rpoifn ␥ p', 'concentration range nm rpoifn ␥ protein antiviral activity rpoifn ␥ commercial rpoifn ␥', '␥ w rpoifn ␥ commercial rpoifn ␥ ± ± ± nm', 'tag protein vector show antiviral activity', 'incubation ␥ w rpoifn ␥ protein dose dependent antiproliferative effect', 'tag protein mock control antiproliferation activity', 'rpoifn ␥ w rpoifn ␥ commercial rpoifn ␥ protein ± ± ±', 'commercial rpoifn ␥ protein antiproliferation activity rpoifn ␥ w rpoifn ␥', 'significant difference antiproliferation activity ␥ w rpoifn ␥ fig', '', 'ifn ␥ stimulate secrete son malu et al', 'induction ␥ protein variant', 'untreated low basal level fig', '', 'contrast secretion dose dependent manner various ␥ nm p', 'rpoifn ␥ w rpoifn ␥ commercial rpoifn ␥ different', 'study novel snps poifn ␥ cdna landrance duroc landrance breed fig', '', 'exon poifn ␥ gene nucleotide al', 'hand exon poifn ␥ gene nucleotide al', 'snps poifn ␥ landrance duroc absent poifn ␥ w duroc poifn ␥ l landrance snps specific', 'allelic landrance duroc investigation', 'polymorphism poifn ␥ amino acid sequence', 'polymorphism poifn ␥ l amino acid replacement', 'helix c helix mammalian ifn ␥ fig', '', 'expect impact poifn ␥ l similar amino acid replacement', 'hand positive charge protein variant poifn ␥ significant replacement', 'study poifn ␥ poifn ␥ w biological', 'antiviral activity poifn ␥', 'antiviral activity poifn ␥ vitro several swine african swine fever transmissible gastroenteritis virus charley al influenza virus horisberger reproductive respiratory syndrome virus prrsv bautista molitor buddaert al classical swine fever virus csfv al', 'sensitive antiviral mechanism interferon', 'rna antiviral effect poifn ␥ dna virus', 'prv swine alphaherpesvirus human simplex virus type', 'anti interferon mechanism prv ifn g', 'viral growth ifn ␤ brukman enquist', 'result study poifn ␥ prv dose dependent manner dosage ifn ␥ prv inhibition rna', 'prv plaque inhibition determine antiviral activity poifn ␥', 'extra fusion peptide vector n terminus amino acid sequence rpoifn ␥ identical commercial rpoifn ␥ protein vandenbroeck al', 'fact antiviral ␥ commercial rpoifn ␥ different indicated fusion peptide antiviral activity ifn ␥', 'plaque inhibition assay rpoifn ␥ w antiviral activity rpoifn ␥ protein p', 'missense polymorphism impact biological activity poifn ␥ protein functional snp region ifn ␥', 'antiproliferative effect friesel al hansson al maekawa al rpoifn ␥ rpoifn ␥ w antiproliferation activity commercial rpoifn ␥ p', 'fusion rpoifn ␥ rpoifn ␥ w', 'addition growth inhibition activation macrophage monocyte important immunoregulatory activity ifn ␥', 'ifn ␥ secretion common activity murine ifn ␥ kim son malu et al', 'poifn ␥ secretion porcine peripheral', 'result response poifn ␥ stimulation porcine peripheral dose dependent manner', 'induction different rpoifn ␥ w rpoifn ␥ commercial rpoifn ␥', 'fusion rpoifn ␥ protein antiviral activity antiproliferation activity ␥ little effect induction', 'independent functional ␥', 'conclusion novel snps poifn ␥ cdna missense', 'antiviral activity poifn ␥ protein', 'potential association disease mechanism immune response high susceptibility virus infection']"
3c3f097f19bb3dbbf56eb0f099af81054b305752,influenza infection diagnosis influenza fever likelihood influenza respiratory cough gastrointestinal non subtypeable respiratory likely respiratory virus subjective fever subtypeable influenza total cohort viral respiratory accurate diagnosis adenovirus metapneumovirus antibacterial antiviral antibiotic use antimicrobial stewardship chest radiograph clinical presentation different influenza different respiratory distinguish influenza hospital system human influenza infection chest influenza important influenza pandemic influenza seasonal influenza virus insensitive diagnosis island hospital likelihood infection likely present mortality rate nonsubtypeable influenza number pregnant nursing home pandemic influenza panel influenza pediatric population percent total potential pathogenic presence subjective respiratory infection respiratory syncytial respiratory viral rhode island seasonal human seasonal influenza stewardship program syncytial virus viral infection xtag rvp abdominal pain able different able distinguish accurate rvp acute disease acute respiratory addition initial administration neuraminidase admission intensive age analysis age covariate age distribution age interaction age likelihood age likely age logistic age main agent use aim study airspace disease airway pressure aminotransferase laboratory analysis assess analysis figure antibacterial direct antibacterial empiric antibacterial many antibacterial third antigen insensitive antigen test antiviral agent antiviral opportunity antiviral therapy appropriate antiviral assess likelihood assure prudent b adenovirus b non b rhinovirus background clinical bacterial infection bacterial pneumonia bilevel positive blood potassium blood pressure blood sent cardiac co,"['background clinical presentation pandemic influenza respiratory', 'viral respiratory responsible large year substantial morbidity mortality', 'etiologic diverse group responsible intermittent', 'reassortment swine origin human significant increase hospital season', 'timely identification influenza important administration neuraminidase duration severity illness', 'rapid insensitive diagnosis unable subtype influenza virus', 'molecular expense technical training limited widespread use technology', 'many clinical influenza pandemic', 'classic influenza illness ili cough sore throat distinguish influenza respiratory', 'respiratory syncytial virus rsv b rhinovirus parainfluenza adenovirus metapneumovirus coronavirus cause similar illness circulate time influenza', 'ili influenza sensitive specific', 'pandemic gastrointestinal aminotransferase laboratory', 'clinical infection similar seasonal influenza scant literature respiratory', 'inability diagnose viral respiratory infection influenza coverage possible bacterial', 'consequence lead clostridium difficile infection high', 'accurate diagnosis influenza respiratory viral important antibacterial direct appropriate antiviral therapy', 'response diagnostic influenza infection hospital system instituted polymerase chain reaction pcr molecular panel able different respiratory', 'aim study examine clinical laboratory radiographic respiratory goal assist', 'knowledge compare clinical sensitive molecular diagnostic methodology large cohort', 'peak season rvp', '', 'fifteen positive final analysis figure mean age', 'forty percent respiratory virus rhinovirus second prevalent population table', 'age likely cardiac co malignancy nursing home', 'likely report use tobacco', 'likely present respiratory fever throat nausea abdominal pain weakness fatigue headache myalgias chest pain', 'respiratory likely present mental status dizziness lethargy table', 'presentation emergency room maximum temperature maximum heart rate respiratory rate systolic blood pressure oxygen saturation table', 'likely white blood potassium', 'likely hemoglobin hematocrit albumin', 'radiograph number acute respiratory table', 'respiratory likely interstitial opacity consistent viral infection chest radiograph', 'thirty percent radiograph focal multi focal airspace', 'oseltamivir', 'half antibacterial third table', 'total cohort sputum sample positive potential pathogenic', '', '', '', 'diarrhea microorganism', 'percent evidence acute disease interstitial indicative viral infection chest radiograph antibacterial', 'fortysix percent total cohort blood sent culture hospitalization potential pathogenic microbe e coagulase negative staphylococci potential skin', 'percent total cohort legionella urine antigen test negative', 'difference respiratory admission intensive care unit use requirement intubation table', 'likely bilevel positive airway pressure ventilation', 'respiratory likely therapy emergency department', 'cohort', 'cough presence subjective fever likelihood infection table', 'cough gastrointestinal subjective fever likelihood', 'fever likelihood influenza infection respiratory virus', 'age covariate age likelihood presenting age', 'age analysis assess likelihood', '', 'intubation viral respiratory diagnosis influenza important provide efficient treatment neuraminidase', 'rapid antigen insensitive diagnosis influenza pandemic season', 'different influenza', 'seasonal influenza resistant oseltamivir critical distinction', 'state public health influenza cleared product clinical', 'many molecular test diagnose influenza', 'luminex xtag sensitive able distinguish respiratory different influenza', 'introduction effectiveness molecular goal efficient use reduction unnecessary antibiotic use', 'rapid turnaround time pcr half documented viral antibacterial empiric coverage bacterial pneumonia', 'half influenza oseltamivir', 'implementation rapid diagnostic respiratory antibiotic use', 'antibacterial antiviral opportunity antimicrobial stewardship program', 'clinical variable', 'occur influenza', 'throat population difference enough make firm clinical diagnosis influenza', 'significant difference cough infected respiratory', 'cough gastrointestinal likelihood pediatric population useful preliminary guide prompt treat influenza infection', 'radiographs superimposed bacterial infection', 'airspace disease non influenza radiographic distinguish influenza infection', 'half non specific radiograph', 'study previous infect elderly young', 'nursing home age distribution', 'many co', 'contrast high infection mortality rate pregnancy study due low number pregnant cohort', 'mortality rate infection', 'mortality respiratory viral importance accurate diagnosis early treatment influenza infection', 'retrospective nature study potential limitation small number pregnant likely due presence gynecologic hospital', 'second limitation time period pandemic typical respiratory season several variety pediatric population', 'fact indicate institution typical peak rsv metapneumovirus parainfluenza presence country', 'third limitation confirmatory nonsubtypeable influenza', 'recent literature subtypeable influenza xtag rvp misinterpretation uncommon', 'addition initial investigation large number early pandemic cdc', 'many prior clinical respiratory negative influenza delineate influenza positive virus', 'compare pandemic influenza respiratory', 'knowledge first comparison clinical common respiratory', 'specific clinical presentation cough gastrointestinal presence subjective fever likelihood infection virus', 'respiratory infection infection death respiratory supportive antiviral', 'use rvp many infected antibacterial many influenza', 'use accurate rvp conjunction robust antimicrobial stewardship program necessary assure prudent antibacterial antiviral agent use future', 'study rhode island hospital institutional review board', 'waiver consent study', 'result nasopharyngeal swab', 'hospital system island hospital tertiary care center hasbro miriam newport bradley', 'respiratory microbiology facility rhode hospital', 'panel influenza b non subtypeable consistent respiratory syncytial virus b adenovirus metapneumovirus rhinovirus enterovirus parainfluenza', 'panel influenza seasonal human influenza seasonal human influenza non subtypeable influenza virus consistent', 'rhode island department health doh initial xtag rvp non subtypeable influenza center disease control prevention cdc', 'subsequent nonsubtypeable influenza rvp', 'medical', 'initial radiographs subsequent chest board', '', 'logistic examine positive positive different respiratory virus', 'series multiple logistic previous literature logistic regression', 'individual retained final model', 'special effort symptoms clinical information', 'co linearity', 'interaction different age logistic', 'main age interaction', 'significant interaction simple age', 'interact age main effect']"
7649a2fc203b3f32bb54f9226adcd108152094d5,rlasota gdfl rlasota gdf gdfl rlasota gdf virus gd specific gd gene gdfl virus cytoplasmic tail vaccine vector day day group rlasota native gd plaque reduction western blot allantoic fluid chimeric gd day post gdf rlasota immune response ndv vector rlasota rlasota transmembrane domain • c antibody response challenge virus domain cytoplasmic expression gd f protein gdfl group mucosal systemic nasal swabs ndv specific ndv virion rla sota specific igg specific monoclonal strain cooper strain lasota control group gdf group goat anti ndv f ndv vaccine partial protection pmei site post challenge post immunization recombinant rlasota respiratory tract rlasota virus sds page alexa fluor anti mouse average normal blot analysis calf sera cell surface complete protection control absorbance coomassie blue day immunization fluor goat gdf table hemagglutination inhibition igg iga influenza virus native chimeric ndv strain non avian normal control pcr primer plasota gdfl protection challenge protective efficacy reduction neutralization reverse primer room temperature sequence analysis single dose sota gdf specific gd spf chicken assay mdbk avian influenza belong rlasota chicken embryo chimeric gds commercial elisa day calf ectodomain gd effective available efficient incorporation elisa kit embryo fibroblast f gene fluid h fresh allantoic gd ectodomain gd ndv gd protein,"['bovine major cause respiratory tract', 'vaccination high priority', 'major concern live ability latent infection subsequent reactivation many', '', 'recombinant newcastle disease glycoprotein gd gene', 'recombinant rlasota gdfl gd modification', 'recombinant rlasota gdf chimeric gd ectodomain gd transmembrane domain cytoplasmic tail ndv fusion f glycoprotein', 'native rlasota gdfl virus ndv virion native ndv chimeric gd cell surface', 'expression gd increase virulence rndv', 'single intranasal intratracheal inoculation recombinant ndv mucosal systemic specific gdfl rlasota gdf', 'challenge recombinant clearance challenge virus empty vector control disease rlasota gdfl', 'challenge specific rndv rndv parent virus secondary', 'ndv vaccine vector gd mucosal vaccine infection augmentation second dose inclusion additional', 'bovine pathogen major economic importance industry worldwide', 'causative agent respiratory infection infectious bovine rhinotracheitis genital infection infectious pustular vulvovaginitis conjunctivitis systemic infection abortion fetal', 'meningo encephalitic infectious balanoposthitis secondary opportunistic bacterial', 'live virus number', 'poor clinical dis gd subunit recombinant baculovirus tobacco mosaic virus gd adenovirus partial protection virus', 'practical use due effective delivery vaccine antigen mucosal incomplete protection', 'need additional viral', 'last genetic many nonsegmented negative strand rna study pathogenesis biology vaccine', 'newcastle disease virus particular interest candidate vaccine vector delivery foreign', 'ndv member genus family paramyxoviridae', 'genome ndv single negative sense rna order', 'ndv important disease', 'severity disease avian pathotype ndv strain host lentogenic mild asymptomatic respiratory tract mesogenic intermediate virulence velogenic systemic high mortality', 'lentogenic live ndv poultry world', 'several useful vaccine vector non avian', 'non human likely non avian due natural host range restriction', 'distinct common animal human immunity', 'ndv infect intranasal route induce humoral cellular immune systemic nonhuman primate', 'protective simian immunodeficiency virus respiratory syncytial virus avian influenza virus human immunodeficiency virus mice human parainfluenza virus type severe acute respiratory syndrome coronavirus avian influenza virus', 'explored viral vector', 'many effective available', 'replication immunogenicity ndv due host range restriction virus specific humoral mucosal antibody unnatural host', 'present study avirulent ndv vaccine strain lasota topical respiratory vaccine vector deliver gd test foreign antigen', 'different recombinant ndvs native gd chimeric version gd', 'replication pathogenicity immunogenicity protection intratracheal immunization', 'single administration recombinant gd induction mucosal systemic antibody partial protection challenge virulent', 'safe ndv elicit antigen specific immune', 'gd complete protection challenge', 'inclusion gd necessary generation complete protection', 'madin darby bovine kidney mdbk human epidermoid carcinoma chicken embryo fibroblast cell american type culture collection atcc manassas va', 'grown dulbecco eagle medium dmem fetal bovine serum fbs dmem fbs', 'mdbk minimum essential medium emem horse serum emem horse serum', 'recombinant wild type ndv specific pathogen free spf chicken', 'strain cooper mdbk', 'vaccinia virus strain rna polymerase grown primary chicken embryo fibroblast', 'construction plasmid plasota full length antigenomic cdna lentogenic ndv vaccine strain lasota', 'gene inserted ndv genome', 'genomic dna purified standard protocol', 'insert unmodified gd glycoprotein gd open reading frame orf genomic dna pcr primer reverse primer pmei gene end gene transcriptional intergenic additional nucleotide order genome length multiple italicized nucleotide sequence efficient translation bold', 'sequence small case', 'pcr ng pre viral dna pmol primer × gc buffer mg dntps la taq tm polymerase takara bio usa madison wi', 'amplification base pair product pmei pcr vector invitrogen', 'integrity gene sequence analysis', 'second version gd gene ectodomain transmembrane domain cytoplasmic tail amino f protein pcr', 'briefly gene pcr primer reverse primer pmei site sequence specific gd gene position lowercase', 'transmembrane domain cytoplasmic tail f gene pcr primer sequence specific gd gene case ndv f gene transmembrane specific sequence uppercase reverse primer pmei site ndv f gene cytoplasmic tail specific sequence uppercase', 'pcr primer reverse primer', 'amplification pcr product pmei vector', 'integrity gene sequence analysis', 'gd gene digestion pmei inserted unique pmei site p plasmid', 'native gd orf gd ectodomain ndv transmembrane domain cytoplasmic tail plasota gdfl pla sota gdf', 'recombinant plasota gdfl plasota gdf antigenomic cdnas procedure', 'recombinant rlasota gdfl rlasota gdf', 'recombinant grown spf chicken', 'gd genomic rt pcr sequence confirm correct gd gene structure absence adventitious', 'expression gd recombinant immunofluorescence', 'briefly confluent tek chamber recombinant multiplicity infection moi', 'h control phosphate saline pbs fixed paraformaldehyde min room temperature detection surface antigen paraformaldehyde min room temperature triton pbs min detection total antigen', 'pbs normal goat serum block nonspecific h dilution pool gd specific monoclonal dr suresh k tikoo vaccine infectious disease organization saskatoon canada', 'dilution alexa fluor goat anti mouse immunoglobulin g antibody invitrogen carlsbad', 'fluorescent microscope', 'confirm expression gd recombinant cytometry assay', 'briefly tissue culture recombinant virus moi', 'h mm edta × g min • c cell deficient pbs normal goat serum', 'gd specific monoclonal dilution min • min ice alexa fluor goat anti mouse immunoglobulin g', 'facsria ii apparatus flowjo software becton dickinson', 'examine incorporation native chimeric gds ndv rndv allantoic fluid h postinfection', 'allantoic low speed centrifugation ultracentrifugation w v sucrose pbs × g • c h pbs', 'viral virus sds page coomassie blue', 'pathogenicity recombinant vivo death time mdt test spf chicken intracerebral pathogenicity index icpi test spf', 'mdt test standard procedure', 'briefly series fresh allantoic fluid test virus sterile pbs ml dilution allantoic cavity chicken', '• daily', 'time embryo dead', 'dilution minimum', 'mdt time h minimum lethal dose kill embryos', 'ndv velogenic h kill mesogenic h kill lentogenic h kill', 'icpi test', 'briefly fresh allantoic fluid test virus inoculated spf intracerebral route', 'inoculation needle stepper syringe dispenser dispense ml inoculum inoculation', 'daily observation normal sick dead', 'icpi value mean score bird observation', 'virulent avirulent', 'gd specific immune response recombinant spf white leghorn norwich ct', 'l fresh allantoic fluid rlasota rlasota gdfl rlasota gdf virus hemagglutination titer oculo route', 'daily respiratory loss post immunization', 'blood start experiment end', 'serum antibody response ndv hemagglutination test gd western blot analysis lysate', 'neutralization ability antiserum plaque reduction neutralization assay', 'immunogenicity protective efficacy recombinant holstein friesian seronegative elisa ndv hi', 'isolation usda aaalac facility thomas morris inc reistertown md usa', 'accordance protocol animal care use committee inc', 'strict biosecurity experimental period', 'old rlasota rlasota gdfl rlasota gdf virus', 'single dose recombinant virus pfu ml ml nostril ml', 'initial study appropriate infection', 'ml nostril virulent strain cooper day immunization post challenge', 'daily veterinarian end study general appearance rectal temperature inappetence nasal discharge conjunctivitis abnormal lung', 'immunization analysis antibody response serum', 'assess vaccine challenge day day antibiotic solution • c nasal ndv isolation titration', 'nasal day day', 'briefly slender inserted nostril min', 'centrifugation snap frozen • c mucosal antibody response', 'day post challenge examined gross pathological', 'isolation titration nasal spf chicken', 'briefly l eluent nasal swabs allantoic cavitiy egg', 'allantoic fluid h post inoculation ndv growth hemagglutination', 'isolation titration nasal swabs plaque assay mdbk cellulose overlay', 'equal amount nasal swab eluent l animal', 'hemagglutination inhibition hi assay measure ndv specific antibody response', 'wild type ndv strain lasota indicator virus', 'serial heat • c min calf sera inhibit ha virus', 'antibody calf sera western blot analysis', 'mdbk moi pfu cell', 'medium h infection', 'harvested medium sucrose gradient centrifugation', 'separated sds page gel nitrocellulose membrane overnight dilution buffer city mo', 'next day h room temperature calf sera dilution buffer', 'solution city mo diluted hrp goat anti bovine igg kpl gaithersburg md h room temperature', 'gdspecific protein chemiluminescence assay kit ge healthcare', 'sera plaque reduction neutralization mdbk', 'serial heat calf sera mixed pfu h • c residual infectious virus serum virus mixture plaque assay mdbk', 'reciprocal dilution serum plaque number', 'specific igg iga serum nasal serelisa total ab mono indirect kit corporation cedex france', 'briefly day sera dilution nasal duplicate viral antigen • c bound horseradish peroxidase anti bovine igg perry lab', 'igg iga serum nasal sample positive p ratio', 'subtracting average normal control absorbance sample absorbance difference positive control difference age positive absorbance average normal control absorbance', 'manufacturer protocol sample positive ratio', 'recombinant lentogenic ndv strain lasota unique pmei site p vector express gd glycoprotein gene', 'gd gene pcr genomic dna purified', 'gd orf control ndv transcriptional pmei site p fig', '', 'transcription cassette maintain rule genome nucleotide length order', 'kozak sequence start codon gd gene orf efficient translation', 'plasmid plasota gdfl antigenome nt parental lasota', 'potential strategy increase efficiency incorporation gd ndv vector virion construct ectodomain gd transmembrane domain cytoplasmic tail ndv f protein', 'chimeric gene ndv transcription ndv antigenomic cdna way fig', '', 'plasmid plasota gdf antigenome nt length plasota gdfl rule', 'recombinant rlasota gdfl rlasota gdf reverse', 'structure gd insert genome rt pcr nucleotide sequence analysis', 'recombinant embryonated chicken', 'ha gdfl rlasota gdf parental rlasota virus', 'result consistent previous moderate attenuation replication result insertion foreign gene', 'determine stability gene rlasota gdfl rlasota gdf chicken chicken embryo fibroblast', 'sequence analysis gd gene virus integrity gd gene', 'expression mdbk rlasota gdfl rlasota gdf indirect immunofluorescence pool gd specific monoclonal', 'intracellular expression permeabilized triton detergent', 'cell gdfl rlasota gdf post infection fig', 'c e f', 'able perform western blot analysis gd specific monoclonal dependent', 'visualize cell surface expression gd mdbk gd specific monoclonal alexa fluor goat anti mouse igg antibody', 'fig', 'extensive expression gd surface cell rlasota gdfl rla sota gdf c e f', 'fluorescent mononoclonal specific gd reactivity surface rlasota virus', 'expression gd surface recombinant quantitated flow cytometry analysis', 'gd specific monoclonal alexa fluor goat anti mouse igg flow cytometry', 'fluorescence rlasota gdfl rlasota gdf rlasota', '', 'rlasota gdfl virus level expression rlasota gdf virus rlasota gdfl rlasota gdf', 'expression foreign envelope nnsv result incorporation various', 'replacement transmembrane cytoplasmic tail foreign envelope protein envelope protein incorporation foreign glycoprotein ndv virion', 'determine native chimeric gds ndv virion', 'recombinant sucrose viral coomassie blue sds page', 'native gd rlasota gdfl chimeric rlasota gdf', '', 'monomeric kda dimeric kda native gd coomassie blue incomplete dissociation gd homoligomer sds page', 'chimeric gd rlasota gdf visible coomassie blue chimeric gd small detection level', 'densitometric analysis gel relative molar amount native gd ndv virion ndv hn protein', 'quantification p f hn l protein molar unaffected rla sota gdf rlasota gdfl parental rlasota virus', 'transmembrane domain gd efficient incorporation heterologous ndv envelope foreign gd displace native ndv', 'pathogenicity rlasota gdfl rlasota gdf parental rlasota virus chicken test', 'ndv basis mdt velogenic h mesogenic h lentogenic h', 'rlasota rlasota gdfl rlasota gdf table', 'pathogenicity recombinant icpi test', 'velogenic whereas lentogenic', 'icpi rlasota gdfl rlasota gdf table', 'incorporation ndv pathogenicity recombinant', 'mdt test presence native chimeric gd gene small amount additional attenuation ndv vector', 'ability rlasota gdfl rlasota gdf serum foreign gd protein', 'week old rlasota rlasota gdfl rlasota gdf virus oculo route', 'induction ndv specific', 'ndv hi log log rlasota rla sota gdfl rlasota gdf table', 'induction gd specific western blot hemagglutination inhibition titer b neutralization titer rlasota reduction rlasota gdfl rlasota gdf group', 'l egg allantoic fluid', 'serum inoculation day inoculation', 'b hemagglutination inhibition hi titer reciprocal serum dilution complete inhibition ha', 'c neutralization plaque reduction mdbk', 'serum dilution plaque reduction neutralizing end point', 'analysis protein plaque reduction assay', 'western blot fig', 'kda gd sera rlasota gdfl rlasota gdf absent sera rlasota virus fig', '', 'densitometric analysis western blot sera rlasota gdfl virus sera immunized rlasota gdf virus', 'titer gd specific rlasota gdfl virus induced rlasota gdf virus', 'ability chicken sera neutralize plaque reduction neutralization table', 'rlasota gdfl virus antibody titer inoculated rlasota gdf virus', 'rndvs native chimeric gds safety replication immunogenicity protective efficacy', 'week old seronegative ndv', 'group single dose × pfu rlasota rla sota gdfl rlasota gdf virus route', 'daily post infection clinical disease', 'none clinical disease inoculation recombinant ndvs', 'nasal', '', 'western blot detection gd specific inoculation ndv route', 'cell culture sucrose gradient centrifugation sds page', 'representative described text table rlasota b rlasota gdfl c rlasota gdf', 'position gd monomer kda right margin', 'post infection ndv vector', 'analysis nasal swabs presence ndv inoculation eluent nasal swabs chicken', 'allantoic fluid h post inoculation ndv replication ha test', 'evidence ndv virus nasal swabs', 'ndv attenuated replication respiratory tract', 'lack vaccine virus environment', 'serum antibody response rndvs previous section ndv specific', 'detectable sera inoculation day', 'single dose rndv ndv specific serum ndv hi test table', 'ndv specific day post immunization p', 'day calf day', 'maximal day calf high hi titer', 'ndv respiratory tract induction', 'agreement previous study', 'mucosal iga systemic igg gd commercial elisa kit antigen', 'rlasota gdfl rlasota gdf specific igg iga antibody serum nasal', 'week immunization day fig', 'b', 'gdfl vaccine group specific igg p ratio iga gdf group', 'specificity response western blot analysis sera inoculation gdf', 'determine ability serum reduction neutralization sera different immunization', 'antibody gdfl group day immunization gdf rlasota negative neutralizing serum challenge table', 'day immunization route high dose virulent strain cooper × pfu animal', 'challenge evaluated temperature severity nasal', 'mean rectal temperature sharp increase fig', '', 'group rlasota gdfl virus temperature normal fifth day post challenge', 'detectable bhv fig', '', 'induction mucosal serum specific gd immunization ndvs', 'rlasota rlasota gdf rlasota gdfl virus', 'belong rlasota control group rlasota gdf group rlasota gdfl group', 'specific serum igg specific iga', 'subtracting average normal control absorbance sample absorbance difference positive control difference average positive absorbance average normal control absorbance', 'manufacturer protocol sample positive ratio', 'table', 'contrast rlasota rlasota gdf increased temperature period', '', 'addition nasal characteristic gdfl group', 'fig', '', 'mean rectal immunized strain copper', 'rlasota rla sota gdf rlasota gdfl virus day calf strain cooper', 'belong rlasota control group rlasota gdf group rlasota gdfl group', 'serum antibody ndv vector', 'calf', 'post immunization hi antibody titer b day day day day day day rlasota gdfl rlasota gdf combined single dose × pfu rlasota rlasota gdfl rlasota gdf virus', 'sera prior inoculation day post inoculation', 'b hemagglutination inhibition hi reciprocal serum dilution complete inhibition ha', 'single immunization rndv table challenged day sera indicated day post immunization neutralization plaque reduction assay', 'partial protection disease rlasota gdfl vaccine', 'challenge virus nasal swabs day day post challenge', 'infectious plaque assay mdbk', '', 'control group rlasota peak mean titer challenge log ml decreased day last study day', 'rlasota gdf peak mean titer challenge virus log day log ml day', 'rlasota gdfl titer challenge virus log day', 'partial restriction challenge rlasota gdfl rlasota gdf virus protective efficacy rlasota gdfl virus rlasota gdf virus', 'measure anamnestic response rndvimmunized challenge sera challenge commercial elisa kit purified fig', 'plaque reduction table', 'day post challenge day immunization serum igg response rlasota gdfl rlasota gdf rlasota group average p ratio rlasota gdfl rlasota gdf rlasota group', '', 'level igg response immunized rlasota gdfl virus immunized', 'serum igg response rndv immunized strain cooper', 'sera commercial elisa kit antigen', 'positive described fig', '', 'belong rlasota control group rlasota gdf group rlasota gdfl group', 'rlasota gdf virus', 'challenge post immunization rlasota gdfl rlasota gdf virus control rlasota table', 'level serum gdfl group rla sota rlasota gdf table', 'difference magnitude secondary support interpretation initial immunization rlasota gdfl immunogenic rlasota gdf consistent protective efficacy rlasota gdfl', 'bovine respiratory disease brd complex cause economic loss u industry', 'major role brd complex', 'safe effective available', 'many cattle foreign u foot mouth disease fmd rift valley fever', 'live prohibitory disease free country u introduction pathogen', 'alternative vaccine foreign animal', 'possible promising use live viral', 'major advantage live viral vaccine require use whole infectious pathogen efficacy live vaccine', 'several promising viral vaccine vector', 'ndv high chicken', 'contrast viral large number competition immune foreign antigen', 'ndv integrate host cell dna', 'genetic exchange rare occur ndv nnsv stable vaccine vector', 'ndv infect route local iga systemic igg antibody cell immune', 'ndv available lentogenic widespread use live danger poultry industry', 'ndv avian virus capable non avian', 'non avian due natural host range restriction', 'non human potential vaccine vector human use', 'addition oncolytic agent bovine papillomatosis safe', 'ndv low level amino acid sequence identity bovine distinct entire bovine population infection vaccine', 'prior immunity common bovine replication immunogenicity vector', 'inoculation lentogenic ndv strain lasota asymptomatic infection respiratory tract induction mucosal systemic antibody', 'ndv attractive vector bovine available improvement', 'study first time potential ndv vaccine vector bovine use', 'primary infection mucosal contact aerosol transmission', 'mucosal infection primary infection', 'level protection magnitude mucosal antibody response', 'envelope major surface gc gd', 'respiratory infection gd attachment penetration virus', 'monoclonal prevent infection gd independent neutralization antigen', 'native recombinant gd protection challenge', 'ndv capable respiratory route humoral mucosal symptomatic disease', 'immunization ndv vector respiratory route direct stimulation immunity primary site infection', 'single intranasal immunization avirulent lasota strain gd specific igg iga nasal', 'immune response single immunization rlasota gdfl rlasota gdf vaccine sufficient prevent challenge virus control group', 'increase gd specific igg rlasota gdfl rlasota gdf sufficient prime antigen specific igg', 'present study failure complete protection ndv gd due induction insufficient mucosal systemic immune', 'previous degree protection adenovirus gene live dna', 'various partial protection', 'possible repetitive gd vaccine boost sufficient mucosal systemic anti body complete protection', 'second gb gc surface major cellular immune response', 'incomplete protection vaccination ndv gd ndv gb gc', 'third experiment high dose virulent strain cooper', 'high dose infection natural', 'hence possibility immune response challenge virus', 'magnitude mucosal systemic intranasal administration effective ndv recombinant rlasota variable group', 'calf low immune response', 'similar variation immune response gd gb', 'variation genetic restriction bred administration multiple', 'study large foreign incorporated ndv virion vector replication pathogenicity', 'amount native gd present rlasota gdfl native hn protein', 'contrast chimeric gd ectodomain gd transmembrane domain cytoplasmic tail ndv f protein native gd', 'maximum level incorporation foreign vesicular stomatitis virus vsv influenza virus hemagglutinin ha neuraminidase glycoprotein h f protein respiratory syncytial virus f protein extra g protein', 'virus glycoprotein gp human parainfluenza virus type vector vector particle efficiency native avian influenza virus ndv vector efficiency native', 'addition incorporation gd change molar ratio ndv hn f relative nucleocapsid matrix affect yield infectivity', 'space constraint incorporation foreign ndv', 'present know basis efficient incorporation gd protein ndv virion', 'possibility feature amino acid sequence transmembrane cytoplasmic tail native gd efficient inclusion', 'possibility gd cell surface molar amount ndv efficient incorporation', 'unexplained chimeric gd protein cytoplasmic transmembrane ndv f protein cell surface', 'potential consequence high virus virulence ndv vector mdt icpi', 'rlasota gdfl virus restricted replication empty vector rlasota gdf vaccine', 'summary first time potential avian virus vaccine vector bovine use', 'ndv vaccine strain lasota express gd', 'recombinant immune response gd partial protection challenge', 'gd component mucosal vaccine infection', 'vectored vaccine replication environment', 'observation ndv negligible incidence recombination cattle population safe vaccine delivery vector candidate bovine population', 'strategy development live viral foreign animal effective available']"
e04029afe3419cb5033feaa3f911d63028eb8060,mhv r et al b cell infectious virus balb c anti protein ab independent stohlman al ϩ b c mice cell fusion mt mice acute infection al stohlman cell lysis jhmv infection mab specific r expression williamson al al williamson b cns cell cell cell cytolysis humoral immunity jhmv protein p ϫ parra al parra et protein mhv r ϩ virus cns williamson williamson ϫ mice ϫ ϫ al parra b balb b naïve cns mt coutelier al fas fasl flow cytometry immune response independent role jhmv clearance nishioka welsh protein mab sjl mice viral clearance viral persistence virus reactivation wt mice ab parra antiviral ab b ab c sjl cns acute cns virus cytolysis interaction dveksler et et stohlman expression mhv fasl ␣ fusion dependent hela mhvr hepatitis virus independent mechanism lysis jhmv majority infectious mice jhmv mouse hepatitis naïve balb neutralizing activity passive transfer potential ab property b protein ab protein fusion protein jhmv r b r fig r mab requirement protein specific viral splenic b tnf ␤ unique property viral protein virus replication wysocka al wysocka et ϩ ϩ ab neutralizing ability b ability lyse accumulation b al prior al role al ϩ alteration host anti jhmv,"['spike glycoprotein neurotropic jhm strain jhmv mouse hepatitis virus mhv susceptible lysis b naïve mice b perforin deficient mice', 'cytolysis interaction viral glycoprotein independent viral induced unique property b', 'anti protein monoclonal mab specific viral receptor inhibit lysis', 'unable induce cell cell fusion resistant lysis lysis jhmv anti protein mab cell fusion', 'b antibody independent innate immune response jhmv infection vivo', 'cellular immune system natural killer nk ϩ recruited central nervous system cns infection jhm strain mouse hepatitis virus jhmv al williamson williamson al', 'mice deficient ϩ ϩ exhibit enhanced mortality infection williamson stohlman predominant antiviral immune', 'ϩ secondary role viral clearance ϩ cell survival function stohlman al', 'similar many viral al interest ϩ major clearance', 'nk exhibit limited antiviral activity observation jhmv replication cns mice deficient ϩ ϩ williamson stohlman', 'little evidence direct role nk infectious virus houtman contrast nk cns viral clearance al', 'humoral immunity jhmv infection cns', 'b cns acute jhmv infection williamson al williamson antiviral antibody ab present cerebral spinal fluid acute infection viral persistence al et al', 'mice immunized acute encephalitis perlman al jhmv resistant brown rapid ab response susceptible lewis al al role humoral immunity', 'passive transfer spike monoclonal antibody mab mice lethal challenge mab neutralizing activity exhibit vivo activity buchmeier et al', 'addition mab specific viral structural neutralizing activity protect mice mouse hepatitis virus mhv infection al lecomte et al nakanaga et al', 'inability jhmv neutralizing ab prior clearance majority infectious virus cns humoral immunity little role initial jhmv clearance parra al parra et stohlman al stohlman al', 'infection mice ability ab virtue absence mature b mt infectious virus cns similar wild type wt mice', 'antiviral cellular immune response infectious virus replication absence humoral immunity', 'contrast wt infectious postinfection p', 'low residual virus cns mt mice', 'initial incomplete clearance virus replication cns mt mice', 'viral reactivation cns mt mice passive transfer polyclonal antiviral ab nonspecific ab humoral immunity critical viral persistence', 'mechanism prevention jhmv reactivation cns wt mice clear', 'absence b mt mice open question b ab independent role virus replication acute infection subsequent cns virus reactivation', 'potential ab independent role b neutralization infectious virus passive transfer polyclonal ab', 'ab critical component cns viral persistence rapid influx b cns al williamson williamson al prior detection antiviral ab parra et stohlman al possible ab independent role jhmv pathogenesis', 'observation splenic b naïve interact vitro mhv lysis cell b cell welsh welsh et al wysocka al potential b viral replication', 'lysis polyclonal neutralizing ab coutelier al role viral protein sole viral target jhmv ab et al', 'analysis cellular distribution mhv receptor mhv r viral protein b extent r coutelier al', 'mhv r murine membrane glycoprotein biliary glycoprotein group immunoglobulin beauchemin et al', 'surface r b cytolysis', 'interaction r cytoplasmic mixed undergo apoptosis lysis wysocka al nishioka welsh', 'addition cytolysis independent interleukin tumor necrosis factor tnf ␤ fas fasl ␣ nishioka welsh', 'consistent fas fasl jhmv clearance patho genesis parra al stohlman al', 'cytolysis fusion dependent process', 'due rapid accumulation b infected mice al williamson williamson al prior detection ab parra et al parra al stohlman al stohlman et al determine susceptible b cell lysis', 'demonstrate cytolysis interaction jhmv protein interaction lysis independent viral induced host cell cytolysis perforin independent process dependent upon cell cell fusion', 'potential protein mhv r jhmv clearance cns prevention jhmv reactivation', 'expression mhv r b naïve b balb c sjl mice flow cytometry detect b detect mhv r expression', 'mice ϩ population mhv r fig', '', 'analysis c mice ϩ mhv r fig', '', 'contrast b balb c mice express mhv r dveksler et al ϩ sjl mhv r fig', '', 'sjl mice resistant jhmv infection stohlman frelinger express r contrast susceptible balb c mouse dveksler et al', 'determine jhmv susceptible b cell lysis spleen prepared naïve balb c sjl mice ability lyse jhmv', 'consistent expression mhv r balb c mice jhmv uninfected', '', 'cytolysis independent', 'protein deletion relative protein jhmv amino acid homology remainder protein parker al', 'difference lysis adherent spleen naïve balb c mice splenic population ϩ ϩ negative selection ab magnetic', 'addition g ml anti mhv r mab lysis jhmv similar previous coutelier al requirement mhv r protein', 'lysis immunodominant l ϩ cell epitope naïve status donor balb c mice', 'similar spleen naïve balb c mice b jhmv', 'demonstrate b naïve mhv r able lyse jhmv major histocompatibility complex independent mechanism', 'determine cytolysis interaction protein mhv r mhv viral component infection lysis recombinant vaccinia virus rvv jhmv protein protein jhmv', 'jhmv comparable jhmv fig', '', 'cytolysis rvv ␤ galactosidase', 'demonstrate expression protein sufficient initiate cytolysis mhv protein viral alteration host b cell cytolysis', 'protein fusion dependent b cell cytolysis b ability lyse nonfusogenic strain tsai al utilizes identical mhv r chen al confirm requirement protein cell cell fusion wysocka et al', 'contrast fusogenic jhmv resistant b cell lysis fig', 'fig', '', 'mhv r expression ϩ splenic b balb c sjl mice', 'adherent cell spleen flow cytometry expression fitc mab', 'mhv r expression mab pe streptavidin', '', 'confirm requirement protein expression cell cell fusion cytolysis fusogenic jhmv presence anti protein mab', 'mab jhmv fusion mab activity inhibit fusion al', 'mab b cell cytolysis fig', 'consistent requirement protein mhv r interaction', 'b cell lysis anti protein mab fig', 'cell fusion activity al', 'contrast mab specific jhmv n protein al surface inhibit cytolysis fig', 'additional isotype control mab specific irrelevant', 'cytolysis protein mhv r induction fusion wysocka et al', 'spleen p ϫ ϫ mice jhmv', 'consistent mechanism dependent cell cell fusion independent perforin potential cytolytic fas fasl ␣ tnf ␤ nishioka welsh', 'determine lysis protein r b dependent unique property b mhvr hela gene lysis jhmv', 'expression mhv r hela mhvr expression ϩ b flow cytometry', 'hela mhvr bimodal distribution mhv r expression average mean fluorescence intensity mhv r expression similar expression cytolytic ϩ b balb c mice fig', '', 'due large size hela splenic b hela control tta cytolytic number nonadherent spleen', 'reduced effector jhmv addition hela mhv r control hela tta fig', '', 'protein mhv r anti mhv r mab g ml cytolysis hela mhvr', 'demonstrate cytolysis high r unique property b', 'potential ab independent role b pathogenesis cns infection susceptibility b lysis similar', 'demonstrate jhmv susceptible lysis', 'expression viral protein', 'mhv protein alteration host cell metabolism al cell cytolysis', 'lysis neutralizing anti jhmv protein mab mab specific mhv r infection vitro vivo dveksler et al coutelier al smith et al', 'contrast mab specific viral mab lysis', 'absence role fas fasl ␣ tnf ␤ welsh lysis ability b p ϫ ϫ mice jhmv infected inhibition lysis anti protein fusion consistent fusion dependent process wysocka et al', 'mechanisms leading loss membrane permeability induction apoptosis nishioka welsh interaction r clear', 'majority b express mhv r capable lysis apoptosis jhmv protein surface', 'ϩ surface ig ϩ williamson williamson al ϩ al b cns jhmv infection', 'b cell lysis apoptosis cns', 'clearance infectious jhmv cns acute infection mt mice lack b unable secrete ab similar wt mice', 'b ab minor contribution immune viral clearance acute infection', 'consistent ab independent b cell mechanism mt mice unable infectious virus cns cell perforin cytolysis', 'addition jhmv cns mt mice initial cell reduction infectious virus', 'ability polyclonal ab neutralizing activity suppress reactivation consistent role anti jhmv viral persistence', 'b clearance infectious virus acute infection suppression virus reactivation active role virus reactivation prior induction anti protein ab', 'potential ability b complete suppression infectious virus prevention viral recrudescence passive ab transfer', 'wt mice induction protein ab neutralizing fusion accumulation b ab potential ab independent b celldependent mechanism viral suppression', 'ab independent mechanism viral clearance early e loss perforin cytolysis cns virus specific ϩ prior induction anti protein fusion inhibiting', 'consistent hypothesis virus cns p ϫ ϫ mice', 'mhv r ϩ b cns acute infection al williamson williamson al specific absence detectable serum antiviral ab parra et al parra al stohlman al stohlman et al', 'clear virus specific anti protein ab infiltrate cns jhmv infection', 'mhv r ϩ b jhmv clearance ab independent manner', 'b virus protein r virus spread addition independent mechanism virus suppression', 'cell protein lysis b cell virus cell wysocka al interaction ab detectable majority infectious virus protein parra al parra et stohlman al', 'demonstrate mhv r ϩ b susceptible jhmv infected fusiondependent mechanism', 'rapid recruitment mhv r ϩ b cns immune response reduction infectious cns virus prevent virus reactivation lytic interaction sequestration infectious virus', 'interaction mhv r ϩ b plausible mechanism appearance jhmv ab majority infectious virus vigorous cell immune response', 'balb c perforin deficient p ϫ ϫ mice genetic background tmlsdz jackson laboratory bar harbor', 'sjl national health frederick md', 'age age', 'p ϫ ϫ mice sterile environment intercrossing', 'age genderdependent', 'plaque plaque dbt cell', 'rvv protein jhmv protein escherichia coli ␤ galactosidase hela plaque assayed', 'single cell naïve mice rpmi medium', 'red blood cell lysis gey solution rpmi medium fetal calf serum fcs plastic petri adherent', 'nonadherent ϩ b flow cytometry', 'macrophage cytolytic', 'hela mhv r hela control line hela tta gallagher dr thomas gallagher loyola university medical center chicago il', 'hela grown dulbecco mem dmem fcs', 'splenocyte min mab pharmingen san diego equal serum human serum horse serum final concentration', 'bovine serum albumin b fluorescein isothiocyanate mab pharmingen min', 'mhv r expression incubation mab al phycoerythrin streptavidin pharmingen', 'flow cytometer becton dickinson mountain view', 'b cell dmem fcs', 'concentration ϫ h prior infection mhv', '', 'prior use', 'rvv', 'h use', 'uninfected h ci nen life boston', 'mixed effector target', 'cytolytic presence anti jhmvspecific mab anti protein nucleocapsid protein al serum free culture mhv r mab', 'h incubation ml gamma counter', 'percentage specific cr release ϭ ϫ experimental cpm ϫ spontaneous cpm maximum release cpm ϫ spontaneous cpm', 'spontaneous release', 'acknowledgment work public health service ai ai']"
384067e97a54bb4960a3b1068fe0d2cb1835c974,aspirin challenge asthma control lung function nonselective b airway inflammation allergic rhinitis allergy test asthma trigger cardiovascular disease care team chronic obstructive chronic rhinosinusitis dry cough health care key role leukotriene receptor low grade nsaid sensitivity obstructive pulmonary patient asthma patient health ppi therapy prevent exposure pulmonary disease respiratory syncytial samter triad supine position symptomatic lpr syncytial virus therapy avoidance triad present abdominal obesity ability inhibit able partner abnormal ph absolute normality accumulation inflammatory acetaminophen aware activation mast activity high acute asthma acute exacerbation acute long addition intense adduction vocal adequate sleep adipose tissue adult asthma advice applicable aerd clinical aerd desensitized aerd samter agent result air pollution air storm airway therapy alcohol reduction alcohol theophylline allergen dermatophagoides allergen environmental allergen hot allergen place allergic amount allergic diathesis allergic management allergic patient allergic trigger allergy pulmonary allergy sublingual alpha beta alternative acetaminophen ameliorate condition amount exposure amount pollen angiotensin enzyme angiotensin receptor answer whereas anti inflammatory antihistamine trigger anxiety depression applicable important approach identify appropriate inquiry appropriate social arachiadonic acid article familiar ash musty aspirin b aspirin daily aspirin desensitization aspirin sensitivity assessment nasal assessment patient association difficult asthma angiotensin asthma aspirin asthma asthma asthma b asthma common asthma concurrent,"['medicine maxim ounce prevention pound cure pivotal role efficacious cost effective patient care', 'asthma pathogenesis atopy hyperresponsiveness part knowledge subsequent avoidance various', 'allergic diathesis allergic trigger true true subset', 'article familiar allergic management comorbid mimic asthma true bronchial hyperresponsiveness', 'many factor trigger optimal control patient health care team work prevent exposure ameliorate condition environmental dust pet dander allergic patient asthma', 'laryngopharyngeal reflux lpr gastroesophageal reflux disease gerd exercise tobacco industrial food viral aspirin b vocal fold dysfunction pvfd', 'investigation obesity stress hormonal status', 'initial assessment patient systematic series possible', '', 'specific appropriate inquiry', 'necessary identify direct therapy avoidance', 'irritant allergic amount exposure patient sensitivity specific allergen place exposure asthma trigger home work school clinical significance sensitivity patient medical history', 'environmental clinician part allergy test smoke trigger asthma ige difficult culprit fact patient workplace home environment', 'new construction high', 'glutaraldehyde disinfectant trigger workplace', 'key role many acute long term control', 'activation mast ige release bronchoconstrictor bronchial narrowing allergic rhinitis', 'common allergen dermatophagoides perennial low grade chronic domestic perennial tree pollen fungal seasonal allergic rhinitis asthma', 'environmental amount pollen air storm pollen disperse air', 'asthma trigger systematic approach', 'identification allergen environmental simple complex', 'water damage patient patient reactive mold correction water leak damage remediation requisite patient health', 'expensive', 'dust mite cockroach trigger pillow mattress allergen hot water weekly former visit pest control company basis latter', 'obvious skin vitro ige specific way potential', 'positive test important allergen', 'example population skin allergy test positivity mite population allergic', 'negative skin positive nasal provocation assessment nasal specific ige allergen', 'complete avoidance possible limiting exposure', 'way avoid limit exposure third option patient extra dose bronchodilator antihistamine trigger exposure undergo desensitization therapy allergy sublingual', 'common acute exacerbation upper respiratory tract infection rhinovirus respiratory syncytial virus coronavirus', 'viral understood increase', 'asthma production type epithelial susceptibility viral inflammatory response infection occur', 'influenza respiratory syncytial virus airway inflammation concomitant mucus production', 'asthma viral infection exacerbate inflammation viral part infection', 'viral patient susceptibility new allergic', 'patient infection follow advice applicable important', 'importance sick adequate sleep prescribed symptomatic treatment infection intranasal', 'recommended intramuscular flu evidence chronic obstructive pulmonary disease pneumococcal vaccine morbidity mortality', 'gerd lpr gerd comorbidity', 'review abnormal ph hernia esophagitis', 'heartburn regurgitation dysphagia chest pain hoarseness dental supine position alcohol theophylline systemic b adrenergic', 'esophageal sphincter tone', 'bronchoconstriction vagal tone sensitization bronchial reactivity microaspiration gastric upper airway', 'patient significance lpr control asthma variable various', 'symptomatic lpr asymptomatic', 'symptomatic lpr proton pump inhibitor subjective quality life number asthma', 'improvement pulmonary function gerd ppi minor', 'silent lpr ppi therapy benefit asthma difficult control likely gerd', 'approach identify likely benefit ppi therapy nocturnal asthma concurrent asthma', 'lpr head night supine position fatty peppermint excessive alcohol reduction abdominal obesity', 'clinical suspicion high trial ppis', 'patient undertaken esophageal ph help cause', 'important aware reactive nonselective b nonsteroidal anti inflammatory', 'nonselective b asthma asthma nasal aspirin', 'respiratory disease aerd samter triad asthma aspirin sensitivity nasal', 'pseudoallergic typical ige reaction common ability inhibit cyclooxygenase enzyme', 'pathophysiology understood related overproduction proinflammatory arachiadonic acid', 'fact leukotriene synthesis leukotriene receptor zileuton montelukast bronchoconstrictive response aspirin', 'diagnosis aerd clinical present', 'samter triad present diagnosis unambiguous part triad present part time association difficult', 'suspicion reaction physician question patient nsaid use reaction reaction point reason nsaid sensitivity prior nonreactivity relevant', 'aspirin challenge way diagnose nsaid sensitivity', 'likelihood positive oral aspirin challenge history single nsaid reaction history', 'aspirin challenge patient regular need therapy rheumatologic disease cardiovascular disease', 'allergy pulmonary specialist test', 'patient typical asthma therapy avoidance desensitization daily therapy', 'pharmacologic therapy leukotriene agent result asthma control medium high', 'alternative acetaminophen aware dose selective', 'aspirin desensitization aerd desensitized patient aspirin daily maintain state', 'nonselective b class medication present problem', 'asthma b bronchial obstruction reactivity blunt effect oral b receptor key role treatment acute asthma', 'concomitant cardiovascular disease routine use cardioselective b treatment hypertension', 'moderate stable asthma selective b low close physician supervision', 'important evidence support b survival chronic obstructive pulmonary disease cardiopulmonary protective current review literature', 'angiotensin enzyme discussion relate asthma common side effect dry cough asthma', 'independent asthma angiotensin receptor blocker incidence dry cough', 'aware increase asthma', 'include limited tobacco fireplace smoke ash musty steam traffic pollution air pollution dust workplace', 'cigarette smoke irritant cause asthma severe hospitalization decline lung function response systemic', 'developed asthma current cigarette similar rate general population', 'patient population unique treatment response short term corticosteroid therapy important role typical treatment', 'mechanism glucocorticoid resistance caused inflammatory cell receptor alpha beta ratio histone deacetylase activity', 'recommendation educate patient various available help smoking efficacy', 'cessation considerable improvement lung function fall sputum neutrophil count', 'difficult maintain cessation chronic addition', 'preliminary leukotriene receptor', 'symptomatic intubation emergency', 'monitoring pulmonary absolute normality', 'pathology pulmonary tree paradoxic closure adduction vocal inspiration', 'obstruction', 'pvfd present video endoscopy larynx exercise stress', 'helpful diagnostic question short breath inspiration expiration', 'patient pvfd answer whereas patient asthma', 'breathing voice therapy helpful treating pvfd', 'emotional stress depression influence level asthma control', 'various stressful prevalence asthma', 'correlation atopic asthma stress anxiety depression nonatopic asthma', 'emotional appropriate social work alleviate', 'positive correlation obesity prevalence incidence asthma control', 'prospective cohort study linear correlation body mass index adult asthma incidence', 'mechanism understood significant portion chronic low grade systemic inflammation function adipose tissue release various soluble', 'recent study increased eosinophilic activity high serum leptin tumor necrosis factor obese nonobese healthy', 'obese lung function functional residual capacity lung volume tidal', 'myriad comorbid obesity dyslipidemia gerd type hypertension complicate management', 'recommended weight loss available', 'last model interrelatedness pathophysiologic upper influence airway therapy', 'nasal obstruction problematic nasal', 'pre endoscopic postendoscopic sinus surgery review chronic rhinosinusitis concomitant asthma improvement reduction emergency room whereas revision surgery nasal', 'addition intense accumulation inflammatory material feed fuel airway inflammation improvement chronic rhinosinusitis nasal inflammatory drip symptomatic asthma', 'patient knowledge disease process identify able partner health care team prevent exposure asthmatic control', 'important asthma understanding many trigger']"
9186317920e18322e9583c8871ce512633da8418,indirect elisa epidemic diarrhea porcine epidemic recombinant protein diarrhea virus et al • c pedv infection pedv protein positive negative sn assay biotech co co ltd pedv gene positive serum protein antigen protein pedv anti pig antigen pedv beijing china c h cross reactivity cutoff value detect pedv elisa sn ltd beijing negative serum pedv antigen pedv antisera pig igg presence pedv recombinant pedv sds page serum sample serum sn tgev prv value mean viral rna accurate diagnosis al stevenson amino terminal antibody positive antigen indirect antigen serum bacterial cell bovine serum china manufacturer china yield common pig comparison sn cross reaction csfv prrsv current study developed indirect diagnosis serological elisa ten enzyme immunosorbent expression vector fan al fetal bovine fusion protein g ml gaithersburg md gel electrophoresis genbank accession gene bp gene viral gst fusion igg hrp incubation • infection vaccination large scale mcnemar test md usa median value negative positive negative presence negative sn od value pbst l pedv al pedv negative pedv significant pedv tgev pensaert debouck pig pedv positive pedv prokaryotic expression protein purification prrsv csfv prv csfv prv prrsv purification kit purified protein reactivity pedv rt pcr sequence gene serological detection serum antibody serum neutralization,"['recent dramatic increase epidemic diarrhea pig potential threat global swine industry', 'accurate diagnosis serological monitoring surveillance specific porcine epidemic diarrhea virus pedv infection vaccination spread', 'validated indirect enzyme immunosorbent assay recombinant membrane protein pedv', 'detect pedv serum ped vaccine elisa parallel serum neutralization', 'positive presence pedv negative', 'excellent agreement elisa sn kappa confidence interval mcnemar test p', 'cross reaction developed elisa common pig', 'elisa serological evaluation indirect diagnosis infection', 'porcine epidemic diarrhea swine disease etiological agent virus pedv', 'porcine epidemic diarrhea watery diarrhea dehydration high death rate pensaert debouck', 'disease united kingdom swine disease transmissible gastroenteritis oldham', 'europe asia north nagy al takahashi al sun al fan al stevenson al', 'porcine epidemic diarrhea virus spread united high mortality substantial economic', 'recent emergence north america virus threat swine industry worldwide', 'accurate diagnosis serological detection specific result pedv infection vaccination control spread', 'porcine epidemic diarrhea virus coronavirus family', 'genome pedv spike membrane small membrane sm open reading frame nucleocapsid n et al', 'protein structural membrane glycoprotein abundant envelope', 'short amino terminal domain virion long carboxyterminal domain protein present virion utiger al', 'immune important role induction protection course disease al vennema et al', 'nucleotide sequence pedv gene low homology gene different pedv al', 'protein candidate detection pedvspecific pedv', 'many enzyme immunosorbent detection', 'preparation appropriate antigen cultivation pedv time expensive', 'current study purified protein pedv', 'antigen indirect elisa', 'serum determine presence specific pedv protein', 'blood healthy unvaccinated pedv free various', 'sera negative presence serum neutralization sn sn', 'sera blood infected reference positive sera sn', 'pedv infection status reverse transcription polymerase chain reaction rt pcr pedv gene viral rna fecal', 'porcine sera transmissible gastroenteritis virus tgev sn titer porcine rotavirus prv porcine reproductive respiratory syndrome virus prrsv porcine circovirus classical swine fever virus csfv hebei center disease prevention control shijiazhuang china', 'total serum pig pedv vaccine', 'developed indirect elisa', 'porcine epidemic diarrhea virus strain hb bd genbank accession', 'isolated hebei province china cell culture', 'viral rna pedv trizol reagent invitrogen carlsbad manufacturer', 'sequence gene viral rna rt pcr oligonucleotide tcc atg tct aac aag ctt tct gtt tag act aaa', 'pcr agarose gel electrophoresis gel extraction kit tiangen biotech co ltd beijing china manufacturer', 'purified vector takara biotech co ltd dalian china yield recombinant plasmid pmd competent escherichia coli', 'positive lacz phenotype restriction enzyme digestion pcr dna', 'gene pmd prokaryotic expression vector sunbiotech inc china yield', 'vector sequence gst tag amino terminal protein', 'vector dna sequencing', 'recombinant protein e biotech co ltd beijing china', 'e transformed g ml ampicillin optical density od point protein expression addition mm isopropyl ␤ thio galactopyranoside', 'h post induction bacterial centrifugation', 'recombinant protein bacterial lysate gst fusion protein purification kit transgen biotech co ltd beijing china manufacturer', 'recombinant protein sodium dodecyl sulfate polyacrylamide gel electrophoresis sds page polyacrylamide coomassie brilliant blue', 'expression recombinant protein porcine pedv antisera', 'prokaryotic expression vector e negative control', 'recombinant sds page nitrocellulose brl gaithersburg md usa', 'prevent nonspecific w v non fat milk powder tris saline v v tween tbst • c h pig pedv antisera • c anti pig igg horseradish peroxidase hrp sigma aldrich st louis mo usa • c h diaminobenzidine sigma aldrich development color protein', 'checkerboard titration combination antigen recombinant pedv protein sera determine optimal indirect elisa', 'antigen serum g ml fold dilution', 'ninety nunc maxisorp denmark recombinant protein phosphate saline pbs •', 'pbs blank control', 'fetal bovine serum pbs ph h • c tween pbst serum duplicate antigen', 'incubation • c h pbst l goat anti pig igg hrp kpl inc gaithersburg md usa', 'incubation • min pbst l tetramethyl benzidine tmb min room temperature', 'color development l h', 'od microplate reader', 'od ratio positive negative serum n value od value positive serum optimal working', 'negative positive cutoff pedv negative serum sn triplicate', 'cutoff value mean absorbance value standard', 'repeatability od serum sample plate repeatability different repeatability', 'coefficient variation cv formula x average od field serum', 'cv value acceptable level variation', 'determine specificity elisa crossreactivity reactivity antigen serum prv prrsv csfv pedv', 'reference serum dilution indirect elisa', 'serum random determine sensitivity elisa', 'fold', 'serum sample determine', '', 'indirect elisa used evaluate presence pedv immune status', 'serum sn', 'level agreement sn assay cohen kappa mcnemar test investigate', 'p value significant', 'spss version', 'gene bp vector', 'positive', 'sequence analysis pedv gene bp amino', 'complete sequence gene genbank accession number', 'recombinant pedv gene e', 'analysis bacterial cell lysate sds page western blotting prominent band kda', 'recombinant protein predicted molecular weight due tag fig', '', 'recombinant protein insoluble fraction bacterial cell extract gst fusion protein purification kit', 'western blotting analysis purified protein pedv antiserum fig', '', 'optimum antigen concentration serum sample dilution g', 'optimum dilution anti pig igg hrp', 'incubation secondary • c min •', 'optimum buffer fetal bovine serum pbs pbst appropriate washing buffer', 'detection threshold indirect elisa serum negative presence pedv', 'cutoff point specific individual assay negative assay', 'mean value elisa sd', 'cutoff value mean negative positive threshold set', 'serum elisa value table cross reaction analysis anti sera pig od value mean ±', 'pedv tgev prv csfv prrsv represent pig sera positive pedv tgev prv csfv prrsv', 'noninfected serum pig negative pedv', 'negative value seropositive pedv', 'reproducibility elisa ten sn negative serum sn positive serum', 'inter cv indirect elisa median value', 'intraassay median value', 'indirect elisa detect repeatable low acceptable variation', 'specificity reactivity pedv protein antigen tgev prv prrsv csfv', 'pedv antisera pedv antigen', 'contrast od sample negative cutoff value table', 'little cross reactivity pedv protein antigen specific', 'sensitivity indirect elisa ten pedv positive serum pedv sample sn', 'result indirect sensitive antibody detection table', 'serum immunization history pig positive pedv elisa pedv antibody negative', 'comparison sn assay parallel indirect elisa antibody positive negative table', 'serum antibody positive negative', 'serum positive sn assay porcine epidemic diarrhea virus member coronaviridae cause fatal diarrhea newborn', 'virus pensaert debouck chasey cartwright prevalent many', 'infection pedv significant economic usa fan al chae al martelli al stevenson al', 'commercial available prevent control china damage pedv significant threat continuous', 'prevent disease detection assess current epidemic situation', 'addition subsequent immunoprophylaxis serum antibody infected', 'local immunity piglet intestine pedv infection maternal', 'presence protection serological examination assessment humoral response pedv vaccination natural infection', 'porcine epidemic diarrhea virus first time vero cell line trypsin medium hofmann wyler', 'various diagnostic detection pedv antigen pedv et al knuchel al kweon al song et al', 'present serological diagnostic diagnosis pedv infection common', 'elisas simple sensitive convenient serological detection number commercial house elisas detect pedv pedv song park', 'majority house detection whole virus antigen carvajal al al viral antigen knuchel et al', 'cultivation laborious time bio security virus difficult upscale production serological', 'use recombinant viral protein antigen large scale preparation native pedv antigen', 'recombinant n protein china hou et al', 'cross reactivity elisa', 'protein pedv viral envelope superior diagnostic antigen pedv al', 'current study protein elisa antigen pedv elicit formation protective al', 'protein antigenicity pedv specific', 'expressed recombinant protein antigenic antigen indirect elisa', 'indirect elisa low variability intra inter assay', 'minor indirect elisa reproducible', 'elisa able detect pedv exhibited cross reactivity common pig', 'developed indirect elisa future', 'vaccination effective china', 'late immunized swine impact', 'confirm immunoprophylactic indirect elisa screen serum', 'seropositive elisa sn', 'indicated vaccination neutralizing', 'seronegative elisa sn', 'protection pedv seronegative able effective', 'vaccine improvement antigenicity', 'comparison sn assay positive negative', 'positive negative sn assay sensitivity', 'reason negative sn positive serum due inherent', 'conclusion report indirect recombinant pedv protein antigen detection china', 'quick convenient labor intensive development reliable tool kit large scale detection', 'interest work paper']"
6824b8522fc9b537dd57e4f11f5b0d4313acfe14,saudi arabia ministry health health care clinical laboratory case fatality demographic clinical fi rst laboratory confi respiratory illness saudi ministry intensive care al hasa case infection confi infection epidemiological demographic fatality rate identifi ed index case respiratory tract aa jaa aaa r acute respiratory arabia june case control chronic renal clinical spectrum community pneumonia confi cov defi nition fi gure health laboratory long term mild respiratory outbreak al range clinical real time renal disease rt pcr severe acute time rt united arab abdominal pain active surveillance admission intensive air space alanine aminotransferase arabia september binary logistic case report chest ct clinical disease clinical epidemiological clinical illness clinical presentation clinical substantial community prevalence comorbid medical control infection cov disease cov infection defi ne dehydrogenase alanine detailed statistical diarrhoea abdominal disease identifi family cluster full range high case hospital outbreak identifi cation illness admission infection confi infection control information available information saudi laboratory fi laboratory jeddah logistic regression major knowledge male female mechanical ventilation median time natural history number mortality number saudi pandemic potential patient long period april prevalence clinical probable case qatar united rapid accurate reporting period respiratory disease respiratory syndrome rfa h rst case saudi arabian severe respiratory sex age,"['clinical', 'report epidemiological demographic clinical laboratory knowledge ne research', 'analysed epidemiological demographic clinical laboratory confi sporadic community health care saudi arabia june', 'rmed real time rt pcr', 'child laboratory confi cov disease identifi male male female ratio', 'case fatality rate', 'case fatality rate age', 'healthy interpretation disease cov wide clinical substantial mortality medical', 'major epidemiology community prevalence clinical spectrum infection disease urgent defi nition', 'none', 'middle east respiratory syndrome new human disease fi saudi arabia september identifi cation novel coronavirus cov male saudi arabian patient severe respiratory illness june', 'virus hcov emc global consensus', 'fi rst saudi case saudi ministry health respiratory admission intensive care virus available clinical', 'laboratory confi date saudi arabia', 'clinical small number appearance', 'clinical information individual cluster case program monitoring control prevention cdc european centre disease prevention control ecdc', 'serious disease medical comorbid immunosuppression', 'case family arabia europe indicate present range respiratory non respiratory many clinical disease', 'recent case arabia uk france germany italy tunisia mild respiratory illness part clinical spectrum infection', 'uk mild respiratory', 'initial disease respiratory', 'fi rst patient france infection diarrhoea abdominal pain respiratory', 'report demographic clinical laboratory saudi arabia june', 'additional information saudi', 'clinical laboratory fi laboratory confi cov infection saudi ministry health june', 'epi dem ological demographic clinical laboratory management outcome information collection study', 'clarifi cation direct communication', 'cross number ed positive saudi ministry health regional reference virology laboratory jeddah', 'global cdc', 'dacron fl nasopharyngeal swabs ministry health laboratory initial infection', 'deep respiratory bronchoalveolar lavage intensive care', 'clinical ministry health laboratory real time rt pcr', 'amplifi cation upstream e protein upe gene confi rmation standard saudi arabia', 'case confi infection positive', 'case discordance result weak positive clinical sample analysed ministry health laboratory', 'radiography', 'chest ct discretion', 'tabulated demographic clinical laboratory descriptive', 'detailed statistical nature', 'univariate sex age mortality binary logistic regression analysis', 'signifi cant', 'study', 'author full access study nal responsibility decision submit publication', 'laboratory confi cov disease saudi arabia june identifi ed', 'saudi arabian', 'identifi ed family villa october november hospital outbreak al hasa', 'transfer transmission health care', 'outbreak al hasa', 'table distribution time arabia', 'table distribution sex age case fatality', 'male female case ratio', 'case fatality rate similar female male ci', 'case fatality age group', 'univariate analysis binary logistic regression age risk factor mortality signifi cant ci', 'common presentation table fever fever shortness breath myalgia', 'gastrointestinal frequent diarrhoea abdominal pain', 'intensive care mechanical ventilation', 'median time mechanical ventilation median time death', 'oseltamivir broad spectrum community atypical pneumonia', 'fl uconazole ribavirin interferon alfa fi intravenous globulin', 'comorbid medical healthy table', 'chronic renal disease chronic cardiac disease hypertension frequent comorbid', 'patient long term immunosuppressive treatment', 'number mortality table', 'infection confi real time rt pcr cycle threshold ct viral load', 'ct available limit detection appendix', 'time onset', 'normal neutrophil admission monocyte normal', 'dehydrogenase alanine aminotransferase aspartate amino transferase fi', 'liver function test normal range', 'none blood respiratory tract bacterial viral fungal positive', 'infection', 'microbiological bacterial community pneumonia', 'radiography', 'fi minor extensive unilateral bilateral increased bronchovascular airspace infi interstitial confl uent air space consolidation nodular reticular pleural eff total opacifi cation lung fi gure', 'chest ct doctor fi gure', 'laboratory confi worldwide table', 'known infection died april public hospital zarqa jordan', 'saudi arabia jordan qatar united arab', 'number saudi arabia date', 'saudi total uk italy germany france tunisia qatar united arab table', 'infection middle close travel history person person mission', 'type transmission confi genome sequencing hasa health care outbreak', 'saudi arabia fi rst case infection june september', 'main reporting apparent', 'fi early period april time central western saudi bishah al qassim riyadh fi gure', 'male small family', 'family cluster index case household', 'secondary grandson infected', 'fi rst reporting period ill health identifi ed health care potential community low', 'second period april july eastern province saudi arabia hasa transmission family health care', 'rise number saudi arabia second reporting period ect transmission augmented case detection result surveillance', 'dissemination information saudi ministry health awareness healthcare public increase daily average', 'transfer addition community transmission health care', 'outbreak al hasa control infection control', 'uk family member patient confi infection recent report france patient topatient nosocomial transmission', 'case french man renal transplant april week dubai', 'pneumonia incidental fi radiography severe respiratory disease', 'second case infection hospital patient long term steroid treatment', 'respiratory presentation index case transmission hospital room', 'infectiousness index case early stage due crosscontamination', 'study design several detailed statistical', 'first referral hospital serious clinical condition', 'second retrospective study clinical case', 'third case record entry', 'fourth comorbidity unavailable cov infection community population', 'follow discharge', 'able delineate epidemiological demographic clinical charac saudi infection', 'main fi study present serious respiratory disease need hospital die', 'sexes mean age', 'quarter gastrointestinal diarrhoea many chronic comorbid medical', 'half medical chronic renal disease', 'study saudi', 'large number infection chronic renal disease hasa hospital outbreak renal unit', 'case control defi ne eff ect susceptibility mortality infection', 'case nition saudi ministry health fever', 'classifi cation identifi cation full range clinical asymptomatic subclinical mild', 'fi rst case report arabia september ministry health mandatory respiratory illness admission intensive care', 'directive selection detection severe infection observed high case fatality', 'clinical laboratory fi similar community respiratory tract', 'example community pneumonia', 'progression unilateral focal air space multifocal bilateral involvement frequent intensive care unit', 'radiographic appearance disease common', 'infection range clinical illness', 'tunisia united arab father illness probable case infection case report show mild respiratory illness admission', 'uk family cluster close household infection confi attack rate individual mild illness severe illness', 'infection healthcare contact index case full personal protective equipment', 'recent clinical laboratory severe acute respiratory syndrome coronavirus', 'southern china case fatality rate', 'basis fi clinical disease bear resemblance caused', 'dyspnoea major hospital', 'common presenting rigor headache myalgia malaise', 'respiratory failure major clinical feature mild disease atypical presentation diarrhoea', 'common laboratory admission infi radiographs lymphopenia thrombo cytopenia lactate dehydrogenase alanine aminotransferase', 'clinical presentation important diff table', 'health care global concern pandemic potential', 'mathematical allow conjecture pandemic potential', 'breban ned rate spread analysis fi rst laboratory confi infection', 'basic reproduction number r ie number secondary index patient infect susceptible population case breban analysis chance r small', 'assess mortality due pneumonia available eastern mediterranean region', 'overall evidence scant region support possibility transmission asymptomatic infected low prevalence symptomatic illness community', 'rate introduction human unpredictable source virus', 'source animal potential transmission', 'active surveillance early detection rapid diagnosis isolation saudi arabia early control virus', 'likelihood path similar unlikely', 'virus form capable causing pandemic', 'proactive surveill ance severe acute respiratory illness saudi arabia', 'respiratory tract presence saudi ministry health reference laboratory jeddah', 'defi nition probable case infection severe acute respiratory illness epidemiological link confi case', 'transmission understood investigation probable confi infection health care contact', 'information available updated', 'long term sequelae acute need defi', 'clinical follow radiological functional psychological', 'early rehabilitation phase many physical function general weakness shortness breath', 'lung function hospital discharge mild moderate restrictive pattern consistent muscle weakness', 'psychobehavioural depression uncommon early recovery phase time', 'study prognostic predictive', 'ability clinical laboratory distinguish respiratory tract large', 'epidemic laboratory neutrophil poorly community pneumonia', 'disease identifi ed date certainty comparison epidemiological demographic clinical', 'study light major knowledge unanswered natural history clinical presentation course disease optimum management eventual control infection panel', 'source infection susceptibility predictive poor unknown need investigation', 'case control community previous limited presentation laboratory', 'show series previous detailed analysis age range sex prevalence mortality full range number mortality', 'scant information available epidemiological clinical individual family hospital case', 'present case series date information demographic clinical epidemiological laboratory', 'medical wide clinical substantial mortality', 'identifi major knowledge source community prevalence clinical spectrum laboratory', 'defi nition clinical epidemiological range community priority multidisciplinary research', 'defi ne clinical range disease', 'early recognition rapid initiation infection control important nosocomial', 'moment available rule febrile respiratory development range rapid accurate diagnostic', 'availability laboratory important transmission risk clinical course natural history infection need panel', 'current high case fatality medical june ministry health cov asymptomatic health care family confi', 'asymptomatic female health care eastern region al hasa', 'fi important present iceberg range clinical illness', 'active surveillance rapid accurate serological diagnostic case control', 'study undertaken major priority global center mass gcmgm ministry health riyadh saudi arabia', 'board aaa r zam aiz rfa h initiated range aiz aaa r research', 'aa jaa aaa r faa r sa h aa b hf wna n hhb rfa h hqm zam collated', 'aa jaa nalised database', 'zam aiz aa fi rst draft manuscript aa jaa several subsequent', 'fi nal report', 'declare confl interest']"
7f8715a818bfd325bf4413d3c07003d7ce7b6f7e,dimer interface neuraminidase activity hn f viral isolation exposure culture brief exposure fusion promotion clinical sample site ii allele frequency clinical isolate receptor cleavage ci wt culture viral fusion complex hn mutation culture clinical culture hn minor allele monolayer culture receptor site amino acid apical surface brief culture f fusion f protein hn dimer hn protein receptor avidity cell culture consensus sequence culture adaptation dmem fbs hn clinical hn hn hn receptor interface footprint interface hn monkey kidney passage virus promotion hn release rbcs supernatant fluid viral isolate activity hn aspartic acid background hn clinical culture clinical strain clinical viral clinical virus culture culture culture isolate culture passage deep genomic deep sequencing f complex functional characterization functional structural genome wide genomic clinical growth culture growth monolayer hn dimerization hn fusion hn neuraminidase hn site human parainfluenza independent viral interface domain isolate hn isolation process kidney rhmk lab f nasal viral original clinical patient culture phylodynamic analysis primary culture primary viral recombinant virus relative ci release min release receptor rhesus monkey sample hn site site supplemental material surface min thermo fisher viral clinical viral transport whole genome acid position acid sodium activation f activity hns activity relative adaptation culture adaptive hn,"['human parainfluenza large burden human respiratory illness', 'much research cultured immortalized human virus culture', 'clinical', 'present genome wide survey culture metagenomic next generation clinical primary culture passage virus', 'nonsynonymous primary viral isolation surface protein hemagglutinin neuraminidase hn fusion protein f', 'primary culture clinical', 'hn primary viral isolation hn dimerization f interaction site site critical activation viral fusion', 'dimer interface favor infection culture', 'novel cluster different face hn dimer interface imply role fusion', 'functional characterization culture hn clinical isolate background acquisition fusogenic phenotype hn f complex enhanced fusion receptor cleaving activity', 'utilize method genome wide brief adaptation culture highlight notion brief exposure key viral balance f complex fitness circulating', 'importance human parainfluenza virus important cause morbidity mortality elderly', 'deep genomic clinical material subsequent viral isolate discover number novel main attachment protein hn brief exposure', 'function fusion complex fusion promotion hn neuraminidase activity hn receptor engagement', 'cul volume issue ® mbio asm org ture primary isolation virus first passage reveal rapid adaptation laboratory', 'altered suit clinical', 'relative dearth sequence information available hpiv respiratory information laboratory selective pressure', 'address question fitness routine viral culture understand genomic brief exposure clinical culture isolation process', 'metagenomic next generation field isolated diversity genomic level paired culture viral isolation', 'strategy sequence clinical passage sequence specific subset case', 'deep genomic clinical primary nasal viral transport medium culture culture harvest passage virus discovery number hn rapid evolution culture', 'assess frequency deep clinical culture university washington virology laboratory confirm brief exposure culture viral isolation found culture', 'functional characterization several specific hn gene cultured clinical isolate ci background hn f culture fusion promotion hn f complex', 'support notion clinical cultured balance fusion', 'brief culture clinical specific relevant control viral entry vivo', 'functional help flexibility fusion complex', 'first characterization culture hn clinical', 'transient exposure culture passage virus act virus genomic evolution viral protein function vivo', 'mutation mixed allele frequency comparison clinical', 'compare brief growth culture nasal paired viral initial isolation rhesus monkey kidney rhmk', 'variant minor allele frequency arose culture', 'swabs clinical sample ten viral', 'clinical respiratory positive quantitative reverse transcription pcr qrt pcr cycle metagenomic nextgeneration exposure culture rhmk viral', 'choice rhmk fact standard viral isolation many diagnostic microbiology question standard process alteration', 'day culture initial isolation', 'mutational consensus genome metagenomic original clinical sample expo sure cell culture minor allele frequency maf', 'total nonsynonymous mutational change response exposure cell culture viral protein p ͻ fisher exact test fig', '', 'ten hn protein l protein f protein', 'l allele frequency separate viral isolation clinical sample high allele frequency original clinical sample fig', 'g', 'evolution polymerase complex focus current paper entry complex', 'viral isolation sample appearance hn mutation maf culture fig', '', 'hn laboratory adapted possible cpe day l n h f p n mutational clinical', 'blue clinical green blue sample inoculated culture several', 'number hemagglutinin adsorption assay cytopathic effect cpe viral isolate', 'virus sample panel g', 'coverage entire genome underneath genome', 'allele scale genome organization', 'mutational relative amino acid consensus genome original patient sample', 'separate unlinked', 'iketani et al', 'enhanced fusion promotion result hn f function', 'independent viral clinical sample selection hn variant allele', 'viral isolation rhmk sample hn mutation allele frequency change allele frequency brief exposure culture fig', '', 'previous comparison direct clinical laboratory clinical strain asparagine n position laboratory aspartic acid position', 'hns clinical showed neuraminidase activity hns aspartic acid position laboratory receptor cleavage laboratory asparagine position essential high propensity receptor cleavage field', 'rapid emergence adaptation culture receptor cleavage remarkable', 'viral isolation mutation adjacent arose', '', 'isolation sample site mutation unlinked mutation arose isolation e separate', 'isolation selection novel hn cluster significant fig', '', 'region hn cluster interest entry independent viral sample hn relevant fitness hn hn', '', 'mutation recovered viral', 'h', 'adjacent hn mutation high allele frequency isolation low level isolation maf maf', 'describe region interest previous structural analysis hn dimer interface', 'phylogeny hn mutation history original', 'dissect influence background hn sequence clinical virus subsequent culture adaptation phylogenetic tree amino acid substitution distance hn clinical', '', 'none direct clinical sample hn receptor site ii second dimer interface domain rapid culture adaptation', 'independent viral', 'hn separate', 'large scale whole genome direct culture culture clinical', 'place clinical culture context sequence information whole additional primary viral virus brief exposure culture viral isolation patient', 'table supplemental material', 'recombination analysis recombination negative strand rna', 'phylodynamic analysis mean mutation rate site year confidence interval', 'analysis complete nt database september similar mean mutation rate site year confidence interval similar', 'phylogenetic analysis multiple present clinical time collection dominant feature sequence viral isolate versus clinical sample fig', '', 'examination deep sequencing viral paired sample isolate analysis', 'original clinical available none clinical variant', 'variant viral variant reflected consensus sequence available', 'addition genome complete partial consensus hn available genbank nt database august total culture', 'culture', 'none consensus ncbi mutation mutation residue range consensus sequence', 'mutation vast majority culture clinical brief exposure culture', 'mutation consensus hn sequence ncbi', 'alteration genbank', 'rt pcr clinical outbreak hospital cancer ward barcelona spain summer', 'likely culture college american sample strain genbank accession', 'primary culture isolate japan ddbj accession', '', 'culture dimer interface hn', 'residue protein arose adaptation brief culture hn protein crystal structure fig', '', 'dimer interface', 'critical dimer interface hn engagement activation f secondary sialic acid site receptor cleavage top hn globular head dimer interface diagram fig', '', 'diagram fact likely contact nac modification glycosylation significant effect binding', 'dimer associated culture adaptation host fitness reduced dimer', 'associated culture virus fitness host notion site involved mechanism hn f natural host', 'appear cluster side dimer interface', 'rapid emergence patient culture role viral entry natural host', 'note specific contact mutation conformation loop loop', 'hn site ii dimer interface modulate fusion promotion', 'understand selection fitness next analyzed biological culture', 'influence specific residue function hn f fusion complex', 'investigate identified hn fusion promotion ability clinical characterized clinical isolate hn clinical isolate', 'hn f adequate fusion compare function clinical isolate hn f unobservable fusion', 'fusion promotion mutant hn f ␤ galactosidase complementation wildtype clinical isolate hn ci wt lab f fig', '', 'influenza virus hemagglutinin ha pair positive control fusion hn property increase fusion relative ci wt', 'fusion mutant hn f ci wt hn f pair increase hn increase hn', 'neuraminidase activity hn culture', 'fusion promotion hn several introduction process', 'assessed neuraminidase receptor cleavage activity release receptor hn measure balance avidity receptor', 'neuraminidase activity cleavage acid sodium salt hydrate hn fig', '', 'culture hn neuraminidase activity ci wt relative activity', 'mutant neuraminidase activity activity relative ci wt', 'mutation hn receptor avidity f thereby fusogenicity effect increase receptor cleavage release', 'release bound receptor rbcs cell surface hns balance neuraminidase activity avidity retain bound', '', 'quantified amount rbcs several time ph', 'time point min ci wt release whereas mutant hns release receptor avidity neuraminidase activity', 'separate capability release rbcs', 'min complete release min', 'contrast group release min release min', 'receptor avidity hn wt neuraminidase activity', 'fig', 'yellow pfu ml single adaptive hn mutation', 'growth clinical virus monolayer culture rhmk culture isolation process confer growth monolayer', 'wt ci negligible fitness monolayer culture adapted day day infectious virus supernatant fluid virus cell culture', 'day adaptive table correlate production infectious', 'yellow', 'hae tissue growth advantage individual culture adaptive hn impair infection hae fig', 'orange', 'day infection ci ϫ infectious apical surface mutant', 'previous growth result emergence table', 'respiratory virus cell interplay context environment host', 'understand natural viral infection infectivity transmissibility analyze field', 'human parainfluenza virus type laboratory regard receptor interaction viral fusion entry fitness vivo', 'analysis clinical f fusion balance inverse correlation fusion growth fusion whole genome field isolated grown analyze diversity', 'define functional structural order genetic basis fitness field', 'ci grown basic f fusion complex receptor fusion receptor cleavage balance cis different laboratory', 'ci fusion fusogenicity f activation laboratory', 'deep genomic clinical portion sample patient culture step portion brief culture viral isolation rhesus monkey kidney rhmk standard cell line clinical identification', 'brief culture hn f fusion complex essential growth culture', 'evolution exposure culture limited hn protein', 'bioinformatic hn hn brief exposure culture consensus adapted culture culture clinical', 'deep clinical third dimer interface consensus present clinical', 'define functional structural laboratory circulating order genetic basis fitness field', 'hn response exposure culture novel characterized', 'dimer interface receptor site ii hn', 'critical role region entry mechanism fitness vivo scale mechanistic', 'residue receptor site ii dimer interface hn dimerization activation f', 'presence glutamine position dimer interface hn oligomerization thereby f hn f', 'virus bearing hn growth human compensatory mutation fusion hn dimerization', 'structural analysis dimer hn present receptor site ii interface monomer face', 'hn compensatory mutation growth dimer interface footprint contact', 'dimer interface footprint several contact monomer critical key hn receptor site ii', 'emergence mutation brief culture flexibility site ii new constraint virus fusion complex respect environment', 'adjacent residue dimer interface contact dimer interface footprint residue conserved clinical', 'residue aspartic acid laboratory dramatic decrease neuraminidase activity consistent overall high receptor contact highfusion laboratory phenotype', 'present study mutation brief exposure culture advantage neuraminidase activity receptor cleavage culture importance neuraminidase human infection', 'cluster altered culture adaptation residue monomer dimer interface cluster', 'precise role residue region', 'several opposite side hn dimer interface cluster', 'hn monomer dimer interface footprint correlate fusion promotion airway adaptation function', 'selection absence important region hn dimer interface receptor site ii functional future', 'numerous deep viral hn absence', 'second dimer interface domain undergoes rapid selection authentic clinical fitness airway', 'biological significance hn characterized clinical virus hn recombinant hn genetic background', 'brief exposure culture diversity increased fusion promotion hn', 'unexpected previous consistency range specific specific functional structural fusion remarkable', 'individual hn mutation fitness recombinant virus infection monolayer culture virus culture parent wt ci', 'explore hn fusion promotion infection hn neuraminidase activity hn release receptor target measure balance receptor avidity cleavage', 'clinical laboratory high neuraminidase low avidity low f fusogenicity', 'hn hn decreased neuraminidase activity', 'interest site affect neuraminidase enzymatic activity site possess enzymatic activity bifunctional active site', 'mechanistic conjecture hn site site ii modulate function site paramyxovirus newcastle disease virus receptor interaction hn site activation site ii', 'unexplored cross talk site site ii neuraminidase activity', 'hn release rbcs clinical strain', 'hn mutant release rbcs face neuraminidase activity relative ci wt agreement previous mutation receptor avidity activity overall retention contact', 'mutation lab hn background neuraminidase activity notion phenotype context genetic background', 'pattern receptor engagement increase fusogenicity vitro', 'individual show fit growth monolayer culture wt parent fit growth hae', 'brief viral isolation process fitness growth monolayer culture', 'single mutation minor allele successful growth culture nonsynonymous minor allele f hn', 'minor f protein ten minor minor allele f protein critical nature hn f fusion complex host adaptation', 'single fatal growth disadvantage fitness monolayer culture', 'interest determine accumulation several fusion necessary absolute inability sensitive experimental system e infection vivo single dimer interface disturbance', 'genome significant resource future genomic epidemiology biochemical characterization number available', 'full genome sequence coverage uniform whole viral genome coverage paired end many single', 'whole genome viral clinical feasible use laboratoryadapted cell', 'deep genome wide clinical viral simple rapid interrogation viral evolution context multiple clinical strain', 'discovery novel hn interest heretofore consensus sequence', 'deep sequencing rapid selection pressure discovery number novel population drift competition variant selection function', 'single mutational scanning limited use singular context culture singular', 'consistent uncertainty principle virology act study clinical viral sample laboratory viral culture cell authenticity viral biology first passage', 'uniquely culture rapid nature evolution culture passage notable', 'adaptive minor clinical viral', 'provision deep coverage viral clinical due diagnostic similar critical pathogenic order previous viral characterization clinical', 'consistent notion use authentic culture growth vivo critical understand characterize pathogenesis', 'specific cultured perspective uncertainty provide wealth information hn critical fitness', 'focus correlation hn hn functional hns lab fusogenic f protein order discern hn potential epistatic evolution', 'particular interest cluster uncovered critical study', 'monomer contact domain interface structural relevant fusion promotion', 'future function hn dimer interface domain fusion cell entry', 'sample description', 'term clinical sample describe primary nasal viral transport viral isolate culture isolate describe culture harvest passage virus e brief exposure culture viral isolation', 'paired clinical sample culture isolate l nasal viral transport medium cycle threshold c primary rhesus monkey kidney rhmk roller drum', 'cytopathic effect hemadsorption guinea pig blood', 'positive stored', 'bronchial alveolar lavage bal fluid nasal swab clinical testing', 'addition culture viral isolation clinical bal fluid swabs sputum washington virology laboratory subjected', 'culture protocol sequencing experiment', 'use excess clinical local university institutional review board irb protocol', 'sample genbank accession available table supplemental material ncbi bioproject', '', 'rna l thawed culture clinical zymo viral rna kit zymo research turbo dnase thermo fisher min', 'cdna random iii reverse transcriptase thermo fisher sequenase thermo fisher dna clean concentrator zymo research', 'third volume nexteraxt illumina dual indexed pcr amplification ampure coulter', 'miseq system', 'viral independent library control library preparation', 'amplicon investigate linkage', 'reverse transcription pcr rt pcr default temperature step pcr kit qiagen pcr r reverse', 'ampure truseq kapa hyperprep kit amplification', 'sequence alignment analysis', 'quality cutadapt reference sequence geneious', 'consensus original patient culture sample consensus', 'consensus visualized minor coverage minor allele frequency maf geneious', 'locus rna phosphoprotein gene variant nonsynonymous deaminase present strand virus minor table', 'phylodynamic analysis', 'phylodynamic analysis nucleotide genious mafft', 'alignment generate bayesian skyline tree relaxed clock hasegawa kishino yano hky substitution model gamma invariant site heterogeneity gamma beast markov chain monte carlo mcmc length', 'tree generation trace information evolutionary clock analyzed tracer', 'treeannotator figtree', 'phylodynamic protocol complete present ncbi nt august', 'recombination detection rdp chimaera maxchi genecov siscan algorithms default', 'determine culture hn amino acid present paired sample partial complete hn nt august', 'metadata specific clinical sample culture material ncbi genbank sequence record', 'possible determine brief exposure culture', 'show background hn protein sequence amino acid culture majority consensus amino acid sequence hn protein putative clinical sample aligned mafft', 'neighbor tree genious tree building algorithm distance method', 'functional characterization hn', 'hn study site mutagenesis pcaggs mammalian expression vector hn gene', 'sequence prior usage', 'hek lipofectamine accordance manufacturer', 'cell surface expression hn standard immunofluorescence assay monoclonal normalization appropriate', 'monoclonal hn custom dna immunization', 'briefly cdna hn expression pegfp', 'laboratory intradermal application dna gold handheld device particle bombardment gene gun', 'serum series flow cytometry hek expression', 'antibody fused mouse myeloma standard', 'measurement fusion promotion', 'ability individual hns promote fusion ␤ galactosidase complementation', 'hns f protein lab strain hek fusion', 'lab f partner fusion minimal ci hn f quantitative', 'measurement neuraminidase activity', 'neuraminidase activity hns', 'hek individual hns detachment mm edta dulbecco phosphate saline dpbs g liter glucose mg liter sodium pyruvate gibco co independent medium ph gibco', 'acid sodium salt hydrate final concentration mm', 'fluorescence min h microplate reader tecan', 'measurement rbc release', 'ability hns release rbcs', 'rbcs bound unbound rbcs', 'co independent medium ph incubated appropriate next time point', 'min rbcs bound ammonium chloride potassium buffer gibco measurement absorbance nm', 'cell culture', 'african green monkey kidney human kidney epithelial eagle medium dmem cellgro mediatech fetal bovine serum fbs', 'recombinant virus production analysis', 'clinical isolate recombinant virus plasmid coding majority consensus sequence deep sequencing green fluorescent protein egfp expression cassette p viral', 'unique sequence', 'recombinant reverse modification', 'briefly', 'day profection mammalian transfection system calcium phosphate kit promega manufacturer pflc plasmid full length viral genome ng p ng l ng n ng polymerase ng lab hn ng lab f', 'day supernatant dmem fbs', 'transfection overlaid culture dish', 'cultured fluorescence microscopy', 'medium dmem fbs', 'supernatant fluid centrifuged ϫ g min use', 'recombinant stage l supernatant fluid confirm ci backbone hn mutation', 'viral propagation human airway epithelia', 'epiairway system mattek corporation normal human tracheo bronchial epithelial differentiated mucociliary epithelium epithelial tissue vivo', 'receipt manufacturer human epithelium hae ml medium apical surface air co', 'hae pfu recombinant clinical isolate egfp apical surface min', 'wild type wt single', 'min medium inoculum fed day medium basolateral surface', 'l phosphate saline pbs calcium magnesium chloride mattek corporation hae apical surface min', 'suspension viral', 'viral collection day postinfection', 'viral propagation', '', 'seventy percent confluent pfu recombinant wt single apical surface min', 'min medium inoculum ml dmem fbs', 'supernatant fluid aliquoted replaced volume dmem fbs viral', 'viral collection day postinfection', 'supplemental material article', 'table pdf file mb']"
6f08b893f2190ac79dbeb85302703bf519037b7b,r application r r application guide award mechanism budget component independent research research training application package component application research related significant research training experience year significant able use additional year announcement foa applicant responsible application r area interest assistance contact attachment foa august august b c behavioral social biomedical behavioral budget research c priority care home category b complete version contact grantsinfo e mail emergence new foa attachment foa time foa use foreign research foreign submit g sample grant award grantsinfo impaired guide foa health care health health human bacterial human microbiota impaired tty low middle microbes present microbial consortium microbiota human middle income modular budget modular htm modular modular new human new viral niaid category nih research nonmodular budget note specific opportunity announcement package foa physical structure program year project grant r g related budget research ability research award research behavioral research focus research health research project research united responsible project return home sample foa structure microbial submit budget time information training united tty e united home use nih use r viral host year training zoonotic origin ability act ability work accordance u act role actual support adaptation human addition research additional research adjunct continuation administrative f agency available,"['social research obssr office dietary office research health orwh office director nih current former nih foreign research compete research return home', 'eligible foreign research training experience fic training grant mechanisms year training experience year significant research experience e g research award small research grant irid niaid program year humphrey fellowship', 'drugabuse international hhhrf html additional year significant research research training experience intramural visiting program year international fellowship program subsequent year research long term fellowship human science program low middle income research training year training united additional year significant research united master degree doctoral degree funded fogarty international center research program preapproval program director foreign trainee low middle income niehs', 'niehs nihgov dert capacity', 'research united part country research degree postdoctoral research award mechanism date announcement', 'training interrupted family', 'interrupted hiatus potential productive independent research', 'current nih timely fashion e preparation return home', 'training', 'various significant investment training biomedical behavioral', 'example nih fellows program junior', 'addition research training capacity cooperative agreement grant foreign prominent united home biomedical behavioral research critical global health', 'summary training critical young independent research', 'junior complete training united home many difficult secure support research independent home', 'global research initiative program grip opportunity junior foreign process', 'critical adjunct continuation independent research home world large', 'underrepresented minority apply entry', 'project research focus high priority health health care home country global importance interest nih first page announcement', 'research', 'specific research announcement', 'research related health progression identification behavioral effective healthy young behavioral prevention prevalence infectious multiple sclerosis depression', 'research healthy pregnancy child survival population research behavioral social economic research', 'research health human environmental', 'research behavioral social health', 'research accordance u government responsible conduct research', 'announcement research enrollment pilot clinical actual support clinical support oversee available award mechanism', 'website office human research protection', 'information animal protection research olaw olaw htm', 'announcement fic mission broad initiative health research infrastructure economic', 'opportunity international health health care home', 'evaluation program basis', 'program move research status independent investigator several development laboratory research potential international peer local participation international u international local funding', 'part assessment impact scientific productivity program fic track independent research', 'evaluation success number quality subsequent employment etc', 'commitment research ability work future international influence development scientific research ability act role local', 'potential success individual researcher success capacity building home institution impact program research institution home', 'opportunity announcement foa use nih research project grant award mechanism', 'applicant responsible project', 'foa time information', 'nonmodular budget modular modular htm', 'foreign submit budget research related budget component application package foa', 'august', 'award nonrenewable', 'investigator receive second award program', 'r r application r application guide foa', 'note specific', 'able use r r g sample foa attachment foa', 'assistance contact grantsinfo impaired tty e mail', 'letter intent august august august application receipt september september complete version par available', 'complete list agency available', 'reference', 'goal foa increase transition nonpathogenic state state pathogenic', 'area interest promote research zoonotic predictive new viral', 'many viral zoonotic origin human infectious zoonotic zoonotic origin', 'recent emergence transmission cov civet avian influenza demonstrate zoonotic viral serious public health problem understood', 'clear principle new viral host range many mechanism zoonotic', 'understanding necessary anticipate prepare emergence new', 'area interest study human bacterial infective', 'human microbes staphylococcus aureus skin mucosal disease clostridium difficile illness nasopharyngeal tract disease', 'little anything full complement present structure microbial consortium', 'important microbes present consortium', 'consortium interface host critical role disease', 'several potential colonizing body concept gastrointestinal nasopharyngeal genitourinary', 'visualization physical structure microbial consortium experimental interest', 'recent new epidemic host workshop basic bacterial research part whole niaid additional research', 'address', 'relevant interest natural history viral natural transmission variation pathogenesis hiv niaid category b c priority host host transmission pathogenesis development human pathogenic viral host control viral infection evolutionary transfer new sequence analysis emergence host transfer event post transfer adaptation human microbial nonpathogenic microbial consortia', 'research focus microbes present consortia metabolism consortia physical structure interaction environment', 'possible experimental single cell analysis microscopy relationship microbiota human health disease new human bacterial communication relevant development pathogenesis emergence new human microbiota human host mammalian immune system chemical human microbiota', 'foa support niaid category b c priority', 'opportunity announcement foa use nih research project grant award mechanism', 'applicant responsible project', 'foa time information', 'modular nonmodular budget', 'gov modular modular htm', 'u organization application direct year consortium administrative f modular budget component r r application package r r application guide section modular budget component application guide', 'u annual direct foreign submit budget research related budget component application package foa', 'august', 'r r application r application guide foa', 'note specific', 'able use r r g sample foa attachment foa', 'assistance contact grantsinfo impaired tty e mail', 'application submission available', 'complete version pa available']"
a3778f543ef74ff3a0dd90250221b77ee38d7533,local search neutral network rna secondary target structure rna pseudoknot b w pseudoknot structure j j structure distance arc length cross serial et al g c g u h j info rna inverse algorithm inverse folding loop decomposition mfe structure rna ssd sequence space stochastic local u g u u w b algorithm inv algorithm rna c g c h c l diagram arcs diagram representation dynamic programming figure figure free energy initio algorithm j h j k l graph linear order minimum arc nonplanar pseudoknot rna structure search routine secondary structure see figure sequence start sequence target stack size ab initio adjust seq algorithm cross arcs cross arcs form arcs j b b b c b figure basic loop canonical pseudoknot compatible l compatible neutral compatible sequence construction neutral crick g cross l decomposition target distance cross distance g distance target end point entire structure folding algorithm g g g h generalization rna graph l graph p hand side inconsistent incompatible initial sequence inv available inv inverse inverse algorithms inverse pseudoknot k j k k l compatible length condition list n mfe configuration minimum free n n natural rna network neutral network structure neutral distance p neighbor parallel arcs,"['background variety structural', 'structure tantamount watson crick g u base secondary structure additional cross serial base', 'whole spectrum rna', 'context natural rna new artificial rna interest find rna specific structure analyze neutral', 'inverse algorithms rnainverse rna ssd rna rna secondary present paper inverse algorithm inv deal canonical pseudoknot', 'paper present inverse folding algorithm inv', 'detailed analysis inv', 'show inv design particular nonplanar rna pseudoknot rna class difficult construct dynamic programming', 'inv available', 'inv inverse pseudoknot', 'comparison rnainverse new instance', 'result inv able novel secondary cross serial', 'structural central importance rna figure', 'represent cross serial base important telomerase rna ribosomal rnas', 'pseudoknot mimicry trna plant virus reverse transcriptase vitro selection', 'basic ribosomal frame', 'key role variety contexts large scale computational', 'problem considerable attention last decade exotic structural concept', 'initio prediction general rna pseudoknot np complete algorithmic fact understood', 'rna secondary et al zuker al dynamic programming dp', 'mfe algorithm rna secondary', 'several eddy pierce reeder giegerich ren et al', 'novel ab initio algorithm cross', 'cross minimum free energy mfe rna', 'arcs stack e', 'sequence parallel arcs eq', 'size equal', 'particular structure arcs see figure', 'notion mfe structure specific concept pseudoknot respective energy', 'thermodynamic model turner', 'clock waterman et al', 'nussinov et al', 'kleitman al', 'rna secondary', 'secondary rna contact figure', 'rna secondary pseudoknot', 'vertex n n vertex horizontal line j j upper half plane figure figure', 'j refer j arc length', 'correspond u crick u g c u g base', 'diagram arcs j j j j', 'k sequence arcs j k j k k j j j k', 'call k k figure', 'rna secondary diagram representation figure figure therefore minimum arc length condition', 'rna pseudoknot structure diagram k minimum arc length condition', 'structure stack size canonical stack size sequence parallel arcs form', 'stem length r figure', 'natural generalization rna secondary rna', 'k rna structure length n k diagram arcs form', 'assume', 'diagram representation arcs minimum arc length minimum stack size base', 'notion k complexity maximal number', 'natural', 'inverse folding algorithm specific rna rationale sequence target mfe configuration', 'fact level entire folding target', 'pseudoknot biophysical c n n constant', 'view central limit fact existence large rna pseudoknot structure rna many single structure', 'set neutral network structure figure', 'term neutral network neutral set giant component induced subgraphs', 'neutral sequence space', 'construction neutral network compatible capable bond u u g c c g g u u g figure', 'sequence point mutation s′ compatible call mutation compatible', 'u unpaired h j base compatible space u p distance point mutation position', 'p neighbor compensatory base pair mutation figure', 'display diagram arcs drawn', 'note neighbor distance g c ↦ g u distance g c g', 'call u p neighbor compatible neighbor', 'light adjacency notion compatible neutral network construction neutral network c', 'neutral network neutral neighbor', 'rise consider compatible neutral distance c s′ n s′', 'minimum length path neutral network s′', 'note neutral path particular compatible path compatible distance equal neutral distance', 'paper study inverse folding problem rna pseudoknot target structure search configuration', 'rna secondary different rnainverse rna ssd info rna', 'generate local search routine target', 'distance figure', 'stem sequence', 'note respective isolated left hand side right hand side', 'neutral network sequence space', 'display sequence space structure space right', 'depict set particular structure', 'red path', 'neutral network structure subgraph sequence space', 'position unpaired incident arc figure', 'common assumption inverse algorithms specific energy entire structure', '', 'rnainverse inverse algorithm rna secondary configuration', 'initialization step compatible sequence target', 'rnainverse sequence s′ s′′ step step structure distance mfe structure s′ target structure observation energy substructure mfe molecule rnainverse small entire structure', 'adaptive walk order decrease structure distance', 'fact walk random compatible', 'rna ssd inverse secondary specific', 'particular compatible sequence non complementary adjacent helical', 'second unpaired helical random specific non uniform', 'third routine occurrence favourable specific sequence', 'hierarchical decomposition target structure', 'structure thereby binary decomposition tree', 'non leaf node tree substructure respective', 'tree rna ssd stochastic local search way root', 'info rna secondary structure dynamic programming method initial sequence', 'sequence energy respect latter due rna relative local search routine stochastic local search order sequence neutral network contrast rnainverse info rna distance target structure', 'time', 'cross ab initio algorithm rna', 'search canonical unique mfe configuration', '', 'input cross arbitrary rna sequence integer n output list n canonical first mfe structure list n c free energy first list element mfe structure cross', 'cross default', 'cross structure specific loop', 'structure let arc arc denote arcs cross \uf061', 'arcs next specify partial order ≺ arcs minimal maximal understood respect ≺', 'arc basic loop arc j interval e', 'sequence consecutive isolated j', 'interior loop sequence multi loop see figure structure substructure interval ω h τ h subject condition figure', 'pseudoknot figure min h j max j h diagram arc set p irreducible e', 'dependency graph p e', 'graph p vertex a′ adjacent cross ii h j h p b p h j h minimal b crossing', 'x j hairpin interior multi', 'basic loop position state theorem rna pseudoknot structure unique loop decomposition', 'figure loop decomposition structure', 'order discuss organization cross basic idea motifs skeleta combinatorial algorithm', 'motif structure ≺ maximal size', 'figure', '', 'skeleton k noncrossing structure • core c arcs • l graph l', 'core structure c single arcs length graph l arcs cross diagram representation figure', 'skeleton cross serial structure', 'general idea cross', 'algorithm structure top bottom routine generate maximal structure', 'note stack maximal respect ≺ stack', 'e', 'top bottom', 'ii skeletonbranch shadow second step cross', 'particular successive', 'skeleton serial arcs', 'tree complexity total number', 'third subroutine skeleton dp', 'saturation structure', 'figure', 'inverse algorithm inv initio algorithm cross', 'input target structure latter character algorithm present inv', 'validation target structure similar info rna inv initial sequence stochastic local search loop decomposition target', 'sequence routine adjust seq', 'decompose target structure endow linear order', 'order use routine local search order loop proper local solution', 'section describe algorithm', 'routine start line sequence start compatible target uniform probability', 'variable seq min sequence start variable ∞ structure distance cross seq sequence start construct potential e', '', 'algorithm show adjust start sequence routine adjust seq', 'n', 'looplength', 'computer cross parameter n subroutine body', 'step', 'c l cross', 'suppose ith step sequence l l start', 'cross l n e', 'list suboptimal l update seq min ii', 'step ii', '', 'introduce specific procedure perturbs arcs rna pseudoknot structure arc l denote start end point', 'perturbation procedure new see figure', 'proceed arc nontrivial perturbation ten', 'use method order generate c l arc structure construction inconsistent incompatible', 'structure inconsistent position base incompatible arc compatible l see skeleton l graph', 'display skeleton l graph right', 'figure outline cross', 'illustration', 'skeletonbranch saturation', 'due space select reason motifs first row arc drawn blue', 'note rise nontrivial skeleton input saturation', '', 'compatibility understood respect watson crick g u base pairing', 'inconsistent incompatible identical target arrive set', 'mutation', 'l respect l previous step', 'suppose', 'pair compatibility incompatible', 'figure show feasibility step', 'end point p w w construction previous step', '', 'note mutation structure distance', 'sequence incompatible', 'instance consider competitor c h arcs l compatible l compatible c h', 'suboptimal scenario', 'practice situation problem type virtue fact mfe target structure', 'situation due important incompatibility minimum free energy', 'distance cross l equal min step l', 'repeat step iii \uf06c \uf06c minimal', 'procedure seq negative paradigm order close', 'sequence seq middle realize target structure mfe fold', 'section introduce pose local search', 'routine decom pose energy independent figure section', 'local search optimal sequence local certain suppose decomposed w target', 'define linear order b w h', 'w h start point w', 'figure display linear order structure figure', 'next define interval loop w interval l w r w b w l′ r′ ⊃ w maximal interval w adjacent unpaired consecutive figure', 'consecutive w b w b adjacent see b b figure • b w ⊆ b w see b b figure', 'b c b c', 'unpaired adjacent w w b w delete b w', 'derive sequence', 'figure illustrate interval sequence target', 'local search sequence', 'local stochastic search seq seq … seq seq middle x x x', 'local search seq w distance target figure adjacent latter', 'use u u store unpaired process increase structure distance probability', 'latter parameter', 'iterate routine distance criterion', 'main result paper presentation inv available input rna structure base pairs', 'output c g g property cross figure', 'core inv stochastic local search routine fact rna structure unique loop decomposition theorem section', 'inv optimal global solution', 'inv inverse algorithm arbitrary canonical pseudoknot', 'inv rna start sequence local search', 'introduction argument inverse pseudoknot rna', 'secondary understood generalization rna nontrivial', 'pseudoknot large neutral', 'specific pseudoknot structure', 'fact possible generate inv neutral pseudoknot figure figure', 'interesting class nonplanar pseudoknot', 'nonplanar pseudoknot structure structure bi secondary structure sense stadler', 'noncrossing arcs upper half', 'dp paradigms gap minimal class implemented', 'figure showcase nonplanar pseudoknot structure neutral network inv', 'complexity inv factor subroutine local search', 'suppose target', 'interval line local search h line g h', 'local search stop line line remainder local search e', 'h complexity h', 'arrive complexity ℓ complexity cross', 'h g h various random order u u see algorithm probability p figure present average inverse folding time several natural rna pkdatabase', 'neutral', 'addition present table total time additional set rna pseudoknot', '', 'paper', 'final manuscript', '∃ c h l c l respective neutral', 'goto phase end end return seq']"
d7c41ee5627012939966d84fc7b61a097c31d7e7,neonatal foal broad spectrum fluid therapy enteral feeding antimicrobial therapy mg kg nasogastric tube ultrasound examination ml kg common cause long term nutritional support respiratory rate spectrum antimicrobial suckle reflex field triage hypoglycemia hypothermia intestinal tract lid margin milk replacer organ dysfunction oxygen delivery respiratory compromise specific gravity tendon laxity triage neonatal weak recumbent antiinflammatory therapy breathing pattern colic diarrhea first life foley catheter gastric distension gastrointestinal tract heart rate incomplete ossification intolerance enteral isotonic crystalloid iv fluid kg iv kg ml kg â lactose intolerance mare milk mineral oil mm hg nonsteroidal antiinflammatory ossification cuboidal oxygen supplementation parenteral nutrition physical examination pleural effusion rate effort respiratory distress respiratory muscle sick neonate support section supportive care urine specific warm water â ml asphyxia syndrome aspiration result bacterial overgrowth barium enema bilateral nasal bloody diarrhea body fat body weight bolus therapy caffeine dose capillary refill cardiac dysfunction cardiac function catheter enema cause irritation cellular injury cerebral edema check reflux chemistry analysis cleft palate clinical organ colic gas colic subtle complete blood compromise hypoxemia culture sensitivity dextrose infusion diazepam mg digital examination dose mouth energy supply enteral nutrition examination evidence examination presence failure colostrum flexor tendon foal mare foal milk foal recumbent,"['heart rate increase table', 'first life urine dilute begin consume liquid diet', 'newborn born persistent frenulum penis urinate', 'condition concern resolve time', 'many normal mild degree carpal fetlock valgus front slight varus hind', 'condition grow', 'meconium first', 'meconium dark tan pasty', 'subsequent milk yellow tan consistency', 'menace response life', 'stimulation auditory visual jerky head', 'neonatal foal primary close contact dam', 'strong suckle reflex nurse brief many hour', 'mare large volume milk foal small volume', 'persistent trigger evaluation rule dysphagia cleft palate', 'lightweight lb kg day', 'udder nurse lack adequate milk production', 'measurement urine specific gravity gain important determine adequate nutritional intake', 'normal dilute urine specific gravity', 'scale available weight tape measure change body girth assess daily weight gain', 'birth heart rate increase normal', 'persistent bradycardia hypoxia hypoglycemia hypothermia', 'oxygen supplementation', 'continuous intravenous iv infusion dextrose see section fluid therapy glucose monitoring available', 'bolus therapy glucose deleterious', 'bolus therapy unavoidable dextrose isotonic crystalloid low percent solution ml glucose', 'foal hypothermic allow slow passive cover foal dry warm area wind hypothermia protective hypoxic brain injury', 'severe hypothermia active warming infusion iv', 'external heat controversial resultant peripheral vasodilation cause reflex drop core blood', 'pain hypovolemia anemia fever excitement', 'pain fever anemia excitement fluid therapy attempt correct hypovolemia section iv fluid therapy', 'foal respiratory rate effort decline', 'prominent rib retraction presence abdominal effort paradoxic collapse wall inspiration distress respiratory cardiac dysfunction', 'foal wall compliant adult animal', 'respiratory muscle contraction maintain thoracic lung volume prevent alveolar collapse atelectasis', 'sick weak hypoglycemic respiratory disease respiratory muscle exhaustion atelectasis pulmonary function', 'parturition mucous gray cyanotic foal', 'pale mucous indicator hypovolemic shock', 'icteric mucous hemolysis neonatal isoerythrolysis utero placental dysfunction liver dysfunction', 'evaluation blood work complete blood count chemistry analysis ultrasound examination evidence internal bleeding', 'cyanosis g deoxygenated hemoglobin deciliter blood anemic presence severe hypoxia', 'mucous septicemia thrombocytopenia', 'examination eye clinician diagnosis hypopyon hyphema septic', 'retinal born equine herpesvirus type infection', 'sick blink tear production susceptible corneal injury', 'dehydration poor body fat development entropion', 'abrasion ulceration', 'treatment abnormal lid position', 'correction lid margin normal position skin staple mattress suture perpendicular lid margin hold lid', 'temporary correction ml procaine penicillin g mm lid margin', 'lid margin normal position', 'technique solution time', 'entropion foal', 'absence cyanosis rule hypoxia', 'presence hypopyon hemorrhage eye indicator sepsis', 'persistent bradycardia deterioration respiratory rate effort cardiopulmonary dysfunction require immediate intervention', 'appear nurse competent suckle aspirate time', 'sick bottle struggle aspirate portion meal', 'auscultation milk trachea nursing accurate way dysphagia milk aspiration', 'common cause dysphagia temporary loss neuromuscular coordination suckle reflex sick premature', 'examination upper airway collapse pharyngeal edema', 'cleft palate digital examination oral cavity cleft soft palate reach examiner', 'speculum examination diagnose condition', 'cause paramount prevent nursing aspiration result pneumonia', 'foal mare prevent nasogastric tube feeding', 'antimicrobial therapy evidence aspiration sepsis present', 'dysphagic dysfunction time', 'time resolution rare', 'aspiration persistent dysphagia bucket ground', 'recumbent weak neonatal foal', 'cause immediate access diagnostic laboratory assessment difficult', 'common weakness inability rise nurse sepsis pas prematurity dysmaturity', 'assessment treatment treatment potential', 'foal respond ability treat foal farm referral', 'treatment therapy specific general treatment weak recumbent neonate', 'sepsis cause foal mortality', 'sepsis utero foaling', 'clinical organ duration severity', 'early hyperdynamic stage poor suckle reflex hyperemic mucous', 'petechial', 'capillary refill time tachycardia tachypnea', 'fever', 'sepsis foal obtunded', 'poor cardiac output cool prolonged capillary refill time poor peripheral', 'hypothermia hypoglycemia', 'common clinicopathologic sepsis leucopenia neutropenia hypoglycemia', 'profound hypoglycemia respiratory compromise hypoxemia hypercapnia mixed acidosis', 'pathologic process pas result severe tissue hypoxia', 'hypoxia pregnancy parturition', 'energy supply loss membrane loss ion influx activation calcium dependent cellular damage', 'subsequent reperfusion result damage production reactive oxygen inflammatory', 'pas normal birth disinterested dams cerebral cellular injury', 'suckle reflex sleepy difficult rouse', 'severe recumbent progress abnormal apneustic pattern breathing', 'gastrointestinal intolerance colic gas distension bloody diarrhea', 'many urinate response bladder distension require catheterization bladder prevent rupture', 'additional clinical organ system dysfunction', 'pas recover supportive care time', 'treatment pas prevent cellular injury control organ dysfunction prevent secondary', 'prematurity foal born gestational age', 'dysmaturity foal normal gestation length physical prematurity', 'small body stature fine silky hair coat floppy forehead tendon laxity incomplete ossification cuboidal inverted neutrophil n lymphocyte l ratio normal n l weak unable stand assistance poor suckle poor tolerance enteral feeding', 'premature unable body temperature blood glucose', 'premature intestinal tract specialized necessary absorb colostral risk failure passive transfer colostral ingestion', 'broad spectrum culture mg kg first life perfusion oxygen delivery', 'fluid therapy maintain perfusion overhydrate overhydration lead cerebral edema worsen neurologic dysfunction', 'cerebral edema', 'mannitol g kg solution infusion neurologic improvement temporary individual', 'respiratory compromise hypoxemia bilateral nasal oxygen min hypoventilation apneustic breathing pattern caffeine dose mouth mg day day unsuccessful mechanical ventilation incomplete ossification cuboidal lateral anteroposterior radiographs carpus tarsus evaluate incomplete ossification cuboidal', 'weight bearing affected crush cartilaginous', 'crush tarsal carpal juvenile arthritis long term catastrophic athletic career serial radiographs important monitor ossification process', 'fpt treated', 'broad spectrum antimicrobial therapy weak recumbent foal prevent treat infection sepsis', 'hypoglycemia frequent problem sick neonate', 'many septic hyperglycemia', 'unable tolerate oral institute iv nutritional support section partial parenteral nutrition', 'healthy full term neonate enough body fat glycogen energy supply', 'premature utero sepsis minimal increased risk hypoglycemia hypothermia organ dysfunction', 'enteral route nutrition parenteral enteral increase gastrointestinal mass function parenteral route', 'sick neonatal foal unable enteral feeding', 'enteral feeding hypotensive hypothermic', 'secondary oxygen deprivation infection absorb colic diarrhea fed', 'detailed history careful repeat gastrointestinal tract ultrasound examination possible critical foal able tolerate enteral', 'measurement abdominal size useful assess gastrointestinal distension', 'colic subtle fussy show increase heart rate respiratory rate', 'deterioration enteral decreased resolution', 'sick stand unlikely adequate suckle reflex', 'small soft nasogastric available place term use international inc erlanger ky', 'important determine tube stomach', 'foal age colostrum provide systemic local passive immunity', 'small volume tolerated volume initial target goal body milk day', 'volume approximate metabolic sick recumbent foal warm draft free environment', 'colic bloating gastric ultrasound intolerance enteral feeding result enteral feeding', 'assessment gastrointestinal tract enteral feeding borborygmi present evidence passage gas meconium gastric ultrasound motility evidence intestinal distension enteral nutrition iv dextrose infusion', 'placenta glucose useful target short term parenteral support', 'rate dextrose solution minute', 'glucose infusion inadequate long term nutritional source complete parenteral nutrition prolonged intolerance enteral feeding', 'appropriate medical care sick weight body weight milk table', 'healthy term foal body weight milk daily first life', 'foal active amount normal', 'failure gain sign uncontrolled illness focus infection result insufficient nutritional support', 'mare milk colostrum ideal enteral feed', 'mare milk kcal l kcal l', 'contrast example foal recumbent weak sepsis', 'physical examination presence auscultable borborygmi', 'ultrasound examination normal stomach size normal small intestine present motility normal intestinal wall thickness evidence gas intestinal', 'nasogastric tube aspiration assess gastric negative', 'ml milk nasogastric tube', 'foal colic residual subsequent ng tube aspiration additional ml fed', 'goal reach ml body period', 'unable reach goal addition parenteral nutrition', 'field triage neonatal foal milk mare milk replacer high potassium low sodium chloride', 'milk replacer important provide fresh water source avoid risk hypernatremia excess salt ingestion', 'milk replacer ideal adequate', 'milk plant', 'complete failure immunoglobulin g igg', 'partial failure igg', 'lack colostral antibody first milk loss inadequate production primiparous debilitated risk', 'failure colostrum foal inability nurse illness musculoskeletal critical period', 'failure colostrum delayed ingestion loss prematurity dysmaturity utero illness lack development', 'age good quality colostrum good quality high igg specific gravity refractive index sugar refractometer', 'age perform plasma transfusion', 'rule thumb l plasma increase igg mg dl healthy foal mg dl septic foal', 'plasma option treat foal broad spectrum', 'poor perfusion hypovolemia sick neonate decreased fluid volume inadequate cardiac function poor contractility vascular shock result hypoxia hypoglycemia sepsis', 'placement jugular catheter fluid ml kg isotonic crystalloid period', 'glucose bolus hypoglycemia result', 'reevaluation foal cardiovascular status bolus', 'improvement second third bolus maximum central venous pressure cvp cm water', 'difficult measure cvp field situation maximum fluid avoid fluid overload', 'respond likely cardiac vascular dysfunction intensive medical support vasopressor therapy', 'neonatal intensive care facility', 'neonatal foal small version adult horse fluid therapy', 'foal effective sodium water vascular permeability adult', 'septic foal foal ischemic injury fluid syndrome inappropriate antidiuretic hormone secretion inability handle excess fluid', 'overhydration result vascular volume expansion excess gain', 'edema delivery exacerbate organ dysfunction', 'human many equine neonatal fluid therapy fluid sodium restriction', 'fluid therapy body mass surface area table', 'sodium intake mg avoid sodium excess', 'continuous rate supplemental', 'include sodium intake', 'example calculation foal kg â ml kg ml kg â ml kg ml kg â ml kg ml ml ml h fluid plan urine specific gravity healthy foal milk diet', 'foal enteral feeding fluid', 'important adjust rate present', 'pressure', 'corneal decreased tear production trauma accumulation debris eye', 'lateral recumbency atelectasis dependant lung', 'atelectasis exacerbate lung disease affect oxygen delivery', 'pao decrease much mm hg foal sternal lateral recumbency important try keep sternal recumbency maintain lung volume ventilation perfusion oxygen delivery', 'physical examination respiratory distress need assessment pulmonary function', 'oxygen monitoring performed', 'soft rubber foley catheter ventral meatus level medial canthus facilitate oxygen supplementation l min oxygen', 'severe hypoxemia bilateral necessary l nostril', 'humidification table maintenance fluid therapy neonatal foal long term oxygen necessary shortterm foal transport', 'weak recumbent hypoglycemia', 'supportive care critical long term recovery', 'hypothermic hypotensive foal', 'gastrointestinal response enteral nutrition ill neonatal foal', 'clinical neonatal isoerythrolysis lethargy tachycardia tachypnea mucous icterus', 'clinical age rapidity severity hemolysis', 'mule', 'blood transfusion anemic weak unwilling nurse', 'goal transfusion oxygen capacity regenerative response', 'ideal unavailable transfusion aa qa blood type negative gelding', 'dexamethasone mg kg iv im peracute hemolysis', 'supportive care nasogastric intubation foal weak nurse broad spectrum common cause respiratory compromise distress bacterial pneumonia', 'condition aspiration bacteremia', 'radiographs reveal presence consolidation cranioventral lung diffuse pattern hematogenous pneumonia', 'thoracic ultrasound examination presence pleural', 'pleural effusion rare neonatal pneumonia', 'viral pneumonia present severe dyspnea high characteristic ultrasound pattern wide spread pleural small consolidated fluid density', 'tracheal bacterial culture sensitivity appropriate antimicrobial therapy', 'transtracheal wash respiratory distress deterioration collapse', 'treatment broad spectrum antimicrobial therapy culture sensitivity available see specific treatment sepsis', 'sternal recumbency oxygenation delivery', 'respiratory distress unwilling nurse nasogastric tube nutritional support', 'nasal oxygen supplementation pao mm hg equal arterial oxygen saturation', 'bilateral nasal min increase oxygen content high', 'long term oxygen', 'ventilatory support paco mm hg', 'caffeine ventilatory failure respiratory muscle failure neurologic dysfunction', 'coupage thorax multiple day clear debris lung', 'foal clearance material', 'common cause apneustic irregular breathing pattern perinatal asphyxia syndrome', 'lack oxygen delivery depression respiratory center medulla', 'potential hypoglycemia hypothermia disease eg meningitis trauma', 'botulism weak abnormal breathing pattern hypercapnia muscle muscle weakness', 'treat disorder hypoglycemia hypothermia', 'caffeine dose mouth mg', 'dose significant stimulation neonate', 'respiratory rate effort pulmonary cardiac dysfunction', 'hypoventilation ventilatory support', 'umbilical stalk detach foal mare', 'temporary clamp umbilical tape', 'chlorhexidine solution iodine solution umbilical', 'iodine scald skin cause edema early separation external umbilical stalk development patent urachus', 'patent urachus birth develop', 'broad spectrum excessive straining cystitis urachitis infection surgical removal umbilical cord common sick secondary dissemination organ lungs', 'ultrasound examination umbilical size echogenicity sick neonate', 'surgical removal medical management broad spectrum culture weak recumbent normal neurologic trigger urinate bladder', 'important monitor urination bladder size ultrasound sick recumbent field triage neonatal foal complication', 'suspect urinary catheter collection system prevent distension rupture', 'urinary bladder rupture utero birth impaired neonate', 'clinical apparent urine electrolyte', 'clinical clinical location rupture duration volume urine', 'rupture ureter urine space peritoneal space', 'ultrasound examination evidence fluid peritoneal space', 'peritoneal fluid creatinine blood creatinine', 'serum chemistry analysis creatinine degree blood urea nitrogen hyperkalemia hyponatremia hypochloremia hypoxemia acidosis', 'electrolyte severity duration rupture foal prior fluid therapy support', 'treatment initial treatment referral surgical correction', 'resolution medical therapy surgical repair', 'hyperkalemia life meq l surgical correction drainage foley catheter iv catheter chest tube', 'catheter place repetitive drainage important obstructed fibrin omentum removal', 'perform iv crystalloid therapy normalize electrolyte', 'replacement volume equal exceed volume urine prevent acute hypotension abdominal pressure', 'sodium bicarbonate saline infusion serum potassium intracellular movement potassium', 'calcium gluconate saline bicarbonate impact hyperkalemia cardiac function', 'insulin dextrose infusion potassium uptake coupled potassium uptake', 'pleural effusion abdominal drainage though several', 'pleural effusion cause pulmonary atelectasis affect respiratory function delay surgical repair effusion', 'broad spectrum antimicrobial therapy', 'flexor tendon laxity flexor tendon laxity time exercise', 'unable severe laxity placement limited exercise laxity', 'light wrap fetlock prevent', 'thicker support exacerbate tendon laxity', 'flexural flexural uterine malposition ingestion toxic nutritional genetic', 'goal therapy tendon loading stretch', 'mild treatment physical therapy support exercise', 'moderate treatment daily bandage change physical therapy', 'severe surgical release necessary severe painful analgesia gastric ulcer prophylaxis', 'oxytetracycline g iv result temporary increase joint extension', 'avoid oxytetracycline sick hypovolemic renal compromise', 'limit exercise stumble risk injury extensor', 'clinical sign septic arthritis osteomyelitis lameness', 'warmth pain affected area obvious osteomyelitis', 'complete blood white blood cell count wbc fibrinogen', '', 'regular palpation assessment gait important early detection treatment athleticism', 'synovial fluid cytology wbc total g dl consistent sepsis', 'absence septic process', 'presence hyperfibrinogenemia leukocytosis', 'synovial fluid culture negative culture rule septic process', 'radiographs region evaluate septic physitis osteomyelitis', 'radiographs limb comparison normal foal irregular', 'lavage joint l isotonic crystalloid solution', 'day lavage cytology clinical', 'excess fibrin purulent debris arthrotomy necessary joint', 'broad spectrum antimicrobial therapy treatment necessary', 'arthrotomy antimicrobial therapy joint', 'nonsteroidal antiinflammatory therapy treatment inflammatory process', 'prophylactic antiulcer therapy painful nonsteroidal antiinflammatory therapy', 'medical therapy similar septic arthritis', 'aspiration culture bone directed therapy', 'regional limb perfusion useful high site infection', 'use third total daily decrease daily iv dose prevent', 'surgical debridement', 'rib history dystocia trauma', 'rapid tachycardia wall edema crepitus fracture site clinical hemorrhage', 'auscultation fracture site click respiratory cycle', 'rib costochondral junction ultrasound examination linear probe parallel top rib', 'limited exercise stall rest surgical stabilization unstable displaced colic subtle unable settle heart respiratory rate', 'tail foot', 'severe pain obvious', 'evaluation colicky foal physical examination careful history digital rectal examination passage nasogastric tube abdominal ultrasound', 'presence gastric reflux small intestinal disorder', 'nasogastric intubation check reflux gastric distension secondary outflow obstruction', 'abdominal radiographs contrast helpful assess location type distension impaction atresia', 'abdominocentesis cytologic evaluation diagnose peritonitis bowel', 'meconium impaction common cause colic neonatal foal', 'clinical decreased nursing defecate tail lack meconium production', 'digital examination hard fecal rectum', 'complete obstruction abdominal distension', 'severe distension result respiratory compromise', 'radiographs ultrasound fecal material distal colon rectum', 'barium enema evaluation attempt rule focal atresia intestinal tract', 'treatment warm water enema ml warm water foal gentle restraint', 'polyurethane stallion urinary catheter enema tube', 'tip tube resistance', 'water gravity advance impaction', 'addition small amount dish soap impaction infusion soap cause irritation mucosa foal discomfort', 'acetylcysteine retention enema meconium warm water enema', 'sedation diazepam mg kg iv foal infused', 'foal recumbent balloon foley catheter balloon saline', 'foal hind end aid gravity flow', 'infusion catheter enema minimum ideal time', 'oral oral mineral oil helpful proximal', 'mineral oil ml nasogastric tube', 'mineral oil syringe aspiration result', 'sodium sulfosuccinate dss castor oil cause irritation intestinal mucosa result colic diarrhea', 'iv iv necessary hydration aid treatment', 'nonsteroidal antiinflammatory potent', 'critical adequate hydration prevent renal toxicity institute gastroprotectant therapy attempt side', 'field triage neonatal foal im butorphanol mg kg analgesia', 'diazepam foal sedation time retention treatment effect', 'neostigmine mg kg subcutaneous effective meconium passage gas', 'atresia difficult disorder diagnose', 'passage meconium rule', 'barium enema serial radiographic area atretic', 'definitive diagnosis surgical exploration', 'successful resection anastomosis atresia', 'ileocecocolic aganglionosis overo lethal white syndrome ileocecocolic aganglionosis lethal white syndrome genetic defect homozygous overo paint', 'affected white small color', 'endothelin receptor b mutation complete aganglionosis myenteric submucosal ganglia intestinal tract', 'normal birth colic ileus intestinal distension', 'diagnosis clinical ultrasonographic evidence profound ileus distension white homozygous overo paint', 'treatment disorder euthanasia', 'genetic test available heterozygous', 'diarrhea bacterial viral protozoal nutritional ischemic necrotizing enterocolitis table', 'bacterial clostridium c clostridium difficile salmonellosis coli hydrophila', 'rotavirus common viral cause coronavirus adenovirus parvovirus', 'cryptosporidium normal', 'nutritional lactose intolerance sudden diet', 'blood flow vital ischemic septic shock ischemic damage gastrointestinal tract', 'clinical ischemic enteropathy range mild colic intolerance enteral profound ileus sepsis bloody diarrhea', 'affected organ dysfunction', 'sepsis bacterial translocation gastrointestinal mucosal barrier', 'foal enterocolitis diarrhea important institute symptomatic treatment cause', 'tolerate oral feeding', 'unable digest bacterial overgrowth large bowel gas production colic', 'auscultation examination assess motility', 'nasogastric tube check reflux gastric distension', 'enteral feeding necessary feeding clinical', 'symptomatic therapy iv fluid support section iv fluid therapy feeding motility gradual reintroduction enteral see nutrition section broad spectrum antimicrobial therapy diarrhea addition metronidazole mg kg parenteral nutritional support section nutritional support antiinflammatory therapy gastric ulcer prophylaxis lactase supplementation large milk replacer gastric distension colic diarrhea', 'large large volume incomplete digestion bacterial overgrowth large intestine colic gas production diarrhea', 'treatment decrease volume feeding', 'milk cold palatable foal', 'lactose intolerance common cause lactose intolerance injury loss enzyme', 'supplementation enzyme lactase helpful clinical', 'time intestinal tract', 'perinatal asphyxia syndrome meningitis trauma idiopathic epilepsy arabian congenital epilepsy lavender foal syndrome glycogen enzyme deficiency difficult detect clinical repetitive abnormal eye hyperesthesia excessive stretching extensor muscle recumbent', 'secondary injury excess neurotransmitter calcium release occur critical control', 'diazepam administer diazepam mg kg iv bolus effect mg foal', 'diazepam short half life effect additional therapy', 'monitor respiratory depression', 'field triage neonatal foal']"
303dd57924047b30670081699eb8c991bf0f41b5,probability emergence spatial heterogeneity outbreak size host population average number emergence introduction village city reproductive number average reproductive human transmission size distribution novel pathogen number infectious spatial structure emergence process heterogeneity human homogeneity coefficient human host public health short term spatial homogeneity emergence novel human population impact spatial infectious period mutation rate population size spatial host analytical probability city city city model critical number effect outbreak effect spatial emergence event emergence extinction emergence infectious evolutionary biology gradual route human human human mobility infectious strain intermediate strain large number number emergence p em pathogen human present model previous work probability extinction route ii unpredictable probability wildtype strain x x zoonotic pathogen adapt human adaptation mutation ana em analytical deviation approach question calculate probability capita rate certain number city example city h different human different world effect emergence em p emergence epidemic emergence p emergence probability event infectious evolution emergence evolutionary course example general figure probability g x general case global public green line heterogeneity emergence heterogeneity function homogeneous population host heterogeneity infection village infinite number infinite population influence spatial intermediate transmissibility large city local city long term many zoonotic n v next event novel infection number city number infected number intermediate,"['many zoonotic novel infectious sporadic influenza', 'adaptation key factor human tohuman transmission', 'simple mathematical different adaptation particular reference spatial heterogeneity human population', 'present analytical probability emergence introduction time successful emergence event', 'derive general analytical statistical probability distribution outbreak', 'compare analytical stochastic model', 'typical connection spatial heterogeneity weak effect outbreak size emergence introduction', 'example r village large city ten day part city outbreak size distribution', 'present empirical vast majority available interconnected', 'plausible parameter spatial heterogeneity evolutionary biology host adaptation', 'conclude surveillance control', 'zoonotic emergence novel human significant risk global public health', 'example spanish flu pandemic', 'virulent subsequent influenza potent capacity virus cross', 'many share capacity outbreak', 'novel arenavirus south africa', 'previous work host evolution host transmission pathogen human zoonotic pandemic potential', 'natural assumption host population homogeneous infection host infection', 'reality contact heterogeneity risk speed emergence', 'concentrate heterogeneity spatial structure human host population area little attention context adapting', 'model separated strengths example village city', 'aim study ecological structure strong effect emergence comparison evolutionary biology infection', 'section overview approach', 'present new analytical simple spatial host population structure', 'use useful important zoonotic pathogen human physiology emergence', 'reliable', 'predict outbreaks turn', 'next ask large single finite host population population size negligible effect', 'incorporate spatial heterogeneity human host population', 'present model small village human travel large city example general case interconnected', 'use model ask strong community separation population structured', 'review available ask typical human mobility', 'close discussion public health', 'model evolution emergence zoonotic pathogen poor onward transmissability', 'infected average reproductive number r r', 'call reproductive number wildtype strain', 'zoonotic pathogen genetic ability pass', 'chain transmission pathogen ease human human transmission r epidemic possible', 'process vector reproductive', '', '', 'n vector mutation', '', '', 'n number adaptive necessary strain n restrict attention case opposite distinct overall complexity number', 'wildtype strain low transmissibility third pandemic potential second strain intermediate transmissibility', 'intermediate transmissibility novel pathogen human host population secondary possible', 'va', 'human strain reproductive number', 'identical mean infectious period', 'first distinguish scenario evolutionary course ½ gradual scenario ½ difference fitness intermediate stage', 'sir model normalized respect infectious period number susceptible number strain r number', 'include zoonotic emergence extinction timescale human lifespan', 'translate model stochastic simulation multitype process gillespie algorithm', 'infection single random susceptible host wildtype strain', 'general introduction possible emergence extinction', 'extinction novel pathogen adapt human transmission stochastic extinction', 'hence introduction limited number infectious outbreak size', 'novel pathogen zoonotic origin human transmission spread self way', 'unlimited host population cumulative number infectious time infinity', 'threshold infectious strain distinguish emergence extinction', 'threshold probability extinction ã', 'number identified small', 'small simulation insensitive precise choice threshold', 'population small relax emergence infectious population', 'special case n', 'possible calculate probability emergence introduction human host population evolutionary course pathogen mutation rate pathogen', 'homogeneous human host population infinite size', 'assumption show', 'calculate probability emergence define next event p mutation recovery r individual host therefore event infectious host note general extend adaptation process many adaptive', 'uni directional strain', 'process approach similar derive probability emergence introduction text summary global public health issue recent example last year swine flu influenza pandemic', 'many zoonotic adaptation cross animal reservoir transmission', 'previous work relationship evolutionary biology pathogen epidemiology pathogen pandemiccapable', 'extend work incorporate important host ecological feature spatial distribution host population', 'many large population', 'example hiv human population bushmeat central', 'ask pathogen adapt human transmission spatial structure human population become important', 'approach question mathematical connectedness', 'show effect emergence process', 'finish public health', 'probability emergence next event probability extinction index infection strain', 'expression possible adaptation', 'underlying population structure pathogen biology estimate number emergence probability emergence introduction p em em text average number emergence', 'average number emergence event', 'addition variance similar way text', 'variance standard deviation order average number', 'number unpredictable probability emergence introduction small p em', 'special case process approach derive sizes emergence text', 'general probability size x g x denoting strain', 'number infected', 'overall outbreak size probability conditional x g x x zx zx x z p n x total outbreak size f probability patient strain', 'summation derivation overall outbreak size probability possible infectious', 'use metapopulation model explore spatial host heterogeneity human population', 'example general case structured simple village city model approximate spatial host heterogeneity rural human mobility', 'many different human mobility short term long term migration', 'information dominant sparse', 'anecdotal evidence vietnam example short term important role subset village agricultural produce local city city weekly basis', 'present model residence time city infectious period', 'supplementary information present model migration text', 'different robust different human movement', 'wildtype pathogen capable human transmission', 'finite number infinite number city', 'allow daily label city city present village', 'c represent village city city', 'village city capita rate x return capita rate x', 'time proportion w city w x x', 'neglect susceptible village infection city infinite number city', 'number village n n v zn define average number non village city equilibrium note equation fact w n vm n v zn vm', 'represent daily infectious period choose w give average number', 'seed wildtype infection village v', 'village city model emergence event infectious strain city', 'use strain model study impact mutation rate average reproductive number intermediate strain probability emergence introduction single infinite population', 'illustrative spectrum possible mutation', 'figure probability emergence different mutation reproductive strain', 'probability emergence linearly probability mutation second strain x x number infected', 'intermediate reproductive number exponent mutation rate direct influence base', 'validate analytical average probability emergence emergence homogeneous population', 'figure excellent agreement analytical', 'small host depletion susceptible significant role outbreak', 'effect finite population size analytical infinite host population', 'figure outbreak size distribution different analytical', 'note close agreement numerical analytical', 'size population size dependence substantial effect', 'village number model sufficient avoid finite size size', 'independent spatial heterogeneity', 'number effect outbreak size distribution', 'figure size distribution short term model', 'average number', 'significant effect outbreak size distribution', 'infectious necessary process formulation analytical', 'noteworthy biology novel pathogen emergence process outbreak group intermediate average reproductive number', 'minimal deviation fact effective village size due absent', 'figure extract probability emergence introduction certain number', 'outbreak size distribution probability emergence introduction', 'introduction x infectious', 'probability extinction cumulative probability outbreak size equal x possible infectious', 'probability emergence number', 'figure effect spatial heterogeneity', 'vcw village city analytical single infinite population', 'probability emergence', 'figure probability emergence function number actual outcome unpredictable probability event average waiting time emergence', 'probability emergence x infectious', 'example probability emergence infectious gradual route ii p em', 'average times emergence happen', 'standard deviation conclusion probability unpredictable lead emergence', 'sufficient connection ability cause spatial structure', 'hence existence threshold spatial heterogeneity matter', 'previous research effect heterogeneity population interconnectivity pathogen spread', 'approach new actual number infectious new community', 'measure connectivity average number rich empirical', 'figure illustrative empirical different world', '', 'independent estimate china', 'next attempt quantify vcw spatial heterogeneity', 'approach question simple analytical derivation effect spatial heterogeneity strain', 'community village village city model pathogen village', 'emergence epidemic village probability emergence epidemic city h spatial spatial homogeneity coefficient impact spatial heterogeneity emergence process', 'isolated spatial heterogeneity homogeneous population', 'f fraction village infectious', 'spatial homogeneity coefficient connection strength vcw average reproductive number r strain', 'strain expect coefficient good approximation multi strain model vast majority infectious strain case emergence', 'figure overview influence spatial heterogeneity function vcw', 'spatial heterogeneity negligible critical number ten', 'low empirical data probability community critical number ten', 'close fit analytical numerical small error analytical expression neglecting adapted', 'error pathogen intermediate strain', 'deviation small', 'light agreement critical average number reproductive number', 'r ten average sufficient spatial heterogeneity average reproductive figure', 'strain pandemic capable e', 'r likely seed epidemic local city spatial structure important', 'example critical number', 'r spatial homogeneity coefficient commuter', 'figure simulated', 'article present analytical epidemiological novel disease', 'influence spatial host contact structure validate result stochastic simple village city example interconnected population', 'study plausible parameter spatial heterogeneity limited impact probability emergence outbreak size distribution', 'change strength spatial heterogeneity e g', 'number', 'short term versus long term commuting significant influence', 'remote rural epidemiological isolation', 'particular available empirical high connection', 'course remote world relevant', 'empirical research spatial heterogeneity form understanding effect need world', 'addition population size important factor population small', 'small number infectious involved emergence process small reservoir successful emergence', 'biological evolution route show strong influence overall emergence process', 'epidemiological size group evolutionary route', 'previous research effect pathogen route evolutionary adaptation mutation rate probability emergence introduction', 'theoretical derivation probability emergence solvable possible route adaptation mutation', 'previous work role significant heterogeneity emergence novel infection', 'example describe effect life history length infection emergence novel pathogen', 'heterogeneity human human transmission population course probability emergence probability emergence', 'concentrated simple spatial heterogeneity significant question future research role mixed example additional heterogeneity human human transmission', 'waiting time outcome novel pathogen introduction unpredictable probability event', 'estimate epidemiological uncertain', 'large number necessary confidence large number extinct rule possibility emergence pathogen', 'similar result measurement upper bound probability emergence', 'probability emergence certain number infectious low', 'large number infectious extinction low mutation stage average reproductive', 'figure', 'different world', 'cumulative fraction specified number', 'national statistical respective', 'gold line red line usa blue line brown line japan line green line independent', 'green line orange pink', 'administrative', 'definition administrative', 'example granularity', 'heterogeneity', 'brazilian level sizes ranging figure', 'deviation analytical probability emergence', 'deviation function average number', 'deviation dp ana em p sim em p ana em', 'analytical probability emergence p ana infinite ulation spatial structure', 'simulated probability emergence p sim short term blue gradual route ii adaptation orange route', 'solid black line spatial vcwf equation main text', 'analytical deviation spatial heterogeneity function spatial homogeneity coefficient', 'analytical deviation', 'gradual route ii theoretical prediction result small significant number intermediate strain', 'number strain probability transmission village city', 'analytical prediction well significant impact spatial heterogeneity critical commuter threshold', 'figure', 'impact spatial heterogeneity disease transmission', 'impact spatial homogeneity coefficient spatial', 'h emergence village emergence city h chance pathogen city', 'figure spatial structure important small average reproductive', 'addition average number show effect spatial heterogeneity small', 'work relevance important public health disease rural setting feasible contain infection village', 'first tight level quarantine chance containment low level vcw figure', 'isolation effective', 'extreme intervention', 'second typical mobility likely detectable number significant number', 'likely late', 'work important research surveillance detect emergence early possible', 'emergence novel infection rural much time travel major urban', 'systematic context population', 'theoretical useful fundamental guide', 'text supplementary material evolution emergence infectious disease', 'found', 'mb pdf author']"
94cd1610fd21b8fc289d65a96973216217a955dd,level knowledge high level present study swine flu infectious disease knowledge disease communication public education level high concern level concern level education p p public health accurate information agreement evident avian influenza concern level concerned agreement incubation period influenza pandemic level precaution mode transmission multiple regression period communicability saudi arabia scientific committee significant predictor spread disease basic knowledge clear communication compliance precautionary comply precautionary concern half concern translate degree concern disease basic disease outbreak disease public disease transmission effective medical epidemic stay first pandemic flu mexico flu special focus public government isolate government real half travel infection high infectious public influenza swine information role information swine isolate flu kingdom saudi low knowledge low level majority government male female many various medical treatment mexico first mild infection minimal mild myths disease novel influenza pandemic century period period play spread potential infectious predictor concern prevalent restrict previous study public play public potential ready number real number restrict travel role public saudi public sectional study shopping jeddah special prevalent stay home study high table multiple translate compliance travel epidemic travel ready various infectious willing participate abdullah international able provide accordance precautionary accuracy completeness actual number adult various affect precautionary age education age gender,"['infectious disease outbreak critical learn much possible behavior public', 'information crucial improvement communication public health', 'aim study awareness related influenza saudi public', 'sectional study adult various shopping jeddah', 'questionnaire knowledge precautionary influenza pandemic', 'half high concern low level knowledge minimal precautionary', 'level significant predictor level concern precautionary male p p p knowledgeable p', 'third moh disease true information health', 'high concern translate compliance precautionary low level knowledge disease public', 'frequent communication public help myths disease spread information role public play spread disease', 'novel influenza swine flu mexico first pandemic century', 'previous anxiety infectious natural terrorist born unnecessary worry chaos situation public', 'inappropriate public precautionary mask vaccination avoidance certain hospital due fear healthcare infection', 'perception public potential infectious disease public health knowledge educational public', 'kingdom saudi arabia transparent early flu place strict method surveillance', 'country pilgrims year important clear plan public potential infectious crisis', 'study pandemic alert status phase', 'time mitigation disease', 'major pandemic saudi public', 'extent radio second internet free uncensored u tube place', 'large accurate information overcome dialogue place tv', 'early initial announcement case kingdom clear communication moh case', 'minister health developed national scientific committee deal pandemic time medication vaccination vaccination prioritization high risk school suspension clear communication ministry education', 'scientific committee able provide educational material dissemination shopping', 'scientific committee provide scientific', 'infectious disease outbreak crucial improve communication public health', 'knowledge study kingdom saudi arabia public awareness pandemic threat', 'age male female shopping jeddah verbal consent eligible participate survey', 'saudi willing participate', 'cross sectional study design', 'riyadh jeddah arabia good representation country', 'number large different geographical', 'proportional quota representative general population age sex work status region social class', 'willing participate study', 'collector spent average mall chosen time day recruit', 'possible response rate', 'interview questionnaire socio demographic gender age education occupation', 'b knowledge disease nature mode transmission incubation period period communicability preventive', 'knowledge factual', 'system assess level knowledge subject point correct answer point incorrect answer', 'level knowledge low average high', 'severity governmental combat disease attitudinal agree agree neutral disagree', 'system likert scale agree point', 'negative attitude', 'total attitude score', 'statement participant concerned', 'level concern concerned agreement evident concerned agreement evident little concerned agreement evident', 'participant report precautionary epidemic prevent infection', 'accordance precautionary u center disease control cdc', 'system participant point precautionary measure', 'total precaution score', 'high level precaution moderate level poor level', 'research research abdullah international medical research center kaimrc conduct', 'day co accuracy completeness collection standardization', 'entry statistical analysis statistical package social science spss software program version', 'descriptive standard', 'categorical square test', 'continuous student anova', 'multiple regression determine significant concern level precaution', 'statistical significance p', 'study protocol application ethical approval institutional review board irb national guard health riyadh saudi arabia', 'table total', 'age', 'half married majority secondary education', '', 'male female p p p unemployed p', 'knowledge assessment table majority aware disease viral illness large number disease immunodeficiency disease', 'accurate information mode transmission sexual contact mode transmission', 'seasonal illness immediate death', 'majority knowledgeable incubation period period communicability', 'half vaccine available disease time survey available', 'government real number underreporting actual number', 'figure low knowledge disease high level knowledge difference p', 'majority information swine flu television information information internet', 'information physician health educator', 'majority government isolate flu special prevalent restrict travel ready number', 'half travel epidemic stay home table', 'figure high concern half p', 'half frequent hand use facemask', 'third mouth tissue', 'fourth tissue trash use normal table', 'minimal mild infection high level', 'table multiple regression concern precaution figure concern flu public', 'several independent', 'education significant predictor concern level education degree concern p', 'hand significant precautionary age gender education level knowledge', 'high level precaution p education level knowledge p', 'novel influenza swine flu mexico first pandemic century', 'infectious disease basic knowledge disease transmission availability effective medical treatment', 'many various infectious public behavior relation avian influenza', 'behavioral attitudinal influenza', 'previous study assess public understanding avian influenza majority pandemic disease responsibility government', 'credibility health information table multiple regression analysis degree concern score precautionary independent belief credibility information local health department', 'study government real number number underreported distrust health', 'realism public', 'infectious disease basic knowledge disease vaccine disease effective medical treatment someone', 'many various infectious public avian influenza', 'present study low high level knowledge', 'low knowledge evident regard period communicability incubation period swine flu', 'recent review behavioral th century strong support scientific literature spread hand hygiene respiratory etiquette', 'school closure legal ethical', 'isolation surgical mask mask cost effectiveness difficult long time', 'present study face mask half', 'important proportion population disease', 'telephone survey age new south department health willing comply precautionary', 'present study precaution minimal mild infection high level', 'frequency high precautionary level education level knowledge', 'study hong kong precautionary threat young educated likely precautionary', 'di giuseppe perception risk level education socio economic level comply precautionary spread disease', 'worry', 'word announcement phase impression many day impression empty fill emergency normal business economic', 'general public swine flu global severe flu pandemic severity', 'present study high concern half different', 'majority government isolate flu special prevalent restrict travel ready number', 'half travel epidemic stay home', 'regional anxiety', 'different', 'present study similar study precautionary hypothetical influenza pandemic european asian', 'agreement previous united kingdom low anxiety flu', 'education present study significant predictor concern level education level concern concern employment individual variable affect precautionary previous study', 'study level threat perception elderly poor self health formal low household rural', 'strong call public health influenza pandemic little focus public catastrophe', 'suggested culture individual anxiety important behavioral pandemic influenza present study high level concern translate compliance precautionary', 'poor understanding disease transmission', 'disbelief government outbreak official advice', 'disease television primary information swine flu', 'study health insufficient role education public', 'communication public myths disease help accurate information role public play spread disease', 'collaborative moh focus public education training']"
920ac358de68e48b50b4d65dc500935ade21c997,et al immune response immune system bursa fabricius cellular immune genetic resistance genetic selection immunosuppressive agent agent turkey causative agent evaluation immunosuppression good management growth rate journal vol open veterinary pierson fitzgerald poultry industry rautenschlein al system several trampel al veterinary journal adherent mononuclear agent bluecomb al al al fujiwara al hussain al itakura al kisary al pierson al trampel animal welfare application strict atrophy bursa atrophy lymphoid avian influenza avian reovirus bird resistance bluecomb disease calnek al carlson al catarrhal enteritis cell immunity commercial turkeys control different control immunosuppressive den hurk depletion lymphoid diarrhea mortality disease virus dna vaccine due viral enteric commercial enteric syndrome escherichia coli essential tool field laboratory fujiwara al gross carlson gross pathology hemorrhagic enteritis immunosuppressive effect immunosuppressive viral immunosuppressive virus important role inclusion body increase mortality itakura carlson kaboudi open kisary et lymphocyte necrosis lymphocyte proliferation main viral marek disease mettifogo et newcastle disease nutritional management peripheral blood problem poultry respiratory tract secondary bacterial several enteric strict biosecurity suresh sharma syndrome rss tcov causative thymus spleen transient immunosuppression turkey industry upper respiratory viral immunosuppressive virulent hev virulent vv water consumption able immune abrogation disturbance accurate evaluation acid production activation interferon activity immune acute disease,"['resistance immunosuppression poultry industry interested immunosuppression', 'strategy good management animal good feeding major infectious', 'genetic resistance intrinsic property select natural resistant poultry strain', 'genetic selection resistance immunosuppressive promising cazaban', 'tool ameliorate bird resistance interfere welfare', 'genetic resistance increase susceptibility', 'selection resistant interaction genetic homeostasis balance animal welfare represent current problem poultry industry', 'article current knowledge viral immunosuppressive', 'detect decrease immune response possible immunosuppression', 'enteritis main problem poultry considerable direct indirect economic', 'several enteric commercial', 'enteric age affect young first age severe nuñez piantino ferreira mettifogo et al', 'enteric susceptibility affected secondary', 'several enteric commercial', 'interaction complex many management infectious', 'various clinical general nonspecific diarrhea mortality poor', 'gross pathology gastrointestinal pancreatic lymphoid damage', 'main enteric syndrome laboratory essential tool etiological alavarez al mettifogo et al', 'important enteric viral hemorrhagic enteritis syndrome rss table', 'hemorrhagic enteritis acute disease siadenovirus group immunosuppressive virus age', 'depression bloody heterogeneity flock mortality characterize disease', 'field varied gross moore', 'virus replication spleen major site al pierson fitzgerald', 'immunosorbent assay immunofluorescent polymerase chain reaction pcr confirm presence many bursa fabricius caecal liver kidney silim thorsen fasina fabricant fitzgerald al trampel al hussain al suresh sharma', 'viral replication b', 'target adherent mononuclear adherent mononuclear van den hurk igm suresh sharma', 'virulent hev capable induce apoptosis spleen due induction secretion spleen rautenschlein al', 'activation interferon type ii tnf production', 'immunosuppressive consequence nitric acid production interferon ii ifn ii dhama et al', 'transient immunosuppression clinical phase disease considerable depletion igm bearing b al', 'vaccination infected', 'significant decrease hemagglutination inhibition antibody virulent hev', 'depression phytohemagglutinin pha inoculated nagaraja al', 'secondary bacterial course illness increase mortality additional al', 'predisposition enteropathogenic escherichia coli infection den hurk et al giovanardi al clostridial dermatitis thachil', 'resistance virus poor hygiene short time persistence pierson fitzgerald', 'due hemorrhage pale', 'gross pathology hemorrhagic intestinal mucosa presence natural blood', 'spleen friable', 'dead spleen pale blood loss subsequent splenic contraction gross carlson al fujiwara al itakura carlson', 'histological apparent lymphoreticular gastrointestinal', 'hyperplasia white pulp lymphoid necrosis intranuclear inclusion body lymphoreticular body microscopic al', 'histopathological evident duodenum congestion hemorrhage infiltration epithelium villus degeneration consist major', 'severe gizzard proventiculus caeca fabricius al pierson fitzgerald', 'intranuclear many bone marrow renal tubular epithelium lung gross carlson al fujiwara al itakura carlson meteyer al trampel al hussain et al', 'many fowl immunosuppressive agent turkey', 'adenovirus responsible inclusion body hepatitis ibh induce atrophy bursa thymus spleen singh al schonewille et al', 'virulent affinity impairment humoral cellular', 'immune system al', 'several fav capable susceptibility coli al', 'vaccination nd avian influenza subtype fav serotype niu et al', 'syndrome rss multifactorial syndrome young general age', 'mortality remarkable heterogeneity aqueous diarrhea mortality important alert clinical wit et al', 'etiology syndrome many affected', 'rss al kisary et al mcnulty et al songserm et al baxendale mebatsion al smyth', 'addition nutritional management poultry', 'virulent avian reovirus cause atrophy lymphoid humoral immunity table', 'immunosuppressive main viral', 'kang al', '', 'lymphoid atrophy reovirus tropism contrast specific infectious bursal disease virus chicken anemia virus mdv', 'bursa fabricius atrophy edema hyperplasia epithelium lymphoid depletion al', 'spleen avian reovirus strain response pha sharma et al', 'infectious transmissible multifactorial disease', 'young week', 'affected high heterogeneity diarrhea increase mortality week', 'market growth rate depression emergence secondary bacterial mycosis vaccination failure major classical', 'etiology', 'many field infectious salmonella escherichia coli campylobacter nutritional management guy', 'initial clinical consist increase water consumption decrease feed ingestion emission watery', '', 'mortality age high spike', 'necropsy examination emaciation catarrhal enteritis atrophy lymphoid', 'histopathological lymphocyte depletion lymphoid al', 'lymphocyte necrosis severe depletion bursa fabricius enteric coronavirus e et al', 'thymus atrophy astrovirus grgić et al', 'replication enterovirus lymphoid lymphocyte necrosis depletion lymphoid reduction lymphocyte blood hoerr', 'several poultry infectious bronchitis enteric syndrome', 'turkey coronavirus tcov causative agent bluecomb disease ruffled feed water consumption addition poor growth rate al guy', 'villous atrophy desquamation catarrhal enteritis hemorrhagic infiltration major microscopic', 'immunosuppressive effect tcov bursa fabricius', 'histopathological examination columnar epithelium squamous epithelium intense heterophilic inflammation underneath epithelium', 'common goose affection young geese derzsy disease gough', '', 'distinct group parvovirinae causative agent enteric possible neurologic al marusak et al', 'genetic turkey parvovirus et al domanska blicharz al sharafeldin et al', 'implication complex enteric chicken turkeys trampel al kisary et al', 'rss', 'field light turkey syndrome mor et al', 'marek disease common avian neoplasm marek disease herpesvirus nair', 'oncogenic immunosuppressive virus poultry', 'frequent chicken diagnosis md turkeys unusual finding', 'mdv serotype mild virulent v virulent vv virulent vv witter et al', 'apathogenic g prepare', 'serotype chickens pathogenic isolated apathogenic herpes virus turkey strain heterologous vaccine', 'replication mdv lymphoid early b cytolysis effect', 'transient immunosuppression inoculation', 'latent infection b', 'infection necrosis', 'capable transforming lymphoid tumor formation death calnek al calnek heidari et al', 'cytolysis b induced virulent severe lymphopaenia', 'mdv induce immunosuppression humoral cell immunity calnek al nair haq et al', 'effect k kaboudi open veterinary journal vol', 'massive apoptosis thymic atrophy reduction al', 'degree immunosuppression virulence viral denesvre hu et al', 'surveillance immunosuppression mdv evident continuous circulation immunosuppressive', 'detection skin early practical inaccurate approach evaluate mdv immunosuppression biggs naire couteaudier denesvre', 'reticuloendotheliosis important immunosuppressive disease', 'rev neoplastic disease similar lymphoid leucosis', 'disease cause significant death condemnation loss commercial turkey potential contaminant vaccine turkey origin', 'immunosuppressive effect rev consequence b abrogation disturbance function etienne emerman', 'disease atrophy bursa fabricius thymus', 'dysfunction spleen payne venugopal', 'rev b et al', 'damage reduction peripheral blood suppression splenic al bi et al', 'decreased number responsible al', 'clinical neurological spleen liver necrosis ulceration woźniakowski al', 'many immunosuppressive agent turkey', 'respiratory negative effect immune system newcastle disease virus ndv avian influenza avian', 'newcastle disease nd worldwide disease severe economic', 'ndv damage lymphoid macrophage secretion phagocytosis role', 'necrosis peripheral blood cheville beard agoha al lam', 'ampv causal agent turkey rhinotracheitis trt', 'replication virus epithelial upper respiratory tract impair mucociliary bacterial coli ornithobacterium rhinotracheale majo al jirjis et al', 'immunosuppressive pathogen ampv able immune red', 'thymus timms et al', 'ampv hev immune response chary', 'evaluation immunosuppression field laboratory', '', 'practical evaluable accurate evaluation', 'field global evaluation flock health statute', 'first orientation', 'general immunosuppression degradation poor feed conversion decrease growth rate heterogeneity low weight mortality', 'due influence immune system vaccination', 'depressed susceptible bacterial parasitic secondary increased mortality fig', '', 'various immunosuppressive viral clinical suspicion', 'many laboratory useful order evaluate immunosuppression', 'global approach main saif • morphometric central peripheral lymphoid • ratio immunoglobulin serum complement level • functional activity immune response • demonstration immunosuppressive agent interfere vaccination exacerbate course disease agent', 'pathomorphological examination lymphoid practicable', 'quantitative rapid correct diagnosis', 'lymphoid thymus spleen contribute objective evaluation halouzka jurajda sellaoui et al', 'histopathological investigation important tool severity immunosuppression several', 'detection specific causal viral isolation molecular detection practical approach', 'serology test diagnosis', 'evaluation cellular immune competency et al', 'hematological heterophil lymphocyte ration significant indicator stress huff et cotter immunocompetency al', 'vitro lymphocyte proliferation response mitogen evaluate integrity cell immunity', 'lymphocyte proliferation tcov infected subpopulation loa', 'lymphoproliferative response phytohemagglutinin phosphate indicator cell delayed type hypersensitivity reaction', 'phagocytic system function assessment study degree clearance blood circulation commercial turkeys cheema et al', 'cellular immune response developed due available commercial elisa pcr wigley kaiser', 'avian available elisa test al al', 'microarray technology evaluate cellular immune response poultry antiviral pro inflammatory cytokine al', 'innate adaptive immune real time rt pcr investigate gene expression il al', 'k open veterinary journal vol', 'evaluation immunosuppression delicate approach poultry pathology', 'exploration different immune system several', 'due complexity immunosuppression etiology consequence several intrinsic extrinsic factor combination many', 'main objective prevent economic viral immunosuppressive infection', 'strategy control different good management application biosecurity immunization genetic selection', 'good management important role turkey bird health welfare', 'good quality air high quality water essential growth', 'control immunosuppressive agent', 'management key control', 'application strict biosecurity fundamental prevent exposition immunosuppressive', 'bird resistance complement essential tool good vaccination tool specific protection', 'order uniform immune response', 'available main viral', 'control immunosuppressive prevent vaccination', 'immunosuppressive viral ampv', 'live effective disease', 'immunosuppressive young opportunistic vaccination', 'control different', 'poultry industry local protection', 'lasting immunity', 'glycoprotein f ovo old effective safety vaccination ampv prevent upper respiratory tract decrease egg production', 'live young inactivated', 'development vaccination interest', 'general strain vaccine viral arthritis partial protection rss', 'tcov causative agent bluecomb disease turkey available control disease', 'recent vaccination promoted', 'vaccination', 'appearance natural disease commercial turkeys vaccination', 'possible immunization hatchery strain blake dyke baigent', 'therapeutic viral kaiser', 'ifn α antibody titer ndv dna vaccine rautenschlein al', 'addition ifn γ dna vaccine rapid humoral response protection ndv challenge turkeys ovo rautenschlein al al', 'vaccination several genetic selection', 'genetic resistance md special focus major histocompatibility complex', 'notable correlation resistance reduction', 'presence resistance gene natural killer region chromosome bumstead haplotype mortality al', 'certain artificial selection growth immune competence al', 'insertion target aiv limit virus spread approach incapable emergence disease looi et al', 'genetic selection optimal immune response natural resistance viral', 'selection innate immunity possible existence toll', 'possible novel', 'immunosuppression common condition intensive breeding stress present', 'pressure immune system several environmental management nutritional infectious parasitic', 'transient permanent immunosuppression considerable economic performance secondary mortality vaccination condemnation slaughterhouse poor animal welfare', 'immunosuppression major cause decrease profitability', 'knowledge many kaboudi open veterinary journal vol', 'immune system several molecular immunological', 'interaction immunosuppressive', 'hand immune cellular immune response due viral infection clarified', 'diagnosis evaluation immunosuppression due viral field laboratory', 'role avian fundamental term early detection immunosuppression', 'emergent immunosuppressive particular turkey industry', 'immunosuppression approach research development field important role refining turkey industry efficient', 'appropriate management environmental nutritional essential minimize', 'application strict biosecurity vaccination immunosuppressive major feasible introduction propagation enhance quality life', 'addition development new novel generation administration genetic resistance promoter relative increase disease resistance', 'author conflict interest']"
13f5fe81e7b9fe7f66655f0a2d5fb1ce6b43bf7f,transfection efficiency gene delivery b cd pei b pei cd cd gene cd core g cd cd transfection cellular uptake co delivery drug gene fa peg gene co gene transfer potential gene unmodified pei dendrimer conjugate membrane permeability peg cde polymer b tat pei viral gene cd cd cd pei cholesterol depletion conjugate transfection delivery future ds value future research intravenous administration luciferase activity non viral patent literature pdna delivery peg ad pei kda pei pei poly ethylene possible use rna transfer star polymer value transfection aand b ability capacity ability form ad conjugate administration mice article discuss b cde cd derivative cd g cd incorporation cd linear cd pamam cd tegafur cde conjugate cde ds cds development cell transfection conjugate cd deliver dna delivery able delivery efficiency depletion membrane development gene development modification development play discuss gene drug delivery drug release ds ¼ e r efficiency cde efficiency g efficiency pei efficiency unmodified eo r et al ethylene glycol example approach example cd fa fa fa incorporation fine adjustment folate fa form inclusion form stable important tool injection mice ligand conjugation linear pei literature scientific low cytotoxicity methacrylate pdmaema modification viral molecular weight much cytotoxicity p eo p ratio,"['b r c cyclic', 'consist glucose basket topology innereouter amphiphilic character', 'substantial undertaken investigate possible use drug delivery drug release potential gene delivery less discussion literature', 'article discuss gene delivery synopsis use cds development modification viral gene', 'cd gene delivery future research', 'due application anticipated important tool vector development play significant non viral gene delivery', 'cyclic', 'reference crystalline substance cellulosine bacterial digest starch', 'substance resistant acid hydrolysis', 'cyclodextrin', 'freudenberg late', 'later basic physicochemical reactivity cavity size chemical structure solubility ability form inclusion cramer book einschlussverbindungen', 'prominence multitude pharmaceutical chiral separation basic drug delivery potential gene delivery attention', 'article discuss gene delivery overview use cds development modification viral gene', 'cd gene delivery future research', 'hoped article synopsis recent field practical future development cd gene delivery', 'common g glucopyranose', '', 'presence extensive hydroxyl soluble water table', 'high crystal energy state', 'aqueous comparable linear', 'addition aand g aqueous ambient l aqueous solubility cd g l', 'formation internal hydrogen secondary hydroxyl capacity cd hydrogen water', 'hydrophilic cavity apolar cavity', 'micro environment encapsulation solubilization hydrophobic guest chemical', 'table', 'drug nucleic evident recent', 'agrawal team study use cellular uptake immune stimulation', 'abdou', 'ability various native action phosphodiester od complementary initiation region mail address', 'u r n l h e p g e w w w', 'e l e v e r', 'c e b e r l mrna spike protein intergenic consensus sequence enteric coronavirus viral growth human adenocarcinoma', 'naked viral inhibition viral inhibition complexed b cd derivative molar ratio', 'way subsequent intense research cd gene delivery', 'fig', '', 'space cd b cd iii g cd', 'space hydrogen carbon oxygen black white gray', 'table physical g cd', 'cd cd g cd gene delivery affinity nucleic ability cytotoxicity gene', 'previous study series cationic b cd condensation diamino cd', 'ic bcdps', 'cd incorporation backbone cationic polymer polymer cytotoxicity', 'addition effective absorption delivery', 'vitro skin permeation cd meglumine antimoniate increase antimony flux', 'similar absorption effect dimentylb cd concentration w v permeability nasal neurotrophic peptide absorption mean ae', 'administration ae ae', 'absorption property property gene delivery', 'latter study adenoviral gene transfer rat jejunum', 'improvement cdmediated enhancement viral internalization host', 'fact large molecular low octanol water partition', 'presence plurality hydrogen unlikely permeable lipophilic biological gastrointestinal mucosa', 'absorption membrane permeability complexation membrane', 'hypothesis study membrane cholesterol porcine bovine human', 'study membrane permeability unaltered level cholesterol removal extensive cholesterol depletion transfer organic membrane', 'biphasic response cholesterol depletion membrane permeability reproducible artificial lipid', 'effect cholesterol depletion membrane permeability obscure study molecular basis cd absorption enhancement', 'practical potential gene delivery due failure form stable dna pdna native transfection efficiency', 'use gene transfer', 'good example cd polycationic amphiphilic amendment facial anisotropy cone cd torus instillation cationic table cd', 'hydrophobic jellyfish', 'fine adjustment molecular g', 'charge density hydrophilic hydrophobic balance nature functional length dna complexation capacity transfection efficiency pacds', '', '', 'modification b cd pyridylamino alkylimidazole methoxyethylamino primary amine group', 'indicated cellular uptake transgene native', 'unmodified amino pyridylamino butylimidazole group performance cell transfection', 'molecular development gene', 'gene delivery derivatization structural development gene', 'link molecular gene', 'example approach low molecular weight poly ethylenimine pei cationic aziridine polymer high proton capacity broad range ph cd tosyl chloride generate amine reactive tosyldeoxy b cd pei generate cd pei conjugate pei b cd', 'vitro pei b cd nontoxic concentration pdna delivery', 'unmodified pei pei cd luciferase expression', 'human insulin hydrophobic palmitate group transfection efficiency order magnitude unmodified pei derivatized insulin', 'worth effect valid premise proper optimization ratio', 'observation modification amine luciferase activity', 'reduction due pk profile pei decrease efficiency endosomal release', 'hypothesis evidence unmodified pei pei cd buffering capacity', 'example cd linear synthesized difunctionalized', 'similar pei b cd high efficiency type polymer gene delivery fine structural optimization', 'luciferase activity transfection efficiency linear bcdp methylene', 'transfection efficiency methylene', 'different cd incorporation influence transfection efficiency polymer', 'linear fabricate star function', 'approach table', 'pdna delivery different development possible use practical', 'native', 'et al', 'cross', 'cytotoxicity pei kda transfection efficiency achieved pei pei kda', 'cd carboxymethyl b cd sodium salt quaternized chitosan form dna carrier', 'carrier polymer dna mass ratio transfection efficiency', 'fabricated native', 'hydroxy carboxy alkylation performance gene delivery unknown', 'performance cd conjugation', 'example peptide facilitate fibroblast growth factor receptor fgfr endocytosis', 'unmodified pei b cd pei b cd transfection efficiency', 'applicability efficiency target specificity gene delivery', 'example transferrin iron transport protein moiety various cancer cell colon cancer ovarian cancer glioblastoma', 'previous study transferrin poly ethylene glycol peg adamantane peg ad conjugate dna imidazole bcdp', 'transferrin peg ad conjugate assemble inclusion complex formation adamantane cd surface high receptor binding', 'luciferase activity leukemia transfection efficiency transferrin peg ad unmodified', 'promise ligand conjugation performance polymeric gene transfer', 'modify gene', '', '', 'group range supramolecular cationic cd blocked poly ethylene ran propylene p eo r po random copolymer', 'cd molecule p eo r po eo copolymer', 'transfection efficiency pei deserve evaluation gene vivo', 'second way utilizing', 'example approach polyamidoamine pamam dendrimer b g', 'table cd shaped architecture', 'description ref', 'star polymer b cd core polyamidoamine pamam dendron polymer transfection efficiency cytotoxicity pamam control ethylenediamine core human neuroblastoma', 'star g cd core folate fa oligoethylenimine oei low cytotoxicity ability target deliver dna specific tumor folate', 'addition polymer able recover recycle frs cellular', 'continuous endocytosis', 'cd derivative poly l lysine pll prepared click conjugation propargyl focal point pll dendron', 'release behavior pdna transfection', 'star polymer b cd core methacrylate pdmaema much cytotoxicity transfection efficiency high molecular weight pdmaema', 'star polymer b cd core poly poly ethylene glycol methacrylate pdmaema polymer b cd core unmodified pdmaema polymer transfection efficiency', 'star cd core oei p ratio polymer dna form', 'transfection efficiency comparable pei kda cytotoxicity', 'pdna protect dnase degradation', 'vitro cde conjugate dendrimer conjugate cd transfection efficiency g', 'transfection efficiency superior lipofectin unmodified dendrimer', 'boost efficiency gene delivery cde various ds', 'unmodified counterpart conjugate ds value transfection efficiency', 'increase transfection efficiency galactosylation insensitive presence galactose transfection availability asialoglycoprotein', 'similar phenomenon cde mannosylation receptor independent increase efficiency transfection', 'mechanism transfection enhancement unclear interaction intracellular galactose mannose binding', 'interaction efficiency intracellular nuclear translocation', 'addition ligand conjugation gene delivery efficiency cde fine adjustment structural', 'instance cde dendrimer transfection efficiency', 'different ds cd different membrane disruptive different cytotoxic gene delivery', 'comparison ds value transfection efficiency spleen liver kidney intravenous administration', 'importance structural optimization conjugate transfection', 'folate fa fa various ds fa dendrimer', 'fa negligible toxicity low immunogenicity high affinity isoform fra normal fa incorporation cde conjugate exhibit tumor cell specificity transfection efficiency', 'low receptor binding conjugate significant difference transfection efficiency fa incorporation', 'table gene delivery', 'ref', 'polypseudorotaxane peg cd pamam dendrimer conjugate cd cd polypseudorotaxane sustained release pdna', 'intramuscular injection mice transfection efficiency g cd', 'polyrotaxane cd cd polyrotaxane stable pdna sirna mixture', 'cellular uptake nucleic low cytotoxicity', 'pamam starburst dendrimer conjugate transfection efficiency unmodified aand b cde', 'endosomal escape efficiency transgene nucleus h transfection', 'intravenous administration mice conjugate gene transfer activity kidney unmodified aand b cde', 'pamam starburst dendrimer conjugate lactose bearing cd transfection efficiency pamam pamam cde', 'negligible cytotoxicity carrier dna charge ratio', 'jetpeiô hepatocyte conjugate transfection efficiency intravenous administration mice', 'cd pamam polymer michael addition copolymerization n methylene bisacrylamide', 'ability condense deliver dna', 'polypseudorotaxane g cd linear unmodified linear pei polypseudorotaxane efficient cellular uptake pdna much cytotoxicity', 'cd poly ε lysine transfection efficiency unmodified poly ε lysine linear pei', 'fr binding activity cde peg spacer dendrimer fa fa peg cde', 'ds value transfection superior binding ability pdna frs', 'h intratumoral injection mice fa peg cde ds ¼ pdna delivery efficiency cde', 'potential fa peg cde ds ¼ carrier tumor gene delivery', 'fa peg cde section many modification', 'table', 'potential performance polymeric transfection', 'major cds gene delivery', 'fig', '', 'future research area exploration drug gene co delivery', 'excellent drug capacity potential gene transfer emerge attractive simultaneous transport', 'technical viability hu tegafur pei cd fabricate prodrug tegafur drug gene co delivery', 'n conjugate pdna', 'conjugation tegafur number primary dna ability capacity pei cd', 'unmodified pei b cd transfection efficiency pei b cdtegafur much inferior', 'addition pei b cd tegafur fu pei cd fpc conjugate deoxyuridine fdurd pei b cd bifunctional anticancer prodrug', 'fdurd anti proliferative cytotoxic cellular uptake', 'pei b cd tegafur fpc stringent confirm pharmacokinetic pharmacodynamic conjugation pei b cd', 'hydrogen bonding radical copolymerization peg b cd peg cd vdt', 'experimentation hydrogel ibuprofen ibu rate drug release', 'top surface hydrogel pdna hydrogen diaminotriazine dna base pairs hence reverse gene transfection gel surface', 'multifunctional potential possible developed tissue engineering scaffold drug gene co delivery', 'drug gene co delivery cell transfection worth', 'recent study cell protein transduction domain ptd tat protein pei b cd tat pei b cd', 'n p ratio polymer reasonable transfection efficiency somatic cell', 'placenta mesenchymal stem level transgene expression tat pei cd comparable fugene pei b cd h post transfection incubation fig', '', 'transfection phenotypic profile pmscs', 'consistent expression negativity hla dr positivity', 'maintenance phenotypic profile pmscs tat pei cd transfection', 'mtt cytotoxicity tat pei cd negligible concentration appreciable loss cell viability pmscs fig', '', 'therapeutic potential stem ability capacity secret therapeutic efficient non toxic non immunogenic gene carrier stem immense practical importance', 'last area future attention small rna transfer', 'cd rna delivery', 'worth focus discussion article gene delivery possibility gene vector interact dna vector complex rna', 'arima et al fa peg gene delivery able deliver sirna elicit rna interference rnai tumor bearing mice', 'detailed evaluation efficiency cd gene rna transfer', 'extra vulnerability enzymatic degradation additional rna matrix able transfect ccd fibroblast', 'dna', 'emergence rnai bright therapeutic target validation longevity enhancement cd gene delivery applicable rna transfer medical vista new', 'issue intellectual property patent literature scientific', 'patent rich knowledge source complementary conventional scientific literature scientific patent amount academic attention', 'patent pharmaceutical use', 'basic method prepare aqueous solution precipitation patent ability duration activity taste chemical stability bioactive', 'patent industrial', 'due safety review article unpublished b cd week', 'toxicity caused substance pharmaceutical acceptance many world pharmaceutical formulation', 'patent literature', 'moment related production structural modification drug use delivery nucleic table', 'awareness potential gene delivery cdbased gene number patent literature', 'gene delivery area biotechnological research high potential biomedical', 'viral clinical gene delivery safety development non viral', 'copious gene possible use', 'fact native form stable much transfection efficiency comparison conventional polymeric poly lactic co glycolic acid plga pei pll', 'evidence article favorable gene e g', 'ability form inclusion chemical drug gene co delivery able function absorption enhancer capable modulating cytotoxicity great versatility gene delivery development new performance transfection', 'promising potential doubt important tool vector development play significant non viral gene delivery future']"
0a52a3d2793f8ca8a4d6f6630e986ea1da115f80,et al nsp nsp amino acid replication pathogenesis cleavage site nsp cleavage viral rna reverse genetic rna synthesis mhv nsp nsp protein immune response replication virulence gene expression mass kda viral replication virus replication active site al tan carboxy terminal course epidemic full length h p infection nsp mrna accumulation nsp fig nsp localization nsp mhv replication complex tan et terminal half wildtype growth adaptation virulence adobe photoshop al prentice carboxy terminus cleavage nsps deletion cleavage denison al dispensable replication distinct addition exon activity genome rna group coronavirus growth culture harcourt al host cell host gene host mrna host specific identity similarity ifn ␤ infectious virus mature nsps mhv infection nsp distinct nsp multiple open reading papain proteinase pathogenesis animal positive selective post infection prentice al rapid change replicase transcriptase replication culture role nsp selective pressure site mutant snijder et strong evidence virulence animal wildtype infection wildtype mutant ␤ mrna aa sequence acid number acid substitution acute respiratory al al al bost al denison al kanjanahaluethai al lu al snijder al su al van alanine substitution anand et animal host animal human apparent mass b c bonilla al bost al cell culture cell host cell line cell surface cellular rnas,"['much progress understanding role structural accessory severe acute respiratory syndrome coronavirus', 'new attention input genome rna replicase transcriptase gene', 'evidence change sequence evidence likely pathogenesis distinct addition involved viral replication', 'recent reverse genetic cellular modification cellular gene expression mechanisms', 'evolution much host range virulence specific intracellular replication', 'complex', 'genome rna open reading replicase replicase transcriptase polymerase recognition demonstrated viral rna synthesis', 'appellation replicase transcriptase appropriate incomplete description probable protein', 'demonstrated polyprotein distinct addition viral rna synthesis', 'clear specific virulence virus cell host response', 'history coronavirus biology accelerated development reverse genetic coronavirus replication', 'rapid identification divergent relationship group hepatitis virus mhv', 'addition analysis animal human cov course epidemic evidence adaptive extent structural', 'rapid establishment reverse genetic system development reverse genetic group et al yount al direct divergent replication', 'clear replicase gene likely demonstrate multiple many novel viral pathogenesis', 'review organization expression putative replication nonstructural nsps describe host immune response describe cov nsps support pathogenesis adaptation', 'attachment virion cell surface receptor first step coronavirus life cycle important tropism determinant coronavirus many different cell', 'human angiotensin enzyme serve receptor li et al', 'attachment genome cathepsin l dependent mechanism al', 'cell genome first open reading frame viral replication processed', 'assemble double membrane sites viral rna synthesis replication', 'replication likely responsible viral rna synthetic viral life cycle', 'viral rna synthesis stage input genome rna transcription minusstrand template', 'genome replication', 'stage subgenomic translation structural accessory orfs', 'stage subgenomic rna transcription translation structural essential virion formation completion productive viral replication cycle sawicki al', 'characterized structural envelope membrane protein nucleocapsid', 'subgenomic', 'mhv e undergo modification golgi virus assembly et al bost al klumperman al krijnse locker al', 'viral n protein mhv colocalize viral replicase late post infection bost al denison al al van der meer et al', 'viral e induce curvature membrane raamsman al', 'viral recruitment rna packaging virion opstelten al opstelten al', 'viral e protein final pinching virion al', 'coronavirus cell surface large exocytic cell process require cell lysis', 'coronavirus input rna positive gene host cell open reading', '', 'translation theoretical polyprotein translation polyprotein baranov et al dos ramos et al', 'orf infection co post intermediate mature proteinase nascent et al', 'number', 'cysteine proteinase nsp proteinase anand et al tan et al', 'nsp proteinase responsible processing c terminus nsp nsp al bost et denison al denison al lu al tan et al', 'contrast nsps papain proteinase nsp anand et bonilla al bonilla al dong baker harcourt al kanjanahaluethai baker snijder et al tan et al teng al ziebuhr et al', 'group group encode group cov group avian infectious bronchitis virus ibv plp position', 'ibv inactive remnant fig', '', 'regardless number plps present papain proteinase', 'distinct liberation intermediate mature protein coronavirus', 'prior epidemic evolution laboratory virus exposure chemical subsequent analysis', 'elegant work gradual adaptation mhv syrian baby hamster kidney bhk', 'virus murine hamster human primate ability', 'report prescient natural experiment cov transmission', 'unique opportunity study virus unexposed human population', 'study animal human chinese consortium determine course epidemic chinese', 'complete detailed direct statistical analysis adaptation variable course epidemic', 'region synonymous amino acid rate significant positive selective pressure manner early rapid change adaptive', 'polyprotein rate nonsynonymous similar gene early rapid change purifying', '', 'polyprotein contrast little evidence rapid change positive selective pressure', 'addition report replicase significant', 'region nonsynonymous nonconservative', 'fig', '', 'organization viable coronavirus nsps', 'organization confirmed', 'gray discrete nsp', 'nsps cleavage amino acid number', 'catalytic cys asp amino acid number', 'deletion cleavage whole inactivation catalytic site delta amino acid', 'nsp acidic domain papain proteinase x x domain adp ribose phosphatase activity proteinase orthologous mhv znr zinc ribbon plps dub core motif activity domain', 'nonconservative', 'nsv nonconservative', 'impressive nsp nonconservative nsp nonconservative', 'contrast nonconservative', 'support conclusion epidemic transmission substantial', 'subsequent overall analysis important survival adaptation host distinct replication', 'adaptation chinese consortium introduction replication precursor virus different stable animal reservoir chinese', 'strong evidence positive selective pressure adaptation virulence maintenance human', 'analysis prospective study capacity adapt new', 'study adaptation virulence mice', 'mice support replication human cov replication pathogenic mortality young mice yount al', 'urbani strain young virus passage rapid reproducible lethality mouse strain al', 'entire genome virus nonsynonymous', 'nsp nsp fig', '', 'structural orf orf', 'genetic recapitulation replicase virulence cov substitution full virulence virus', 'strong evidence virulence', 'conservative nonsynonymous g val important virulence new host', 'recombinant form severe acute respiratory syndrome coronavirus urbani strain urbani cov report wildtype control cov', 'urbani reference sequence', 'african green monkey kidney grown fbs', 'rabbit polyclonal report', 'include ␣ ␣ ␣ nsp prentice et al', 'acid site mutagenesis fragment', 'mutagenesis table', 'primer wildtype fragment b c', 'form abcd fragment background native nci nco restriction', 'full length mutant detailed graham et al', 'yount et al', '', 'mm tris hcl ph mm nacl doc nonidet sds confirm inactivation darnell al', 'centrifugation × g min pellet nuclei volume mm sds', '• c min use', 'described prentice et al', '', 'adobe photoshop cs', 'table mutagenesis grown confluency mm glass wildtype mutant', 'h p', 'h p medium permeablized • c methanol', 'clean fresh methanol prior removal', 'pbs min pbs bovine serum albumin bsa', 'immunofluorescence assay ifa wash solution pbs bsa nonidet room temperature', 'solution incubated primary dilution h ifa wash solution wash', 'secondary ␣ rabbit alexa goat ␣ guinea pig molecular min', 'wash final wash pbs distilled water', 'aquapolymount confocal immunofluorescence microscopy zeiss laser confocal microscope nm oil immersion lens', 'assembled adobe photoshop', 'comparative analysis selection animal host importance host adaptation virulence', 'work protein replication innate immune response virulence', 'methodical approach requirement nsps replication', 'end numerous amino acid protein dispensable replication modification attenuation', 'orthologous protein amino acid reverse genetic', 'critical efficient replication virulence', 'addition clear order expression level proteolytic processing distinct virulence', 'aa nsps', '', 'region variable', 'group coronavirus related animal similar organization protein group distinction single plp', 'alignment protein cov group significant identity similarity limited identity similarity nsps', 'variability nsp epidemic nsps perform cell host specific replication virulence', 'high capacity new selective', 'result likely dual pathogenesis virus', 'recent cov nsp protein specific interaction virus innate immune response', 'kamitami et al', 'observed cov replication human ifn ␤ mrna accumulation al', 'overexpression nsp inhibition host gene expression degradation host mrna ifn ␤ mrna accumulation alteration phosphorylation dimerization translocation', 'analysis cov sendai virus ifn ␤ mrna accumulation reporter mrna accumulation', 'degradation overall inhibition cellular protein synthesis', 'degradation host mrna immune response ␤ likely virulence factor', 'overexpression nsp lung epithelial cell line production transfected nsp law et al', 'similar cell line specific induction', 'nf expression h post nsp transfection cytokine induction nf b dependent pathway', 'support hypothesis expression nsp presence ikk ␤ inhibitor sodium salicylate', 'contrast cytokine induction expression group group coronavirus', 'expression nsp role unique group regulation chemokine expression', 'recent nsp multiple pathogenesis', 'protein virus replication', 'mutagenesis deletion nsp protein tolerate substitution deletion terminal half protein recovery viable virus modest replication', '', 'lack effect mhv chemokine study limited amino acid identity mhv nsp', 'question host mrna degradation specific gene expression', 'confirmation permissive ace cell crucial reconcile', 'critical test vitro virus infection nsp determine alter replication pathogenesis animal', 'unknown nsp multiple plp activity putative replication complex formation viral rna synthesis processing al', 'recent pathogenesis', 'nsps reverse genetic mutation deletion modification cleavage viral', 'nsps mhv detected mature intermediate et al graham al harcourt et schiller et nsps precursor important replication distinct availability mature nsps', 'requirement processing engineered deletion cleavage nsps', '', 'mhv deletion nsp nsp cleavage site recovery infectious virus − log reduction peak virus titer culture', 'deletion cleavage site recovery virus mature nsps', 'wildtype peak titer initial increase virus titer wildtype virus abolish cleavage nsps', 'nsp nsp nsp nsp cleavage site replication pathogenesis mice', 'nsp', 'entire sequence mhv inframe nsp nsp junction new chimeric nsp nsp cleavage site', 'nsp deletion cov mhv viable able process chimeric nsp nsp cleavage site', 'mutant delayed growth', 'nsp nsp cleavage site nsp nsp cleavage site fact entire nsp protein dispensable replication culture fig', '', 'absolute replication requirement mature nsps mhv', 'complete dispensability nsp', 'ability test complete nsp deletion nsps maturation study role nsp replication pathogenesis animal', 'vitro reverse genetic nsp mhv important possible replication pathogenesis', 'p domain viral rna synthesis', 'al nsp p subdomain vitro possess p activity activity catalytic al', 'mutation recombinant change virus growth synthesis p activity essential replication culture role host', 'plp pathogenesis unique host cell', 'single orthologous mhv', 'nsp nsp nsp nsp nsp nsp recognize cleave sequence clear requirement position', 'l x gg motif similar recognition site cellular deubiquitinating', 'purified activity barretto et al lindner al', 'structure cov core catalytic plp demonstrating structural biochemical recognition core ratia et al', 'mechanism role activity replication efficiency activity plp artificial role modification host cell addition recognition viral', 'cleave plp group bcov group phylogenetic grouping group coronavirus cov plp al', 'regard mhv proteinase inactivation abolished cleavage nsp nsp nsp nsp fig', 'uncleaved nsps precursor', 'impaired recovery passage regain wildtype growth culture reversion cleavage nsps', 'multiple putative adaptive compensate growth denison unpublished', 'introduction complete genome virus culture new n addition leader transcriptional regulatory increased growth fitness', 'nsp multiple structural nonstructural regulatory viral rna', 'likely additional replication pathogenesis', 'similar group many nsps', 'discussed nsp nsp nsp nsp cleavage single plp ortholog activity mhv infection harcourt al', 'v amino acid sequence similar mhv terminal gg amino acid tripeptide aa cov', 'determine rg v sequence plp context infection amino acid v gg cov genome reverse', '', 'single amino acid substitution position mutant allow processing occur', 'recovery infectious virus', 'examination nsps infected immunoblot gg deletion loss processing lack detection mature nsp nsp', '', 'nsps detection protein mobility kda size uncleaved nsp precursor', 'infection evidence alternative processing rg v site mutant', 'mutant infection additional infected nsp antiserum approximate size', 'wildtype mutant mutant nsp antiserum represent nsp wildtype infection infection spite lack processing', 'strategy nsp distinct infection reminiscent mhv jhm infection nsp mature kda nsp gao et schiller et al', 'possible alternative nsp', 'mhv nsps localize replication et al brockway al al', 'mhv localization replication stable course infection nsp localization stable', 'interaction mhv nsp membrane peripheral biochemical late post infection nsp similar nsp hel nucleocapsid n translocate virion et al', 'determine mhv nsps vero wildtype fig', '', 'immunofluorescence infected', 'vero wildtype wt b c', 'mutant fig', '', 'permeablized methanol h p', 'nsp marker replication', 'zeiss lsm confocal microscope adobe photoshop', 'aa', 'viable mhv', 'box region mhv nsp carboxy terminus viable mutant cov aa sequence note nsps cleavage site', 'black location charge alanine viable mhv', 'white circle location mhv alb mutation residue', 'permeablized nsps indirect immunofluorescence assay fig', '', 'h post infection p', 'wildtype nsps bright punctate perinuclear localization similar mhv infection fig', '', 'replicase protein marker replication', 'similar localization h p distinct nsp mhv infection', 'infection mutant similar pattern localization fig', '', 'mutant nsp localization similar wildtype infection altered localization nsp relation replication complex marker nsp fig', '', 'nsp localization punctate pattern match reduction proportionate number yellow image', 'deletion rgv mutant domain proper replication complex interaction formation replication evidenced localization nsps', 'mhv nsp replication complex formation case nsp localization punctate altered', 'nsp protein membrane protein multiple hydrophobic span intracellular fig', 'bonilla et al', 'function nucleate anchor viral replication double membrane gosert al prentice al van der meer et al', 'nsp n terminal protein identity similarity coronavirus nsp protein function important essential viral replication', 'prior establishment coronavirus genetic system analysis nsp level identifica tion cleavage responsible protein polyprotein', 'first amino terminus plp mhv carboxy terminus harcourt al kanjanahaluethai al prentice al', 'polyprotein carboxy terminus intermediate precursor product nsps approximate mass kda kanjanahaluethai et al', 'intermediate important replication pathogenesis', 'second cleavage event nsp mhv protein mass kda apparent mass kda mass kda apparent mass kda kanjanahaluethai al lu al prentice al', 'described nsp evidence substantial adaptation course epidemic rate nonconservative chinese', 'substitution identical nsp fig', '', 'approach nsp mutant multiple plaque growth small plaque size growth wild type plaque size growth unpublished', 'surprising deletion carboxy terminal aa sequence mutant virus deletion detectable growth defect wild type virus', 'nsp carboxy terminal deletion introduction genome', 'infectious virus strong candidate evaluation replication pathogenesis animal', 'nsp dispensable replication dedicated virus replication', 'nsp protein downstream nsp rdrp nsp helicase ntpase rna triphosphatase upstream nsp nidovirus uridylate specific bhardwaj et al ivanov al snijder et al thiel al', 'expression nsps intermediate precursor denison et al', 'likely nsps modification viral cellular rnas', 'biochemical full length nsp possess exonuclease activity dna et al snijder et al', 'coronavirus nsp putative active site assignment invariant acidic active site fig', '', 'alanine substitution active site eliminated exonuclease activity cov nsp vitro', 'alanine substitution active site context full length infectious clone genomic subgenomic viral transfected virus nsp essential virus replication al', 'initial observation original recombinant clone wildtype growth culture measurable ld attenuated mice sperry al', 'unexpected result comprehensive sequencing cdna assemble full length mhv cdna analysis single nucleotide nonconservative amino acid accessory protein unique mhv protein', 'recombinant virus presence substitution', 'wildtype mutant displayed wildtype growth cell culture', 'virus virulent mice absence mutation protein al', 'first demonstration coronavirus mutation impact replication culture virulence animal host study strong evidence role nsp distinct addition function replication', 'reconsideration domain organization possible replication pathogenesis', 'exoribonuclease amino terminal half mhv nsp protein nsp aa', 'contrast residue carboxy terminal half protein role exon activity function significant homology', 'address role nsp mhv replication variety deletion proteinase cleavage terminus substitution catalytic substitution amino deletion fig', 'eckerle al sequence virus viability growth cell culture', 'nsp nsp nsp nsp cleavage site mutant growth nsp nsp cleavage site mutant', 'nsp substitution equivalent wildtype growth culture', 'substitution conserved residue viable virus effect replication virulence animal', 'current previous important role virus replication pathogenesis', 'natural activity viral cellular rnas', 'carboxy terminal half nsp modulate exon activity', 'replication', 'protein unique role subgenomic rna synthesis', 'exon activity coronavirus replication virulence', 'mechanism attenuation substitution mhv nsp', 'answer essential biochemical additional nsp virus replication viral rna synthesis virulence', 'express process predicted mature addition intermediate additional', 'scope review detail putative biology mutagenesis', 'relation viral pathogenesis important basis pathogenesis', 'first nsp chou egloff et al joseph al lee al ratia al ricagno al saikatendu al su sutton al tan et al zhai al', 'remarkable multimeric protein important polyprotein', 'example hexameric structure nsp xu al interact dodecameric structure nsp joseph al su et al', 'second recent careful analysis temperature sensitive mhv new rich reverse genetic replication pathogenesis', 'sawicki al', 'large panel available temperature sensitive ts different conditional lethality several labs basis complementation', 'report single point nonsynonymous', 'overall nsp distinct nsps form single complementation group conclusion line processing location sequence', 'valuable', 'ts amino acid identical eighth asn mhv nsp asp nsp', 'conditional growth possible synthesis possible reproduce amino acid multiple nucleotide amino acid substitution', 'approach selection phenotypic protein new replication pathogenesis', 'addition allow cov determine ts phenotype possibility panel conditional growth', 'evolution replication pathogenesis many important role pathogenic pathway', 'replicase important host range pathogenic', 'host specific replication virulence', '', 'viable altered replication virulence animal', '', 'replicase host gene expression alter immune response', '', 'nsp alter interferon cytokine', '', 'replicase host gene expression immune response host specific', '', 'avirulent cov replicase protective immunity wildtype infection', 'understanding interplay replication pathogenesis host']"
e4d752fd72eb7b1089e4b820598b1f69f50bc636,delay distribution time series benchmark approach week week reporting delay real time infectious disease log score average score nobbs benchmark public health reuse permission total number true number vs benchmark author funder biorxiv preprint copyright holder dengue ili disease surveillance doi biorxiv full time holder preprint number week peer author pi coverage predictive distribution preprint peer absolute error bayesian approach benchmark model delay probability dengue time historical information ili united illness ili mean square nobbs approach nowcast performance probability reporting r package root mean square error approach accurate approach full average log case reporting change rmseδ change week delay window dengue high disease activity disease transmission distribution time e g function time ili benchmark ili dengue logarithmic score maeδ rmse mean absolute place informative puerto rico random walk rmse change score prediction surveillance system time delay time evolution true case week fig weekly dengue accuracy change accuracy log accuracy point accurate real actuarial literature amount historical approach bayesian approach log approach nobbs approach prediction autocorrelation dengue autocorrelation week available real available window benchmark average benchmark rrmse bin number black line blue line brown line c approach case common case delay case incomplete case nobbs case related certainty outcome chain ladder,"['case common disease surveillance difficult track real time', 'nowcast attempt estimate complete case date time series case incomplete due reporting', 'reporting delay distribution common feature nowcast', 'many nowcast crucial feature infectious disease transmission future single application generalizability', 'present bayesian approach bayesian capable smooth accurate multiple disease', 'test nobbs dengue puerto illness ili united performance robustness range common reporting delay stable compare approach nowcasting package', 'show temporal relationship performance reporting delay distribution time identify trade role', 'present software new approach r package nobbs widespread application', 'accurate real time activity case reporting', 'estimate reporting temporal relationship identify robust wide range surveillance contexts different reporting', 'present smooth bayesian approach accurate time evolution epidemic curve outperform previous approach literature', 'assess performance important delay distribution contribute model performance robustness surveillance', '', 'reuse permission', 'effective public health action surveillance accurate', 'surveillance information assess allocate public health discontinue interrupt transmission monitor impact', 'disease surveillance outbreaks true', 'importance timely surveillance substantial collect report case information real time', 'multiple surveillance system contribute reporting infection medical care onset diagnostic information level awareness disease activity care reporting system level processing complex multi disease reporting communication multiple administrative', 'reporting resource', 'consequence surveillance complete incomplete picture current disease activity', 'present approach mitigate impact reporting', 'insurance actuarial literature nowcast estimate number', 'insurance time incomplete set', 'public health consequence long incubation period hiv infection development', 'infectious disease foodborne illness', 'survival analysis actuarial delay draw historical', 'majority reporting delay distribution legacy actuarial rise many key feature future reported fact strong autocorrelation true number short time', 'infectious disease transmission process additional signal number future common reverse time hazard model chain ladder method', 'approach state space temporal existed literature development infectious disease context', 'disease surveillance critical demonstrate performance diversity infectious disease nowcast date specific common many different', 'investigation proportion week low reporting variable', 'result broadlyapplicable difficult', 'several previous point number', 'point uncertainty important context infectious disease uncertainty intrinsic accounting plausible prediction critical', 'introduce bayesian nobbs simple flexible bayesian model infectious different', 'demonstrate robustness approach different disease surveillance contexts application distribution time', 'nobbs uncertainty delay distribution time evolution epidemic curve smooth time', 'demonstrate nobbs weekly rico illness ili united disease specific parameterization different vector borne vs different reporting', 'previous bayesian nowcast method nobbs benchmark multiple time', 'particular show point similar time report fixed time nobbs uncertainty temporal variation delay', 'present r package nobbs tool complement routine public health surveillance', 'developed bayesian approach total case incomplete case delay distribution intrinsic autocorrelation transmission process historical case', 'approach historical information multiple g', 'delay delay delay etc', 'week case estimate reporting delay probability delay relationship case week week relationship predict number present', 'approach nobbs different infectious disease surveillance surveillance puerto national illness ili united', 'available case reporting point prediction weekly dengue time period november weekly ili period', 'comparison weekly bayesian approach benchmark approach', 'leverage large amount historical data fit nowcast model large window assess window dengue window ili', 'primary outcome metric assess nowcast performance logarithmic score proper score probability outcome error point prediction', 'discussion exponentiated form mean logarithmic score geometric mean metric scale certainty outcome complete certainty outcome', 'addition performance point absolute error mae root mean square error rmse relative root mean square error rrmse prediction interval pi coverage focus rrmse pi coverage', '', 'show weekly dengue ili benchmark approach multiple', 'table probability accuracy average mae rmse rrmse distance pi coverage', 'nobbs model autocorrelated progression transmission successive week', 'benchmark model initial case common dengue puerto rico hence', 'discontinuous', 'compare report accuracy nobbs benchmark approach full time series case first week e', 'subset', 'error model full time series point', 'accuracy log score prediction error c approach log prediction', 'number week blue line available real time week help estimate total number red line prediction', 'true number black line nowcast target', 'historical information reporting available window grey make', 'log brown line difference true mean number line function time', '', 'reuse permission', 'copyright holder preprint peer author funder', '', 'doi biorxiv preprint accuracy log score prediction error c approach log prediction', 'number week blue line available real time week help estimate total number red line prediction', 'benchmark approach prediction difficult see', 'true number black line nowcast target', 'historical information reporting available window grey make', 'log brown line difference true mean number line function time', '', 'reuse permission', 'copyright holder preprint peer author funder', '', 'doi biorxiv preprint table', 'performance approach disease', 'benchmark approach dengue time series table', 'subset smooth accurate dengue time series rrmse average low week onset fig', 'b', 'pi coverage pi true number', 'comparison benchmark approach accurate point uncertainty average score pi coverage fluctuation week week fig', '', 'many low incidence prediction benchmark approach full time series subset model nobbs benchmark model accuracy table', 'nowcast point ili time series point error approach nobbs rrmse vs benchmark rrmse table', 'nobbs approach prediction', 'log nobbs average score vs benchmark average score coverage prediction coverage benchmark table', 'degree autocorrelation smoothness nobbs lagged autocorrelation lagged autocorrelation', 'addition accuracy change week week absolute error change maeδ rmse change rmseδ table', 'magnitude change ili dengue absolute value change week versus week high autocorrelation ρc dengue ρc ili', 'full time series high autocorrelation dengue ili benchmark approach autocorrelation dengue dengue ili', 'dengue case nobbs approach mean absolute difference observed maeδ vs benchmark maeδ rmse change rmseδ vs benchmark rmseδ', 'addition nobbs benchmark approach full time series dengue table', 'ili weekly change similar table', 'delay different', '', 'case dengue surveillance system collection laboratory week average', 'contrast u outpatient influenza illness ili surveillance network ilinet syndromic ili average week present e', 'delay', 'overall accuracy nowcast point ili dengue high proportion delay', 'large weekly absolute number initial case related increased error dengue high number initial time table fig', '', 'note difference predictive distribution bin number influenza vs dengue average comparable', 'dengue ili exhibit time', 'dengue observe time probability reporting extreme initial ili constant tighter week week fig', '', 'independent initial proportion high vs low constant vs time impactful performance nowcast constant reporting ili accuracy', 'test robustness model ili final true imposing time delay distribution initial reporting high incidence', 'robust fig', 'table', 'context stable reporting original ili benchmark model fig', 'table', 'presence simulated time reporting benchmark confidence nobbs average score vs benchmark average ≈ point rrmse vs benchmark rrmse accuracy change table', 'many', 'performance ili accuracy consistent year year year performance dengue table', 'average high low number dengue g', '', 'model effective low incidence high outcome bin number low fig', '', 'hand high dengue activity correct bin uncertainty', 'overall nobbs benchmark approach performance year table', 'nobbs benchmark performance', 'poor point estimate rrmse predictive distribution true value interest consequence dramatic', 'windows time series time series leverage large number historical training nowcast', 'stable estimation recent delay distribution information old relevant', 'size window smoothly model sensitive abrupt e g', 'outbreak shorter interval secular', 'seasonality', 'availability choice window size nowcast performance', 'light different lengths assess impact nowcast performance dengue', '', '', 'window accuracy several steep case', '', 'accuracy windows similar full week window range rrmse average score table fig', '', 'shorter accurate delay probability fig', 'variance random walk process week week fig', 'dramatic certain extreme time trade delay estimation accuracy stable weekly', 'new approach bayesian demonstrate application disease contexts different method estimate probabilistic logarithmic predictive performance', 'particular nobbs case change time', 'demonstrate important trade window distribution short real time characterization delay distribution susceptible variability nowcast accuracy', 'disease specific parameterization historical case input approach variety disease', 'benchmark approach accuracy uncertainty comparable point', '', 'reuse permission', 'copyright holder preprint peer author funder', '', 'doi biorxiv preprint case point accurate benchmark model dengue accurate ili', 'analysis probability much substantial difference average nobbs high dengue high ili table', 'approach probability actual outcome point accuracy ili', 'similar modeling structure case reporting model nobbs simple dependency case time case related first order random walk process logarithmic scale', 'feature critical context infectious disease transmission number true week part number true previous due infectious process pathogen', 'hence autoregressive common disease forecasting', 'time case nobbs approach accurate performance stable delay distribution improvement benchmark approach likely nobbs approach number previous distribution robust', 'accuracy part number surveillance system week', 'proportion delay case ili dengue point estimate accuracy', 'large fraction true predict', 'volatility initial number low', 'dengue time series highlight august august', 'number previous week week average absolute change', 'increase distribution reporting particular delay model true number week', 'shorter issue e g', 'similar overestimate e g', 'fig', 'consequence volatility variance random process accurate estimation reporting delay probability fig', '', 'relationship fit nobbs model effect week week variability reporting', 'mind trade apply', 'nobbs time delay distribution case estimation e', 'history anchor case recent temporal probability case delay window', 'shorter estimation delay presence distribution additional robustness presence systemic', 'example smooth estimate time delay distribution p spline smoothing', 'time specific change empirical identification change point real time impossible context nowcasting', 'challenge described ability model pick distribution smoothed', 'real time disease public health complement disease forecast accurate real time reporting', 'example control prevention epidemic prediction initiative g', 'flusight use initial surveillance upto date available', 'help account later prospective', 'present r package provide easy flexible implementation approach wide audience public health', 'package installable cran final form', 'rico ili united period', 'time weekly dengue laboratory puerto rico puerto rico department health control prevention', 'analysis time clinician time laboratory report completion', 'ili u outpatient influenza illness surveillance network ilinet information outpatient healthcare united report number', 'analysis week care week online fluview delphi epidemiological api', 'ili', 'x dimensional reporting triangle recent week maximum reporting delay', 'week', 'example week delay observable', 'future', 'table present example reporting triangle ili', 'week goal produce total number incomplete set nt', 'nt delay unknown time point future nt sum nt', 'approach marginal cell triangle nt adaptation loglinear chain ladder method actuarial literature', 'nt number week delay poisson process', 'extra poisson variation variance mean negative binomial process poisson special case appropriate', 'case influenza', 'model mean simple log linear equation true epidemiologic signal week probability reporting delay', 'random week reporting delay equation', 'place prior', 'probability vector … place dirichlet prior length maximum delay maximum observable delay time series value represent long delay', 'latter case probability delay ≥ dengue choose fix sample', 'influenza possible delay window', 'maximum delay window w nowcast equal equal w w see table', 'place informative small number hypothetical total delay probability reporting dengue first', 'sensitivity weak equal probability material difference table', 'allow dependency successive capture time evolution autocorrelation week week epidemic', 'model first order random natural log form geometric random walk', 'place informative normal distribution', 'negative binomial stopping time parameter r place informative prior reflect belief process poisson', 'posterior', 'trace convergence', 'weekly th week influenza th week final week series', 'resulted weekly sample weekly sample', 'time series key posterior fig', '', 'year window estimate stable delay distribution window', 'sensitivity gauge minimum amount historical information produce accurate', 'benchmark comparison nowcast function r package surveillance höhle ref', 'bayesian hierarchical model nt ≤ nt conditional total number', 'function time homogenous delay distribution parameterization comparability window time', 'mean absolute error mae root mean square error rmse relative root mean square error rrmse accuracy point true case different week', 'accuracy point change week week mean absolute error change maeδ rmse change rmseδ', 'reuse permission', 'copyright holder preprint peer author funder', '', 'doi biorxiv preprint ∆ √ − ∑ − − − capture smoothness week week autocorrelation week week', 'x true week', 'logarithmic scoring rule accuracy posterior predictive distribution nowcast', 'predictive series possible true case', 'bin widths number case', 'dengue ili', 'predictive distribution probability pi logarithmic score ln pi', 'example week january', 'nowcast week probability bin log score', 'low log score predictive distribution true case value probability ≤ e', 'rule limit score inaccurate', 'average log score prediction nowcast performance', 'average log score interpreted average probability true number metric model comparison several forecast contexts', 'paper present average log score refer average score', 'simulate ili time probability reporting delay week total number observed mean ili series total observed case count equal', 'probability calculate number total number week', '', 'rough approximation hypothetical scenario probability disease activity', '', 'reuse permission', 'copyright holder preprint peer author funder', '', 'doi biorxiv preprint']"
50594e77d3f89b03a428dcefb8fb08f3179eca30,gi gii gii novs sialic acid acid ligand stool shellfish gi novs glycan ligand le guyader mixture gi novs bind virus food atmar le bioaccumulation efficiency bioaccumulation gii blood group cause responsible field study food contamination food important foodborne illness frequency gi gi shellfish gii sialic gii stool gii viral giii nov glycan binding guyader atmar high proportion high risk impact bioaccumulation important role infection shellfish le pendu ligand expression ligand present mantle sialic nov gi nov strain novs gi oyster consumption oyster tissue proportion gi seasonal impact shellfish consumption shellfish le shellfish outbreak transmission shellfish viral rna accordance strain accumulation efficiency accumulation retention accumulation survival acid sequence act ionic acute gastroenteritis addition cocktail addition introduction additional evidence agal virus age wide agent due aichi virus alert system analysis polymerase analysis shellfish anti blood antigen concentration antigen contribute antigen digestive approach nov area large area percentage ariakensis c ariakensis time associated high association infection association multiple association shellfish atmar pendu attachment factor attachment virus awareness illness b morocco b norwalk b variant bacterial depuration belong family bias role bias shellfish bias tendency bind histo bind midgut binding oyster binding site binding specificity binding sufficient bioaccumulate viral bioaccumulation antigen bioaccumulation ariakensis,"['françoise le guyader robert l atmar pendu shellfish human regulation enteric implicated viral', 'shellfish common vector contamination outbreaks responsible acute gastroenteritis', 'analysis shellfish outbreak worldwide show unexpected high proportion gi', 'recent vitro vivo environment passive norovirus viral carbohydrate', 'gi bias shellfish', 'first clear food important role virus transmission', 'cdc causative agent due food consumption identifiable etiologic agent', 'novs common cause responsible salmonella second cause responsible', 'recent foodborne illness major united responsible', 'novs foodborne transmission viral table', 'viral zoonotic transmission e g', 'hepatitis e primary food contamination food production process contact food sewage', 'several transmission process contamination attachment virus food survival persistence virus food manner food preparation raw peeled susceptibility person food virus', 'food important role', 'example lettuce quantity viable hepatitis virus period time', 'recognition foodborne illness public sensitivity awareness illness bias tendency report illness', 'outbreak period european food alert system food feed rasff due novs', 'recent hav', 'nov foodborne', 'bias role predominance associated high risk association shellfish viral gastroenteritis', 'belong family group icosahedral single positive sense genome', '', 'iv contain human', 'genogroup acid sequence major capsid protein', 'analysis polymerase gene', 'new', 'nov infection gastroenteritis diarrhea', 'prevalence short incubation period short clinical illness probable gastroenteritis', 'infectious low', 'novs bind histo blood group complex present many different cell attachment factor necessary initiate infection', 'major cause epidemic nonbacterial gastroenteritis worldwide cause', 'age wide variety large dominance gii clinical', 'past nov sequence world show human', 'shellfish high risk food viral clear strain identification shellfish difficult', 'first sequence nov strain outbreak', 'strain identical', 'time japan mixture gi gii stool oyster', 'detection development harmonization molecular typing compilation outbreak comparable table', 'characteristic shellfish frequent association multiple virus infected shellfish', 'number different virus association infection shellfish consumption difficult', 'essential many stool possible affected', 'important outbreak order trace oyster production outbreak', 'collected epidemiological role shellfish outbreak', 'specific nov genogroup detection real time rt pcr', 'challenge shellfish low viral several different', 'addition cocktail various nov diversity', 'shellfish nov disease oyster consumption shellfish raw cooked', 'overall contamination multiple nov gi gii novs stool shellfish', 'frequency genogroup shellfish distinct', 'gi shellfish genotype dominant figure', 'gi genotype figure', 'gii stool shellfish', 'gii b variant patient stool shellfish', 'frequent involvement human human outbreaks possibility source infection shellfish', 'transmission shellfish le guyader atmar le pendu report individual', 'stool shellfish description outbreak uk', 'japan gi related oyster consumption mixture gi gii novs', 'study strain', 'previous study presence mixture gi gii novs', 'contrast shellfish consumption due gii novs gi gii', 'shellfish presence novs several', 'variable contamination', 'frequency gi nov contamination community table', 'shellfish', 'numerous viral contamination shellfish depuration bacterial', 'example study decrease virus reduction bacterial depuration', 'study depuration calicivirus', 'third study contaminating event french production area percentage positive gi gii novs', 'prevalence persistence oyster gii', 'hypothesis novs oyster bioaccumulation increase persistence shellfish', 'immunohistochemistry nov gigas oyster specific variation binding', 'novs bind midgut digestive diverticula mantle whereas novs bind', 'human saliva type b norwalk accordance strain hbga binding specificity', 'addition introduction mutation virus glycan binding site glycan binding sufficient eliminate binding oyster specificity binding', 'lectin anti blood group nov crassostrea antigen', 'antigen digestive', 'gii mantle sialic residue', 'influence ligand expression oyster vlps', 'c gigas low level exposure mutant vlp unable recognize antigen concentration', 'stool table frequency gi gii shellfish contamination non different', 'individual individual shellfish study individual', 'b morocco peru south korea', 'dose dependant manner', 'different year clear seasonal impact bioaccumulation efficiency expression hbga digestive tissue', 'quantitative approach nov digestive negligible concentration', 'bioaccumulation gii positive stool positive strain different', 'digestive similar pattern', 'low number', 'contrast strain transient retention likely due sialic acid', 'contrast seasonal impact bioaccumulation gii sialic acid ligand present', 'interpretation ligand present gut', 'gii sialic acid ligand destruction elimination mechanism', 'latter process case strain', 'shellfish bioaccumulation ariakensis c virginica', 'strain c ariakensis time', 'compare glycan ligand expression', 'many environmental filter capacity contamination field study determine laboratory environment', 'gii novs year digestive', 'novs gi', 'gi novs degree gii viral rna water bioaccumulate viral rna copy g oyster tissue gii viral water viral copy gram oyster tissue', 'additional evidence specific selection persistence gi novs', 'field study area large amount', 'bovine novs giii water high shellfish sample giii nov strain', 'agal virus specific glycan ligand bovine poor bioaccumulation efficiency giii nov', 'selective transmission nov specific carbohydrate', 'bioaccumulation antigen contribute elimination virus sialic acid ligand nov accumulation survival', 'long time act ionic', 'case novs nov concentrated gii', 'differential accumulation efficiency possible explanation high proportion gi shellfish', 'new concept special relationship transmission shellfish le guyader atmar le pendu influence oyster selection transmission', 'environment large novs much gi red due predominance nov gii human', 'nov giii green', 'present ingested', 'gi novs gut mantle sialic acid ligand', 'giii novs', 'nov gi gii gut hbga ligand gii giii gut', 'consumption oyster infection gi gii similar frequency selective accumulation retention viral', 'giii transmission unlikely happen express glycan ligand', 'enteric aichi virus nov virus', 'food trade dispersal virus strain virus imported shellfish responsible table', 'virus food contamination increase viral elimination consumer safety']"
1303fb3e8121ed8410ee45de884a4609e776fe05,pr china syndrome virus ability k activity ability activity vitro adult mice aleyas h almeida h amino glycoprotein anaemia virus analysis yellow anatid replication angelopoulou g antagonist protein anti inflammatory antigenic analysis antiretroviral drug apoptosis mouse arce h artiodactyl papillomavirus ashrafi l aspehaug e attachment glycoprotein b collet b drug b marchetti b mondal b nautiyal b ozanne b sahay babič zelnikar belgium prevalence bendfeldt j biotype bvdv bonilla villegas boonsaeng p bovine mouse bovine respiratory brain c branch point brazilian bovine brellou greenland bro domain browdy usa bvdv babič bvdv type c gonzález c guan c l c poiesi c prior campo uk capra hircus casal martín cell culture characterization capra characterization spodoptera china characterization china phloem close root collet r culture system cymerys winnicka cytoskeleton motility darwich j deletion ltr dengue type dispensable replication dna env dna virus domain k drug naïve drug resistance duraffour v díaz l e j e sreekumar e tsirimonaki env v esteban spain evolution spanish fas fasl fasl virus ferreira j france novel g aleyas g brellou g h g warr garcia c garzón rodríguez genetic characterization germany lymphocytopathogenic germany switzerland glycoprotein responsible glycoprotein tajima gong k gonzález bonilla greece france greek small,"['cymerys winnicka niemialtowski poland involvement fas fasl virus apoptosis mouse brain c guan x zhou pr china phloem specific promoter satellite dna virus e tsirimonaki r ullah b marchetti g h', 'ashrafi l mcgarry b ozanne', 'campo uk type cytoskeleton motility invasiveness bovine mouse ito n ito k yamada sugiyama n minamoto japan multiple amino glycoprotein responsible pathogenicity adult mice j', 'mcbeath b collet r duraffour v aspehaug e j', 'uk norway identification interferon antagonist protein segment infectious salmon anaemia virus z li l pan yu l li gong k yang pang pr china characterization spodoptera litura multicapsid nucleopolyhedrovirus protein bro domain k', 'mallanna j rasool b sahay g aleyas h ram b mondal b nautiyal premraj e sreekumar p', 'india inhibition anatid replication small rnas cell culture system short mateu díaz l darwich j casal martín j evolution spanish porcine reproductive respiratory syndrome virus quadt k', 'günther voß schelhaas knebel mörsdorf germany switzerland j r rodríguez garzón rodríguez esteban spain uk recombinant mva immune potentiation immune dna env v boonsaeng p j', 'walker thailand structural antigenic analysis yellow head virus nucleocapsid protein r', 'spilki r', 'almeida h g', '', 'arce h l', 'ferreira j b', 'costa', 'phylogenetic brazilian bovine respiratory syncytial virus molecular homology attachment glycoprotein tajima nukui ito takasaki kurane japan nineteen variable region region dispensable replication dengue type virus vitro rosa salazar martínez garcia c gonzález bonilla villegas sepúlveda méxico intron hpv suboptimal branch point guanosine j robalino payne p parnell shepard c prior j witteveldt j', 'vlak p', 'gross g warr c l', 'browdy usa inactivation white spot syndrome virus wssv normal rabbit serum role protein wssv infection shrimp j f', 'ridpath bendfeldt j', 'germany lymphocytopathogenic activity vitro high virulence vivo bvdv type third biotype bvdv babič zelnikar k seme vandamme j snoeck j tomažič l vidmar p karner poljak slovenia belgium prevalence antiretroviral drug resistance b drug naïve genetic characterization capra hircus papillomavirus novel close root artiodactyl papillomavirus', 'c poiesi ricotta n manca italy hiv anti inflammatory activity ability k angelopoulou g brellou greenland greece france novel deletion ltr region greek small ruminant lentivirus low pathogenicity']"
ffc9bc4ac6548cb1c03c2c6f088ab1c1c2067c6f,copyright holder holder preprint preprint peer et al author funder available copyright biorxiv preprint cc nc doi biorxiv hepatitis c international license license author nc nd nd international viral polymerase analogue viral drug epclusa genome replication ju al viral genome active triphosphate al guo anti viral approach development broad spectrum c virus coronavirus use design viral development sofosbuvir example synthetic guo et inhibit rna insight hepatitis mechanism drug novel strategy polymerase inhibitor polymerase protide prodrug approach protide prodrug replication mechanism rna polymerase similar viral sofosbuvir use sofosbuvir velpatasvir strategy design treatment hepatitis triphosphate form use similar viral free virus coronavirus activation triphosphate active site active various additional information afford nucleoside afford treatment al ju al nat alanazi et allow incorporation allyl propargyl amino group analogue biocryst analogue fig analogues function application work azidomethyl ju background information biocryst galidesivir blocked phosphate c responsible cell side chain extension chain terminator china regional chlorophosphoramidate reagent columbia university contrast analogue contrast sofosbuvir coronavirus replication coronavirus rna cyano group dependent rna deprotection free derivatization afford describe novel development resistance drug active drug discovery due low due position ebola marburg ebola virus encourage incorporation entry infected entry nucleoside epclusa inhibit epclusa sofosbuvir epclusa treatment ethyl propyl,"['virus wuhan china regional global public health', 'molecular insight hepatitis virus coronavirus use similar viral genome replication mechanism drug epclusa sofosbuvir velpatasvir treatment hepatitis c', 'broad spectrum anti viral novel strategy design viral polymerase protide prodrug approach development sofosbuvir use nucleotide polymerase', 'virus host treatment coronavirus replication cycle', 'zumla al nat rev drug discovery', 'cc nc nd international license author funder', 'available copyright holder preprint peer', '', '', 'important druggable', 'example gilead sofosbuvir velpatasvir drug epclusa inhibit rna dependent rna polymerase hepatitis c virus', 'sofosbuvir pyrimidine analogue fig', 'blocked phosphate group eukaryotic active triphosphate form cellular', '', 'drug active site rdrp due position chain extension replication', 'polymerase inhibitor natural', 'insight hepatitis c virus coronavirus use similar viral genome replication mechanism drug epclusa treatment hepatitis c responsible', 'many rna polymerase inhibitor', 'related purine prodrug remdesivir fig', 'gilead treat ebola virus treat outbreak', 'contrast sofosbuvir unmodified cyano group position', 'cc nc nd international license author funder', 'available copyright holder preprint peer', 'doi biorxiv preprint inhibit rdrp active triphosphate form', 'additional information prodrug technology alanazi et al', 'related prodrug analogue biocryst galidesivir fig', 'inhibit rna broad spectrum rna ebola marburg virus al', 'entry nucleoside triphosphate chain terminator', 'background information describe novel strategy design viral polymerase protide prodrug approach development sofosbuvir use analogues function reversible ju al ju al guo et al', 'phosphate entry infected group free position encourage incorporation triphosphate analogue viral host cell side extension virtue group viral replication', 'nucleotide potent polymerase active various viral limited', 'cc nc nd international license author funder', 'available copyright holder preprint peer', 'doi biorxiv preprint', 'viral genome replication', 'contrast analogue viral free group possibility polymerase extension viral', 'reason high analogue viral free oh potential host', 'rna high frequency due low fidelity viral polymerase development resistance treatment', 'promiscuous nature viral polymerase allow incorporation anti viral', 'fig', '', 'fig', 'activation triphosphate fig', 'inhibit coronavirus rna virus', 'copyright holder preprint peer', 'doi biorxiv preprint copyright holder preprint peer', '', 'synthesis phosphoramidate et al', 'exocyclic amino group base', 'variety methyl ethyl propyl allyl propargyl methoxymethyl methylthiomethyl azidomethyl ju al guo et al', 'deprotection free afford treatment prepared chlorophosphoramidate reagent presence n methyl imidazole sofia et al', 'fig', 'fig', 'show example synthetic', 'derivatization afford nucleoside phosphoramidate', 'fig', 'example synthetic route phosphoramidate', '', 'research columbia university patent application work', '', 'cc nc nd international license author funder', 'available copyright holder preprint peer', 'doi biorxiv preprint']"
6bde3798df501fc40dd89e2cff0a1a8fd2b9dd47,gene expression et al disease pathogenesis functional genomic host pathogen microarray analysis al al infectious disease innate immunity wide variety application microarray band al bovine microarray bovine rotavirus commensal microflora differential gene expression specific mucosal immune p change specific cell bovine cdna bovine genome control sample host gene host infectious immune system intestinal loop microarray detection microarray technology mucosal epithelial present review respiratory disease adaptive immune al bauersachs al derisi al hernandez al mermillod al schena al weiss analysis gene annotation available bauersachs al bovine gene bovine respiratory characterization disease complete bovine coronavirus infection cpg odn custom bovine disease resistance effective approach environmental host epithelial cell epithelium immune experimental manipulation expression al expression bovine expression level gene activation gene prediction genome sequence genomic host high quality high throughput host enteric identification potential immunity critical impact gene induction innate infection fig infection presence ingesta commensal innate immune ishiwata et level individual loop model macpherson uhr microarray host microarray total molecular characterization mucosal epithelium odn stimulation post infection powerful tool prior infection relative time research clinical respiratory infection right panel role host rotavirus infection significant impact small intestine specific pathogen substantial promise sudre et unique pathogen viral bacterial viral infection vitro vivo,"['molecular analysis disease pathogenesis lack availability host pathogen', 'advent rapid characterization global gene expression level individual', 'present review microarray functional infectious disease', 'discuss number unique vitro vivo model host specific pathogen', 'comparative functional genomic used address host common variety unique individual', 'immune', 'microarray host pathogen substantial promise generation future address wide variety', 'critical component comparative quality complete functional annotation bovine genome', 'indication future validation molecular characterization disease pathogenesis', 'important wide variety acute chronic animal production veterinary immunology immunopathology welfare', 'many infectious investigate host pathogen', 'many disease substantial relevance human paucity research molecular characterization disease pathogenesis host hein griebel', 'variety molecular biological substantial promise scope infectious disease research basis effective disease pathogenesis', 'present review application microarray technology investigation disease pathogenesis', 'future microbial critical evolutionary balance host pathogen', 'variety last large scale gene expression level individual whole', 'used present time oligonucleotide et al southern maskos cdna al serial analysis gene expression al', 'microarray technology numerous critical experimental design yang al application microarray technology investigate normal physiology lockhart disease pathogenesis steinman', 'wide variety microbial application technology functional genomic', 'variety commercial available specific cell biological routine address basic research clinical', 'substantial delay application microarray investigation biological veterinary importance', 'small number bovine microarray last', 'variety gene expression wide variety pbmc burton et al hernandez al al al al tao et al pmn madsen al spleen band al brain band al placenta band al reproductive et al mermillod bauersachs et al bauersachs al ishiwata et sirard et al et mammary gland suchyta al herath et al muscle reverter al sudre et al', 'microarray gene expression address variety normal physiological differentiation pregnancy lactation parturition', 'majority custom bovine cdna number practicality cross human micro et al mermillod sudre et al hernandez et al', 'cross hybridization potential approach circumvent number associated custom bovine cdna small et al much limited annotation ishiwata et reverter et al bauersachs al weiss et al', 'substantial need high density bovine cdna functional genomic', 'present review focus use hostpathogen', 'microarray focus bovine infectious et al al weiss et al', 'band al', 'gene bovine microarray total available', 'annotation available microarray probelynx utility microarray presence unannotated selection range cell function selection immune', 'disease pathogenesis complex interaction host pathogen environmental host pathogen', 'potential environmental host major concern scientific experimental control variable', 'sensitive methodology microarray critical control experimental manipulation', 'isolated whole animal', 'cell unique opportunity correlate gene expression specific cell cell minimize impact gene expression', 'example h prior experiment equilibrate gene expression al', 'understand isolation bovine primary monoclonal magnetic cell macs', 'isolation methodology rapid isolation purified function viability miltenyi biotech minimacs midimacs', 'target molecule transmembrane domain mab initiate cell', 'contrast molecule integral membrane protein bovine monocyte isolation', 'rna macs purified isolation time culture medium aim v fbs h microarray analysis biological technical culture interval relative time', 'bovine extensive gene activation h culture gene expression time table', 'gene activation number level h macs isolation significant impact monocyte gene expression effect surface molecule cell selection', 'comparison table lap gene expression', 'observation time cell specific experiment', 'surgical preparation multiple sterile intestinal model analysis mucosal immune et al differential gene expression bovine rotavirus infection al', 'inflammation surgical creation intestinal significant impact gene expression', 'removal loop preparation host gene transcription', 'evidence mucosal immune rna culture h b bovine microarray relative time c macs blood male', 'system mucosal epithelial response presence commensal microflora al macpherson uhr inflammation disease gastrointestinal tract macpherson uhr miniello et al', 'intestinal loop model functional genomic host enteric investigated surgical manipulation elimination commensal microflora', 'isolated intestinal loop tissue sample adjacent intact intestine control n', 'animal change expression post surgery aich et al', 'differential gene expression variety cell apoptosis cell cycle cell differentiation', 'absence inflammation cell recruitment low abundance relevant immune microarray host gene expression small intestine', 'similar experiment young n time intestinal flushed saline àmicroflora intact microflora h', 'microarray tissue expression p change antibiotic treatment eliminate', 'experimental manipulation host gene expression importance animal', 'importance commensal normal development function mucosal epithelium immune system', 'address question host enteric viral infection presence absence commensal', 'intestinal prepared young n bovine coronavirus', 'microarray removal ingesta commensal microflora impact host post infection fig', '', 'common experimental stringent analysis p number', 'small intestine coronavirus infection presence ingesta commensal microflora', 'substantial evidence significant interaction intestinal microflora mucosal epithelium immune system', 'surgical functional genomic host pathogen', 'bovine mucosal pathology protection unknown', 'potential provide significant insight induction differentiation mucosal immune', 'identification host unique pathogen', 'strategy host immune intestinal loop model', 'model system minimize due genetic variability outbred population uninfected infected intestinal animal', 'fig', 'differential expression lenient stringency p change unique pathogen', 'preliminary validation quantitative real time pcr table indicate pcr concur microarray validation efficiency constant stringency significance microarray analysis', 'reduced stringency initial microarray analysis approach identification potential gene biological investigation', 'relation microarray biology rna', 'example rotavirus coronavirus infection substantial destruction mucosal epithelial', 'addition immune cell change response infection', 'apparent gene expression altered abundance mucosal epithelial cellular composition mucosal immune system', 'approach gene expression complex parallel differential gene expression specific cell population model', 'approach primary bovine intestinal epithelial cell line assess bovine rotavirus infection', 'primary jejunal epithelial cell bovine rotavirus rna h post infection', 'microarray total p change epithelial viral infection fig', 'vitro', 'common bovine rotavirus intestinal', 'vivo', 'important vitro model independent confirmation vivo evidence link expression specific epithelial', 'combination vitro vivo powerful functional genomic associate gene expression specific cell', 'comparative analysis gene expression enteric strategy identification mucosal broad relevance disease protection', 'innate immune pivotal role host pathogen', 'diverse number viral bacterial bovine respiratory disease', 'epidemiology bovine respiratory disease north america environmental nutritional husbandry incidence respiratory disease time', 'stress significant factor compromise host increase disease susceptibility', 'date difficult stress adaptation period eliminate stress host infectious disease', 'microarray able global view physiological stress', 'interplay stress disease resistance microarray profile gene expression peripheral blood mononuclear', 'single pen group prior bovine infection second group grain viral challenge pre', 'rna pbmc prior infection respiratory infection microarray analysis relative reference rna mg pbmc', 'microarray common transcriptional p change day postinfection', 'apparent abrupt pre conditioning effect host respiratory infection', 'gene expression change stress transport prior infection', 'variability gene expression critical management diet functional genomic', 'apparent microarray powerful tool determine stress compromise innate immunity disease resistance', 'innate immunity critical role host infectious disease evidence innate immunity adaptive immune', 'become apparent activation many immune pattern recognition specific structural pathogen', 'important family prr toll wide variety viral bacterial fungal', 'understanding role tlr regulation innate immunity critical full understanding host infectious disease', 'microarray analysis differential gene expression exposure dendritic specific pathogen effective approach induction innate adaptive immune al', 'lipopolysaccharide cpg bacterial dna pathogen innate immune', 'lps activation binding protein lbp complex', 'complex intracellular inflammatory response hemmi et al', 'synthetic cpg immune nk dendritic al takeshita et al', 'determine contribute induction innate immunity important understand leukocyte population', 'common unique tlr activation cellular bovine gene expression bovine lps class b cpg odn stimulation', 'microarray large number lps odn stimulation', 'common presence cpg odn majority unique', 'effective tool response specific determine distinct cellular', 'advent microarray high throughput analysis whole cell gene expression disease al derisi et al derisi al mckendry al schena schena al schena et al al', 'traditional microarray hybridization fluorescence technique low sensitivity high signal ball al pan al wang al', 'resonance rls infrared popularity research clinical application microarray detection due sensitivity robustness bao al waddell al', 'rls technique several microarray increased sensitivity signal noise ratio', 'microarray detection fluorescence fig', '', 'substantial capacity functional genomic microarray detection limited quantity', 'molecular diagnostic key protein dna rna specific', 'immunohistochemistry western dna southern northern quantitative polymerase chain reaction molecular clinical diagnostic', 'molecular simultaneous analysis clinical sample fluorescence control sample left panel gold control sample right panel', 'amount total rna fluorescence rls', 'b scatter plot normalized gene expression fluorescence panel rls analysis right panel', 'center line regulation gene expression unchanged control sample', 'allow maximum translation postgenomic research patient care', 'important today rapid identification potential therapeutic nile', 'inherent variability microarray global standard facilitate comparison', 'critical realize huge biological potential performing functional', 'powerful technology interrogate bovine gene expression response disease pathogenesis quality microarray analysis upon accurate high quality annotation array', 'annotation assessment specificity probe sequence transcript detect hybridization high quality information', 'annotation critical order extract meaningful biological signal intensity', 'absence complete bovine genome sequence availability accurate gene prediction annotation', 'probelynx bioinformatics tool annotation', 'probelynx microarray annotation update tool assess specificity date gene sequence annotation available particular', 'tigr gene index eukaryotic gene quackenbush al probelynx probe bovine transcript information putative uncharacterized transcript inference gene function', 'integration probelynx powerful tool bovine microarray date accurate probe gene annotation information biological interpretation', 'future additional integration meta probe protein subcellular localization information metabolic order', 'complete bovine genome sequence critical future bioinformatic laboratory gene regulatory', 'use high throughput metabolite effective approach accelerate validation gene prediction gene expression predict definitive way', 'continuous development array annotation new analysis enable cross enhance extraction biological information bovine advance understanding disease pathogenesis']"
c8eea85b7ab160588489e237470aff0ca1f1c5cd,c q p c e p q rating rating exp q certainty j e time scale exp j certainty exp rating mean exp p knowledge acquisition round questionnaire expert system rating e rating variant e j novel approach acute bronchitis exp e mean q number time repertory grid certainty e delphi questionnaire element construct impact factor knowledge multiple respiratory tract second round approach knowledge third round throat pain acute respiratory application domain c j construct c delphi technology element e respiratory syndrome severe acute variant q acute tonsillitis bronchitis bronchopneumonia case rating characteristic trait confidence degree construct relationship degree importance different time domain knowledge e tth element likely elicit integrate et al expertise multiple handle case hence third integrated rating q p q rule rating confidence represent importance rule handle side element allergic rhinitis bronchopneumonia pneumonia case opposite chronic obstructive construct support copd emphysema cope problem degree relevance degree set delphi method discussion q disease rating domain expertise edit comment element disease illustrative example importance degree importance element infection acute influenza severe integrate knowledge j degree j element knowledge integration medical diagnosis medical expert obstructive pulmonary opposite construct opposite side panel rank positive trait pulmonary disease pulmonary tb q q,"['knowledge acquisition critical bottleneck knowledge', 'past several cope problem', 'deal acquisition domain knowledge single expert', 'multiple different application domain necessary elicit integrate knowledge multiple effective expert system', 'recent literature time important parameter accuracy inference expert system elicitation domain expertise multiple important issue time factor consideration', 'cope approach knowledge multiple', 'application diagnosis severe acute respiratory syndrome superiority novel approach', 'past various', 'subject defense education engineering finance medical diagnosis', 'example mycin project medical expert system infectious shortliffe isodepor evaluate muscle strength spanish top competition et al frbs gp fuzzy rule system aphasia classification smear', 'successful system approach expert system approach medical diagnosis difficulty', 'building expert system critical bottleneck knowledge special domain domain knowledge acquisition', 'past several cope problem', 'deal acquisition domain knowledge single expert', 'multiple different application domain necessary elicit integrate knowledge multiple effective expert system', 'recent literature time important parameter accuracy inference expert system elicitation domain expertise multiple important issue time factor consideration hwang chen hwang chu', 'cope delphibased approach knowledge multiple', 'application medical expert system superiority novel approach', 'cope knowledge acquisition problem many knowledge acquisition build rapid quality knowledge e g boose kahn nowlan mcdermott salt marcus marcus mcdermott wang bradshaw kitto boose knack klinker bentolila genetet bradshaw shema boose kriton gale rule mole eshelman mcdermott tan shaw gruber word net millar navigli velardi gangemi wielinga breuker schreiber breuker mcrdr kang frame cadiag iv boegl kolousek leitich et al', 'repertory method personal construct theory different', 'single repertory grid matrix columns', 'rating mechanism grid e rating integer element likely trait element unknown relevance element characteristic trait element likely opposite characteristic trait', 'repertory grid approach enhance representative ability', 'example jose shadbolt technique fuzzy repertory grid finite classification problem set', 'addition several generate meaningful method generate repertory element hwang tseng', 'al', 'indicated building medical expert previous knowledge acquisition different time account', 'repertory grid table example knowledge various gastrointestinal', 'note rating acute bronchitis throat pain entry tendency acute bronchitis throat pain', 'practical situation influenza significant appearance throat early time scale', 'addressed repertory grid last time scale acute bronchitis', 'time scale throat pain symptom become significant', 'variant disease different time conventional knowledge acquisition', 'knowledge system difficult elicit integrate knowledge multiple application various time account', 'cope problem novel approach knowledge acquisition multiple time section time consideration expertise multiple', 'addition time importance degree construct element different time knowledge', 'e tth stage period element disease e j denote construct symptom n j entry triplet rating relevance e j certainty degree rating impact factor represent importance c j e rating e j degree relevance element e tth time scale construct c j element likely opposite characteristic trait element characteristic trait unknown relevance element element likely trait', 'certainty e j degree certainty rating e j n sure sure', 'impact factor degree importance construct c j element e tth time scale', 'impact factor x relationship element construct construct value construct impossible element integer degree importance element dominate implication element', 'step detail', 'loss generality knowledge elicitation process medical diagnosis expert system medical example novel approach', 'illustrative example element disease construct symptom', 'elicit integrate time scale information multiple delphi method initial negotiation', 'delphi delbecq van gustafson method systematic solicitation collection particular topic sequential information feedback', 'reliable qualitative research method potential use problem decision group consensus wide variety uhl', 'delphi important anonymous group interaction', 'multiple iteration collection statistical group feedback', 'presentation statistical group', 'problem delphi procedure domain delphi panel', 'pre number researcher multiple', 'round questionnaire open elicit individual member panel particular issue problem study', 'essence round anonymous session', 'round reviews panel', 'second round questionnaire researcher panel rank rate edit comment', 'ranking likert scale', 'round tabulates frequency standard item', 'third subsequent questionnaire panel previous round', 'information panel composite individual item', 'panel rank rate edit comment item', 'goal third round subsequent round consensus stability panel member', 'consensus stability individual case delphi procedure', 'typical first round questionnaire openended format elicit individual member panel particular issue problem study', 'phase expert provide e g respiratory tract infect', 'expert upper respiratory tract infection acute tonsillitis acute bronchitis bronchopneumonia pneumonia pulmonary tb influenza severe acute respiratory syndrome expert b uri upper respiratory tract infection acute tonsillitis acute bronchitis bronchopneumonia pneumonia pulmonary tb influenza severe acute respiratory syndrome allergic rhinitis copd emphysema etc', 'redundant', 'kamet delphi technology inquire expert union', 'delphi questionnaire table e e', '', 'e table illustrative example repertory grid gastrointestinal bronchitis bronchopneumonia diarrhea diarrhea cough cough throat pain throat pain fever fever table analysis respiratory tract infect', 'analyze consistency stability second round questionnaire summary first round rating expert', 'second round questionnaire kamet panel rank rate edit comment round', 'second round standard item', 'table summary second round', 'calculate mean standard deviation fourpoint rating numeric', 'expert respond certain statement computation standard', 'threshold minimum requirement agreement particular item second round', 'stability convergence panel round murry', 'principle delphi technology table rating mean q mean item q rating variant q ratio quartile range', 'delphi questionnaire questionnaire', 'undetermined questionnaire rating variant', 'table analysis', 'rating allergic rhinitis chronic obstructive pulmonary disease copd copd emphysema asthma rating variant equal questionnaire allergic rhinitis chronic obstructive pulmonary disease copd copd emphysema asthma disease irrelevant domain', 'rating mean copd bronchiectasis disease rating variant value equal third round questionnaire', 'pneumonia rating mean grater rating variant value hence third round questionnaire', 'empyema disease rating mean second round hence third round questionnaire', 'delphi questionnaire round questionnaire', 'table multiple approach round delphi questionnaire round delphi questionnaire round delphi questionnaire rating mean q p rating mean q p q rating variant q q discussion q rating mean q rating mean q p rating variant q rating mean q p q rating variant q q discussion q rating mean q rating mean q q rating variant q', 'discussion q table analysis degree relevance respiratory tract infect domain', 'asthma round round union element application domain delphi method time scale information element multiple', 'phase expert number time', 'inconsistent time delphi technology', 'example expert time time expert b time time scale uri delphi method number time', 'table illustrative number time scales element', 'table time consistent conclusion discussion number time', 'inconsistent table', 'process questionnaire number time element similar previous phase', 'time expert asked give distinguish different time technology repertory grid approach', 'inconsistent c method determine construct agreement', 'entry triplet hwang et al', 'rating e j indicate relevance disease symptom certainty e j rating impact factor represent importance symptom disease', 'rating mechanism rating e j rating integer tendency pole construct c j positive trait construct support positive trait construct support positive trait opposite construct support opposite construct sup port opposite construct', 'value certainty j sure rating e j n sure', 'value impact factor j degree importance construct c j element e tth time scale', 'impact factor x represent relationship element construct represent necessary construct element integer indicate construct degree importance element', 'example grid table element e kth time scale k e e k', 'example second time scale acute bronchitis acute bronchitis', 'time', 'time scale acute tonsillitis', 'time tonsillitis', 'time tb', 'time tb', 'time', 'time', 'time', 'time', 'time scale allergic influenza', 'time', 'time scale flu influenza', 'time influenza', 'multiple expert system difficult domain knowledge multiple knowledge integration technology', 'cope knowledge integration problem exp element e p construct c q rating exp p c q certainty exp e p c q impact factor exp e p c q meta rating exp p c q rating exp j e p c q certainty exp e p c q certainty exp j e p c q rating e p c q rating exp p c q certainty e p c q rule handle case opposite side element construct relationship different confidence', 'case rating expert confidence integrated rating confidence degree set', 'rating exp p c q rating exp j e p c q certainty exp e p c q certainty exp j e p c q rating e p c q max rating exp p c q rating exp j e p c q certainty e p c q rule handle case opposite side element construct relationship degree confidence', 'case rating opposite tendency integrated rating confidence degree set', 'rating exp p c q rating exp j e p c q certainty exp e p c q n certainty exp j e p c q rating e p c q rating exp p c q certainty e p c q n rule handle case opposite side element construct relationship degree confidence n', 'case rating opposite tendency integrated rating confidence degree n', 'rating exp p c q rating exp j e p c q certainty exp e p c q certainty exp j e p c q rating e p c q rating exp p c q certainty e p c q rule handle case positive side element construct relationship different confidence', 'case rating expert confidence integrated rating confidence degree set', 'rating exp p c q rating exp j e p c q certainty exp e p c q certainty exp j e p c q rating e p c q min rating exp p c q rating exp j e p c q certainty e p c q rule assign x represent importance degree sure integer sure result x', 'impact e c q x impact exp j e p c q integer certainty exp e p c q certainty exp j e p c q ask rule assign x represent importance degree sure integer sure negotiation', 'knowledge multiple rule hwang et al', 'applied generate set', 'novel approach knowledge acquisition system implemented server', 'kamet main elicitation module knowledge transformation module delphi group decision module expertise integration module', 'knowledge acquisi tion module web knowledge elicitation tool approach knowledge', 'knowledge transformation module transform domain expertise rule knowledge format inference engine', 'group decision module delphi technology murry', 'anonymous feedback multiple number scales element knowledge acquisition process', 'expertise integration module knowledge integration certainty importance element construct', 'specific application union element integrating element individual redundant', 'kamet delphi technology inquire expert union', 'illustrative example delphi questionnaire fig', '', 'kamet questionnaire analysis secondround questionnaire', 'fig', 'interface analysis', 'fig', 'summary first second analyze consistency stability item', 'fig', 'rating copd chronic obstructive pulmonary disease pneumonia grater rating variant hence third round questionnaire', 'empyema disease rating mean round round hence third round questionnaire see fig', '', 'phase relevant irrelevant application domain', 'determine number time element disease fig', '', 'inconsistent number time individual questionnaire number time element fig', '', 'relevant expert asked enter triplet construct pair', 'procedure previous section final knowledge set', 'evaluate performance novel approach domain participate experiment medical hospital department thoracic internal medicine department department emergency medicine', 'family', 'dietician', 'application domain severe acute respiratory syndrome twelve uri upper respiratory tract infection acute tonsillitis acute bronchitis bronchopneumonia pneumonia copd chronic bronchi tis copd bronchiectasis empyema pulmonary tb tuberculosis flu influenza severe acute respiratory syndrome avian influenza', 'tract index physical examination respiratory tract sneeze nose snuffle snot regorge throat pain cough dense phlegm pant breath hard pleurisy chest pain', 'second category fever headache muscle serious tired longterm cough night sweat weight adate', 'third category physiology index physical examination body temperature tachypnoea pulse frequency hypertrophy fester larynx hyperemia respiratory rhonchus', 'thirty medical test', 'table correct diagnosis individual kamet', 'performance approach individual knowledge acquisition approach', 'study knowledge acquisition method elicit expertise multiple element time systematical procedure elicit degree relevance symptom time scale', 'evaluate effectiveness novel approach knowledge sition system medical participate experiment', 'experimental novel approach able performance hence new approach helpful repertory grid efficacy', 'employ novel approach several e medical education']"
e5073f61639f9524e70d832bf62e30bcd19329e8,pedv infection et al erk activation pedv replication pedv moi viral protein viral rna activation pedv erk pathway infected pedv n protein chemical inhibition pedv n viral replication protein expression rna synthesis β actin blot analysis genomic rna sg mrna annexin v h pedv inhibitor h inhibitory effect mek inhibitor presence inhibitor rna sg cell death dmso h erk pedv h presence independent treatment inhibition erk kim lee life cycle microscope magnification moi h pedv uv present study real time replication cycle representative independent role erk secondary antibody treatment mek vero inhibitor viral production virus propagation western blot μm μm absorbance solution al lee al saif alexa fluor apoptotic cell equal amount equal protein flow cytometry gene expression h prior independent represent infection hpi inhibitor dmso mek erk mock infected pedv apoptosis pfu ml positive sense presence dmso prior infection represent standard rna replication rt pcr solution nm synthesis viral tissue culture total rna vehicle control vero pedv viral infection virus entry † po actin verify anti mouse antibody pedv blot mouse briefly vero cai al computer densitometer culture plate density value dependent manner effect virus entry process goat anti hpi fig hpi western inactivated pedv indicated time infection viral,"['porcine epidemic diarrhea virus pedv enteropathogenic coronavirus swine acute high mortality nursery', 'date cellular pedv replication', 'extracellular signal kinase erk critical component cellular signal transduction variety cellular regulate several viral', 'present study early infection viral replication', 'pedv activation phosphorylation downstream substrate', 'treatment erk viral progeny production', 'inhibition erk activation viral protein expression genomic subgenomic rna transcription', 'erk pathway important role pedv life cycle viral infection', 'porcine epidemic diarrhea important swine disease acute high mortality pensaert al saif et al', 'villous atrophy small serious newborn malabsorptive watery diarrhea fatal dehydration et al saif al shibata et al', 'mortality age due age dependent disease severity neonatal al', 'disease united kingdom spread multiple swine european cartwright oldham pensaert et al', 'asia ped major concern asian south korea chen et al kweon al li al puranaveja al sun et al takahashi al', 'severe large scale epizootic united south korea taiwan japan tremendous financial pork et al lee al lin et al mole stevenson al', 'etiological agent ped virus pedv coronavirus member genus alphacoronavirus family coronaviridae order saif al', 'large virus single positive sense long cap tail pensaert saif al', 'pedv genome untranslated region open utr al', 'large genome encode non structural', 'orfs terminal region code major structural spike protein membrane protein envelop e protein nucleocapsid n protein duarte al saif et al', 'pedv infection viral protein receptor host viral genome cytoplasm viral entry process', 'positivestrand rna genome synthesis viral', 'translation lab replicase à ribosomal frame shift', 'functional nsps viral rnadependent rna polymerase rdrp', 'rdrp replication complex turn viral genomic rna synthesis subgenomic sg mrna transcription co terminal sg translated structural et al saif et al', 'recent report pedv independent apoptosis activation mitochondrial apoptosis factor aif facilitate viral replication pathogenesis kim lee', 'cellular pedv infection unknown', 'mitogen protein kinase mapk cascade central building network', 'global cellular response various extracellular intracellular numerous cellular', 'extracellular regulated kinase erk mapk important various cellular johnson roux blenis', 'activation signal', 'stimulation raf mek erk cascade receptor tyrosine signal small gtp protein', 'event raf activation dual specificity phosphorylation', 'nucleus numerous downstream transcription transcription large number', 'erk pathway wide range important cellular proliferation differentiation survival apoptosis roux blenis shaul seger', 'intracellular multiplication host erk pathway', 'fact several exploit host erk optimal viral replication gene expression cai al lee lim al marjuki schultz cherry dobbelstein wang al wei liu zampieri et al', 'role erk pedv replication', 'present study examine pedv infection erk erk activation pedv replication', 'pedv strong transient activation independent maximal viral gene expression', 'uvinactivated virus sufficient trigger activation absence critical action viral replication phosphorylation', 'pedv production mek', 'independent treatment mek inhibitor distinct reduction viral rna synthesis viral protein translation affect viral entry', 'addition inhibition erk activation effect pedv apoptotic cell death', 'pivotal role erk post attachment stage pedv life cycle', 'order investigate effect pedv cascade phosphorylation vero pedv moi different postinfection western blot analysis', 'fig', 'small detected mock vero negative control', 'level response', 'contrast pedv infection activity h postinfection hpi hpi baseline level', 'addition activation profile pedv moi', 'pedv infection strong transient activation', 'new viral protein synthesis evident hpi fig', 'maximal phosphorylation status time point activation pedv replication', 'data regulation replication cycle early virus infection considerable protein production obvious late time', 'demonstrate hypothesis vero equal amount inactivated virus capable viral attachment internalization incapable viral gene expression fig', '', 'pedv activation comparable phosphorylation pattern infected fig', '', 'inactivated pedv infection sufficient activate erk initial entry virus life cycle responsible early erk activation', 'next tried confirm phosphorylation uvinactivated pedv cell elisa face', 'consistent phosphorylation h pedv infection level phosphorylation mock fig', '', 'activation pattern uv irradiated pedv infected fig', '', 'addition total unchanged various time infection', 'pedv replication phosphorylation', 'pedv nuclear translocalization phosphorylation stimulation significant population erk nucleus series transcription', 'investigate activation pedv infection subcellular localization pedv uv pedv fig', '', 'active cellular entire period experiment fig', 'b top', 'contrast hpi distinct nuclear weak punctuate cytoplasmic signal nucleus hpi fig', '', 'pedv replication punctuate cytoplasmic active', 'exposure uv inactivated pedv majority nuclear distribution punctuate', 'localization pattern active erk unchanged h pedv infection fig', '', 'transcription erk pathway shaul seger wei liu activation status pedv erk activation fig', '', 'activation mock', 'contrast pedv infection phosphorylation observed activation fig', '', 'uv inactivated pedv profile comparable pedv fig', '', 'result erk pedv infection appropriate downstream key inducible cellular', 'biological importance activation pedv infection specific pathway', 'vero inhibitor various vehicle control h prior infection', 'inhibitor dmso present entire period infection', 'cytotoxicity mek vero', 'present study detectable cell death vero', 'viral production monitoring cytopathic effect cpe infection immunofluorescence n protein specific mab hpi fig', '', 'vehicle control visible cpe hpi predominant hpi n specific evident many cell infection spread virus', 'contrast inhibitory effect virus propagation detectable', 'fig', 'inhibitor pedv cpe viral gene expression second dependent manner', 'n protein percentage independent treatment inhibitor maximal inhibition concentration fig', '', '', '', 'pedv', 'vero infected pedv moi equal amount pedv', 'whole cell indicated pedv infection hpi western blot analysis antibody specific pedv n protein', 'blot mouse mab β actin verify equal protein loading', 'fold', 'c activation pedv infection face assay', 'vero indicated time antibody hrp igg', 'absorbance solution nm spectrophotometer', 'representative independent represent standard', 'n p † po activation phosphorylation capable activation activity alessi et al davis et al', 'potent inhibitor activation favata et al', 'effective pedv production reduction virus propagation concentration μm reduction virus propagation concentration', 'show relevance activation status downstream activator fig', '', 'activation downstream target', 'vero infected pedv moi equal amount pedv b', 'whole cell indicated pedv infection hpi western blot analysis antibody pedv n blot mouse mab β actin verify equal protein loading', 'fold', 'representative independent represent standard', '† po', 'indicated time infected labeled green pedv n', 'dapi intracellular localization virus confocal microscope magnification', 'treatment mek', 'decrease fig', '', 'inhibitory effect inconsistent significant inhibition μm μm', 'indicated effect production ability compound inhibit phosphorylation', 'mek inhibitor activation pedv propagation raf mek erk pathway role pedv replication', 'addition virus yield treatment mek erk activity necessary pedv replication', 'infection viral hpi viral', 'fig', 'presence inhibitor release viral progeny dose dependent manner', 'peak viral titer pfu ml vehicle control', 'addition μm pedv titer pfu ml reduction control', 'virus titer concentration comparable inhibitory effect virus titer', 'growth overall process pedv replication optimal respective', '', 'activation successful pedv replication', 'direct evidence involvement erk regulation pedv vero small interfering rna sirna specific commercial control nonspecific sirna negative control', 'h posttransfection pedv h determine virus propagation fig', '', 'expression sirna treatment untreated control sirna specific knockdown μm h prior infection mock infected pedv moi', 'virus h presence dmso', 'pedv specific hpi microscope magnification â', 'infected mab n protein alexa green goat anti mouse secondary antibody second', 'dapi third fluorescent microscope magnification', 'b viral production presence inhibitor quantifying percentage n cytometry', 'representative independent represent standard', 'c chemical inhibition activation face assay', 'vero pedv presence dmso μm μm', 'hpi formaldehyde antibody hrp igg', 'absorbance solution nm spectrophotometer', 'represent independent represent standard', 'p¼ po', 'sirna fig', '', 'transfection sirna decrease number pedv reduction virus titer mock nonspecific sirna c', 'inhibitory effect sirna virus production comparable chemical inhibition', 'knocked expression propagation essential role erk pedv replication', 'determine point mek pedv infection vero different time post infection', 'hpi replication viral production n protein flow cytometry fig', '', 'treatment hpi decrease pedv production control', 'addition hpi inhibition pedv infectivity', 'inhibitory profile similar effective concentration', 'contrast little significant reduction pedv propagation inhibitor hpi', 'production early virus life cycle importance erk initial stage infection', 'next identify step replication cycle pedv inhibition erk activation', 'address issue step virus entry internalization treatment mek inhibitor', 'vero pedv h allow virus attachment permit virus internalization presence μm μm dmso treatment proteinase surface', 'infected infectious center uninfected vero cell fig', '', 'minimal viral production due inefficient removal virus', 'viral identical vehicle pfu ml indicating treatment', 'inhibitory effect virus entry process', 'positive sense rna genome cytoplasm uncoating process template viral translation use translation machinery host cell', 'pedv translation replicase', 'nonstructural replicase synthesis viral rna genomic rna replication sg transcription', 'pedv structural late cycle respective sg mrna', 'determine functional mechanism regulation pedv infection postentry viral protein translation erk inhibition', 'approach vero inhibitor h prior infection present infection subsequent incubation', 'expression level pedv n protein presence inhibitor dmso hpi western blot analysis', 'chemical inhibition detrimental effect viral protein production different', '', 'densitometric analysis western intracellular expression n protein prevented maximal inhibition fig', '', 'inhibitory effect viral protein expression due specific action inhibitor viral translation pedv replication', 'synthesis viral nsps viral rna replication transcription conceivable suppression viral protein expression result inhibition viral rna synthesis', 'pedv infection rna genomic subgenomic inhibitor genome replication sg transcription', 'question relative genomic rna sg mrna quantitative real time strand specific rt pcr presence absence pedv infection', 'fig', 'viral rna synthesis dose dependent manner maximal reduction viral genomic rna sg mrna dmso infected', 'decrease viral rna addition inhibitor due nonspecific inhibition transcription level internal gapdh control unchanged', 'impairment pedv transcription presence inhibitor cellular subjected antibody erk protein', 'blot anti β actin antibody equal protein', 'erk protein expression analyzed densitometry relative density value β gene fold total erk β actin ratio', 'b pedv specific hpi microscope magnification â', 'infected pedv n antibody alexa green goat anti mouse secondary antibody second', 'dapi third fluorescent microscope magnification', 'viral production legend northern blot analysis fig', '', 'untreated lane vehicle lane virus pedv rna synthesis', 'consistent real time rt pcr significant reduction rna activity treatment', 'erk suppress synthesis pedv genomic rna sg mrna', 'raf mek erk pathway various cell different pro proliferative antiproliferative stimuli', 'evidence activity classical execution apoptotic cell death certain chambard', 'pedv induce apoptosis vitro vivo facilitate viral replication pathogenesis kim lee', 'erk pathway role induction apoptosis pedv replication', 'examine erk activation pedv induced apoptosis process pedv apoptosis presence absence erk inhibitor annexin v propidium iodide pi flow cytometry', 'vero dmso compound pedv infection', 'indicated time postinfection infected v pi facs flow cytometry determine percentage viable apoptotic dead', '', 'vehicle caused significant apoptosis', 'pedv infection presence dmso high level apoptosis annexin v positive pi negative hpi percentage early apoptotic infection time', 'chemical inhibition activation incapable apoptotic cell death', 'percentage early apoptotic treatment comparable vehicletreated course infection', 'chemical inhibition erk activation nuclear translocation hallmark pedv apoptosis kim lee fig', '', 'erk pedv apoptosis mechanism', 'significance interplay host numerous extracellular viral infection', 'transduction plays multiple pivotal cell fate cagnol chambard roux blenis shaul seger', 'ability control cell cycle progression reasonable target modulation viral multiplication specific virus life cycle entry gene transcription expression progeny release cai al lee schultz cherry planz al pleschka al wei liu wong et al', 'widespread erk involvement general characteristic optimal viral infection global viral strategy enhance replicative machinery', 'research little intracellular pedv infection pathogenesis', 'present study first time erk activation efficient pedv replication', 'study pedv activation vitro crucial role erk pedv infection', 'independent treatment erk impaired pedv propagation', 'chemical inhibition erk activation significant attenuation viral replication post entry overall downregulation viral protein expression viral rna synthesis progeny release', 'erk pathway pedv infection competent viral reproduction target', 'infectious pedv uv virus erk activation analogous phosphorylation activation virus entry process virusreceptor uncoating event', 'productive growth pedv hpi detection considerable amount viral protein phosphorylation status hpi reduction amount level', 'contrast total consistent infection uv irradiated pedv', 'initial round pedv replication cycle likely hpi essential maximal activation erk pathway', 'similar activation independent virus replication response virus entry unique feature nidovirus biology cai al lee lee', 'addition coxsackievirus astrovirus mediate rapid ephemeral erk activation min postinfection luo al moser', 'current study due slow growth rate pedv unable determine infection', 'step growth eclipse period progeny detectable', 'productive infection pedv multiple step cycle entry genome replication transcription viral translation assembly progeny release', 'eclipse period virus attachment internalization disassemble viral capsid genome release ready initiate replication cycle cytoplasm', 'exact mechanism activation pedv infection unclear present study speculate virus receptor responsible erk activation pedv', 'possibility erk fig', '', 'chemical inhibition activation viral synthesis', 'vero dmso mock infected pedv moi h presence dmso inhibitor', 'total cellular rna hpi strand specific viral genomic rna black mrna white quantitative real time rt pcr', 'viral positive sense genomic rna sg mrna monkey gapdh relative mrna accumulation', 'inhibitor sample', 'representative independent standard', '† po', 'b rna northern blot analysis specific biotin specific utr probe', 'monkey control correct viral rna quantification', 'rna sg next gel', 'inhibitor vero infected pedv moi h presence absence inhibitor', 'hpi cellular sds page nitrocellulose membrane antibody pedv n protein', 'blot mouse mab β actin verify equal protein loading', 'viral protein expression analyzed densitometry density value β gene inhibitor sample dmso control', 'representative independent standard', 'p¼ † po virus direct fusion cell membrane exposure viral genome uncoating process', 'herein question definite function pedv infection', 'conceivable explanation activation pedv infection pathway viral replication', 'independent treatment pedv erk inhibitor individual postinternalizaton viral replication process viral rna synthesis protein expression virus production', 'positive sense rna virus rdrps host regulation viral rna replication phosphorylation polymerase protein jakubiec jupin', 'previous activity necessary phosphorylate viral rdrp initiation viral rna replication luo schultz cherry', 'similar phosphorylation modification pedv rdrp optimal viral rna synthesis', 'erk activation intrinsic extrinsic mitochondrial cytochrome c release activation cagnol chambard', 'several erk pathway modulate apoptosis replication et al zampieri et al', 'pedv apoptotic cell death vitro vivo favor viral infection kim lee', 'current study negative correlation activation apoptosis pedv infection', 'result caspase activation cytochrome c release pedv apoptosis pathway kim lee', 'activation pedv infection signal downstream cellular transcription necessary maximal virus propagation', 'experimental unable eliminate viral replication chemical inhibition', 'indirect influence activity case erk intracellular important replication', 'summary pedv infection early infection activation efficient pedv replication vitro', 'viral erk activation remain', 'suppression viral protein expression viral rna transcription erk activation precise mechanism erk activity pedv replication cycle infection unclear next issue address future', 'precise role erk activation replication pedv new molecular biology pathogenesis pedv infection', 'vero alpha minimum essential medium α mem invitrogen carlsbad bovine serum fbs invitrogen antibiotic antimycotic invitrogen', 'humidified co incubator', 'pedv strain korean animal plant quarantine agency vero hofmann wyler nam lee', 'inactivation pedv uv irradiation virus suspension mj cm uv crosslinker stratagene la jolla', 'virus inactivation inoculation uv virus vero n protein specific described inactivated virus', 'pedv proteinspecific monoclonal antibody mab choogang vaccine laboratory cavac daejeon south korea', 'specific aif β actin santa cruz biotechnology santa cruz', 'phosphorylated erk specific unconjugated control sirnas cell technology', 'cytotoxic colorimetric bromide sigma st louis mo detect cell viability', 'briefly vero grown â tissue culture plate treatment h day incubation μl mtt solution mg ml additional h supernatant μl dmso dissolve formazan mtt', 'absorbance solution nm enzyme immunosorbent assay plate reader', 'mtt triplicate', 'vero grown tissue culture day mock infected pedv multiplicity infection equal amount virus', 'μl lysis buffer mm β glycerophosphate mm ρ phenyl phosphate mm mgcl mm nacl mm egta ph mm sodium orthovanadate μg ml μg ml aprotinin μg ml leupeptin mm pmsf ice', 'min ice centrifugation â g eppendorf centrifuge hamburg germany min', 'examine effect erk inhibition pedv replication mek inhibitor h pedv moi', 'virus presence μm μm dmso vehicle control cell prepared lysis buffer h hpi', 'total protein bca pierce rockford il', 'equal total protein nupage gradient bis tris gel invitrogen immobilon p millipore bedford', 'powdered skim milk bd tbs mm tris hcl ph mm nacl tbst h overnight primary antibody pedv n β actin', 'secondary hrp dilution h', 'enhanced chemiluminescence ecl healthcare piscataway manufacturer', 'total phosphorylated densitometry computer densitometer cell facility wcif version imagej software package wcif imagej', 'viral protein production band n computer densitometer imagej software density value relative β actin gene', 'face kit active motif carlsbad determine activation manufacturer', 'briefly vero tissue culture plate day pedv uv virus described', 'infected', 'addition vero mek inhibitor h pedv infection hpi', 'overnight antibody', 'incubation hrp secondary antibody colorimetric analysis absorbance solution nm spectrophotometer', 'vero tissue culture infected pedv uv pedv moi', 'assess effect mek infection dmso h pedv', 'virus presence vehicle inhibitor h paraformaldehyde min rt triton pbs rt min', 'bovine serum albumin bsa pbs min rt pedv n specific mab h pbs h rt goat anti mouse secondary antibody alexa fluor invitrogen dapi sigma', 'microscope glass buffer cell fluorescent leica dm il microscope leica wetzlar germany', 'examine aif subcellular localization chemical inhibition pedv erk activation mitotracker invitrogen vehicle mek virus vero min prior fixation', 'specific antibody cell confocal laser microscope carl zeiss gattingen germany', 'quantification pedv independent treatment mek inhibitor flow cytometry', 'vero dmso h presence vehicle inhibitor', 'virus â g hanil centrifuge fleta min', 'cell pellet cold washing buffer bsa sodium pbs formaldehyde solution wash buffer fixation dark min centrifugation incubation pellet triton pbs min permeabilization', 'centrifugation cell pellet solution primary anti n mab mixture min', 'react alexa fluor igg secondary antibody min dark', 'analyzed facsaria iii flow cytometer bd', 'vero pedv moi', 'hpi give indicated final concentration remainder time course experiment', 'pedv inhibitor infection hpi min rt', 'facs analysis assess presence pedv infection', 'vero treated dmso', 'culture different time', 'pedv titer plaque assay vero nam lee plaque ml', 'internalization assay et al', 'briefly vero grown culture plate infected pedv moi h presence respective', 'unbound pbs presence inhibitor dmso h treatment proteinase k mg ml min uninternalized virus', 'pedv diluted culture medium fresh vero cell culture', 'h postincubation plaque pfu ml', 'vero inhibitor dmso h prior infection pedv moi h', 'virus inoculum infected fresh medium dmso h total rna infected trizol reagent invitrogen dnase takara japan manufacturer', 'rna nanovue spectrophotometer ge healthcare', 'quantitative real time rt pcr thermal cycler dice real time system takara gene specific primer lee', 'rna viral mrna dehydrogenase gapdh gene relative mrna accumulation à δδct method', 'detect rna sg mrna presence inhibitor pedv infection inhibitor dmsotreated', 'vero inhibitor h pedv inoculation', 'total rna infected trizol reagent dnase', 'northern blotting northernmax kit ambion austin tx manufacturer', 'total rna μg separated electrophoresis gel buffer agarose gel', 'total rna brightstar nylon membrane ambion h cross uv light min', 'prehybridization min detection pedv specific utr probe monkey dehydrogenase gapdh', 'blot biotin probes ultrahyb reagent low stringency buffer wash buffer', 'target viral rnas brightstar biodetect kit ambion manufacturer', 'membrane alkaline phosphatase streptavidin reaction chemiluminescent substrate cdp star ambion', 'overlaid exposure dark cassette box dark room', 'vero nm sirna control sirna lipofectamin invitrogen manufacturer', 'h post transfection pedv moi h western blot analysis computer densitometer', 'hpi pedv n specific ifa culture subjected virus titration plaque', 'vero inhibitor h mock infected pedv moi', 'virusinoculated presence μm μm dmso', 'phosphatidylserine exposure annexin v binding alexa fluor annexin v dead cell apoptosis kit invitrogen manufacturer protocol', 'brief cold pbs μl â annexin binding buffer', 'alexa fluor annexin v pi rt min dark', 'incubation period μl annexin buffer sample ice', 'fluorescent v pi facsaria iii flow cytometer', 'negative positive annexin v apoptotic', 'statistical student test p significant']"
3a1e5b32469718163ebe7cd825c248ff59d3cc8e,cell culture cell line culture medium primary cell continuous cell negative test nucleic acid cause animal culture monolayer organism cause veterinary aware acid detection agent optimum anatomic site animal clinical category b cell available cell isolation cell monolayer culture canine culture important cytopathic effect density gradient electron microscopy essential medium fcv cell gradient centrifugation hela cell immune status important technique incubation period infectious agent intracellular bacterial isolation intracellular isolation respiratory isolation virus laboratory transport loss organism low speed maintenance medium minimum essential molecular serology nature infection organism viability patient signalment presence infectious replication cell respiratory tract result inadequate serology unavailable signalment history status travel sterile technique test result tissue culture tract disease transport culture travel history unavailable equivocal viral chlamydial viral infection virus isolation virus present absorbent secondary acid cell active communication acute convalescent additional diagnostic adenovirus viral advent molecular agar methylcellulose agent amphotericin agent physiologic agent presence air transport american type amino buffering amino indicator amount virus amphotericin b animal chance animal disease animal present animal primary animal serum animal time antibody acute antibody viral antifungal agent antigen detect antigen electron antiseptic preparation antiviral reduction appearance characteristic appropriate collection area swab assess antiviral association iata assume virus assumption organism,"['• availability nucleic acid cell culture diagnosis obligate intracellular', '• cell culture important technique confirmation diagnosis molecular serology unavailable equivocal b pathogen discovery c vaccine manufacture', 'culture sensitive specific method organism detection', '• collection veterinary laboratory perform culture discuss patient signalment history immune status travel history nature infection number', '• organism presence characteristic cytopathic effect predictable incubation period confirmatory antigen electron microscopy nucleic acid', '• false negative result inadequate collection deterioration transport culture contamination', 'positive organism cause animal present disease', 'case gastrointestinal disease', 'cell culture culture eukaryotic laboratory', 'infectious host replication cell culture', 'advent molecular diagnostic nucleic acid detection cell culture routine clinical diagnostic cost requirement significant technical expertise perform cell culture interpret table', 'isolation viral intracellular bacterial protozoal culture important technique discovery new identification involved disease molecular serology unavailable equivocal propagation research generation vaccination efficacy novel antimicrobial', 'cell culture canine distemper canine adenovirus viral chlamydial respiratory tract disease', 'veterinary aware culture technique presence infectious agent optimum collection submission', 'knowledge cell culture veterinary optimum laboratory turnaround potential', 'cell culture propagate intracellular diagnosis viral', 'active communication clinician laboratory viral isolation', 'successful detection dependent appropriate collection rapid proper transport processing', 'veterinary clinician play critical role positive test present', 'clinician discuss laboratory light animal clinical presentation', 'patient signalment history clinical immune status travel history number discussed generate nature infection box', 'coronavirus fcov difficult isolate cell culture whereas calicivirus fcv cell culture sensitivity cell culture high', 'respect cell type replicate', 'result laboratory information specific', 'important viral', 'early possible onset clinical first week viral shedding onset', 'duration viral type virus anatomic site', 'multiple collection animal chance isolate', 'possible antibody acute convalescent phase serology help diagnosis chapter', 'selection collection site culture knowledge pathogenesis infectious agent optimum site site clinical severe', 'collection prevent contamination normal possible', 'size example ml blood body fluids lavage blood increase chance positive isolation', 'general nasal nasopharyngeal nasal swabs human isolation respiratory study nasal swab sensitive nasopharyngeal isolation respiratory', 'nasal oropharyngeal swab swab area swab mucosa', 'small tissue isolation virus transport medium protein', 'laboratory commercial', 'important medium expiry date', 'liquid cerebrospinal fluid bronchoalveolar lavage fluid need transport', 'blood sterile technique antiseptic preparation site venipuncture edta anticoagulant', 'collection possible laboratory transport lead loss organism viability', 'excess', 'possible dramatic loss virus viability', 'unavoidable c preferable c shipping dry ice preferable possible', 'laboratory submission guide', 'table recommended isolation intracellular companion', 'patient site specific time date collection', 'leakproof triple packaging wet ice cold laboratory transport hour', 'absorbent secondary container order absorb', 'governmental international air transport association iata infectious category category b', 'category infectious capable permanent disability life fatal disease healthy', 'category b fall inclusion category', 'updated guidance infectious online world health organization', 'import interstate international transportation', 'general plastic plate', 'monolayer animal primary cell culture tend life span continuous cell', 'primary cell isolation resemble present vivo replication primary cell continuous cell', 'subculture primary cell sensitivity viral infection', 'primary cell culture treatment tissue enzyme trypsin collagenase', 'primary white blood cell peripheral blood mononuclear cell separation white cellular density gradient centrifugation culture medium', 'ficoll polysaccharide example medium density gradient centrifugation', 'primary cell isolation intracellular', 'low passage cell viable sensitive viral', 'continuous cell cell line diagnostic research commercial', 'cancer hela cell line human cervical cancer patient henrietta experimental induction cellular example carcinogen', 'continuous cell wide variety cell available commercial table', 'virus isolation disease diagnosis inoculate different replicate differing cell', 'mixed cell available facilitate isolation multiple different viral', 'culture laboratory liquid nitrogen', 'cell culture medium settle bottom plastic flask figure', 'cell culture medium moist', 'minimum essential medium mem eagle minimum essential medium dulbecco medium synthetic cell culture', 'cell culture medium balanced salt solution essential amino buffering system', 'available contain nonessential amino indicator phenol red ph agent physiologic ph concentration co result cellular respiration', 'medium supplementation animal serum fetal calf serum spread plate serum free medium culture canine feline', 'cell culture growth maintenance culture former concentration serum versus maintenance medium', 'prevent bacterial fungal contamination viral careful attention sterile technique', 'manipulation laminar flow hood culture medium antifungal agent amphotericin b nystatin', 'cell culture humidified incubator gas mixture co', 'cell culture incubator daily inverted binocular tissue culture microscope figure examination unstained bottom flask', 'medium fresh medium ph indicator', 'form semiconfluent monolayer reach confluence inoculation', 'order passage small volume trypsin edta solution monolayer', 'monolayer solution several flask medium new', 'cell cross cell', 'hela cell line example prolific hardy cell line', 'major cell line american type culture collection atcc use genetic typing identity collection', 'cell mycoplasma spp pass exclude', 'presence spp', 'interfere replication cellular morphology', 'mycoplasma contamination stain culture mycoplasma available pcr mycoplasma dna purpose cell culture quality assurance', 'infection cell monolayer removal medium inoculation monolayer suspension viral bacterial', 'tissue culture homogenized culture medium monolayer', 'remove cell', 'passage filter inoculation', 'inoculum monolayer', 'inoculum settle monolayer hour residual inoculum fresh maintenance medium', 'isolation virus monolayer daily evidence cytopathic effect cpe', 'medium weekly biweekly', 'cpe cellular viral replication cell culture monolayer cell lysis cell fusion syncytium formation', 'presence particular viral pathogen appearance characteristic cpe pathogen incubation period figure', 'example cpe fcv cell detachment occur virulent', 'presence cpe comparison control', 'examination cell monolayer light microscopy fixation reveal additional diagnostic presence inclusion formation', 'noncytopathogenic', 'presence washed examination monolayer evidence hemadsorption figure organism cell culture monolayer fixation monolayer fluorescent certain figure use nucleic acid detection use electron microscopy', 'spin cell culture monolayer low speed inoculation', 'enhance recovery certain intracellular bacterial chlamydiae', 'entire plate cell culture spun plate centrifuge shell shell vial technique', 'shell small flat figure', 'monolayer grown glass coverslip bottom vial inoculation low speed', 'method fluorescent antibody viral chlamydial antigen detect pathogen cpe', 'virus specific fluorescent fluorescence microscope', 'overlay monolayer agar methylcellulose inoculation virus subsequent viral movement monolayer damage viral particle small area', 'formation', 'monolayer number order information amount virus inoculum', 'plaque assess antiviral reduction plaque formation', 'processing biological safety cabinet contamination protect laboratory worker laboratory', 'veterinary diagnostic biosafety level bsl', 'biosafety table', 'united prevention cdc assigns', 'important veterinary aware isolation hazardous accredited', 'negative test virus isolation numerous clinician assume virus present negative test result box', 'negative test result inadequate size viral animal time collection inadequate organism anatomic site loss organism viability transportation laboratory', 'loss viral viability occur virus non hardy parvovirus fcv', 'negative test cell line sensitive virus present', 'lowpassage infectivity viral infection undergone multiple serial', 'false', 'treatment viral transport culture resistant fungi', 'multiple present virus', 'example mixed feline upper respiratory tract disease', 'crandell reese feline kidney cpe concurrent presence', 'imperative veterinary aware detection virus organism cause animal clinical', 'true respiratory gastrointestinal infectious many clinical illness', 'development clinical simultaneous presence infectious', 'specimens test negative presence agent presence significant organism fcv co incorrect assumption organism cause animal disease']"
21100aba41a4bfb48d7dc37f1bf5dbb38bf3867a,author funder display preprint funder medrxiv license display medrxiv license preprint perpetuity available author cc nc copyright holder holder preprint international license license available nc international peer copyright doi medrxiv medrxiv preprint drug target human interactome network proximity hcov host viral infection host interactome interactome network virus host drug discovery gsea score human protein potential treatment repurposable drug sequence identity supplementary table drug potential ebola virus estrogen receptor permutation test protein interactome putative repurposable target network treatment hcovs acute respiratory anti inflammatory complementary exposure current network drug gene drug human drug repurposing gene expression high throughput host human host protein prevention treatment protein sequence recent study respiratory syndrome specific hcov spike protein syndrome coronavirus viral replication z gsea antiviral drug candidate drug drug combination drug hcov effective drug enrichment analysis exposure pattern human cell interactome figure mercaptopurine melatonin network drug papain protease pathogenic hcovs potential drug potential prevention potential repurposable preclinical clinical protein protein rna synthesis role viral throughput hybrid treatment hcov z score anti virus binary ppis bowel disease c jun cmap database combination effective comprehensive human coronavirus middle cost drug differential gene discovery strategy disease module dna topoisomerase drug drug drug figure drug inflammatory drug methodology drug multiple,"['human severe acute respiratory syndrome coronavirus middle east respiratory syndrome coronavirus novel coronavirus lead global high morbidity mortality', 'effective', 'drug repurposing effective drug discovery strategy time cost drug discovery', 'study present integrative antiviral drug methodology pharmacology network medicine platform interplay hcov interactome drug human protein interaction network', 'phylogenetic whole nucleotide sequence identity pathogenic hcovs', 'nucleocapsid sequence', 'network proximity drug hcov host human protein interactome putative repurposable potential prevention treatment hcovs', 'addition potential anti hcov repurposable melatonin mercaptopurine sirolimus enrichment drug gene induced', 'potential drug sirolimus dactinomycin mercaptopurine melatonin toremifene emodin', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'affect respiratory tract lead severe respiratory tract', 'past pathogenic human covs hcovs severe acute respiratory syndrome coronavirus middle east respiratory syndrome coronavirus animal global high morbidity mortality', 'example died pandemic cost global economy', 'world health organization total diagnosed majority arabia', 'december third pathogenic hcov novel coronavirus china', 'february pandemic human human transmission close', 'effective', 'several national international research', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint development treat effective available', 'urgent need development effective prevention treatment', 'investment biomedical pharmaceutical research development past annual number new u food drug administration fda constant', 'recent study pharmaceutical development new chemical entity drug', 'drug repurposing effective drug discovery strategy time cost drug discovery clinical', 'experimental drug costly', 'computational novel testable systematic drug repositioning', 'traditional structure dimensional unavailable case majority human viral', 'addition single virus high risk drug resistance rapid evolution virus', 'hcov require host cellular successful replication', 'systematic identification virus host protein protein effective way elucidation viral infection cov ebola virus virus', 'integrated antiviral drug discovery pipeline gene trap insertional mutagenesis functional drug gene network', 'methodology several candidate repurposable virus', 'work last decade network example effective repurposable drug multiple human', 'example network drug disease proximity light relationship g drug molecular pathobiology ppis useful tool efficient new drug recent', 'study present integrative antiviral drug methodology pharmacology network medicine platform virus host interactome drug human ppi network', 'basis associate viral infection subnetwork comprehensive human ppi network ii drug specific disease suitable drug potential antiviral infection common ppis functional human interactome figure', 'follow analysis validation drug gene induced', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint human cell mechanism action specific hcov propose repurposing figure', 'date pathogenic hcovs figure cov b genera ii genera', 'phylogenetic whole genome sequence hcovs evolutionary relationship hcovs', 'whole nucleotide sequence identity supplementary table', 'sequence identity pathogenic hcovs evolutionary relationship figure', 'hcovs major protein structure viral replicase complex spike envelope membrane n figure', 'gene non structural nsp viral rna synthesis complex proteolytic processing', 'viral rna dependent rna polymerase high polymerase activity', 'protein threedimensional structure view cov n terminal extension polymerase domain figure', '', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint spike transmembrane glycoprotein pivotal role viral infection host receptor', 'figure structure spike protein host receptor cov pdb id', 'recent study able utilize entry receptor potential drug therapeutic development', 'addition nucleocapsid important subunit packaging viral genome protein oligomerization single nucleocapsid structure figure', 'protein sequence alignment supplementary table', 'nucleocapsid sequence table', 'spike protein sequence conservation sequence identity', 'spike protein sequence identity', 'cov host hcovs mouse avian ibv n protein supplementary table', 'total host various experimental', 'host', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint direct crucial infection', 'hcov host interactome network figure', 'several jun number', 'pathway enrichment analysis multiple significant biological value transport nf kappa b epstein barr virus infection influenza figure', 'gene ontology biological process enrichment multiple viral infection value viral life cycle modulation virus host morphology physiology viral process positive regulation viral life cycle transport virus virion attachment host cell figure', 'drug target network host interactome search druggable cellular', 'human blue nodes figure drug experimental drug clinical trial', 'example ikbkb targetable', 'high druggability hcov host interactome therapeutic strategy cellular hcovs drug repurposing', 'basis network drug govern viral infection corresponding subnetwork figure comprehensive human interactome network', 'drug multiple effective', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint hcov target immediate vicinity subnetwork human interactome figure multiple drug repurposing strategy', 'state ofthe art network proximity measure relationship hcov specific subnetwork figure drug human interactome', 'drug target network target information fda experimental', 'quality completeness human protein interactome network ppis experimental binary ppis protein binary unbiased high throughput hybrid kinase substrate experimental literature various experimental', 'z score z measure permutation test study bias network proximity hub human interactome network ppi bias recent', 'total z p permutation test hcov host interactome figure author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint vs p distribution vs p vs ibv p vs mhv p', 'network proximity putative repurposable potential prevention treatment hcovs', 'validate repurposable gene enrichment analysis gsea transcriptome host', 'transcriptome gene', 'expression drug human cell connectivity cmap database drug gene', 'gsea score drug score indication validation', 'enrichment score es hcov es p permutation test cut significant association gene drug specific hcov', 'gsea score number specific drug', 'mesalazine drug inflammatory bowel disease sirolimus immunosuppressive drug equilin agonist estrogen receptor menopausal gsea paroxetine melatonin gsea', 'potential repurposable figure table hcovs subject matter expertise combination strength network network proximity score supplementary table ii validation gsea', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi iii literature antiviral side', 'showcased several repurposable literature antiviral', 'selective estrogen receptor', 'overexpression estrogen receptor crucial role viral replication', 'play role viral replication classical estrogen receptor', 'viral entry step fusion antiviral activity absence detectable estrogen receptor expression', 'toremifene z figure first generation nonsteroidal serm potential various viral ebola virus cell', 'different classical antiviral pathway toremifene fusion viral endosomal membrane virus membrane glycoprotein viral replication', 'figure toremifene several key host hcov', 'equilin z gsea score estrogenic steroid moderate activity entry zaire ebola virus glycoprotein human immunodeficiency virus zebov gp hiv', 'network toremifene equilin potential repurposable', 'viral infection hcovs', 'irbesartan z typical arb', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi approved fda treatment hypertension diabetic nephropathy', 'network proximity analysis significant association irbesartan host human interactome', 'figure irbesartan sodium bile acid cotransporter ntcp protein functional receptor hepatitis b virus hbv hepatitis delta virus hdv', 'irbesartan inhibit ntcp viral entry', 'potential transcriptional repressor cov', 'several eletriptan frovatriptan zolmitriptan hcov host human interactome', 'mammalian target rapamycin complex key factor various', 'sirolimus z gsea score inhibitor mammalian target rapamycin mtor block viral protein expression virion release', 'study clinical application sirolimus cov infection', 'sirolimus usage severe pneumonia acute respiratory failure', 'mercaptopurine z gsea score antineoplastic agent immunosuppressant property treat cancer application several autoimmune rheumatoid arthritis systemic lupus erythematosus crohn disease', 'mercaptopurine selective inhibitor', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint papain protease key viral maturation antagonism interferon stimulation', 'several host jun ncl figure', 'anti inflammatory', 'inflammatory essential viral', 'biogenic amine melatonin z gsea score key role various biological potential strategy management viral', 'viral immune inflammatory injury level oxidative stress negative multiple organ', 'antioxidant effect melatonin putative candidate drug relieve clinical antiviral treatment melatonin eradicate viral replication transcription', 'addition application melatonin survival time chance immune', 'figure melatonin several cellular jun ikbkb', 'eplerenone z aldosterone receptor antagonist similar anti inflammatory effect melatonin', 'mast fibrosis eplerenone survival mice encephalomyocarditis virus', 'summary network proximity multiple putative repurposable diverse cellular potential prevention treatment', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint hcovs', 'preclinical clinical clinical network clinical use', 'drug offering therapeutic efficacy toxicity play important role various viral', 'ability validate effective combinatorial explosion large number drug dosage', 'recent study novel network methodology efficacious drug', 'drug hypertension cancer drug combination effective complementary exposure pattern disease module target separate figure', 'sought drug synergistic effect hcovs mechanism action network analysis', 'potential repurposable figure network candidate drug potential treatment hcovs', 'sirolimus inhibitor mtor antifungal antineoplastic severe pneumonia acute respiratory failure', 'mtor essential role infection', 'dactinomycin rna synthesis inhibitor treatment various cancer', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint', 'study dactinomycin microgram ml growth feline enteric cov', 'figure network analysis sirolimus host protein subnetwork complementary exposure pattern potential combination treatment hcov', 'sirolimus dactinomycin mtor rna synthesis pathway dna topoisomerase dna topoisomerase hcov figure', 'toremifene first generation treatment metastatic breast cancer', 'toremifene ebola virus infection ebola virus glycoprotein', 'vitro toremifene inhibited growth sara cov table', 'derivative tanguticum various virus', 'inhibited protein interaction spike protein', 'network experimental toremifene emdoin potential therapeutic approach hcovs figure', 'figure melatonin strong network proximity hcov host human interactome network', 'recent vitro vivo mercaptopurine selective inhibitor papain protease', 'melatonin potential treatment', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint viral infection anti inflammatory antioxidant', 'melatonin expression key entry receptor viral infection hcovs', 'jun c jun key host protein infectious bronchitis virus', 'figure mercaptopurine melatonin jun multiple cellular', 'summary combination mercaptopurine melatonin potential combination therapy papain protease c jun anti inflammatory figure', 'experimental clinical', 'study network methodology systematic identification putative repurposable drug potential treatment hcov', 'integration drug target host induced transcriptome human cell human protein protein interactome network essential identification', 'comprehensive evaluation putative repurposable putative drug potential treatment hcovs', 'network repurposable drug preclinical clinical', 'several current study', 'study low affinity value µm define physical drug target', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint interaction', 'affinity threshold e g cut drug discovery generate drug target network', 'sizeable large scale drug target available network drug physical', 'computational drug target', 'addition virus host complete quality multiple different experimental cell line', 'new virus host interactome hcovs sequence structure', 'current pharmacology model separate therapeutic antiviral due detailed pharmacological drug unknown functional', 'drug cellular therapeutic adverse activate protein versus', 'comprehensive identification virus host interactome specific biological functional accuracy current network', 'lack complete drug target information molecular promiscuity response dose toxicity repurposable drug current network', 'example mesalazine drug inflammatory bowel disease', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi top network candidate drug figure hcovs', 'several clinical potential pulmonary pneumonia usage', 'preclinical evaluate vivo efficiency side clinical', 'limited predict pairwise drug previous network framework', 'methodology useful network prediction multiple network host subnetwork human interactome', 'repurposable ncov host', 'current network repurposable anti virus virus', 'combination anti virus repurposable drug figure coverage current network multi layer network framework', 'conclusion study powerful network pharmacology methodology rapid identification repurposable drug potential treatment hcov', 'approach translational gap preclinical clinical significant problem rapid development efficient treatment outbreak', 'translational perspective network effective treatment virus human', '', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint total dna recent genbank database january supplementary table', 'whole genome alignment protein sequence identity calculation multiple sequence alignment embl ebi database default', 'neighbor nj tree phylogenetic distance matrix mega x bootstrap', 'protein alignment phylogenetic tree hcovs mega x', 'hcov host protein various sizeable', 'hcov host several cov ibv mhv', 'direct critical infection multiple experimental high throughput hybrid viral protein pull vitro coimmunoprecipitation rna knock experiment', 'total virus host interaction network hcovs host supplementary table', '', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi next performed kyoto encyclopedia gene ontology enrichment biological relevance functional', 'functional enrichr', 'drug target interaction information drugbank database therapeutic target database ttd pharmgkb database chembl bindingdb iuphar bps guide pharmacology', 'chemical structure drug drugbank', 'drug target meeting ki kd ≤ μm ii target reviewed uniprot database iii human target unique uniprot accession number', 'drug target network recent study', 'comprehensive list human ppis total biology experimental', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint binary ppis high throughput hybrid ii binary physical ppis protein dimensional kinasesubstrate low high throughput network literature low throughput v literature ppis identified affinity purification mass spectrometry ap ms literature low throughput', 'evolutionary analysis gene expression metabolic', 'id ncbi database official gene', 'total human protein protein interactome study unique ppis increase number ppis', 'detailed human protein interactome previous', 'posit human ppis unbiased rational roadmap potential treatment hcovs', 'host specific hcov drug network proximity target drug method', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint distance gene human interactome', 'network proximity score permutation ccc e mean standard deviation permutation test time gene similar degree', 'p value permutation test', 'z score p proximal drug hcov', 'gephi', 'network approach drug effective topological relationship drug target biological pharmacological network relationship drug host drug drug hcov', 'potential drug top', 'separation measure hi pair method', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint 〈 • 〉 method', 'key methodology drug combination effective specific relationship disease module complementary exposure toxic', 'gene enrichment analysis additional prioritization method', 'differential gene expression hcovs ncbi gene expression geo', 'transcriptome patient peripheral blood', 'transcriptome infected', 'p value', 'hcov host treatment', 'differential gene expression various connectivity map cmap database gene', 'drug drug target network enrichment score es hcov signature set', 'cc nc international license available author funder medrxiv license display preprint perpetuity', '', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint', 'effective drug combination complementary exposure pattern hcov host subnetwork target separate human interactome network', 'zca zcb denote network proximity z score specific hcov', '', 'cc nc international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint']"
3e5633a9a76a8c03e4ec57e4659872a63f045117,acute respiratory respiratory syndrome syndrome coronavirus severe acute biorxiv preprint copyright holder holder preprint preprint peer doi biorxiv genome sequence author funder available copyright candidate virus cc nc e g international license license author nc nd nd international virus taxonomy framework virus public health virus host virus novelty causative agent disease spectrum green diagonal homologous recombination median pd study group virus genome virus isolate virus severe classification taxonomy committee taxonomy comparative sequence coronavirus study criterion novelty definition virus demarc framework discovery virus due minute failure causative family classification family coronaviridae full taxonomy genomic variation group international human covs human pathogen individual pathogenic international committee isolate genome name disease naming convention novelty group official classification particular virus pd human phylogenetic analysis recombination common respiratory coronavirus sequence analysis sequence public small median specific disease spectrum clinical st century term novel virus acute virus different virus novel abbreviated form acknowledge immune acronyms virus addition constitute additional important address significant addressed framework adjustment major advanced part advancement coronavirus aeg context african bat agency communicable agent control agent diagnostic agent disease along ictv amino genome analysis family analysis maximal analysis pathogenic analysis replicative analysis role analysis uneven animal major answer research anything different apparent failure,"['present respiratory tract respiratory distress syndrome third spillover animal major epidemic', 'coronavirus study group international committee taxonomy responsible official classification taxonomy coronaviridae family novelty human pathogen', 'phylogeny taxonomy practice csg virus sister severe acute respiratory syndrome covs severe acute respiratory syndrome coronavirus severe acute respiratory syndrome coronavirus', 'facilitate communication csg naming convention individual', 'spectrum clinical', 'independent zoonotic transmission entire virus research individual pathogenic significance', 'research virus host environment enhance preparedness future', 'biorxiv preprint novelty place taxonomy family st century family positivestranded rna several coronavirus novelty severe life disease zoonotic reservoir severe acute respiratory infectious disease new virus box', 'first principal informs causative agent control transmission potential', 'name', 'different time scale answer research public health', 'novelty naming relation coronavirus outbreak respiratory syndrome wuhan', 'novel coronavirus', 'term novel disease spectrum clinical infected particular virus', 'term novel name incomplete match appropriate criterion novelty', 'disease host range ascertain virus novelty identity genome virus cause host switch', 'rna swarm co related sequence', 'genome sequence consensus cooperative population vivo single infected person time outbreak', 'strict match criterion novelty rna virus genome novel virus criterion informative', 'potential problem identical similar genome question much difference large recognize candidate virus novel distinct', 'question practice degree relatedness candidate virus host monophyletic different', 'addressed framework virus taxonomy box', 'study present assessment novelty detail basis virus severe acute respiratory syndrome coronavirus hereafter', 'syndrome east respiratory syndrome', 'time pathogen new human coronavirus case current outbreak time issue family classification', 'current classification taxa fifteen available forty family coronaviridae suborder cornidovirineae order', 'family classification taxonomy coronavirus study group group international committee taxonomy', 'csg responsibility novelty relation purpose paper context severe acute respiratory syndrome coronavirus', 'appreciate difference severe acute respiratory syndrome coronavirus e', 'look relation context full taxonomy structure several taxonomy virus host fig', '', 'urbani particular genome sequence equivalent single human acute respiratory syndrome coronavirus', 'parallel meaningful practice extension concept virology', 'anything different life human human member', 'individual living organisms knowledge inter individual', 'csg computational framework comparative several study concerned classification nomenclature order group box', 'study partition variation replicative open reading genome fig', 'identify wise patristic demarcate virus different', 'respiratory coronavirus fig', 'genus betacoronavirus fig', '', 'distance related different choice measure amino genome region', 'exact taxonomic position e', 'dataset recent update taxonomy ictv composition virus severe acute respiratory syndrome coronavirus', 'threshold limit family coronaviridae imposed ppd inter threshold', 'due minute share total number intra inter conventional diagonal plot basis fig', '', 'virus acute respiratory syndrome coronavirus evident analysis maximal coronavirus', 'pds', '', 'genomic variation sampled g', 'prototyped ibv fig', 'coronavirus sequence space', 'acute respiratory syndrome coronavirus facilitate unambiguous assignment', 'intra belong top pd african bat virus isolate fig', 'basal severe acute respiratory coronavirus constitute', '', 'contrast shallow populous lineage human related bat asian origin search potential zoonotic source epidemic', 'note clade structure susceptible homologous recombination common clade definition virus deep', 'current small median pd human covs median pd', '', 'small median pd human covs wide pd distribution fig', '', 'initial failure causative agent disease specific pcr separation phylogeny pd space novel many', 'guidance virus acute respiratory syndrome coronavirus', 'respect discovery virus zoonotic st century fig', '', 'novel study group informal', 'cc nc nd international license author funder', 'available copyright holder preprint peer', 'doi biorxiv preprint subgenera sarbecovirus merbecovirus', 'due first new practice state virus taxonomy respective', 'box', 'applicable diverse', 'human outbreak cause', 'reference use specific genome sequence public phylogenetic respective virus isolated example urbani virus specific disease e', 'practice virus distant relationship prototype cov distance space', 'csg', 'contrast name name disease fig', 'way predefine name disease spectrum', 'available limited epidemiological clinical disease spectrum transmission', 'diagnostic confirm identical', 'specific public health laboratory diagnostic staff e g', '', 'wish help naming appropriate way fig', '', 'facilitate good practice scientific exchange csg new standardized format public', 'naming convention reference host organism virus time isolation place isolation geographic location virus isolate host date location e g', '', 'complete designation additional important association pathogenicity submission isolate genome sequence public e g', 'genbank', 'name sequence database id e g', 'text', 'format inform major particular virus isolate genome', 'cc nc nd international license author funder', 'available copyright holder preprint peer', 'doi biorxiv preprint sequence critical subsequent epidemiological', 'public health fundamental research detection containment treatment analysis pathogenic little regard genetic diversity biological', 'framework emergence human pathogen december independent outbreak', 'descendent fig', 'introduction unknown external fig', 'evolutionary', 'advanced part severe acute respiratory syndrome coronavirus long term goal biology evolution biology', 'connect development health care diagnostic target entire complement detect individual pathogenic', 'paper single virus concern family', 'first step appreciation relevant proper full taxonomy', 'relevant virus along ictv observed common practice proliferation mixing literature paper wish acknowledge immune problem several', 'necessary adjustment major revision virus ictv future', 'change place csg address significant overlap virus appreciation use application', 'understanding cause specific disease biological infectivity major force discovery virus many life', 'range specific', 'cc nc nd international license author funder', 'available copyright holder preprint peer', 'doi key define invisible naked eye due minute size', 'phenotype disease virus host g', 'transmission rate immune protection specific e g', 'architecture virus', 'phenotypic critical importance many important severe infectious general perception', 'definitive pathogenicity major fast share many next generation technology', 'diverse environmental assemble genomic sequence nature phenotypic level', 'genome sequence characteristic vast majority virus identity available choice', 'framework virus genome sequence polynucleotide capable autonomous replication dissemination organisms appropriate', 'natural host', 'experimental fraction computational comparative classify deduce', 'virus common use refer virus genome different term specific context', 'candidate virus group variant group virus', 'hand candidate virus comparable observed different intergroup novel', 'evaluation silico phylogenetic analysis uneven vary different virus due mutation exchange genome related homologous recombination', 'comparative basis pcr suitable detect', 'pcrs candidate virus novel', '', 'current sampling small significant medical economic interest group composition different novelty group specific dependent choice specific', 'cc nc nd international license author funder', 'available copyright holder preprint peer', 'doi biorxiv preprint', 'definitive evidence novelty group scrutiny', 'framework virus taxonomy genomic variation strain isolate level unique taxa nomenclature supervision ictv', 'virus novelty different comparative sequence analysis role primary tool classification box', 'taxonomical classification hierarchical nested populate different classification', 'taxa different respect intrataxon pairwise divergence realm rank', 'taxon specific natural', 'virus define name taxa optional', 'mandatory unit virus taxonomy', 'virus new novel taxonomy wise', 'framework virus barrier novel part original', 'association permanent circulation new host likely', 'past classification serologic cross reactivity protein till comparative sequence analysis replicative', 'choice start century', 'niran fig', 'analysis', 'current knowledge essential conserved order classification nidovirus sgs nsg', 'classification demarc diversity hierarchical clustering software taxa', 'involvement coronavirus genome available time analysis family wide demarcation size single es', 'demarc monophyletic weighted linkage pairwise patristic distance ppd space classification cost cc minima ppd', 'persistence virus demarc framework reflection biological environmental', '', 'cc nc nd international license author funder', 'available copyright holder preprint peer', 'doi biorxiv preprint homologous recombination common restricted essential classification', 'restriction intra diversity inter separation biological current ictv definition virus man', 'facilitate use rank demarc framework pair wise arrive tentative assignment coronavirus taxonomy conventional phylogenetic analysis', 'single representative addition constitute official classification virus taxonomy', 'exceptional treatment product historical perception box way classify expression appreciation virus individuality', 'disease organism isolated dominate name vocabulary typical virus nature', 'virus recognition virus novelty box national global virus novelty virus', 'virus uncommon virus different different', 'world health organization agency communicable coordination international public health major virus', 'novelty responsibility disease human', 'traditional approach specific novelty apparent failure causative agent diagnostic', 'related nomenclature taxonomy', 'study virus case case basis extension official remit special expertise', 'study responsible virus important role research community significance', 'csg approach define virus', 'virus confused part', 'problem', 'copyright holder preprint peer', 'doi biorxiv preprint italicized capital letter abbreviated form virus severe acute respiratory syndrome coronavirus', 'work demarc advancement coronavirus nidovirus eu evag project mobile program mercator fellowship deutsche forschungsgemeinschaft aeg context jz', 'tree alphacoronavirus', 'red zoonotic pathogenicity common respiratory', 'asterisk approval coronavirus', 'populous right green white ppds inter panel b', 'green diagonal proportional virus respective sampled left asterisk threshold', 'appear white green diagonal green diagonal dots kind total panel indication strong support', 'b maximal intra x axis linear scale virus axis log scale green', 'acronyms virus', 'green blue plot intra subgenera ppd', 'vertical black line inter', 'pds identical major phylogenetic', '', 'pd ppd', '', 'copyright holder preprint peer th', 'doi biorxiv preprint']"
b9d587239806b4c15ec6412ce1f03015c47d5e58,ebov sgp cytokine production μg ml ng ml production inflammatory inflammatory cytokine additional h ml h sgp μg flow cytometry ml sgp pro inflammatory sgp h basal chamber h sgp inhibitory effect ml ng pbs h presence sgp glycoprotein sgp h lps incubation time sgp fig sgp pbs treatment sgp viral protein → sgp c type chemotactic ability ebov glycoprotein inhibit production lps sgp lps μg major role mg ml production sgp production tnfα sgp ability sgp able sgp activation sgp inhibit sgp polarization sgp pro sgp production test sgp viral replication able inhibit activation activation adaptor protein anti ebov anti inflammatory anti viral apical chamber attachment factor b ng chamber complete cold pbs ebola virus ebov infection effect sgp fitc mg h c h h h incubation h total half life hemorrhagic fever high μg ifnγ h immune response incubation sgp inflammatory high inflammatory tnfα innate response low inflammatory low μg lps pbs macrophage polarization macrophage production migration cytokine migratory ability min h ml b ml high n p ns significant number basal ova fitc p ns pbs → percent chemotaxis phagocytic ability phagocytic activity phenotype ng polarization fig polarization sgp pool susceptible possible attachment presence ebov production ebov,"['ebola virus ebov infection glycoprotein sgp large animal', 'decoy anti ebov', 'vitro model treatment infected human ebov sgp study examine impact sgp key macrophage', 'macrophage polarization phagocytic capacity unaltered sgp treatment', 'treatment sgp inhibited macrophage production inflammatory tnfα yield anti inflammatory cytokine intact', 'migratory ability sgp due decrease expression vital macrophage integrin', 'ebov sgp diminish functional potential viral dissemination', 'recent outbreaks zaire ebolavirus ebov western world healthcare system', 'much pathogenesis virion unclear', 'much effort action viral immune dendritic tissue much discovered regard soluble ebola virus immune', 'order family genus ebolavirus virus', 'zaire sudan reston bundibugyo taϊ forest', 'cause disease reston virus', 'zaire strain common outbreaks laboratory', 'ebolavirus virion virion negative rna genome', 'genome different envelope spike glycoprotein gp', 'glycoprotein g', 'g subunit mucin domain attachment host', 'glycoprotein transmembrane portion terminal end tumor necrosis factor enzyme tace', 'cleavage delta peptide portion', 'subject several biological function', 'suggestion glycoprotein virion immune evasion production inflammatory', 'glycoprotein tace cleavage site intracellular protein transmembrane domain delta normal secretory pathway', 'protein secreted glycoprotein sgp', 'soluble high patient blood serum', 'important respond body', 'type challenge relative', 'bacterial viral infection classical phenotype high inflammatory tnfα etc', 'cytokine production high phagocytic', 'helminth infection phenotype production inflammatory', 'effector', 'cell', 'dendritic early pathogenesis', 'infected access blood disseminate virus blood vasculature', 'viral invasion endothelia production inflammatory infected lead development viral hemorrhagic fever characteristic ebov infection', 'report reduced pro inflammatory cytokine production ebov sgp', 'inhibitory sgp insufficient counter concomitant stimulation lipopolysaccharide lps', 'sgp effect capacity antigen', '', 'overall ebov sgp major role pathogenesis impairment', 'human monocyte complete rpmi ge healthcare fbs heat min mm gentamycin', 'incubator co', 'monocyte incubation phorbol pma stimulation rest', 'phenotype ng ml ifnγ h phenotype ng ml ng ml h', 'flow cytometry assessment characteristic cellular', 'μg ml sigma pbs h incubation low μg ml high μg ml recombinant ebov sgp transmembrane domain ibt h ebov sgp study mammalian inhibition formation', 'test sgp impact prior stimulation μg ml polarization h activated additional h ml', 'assessment effect sgp time activation stimulation μg ml sgp μg ml sgp pbs h completion h cell tested elisa', 'elisa utilizing ready elisa scientific tnfα manufacturer', 'elisa eon microplate spectrophotometer biotek gen software version', 'incubation sgp pbs adherent culture trypsinization trypsin edta', 'standard formalin', 'human specific ebioscience utilized', 'flow cytometry guava cytometer millipore guavasoft software', 'ability foreign utilizing fitc chicken ovalbumin peptide fitc fisher', 'lps µg ml pbs h treated sgp µg ml additional h ova fitc mg complete unconjugated ovalbumin protein mg ml invivogen pbs', 'min h h incubation time adherent treatment trypsin edta', 'cold pbs bound', 'flow cytometry', 'debris', 'chemotaxis', 'brief transwell μm pore size', 'lps sgp pbs', 'apical chamber complete', 'ng ml peprotech basal chamber', 'incubated h hemocytometer becton dickinson company flow cytometry', 'exclude debris membrane flow percent increase chemotaxis number basal chamber chemokine number basal chamber presence chemokine ×', 'standard statistical significance unpaired student test', 'value significant', 'minimum consistent', 'infection tissue dendritic systemic dissemination entry point', 'virus synthesis secretion glycoprotein sgp blood', 'purpose maneuver immune reactivity replication dissemination process anti ebov antibody sink', 'likely case early prior antibody synthesis', 'importance early innate response viral examine effect ebov sgp activation', 'order test vitro human monocytic cell line treatment pma day rest source', 'way activate trigger cytokine production', 'low μg ml high μg ml dose sgp h production dosage sgp fig', '', 'production presence sgp fig', '', 'low high affect activated chose use low dose remainder study', 'sgp inhibitory effect non', 'phenotype treatment ifnγ', 'test sgp inhibit polarization sgp ifnγ washed lps cytokine production', 'ebov sgp present polarization significant effect cytokine profile characteristic', '', 'production inflammatory high significant cytokine ifnγ presence sgp', 'low inflammatory cytokine stimulation level cytokine presence sgp polarization fig', '', 'basal level production lps', 'likely due ability promote macrophage production', 'note basal production sgp relative lps', 'sgp ligation unknown receptor activation adaptor protein basal release', 'activation sgp restoration', 'test sgp effect polarization sgp h lps additional h low inflammatory high', '', 'time production tnfα unchanged fig', '', 'addition significant inhibition basal evident', 'overall sgp disturb process macrophage polarization role function', 'sgp impact infected macrophage function sgp soluble viral protein body undergoing activation', 'test hypothesis sgp microbial ifnγ h lps pbs h sgp pbs additional h total incubation time polarization activation supernatant harvest h sgp able inhibit production inflammatory anti inflammatory cytokine', '', 'provoke cytokine production treatment polarized sgp cellular viability', 'order determine experimental approach cell death assessed expression cell viability flow cytometry', 'viability lps lps → sgp supplementary fig', '', 'sgp able inhibit production inflammatory polarized', 'sgp restrain', 'test possibility lps sgp h significant difference sgp production fig', '', 'ebov sgp inhibits production inflammatory inflammatory', 'inhibitory effect stimulatory effect lps', 'important effector capacity phagocytose microbial', 'non self destruction antigen presentation', 'ebov sgp able interfere pro inflammatory cytokine production', 'b early immune response general', 'professional early response control clear body microbial', 'prior assessment sgp ability impair phagocytic activity unconjugated complete ova protein mg ml fitc mg ml min h h determine optimum incubation time', 'trypsinization cold pbs stop antigen uptake remove cellular surface antigen accumulation', 'fig', 'period intensity ova accumulation culture time optimal incubation time', 'test capacity sgp modulate phagocytic lps pbs h sgp additional h fig', '', 'percentage ova fitc particle unremarkable group group sgp fig', 'phagocytic ability pivotal macrophage presence ebov sgp', 'phagocytic activity ebov sgp pro inflammatory cytokine production viral protein ebov survival dissemination impairment inflammation related migration cytokine production', 'chemotactic ability treatment sgp', 'sgp h placed apical chamber', 'chemokine monocyte chemoattractant pbs basal chamber complete', 'migrate h live basal chamber assessment live cytometry', 'fig', '→ pbs → sgp significant increase percent chemotaxis inactivated → pbs pbs → sgp', 'percent chemotaxis sgp activated pbs', 'lps migratory operate impair migration', 'macrophage migration presence ebov sgp', 'integrin critical migration dendritic', 'ebov sgp expression impact migratory capacity', 'test possibility sgp h expression flow cytometry', 'activated sgp μg ml sgp μg additional h sgp → group ifnγ ml ng ml ng ml sgp μg ml h lps μg ml h total incubation production tnfα elisa', 'n p ns significant', 'fig', '', 'sgp chemotactic ability expression', 'major role sgp pathogenesis', 'primary role sgp pathogenesis decoy molecule antibody production', 'study first time sgp inhibitory susceptibility infection progeny virion', 'ebov sgp production inflammatory chemotaxis integrin expression', 'phagocytosis unaffected consistent recent notion ebov utilizes apoptotic mimicry phagocytosis', 'sgp halt macrophage anti viral entry site virion', 'addition ebov glycoprotein viral sgp inhibition restore migration cytokine production systemic dissemination virus viral hemorrhagic fever', 'ebov peak plateau day postinfection titer virus infection', 'high rate viral replication large pathogen molecular viral nucleic', 'response fig', '', 'macrophage pro inflammatory cytokine production ebov sgp activation activation', '', 'pbs sgp h c ifnγ ng ml b ng ml ng ml', 'pbs lps μg ml sgp μg additional h → sgp group ml b ng ml ng ml h lps μg ml h sgp μg ml h c sgp group μg ml sgp μg ml h polarization', 'production tnfα elisa', 'n p ns significant', 'bone marrow bloodstream microbial infection', 'systemic spread virus high mortality rapid mobilization innate response ebov able host response order infect carrier', 'purpose virus site initial infection', 'hypothesis work ebov sgp inhibit effector prior infection', 'assess modulation dcs unpublished', 'focus', 'little impact viral replication limited phagocytic ability cytokine production target ebov sgp', 'notion inability sgp alter production', '', 'contrast differentiation pma activation lps fig', '', 'sgp differentiation', 'receptor sgp differentiated', 'work sgp receptor incubation sgp', 'undergo polarization effector order support microbial elimination genetic program particular', 'severe acute respiratory syndrome coronavirus human immunodeficiency virus human cytomegalovirus polarization support successful viral replication', 'ebov polarization secretion viral protein modulate process', 'vitro model ebov sgp demonstrate ability polarization fig', '', 'spread ebov benefit', 'sgp prior activation receptor viral protein upregulated', 'production sgp macrophage activation activation', 'production sgp polarization', 'sgp polarization production', 'activity sgp activation regulatory adaptor protein interferon regulatory profound inhibitory effect proinflammatory cytokine production milder inhibitory effect production', 'fact sgp production polarization step role regulatory protein differentiation process hematopoietic stem', 'target viral suppress immune response promote viral pathogenesis', 'possible presence sgp activity inflammatory production', 'possibility future work', 'previous shed ebov glycoprotein mitigate production inflammatory immune state version unable stimulate', 'soluble ebov glycoprotein spike effect', 'non glycoprotein sgp cytokine production', 'sgp inhibit production inflammatory fig', '', 'inhibitory effect sgp tnfα production genetic protein secretion level', 'mice half life much vitro', 'lps h excess lps sgp sgp compete gp', 'ebov sgp lps induced downstream inhibit activation κb action iκb kinase ikk', 'lps pathway sgp mitogen protein', 'lps toll receptor recruitment phosphorylation receptor kinase turn', 'mapk κb leading cytokine production', 'block tollip irak protein suppressor cytokine sgp interfere cytokine production', 'production unchanged presence sgp unlikely sgp pro inflammatory cytokine production protein secretory', 'sgp nf κb cytokine production underway', 'sgp capacity activation incapable lps time stimulant fig', '', 'much half life short term time cytokine endpoint experiment', 'examination cytokine production h address issue', 'rapid turnover high blood', 'ebov gp compete receptor possible attachment factor virus', 'truncated version gp unknown', 'appeared impact cellular receptor', 'natural killer nk treatment sgp inhibition nk effector sgp alternate receptor unpublished', 'ability phagocytose cellular debris', 'phagocytic action phenotype phenotype', 'soluble antigen phagocytosed dcs c type lectin mannose receptor', 'type possible attachment factor ebov entry host', 'phagocytosis ovalbumin treatment sgp fig', '', 'hypothesis correct sgp ability virus c type', 'c type important entry', 'migratory ability essential function antigen', 'ebov sgp ability diminish capacity response fig', '', 'integrin marker macrophage necessary chemotactic ability', 'assessment expression cellular marker', '', 'conclusion novel mechanism ebov sgp anti viral immunity activated pool susceptible infection', 'ebov sgp pro inflammatory cytokine production chemotaxis cellular ability take', 'sgp major role ebov pathogenesis', 'progeny virion spread body', 'second paralyzed pool susceptible host infection', 'information important consideration high replication rate virus copious production soluble viral efficacy host immunity']"
7cd5321d8b9deb046502c0f1ab1581e7200bc378,dna vaccine needle free biojectorh delivery post boost delivery dna needle syringe elispot response ifn c visp r western blot antibody response c elispot dna needle dna prime gag pol intracellular cytokine n delivery biojectorh device biojectorh n biojectorh vs cell post clade b delivery needle dna biojectorh dna delivery end point high pre low high n group pol nef positive response administration device antibody single axis figure b clade b env biojectorh blue biojectorh group blue n booster vaccination cell response clade c clinical evaluation clinical trial comparison median consort checklist cumulative median cytokine biojectorh cytokine production day dna device delivery dna immunization dna technology dna vaccination dna week drug administration elispot cell env glycoprotein enva gag enva range enva specific envb envc evaluation dna exact test food drug free biojectorh free injection frequency antigen frequency biojectorh gag peptide glycoprotein clade group high group positive high frequency high titer hiv vaccine immunogenicity dna indeterminate unreadable injection x institute infectious magnitude th median elispot median enva median magnitude n primed national institute needle injection p magnitude peptide recombinant phase iib plasmid dna point titer positive indeterminate positivity sero potency dna pre antibody pre enva pre immunity pre threshold primed day,"['background dna vaccine immunogenicity inefficient delivery', 'needle free delivery dna co biojectorh device delivery needle syringe safety immunogenicity', 'intramuscular im vaccine tm needle syringe im week n particle', 'equal schedule low high reciprocal antibody', 'dna follow research sample', 'ifn response n delivery week post boost', 'magnitude elispot response biojectorh n', 'similar response cell', 'env specific antibody biojector', 'vaccination biojectorh needle injection ifn c elispot cell antibody', 'immunization plasmid dna technology gene antigen delivery', 'many microbial part simplicity', 'particular pre vector immunity construction manufacturing rapid candidate dna stable safe', 'dna vaccine immuno genicity expected preclinical', 'basis likely inefficient transfection plasma nuclear host major factor', 'last research center significant effort evaluate dna technology platform several virus hiv nile virus wnv', 'number protein expression codon modification translation backbone', 'variety early program decision use needle free biojectorh device delivery antibody response dna delivery needle syringe n', 'particular vaccine influenza hiv favorable immunization merit development', 'dna vaccine prm e substantial antibody comparable', 'influenza program single dose influenza ha dna vaccine fold increase hai antibody single month boost inactivated vaccine vaccine', 'concept phase ii seasonal influenza', 'hiv vaccine development program dna broad durable cell consistent antibody', 'hvtn phase iib test concept study determine efficacy', 'progression dna clinical important understand delivery immunogenicity', 'report study biojectorh n delivery dna vaccine healthy volunteer population', 'factorial design evaluate effect pre immunity dose boost addition biojectorh delivery dna', 'biojector humoral cellular immunogenicity pre immunity booster affect vaccine immune', 'protocol trial consort checklist available information see protocol checklist', 'national institute infectious institutional review board accordance cfr part u food drug administration declaration helsinki', 'informed consent', 'safety tolerability immunogenicity profile dna prime boost vaccine different intramuscular dna administrationneedle syringe vs needle free pressure injection device biojectorh', 'healthy hiv negative ages time enrollment', 'vrc national health clinical center bethesda vaccine research center national institute infectious nih department health human dhhs', 'forty low high adenovirus serotype antibody ratio receive dna needle syringe biojectorh ratio booster vaccination dose particle', 'randomization sequence statistician computer random titer positive negative achieve balance study', 'stratum titer combination administration device booster random', 'dna administration device known completion electronic enrollment study database dose vaccine blinded statistician pharmacist safety collection vaccine boost', 'im needle syringe', 'dna vaccine injection vaccine week', 'solicited reactogenicity diary injection', 'local reactogenicity dna clinician photographs injection', 'laboratory clinical followup week', 'division table severity unsolicited adverse aes medical dictionary regulatory summary', 'significant design trial commencement addition long term contact week part response food drug administration fda design', 'study', 'primary objective safety vaccination secondary immune dna vaccine basis sample size', 'secondary antibody social impact vaccine clinical trial', 'study vrc niaid nih closed circular dna gag pol nef clade b env glycoprotein clade b clade c equal phosphate saline pbs recombinant non adenoviral serotype gag pol b env glycoprotein clade b clade c ratio final formulation buffer ffb', 'specific purity', 'antigen enva envb envc gag pol nef final concentration mg ml vaccine', 'frequency antigen vaccine specific', 'pbmcs overnight peptide individual vaccine', 'ifn c elispot commercial kit bd ctl elispot image analyzer cellular technology ltd cleveland mean spot sfc pbmc', 'pbmcs peptide fixed flow cytometry expression ifn c flowjo software treestar', 'research elisas delineate antibody response viral vaccine', 'end point dynex coated preparation recombinant hiv vaccine', 'end point titer dilute serum concentration optical density reading background', 'commercial eia abbott western blot laboratory genetic western blot kit biorad', 'serum antibody single round replication defective env cell line luciferase viral infection', 'virus', 'abbott hivab tm rdna eia kit diagnostic testing', 'reactive western blot mayo laboratory gs western blot biorad wa', 'monitor test roche molecular hiv rna pcr eia result time', 'exploratory analysis assess vaccine sero positivity sero reactivity visp r alternative peptide diagnostic multiple diagnostic manufacturer', 'statistical predecessor post hoc', 'positive cell response statistical test minimum magnitude threshold', 'positive response sfc pbmc non background mean fold mean negative stimulation sample', 'positive response p value fisher exact test magnitude pre threshold', 'pre threshold validation negative vary different', 'value threshold env gag b', 'positive response measure end point titer', 'exact test wilcoxon rank dna response vector', 'table', 'balance low high pre antibody vaccination schedule', 'low', 'high ab group', 'enrollment randomization figure study protocol clinical follow', 'subject group high titer needle administration dna vaccine pu receive booster vaccination', 'adverse ind safety report', 'prospective scrutiny vaccination small skin lesion papule scab study team clinical evaluation dna injection biojectorh biojectorh dna self diary card study treatment', 'present vaccination n dna vaccine', 'reactogenicity study review safety monitoring team', 'grade fever maximum temperature first day injection erythema induration maximum diameter cm injection duration', 'overall reactogenicity dna vaccine biojectorh n injection dose pu dose', 'reactogenicity sequelae consistent phase experience study', 'vaccine pu dosage p pu dosage pattern severe systemic reactogenicity case acute onset first injection fever', 'evident difference incidence moderate severe reactogenicity pre antibody titer low titer group high titer group', 'antibody research elisa similar envb envc', 'dna biojectorh positive antibody response average median enva range post boost dna positive median enva range figure', 'significant neutralizing activity tier hiv consistent prior', 'magnitude hiv specific antibody response frequency duration visp r', 'serology hiv abbot kit positive week hiv pcr negative table', 'dna vaccination group p group vaccine reactive eia', 'administration week group group eia', 'regard western blot group positive indeterminate unreadable n group positive indeterminate unreadable test', 'high frequency visp r development vaccine platform ancillary utility peptide recombinant diagnostic test', 'multiple hiv dna prime modest significant cumulative median elispot response sum gag pol nef env n', 'post boost week cumulative median elispot response p', 'frequency ifn c elispot pool post boost biojectorh group n group figure', 'individual high pre background enva specific elispot response n group', 'cell post boost different frequency biojectorh vs n p magnitude', 'subject high pre enva elispot response high background pre enva specific cell response', 'biojectorh group magnitude cell peptide rd dna immunization p figure', 'cell post boost similar pattern elispot frequency biojectorh vs p magnitude post boost p', 'variable time point statistical difference dna delivery figure', 'lack vector specific immunity ease manufacturing stability plasmid dna ideal vaccine platform', 'current study delivery biojectorh factor immunogenicity dna', 'dna biojectorh vs n candidate phase iib clinical trial', 'biojectorh delivery dna significant contribution immunogenicity product', 'addition high frequency magnitude immune peptide recombinant hiv bead problem visp r', 'administration injectable needle syringe n', 'mass production economical standard commodity health care', 'little risk sterile disposable problem non sterile blood borne', 'risk stick needle disposal concern', 'needle free injection alternative n', 'biojectorh small orifice pressure deliver liquid table', 'vaccine sero positivity sero reactivity visp r study week', 'deposition intramuscular subcutaneous intradermal im injection subcutaneous muscle conical distribution', 'needle free injection immunogenicity dispersion injectate n', 'study guinea biojectorh delivery uptake dna muscle skin injection site', 'vaccine delivery needle free association local inflammation immunogenicity recruitment immunocompetent inflammatory', 'basic biojectorh delivery potency dna vaccination unknown consistent transfection frequency antigen production', 'ballistic nature injection due dispersal number dna needle injection much injectate needle track', 'dna needle free clinical', 'powderject tm system compressed helium project dna form dry powder skin', 'device gene gun dna delivery', 'helium shoot nanoparticle gold dna skin', 'dna immunization device immune n delivery device', 'biojectorh hand portable easy use fda device im delivery clinical', 'dna vaccine transfection efficiency', 'electroporation immunogenicity dna human date modest', 'study biojectorh delivery dna reactogenicity n delivery unnoticed subject', 'delivery dna needle free biojectorh device antibody ifn c elispot cell post boosting', 'subtle post dna post', 'support clinical evaluation dna biojectorh delivery transfection efficiency key factor potency dna', 'figure intracellular cytokine production', 'represent side side comparison median magnitude th th intracellular cytokine biojectorh blue n primed day dna prime', 'response enva gag peptide', 'dna week study injection x axis figure', 'dose', 'sum test', 'pptx figure', 'intracellular cytokine production biojectorh delivery', 'represent side side comparison median magnitude th th intracellular cytokine biojectorh blue n primed day dna prime', 'response enva gag peptide', 'dna week study injection x axis figure', 'dose', 'sum test', 'checklist consort checklist', 'protocol trial protocol', 'pdf']"
f2bf9fa9b4ea72ffda6b0b52c190265ac17ba848,innate immune viral rna cap structure immune evasion host cell ifn response viral replication endou domain immune system viral cellular cell viral cov dmvs cov infection cov rna distinguish self hepatitis virus host cytoplasm host innate immune cell immune suppression important animal infection role innate immunity large viral mechanism immune mouse hepatitis murine coronavirus novel antiviral particular sensing replication innate replication nile replication spread respiratory syndrome rna synthesis role context self non sense viral sensing complex ability impact ability restrict absence dmvs absent invertebrate access cov accessible translation acid inducible acquisition cap activation immune activation innate activation ultimate activity activity activity number activity rna activity structural actual site acute respiratory adaptive immunity addition viral additional function additional mechanisms adenocarcinoma cell affect viral alveolar adenocarcinoma animal human animal molecular antagonist plausible antagonistic infection antigenic pass antiviral important antiviral intervention antiviral relevant antiviral state antiviral viral applicable wide array ifn arrest similar arterivirus cov arterivirus endous assess molecular assumption dsrna backbone protect basic crucial bearing triphosphate belong order biochemical rna blunt end broad array cap ribose catalytic domain cell hiding cell line cell pathogen cell rlrs cell type cellular antiviral cellular engagement cellular ifn cellular machinery cellular origin cellular rnas cellular viral,"['weiss sr murine coronavirus mouse hepatitis virus interferon brain', 'j virol', '', 'li j liu zhang x murine coronavirus interferon rig', 'sense sense viral rna innate immune evasion kindler volker essential function innate immunity distinguish self non self recognize viral initiate expression antiviral viral replication', 'host cytoplasm evade innate immune cell hiding viral exposure viral', 'many cytoplasmic similar immune evasion mechanistic insight direct interplay viral rna viral cellular antiviral relevant develop novel antiviral important animal human', 'immune system network lymphoid humoral pathogenic', 'line host defence immunity evolutionary main task limit replication spread', 'response adaptive immunity antigenic pass epithelium', 'emphasis present review covs positive rna veterinary medical importance respiratory enteric', 'human present mild respiratory tract disease common cold elderly immune', 'epidemic severe acute respiratory syndrome cov middle east respiratory syndrome coronavirus demonstrate zoonotic potential covs ability impact human health', 'covs belong order large single ss rna genome positive polarity complex replication cycle', 'entry host viral genome primary translation large viral non structural nsp figure', 'cov nsps form replication transcription complex rtc responsible synthesis viral rna major cov pathogen molecular pattern pamp host cell pathogen recognition', 'prrs responsible sensing g', 'toll cytosol e g', 'retinoic acid inducible gene rig presence nucleic', 'prrs activation ultimate expression numerous ifns', 'ifns turn expression broad array ifn isgs antiviral state', 'much current concerning covinduced innate immune mouse hepatitis virus mhv context murine model infection', 'mhv infection plasmacytoid dendritic secrete high stimulation ifn regulatory factor irf', 'type ifns cell', 'pdc type ifn important protect raise significant ifn response cov integrity virus replication spread', 'human covs hcovs infection human epithelial haes primary target tissue entry port respiratory upregulation ifns inflammatory exogenous type type iii ifn', 'line pronounced ifn response epithelial human alveolar adenocarcinoma cell line human monocyte', 'covs innate immune cell viral induction ifn expression', 'distinguish host cell viral foreign', 'cap structure present termini eukaryotic pivotal role context rna bearing triphosphate terminus rna methylated cap structure viral', 'addition viral pamp replication rna virus replicative dsrna', 'cytosolic rlrs rig melanoma differentiation protein sense viral rnas short blunt end triphosphate rnas e', 'cap ribose methylation dsrnas', 'host cell rlrs nucleus nascent triphosphate end co form cap structure', 'many cytoplasm cap structure mrnas order rlr recognition eukaryotic translation', 'acquisition cap structure cellular machinery cellular viral capping', 'cov cap structure cov rtc eifs viral template result translation arrest', 'marginal replication virulence wildtype', 'replication nile virus vaccinia methylation wildtype', 'ability restrict replication nile methylation cell type specific additional mechanisms independent control infection', 'biochemical rna prerequisite methylation inactive mtase methylation', 'wnvs non replicative transfection rna weak activity number compensatory', 'coronaviral reside unknown inactivation affect viral replication innate immune recognition figure', 'rna likely translational arrest similar rna lacking methylation', 'cov internal nascent similar mechanism marburg virus multifunctional protein termini backbone protect rna length dependent', 'efficient removal rna pamps activation immune system successful replication host cell', 'lassa fever virus lasv potent mechanism immune suppression exoribonuclease exon lasv similar family', 'lasv viral rna cellular ifn response', 'exon deddh n terminal part', 'enzyme dsrnas single dsrnas', 'replacement catalytic domain mhv viable', 'obvious fitness exon unique enzyme thereby high replication fidelity stable propagation large viral rna kb', 'rnase target specific prevent unwanted cleavage viral cellular rnas', 'dna rna unpaired ribonucleotide rnas resistant exon cleavage', 'regulate mtase activity activity', 'important regulatory role immune suppression dual impact exon mtase host innate immunity', 'ifn induction cov infection role exon ifn antagonistic infection', 'second ribonuclease covs endoribonuclease endou nidovirus specific feature', 'discovery insect nidovirus evaluation invertebrate ronivirus lack endou domain utilization endou domain vertebrate', 'cov endou domain moderate sequence conservation', 'dsrna similar xendou rnase reaction possess cyclic phosphate', 'ectopic expression colocalized rtc cytoplasm additional function involvement viral replication', 'overexpression cov infection role robust ifn antagonist plausible covs rnase activity rna activation innate immune system similar pestivirus ribonuclease activity structural protein e', 'mind virus infection arterivirus endous co localize determined mechanism immune evasion place arterivirus cov rtcs', 'elusive endou substrate viral cellular origin utilization enzyme absent invertebrate', 'hallmark cov replication induction double membrane part reticulovesicular network host cytoplasm', 'particular replication outer membrane dmvs dsrna inner', 'connection dmv cytoplasm', 'dsrna cov dmvs viral origin enigmatic viral accessible translation', 'question dsrna dmvs replicative dead end innate immune cytoplasmic', 'determined dmvs actual site rna synthesis', 'assumption dsrna potent hidden innate evaluate strength ifn response absence dmvs role context', 'considerable zoonotic', 'important animal molecular replication strategy past', 'covs versatile host innate immune cellular engagement virus dsrna innate immune', 'number target evolutionary innate immune', 'mechanistic innate immune evasion', 'important future theme cov rna infection', 'example important clarify rna synthesis place role cov dmvs play context viral replication innate immune evasion', 'cytosolic prrs access cov rna distinction', 'important consideration infection viral rna prrs interact ii particular sensing complex rlrs assess molecular methylation order distinguish self non iii particular sensing complex detect mis rna example viral rna dmvs', 'basic crucial design novel antiviral intervention applicable wide spectrum virus']"
8f35b94ba81db851c3c20ab2a4495f1ec4ab590b,et al viral replication rna replication h post post infection viral rna jackson al electron microscopy golgi marker infection golgi electron dense golgi apparatus h p bovine serum cell line cisternae visible fetal bovine genomic rna giantin signal goat anti golgi complex golgi fragmentation hepatitis virus immuno em lentivirus expression pattern giantin ph mm poliovirus replication secondary antibody source replication able detect alexa fluor anti giantin anti rabbit antibody capsid antibody giantin antigenic tag apparatus golgi association cellular association golgi autophagic induction autophagic pathway bio spin brefeldin golgi calf serum capsid antibody co golgi colloidal reagent complex al continuous cisternae copii hypothesis course infection culture fixation dreux al endoplasmic reticulum expression protein fixation min fluor nm gfp expression giantin goat gold colloidal golgi morphology golgi replication golgi signal h h ha antigenic ha tag invitrogen manufacturer isomerase pdi juxtanuclear region likely represent localize viral lysis h marker giantin mem fetal micro bio min formaldehyde minor group mm nacl mm ph mock fig mock infected mostoslavsky et negative viral nikon eclipse nm gold nm secondary non punctate open white origin replication palmenberg et poliovirus al positive strand previous work production lentivirus protein expression punctate non pv infection pv replication redistribution golgi,"['positive rna genome replicate genomic rna association host cell', 'demonstrate novel source replication human rhinovirus', 'infection golgi apparatus golgi diameter', 'golgi localize viral rna replication viral replication', 'expression protein pattern similar viral infection', 'infection protein role golgi complex site viral rna replication', 'positive strand rna date replicate rna association cellular miller krijnse locker', 'origin', 'example alphanodavirus flock house virus mitochondrial membrane miller et al', 'coronavirus reticulovesicular network endoplasmic reticulum er al', 'flavivirus hepatitis virus replication membranous web er lipid grise', 'semliki virus alphavirus cytopathic et al spuul et al', 'comprehensive serve large variation viral replication', 'origin replication picornavirus poliovirus controversial', 'poliovirus replication jackson al', 'autophagic machinery enhance viral replication dengue fever virus hepatitis virus coxsackie virus goughoulte al dreux al jackson al khakpoor et al lee al sir al al', 'autophagy machinery way', 'example hepatitis virus replication conventional autophagosomal machinery important viral replication dreux al', 'second hypothesis generation poliovirus replication diversion secretory complex rust et al', 'co localize viral replication protein er', 'several evidence argue copii hypothesis sensitivity poliovirus brefeldin copii vesicle formation gazina al maynell al', 'addition poliovirus replication expression dominant negative allele copii protein transport taylor', 'copii hypothesis autophagy hypothesis copii important autophagy hamasaki al ishihara et al', 'previous work autophagic poliovirus al', 'result controversial report different experimental respond autophagic induction brabec zaruba al', 'plan controversy separate study', 'enormous genetic diversity likely find diverse membrane related', 'poliovirus part enterovirus genus large diverse collection palmenberg et al', 'human classified major group receptor cell entry minor group low density lipoprotein receptor uncapher et al', 'hrv hrv b hrv c resistance distinct antiviral al', 'hrv group viral genomic array technology refined modern sequence analysis kistler et al palmenberg et al', 'complete cdna available several callahan al duechler et al', 'availability production isogenic virus genomic drift due low fidelity rna dependent rna polymerase al', 'study large related group reveal replication', 'origin replication minor group type virus', 'show poliovirus induce respond autophagic pathway', 'addition evidence infection golgi substrate viral rna replication', 'expression protein reminiscent co golgi signal', 'indicate apparatus source rna replication', 'previous work poliovirus formation cytoplasmic substrate viral rna replication jackson al', 'extend rhinovirus strain', 'background vary cell line cell line human embryonic kidney low level autophagy tanida et al', 'marker autophagosome formation light chain protein generating nascent autophagic et al', 'autophagic induced cellular associated autophagosome', 'cytoplasmic low punctate signal membrane association klionsky et al', 'examine induction plasmid fusion protein jackson al', 'transfection virus moi mock treated rapamycin induce autophagy', 'condition replicate transfected blinded', 'signal punctate non punctate', 'representative', '', 'quantitation punctate non punctate fig', '', 'mock low intrinsic equivalent', 'rapamycintreated half population puncta increase puncta formation similar pv taylor et al', 'addition yield vary stimulation inhibition', 'autophagic pathway subverted infection', 'observe autophagic induction infection observe cellular organelle potential infection', 'embryonic lung morphology immunofluorescence analysis cell al', 'single cycle poliovirus rhinovirus infection cytopathic effect al time course infection', 'fixed h postinfection morphological point viral life cycle', 'virus tcid assay matched tcid', 'endoplasmic reticulum er fig', 'top', 'infected protein disulfide isomerase pdi relative morphology er', 'characteristic lacelike pattern denser nucleus', 'er pattern mock infected indistinguishable infected', 'next infected stain mitotracker potential distribution structure mitochondria', 'typical reticulotubular pattern mitochondrial significant pattern uninfected', 'second row', 'next analyzed golgi apparatus', 'fixed golgi cisternae marker giantin fig', '', 'continuous cisternae visible perianuclear region mock', 'typical pattern visible majority', 'giantin fragmented puncta small oval cell', 'effect infection co giantin red antibody capsid green', 'capsid protein present replication presence capsid cell viral entry', 'mock capsid antibody golgi normal fig', 'bottom row', 'population capsid antibody giantin signal abnormal cytoplasm', 'fluorescent dic perinuclear location signal', 'observe development unusual giantin performed time course infection fig', '', 'h post infection golgi matched pv mock', 'h post infection golgi complex spread cell', 'pattern h giantin signal cell small oval reticular visible', 'h post infection pv complex network continuous golgi comparable uninfected', 'infection significant morphological complex', 'epithelial primary infection vivo determine golgi epithelial cell line souza al', 'lung epithelial fig', '', 'h h post infection giantin second golgi marker redistribution signal specific giantin', 'h p redistribution golgi', 'giantin cytoplasm uninfected small juxtanuclear region', 'pattern identical h p', '', 'h p', 'difficult golgi pattern punctate spread cytoplasm fig', '', 'lyse h h post infection', 'observed time point giantin redistribution likely golgi membrane redistribution movement single marker different cellular location', 'giantin pattern infection determine site viral rna replication similar pattern', 'active rna replication fluorescent positive sense rna', 'negative sense rna intermediate template genomic synthesis teterina et al', 'antibody rna signal due antibody experiment', 'golgi organelle reagent invitrogen visualization golgi et al', 'reagent golgi resident protein', 'h treatment organelle infected h golgi likely active replication', 'understand cellular ultrastructural level electron microscopy mock fig', '', 'infection portion culture fixation synchronous cell lysis h p', 'mock able identify membrane golgi white', 'ultrastructure h distinct uninfected', 'elongated open white', 'infected similar visible mock ordered', 'ovoid diameter', 'electron dense cytoplasm cytoplasm', 'observe size', 'alter cellular morphology small autophagic pv jackson al', 'order redistribution signal infection immuno em analysis giantin antibody gold secondary fig', '', 'golgi difficult immuno em due fixation protocol', 'able detect giantin linear apparent mock', 'contrast pattern giantin large open', 'giantin light vesicular result immuno em preparation', 'observation linear golgi', 'likely represent golgi', 'nonstructural protein poliovirus transmembrane protein rna replication berstein choe kirkegaard teterina et al', 'pv infection replication', 'isolation pv er suhy et al', 'interested effect protein expression localization', 'lentivirus express protein interest gfp', 'ha antigenic tag c terminus', 'observed gfp expression visible e giantin b f j ha c g k', 'production lentivirus robust order detect expression concentrate lentivirus centrifugation', 'concentration cell target lentivirus', 'presume low production lentivirus due toxicity protein problem express lama et al', 'internal experiment', 'lentivirus expression direct comparison fig', '', 'vector lentivirus protein normal golgi morphology continuous cisternae visible lentivirus system alter golgi', 'able detect ha form lentivirus vector presence gfp e h', 'pattern golgi juxtanuclear region cell distinct cisternae visible', 'field lentivirus normal pattern giantin', 'pattern giantin version golgi', 'determine ha antigenic tag function protein untagged version protein fig', '', 'gfp positive open giantin signal continuous puncta', 'untagged protein experiment demonstrate dramatic effect expression golgi morphology', '', 'indicate sufficient induce morphology', 'addition protein golgi', 'work rna investigated date association cellular', 'novel genomic rna replication source replication', 'redistribution golgi marker giantin place infection condensation signal perinuclear region puncta cell', 'negative viral rna intermediate viral replication golgi marker viral rna replication association golgi', 'electron microscopy', 'infected presence electron dense diameter', 'multilamellar visible mock', 'correlation appearance electron dense difficult identify stack disorganized nature fig', '', 'em', 'show giantin', 'giantin dense extraction vesicle preparation immunostaining', 'likely conventional em', 'significant giantin infected represent giantin puncta immunofluorescence microscopy', '', 'golgi marker negative viral rna fig', 'electron dense', 'likely represent viral replication', 'model unique golgi viral replication', 'poliovirus fragmentation golgi late infection viral replication', 'beske et al', 'h pv infection golgi fragmentation', 'foot mouth disease virus fmdv replication golgi apparatus golgi replication et al', 'study first demonstration knowledge golgi replication positive strand rna virus', 'insight possible mechanisms replication fragmentation', 'example brefeldin golgi fragmentation', 'effect brefeldin golgi similar infection hidalgo al radulescu et al', 'pv replication sensitive brefeldin treatment function important virus kirkegaard', 'sensitivity brefeldin gazina et al', 'key golgi fragmentation mitosis nocodazole treatment bui al tang al', 'guanine exchange poliovirus different poliovirus al', 'gef poliovirus protein picornavirus coxsackievirus al', 'recruit replication universal al', 'replication sensitive brefeldin', '', 'importance picornavirus replication independent source viral replication membrane', 'picornavirus transmembrane protein organelle replication', 'study show isolation induce marker', 'addition epitope version co golgi signal', 'fish fig', 'lead association golgi role replication', 'effect picornavirus golgi distinct viral origin protein', 'isolation poliovirus er distension complex al suhy et al', 'group expression poliovirus capable dispersing golgi', 'study coxsackievirus localize golgi complex al', 'coxsackievirus protein fragment golgi al', 'replication derive golgi apparatus unknown mechanism', 'contrast pv replication mock fig', '', 'electron microscopy lung', 'mock infected tcid golgi infected white disorganized membrane open white', '', 'rough er distinct black', 'dark nm infected open black', 'note gold particle small visible likely', '', 'derive er autophagosome copii', 'isolation source replication pv golgi', 'insight picornavirus strategy', 'presence protein early infection source viral replication', 'summary difference membrane phenotype similar lead mechanism membrane generation rna', 'common marker become viral replication viral novel localization membrane', 'american type culture collection atcc manassas virginia united atcc', 'minimal essential medium mem fetal bovine serum sodium pyruvate', 'high glucose mem calf serum fetal bovine serum', 'calf serum', 'gift department pharmacology toxicology medical college wisconsin grown mem fetal bovine serum complete medium invitrogen', 'cell co presence penicillin streptomycin', 'viral transfection vitro rnas al racaniello', 'virus pbs cacl mgcl cell absorption min addition', 'plaque assay', 'effectene invitrogen manufacturer', 'plasmid empty vector expression', 'plasmid available addgene plasmid jackson al', 'lentivirus dr richard mulligan mostoslavsky et al', 'tamoxifen sigma rapamycin lc solution dmso etoh', 'sigma', 'immunofluorescence room temperature rt min formaldehyde pbs bt pbs triton rt min', 'primary secondary antibody rt antibody', 'mitotracker molecular manufacturer', 'antibody disulphide isomerase pdi abcam', 'antibody giantin covance', 'antibody capsid atcc', 'appropriate secondary visualization molecular', 'vectashield vector nikon eclipse microscope metamorph software', 'adobe photoshop', 'cm coverslip', 'tcid control h coverslip culture fixation confirm lysis h post infection', 'buffer ph mm cacl', 'fixation dish glutaraldehyde paraformaldehyde min', '', 'post fixation min reduced osmium tetroxide potassium haxacyanoferrate water h ice graded methanol embed resin em observation ultrathin nm', 'jeol', 'cell situ mixture paraformaldehyde glutaraldehyde sörensen buffer ice min', 'fixation min buffer culture min', 'cell lowicryl resin temperature plt method berryman rodewald protocol burleigh et al', 'berryman burleigh', 'uv polymerization ultrathin nm mounted formvar carbon copper electron microscopy μl chamber', 'anti giantin goat anti rabbit gold colloidal reagent electron microscopy pa', 'first incubating goat anti mouse nm gold colloidal reagent incubation anti giantin goat anti rabbit nm gold conjugate', 'hybridization organelle rfp invitrogen manufacturer', 'portion golgi', 'h', 'h prepared hybridization', 'positive genomic rna full length cdna ambion presence nm utp molecular', 'transcription product dnase unincorporated micro bio spin protein expression proceed h immunofluorescence', 'giantin golgi marker alexa fluor nm secondary antibody ha tag alexa fluor nm secondary antibody', 'open gfp', 'closed lentivirus', 'biorad', 'alkaline hydrolysis min mm mm ph nt et al', 'hydrolysis reaction addition ph glacial acetic acid', 'micro bio spin column', 'mock cover permeabilized min formaldehyde', 'pbs wash pbs ammonium chloride min', 'moist chamber top μl hybridization buffer formamide mm tris hcl ph mm nacl dextran sulfate mm dtt sds μg ml salmon sperm dna ng probe', 'hybridize h ssc nacl sodium citrate rt', 'protein pcr hemaggluttanin ha tag sequence lentivirus expression vector cytomegalovirus cmv promoter sequence gfp mostoslavsky et al', 'lentivirus lentivirus expression plasmid hek confluency dish transfection reagent mirus mir', '', 'supernatant pvdf membrane create cell free solution rpm h filter sucrose solution g ultrapure sucrose mm nacl mm ph mm edta', 'virus pellet μl pbs min h', 'virus ultracentrifuge tube μl pbs μl total virus stock', 'virus pbs', 'lentivirus h ml', 'h post infection immunofluorescence observation gfp expression h post infection', 'nikon eclipse ti microscope software']"
8a3678c3ee2208d7417bfdc62558fe0e32588eab,full length length genome amino acid genome sequence accession number available genbank diarrhea outbreak nonstructural protein nucleocapsid n pdcov amino pdcov isolate related pdcov thai pdcov acid level acid position acid united amplification cdna analysis gene analysis isolate cdna race china united comparison amino complete genome deletion n deltacoronavirus pdcov detected presence diarrhea low e membrane easy vector envelope e epidemiology prevalence evolution pdcov frame spike genbank accession genbank phylogenetic gene order gene related genetic analysis genome available genome organization genome pgem genome thai group pdcovs homologous pdcov identify pdcov intestinal diarrhea isolate gene isolate group isolate related length pdcov low mortality membrane nonstructural membrane nucleocapsid molecular epidemiology molecular thailand n amino n nonstructural novel isolate nucleotide sequence open reading order untranslated organization isolate pdcov available pdcov november pdcov presence pdcov rna pdcovs china pgem easy phylogenetic analysis phylogenetic tree porcine deltacoronavirus position similar presence pdcov presence thailand prevalence evolution promega protocol protein nucleocapsid protein utr rapid amplification reading frame region utr rna detected rna specific sequence accession sequence genbank sequence length sequence thai specific membrane spike envelope study identify surveillance study terminal rapid thailand diarrhea thailand porcine total rna tree full understanding molecular untranslated region utr open vector promega,"['thailand porcine deltacoronavirus pdcov november', 'virus diarrhea outbreak', 'full length genome sequence thai pdcov isolate', 'understanding molecular thailand', 'surveillance study identify pdcov presence thailand diarrhea low mortality', 'intestinal diarrhea outbreak', 'total rna detected presence pdcov rna specific membrane nucleocapsid n', 'positive', 'full length genome pgem easy vector promega protocol', 'terminal rapid amplification cdna race', 'full length genome thai pdcov isolate', 'full length genome sequence length', 'genome organization isolate gene order untranslated region utr open reading frame spike envelope e membrane nonstructural protein nucleocapsid n nonstructural protein utr', 'n', 'phylogenetic tree full length pdcov available genbank phylogenetic analysis isolate group pdcovs china united', 'full length genome available genbank', 'homologous pdcov amino acid', 'comparison amino acid united', 'genetic analysis gene related pdcov amino acid', 'acid level', 'deletion n amino acid position similar', 'novel isolate related pdcov', 'molecular epidemiology prevalence evolution pdcov', 'nucleotide sequence accession number', 'complete genome sequence genbank accession number']"
efdf0a3bdc300ce80392b2b52be33728db54a51f,et al bleomycin response confidence interval figure file optical density response variation chromosome v genetic background median optical peak marker linkage mapping bleomycin sensitivity parental strain tukey hsd p tukey vs p bleomycin resistance epistatic loci expression variation gene expression natural variation residual median sensitive bleomycin significant qtl bleomycin figure p vs r package response qtl riail panel supplemental information underlie bleomycin allele replacement control condition density bleomycin dose response function bleomycin k medium ml mm nonsynonymous variant qtl confidence rna seq whole genome x axis allele frequency amino acid expression bleomycin factor genome file p genome scan introgressed region loci underlie lod score region chromosome strain figure tukey box variation function bendesky et broad sense brood size dependent variable drug response expression difference genotype qtl high throughput independent deletion phenotype dependent phenotypic variation reciprocal hemizygosity repair construct response bleomycin response linkage seidel et sense heritability allele figure available file axis genomic background strain bacterial lysate biological replicate bleomycin file concentration bleomycin deletion strain figure bleomycin figure figure file file file linkage function r genetic bleomycin genetic variation genome wide gwa mapping hemizygosity test hta figure identify genetic increase bleomycin increased sensitivity independent variable interval peak kb side kit catalog,"['bleomycin powerful chemotherapeutic drug treat variety', 'individual vary', 'identification genetic underlie response variation treatment bleomycin', 'model organism caenorhabditis identify genetic response linkage mapping cross laboratory strain wild strain', 'approach small genomic region chromosome v response variation', 'isogenic allele novel nematode specific gene resistance', 'mechanism gene variation bleomycin unknown rare variant present strain potential stress response function leading resistance', 'bleomycin qtl drug response linkage variation drug low al', 'tumor complexity progression mcclellan c ancer second cause death worldwide cancer extensive research identification effective chemotherapeutic al', '', 'bleomycin antitumor antibiotic oxygen transition double stranded dna stubbe', 'cytotoxicity bleomycin cell death tumor target range harmful gastrointestinal irritation severe bleomycin pulmonary fibrosis blum al', '', 'tradeoff efficacy toxicity genetic bleomycin response therapeutic range dervieux al', '', 'bleomycin sensitivity heritable genetic bleomycin al', '', 'many identify genetic variant underlie bleomycin response cancer potential metabolic bleomycin hydrolase blmh patient', 'none causal connection genetic variation bleomycin', 'al', 'gu et al', 'altés et al', '', 'inability human genetic variant limited sample purcell environmental liu et al', 'dagogo jack shaw', 'dna damage bleomycin lehmann', 'bleomycin organism natural genetic variation offer response clinic', 'caenorhabditis microscopic roundworm excellent model basic cellular organismal al', '', 'reference genome c consortium stein al', 'et al', 'broad genomic diversity global', 'strain strain divergent single nucleotide variant bp al', 'swan et al', 'thompson al', '', 'generate panel recombinant advanced intercross rockman kruglyak andersen et al', 'correlate genetic quantitative al', 'palopoli et al', 'seidel et al', 'seidel et al', 'mcgrath et al', 'reddy et al', 'bendesky et al', 'bendesky et al', 'al', 'schmid et al', 'lee al', 'zdraljevic et al', '', 'high throughput fitness measure bleomycin panel al', 'linkage quantitative trait loci qtl underlie bleomycinresponse variation', 'isogenic effect qtl chromosome v nil epistatic loci underlie bleomycin factor genome scan unable detect significant genetic', 'mediated deletion candidate region', 'nematode specific gene', 'gene variant gene expression riail panel', 'genome wide association gwa approach different qtl linkage mapping approach common rare underlie bleomycin response variation', 'genetic complexity bleomycin response phenotype study power system identify elusive causal', 'cm nematode growth medium ngma', 'parental study', 'canonical laboratory strain c brenner', 'studied hawaiian wild isolate divergent genome al', 'swan et al', 'thompson al', '', 'several panel parental strain', 'rockman kruglyak andersen et al', 'allele panel identify drug response', 'construction deletion replacement', 'strain supplemental information', 'high throughput hta et al', 'summary assay supplemental material figure', 'passaged cm animal starvation', 'gravid stage synchronization aliquoted final volume ml k medium boyd al', '', 'day larvae fed mg bacterial lysate k medium pennsylvania state university fermentation facility state college pa garcía gonzález et al', 'grown hr constant shaking', 'large particle flow cytometer copas biosort union holliston sort larvae ml k medium lysate mg ml mm kanamycin distilled water control water bleomycin drug', 'larvae grown hr constant shaking', 'population treated sodium mm several fitness', 'bleomycin exposure animal proliferation brood size animal growth length animal development optical density fitness biosort brood size animal length time flight tof optical density extinction time ext', 'phenotypic biosort r package easysorter shimko andersen', 'package contamination contaminated analysis', 'sumplate function normalized norm brood size normalized number norm ext ext tof summary median percentile interquartile range covariance variance trait population', 'total hta', 'multiple true function fit linear model phenotype dependent variable assay independent variable phenotype assay account variation assay', 'next prune phenotypic standard mean outside range case riail', 'specific regress assay false function easysorter model phenotype dependent variable control phenotype independent variable phenotype control phenotype', 'residual phenotypic present control', 'dose response hta divergent various file', 'broad sense heritability concentration function r package phenotype dependent variable strain random effect phenotype file', 'concentration bleomycin mean broad sense heritability hta linkage mm mean h', 'bleomycin sulfate biotang fisher', 'whole genome sequencing low coverage sequencing', 'dna ml omega biotek ez tissue dna kit catalog', '', 'ng ml diluted illumina transposome catalog', '', 'barcoded', 'unique ml library', 'material size material agarose gel bp', 'sample qiagen gel extraction kit catalog', 'ml buffer eb', 'concentration sample qubit dsdna hs kit catalog', '', 'low coverage mean illumina hiseq platform end bp reaction lane', 'riail nil vcf kit', 'determine list high quality parental possess different variant dataset cook et al', '', 'whole genome previous goldengate', 'riail r package github com andersenlab', 'nil available file file', 'linkage mapping hta r package linkagemapping', 'github com andersenlab', 'function load cross object snps describe genetic recombination riail panel high quality', 'genotypic residual phenotypic control condition regression cross object merge pheno function allele frequency chromosome', 'fsearch function calculate logarithm lod trait r r pearson correlation coefficient riail trait et al', 'lee al', 'al', '', 'genome wide error rate phenotype genotype', 'time marker lod score cofactor significant qtl', 'annotate function calculate percent variance riail qtl confidence interval peak marker chromosome drop peak marker', 'identical strain small genomic region alternate strain', 'test effect particular genomic consistent genetic background', 'nil riail parental background bulk male progeny parental strain bulk generation', 'nil single parent isogenic homozygosity genome', 'cross pcr select nonrecombinant progeny introgressed region insertion deletion indel right side region', 'nil bulk', 'heterozygous individual k medium mg bacterial lysate starvation', 'starvation region', 'recombinant cm individual several homozygosity genome', 'nil whole genome described confirm file', 'generate nil introgressed region supplemental information', 'factor genome scan epistatic loci traits interest bleomycin gene expression', 'scantwo function r qtl package perform analysis', 'pairwise combination loci variation', 'summary scantwo output maximum interactive lod score pair', 'determine threshold significant scantwo analysis percentile', 'bleomycin response variation scantwo significant interaction score', 'significant interaction threshold expression variation scantwo', 'bleomycin response variation scantwo summary available file scantwo summary expression variation available file', 'db function cegwas r package query wormbase confidence interval', 'initial linkage marker rockman kruglyak qtl confidence interval interval whole genome marker', 'confidence interval conservative kept subsequent candidate', 'interval additional kb side whole genome marker confidence interval file', 'snpeff function cegwas r package identify region interest file', 'moderate coding variant inframe insertion deletion missense variant regulatory region ablation splice region variant high chromosome number variant exon loss frameshift variant rare amino acid variant splice donor acceptor variant start loss stop loss gain transcript ablation phenotypic sequence ontology eilbeck et al', '', 'search candidate nonsynonymous variant', 'deletion interest test loss function', 'deletion possible target target doench algorithm doench et al', '', 'hermaphrodite larvae cm agar escherichia coli hr injection', 'crispr injection mix ml mm altr tracrrna idt catalog', 'ml altr crrnas stock concentration mm duplex buffer idt ml mm co injection crrna min', 'ml mm altr catalog', 'idt tracrrna crrna complex mixture room temperature min', 'ml mm repair construct water final volume ml', 'injection mixture injection capillary mouth pipet avoid injection solution', 'young adult agar injection anterior posterior arm gonad cm', 'hr injection individual cm', 'successful co injection marker obvious locomotive defect roller rol morphological phenotype dumpy dpy', 'presence rol dpy progeny', 'rol progeny individual cm lay edit hr', 'pcr site deletion', 'heterozygous homozygous homozygosity cross rol mutation', 'deletion identify exact location deletion', 'generate deletion supplemental information', 'allele replacement test effect particular amino acid substitution bleomycin', 'guide rna bp natural variant target score target score doench et al', '', 'repair replacement vice versa', 'repair homologous background strain nucleotide variant silent mutation pam site repair construct cleavage silent mutation restriction enzyme cut site', 'repair homology arm pam proximal side edit homology arm pam distal side edit', 'injection ml mm repair construct repair construct last step protocol', 'rol progeny pcr restriction enzyme digestion', 'deletion sequencing', 'generate allele replacement detailed supplemental information', 'microarray synchronized young adult', '', 'linkage described expression significant file', 'probe full lod frame file', 'hemizygosity test effect deletion deletion wild type wild type functional gene product bleomycin', 'phenotype gene function bleomycin scale number functional gene present strain', 'heterozygous hemizygous genotype mate hr', 'process homozygous presence male', 'clean plate embryos hr', 'egg period egg lay conical combination pasteur pipette plastic inoculation', 'embryos k medium mm kanamycin', 'larval stage conical', 'next morning larvae k medium mg bacterial lysate mm kanamycin distilled water water bleomycin biosort dose response assay figure file hemizygosity figure', 'ith paralyzed mm sodium phenotypic biosort', 'statistical nil deletion strain allele replacement strain r version tukeyhsd function r core team model phenotype dependent variable strain independent variable phenotype strain', 'p individual pairwise strain p significant', 'figure exception hemizygosity nils deletion replacement respective background statistical significance asterisk boxplot strain', 'p file', 'correlation riail expression median optical density bleomycin spearman correlation test', 'statistical difference expression rna seq likelihood ratio wald test threshold p', 'independent', 'bleach embryos cm hr', 'embryos plate young plate', 'sterile water', 'homogenized trizol ambion liquid nitrogen', 'extract rna sample chloroform isopropanol ethanol phase separation precipitation', 'rna te buffer quality bioanalyzer agilent', 'library preparation rna illumina facility university chicago', 'rna seq kallisto sample sample normalization sleuth deseq bray et al', 'pimentel et al', '', 'significant likelihood ratio wald', 'rna seq file', 'bleomycin c high throughput fitness file', 'gwa mapping zdraljevic et al', 'genotype cendr release', 'short genotype minor allele frequency li plink prune disequilibrium threshold r purcell al', 'chang al', 'total', 'kinship matrix mat function rrblup r package endelman endelman jannink', 'gwas function rrblup package perform gwa emma kinship kang al', 'covarrubias pazaran', 'relatedness wild et al', 'zdraljevic et al', '', 'identification rare vcf release elegansvariation org', 'vcf select linkage confidence interval alternate file', 'minor allele frequency wild median optical density measurement rare', 'protein c file input muscle edgar generate multiple sequence alignment', 'clustalw generate neighbor tree output file file', 'file high throughput bleomycin', 'file broad sense heritability drug concentration hta dose response hta dose response', 'file hta', 'file linkage control hta', 'file vcf genotype whole genome sequence manuscript', 'file version file information recombination friendly visualization nil', 'file statistical information hta phenotypic manuscript', 'file summary scantwo analysis bleomycin maximum interaction lod chromosome pair', 'file information confidence interval kb side', 'file region', 'file nonsynonymous region', 'file rockman et al', 'riail microarray expression expression', 'file significant qtl linkage file', 'file linkage expression', 'file expression residual median optical density panel', 'file seq expression young', 'file summary scantwo analysis expression maximum interaction lod chromosome pair', 'file control phenotypic response bleomycin', 'file file', 'file genotype information strain file linkage confidence interval qtl', 'file fasta file protein', 'file neighbor tree multiple sequence alignment newick tree format', 'supplemental material available figshare', 'bleomycin stranded dna cytotoxicity cell', 'exposure bleomycin development c germ cell production adult', 'hta measure development brood size figure', 'determine concentration bleomycin strain withinstrain phenotypic variation hta perform dose response assay', 'bleomycin divergent hta figure file', 'concentration bleomycin broad sense heritability heritability mm bleomycin mean h file', 'bleomycin future hta', 'dose response genome level al', 'swan et al', 'thompson al', 'divergent bleomycin figure', 'rockman al', 'identify genetic phenotypic kammenga', 'palopoli et al', 'seidel et al', 'seidel et al', 'mcgrath et al', 'reddy et al', 'bendesky et al', 'bendesky et al', 'al', 'schmid et al', 'lee al', '', 'genetic differential bleomycin', 'hta fitness file', 'combination hta several figure', 'summary biosort independent linkage mapping', 'median optical density median ext future animal length optical extinction trait many hta heritable h file', 'linkage residual median optical density bleomycin significant qtl figure', 'qtl center chromosome v significant total variation genetic variation lod score hta figure file', 'qtl confidence interval kb', 'peak marker median optical density bleomycin sensitive allele figure', 'qtl genetic background genetic background strain region chromosome v opposite parental genotype', 'hta test response bleomycin file', 'nil genotype qtl sensitive bleomycin figure file p tukey hsd', 'phenotype genotype introgressed region qtl confidence interval sensitivity bleomycin', 'reciprocal nil locus background bleomycin response different strain figure file p tukey hsd loci bleomycin dependent manner', 'factor genome scan map potential epistatic loci identify significant interaction chromosome v loci figure file', 'failure detect significant interacting qtl riail', 'loci transgressive phenotype factor genome scan able capture complexity', 'qtl phenotype introgressed region locate causal variant', 'figure linkage mapping analysis bleomycin response variation residual median optical density bleomycin', 'x axis genomic correlation phenotypic variation riail panel', 'lod score marker axis', 'significant qtl red triangle peak marker blue ribbon confidence interval peak marker', 'total amount phenotypic variance riail panel genotype peak marker percentage', 'residual median optical density split qtl peak marker x', 'significant qtl allele orange allele blue', 'tukey box individual strain box', 'addition region chromosome v nil region introgression underlie phenotypic difference', 'small region chromosome v qtl confidence interval figure', 'sensitive bleomycin parental strain', 'result introgressed region qtl conferred bleomycin response variation figure', 'hypersensitivity presence dobzhansky muller snoek', 'stress', 'sensitive bleomycin figure file', 'genotype qtl region genotype qtl genotype bleomycin sensitivity figure vs strain p tukey hsd', 'region chromosome v linkage confidence interval chromosome v', 'recombination rate chromosome difficult generate additional narrow qtl region', 'approach directed region', 'kb confidence interval chromosome v ncrna protein file', 'narrow confidence interval search additional kb side interval', 'region contain nonsynonymous figure', 'differential bleomycin sensitivity', 'test response variation deleted candidate', 'genome generate independent deletion gene genetic background possibility target phenotypic supplemental information', 'bleomycin response deletion comparison parental figure file', 'deletion response similar respective parent genetic background bleomycin file p', 'tukey hsd', 'contrast deletion resistant bleomycin respective parental file vs p vs p vs p vs p tukey hsd', 'noted sensitive control condition deletion figure', 'relative bleomycin resistance deletion increased sensitivity control condition', 'nonsynonymous variant bleomycin response', 'residue strain proline serine figure', 'generate reciprocal allele single nucleotide polymorphism amino acid change background supplemental information', 'independent allele genetic background strain bleomycin response parental file', 'allele replacement genetic background different parental strain sensitive bleomycin figure file vs p vs p tukey hsd', 'sensitivity unexpected allele locus confer resistance', 'nil genotype qtl different parental strain kb right displayed', 'protein gene region arrow direction transcription', 'nonsynonymous red gene name', 'b deletion response bleomycin', 'bleomycin tukey box name x axis split gene residual median optical density axis', 'point biological replicate', 'genotype orange genetic blue genetic background', 'gene independent deletion', 'red significant difference p tukey hsd strain deletion parental strain genetic background', 'deletion phenotype candidate gene', 'white diagonal', 'utrs gray', 'region gene directed genome red bar beneath gene model', 'figure file qtl increased sensitivity allele background', 'unclear allele replacement parental background resistance', 'background sensitive phenotype parental strain figure file', 'phenotypic variation variant clear impact bleomycin response', 'nils displayed significant increase bleomycin sensitivity parental strain figure file', 'phenotypes reciprocal allele replacement amino acid change underlie bleomycin response variation deletion gene cause resistance bleomycin genetic background', 'reciprocal hemizygosity test natural variation function bleomycin', 'increase bleomycin resistance homozygous parental file p tukey hsd increased sensitivity control condition figure', 'bleomycin resistance deletion strain genetic background similar reciprocal hemizygous equivalent bleomycin figure', 'natural variation function qtl', 'nematode specific gene bleomycin variation none nonsynonymous variant natural variation bleomycin', 'snps perform linkage gene expression expression qtl eqtl genome rockman al', '', 'bleomycin response qtl expression previous microarray study', 'significant eqtl chromosome v file', 'center chromosome v bleomycin response qtl', 'underlie bleomycin response variation figure bleomycin response qtl', 'eqtl variation expression riails figure b file', 'length expression riail file r p spearman correlation', 'gene nonsynonymous variant natural variation gene expression bleomycin', 'independent deletion measured bleomycin parental supplemental information', 'deletion strain sensitive bleomycin respective parental strain figure p vs p vs p vs p tukey hsd', 'function resistance bleomycin', 'gene sensitivity chemotherapeutic bleomycin', 'deletion deletion significant control condition file', 'bleomycin sensitivity deletion control condition', 'nonsynonymous variant function bleomycin response', 'qtl peak marker expression bleomycin resistance allele figure figure', 'expression bleomycin response variation parental', 'rna seq assess expression parental significant increase expression strain figure file p wald test p likelihood ratio test', 'result low sample size n rna seq experiment riail variant arose strain construction expression variation', 'expression difference riail epistatic loci', 'factor genome scan epistatic loci underlie expression variation significant loci iv x loci ii v figure file', 'result epistatic loci underlie expression variation expression variable parental', 'test role natural variation function reciprocal hemizygosity test control bleomycin file', 'increase sensitivity homozygous parental', 'hemizygous strain allele bleomycin phenotype similar heterozygous strain hemizygous allele sensitive bleomycin heterozygous strain', 'natural variation function response difference', 'natural variant unknown', 'gene nonsynonymous variant gene expression bleomycin response', 'potential candidate expression difference variant kb upstream gene variant third intron', 'gene expression distant loci identification specific variant difficult', 'understand natural variation response bleomycin response linkage mapping gwa mapping', 'hta measure median optical density bleomycin divergent wild gwa mapping figure', 'none qtl qtl linkage mapping figure file', 'strain variant bleomycin resistance strain', 'single nucleotide small insertion structural svs present reference strain', 'qtl confidence interval snvs strain allele figure file', 'snvs minor allele frequency low frequency likely insufficient power map gwa', 'region rare bleomycin response difference figure file', 'rare unique wild isolate panel figure linkage mapping expression difference', 'x axis genomic correlation expression variation riail panel', 'lod score marker yaxis', 'significant qtl red triangle peak marker blue ribbon confidence interval peak marker', 'total amount expression variance riail panel genotype peak marker percentage', 'b riail gene expression split qtl peak marker x', 'allele orange allele blue', 'tukey box expression individual strain', 'c correlation animal size bleomycin expression scatterplot riail point', 'axis mean sd', 'line fit blue', 'identity line black reference', '', 'none phenotypic consistent alternate resistance bleomycin figure', 'rare unique set', 'bleomycinresponse qtl work identify difference', 'blastp search release caenorhabditis none nematoda phylum figure edgar', 'none', 'predict protein protein unable detect functional sequence homology protein sequence hydrolase middle east respiratory syndrome coronavirus zhang al', '', 'low confidence model function', 'linkage bleomycin response variation significant qtl chromosome v candidate qtl region causal gene response variation divergent', 'impact bleomycin', 'gene bleomycin resistance parental', 'analysis allelereplacement hemizygosity qtl', 'gene expression difference caused increase bleomycin sensitivity', 'reciprocal hemizygosity natural variation function bleomycin', 'lossof function increased bleomycin sensitivity figure expression bleomycin sensitivity figure natural expression bleomycinresponse variation', 'function bleomycin response unknown', 'previous study impaired lifespan extension role stress response riedel et al', '', 'bleomycin dna oxidative stress kozarich reduction function ability animal respond bleomycin', 'model agreement observation expression sensitive bleomycin figure figure', 'amino acid sequence query database weak homology viral hydrolase kelley et al', 'zhang al', '', 'result hydrolase cellular stress', 'finding figure bleomycin deletion tukey box name x axis split genotype residual median optical density axis', 'point biological replicate', 'genotype orange genetic blue genetic background', 'independent deletion genetic background', 'red significant difference p tukey hsd strain deletion parental strain genetic background', 'depiction deletion box', 'white diagonal', 'utrs gray', 'region gene directed genome red bar beneath gene model', 'similar clinical role blmh bleomycin response variation lazo', 'al', 'gu et al', 'altés et al', '', 'nucleus somatic gene ability bleomycin cause dna damage cell turek et al', '', 'bleomycin import export mechanism', 'mechanism discovery clinical', 'presence cause bleomycin response', 'inform use bleomycin clinic', 'lack conservation homologous nematode', 'bleomycin soil bacterium calcutt schmidt du et al', 'shen al', 'association wild samuel et al', '', 'figure genome wide association study residual median optical density bleomycin wild', 'x axis genomic marker correlation phenotypic variation wild', 'log value axis', 'marker significance threshold eigenvalue decomposition snp correlation matrix red', 'qtl interest blue significant', 'reciprocal hemizygosity', 'axis residual median optical density strain x axis', 'bleomycin tukey box biological replicate', 'colored box plot rectangle homolog orange blue genotype', 'maternal top paternal bottom', 'gray deletion rectangle background deletion', 'box parental colored genotype', 'niche bleomycin resistance', 'wild isolate resistant bleomycin laboratory strain', 'fact sensitive bleomycin hta figure bleomycin resistance beneficial wild', 'potential role insulinlike pathway multiple', 'gene toxin response qtl hotspot chromosome v al', '', 'mechanism role toxin evolutionary genomic diversity c nematode', 'previous linkage gwa genetic underlie drugresponse et al', '', 'drug response qtl overlap linkage mapping gwa common strain underlie drug response qtl', 'case bleomycin response linkage mapping qtl qtl gwa', 'variant likely present allele frequency panel wild bleomycin gwa', 'difference linkage gwa rare common natural underlie bleomycin response variation', 'study power c model system dissect complex', 'linkage mapping significant qtl manner genetic bleomycin simple', 'certain transgressive figure figure multiple loci interact create extreme bleomycin sensitivity particular mixed genetic', 'epistatic loci underlie bleomycin unsuccessful complexity epistatic', 'complexity increased bleomycin sensitivity parental expression variation riail panel bleomycin response qtl', 'parental vary expression rna seq figure', 'evidence epistatic loci underlie expression variation parental expression figure', 'additional lack overlap gwa linkage qtl potential effect lossof function bleomycin', 'complicated manner genetic affect bleomycin powerful model c identify single gene complex trait']"
435c259a0b1c77cb1fab63dabf76fa1637d8e645,inflammatory response pro inflammatory anti inflammatory r hlf role blf inflammatory cytokine tissue damage bcg vaccine crohn disease antimicrobial activity effect blf mammary gland mg ml murine model protective action protective role small intestine therapeutic action c mice cytokine response hlf transgenic innate adaptive lf inflammation lf inflammatory role lf action blf adaptive immune balb c biotechnological development blf administration blf hlf blf treatment cell line e coli gastrointestinal respiratory gram negative gut systemic inflammatory process intraperitoneal administration key role nitric oxide post infection potential clinical staphylococcal mastitis action inflammatory action lf administration blf administration murine bacterial infection bacterial invasion bacterial load barrier function blf bacterial blf inflammation blf inflammatory blf pro cervical lymph challenge tuberculosis day post defense system development nanoparticle disease due effect lf effect viral expression inflammatory gut homeostasis h post h pylori holo lf human lf immune defense immune tissue impact lf infection e infection effect infection inflammatory infection mice inflammatory role intestinal inflammation iron free lf different lf due lf iron lf potential lf present mice underwent modulatory effect modulatory impact modulatory inflammatory mrna expression nf κb oral administration post rsv prophylactic therapeutic protective activity regulation inflammatory resolution infection respiratory syncytial response infection rotavirus infection,"['lactoferrin lf glycoprotein primary innate immune defense system present milk mucosal', 'protein family broad antimicrobial iron plasma cationic charge', 'noteworthy lf immunomodulatory regulation innate adaptive immune homeostasis mucosal myriad microbial gastrointestinal respiratory', 'inflammatory process essential control infectious development chronic inflammation tissue damage life', 'review recent vivo lung oral cavity mammary gland liver experimental evidence therapeutic role human bovine lf deleterious bacterial viral fungal protozoan inflammation', 'new knowledge lf immunomodulation way effective design native synthetic lf useful immune tissue damage infectious', 'int', 'j mol', 'sci', 'gastrointestinal respiratory', 'study modulatory inflammatory response biotechnological development nanoparticle lf potential clinical', 'lf time human hlf bovine blf milk', 'monomeric molecular weight kda cationic pi', 'tertiary structure figure lf main lobes', 'chain', 'cleft ferric ion fe k', 'total lf bind ferric diet iron transferrin holo tf bound carbonate ion co bound metal ion', 'int', 'j mol', 'sci', 'gastrointestinal respiratory', 'study modulatory inflammatory response biotechnological development nanoparticle lf potential clinical', 'lf time human hlf bovine blf milk', 'monomeric molecular weight kda cationic pi', 'tertiary structure figure lf main lobes', 'chain', 'cleft ferric ion fe kd', 'total lf bind ferric diet iron transferrin holo tf bound carbonate ion bound metal ion', 'lactoferrin lf iron mammalian glycoprotein antimicrobial activity present mucosal entry invasion pathogenic', 'antimicrobial activity lf bovine human origin milk', 'antimicrobial action result direct microbiostatic microbicidal indirect immunomodulatory', 'present therapeutic prophylactic microbial antibiotic multiresistance inflammatory response antimicrobial modulatory', 'review modulatory impact lf inflammatory response infectious lactotransferrin due milk glycoprotein iron', 'protein transferrin family avian egg ovotransferrin ovotf mammalian serum lymph transferrin tf family affinity iron', 'lf mammary gland abundant colostrum milk participate initial protection', 'content human mature milk lf mg ml comparison bovine milk mg ml', 'amino acid identity', 'lf present many mucosal respiratory urinary reproductive intestinal lf primary immune defense system antimicrobial activity extensive variety', 'lf natural cellular development important component secondary pmn', 'lf infection acidic due activity', 'plasma lf neutrophils concentration low μg ml sepsis degranulation neutrophils secretion significant mg ml bloodstream', 'lf inflammatory inflammatory bowel disease ibd ulcerative colitis crohn disease due response pathogenic', 'lf lactotransferrin due milk glycoprotein iron', 'protein transferrin family avian egg ovotransferrin ovotf mammalian serum lymph transferrin tf family affinity iron', 'lf mammary gland abundant colostrum milk participate initial protection', 'content human mature milk lf mg ml comparison bovine milk mg ml', 'amino acid identity', 'lf present many mucosal respiratory urinary reproductive intestinal lf primary immune defense system antimicrobial activity extensive variety', 'lf natural cellular development important component secondary pmn', 'lf infection acidic due activity', 'plasma lf neutrophils concentration low µg ml sepsis degranulation neutrophils secretion significant mg ml bloodstream', 'lf inflammatory inflammatory bowel disease ibd ulcerative colitis crohn disease due response pathogenic', 'lf holo lf iron free protein lf', 'holo lf rigid resistant denaturation proteolysis lf lf effective lf', 'regard holo lf utilized iron source several', 'case epithelial barrier function mucosal inflammation model lps lf inhibited pro inflammatory response', 'apo effective inflammation due ability bind neutralize neutralize microbial pro inflammatory effect', 'much evidence successful experimental use lf different human porcine caprine camelid buffalo growth diverse', 'lf different bacteriostatic due iron chelating activity due interaction gram negative teichoic positive', 'membrane damage bacterial death', 'antimicrobial activity lf dependent cationic addition positive amidation antibacterial antiviral addition negative acylation', 'lf antiviral common virus', 'antiviral ability block cellular attachment replication virus type β antiviral action', 'lf diverse potent activity replication human immunodeficiency virus cytomegalovirus hepatitis c virus', 'information microbicidal action lf fungi protozoa', 'important lf immune system lysozyme natural secretory iga siga antimicrobial effect', 'external source lf milk consumption', 'lf pepsin stomach trypsin small intestine', 'hlf blf proteolytic digestion pepsin', 'noteworthy mention digestive tract high ph low pepsin innocuous transit hlf epithelial important stage life', 'native hlf pancreatic exocrine mucosal', 'addition diverse biological facilitation iron absorption modulation mucosal immunity stimulation mucosal differentiation result interaction lf gastrointestinal', 'reason lf pharmaceutical activity component proteolytic g terminus lf pepsin iron chelating activity strong cationic charge', 'microbicidal activity parental lf act', 'several', 'hand synthetic lactoferrampin fusion peptide lfchimera multiresistant form', 'synthetic lfchimera effective parasitic protozoa', 'synthetic lfchimera fusion effective pseudomonas aeruginosa pyocyanin elastase biofilm formation', 'presence lf various mechanisms action glycoprotein combat mucosae different bodily', 'site different lf diverse', 'time lf help inflammatory process strong immune reaction', 'lf lf potential use antimicrobial anti inflammatory alone conventional', 'sense commercial point view nutraceutical supplement diarrheic cancer immunity improvement memory several', 'human lf different recombinant r hlf overall eukaryotic glycosylate product transgenic', 'r cow mammary gland systematic intestinal immune model', 'addition meat progeny hlf transgenic nutrient composition', 'wide use lf human health care promissory', 'next review anti inflammatory protein number infectious gastrointestinal respiratory', 'inflammatory response germ line pattern recognition many cell interact exogenous endogenous origin pathogen molecular molecular', 'prrs comprise large family', 'ligand tlrs lead activation translocation nuclear factor κb nucleus', 'nf κb expression inflammatory type interferon ifn α ifn β tumor necrosis factor tnf α chemoattractant', 'class prrs function', 'activation signal activation inactive pro active', 'generate active pro inflammatory death response microbial endogenous danger', 'lf direct microbiostatic microbicidal antimicrobial capability wide array humoral cellular adaptive immunity', 'immunomodulatory role lf due part surface elicitation signal translocation nucleus gene', 'summary modulatory lf inflammation due microbial table', 'gastrointestinal treatment cultured coli crohn disease ↓tnfα expression blf treatment intestinal cell e crohn disease infected blf action inflammatory response epithelial iron homeostasis blf nano administration balb c mice enterica serovar typhimurium ↑interferon ↑ifniii proinflammatory administration mice entamoeba histolytica e histolytica ↑iga ↓damage ↓inflammation blf treatment balb c mice pylori h pylori ↓gastric colonization ↓inflammation histopathology score blf treatment rotavirus infection ↔rotavirus incidence fed unfed blf gut systemic sepsis ↓lung infection ↑ifnγ spleen cell ↓lung pathology', '↑lymphocytic recall response recombinant human lf mixed bcg vaccine mice tuberculosis early↑ late↓ pro inflammatory ↓lung pathology blf effect bcg vaccine oral route mice tuberculosis ↓colony cfu ↓inflammation blf cystic fibrosis bronchial cell burkholderia cenocepacia b cenocepacia pro inflammatory cytokine inflammatory cytokine blf administration murine model lung injury ↓bronchioalveolar α ↓myeloperoxidase mpo activity ↓lung edema inflammation administration murine model respiratory syncytial virus infection ↔viral inflammation blf administration murine model influenza ↔viral load ↔ifnγ mucosal systemic mammary gland staphylococcous aureus aureus mastitis ↓bacterial load mrna expression nuclear factor κb inhibition ↑curation ↑proinflammatory blf elastase proteolysis blf oral candidiasis candida suppressive candidiasis pmn tnfα production cervical lymph abscess e histolytica damage inflammation liver human lf hlf c mice listeria ↓bacterial load ↓necrotic foci ↔necrotic foci spleen ↓tnfα ifnγ mrna hlf hlf administration e uropathogenic ↓bacterial load bladder urine ↓urinary systemic post infection hlf transgenic mice aureus ↓bacterial growth ↓septicemia ↓mortality litter', 'polarization ↑tnfα ↑ifnγ stimulation toxic shock syndrome congenic ↓ decrease ↑ increase ↔', 'gastrointestinal tract lf present iron multifunctional glycoprotein natural compound able inhibit growth', 'lf able modulate humoral cellular immunity regulation inflammatory response key role gut homeostasis', 'balance homeostasis tight regulation several little inflammation process tissue much inflammation collateral impact tissue damage life', 'mucosal compartment small intestine scenario place physiologic inflammatory response innate adaptive intestinal epithelial wide array immunocompetent dendritic key role gut homeostasis combating', 'infectious clinical large intestine ibd inflammation sword role cancer development progression', 'antimicrobial activity blf wide array', 'contrast regulatory role blf inflammation enteropathogenic limited number', 'vivo infection blf modulatory pro inflammatory cytokine profile', 'role blf resolution inflammation infection several enteropathogenic', 'lf development bifidobacterium major genera bacteria colon independent iron saturation level lf', 'effect help gut homeostasis', 'gastric inflammation treatment blf hlf single antimicrobial favor eradication gastritis helicobacter pylori helicobacter felis murine', 'human murine bacterial growth gastric inflammation enhanced blf hlf administration', 'controversial experimental clinical treatment', 'lf single component eradicate h pylori infection combination triple esomeprazole clarithromycin amoxicillin therapy resolution infection inflammatory response combination antibiotic treatment experimental mice r hlf transgenic native blf', 'r hlf growth h pylori expression major virulence', 'hand several effect lf inflammation small intestine', 'example anti inflammatory native blf bacterial infection shigella flexneri salmonella enterica serovar typhimurium susceptible balb c mice', 'lf untreated microscopic lf resolution infection mice tissue damage intestinal inflammation', 'anti inflammatory role blf part elicitation siga response key role luminal clearance intestinal inflammation', 'lf inflammation growth ability apo lf iron free form lf murine typhoid model pharmaceutical formulation iron blf holo blf antimicrobial activity modulatory inflammation', 'latter modulation innate adaptive immune hematopoietic key role generation pmn', 'iron blf evoke convergence innate adaptive immune anti inflammatory protection typhoid infection concomitant intestinal inflammation', 'modulatory blf pro inflammatory monolayer recombinant escherichia invasive strain inv gene yersinia pestis strain able accomplish invasion intracellular multiplication epithelial', 'model apo blf blf decreased invasive e type strain tnfα e', 'addition apo holo blf increased response e invasive strain elevated', 'effect blf inflammatory independent constant high protection recruitment infection', 'large intestine regulatory impact blf inflammatory response vitro infection adherent invasive e presumable role pathogenesis crohn disease', 'disease ulcerative colitis clinical abnormal response commensal intestinal', 'aiec strain colon tissue crohn disease preponderant pro inflammatory response', 'model infection blf bacterial invasion inflammatory cytokine response tnfα epithelial colonic crohn disease potential therapeutic role blf antibacterial anti inflammatory agent', 'modulatory inflammatory response bacterial infection ifn γ mimic preponderant response crohn disease', 'unstimulated infected bacterial invasion survival ifn γ blf production inhibitory effect aiec infection ferroportin protein expression', 'ferroportin iron exporter protein inflammation intracellular intracellular iron', 'apparent infection model aiec strain anti inflammatory versus pro inflammatory role blf evidence e ability blf modulate inflammatory response iron availability resolution infection', 'parasitic large model intracecal infection protozoan entamoeba histolytica susceptible mice strain spontaneous mutation tlr gene intestinal infection parasite', 'model oral therapeutic administration blf intestinal infection high efficiency effect increased local expression elicitation siga cecum salmonella infection', 'regulation siga secondary inflammatory cytokine pro inflammatory', 'oral blf administration anti inflammatory response iga collaborate protection parasite maintenance homeostasis protective impact tissue integrity', 'hand experimental enterovirus blf treatment protective action viral interaction host', 'vitro blf exhibit suppressive activity rotavirus', 'addition assessment rotavirus infection incidence blf viral infection effect γ anti inflammatory', 'therapeutic action viral enteritis unclear administration whey concentrate containing blf bioactive resolution acute gastroenteritis rotavirus infection', 'result synergic effect bulk single bioactive component protection enterovirus', 'sepsis life syndrome harmful inflammatory response gut systemic', 'case infectious intestinal assessment inflammatory blf response systemic limited number infection e enteral parenteral', 'sepsis human systemic enteropathogenic immunocompetent opportunistic nosocomial neonatal adult underwent parenteral nutrition post surgery antibiotic treatment immunosuppression', 'therapeutic action blf synthetic peptide lfchimera balb c mice intragastric route enterohemorrhagic e latter food borne pathogen mild diarrhea hemorrhagic colitis hemolytic uremic syndrome anemia thrombocytopenia kidney injury', 'infected mice underwent lf lfchimera fecal bacterial output kidney colonization lfchimera mortality rate', 'histological analysis hematoxylin eosin tissue inflammatory response lf lfchimera damage comparison mice blf tubular necrosis glomerular injury intratubular hyaline cast', 'vivo vitro role r hlf gut systemic infection e meningitis infected neonatal', 'model clinical evidence parenteral feeding sole route nutrition risk factor sepsis translocation g gram negative enterobacteria intestinal tract systemic bloodstream fatal', 'treatment r hlf clinical sepsis illness bacterial blood vitro macrophage nitric tnfα nf κb expression addition r hlf', 'protective action r hlf optimal activation pro inflammatory cytokine elicitation enhance bacterial killing activity', 'effect blf sepsis e cyclophosphamide immunosuppressed mice model mimic immunosuppressive therapy autoimmune neoplastic', 'antisepsis action blf reduction bacterial load spleen rise induced elicitation spleen peritoneal blf', 'e coli blf activity recruitment', 'action blf e coli sepsis elicitation production acute phase amelioration tnfα response infection', 'high pro inflammatory lethal consequence suggest ability blf control tnfα increase protective action sepsis vivo', 'clinical potential application blf prevent nosocomial sepsis enterocolitis premature associated modulation regulatory intestinal immune response essential role blf control intestinal homeostasis', 'pro inflammatory bacterial ability act', 'modulatory hlf blf inflammation intestinal systemic endotoxemia endotoxin gram negative enterobacteria', 'experimental assess impact lf intestinal systemic inflammatory lps affect gut bacterial translocation diarrhea tissue damage endotoxic shock', 'administration encompass use zymosan galactosamine galn carrageenan increase sensibility toxic low', 'porcine lf plf bioactive confer protection mice colon modulatory action inflammatory ifnγ', 'expression tight junction regulation intestinal permeability e zonula colonic apoptosis', 'protective action hlf gut barrier function induced intestinal damage hlf vitro jejune mice underwent', 'iron status blf impact function cell murine blf neutralizing blf pro inflammatory cytokine generation response e coli iron content protective role lf inflammation gut endotoxemia sepsis', 'intestinal level activity blf hlf endotoxemia intraperitoneal administration lps', 'neutralization enterogenic endotoxemia carrageenan intraperitoneal route infection e coli nebacetin intraduodenal enable lps release', 'model mice endotoxemia intraperitoneal administration hlf protection deleterious intestinal integrity', 'intraperitoneal route mice diarrhea production inflammatory powerful diarrheagenic activity e prostaglandin e pge small intestine nitric oxide plasma', 'enterogenic endotoxemia model endotoxic activity dose dependent manner bacterial mesenteric lymph', 'experimental neonatal blf intestinal tnfα ifnγ peyer', 'systemic level activity hlf intravenous administration', 'protective activity intravenous circulating', 'dual action lf tnfα underlie protective role modulation tnfα protection deleterious impact endotoxemia modulatory role lf control tnfα elicitation critical eradication gut systemic', 'example blf prophylactic action lethal shock intravenous injection germ free valuable model study primary toxicity endotoxin portion lipid secondary toxicity r', 'interaction antigen surface marker mononuclear', 'phagocytic ligation elicitation powerful pro inflammatory tnfα lethal outcome host endotoxemic', 'oral administration blf intravenous protection mortality induced hypothermia', 'blf protective activity hypothermia hlf mice underwent', 'effect blf neutralization e bacteremia lps toxicity susceptible mice defective gene cba mice resistant lps', 'protective activity cba mice blf confer protection endotoxemia e bacteremia due inability elicitation tnf α ifnγ prevent decrease', 'unbalanced cytokine response responsible high susceptibility endotoxemia mice', 'differential impact concurrent prophylactic therapeutic intraperitoneal administration hlf analyzed intravenous administration lps', 'concurrent scheme hlf lps challenge serum nitric oxide', 'prophylactic therapeutic serum tnfα nitric oxide significant', 'mice model hepatitis intraperitoneal co administration zymosan serum aspartate aminotransferase activity marker liver inflammation small intestine production inflammatory cytokine role amelioration inflammatory response', 'modulation provide therapeutic action small intestine zymosan model hepatitis', 'treatment r hlf mice hepatitis', 'experimental scenario r hlf protection hepatitis development decrease alanine transaminase activity marker liver damage modulation serum tnfα', 'protective effect r hlf treated gadolinium chloride source tnfα hlf', 'lf action inflammatory response ability lf interact interaction vitro intestinal cell peritoneal cell line', 'lf inflammatory response dependent independent signal pathway', 'modulatory impact inflammation intestinal porcine epithelial cell line plf derivative peptide effect ability inhibit', 'human monocyte cell mac hlf modulatory activity cytokine response nf κb tnfα promoter', 'human peripheral blood mononuclear anti inflammatory response differentiation lps dendritic low capacity differentiation elicitation response activation', 'hand modulatory impact lf inflammatory raw macrophage cell line peritoneal blf form complex lps cytokine response tnfα signal pathway', 'study modulatory effect lf lps inflammation', 'raw macrophage cell line lps elicitation', 'lf dual role response pro inflammatory alternative signalization', 'presumable mechanism inflammation ability lf control expression iron regulating monocyte macrophage lps decreased ferroportin reducing', 'ferroportin iron iron inflammatory response', 'summary provide experimental evidence support protective role deleterious induced pro inflammatory cytokine response gut barrier function bacterial translocation tissue damage', 'mind antimicrobial lps protein application alone combination adjunctive compound strategy treatment prevention sepsis endotoxic shock', 'human respiratory tract rt responsible mobilization life', 'delivery life oxygen systemic circulation potential incorporation countless local innate adaptive immune entry lung tissue circulation protect lung structure function', 'frequent population represent considerable cause worldwide morbidity mortality', 'upper rt common cold laryngitis pharyngitis epiglottitis otitis sinusitis virus extension', 'example common cold viral disease frequent infection parainfluenza adenovirus respiratory syncytial virus enterovirus', 'influenza virus common cause seasonal flu affect tract', 'rt', 'include bronchitis pneumonia pulmonary', 'tuberculosis bacterium mycobacterium tuberculosis prevalent rt pneumonia', 'rt inflammatory process intensity many type pathogen virulence inoculum tissue host immunological status infection acute chronic', 'inflammatory process essential control infectious development chronic inflammation respiratory capacity due lung tissue damage edema resistance mucus production infection influenza virus', 'inflammation respiratory system indispensable development therapeutic support lung plasticity clinical treatment', 'regard evidence modulation rt inflammation blf certain several vivo', 'second important antimicrobial anti inflammatory peptide upper rt', 'tuberculosis vivo model microbial pulmonary infection', 'bacterial infection third world population rate new year calmette guerin bcg vaccine vaccine world unchanged', 'study single subcutaneous immunization mice mix bcg blf freund adjuvant challenge tuberculosis aerosol decreased mycobacterial spleen', 'splenocyte proliferative response heat bcg increased ifnγ production', 'subsequent study group admixed bcg vaccine incomplete freund adjuvant pbs mice protection tuberculosis challenge bcg', 'addition significant reduction lung bacterial load increased production ifnγ study blf addition vaccine clear reduction lung pathology concomitant regulation inflammatory main action lf enhance bcg vaccine immunomodulatory immune tissue pathology part dendritic ability present', 'noteworthy lymphocytic recall response infection mice lf adjuvant lf specific cell response increase infγ production', 'potential r hlf tuberculosis tissue damage pulmonary histopathology ulterior group', 'r hlf yeast pichia pastoris expression system glycosylation pattern similar natural human neutrophil counterpart contrast non r hlf able efficacy bcg vaccine challenge tuberculosis aerosol significant reduction pulmonary pathology', 'case mycobacterial spleen bcg r hlf group protection pathological manifestation lung disease due notable immunomodulatory function granulocytic lf study lf form', 'hlf chinese hamster ovary cho mixture bcg vaccine slight decrease time lung pathology aerosol challenge tuberculosis initial increase secretion inflammatory posterior decrease', 'efficacy blf bcg vaccine action amenable route administration', 'study mice drinking water blf day post infection colony inflammation', 'noteworthy blf vitro replication tuberculosis nitric oxide dependent way', 'pulmonary infection tuberculosis lf certain regulation inflammatory response overall tissue immunopathology', 'role lf inflammation pulmonary addressed', 'homeostatic effect blf inflammation vitro cystic fibrosis cf bronchial gram negative opportunistic bacterium cf resistant available broad spectrum', 'addition blf bacterial invasion release pro inflammatory secretion inflammatory role blf cf bronchial infected inflammation damage', 'noteworthy study previous sputum inverse association inflammation burden', 'study decrease lf due cleavage cathepsin activity positive sputum biofilm opportunistic pathogen', 'similar result lf tf undergoing proteolysis bronchioalveolar lavage p aeruginosa cf', 'proteolytic cleavage lf contribute b cenocepacia p aeruginosa lung damage infection lung damage exogenous therapeutic administration lf due potent immunomodulatory', 'similar protective effect blf murine model lung injury lps', 'study intraperitoneal injection blf mg mouse h prophylactic effect h therapeutic effect challenge significant reduction total number bronchioalveolar lavage decreased tnfα activity', 'attenuation lung inflammatory infiltration protective role blf damage acute inflammatory response', 'protective role lf regulation inflammation', 'several viral infection immunomodulatory effect lf', 'lf vitro antiviral activity respiratory syncytial virus rsv immunomodulatory effect release rsv oral intraperitoneal administration different animal day mice h post rsv infection effect viral pulmonary airflow resistance obstruction type pulmonary inflammation serum cellular day post rsv infection', 'similar result study intranasal route blf day post rsv infection', 'example mouse model influenza infection daily oral administration mg blf h infection effect viral load concentration ifnγ infection untreated infected mice', 'reason lack blf effect viral infection mice possible route blf administration', 'contrast oral blf curcumin supplementation recurrent viral rt immune modulation lymphocyte population cytokine rate', 'recent study determine effect supplementation blf formula respiratory tract chinese weaned age similar reduction incidence rate respiratory group', 'study chronic rhinosinusitis association genetic deficiency lf synthesis upper rt susceptibility certain bacterial colonization biofilm development recalcitrant sinus disease', 'new knowledge lf immunomodulation way general design cell dependent granulocytic infectious immune tissue damage', 'role blf inflammatory response infection mucosal mammary gland staphylococcal mastitis', 'assessment mammary gland sick intramammary infusion blf healthy blf infusion integrin complexed complement fragment', 'modulatory effect blf pro inflammatory immunity therapeutic action mastitis fact alternative decrease deleterious effect inflammation tissue integrity', 'combination blf effective control staphylococcal mastitis attenuate mrna expression tnfα inhibition activation', 'approach decrease tissue damage antibiotic dosage eradication staphylococcal infection multiresistant', 'inflammatory response staphylococcal mastitis elicitation blf elastase proteolysis display low concanavalin low iron binding antibacterial expression inflammatory neutrophil infiltration', 'staphylococcal mastitis elicitation low cona affinity lf peptide severity periodontitis', 'oral cavity modulatory action blf infection inflammatory response candida', 'experimental oral candidiasis mice oral administration blf therapeutic effect suppressive infection inflammatory response pmn cervical lymph node generation ifnγ tnfα cervical lymph heat mice', 'vitro full length blf blf therapeutic effect parental blf terminal portion ability modulate action pmn superoxide generation protein c mapk activity expression', 'murine model candidiasis modulatory effect blf protection infection', 'assays support role blf hlf modulation inflammatory response extra intestinal hepatic amoebiasis listeriosis urinary tract staphylococcal septicemia', 'experimental amoebic liver abscess treatment gavage protective action hepatic histolytica normalization liver function', 'mind intrinsic anti inflammatory therapeutic action low toxicity use blf adjunct conventional metronidazole decrease drug dosage treatment amoebiasis decrease drug resistance parasite', 'vitro infection ifnγ thp cell blf displayed protective action cell death necrosis bovine lfcin b death cell necrosis apoptosis', 'protective role blf lfcin b inflammatory response necrosis intracellular infection pathogenic anti inflammatory death apoptosis', 'data l treatment hlf significant main organ target pathogen bacterial colonization necrosis mrna expression inflammatory', 'majority experimental lf experimental hlf antibacterial anti inflammatory action', 'murine model infection urinary bladder uropathogenic e hlf bacterial load urinary bladder inflammatory response reduced urine h post infection plasma h post infection', 'hlf peroral route therapeutic action infection inflammation urinary tract', 'vitro pneumophila infection healthy holo hlf bacterial apo hlf intracellular multiplication pathogen', 'synergy antibacterial effect iron free human lactoferrin killer pro inflammatory cytokine ifnγ leading bacterial multiplication', 'model aureus infection hlf transgenic mice pivotal role hlf elicitation profile resolution systemic infection', 'polarization immune response profile hlf transgenic mice modulation tnfα ifnγ modulation culture spleen', 'summary show derivative bimodal regulation inflammation resolution extra intestinal', 'biotechnological development potential clinical use addition lf hydrolysate native lf combination control inflammation', 'evidence basic prophylactic therapeutic activity antimicrobial modulatory agent inflammatory response glycoprotein innate immune system focus interest biotechnological development nanoparticle potential clinical use', 'addition lf hydrolysate native lf combination application control neonatal inflammation', 'necessary support practical application control inflammation', 'mexican council science technology conacyt julio césar carrero', 'julio césar carrero programa innovación tecnológica papiit unam grant', 'institutional program nuatei financial support', 'villasana luisa samaniego technical assistance pavel petrosyan english editing manuscript', 'conflict interest']"
b4563e2063857020585678fe9a2d36065e88a72e,et al heated water hot water inactivation pedv nucleic acid cell culture present study thermal inactivation treatment water bowman al chemical disinfection organic material pedv nucleic pedv ten rrt pcr second treatment swine production tcid ml temperature time ten second thomas et viable pedv viable virus acid rrt culture pedv decontamination chemical diarrhea virus disinfection impractical epidemic diarrhea inactivate pedv mean tcid method rapid pedv control pedv swine porcine epidemic post treatment production chain rapid thermal swine industry time temperature treatment positive u swine virus contagious virus united water decontamination water method water viral ability heated ability survive able inactivate accidental spread acid detection acid treatment actual viral addition sample additional swine additional testing adequate initiate advisory committee age high agriculture usda al bowman al cima al et al inoculation al manure al order al schneider al thomas alternative chemical alternative disinfection american detection american type analysis variance animal harvest animal health animal human animal min anova time application hot application water assay actual asset many attention many attention time ayliffe racioppi b r babb bradley become major bedding etc biosecurity control biosecurity krogwold block bowman bowman et box combat bradley ayliffe bulk likely burden u c porcine capable infection,"['b r c porcine epidemic diarrhea virus contagious swine pathogen fecaloral route', 'present study heated water method rapid thermal inactivation pedv', 'cell culture pedv treated water viral multiple time post treatment', 'viable pedv ten second treatment water pedv nucleic acid treatment', 'hot water decontamination chemical disinfection impractical', 'porcine epidemic diarrhea virus contagious pathogen become major economic burden u swine initial north american detection', 'coronavirus significant additional swine morbidity mortality subsequent al cima cima', 'infection pedv severe diarrhea dehydration age high mortality neonatal stevenson al', 'fecal oral transmission equipment clothing wide spread distribution virus neill clement christopher nelson dee et al et al', 'global distribution pedv swine strict biosecurity control prevent accidental spread', 'vast majority pedv control various chemical heat', 'chemical attention many able inactivate pedv bowman al schneider zhang ramirez wang holtkamp', 'chemical corrosive metal hazardous human animal health organic material water high mineral content babb bradley ayliffe racioppi al', 'chemical contact maximum effectiveness rutala weber david healthcare infection control advisory committee problematic various swine production chain', 'alternative chemical disinfection thermal inactivation virus inanimate', 'infectivity high infectivity min hofmann wyler', 'u swine industry animal min inactivation pedv thomas et al', 'use heat specialized equipment prolonged period high turn industry', 'pedv animal harvest application water many equipment taormina dorsa', 'present study hot water method rapid thermal inactivation pedv', 'forty distilled water mixed treatment positive control', 'water temperature ml tcid ml cell culture pedv strain al inoculation water time mixed maintenance medium mm ice block bowman al', 'manner vial heated water prior inoculation pedv negative control', 'triplicate', 'cell culture american type culture collection manassas va sample', 'remainder sample frozen additional testing', 'inoculated daily cytopathic inoculation positive', 'measure tissue culture dose positive al', 'mean tcid triplicate transformed normality way analysis variance anova', 'p value significant', 'addition sample rrt pcr n gene jung al bowman et al order determine hot water viral nucleic acid', 'infectious pedv control group', 'viable virus post treatment', 'heated water effective rendering pedv nonviable temperature time table', 'treatment positive pedv nucleic acid rrt pcr posttreatment ct range', 'treatment water reduction viable virus tcid ml', 'viable pedv ten second treatment water table', 'anova time temperature interaction time temperature significant viral infectious p', 'inactivation pedv water wide range temperature time potential use alternative disinfection method', 'ability heated water inactivate pedv little asset many production economic great attention time sensitive', 'importance transmission flexible intermediate bulk likely method intercontinental movement virus united u department agriculture usda', 'virus united country gaps biosecurity krogwold price davis moeller lowe et al', 'relative ease virus spread due part low dose infect naïve miniscule viable virus adequate initiate large swine', 'ability survive environment meal dee al manure storage swine production chain circumvent typical management health', 'heated water useful penetration chemical difficult corrosion target g', 'metal', '', 'swine industry nucleic acid detection presence pedv diagnostic tool determine intact viral capable infection', 'limitation important consider disinfection transmission pedv swine', 'challenge use many inability rna threshold detection impossible discern disinfection effectiveness pcr positive test result bowman al thomas et al', 'heated water immune challenge pedv nucleic acid rrt pcr present study infectious treatment', 'limitation present study cyclic heat element difficult maintain constant temperature entire treatment period', 'treatment temperature time inoculation rapid temperature minimal impact', 'first sampling time point post inoculation sufficient time prior sample collection', 'important note cell culture assay actual viral infectivity animal', 'infectivity neonatal comparison hot water disinfectant swine farm thomas et al', 'follow experiment field g', 'fecal material pavement bedding etc', 'mimic swine production harvest', 'presence organic material inactivate many chemical', 'thermal inactivation impacted organic material viral protectant application hot water', 'viable pedv ten second treatment water hot water decontamination chemical disinfection impractical rapid inactivation pedv', 'heated water due animal human health hot water water tool veterinarian tool box combat pedv', '', 'mean tcid ml significant difference treatment', 'positive initial inoculation viral titer limit quantification subsequent assay']"
39b54c3e0c3560b23189d363831c0b04f213055f,et al bovine norovirus amino acid new genotype rt pcr bull et capsid protein p domain partial rdrp polymerase rdrp al al al mauroy calf diarrhea cbecu f dependent rna detection rate kit qiagen mauroy et norovirus giii qiagen manufacturer rdrp gene reference strain rna polymerase viral rna acid reference acid sequence agarose gel al smiley b c blast tool buenos province cell receptor circulation bovine conventional rt di martino diarrheic dairy domain p e value enteric fecal f r genetic diversity genotype bovine genotype giii genus norovirus immunogenic determinant information bovine jor al kapa library kit kapa ligand immunogenic major capsid martino al mini kit negative rva norovirus study nucleotide identity pcr sanger phylogenetic analysis potential new prevotella sp qiaamp viral rdrp region receptor ligand recombination junction reverse transcription rna dependent rna mini rva bcov sample calf santa fe sequence genotype sequence p smiley et south america south american strain genotype strain jena swiss model tblastx search terminal part μm μm ability exchange absence relevant accurate representation acid alignment acid characterization acid domain acid p activity argentina additional clarify address nomenclature affect phylogenetic agent combination agreement fecal agriculture technology aim study al absence al bcov al bok al bovine,"['bovine enteric fecal non diarrheic several', 'epidemiological information bovine many important', 'study bovine genogroup iii conventional rt pcr sanger diarrheic dairy', 'phylogenetic partial region dependent rna polymerase rdrp belong genotype third related genotype', 'deep sequencing capsid region', 'circulation genotype presence sequence genetic relatedness genotype distant constitute new genotype', 'latter silico recombinant phylogenetic divergence rna dependent rna polymerase sequence genotype capsid protein sequence genotype potential norovirus genotype', 'strain genotype bovine norovirus recombinant described literature worldwide', 'analysis strain norovirus giii genotype', 'important epidemiological evolutionary information bovine america', 'major cause epidemic sporadic gastroenteritis green', 'animal clinical gastroenteritis bridger al hsu al martella al wolf al', 'genus norovirus family', 'non nm possess positive sense single rna genome open green', 'large non structural viral protease rna dependent rna polymerase rdrp p', 'encode major minor capsid green', 'capsid domain n terminal part domain p domain terminal part sub prasad al', 'hypervariable domain external localization compatible function cell receptor ligand immunogenic determinant tan et al', 'diverse green zheng et al', 'cell culture system norovirus exception murine reverse transcription polymerase chain reaction rt genomic sequencing infection phylogenetic', 'genotyped analysis partial capsid polymerase rdrp gene', 'region genome accurate representation viral epidemiology due frequent recombination et al', 'recombination junction recombination bull et al bull et al chhabra al et al', 'address nomenclature system polymerase capsid kroneman et al', 'gvi genus norovirus tentative genogroup vii green vinjé', 'norovirus giii', 'genogroup di martino al green mauroy et al al bovine norovirus ovine', 'bovine norovirus otto liu et al al dastjerdi al woode bridger prototype strain wolf et al', 'genetic small number partial available paucity complete genome martino et al mauroy al mauroy et al', 'viral rna recombination major evolutionary mechanism', 'affect phylogenetic virulence prophylactic diagnostic', 'bull et al', 'recombinant norovirus cluster distinct different rdrp genome analyzed bull et bull et al al', 'molecular characterization bovine diverse geographical circulation number recombinant di martino al han al jor al mauroy et al', 'knowledge bovine norovirus', 'livestock industry major economic activity argentina', 'infectious neonatal calf diarrhea important sanitary problem beef dairy al', 'molecular detection bovine norovirus calf diarrhea scipioni et al', 'pathogenicity low moderate jung economic impact weight loss health status veterinary treatment cost co agent combination enteric', 'molecular cattle different world scarce south american large cattle argentina brazil', 'aim study investigate presence genetic diversity bovine fecal diarrheic dairy', 'total fecal diarrhea major dairy', 'buenos santa fe entre ríos', 'old', 'diagnosis service virology institute national institute agriculture technology inta', 'negative group rotavirus bovine coronavirus bcov', 'bovine rva antigen capture cornaglia al bcov elisa monoclonal smith et al', 'badaracco al bok et al', 'dairy survey southern buenos province study microbiology calf diarrhea dairy dairy region cuenca lechera mar sierras negative rva bcov salmonella ssp', 'cryptosporidium ssp', 'viral fecal water', 'min', 'rna qiaamp viral rna mini kit qiagen manufacturer volume fecal', 'μl elution buffer use', 'amplification partial rdrp region step pcr qiagen manufacturer', 'cbecu f cbecu r amplicon size nt smiley et al', 'mixture min reverse transcription min initial pcr activation', 'amplification min min final extension step min', 'amplification agarose gel electrophoresis uv light', 'agarose gel purification rt pcr size qiaquick gel extraction kit qiagen', 'rt pcr sanger region primer', 'fecal min rpm minilys homogenizer bertin france μm μm μm membrane', 'filtrate cocktail benzonase micrococcal nuclease new england biolabs', 'h homemade tris mm cacl mm mgcl free nucleic', 'rna dna qiaamp viral rna mini kit qiagen manufacturer carrier rna lysis buffer', 'second strand synthesis random pcr amplification whole transcriptome amplification kit procedure sigma aldrich denaturation temperature allow denaturation dsdna dsrna', 'modification amplification dna rna', 'wta msb spin pcrapace spin columns stratec illumina kapa library preparation kit kapa', 'kapa library quantification kit kapa hiseq platform illumina', 'sample total paired end', 'raw quality trimmomatic bolger bankevich al', 'tblastx search complete viral e value cut', 'significant tblastx hit used second tblastx search genbank database e value altschul al', 'consensus sequence validation bwa li durbin', 'bioedit sequence alignment editor hall', 'nucleotide similarity genbank blast tool available', 'mega version software package tamura al', 'phylogenetic software', 'identity partial rdrp region single capsid protein small basic protein bovine norovirus reference simplot software version available', 'dimensional swiss model tool et al chimera software available basis amino acid reference strain', 'total amplification product size step rt pcr cbecu f r rdrp genomic region bovine norovirus genome', 'strong signal', 'sanger sequence analysis bovine', 'apparent detection rate negative rva bcov', 'important phylogenetic analysis related ruminant bacteria prevotella sp', 'supplementary material', 'particular prevotella ruminicola hindgut sheep nathan et al', 'positive norovirus bo ar', 'young different', 'sample calf dairy herd santa fe province', 'sample calf buenos province animal córdoba province', 'positive', 'blast tool partial rdrp gene related norovirus', 'sequence related related', '', 'fact recombination junction complete next generation successful', 'phylogenetic related', '', 'contradictory phylogenetic polymerase rdrp capsid different recombination rdrp level', 'order clarify strain genotype nucleotide identity plot simplotanalysis sequence end rdrp gene region entire', 'analysis reference jena', 'percentage nucleotide identity jena similarity fig', '', 'fig', 'recombination breakpoint overlap nucleotide sequence similar sequence jena', 'region similarity jena low variable region capsid sequence p domain', 'sequence potential new genotype giii', 'explore acid reference strain jena dimensional fig', '', 'major capsid protein important evaluate amino acid domain domain p domain cell receptor ligand immunogenic determinant', 'number jena reference sequence', 'clear amino acid p domain', 'circulation bovine south america single report partial rdrp enteric alcala et al', 'present work screening detection norovirus argentinean main dairy country', 'genotype circulate argentinean dairy', 'genetic potential new genotype bovine norovirus giii', 'detection rate norovirus study agreement fecal cbecu f r primer dairy beef korea stool old et al park al', 'contrast prevalence bovine usa fecal healthy veal human enteric fecal real time rt pcr jor al smiley al smiley et al', 'detection rate pcr depend continent country strategy test strategy conventional rt pcr qpcr test temperature', 'amplification bovine norovirus identity several prevotella sp', 'phylogenetic analysis circulation rare south america', 'new genotype partial sequence close genotype', 'evolutionary point view ability exchange different bovine alternative herd immunity evasion potential evolutionary strategy', 'genetic diversity giii et al zheng al absence relevant virus neutralization analysis definition clear cut term pairwise divergence', '', 'amino acid characterization putative recombinant bovine norovirus strain', 'amino acid alignment capsid protein jena strain argentinean bovine norovirus study', 'sequence p domain gray', 'b c p threedimensional modeling b c', 'swiss model workspace arnold et al homology pdb', 'amino acid sequence reference strain jena black', 'axial view', '', 'important acid sequence level domain major capsid protein', 'major immunogenic novel genotype', 'determine matter relative prevalence new genotype world', 'epidemiological analysis specific region world hypothesis genetic divergence region', 'conclusion work circulation bovine dairy geographical', 'new genetic prevalent worldwide', 'presence new genotype giii genogroup', 'additional clarify situation argentinean south american']"
495132370917fdb1762cd47fa73e9e6ff94a60b6,e gene full length genotype iii parent clone immune sera variable neutralization figure text genotype ii bgli site den b dengue virus ffu ml genotype iv log ffu recombinant virus vero cell virus genotype convalescent sera e glycoprotein fragment den genbank accession genotype e genotype indonesia homotypic sera human sera ii iii iii iv infection serotype isogenic recombinant isolate genotype length cdna molecular clone pr iv primary infection puerto rico serum sample sri lanka table text amino acid antibody neutralization b e clone platform denv infection dhf dss gene genotype genetic basis genotype prm genotypic variation human polyclonal ii thailand iii cuba iis restriction infectious clone kb fragment low titer pcr xl post vaccination primary secondary prm e prm gene restriction enzyme sample traveler secondary denv sera figure severe disease sri lankan topo vector type iis variability neutralization variation neutralization xl topo accession genotype anti denv antibiotic mix antibody response assess role b fragment bgli bsmbi bio basic buffer hr clinical isolate clone backbone clone indonesia clone panel cloned pcr clustalx version columns show construct insertion den fragment dengue genome dengue infection dengue vaccine denv cdna differential neutralization dilution serum e construct e ii e sequence end fragment envelope different,"['dengue single positive sense rna spp', '', 'distinct distinct', 'dengue scientific community infection serotype lifelong protection subsequent infection serotype irrespective virus genotype', 'hypothesis scrutiny role denv variation protection infection certain', 'dengue vaccine field urgent need develop define role genotypic variation denv infection immunity', 'understand genotypic variation neutralization protection panel isogenic recombinant infectious envelope different genotype genotype thailand genotype ii sri lanka cuba genotype iii puerto rico genotype iv', 'panel natural envelope variation polyclonal serum', 'recombinant neutralization immune sera primary denv neutralization much depending envelope glycoprotein', 'variability neutralization residue glycoprotein significant specific humoral immunity influence antibody protection disease enhancement natural infection vaccination', 'genotypic likely important temporal spatial microevolution background heterotypic neutralization', 'recombinant synthetic valuable testing genetic immunopathogenesis', 'dengue virus denv virus family flaviviridae genus flavivirus bite', '', 'denv', 'distinct', 'prospective asymptomatic proportion fever rash myalgia severe disease hemorrhagic fever dengue shock syndrome dhf dss hemorrhage vascular leakage hypovolemia shock end organ failure death', 'dhf', 'dhf dss secondary context pre heterotypic immunity dhf dss immune phenomenon reactive denv specific', 'virus genotype important role severe disease pathogenesis', 'multiple molecular epidemiology virus genotype disease severity', 'genetic basis virulence', 'fundamental vaccine development concern denv vaccine secondary infection severe disease secondary infection', 'vaccine protection prototype vaccine virus address degree intra serotype genotypic antibody immunity denv', 'genotype specific genetic viral genome envelope glycoprotein e main target human antibody logical first choice genetic basis differential antibody neutralization infection', 'e glycoprotein homo dimer distinct ii iii mature denv virion flat herringbone pattern icosahedral symmetry', 'ii discontinuous fold form central ß barrel domain lateral protrusion domain ii fusion loop virion fusion', 'domain iii continuous peptide fold ligand unidentified cellular receptor', 'successful dengue vaccine protective geographic serotype', 'dengue community primary infection serotype immunity serotype irrespective infecting virus genotype', 'early human challenge multiple observational particular region infection serotype', 'geographic denv understanding role strain variation protective immunity vast majority denv endemic', 'several recent genotypic variation important immunity', 'recent recombinant whole virus neutralization genotype limited neutralization activity heterologous', 'primate vaccination immune sera variable neutralization', 'study pediatric dengue significant ability sera neutralize reference clinical', 'recent report dengue neutralization need vaccine immune contemporary different', 'distinct iii iv specific geographic region', 'genotype ii asia genotype iii indian subcontinent africa latin america genotype iv caribbean', 'construction fragment infectious clone platform panel isogenic recombinant e heterogeneity', 'approach novel human coronavirus cov similar system large genomic recombinant genetic variability cov biology pathogenesis', 'cov powerful tool understanding genetic application powerful', 'isogenic recombinant panel immune sera primary secondary denv', 'demonstrate role natural epitope variation virus neutralization escape', 'molecular clone valuable tool variety pathogenesis immunopathogenesis epitope mapping evolution', 'institutional review board university carolina chapel hill protocol blood', 'informed consent', 'vero fcs gibco non essential amino l glutamine gibco anti antibiotic mix co', 'fcs non essential amino glutamine anti', 'strategy clone figure covs circumvent sequence instability', 'clone parent sri lankan isolate genotype iii genbank', 'isolate transcription amv reverse transcriptase roche manufacturer primer bsmbiden', 'cdna synthesis cdna pcr expand taq polymerase boehringer mannheim biochemical cycle size amplicon', 'dengue genome cdna figure text', 'fragment pcr primer set', 'rna promoter end fragment bsmbi restriction site end', 'pcr product gel qiagen qiaquick gel extraction kit pcr xl topo vector invitrogen', 'infectious virus valuable viral genetic viral biology', 'dengue virus important mosquito borne virus worldwide dengue virus infectious manipulate difficult study variety genetic dengue', 'describe construction panel dengue virus serotype novel strategy dengue research', 'strategy genetic genetic virus', 'recombinant distinct envelope different world', 'recombinant sera human impact e variation neutralization', 'demonstrate recombinant neutralization sera', 'presumed infection vaccination serotype lifelong protection serotype assumption rigorous assessment denv community', 'variable neutralization second fragment b', 'primer bsmbi site directional ligation b figure text', 'primer silent genome nt unique bgli site amino acid sequence', 'fragment c', 'primer bgli site b fragment bgli site nt', 'pcr c gel cloned pcr xl topo vector', 'fragment', 'pcr product nt end dengue genome bgli nt nt', 'bgli site nt pcr', '', 'extension pcr reaction', 'product sapi den fragment', 'final cdna fragment bgli site big easy linear vector lucigen', 'fragment sequence', 'den create full length cdna dengue viral genome', 'full length cdna silent polymerase ambion', 'rna infectious dengue virus', 'construct e glycoprotein variant figure envelope genome basic', 'portion envelope plasmid pcr forward reverse primer primer text', 'bsteii bsmbi', 'dengue b envelope first pcr synthetic den primer primer text parent b fragment primer egene text', 'bsai', 'cloned pcr xl topo vector', 'parent clone prm gene genotype prm gene rna lab stock genotype virus reverse random pcr', 'amplicon bstapi pflmi', 'product den plasmid indonesia genotype e gene', 'plasmid den sequence used construct genotype recombinant virus', 'plasmid e competent lb selective c kanamycin chloramphenicol', 'individual', 'high concentration selective lb plasmid qiagen mini spin kit spei neb calf intestine phosphotase neb bsmbi neb kb fragment den b bgli neb bsmbi kb fragment den c bgli kb fragment den bgli bsmbi fragment', 'isolated qiagen gel extraction kit agarose mixed equivalent copy number ligase neb overnight', 'full length vitro described manufacturer ambion austin tex mmessage mmachine reaction ml mm gtp stock ratio gtp cap analog', 'vero grown confluence resuspended rnase free pbs', 'rna mixed ml vero cell suspension electroporation cuvette electrical rad gene pulser ii electroporator', 'vero ml flask', 'supernatant vero day confluent vero flask', 'fresh final volume ml', 'day supplemented fbs centrifugation amplify virus stock', 'time study unique fulllength envelope available genbank sri lankan laboratory', 'envelope amino acid clustalx version representative sequence genotype', 'representative sequence amino acid conservation figure', 'design infectious clone chimeras', 'panel schematic representation genome structural nonstructural', 'primer name approximate primer genome', 'different cdna appropriate terminal restriction enzyme recognition', 'promoter primer', 'primer complete', 'clone circular linear plasmid', 'denv plasmid blue', 'final generate clone bottom figure blue', 'lengths restriction site exact primer fragment text', 'panel b strategy gene construct insertion', 'top den b e protein', 'approximate introduce bsai recognition sequence end fragment den b', 'bio basic e construct black e gene schematic arrangement e gene restriction', 'roman e transmembrane region', 'primer location pair orientation introduce restriction enzyme recognition lengths approximate', 'e construct insertion den fragment fragment', 'sequence confirmation den b indicated subjected ligation new den den b e', 'type iis restriction endonuclease', 'variable neutralization genotype cluster consensus amino representative', 'representative genotype indonesia genbank accession genotype ii thailand genbank accession genotype iii cuba genbank accession puerto rico pr genbank accession', 'subsequent vero', 'passage', 'assess viral replication triplicate confluent multiplicity infection ffu ml', 'vero maintenance line ml pbs', 'monolayer total volume ml', 'min ul cell supernatant day sample duplicate equal volume', 'fcs clarified centrifugation', 'additional', 'virus', 'sera adult infection anonymous donor dengue infection serology sample', 'sera flow cytometry unc prnt nih md prnt cdc san juan confirm exposure primary secondary denv serotype responsible primary', 'note virus genotype experimental sera neutralization', 'capture genotype ii thailand iii latin america donor travel history', 'frnt procedure whitehead', 'briefly vero fetal bovine serum grown', 'growth', 'virus titration virus ten fold ul dilution individual', 'hr incubation rocker ml methylcellulose gibco fbs cellgro antibiotic mix gibco anti anti', '', 'day methanol', 'instant milk pbs incubation anti flavivirus mab buffer hr', 'incubated horseradish peroxidase hrp goat anti mouse ab sigma buffer hr', 'pbs foci addition trueblue hrp substrate kpl', 'foci light box viral standard', 'frnt human sera fold', 'dilution focus final volume ul hour co triplicate', 'mean focus diameter foci clone magnification', 'multiple clustalx version phylogenetic protein mr version huelsenbeck jp', 'briefly amino envelope clustalx alignment default', 'structural macpymol delano scientific crystal structure envelope pdb', 'mean focus way analysis variance anova dunnett test multiple', 'growth frnt graphpad prism version graphpad software san diego california usa', 'frnt dose response curve upper', 'error confidence', 'mean frnt anova tukey hsd multiple comparison test significance level alpha p set', 'parent clone genotype iii variant sri lankan df patient figure', 'full length unstable toxic traditional e coli clone', 'disrupt putative toxic creation chimeric segmented sequential', 'final platform multiple insert plasmid stability e', 'clone type iis restriction enzyme bsmbi bgli figure directional assembly fulllength cdnas', 'digestion purification individual full length cdna vitro ligation recombinant first passage vero cell culture supernatant', 'sequence indicator cdna clone nucleotide entire genome recombinant virus', 'evaluate role e sequence variation antibody e ii iii iv figure text', 'e gene represent genotype sequence consensus e sequence genotype', 'genotype indonesia isolate genotype ii thailand isolate genotype iii cuba isolate genotype iv puerto rico isolate', 'total informative representative variable neutralization e ii iii text', 'generate variable neutralization representative bio basic parent clone background parent e gene figure', 'variant correct replacement e gene', 'variant indonesia genotype replacement parent sl genotype iii prem gene genotype prem gene evolutionary efficient e gene function select', 'full length passage recombinant virus nucleotide mutation silent c pyrimidine transition mutation genomic position genotype virus', 'denv clinical cell viral growth vero cell focus formation', 'foci vero cell', 'parent clone sl iii cuba iii moderate uniform foci growth vero cell monolayer table', 'e foci thailand ii pr iv foci formed parent clone table', 'difference plaque phenotype importance structural basic viral biology gene envelope prm e mismatch virus particular genetic phenotype paper scope', 'growth panel recombinant mammalian vero denv propagation quantification', 'cell parent multiplicity infection moi ffu cell grown', 'vero growth parent virus similar focus virus viral', 'peak viral log ffu parent clone log ffu ml genotype ii clone', 'early growth genotype indonesia recombinant virus peak equivalent', 'growth similar vero virus hrs post infection figure', 'peak similar parent clone single peak log titer log ffu ml virus', 'peak log ffu ml log ffu ml', 'genotype indonesia clone show early infection figure', 'overall inter genotypic e variability minimal impact growth tissue culture', 'assess role denv glycoprotein variation viral neutralization human polyclonal sera isogenic panel late convalescent human denv primary secondary sera north foreign travel table text', 'majority neutralization independent reproducible frnt', 'original virus sera', 'primary serum parent isogenic recombinant variable e different text', 'differential neutralization sera figure b e', 'serum sample traveler primary infection thailand', 'frnt iii indonesia text', 'serum sample traveler primary infection puerto rico', 'frnt similar low titer pr high sri sl iii clone indonesia text', 'serum sample traveler nicaragua', 'low pr iv high thailand ii text', 'frnt consistent accepted true homotypic neutralization low fifteen clone group text', 'variability neutralization recombinant neutralized homotypic sera', 'serum sample el salvador infection difference low group indonesia pr iv second high group cuba phylogenetic tree genetic relatedness virus representative e', 'tree display diversity evaluate genetic variability e gene', 'representative inclusion tree', 'maximum likelihood method tamura nei model', 'tree drawn scale branch number site', 'analysis', 'total final dataset', 'evolutionary figure infection potent clone pr iv recombinant virus neu tralization titer text', 'figure neutralization fold recombinant pr e glycoprotein', 'extreme neutralization serum figure sri lanka donor', 'serum indonesia thailand genotype iii lanka cuba text', 'significant variation neutralization primary homotypic sera', 'human anti denv secondary sera neutralizing show high broad frnt intragenotypic variability', 'test assumption serum patient secondary denv infection india sri lanka', 'high indonesia cuba differ text figure difference fold', 'heterotypic primary anti denv serum level serotype cross activity study protective heterotypic infection', 'assess role e glycoprotein variation heterotypic crossneutralization clone panel representative primary sera table text', 'sample primary infection sri lanka', 'low level detectable figure text', 'serum frnt figure text sample infection frnt range figure text', 'repeat frnt clone panel homotypic sera reproducible neutralization reproducible heterotypic sera text variable heterotypic neutralization', 'cj lai et al', 'first full length infectious denv clone isolate patient dominican republic', 'time full length denv cdna unstable e', 'overcome fragment system toxic genomic', 'subsequent new guinea pacific similar fragment genomic stability single plasmid clone considerable use', 'blaney al clinical isolate sleman infectious clone', 'full length cdna plasmid successful propagation plasmid dna inserting nt linker region termination open junction', 'date parent sleman clone backbone vaccine', 'table text', 'fold dilution serum clone', 'columns show gmt frnt frnt triplicate', 'error confidence', 'columns horizontal different frnt', 'individual tukey hsd', 'sera figure figure figure instability toxicity principle tractable denv infectious', 'denv cdna sub clone platform employ several', 'individual stable e distant genome allow fragment assortment denv', 'type iis restriction bgli bsmbi unique spurious sub technical problem palindromic restriction', 'multiple separate iterative mutation entire molecular clone reassortment', 'exception genotype e gene parent molecular clone backbone receptive heterotypic e', 'genotype specific prm e iii parent prm genotype e failure recover viable genotype e chimera', 'genotype prm ii iii iv', 'histidine lysine mutation prm position', 'region form strand parallel beta e fusion polymorphism position likely original genotype clone viable', 'second difference leucine phenylalanine mutation position', 'polymorphism hydrophobic character residue hence unlikely mutation original genotype chimera viability', 'parent prm gene genotype prm viable clone future prm e genotype', 'overall clone platform stable full length passage silent nucleotide mutation indonesia', 'recombinant equivalent peak parent clone indonesia delayed growth', 'different plaque e', 'chimeric construction nonstructural rna rna likely subtle similar clone growth tissue culture unlikely chimeric clone neutralization polyclonal sera', 'variable neutralization clinical immune sera low passage wild type', 'observed neutralization due serotype antigenic', 'al', 'similar human immune sera', 'human convalescent sera mouse hyper immune sera tahitian caribbean thailand clinical isolate hemagglutination inhibition hi', 'different evidence genetic time novel idea genetic basis variable phenotype unclear', 'caribbean poor antigenic neutralizing homotypic', 'early observation variable neutralization phenomenon unexplored part isolate antigenic variation stable genetic background', '', 'human sera acute genotype iii nonreactive recombinant genotype iv reactive genotype iii ediii', 'study use acute human sera binding neutralization individual human polyclonal serum', 'related set cuban convalescent sera twenty df dhf epidemic panel', 'sera prnt clinical virus epidemic', 'table text', 'fold dilution serum clone', 'columns show gmt frnt neutralization wild type iii iv', 'thomas et al', 'human denv sera prnt virus strain tissue virus', 'e gene dependent polyclonal antibody neutralization variability neutralization isogenic e gene late convalescent sera', 'early recent work argue antigenic variability intraserotypic neutralization', 'panel sera e variant large low homotypic sera text', 'variation e viral isogenic', 'prospective transmission low titer pre ab prnt endemic homotypic infection prospective study maternal antibody neutralization homologous virus', 'recent human challenge study titer volunteer protective volunteer viremia pre titer', 'current vaccine neutralization evidence immunity protective', 'recent vaccine al', 'guy al', 'vaccinee sera representative', 'durbin al', 'early convalescent sera post vaccination early post vaccination capture durable long term antibody response', 'guy al', 'vaccinated vaccine sera denv genotypic human sera post vaccination', 'magnitude neutralization report partial protection loss protection genotype', 'possible context live virus vaccination broad serotype protection low titer context protection', 'genotype iv non reactive homotypic human immune sera figure question vaccination immunologic niche human sylvatic distant serotype', 'point departure important human antibody response denv infection', 'antigenic e text facilitate initial mapping responsible differential neutralization', 'key human polyclonal immune response inform rational vaccine therapeutic monoclonal antibody design elicit potent neutralizing', 'speculative molecular clone invaluable epitopes responsible dengue infection', 'text', 'docx']"
c4023f77cce21fa2776be0c1d1f19a38dda5ae11,et al drinking water food sector nanotechnology microbiology antimicrobial activity biology immunology environmental ecological food food hbv hcv long term medical biology microbiology nanotechnology sensitive detection wastewater treatment adequate nanotechnology application nanotechnology avian influenza cell wall considerable attention detection food detection single early detection ecological balance era nanotechnology field nanotechnology food chain food deterioration food safety health environmental high surface human environmental human health influenza virus interdisciplinary science large scale leakage intracellular li et life food many food microbial detection nanomaterial science nanotechnology food natural environment new food pharmaceutical industrial pinchuk pinchuk ranjan et rapid sensitive safe drinking scale production science technology sewage wastewater shelf life technology detection tripp et virus detection virus particle waste water abbe carl ability biocompatibility ability extreme ability staphylococcus absorption nps access safe action characterization action food action life activation innate activity bacteria activity coli activity ismail activity stability acute respiratory adaptive immune addition amount addition large addition photocatalysis addition several adhesive ability adsorption capacity adulteration food advance molecular advancement book advancement drug advent electron advent year afm new african asian ag membrane ag nano ag se agent food aggregation chemical agri food agricultural environmental agricultural number agriculture environmental agriculture food air borne akin bashir,"['discipline microbiology analysis living non fungi invisible naked human', 'microorganisms form significant component biota unique due cell structure', 'example eukaryotic prokaryotic group', 'intracellular', 'due genetic diversity first life earth existence plant animal', 'unique ability extreme environmental', 'example survive extreme cold hot water high heavy life', 'microbial natural environment minocheherhomji', 'field microbiology advent year antony van leeuwenhoek first time', 'visual microbiological world combined work abbe carl zeiss field', 'ernst ruska possible study structure advent electron microscope', 'crystallization tobacco mosaic virus tmv wendall', 'atomic force microscope afm new path investigation manipulation small scale study biological high resolution physiological binding target', 'microbiology visual characterization various microbial', '', 'era nanotechnology precise development manipulation application nanoscale rapid pace', 'u national nanotechnology initiative nni research development molecular level create applicable diverse drexler peterson', 'history nanotechnology traditional medicinal china gold suwarna bhasma ancient india therapeutic chugh', 'middle paracelsus colloidal gold mental dykman khlebtsov', 'periodical advancement book preparation therapeutic gold doctor francisco antonii', 'scientific publication gold michael faraday', 'real interest field nanomaterial science feynman', 'concept nanomaterial science eric drexler book creation era nanotechnology', 'field nanotechnology spread medical pharmaceutical industrial food agriculture environmental wide range', '', 'possible build atom desired numerous area composite development electro mechanical biomedical renewable energy environmental remediation daima major shape size composition surface charge aggregation chemical nature', 'table nanomaterial', 'science technology microbiology nanotechnology microbiology nanotechnology field science technology novel environmental ecological balance', 'due frequent use antibiotic multidrug resistance microorganisms delivery metal food chain necessary develop interdisciplinary microbiology nanotechnology combat secondary human health environmental ecological damage', 'amalgamation sustainable rational manner', 'present chapter highlight relationship great potential interdisciplinary research', 'nanoscience several microbiology', 'visualization molecular assembly process', 'molecular recognition self assembly assessment', 'nanotechnological single nanoscale optical tweezer spatial organization field microscopy present number key application nanotechnology microbiology', 'world health organization world access safe drinking water day due waterborne', 'bring safe drinking water sanitation everyone african asian', 'important challenge rapid specific sensitive detection waterborne water', 'microbial detection time consuming culture probable substrate method antibody detection', 'enzymatic immunological genetic support classical microbial detection', 'moreover nanotechnology significant impact wastewater sewage wastewater decontamination', 'example porous thin material water passage bacteria', 'electrospun potential improvement water filtration', 'bacterial load water quality drinking water major problem', 'several inhibition exposure', 'metal high antimicrobial activity stability water', 'carbon feo tio al specific surface excellent adsorption capacity organic inorganic industrial sewage wastewater treatment kunduru et al', 'example bioconjugate fungal effective antimicrobial concentration parathion wastewater', 'addition amount escherichia initial negligible treatment', 'nano ag membrane biofouling due antimicrobial', 'inhibition bacterial attachment biofilm formation surface nano polymeric', 'addition photocatalysis oxidation process treatment water wastewater oxidative elimination microbial titanium geiser somborn schulz', 'current disinfection treatment drinking water microbial', 'used chemical water industry chlorine ozone', 'react water harmful disinfection', 'carcinogenic hossain hwang roman dbps halogenated dbps carcinogenic krasner et al', 'uv disinfection alternative oxidative disinfection generate fewer dbps high dosage certain', 'need development alternative enhance robustness disinfection process dbp formation li et al', 'ag nano zno nano tio antimicrobial strong oxidation tendency form dbps hossain al li et al', 'antimicrobial effective surface waste water treatment table', 'nanotechnology beneficial sewage industrial wastewater treatment human environmental safety', 'many demonstrated laboratory scaling commercialization significant hurdle', 'due lack clear understanding fate natural environment notable feo', 'long term risk assessment crucial nanotechnology freshwater groundwater wastewater treatment', 'addition large scale production nps widespread application nps', 'cost efficiency', 'overall future research safety evaluation large scale production safe disposal energy efficiency nps production disposal key scaling environmental benefit', 'spectrum activity bacteria toxicity chitosan cell increase membrane permeability eventual rupture leakage intracellular al', 'food microbiology third food world human consumption approx', 'p', 'spoilage poor handling', 'cost food waste economy year', 'result intensification food production major food safety new food ii adulteration food unknown long term consumption food iv presence significant chemical food yuan et al', 'numerous different food safety', 'include industrialization mass production agricultural number food food consumption due consumer lifestyle motarjemi stadler studer damiano', 'moreover ready eat cost time', 'many new food borne new g', 'raw food transmission', 'result many foodborne last many food contamination year maruši c', 'annual cost medical treatment productivity illness mortality united fortune magazine', 'nanotechnology important food sector shelf life food quality safety control delivery storage packaging ii development food detection ranjan et al', 'conventional food inefficient consumer demand nanofood sector ideal option consumer', 'example essential bioactive antimicrobial increase shelf life food', 'bioactive nanoemulsion form exhibit enhanced antimicrobial conventional due minute droplet size ranjan dasgupta ramalingam kumar', 'various essential cinnamaldehyde limonene significant antimicrobial activity coli lactobacillus delbrueckii ranjan et al', 'addition several zinc copper cerium antimicrobial activity ismail pinchuk pinchuk pinchuk', 'silver broad spectrum toxicity numerous algae extent gade', 'nanosilver significant structural cell wall cell membrane due key cell disruption death', 'dna rna death bacterial replication', 'hence silver sterilizer agent food', 'antimicrobial rabea badawy chelation trace microbial enzyme penetration cell wall dna inhibit rna synthesis', 'carbon nanotubes antibacterial contact coli due microbial thin irreversible damage leakage intracellular material', 'oxygen responsible many food deterioration oxidative', 'food deterioration indirect action food spoilage aerobic', 'spoilage process incorporation food low', 'xioa e durrant tio nps different', 'nanocomposite packaging film variety oxygen sensitive food', 'role food packaging detection food key field application bhattacharya jang yang akin bashir', 'application fluorescent detection food particular interest stewart foodborne pathogenic bacterial typhimurium shigella flexneri e quantum immunomagnetic due fe milk apple juice zhao al', 'light way presence e food', 'technique principle protein characterized bacterium silicon chip e coli present food sample nanosized light digital image horner mace miller', 'similar technique fu huang feng detection salmonella food', 'silicon gold anti salmonella fluorescent dye visible attached', 'agri food sector food nanotechnology new concept product potential health unifying development sector handford al', 'research application food sector', '• clear strict definition', 'situ detection characterization complex food', '• precise toxicology', 'long term health food', 'adequate nanotechnology food food regulatory', 'recent nanotechnological world drawn considerable attention new application nanoscience medical biology immunology', 'miscellaneous nanoscopic polymeric polymeric metal bio promising diagnostic', '', 'numerous therapeutic smarter way precise diseased tissue', 'nanomedicine way early detection cure diagnosis cancer parkinson disease alzheimer disease tuberculosis ophthalmology', 'nanotags quantum nanoprobes nanotechnology medical biology immunology schematic diagram various bio nanotechnological medical biology immunology', 'today major public health concern', 'cause gastroenteritis many world', 'peptide nanospray tandem ms method identification capsid protein stool concentration low fm colquhoun schwab cole halden', 'method virus detection surface raman spectroscopy', 'great promise detection single virus particle', 'silver nanorod array obliqueangle deposition oad sensitive', 'nanotechnology functional design enable diagnosis molecule single cell level hence great advance molecular', 'biological nucleic nanoprobes molecular detection', 'nps provide direct rapid sensitive virus detection method tang al tripp et al', 'waveguide technology nanomedicinal tool rapid pathogen detection', 'application technology detection simplex virus type waveguide', 'technique virus range low ml ml', 'technology wide application antibody coat channel detection jain', 'sensor virus human immunodeficiency virus hiv severe acute respiratory syndrome virus hbv hcv avian influenza virus al', 'hbv hcv hbv hcv gene silver np amplification useful detecting patient', 'method respiratory syncytial virus rsv monoclonal detect rsv clinical great degree sensitivity tripp et al', 'area development piezoelectric point care viral interferometric biosensor direct label detection', 'monochromatic light laser source parallel reference channel measuring', 'simultaneous detection different individual specific et al ymeti et al', 'detection avian influenza virus whole virus capture planar optical waveguide xu suarez', 'assay response index refraction virus unique antigen specific haemagglutinin surface', 'quantum aspect nanobiotechnology fluorescent semiconducting broad excitation spectra narrow emission good stability exposure chan al', 'effective study rsv pathogenesis antibody', 'research qd multiple respiratory jain', 'new nanoparticle biobarcode amplification sensitive detection capsid antigen', 'cantilever technology tool nanomedicine microscale nanoscale cantilever sensitive mass', 'technology detection single vaccinia virus particle average mass fg', 'useful air borne virus kannangai sridharan', 'likewise high surface area nanoscale promising tool advancement drug gene delivery biomedical imaging diagnostic', 'future enable immune new unexpected', 'absorption nps unique rapid activation innate adaptive immune protection endemic simon baker', 'bright future nanotechnology subsequent emergence complex innovative hybrid early detection control diagnosis human animal', 'biology nanotechnology manipulate genetic material', 'nanotechnology silicon sirna transcriptional profiling time selective perturbation immune response', 'medicine regenerative medicine stem research nanotechnology', 'tremendous development field nanotechnology synthesis action characterization', 'physical chemical synthesis efficient time effective', 'production metal chemical physical ecotoxicological environment', 'green synthesis biosynthesis microorganisms considerable attention', 'different different horsfall', 'metal surface microbial ii metal presence', 'variety inorganic defined chemical composition size morphology different many edge technological drug delivery cancer treatment gene therapy dna analysis antibacterial reaction science magnetic resonance mri taranath', 'interested interaction inorganic biological', 'many inorganic intracellular extracellular shanmugam yeh', 'semi conductive qds potential biomedical diagnosis', 'xiong et al', 'targetable cellular diagnosis biosynthesis strategy antibody combination ability staphylococcus aureus', 'taherkhani mohammadi daoud martel tabrizian facile strategy application cancer therapy marinus', 'ghosh al', 'virus phage display technique magnetic diagnosis prostate cancer', 'quasi ag se good lowtoxicity fluorescent diagnosis gu cui zhang xie pang', 'overall biomedical application', 'comprehensive biosynthesized', 'prevalence increase microbial resistance multiple application recent', 'silver fungus trichoderma viride fayaz et al', 'durán marcato silver fusarium oxysporum textile infection pathogenic durán et al', 'spherical selenium bacillus wang yang zhang high surface volume ratio good adhesive ability biocompatibility hrp horseradish peroxidase biosensor', 'magnetic biological attractive assay biological label', 'competitive chemiluminescence enzyme rapid sensitive detection small environmental toxic ueki al tanaka takeda ueki et al', 'nanoparticle biosynthesis considerable interest simplicity cost effectiveness eco friendliness various', 'cellular molecular biochemical synthesis biological detail increase application various', 'wealth information science microbiology enormous fact recent interdisciplinary science human environmental ecological', 'nanotechnology microbiology pharmaceutical industrial agricultural environmental microbiological', 'inevitable interdisciplinary science', 'application nanotechnology microbiology formidable combination toxicity environment human health serious', 'important potential ecotoxicity health environmental environment various', 'numerous medical immunology agriculture food sector positive negative investigated vivo', 'urgent need mechanism action life cycle delivery system fate food chain living', 'adequate nanotechnology food food fresh waste water drug development delivery', 'approved various excellent environmental sustainability maintenance ecological balance']"
8e39a08ac568a58302f262afef2300ffebd6661c,hai test cf test detection antibody ifa test antibody detection mhv jhm reovirus type antibody sera detect antibody rapid diagnosis sendai virus sera mice test detection vaccinia virus virus mice antigen antibody antigen sensitive commercial elisa ifa elisa iip test large scale mad fl minute virus sensitive hai virus antibody virus antigen virus serum antibody homologous antibody mice antibody minute antibody reovirus antibody virus antigen elisa available test cell culture cf hai cf ifa chapter volume commercial antibody complement fixation cross reactivity diagnosis human diagnosis infection diagnostic laboratory due cost edim virus elisa detection elisa ifa elisa sensitive et al fluorescence microscope great importance h l hai antibody hai cf homologous virus ifa detection ifa sensitive ifa specificity l virus labor intensive laboratory mice lcmv antibody mhv antigen mhv mhv mvm antibody plaque reduction polyvalent mhv positive negative post inoculation potential virus rcv sdav reovirus antibody rodent virus rv h sensitive cf sensitive ifa sensitive nt sensitive specific sensitivity sensitive sheep erythrocyte test detect test prepared viral antibody virus isolation zoonotic potential ability test ability viral absorption method absorption sera acceptable specificity acceptance diagnostic acceptance tmev accuracy specificity accurate assessment accurate biological accurate interpretation accurate sensitive acetone extraction acetone long,"['relative available viruses· symposium many discussion chapter', 'sentiment drastic clinical action basis single sérologie test· independent sérologie assay virus detection virus isolation antigen detection', 'whole blood choice', 'care encourage hemolysis blood small gauge needle blood prior separation serum fraction· serum collection', '', 'antibody detection jln vitro host vivo neutralization detected ability viral infectivity· vitro complement fixation hemagglutination inhibition inexpensive neutralization costly time due biological nature', 'vitro expensive equipment sensitivity cost', 'sensitivity specificity evaluate sérologie', 'sensitivity ability test detect antibody sample antibody', 'specificity extent antibody', 'table', 'cf test applicable vast majority human diagnostic laboratory test complement bound antigen antibody complexes competition antigen antibody sheep erythrocyte anti sheep erythrocyte indicator amount complement', 'wide variation cf test methodology difficult inter laboratory', 'specific virus uniform procedure preparation', 'sérologie cf test reference appropriate', 'hai test much simpler cf test', 'related need pre treat sera eliminate non specific mimic antibody false positive', 'treatment sera receptor enzyme rde neuraminidase kaolin periodate', 'acetone extraction remove common specific hai', 'sera contain effect specific viral antibody', 'prior absorption sera', 'accurate interpretation hai dependent appropriate', 'bioassay culture', 'cell culture due cost', 'addition desirable use standpoint potential study animal natural', 'challenge dose virus incubation temperature virus serum mixture prior inoculation', 'important infectivity incubation', 'fluorescent foci semi quantitative proportion infection inoculation virus serum', 'addition nt variable virus mixed constant concentration serum single virus concentration mixed serial', 'former method insensitive low antibody serum available small mice', 'latter method sensitive', 'nt differentiation', 'antigen ifa test proportion virus interest microscope', 'permeabilization acetone long loss antigenicity', 'sera individual slide addition fluorescein isothiocyanate anti', 'bound', 'test read fluorescence microscope sensitive', 'experienced reader interpret great accuracy specificity reaction', 'infected figure specificity control', 'specific different immunoglobulin available', 'infected antibody structural nonstructural chapter tattersail cotmore volume', 'high sensitivity test', 'major test', 'fluorescence microscope', 'second test labor intensive practical large scale', 'confirmatory test large scale enzyme immunosorbent assay', 'photomicrograph glial clone minute virus mice parvovirus', 'fluorescence proportion', 'inclusion ifa internal control specificity reactivity', 'magnification x', 'basis test similar ifa anti reagent horseradish peroxidase alkaline phosphatase', 'addition substrate color development eye', 'different discussed chapter volume virus isolation identification', 'sensitive test antibody distinguish immunoglobulin', 'microtiter small', 'plate large scale quantitative expensive', 'addition use antigen attain acceptable specificity', 'laboratory ultracentrifuge prepare', 'modified detection antibody minute virus mice mouse hepatitis virus', 'test infected cluster sensitive for· antibody detection ifa laboratory', 'automated spectrophotometric', 'test nonstructural structural', 'similar test sendai virus cumbersome microscopic', 'test prepared imperative quality consistent high', 'way insure reagent quality appropriate', 'include positive negative antigen positive negative serum', 'decision use available test kit kit contain', 'reference test run order test interpretation valid', 'negative control prepared fashion virus instance batch protein preservative', 'technical test theoretical basis assay', 'adequate record great importance', 'chapter volume rapid diagnosis rodent virus crucial rapid diagnosis human infectious disease different', 'rodent virus serology laboratory time week acceptable', 'lymphocytic choriomeningitis virus hantavirus virus infection rapid diagnosis urgent', 'case process provide decision making', '', 'pneumonia virus mice early data antibody pvm cf hai cf antibody hai antibody', 'sensitive hai test detection antibody early experimental infection', 'work nt unacceptable proportion positive nonspecific conclusion', 'course study sensitive nt hai test', 'study commercial elisa sensitive hai test pvm antibody sera mice', 'hai cf discriminate rodent', 'hai test easy perform', 'sera antibody minute virus mice mvm hai nonspecific', 'guinea pig hai test pre sera test', 'use mouse eliminate problem', 'ifa elisa advantage antibody crossreactive antigen antibody rat virus rv h l virus homologous virus', 'reactivity ifa mvm rat reciprocal strain rv h l virus mvm antibody', 'ifa test commercial elisa sensitive mvm antibody sera mice homologous virus', 'cf hai elisa ifa sensitive sendai virus antibody detection', 'enzyme immunoassay indirect immunoperoxidase iip test detection sendai virus antibody', 'antibody mice iip test conventional elisa hai test nt', 'sendai virus antibody housed iip test mean test', 'test sera prior treatment antigen several refrigeration temperature', 'rat coronavirus sialodacryoadenitis virus rcv sdav sentiment cf test inadequate detection antibody mhv several several sensitive way general use· comparison igg polyvalent mhv antigen cf test prepared antigen elisa sera cf', 'polyvalent mhv antigen elisa detect antibody sdav rat sera cross reactivity rat fortuitous diagnostic virologist primary growth rat', 'extensive rat cell cell line rcv sdav growth', 'spontaneous mammary tumor rat support mhv replication', 'ifa test mhv mhv jhm bivalent antigen sensitive cf test homologus antigen sdav antibody', 'ifa test equal sensitivity commercial elisa kit detection mhv antibody', 'mhv jhm sensitive ifa detection antibody homologous mhv strain antigen table ii manuscript preparation', 'nt mhv', 'kinetic nt necessary discriminate form hyperimmune reagent', 'single injection early collection sera mhv constant virus serum dilution nt', 'value exercise diagnostic setting questionable antigenic field prototype mhv accurate biological intact host western blot procedure viral antibody', 'powerful sensitive tool research laboratory widespread acceptance diagnostic laboratory due cost', 'week old mice tcid mhv jhm', 'number positive number geometric mean antibody titer', 'sera ifa mhv mhv jhm antigen mhv jhm enzyme prior titration', 'labelled anti mouse immunoglobulin davis peroxidase mouse igg biorad richmond', 'outbreak mousepox nih sérologie detection antibody virus', 'cf test detect antibody sera half mice nih isolate virus', 'igg elisa vaccinia virus antigen proved sensitive hai test', 'ifa specificity false elisa', 'hai test specificity available test needless destruction valuable', 'hai test distinguish infected mice', 'sera mice ectromelia virus buller et al', 'antibody homologous antigen vaccinia virus antigen', 'serum elisa virus equivalent viráis vaccinia virus', 'cf elisa ifa detection antibody vaccinia virus sera mice cf ifa antibody vaccinated mice day available antibody sera day', 'sera study dilution cf ifa dilution elisa', 'negative cf test clinical mad indigenous virus laboratory mice', 'recent experience laboratory conclusion', 'infected failure detect mad use insensitive test cf improper antigen fl strain virus', 'mice ifa sensitive cf test detection antibody known mad mad fl', 'mad fl antigen detect antibody virus', 'survey commercial antibody low prevalence', 'antibody prevalence institutional', 'addition commercial antibody reactive mad fl', 'nt', 'accurate assessment mad status laboratory use form bivalent reagent', 'lcmv common contaminant transplantable neoplasms mice', 'zoonotic potential virus accurate sensitive serology great importance', 'cf test lcmv high proportion complementary uninterpretable unreliable antibody chronic lcmv carrier mice', 'hotchin ifa test early phase infection micro plaque reduction antibody later infection', 'comparison lcmv antibody human sera', 'ifa test choice rapid diagnosis infection antibody nt late infection', 'addition complement fixation test little value serological diagnosis infection virus opinion author', 'laboratory igg igm elisa detection lcmv antibody cba j mice', 'mean igm post inoculation day lcmv mean igg day post inoculation', 'state system', 'advantage ifa specificity suspect serum specific control', 'absorption method review', 'method use elisa', 'potential sensitive recommended serodiagnosis lcmv', 'ifa elisa detection antibody', 'edim virus', 'cross reactivity different cell culture virus antigen', 'elisa sa antigen sensitive ifa edim virus nebraska calf diarrhea vaccine virus', 'current practice monitoring reovirus type derive early reovirus type wild laboratory type certain wild mouse laboratory mice', 'contrast reovirus type infection widespread laboratory', 'addition contaminate transplantable mouse suggestion hartley et al', '', 'hai test serological method choice detection antibody reovirus type specificity hai serology', 'cf low nt specific sensitivity', 'vitro nt disadvantage incubation prior final reading', 'elisa reovirus type antigen sensitive detection reovirus antibody group reactive antibody reovirus', 'ifa test reovirus antibody detection sensitive available elisa specific unpublished', 'hai test serodiagnosis tmev specificity test hai antibody mice subsequent percentage testpositive mice', 'ifa elisa wide acceptance tmev antibody detection', 'equivalent sensitivity sensitive nt', 'related serious disease man', 'isolation hantavirus transplantable rat tumor zoonotic potential virus analogue lcmv', 'ifa test detection antibody sensitive specific labor intensive plaque reduction nt', 'ifa nt', 'nt advantage hantavirus avidin biotin double sandwich elisa capability expensive time', 'serodiagnosis', 'category polyoma k test used murine cytomegalovirus lactic dehydrogenase virus', 'table summarizes current rodent', 'principle many progress diagnosis human virus', 'sense false security', 'optimal sensitivity', 'addition sensitivity sensitive', 'development sensitive specific sérologie crucial basic biology facets biomédical research']"
8cd645b337ac36abbd467302eb73b4ae086e60ac,hcv infection rc hcv hcv entry anti hcv viral entry entry fusion host cell luciferase reporter free viral hcv infectivity presence absence rc anti • c viral attachment viral infectivity attachment entry cell free early viral fusion host hcv activity hepatitis c methanolic extract pan genotypic viral infection absence test cell surface effect rc extract rc hcvcc presence liver transplant luciferase activity medicinal herb rc treatment reporter activity significant decrease µg ml μg ml activity rc antiviral activity decrease viral effect viral effective concentration end incubation gaussia luciferase hcv effect hcvcc infection hcvcc moi ifn α infection treatment key host post infection pre hcvcc pre treatment presence rc significant difference test drug treatment hcv virus host absence rc chronic hepatitis cirrhosis liver co addition continuous identification determine effect end stage genetic variability hcv attachment hcv genotype identification novel incubation • infection early infection several infection viral liver cancer medicinal plant moderate decrease positive control rc luciferase rc post rhizoma coptidis sr bi stage liver test agent variability hcv viral key acid limonium acting viral action important activity determine activity h activity hcv activity identified addition infection addition wherein alcoholic herb analysis elucidate antagonist pan anti mouse antiviral discovery antiviral efficacy,"['hepatitis hcv important public health threat risk hepatitis c end stage liver', 'improvement hcv treatment novel direct acting viral replication lack prophylactic protection hcv infection', 'novel viral entry therapeutic arsenal hcv', 'herein anti hcv activity methanolic extract rhizoma coptidis rc traditional chinese medicine possess several pharmacological antiviral', 'cell culture hcv system rc dose hcv infection non cytotoxic', 'particular rc hcv attachment entry fusion host significant effect cell free viral key host cell entry', 'hcv infection infection several hcv', 'rc potent antagonist hcv entry potential pan genotypic evaluation use anti hcv agent', 'several notable cell surface tight junction heparin sulfate differentiation low density lipoprotein receptor ldlr scavenger receptor class b type sr bi occludin ocln', 'additional viral entry apolipoprotein e apoe infectious hcv exchangeable apolipoprotein hcv lipoviroparticle lvp hcv infection', 'hcv', 'hcv infection lead chronic hepatitis cirrhosis liver cancer effective vaccine virus', 'previous standard care interferon ifn α combination ribavirin several important severe side low efficacy hcv genotype recent introduction direct acting viral non structural sustained virological response svr difficult treat genotype', 'daas potential toxicity drug drug', 'instance hcv protease high risk ddis cyp system interfere metabolism', 'cyclosporine tacrolimus co liver transplant', 'drug drug daas acid suppression g', 'famotidine omeprazole human immunodeficiency virus hiv antiretroviral g', 'rilpivirine decrease effectiveness hcv inhibitor ledipasvir adverse drug inhibitor paritaprevir', 'addition due great genetic variability hcv selection resistant challenge number real world daa', 'continuous identification novel candidate different mode action current therapeutic', 'rhizoma coptidis rc rhizome coptis chinensis franch chinese goldthread medicinal plant family', 'chinese medicinal herbs huang lian various bioactive', 'heat detoxification treatment arthritis microbial gastrointestinal', 'addition traditional usage several recent antimicrobial several', 'rc major exert inhibitory respiratory syncytial virus mouse hepatitis virus', 'rc source discovery novel antiviral', 'effect rc hcv infection unexplored attempt novel hcv impact methanolic extract rc hcv infection', 'rc hcv infection early viral entry', 'targeted viral attachment entry fusion host', 'addition rc inhibition hcv genotype specific drug hcv rc potential pan genotypic anti hcv agent', 'culture human hepatoma cell derivative production cell culture hcv gaussia luciferase reporter construct genotype dr', 'virus concentration multiplicity infection moi hepatitis virus hcv important liver pathogen flaviviridae family positive single rna genome', 'genotype genome size kb amino', 'polyprotein translation viral host matured protein structural ion channel structural', 'hcv entry host interaction basal viral infection dulbecco eagle medium gibco invitrogen carlsbad fetal bovine serum', 'rhizoma coptidis chinensis franch plant list local pharmacy store kaohsiung taiwan dr ming hong yen anatomical analysis comparison molecular', 'kaohsiung medical university herbarium', 'methanol extraction dried homogenized extraction methanol concentration vacuo', 'methanolic rc stock dimethyl sulfoxide dmso sigma st louis mo usa use', '×', 'phosphate saline pbs xtt cell viability analysis', 'antiviral activity virus moi test drug various incubation • c', 'anti hcv activity luciferase reporter biolux™ gaussia luciferase new england canada luminometer promega madison usa', 'percent hcv infectivity test relative medium control virus', 'ifn α sigma positive control', 'time drug addition information target test viral life cycle pre treatment co addition treatment post infection treatment', 'density overnight infection hcvcc moi', 'luciferase activity h incubation • infection analysis determine effect test early viral entry', 'examine viral inactivation test drug cell free virus virus drug mixture subtherapeutic concentration host final hcvcc moi', 'investigate influence viral attachment pre hcvcc moi presence absence test agent • c viral host entry', 'test impact viral entry fusion hcvcc moi • c • c incubation presence absence test drug', '× luciferase activity h incubation • enzyme immunosorbent assay assay', 'briefly pre hcvcc presence absence test drug • c h pbs paraformaldehyde', 'cell virus primary antibody austral biological san ramon secondary goat anti mouse igg horseradish peroxidase antibody invitrogen assessment tmb component microwell peroxidase substrate kit kpl gaithersburg md usa absorbance nm microplate reader instrument inc winooski vt usa', 'retroviral hcv method', 'plasmid vector invitrogen complete hcv core genotype co conjunction pnl luc env − r construct defective retroviral backbone firefly luciferase dr éric cohen omnifect™ transomic huntsville al usa', 'supernatant viral filtered µm v v polyethylene glycol •', 'infectivity experiment hcv inoculate cell presence absence test agent h • c basal h assessed reporter luciferase activity firefly luciferase kit promega luminometer', 'viral infectivity percent relative light control virus', 'antiviral activity recombinant hcv genotype dr bukh method', 'moi presence absence test agent', 'incubation detection viral infectivity immunofluorescence hcv foci primary mouse anti core clone antibody anogen mississauga canada cross different hcv core antigenic secondary alexa fluor goat anti mouse igg h l invitrogen', 'positive foci dmso control', 'statistical analysis way analysis variance anova tukey multiple comparison test unpaired test', 'p value p significant', '± standard error sem independent', 'numerous pharmacological medicinal herb antiviral', 'possibility gaussia luciferase reporter hcvcc presence different methanolic extract rc luciferase activity determine viral infectivity', 'cytotoxicity drug', 'rc hcv infection dose µg ml significant cytotoxicity figure', 'cytotoxic concentration cc effective concentration selective index ec ± µg ml ± µg ml figure', 'antiviral efficacy rc comparable µg ml concentration µg ml remainder', 'numerous pharmacological medicinal herb antiviral', 'possibility gaussia luciferase reporter hcvcc presence different methanolic extract rc luciferase activity determine viral infectivity', 'cytotoxicity drug', 'rc hcv infection μg ml significant cytotoxicity figure', 'cytotoxic concentration effective concentration selective index si \uf0b1 μg ml ± μg ml figure', 'antiviral efficacy rc comparable μg ml concentration μg ml remainder', 'order narrow window antiviral activity rc time ofdrug addition wherein drug h hcvcc infection pretreatment time viral infection co addition infection post infection luciferase reporter activity', 'significant difference hcv infectivity presence absence rc pretreatment figure drug modulate host hcv infection', 'contrast rc hcv infectivity viral challenge substantial drop signal figure', 'moderate decrease viral infectivity drug establishment viral infection', 'contrast ifn α positive control hcvcc infection treatment', 'rc anti hcv activity order narrow window antiviral activity rc time drug addition wherein drug h hcvcc infection pre treatment time viral infection co addition infection post infection luciferase reporter activity', 'significant difference hcv infectivity presence absence rc pretreatment figure drug modulate host hcv infection', 'contrast rc hcv infectivity viral challenge substantial drop signal figure', 'moderate decrease viral infectivity drug establishment viral infection', 'contrast ifn α positive control hcvcc infection treatment', 'rc anti hcv activity present host cell viral inhibitory effect early phase hcv infection viral entry', 'peer review present host cell viral inhibitory effect early phase hcv infection viral entry', 'mechanism rc anti hcv effect rc present virus host cell surface synchronized infection early viral entry', 'test rc cell free viral drug pre hcvcc h dilution', 'drug virus mixture yield effective concentration incubated', 'luciferase incubation significant difference rc drug impact free viral figure', 'determine effect viral attachment rc hcv cell °c viral internalization reporter readout end incubation', 'significant decrease luciferase reporter activity rc interfered attachment virus host figure', 'ascertain rc post attachment viral entry fusion step hcv °c temperature °c presence rc', 'similar effect viral attachment significant decrease hcv infectivity end incubation hcv entry fusion figure', 'mechanism rc anti hcv effect rc present virus host cell surface synchronized infection early viral entry', 'test rc cell free viral drug pre hcvcc h dilution', 'drug virus mixture yield effective concentration incubated', 'luciferase incubation significant difference rc drug impact free viral figure', 'determine effect viral attachment rc hcv cell • c viral internalization reporter readout end incubation', 'significant decrease luciferase reporter activity rc interfered attachment virus host figure', 'ascertain rc post attachment viral entry fusion step hcv • temperature • presence rc', 'similar effect viral attachment significant decrease hcv infectivity end incubation hcv entry fusion figure', 'validate rc attachment host binding assay', 'hcvcc presence rc • c h colorimetric analysis cell surface hcv anti hcv antibody', 'figure rc treatment dose viral attachment sharp decline absorbance signal agreement', 'hcv entry viral', 'inhibitory rc hcv entry antiviral potency hcv entry impact rc treatment infection retroviral hcv', 'tagged hcvpp infect presence absence rc luciferase reporter activity viral infectivity', 'demonstrated figure hcvpp infection hepatoma control', 'result antiviral capacity viral entry stage hcv', 'hcv infection orchestrated process engagement several host sr bi ocln', 'addition apoe play role hcv entry', 'rc treatment hcv infection viral entry asked drug expression key host entry', 'end rc h cell western blot analysis', 'figure pre treatment alter expression sr bi ocln', 'expression apoe rc treatment figure', 'apob hcv virion release comparison affected drug treatment', 'rc inhibit hcv infection host consistent pre treatment analysis figure', 'rc hcv entry examine medicinal herb pan genotypic activity hcv', 'purpose infected recombinant hcvcc presence rc incubation analysis hcv infectivity immunofluorescence', 'significant decrease viral infection hcv present suggesting pan genotypic activity hcv figure', 'continuous identification novel various action important development drug resistance commonplace exhibit genetic variability hcv', 'study first time methanolic extract rc hcv infection', 'early viral entry attachment entry fusion host', 'rc hcv infection several', 'rc promising antagonist pan genotypic function hcv entry hcv prophylaxis', 'therapeutic treatment hcv entry chronic hepatitis c risk end stage liver cirrhosis liver cancer necessitate liver transplantation', 'donor infected transplantation hepatitis c', 'current use prevent liver graft infection propensity select drug resistant entry broaden treatment c liver transplant setting', 'previous daas virus entry synergistic effect drug efficacy', 'discovery rc hcv entry ideal candidate use liver transplant combination daas therapeutic efficacy', 'natural plant excellent point antiviral discovery', 'rc anti hcv bioactivity medicinal herb important antiviral source treatment hepatitis various medicinal plant possess anti hcv source small molecule', 'hcv entry silibinin silymarin silybum marianum gallic acid limonium sinense loliolide butenolide urinaria isolated marrubium peregrinum l lamiaceae bupleurum kaoi terpenoid saikosaponin', 'molecular anti hcv activity identified potential candidate major present alcoholic herb', 'berberine coptisine palmatine epiberberine columbamine jatrorrhizine groenlandicine major', 'single compound combination rc antiviral', 'depth analysis elucidate bioactive responsible rc anti hcv effect', 'rc hcv attachment entry fusion host cell free viral key host cell continuous identification novel various action important development drug resistance commonplace exhibit genetic variability hcv', 'study first time methanolic extract rc hcv infection', 'early viral entry attachment entry fusion host', 'rc hcv infection several', 'rc promising antagonist pan genotypic function hcv entry hcv prophylaxis', 'therapeutic treatment hcv entry chronic hepatitis c risk end stage liver cirrhosis liver cancer necessitate liver transplantation', 'donor infected transplantation hepatitis c', 'current use prevent liver graft infection propensity select drug resistant entry broaden treatment c liver transplant setting', 'previous daas virus entry synergistic effect drug efficacy', 'discovery rc hcv entry ideal candidate use liver transplant combination daas therapeutic efficacy', 'natural plant excellent point antiviral discovery', 'rc anti hcv bioactivity medicinal herb important antiviral source treatment hepatitis various medicinal plant possess anti hcv source small molecule', 'hcv entry silibinin silymarin silybum marianum gallic acid limonium sinense loliolide butenolide urinaria isolated marrubium peregrinum l lamiaceae bupleurum kaoi terpenoid saikosaponin', 'molecular anti hcv activity identified potential candidate major present alcoholic herb', 'berberine coptisine palmatine epiberberine columbamine jatrorrhizine groenlandicine major', 'single compound combination rc antiviral', 'depth analysis elucidate bioactive responsible rc anti hcv effect', 'rc hcv attachment entry fusion host cell free viral key host cell entry', 'ability rc inhibit hcvpp infection mechanistic target hcv host cell', 'potential mechanism transient interaction hcv inadequate inactivate free viral effective hinder contact cell surface', 'additional action concentration dependent reversible conformational viral structure block viral entry', 'moderate effect rc post infection stage figure pronounced impact hcv entry', 'effect due inhibition entry subsequent infection treatment subgenomic hcv replicon rc moderate decrease viral rna preliminary experiment figure', 'possible rc multiple hcv infection clarification', 'hcv entry', 'rc prophylactic therapeutic management hepatitis c supplementary available online figure effect rc treatment hcv subgenomic replicon']"
e0ef85a120c99787e1ec818a0d0251410d3d04c0,et al old type decaro al mgb probe decaro et type type al decaro original type real time type field al buonavoglia type virus vaccine field vaccine virus • min able discriminate able recognise bio rad buonavoglia al capsid protein dna polymerase faecal suspension negative faecal nobivac ® parrish et pcr rflp probe able sequence analysis standard dna time pcr type decaro type mgb type n type vaccine vaccine wild wild type able detect absolute copy activation itaq administration type al pcr al truyen antigenic type available market binder mgb buonavoglia et canine parvovirus carmichael nakamura characterisation cpv copy number correct discrimination cpv dna cpv negative cpv pfizer denaturation • desario al discriminate old discriminate type discrimination vaccine dna copy dna cpv dna l dog population enzyme mboii extension • faecal diarrhoea field cpvs fluorescence dna groove binder hi test itaq dna l milan l template low time martella al milan italy minor groove n type nakamura al nucleic acid parrish al parrish carmichael pereira al polymerase • primer extension probe rapid r l rad nm residue capsid resolution diagnostic respect field rflp enzyme specific vaccine standard old sterile water time period truyen al type dog type responsible vaccine old,"['minor groove binder mgb probe type field canine parvovirus cpv', 'cpv old type canine population mgb specific antigenic different', 'mgb probe able discriminate old type detection limit dna good reproducibility', 'quantitation viral dna cpv dna taqman cpv', 'assay resolution diagnostic cpv disease vaccination discriminate field type market', 'canine parvovirus type responsible acute fatal gastroenteritis binn', 'late et al burtonboy al johnson spreadbrow antigenic parrish al parrish et parrish et al', 'main antigenic type dog population greenwood et al truyen al truyen al steinel et al sagazio al buonavoglia al pereira al buonavoglia al martella al desario al decaro al decaro al c', 'cpv mutant detected et al', 'pathogenicity decaro et', 'original type disappeared field present available market parrish et al', 'identification means time haemagglutination inhibition hi test monoclonal parrish carmichael nakamura al pcr rflp enzyme mboii pcr pereira al sequence analysis use definitive prediction antigen specificity', 'realtime pcr minor groove binder mgb rapid unambiguous characterisation decaro al decaro et al', 'mgb probe able recognise single snps presence residue capsid protein amino asp glu parrish al buonavoglia al table', 'type type sensitive specific type probe able discriminate type cpvs inal type', 'fact present nucleotide position viral genome old type type mgb strategy decaro al decaro et al', 'type mgb probe inadequate discrimination original type type noted vaccine virus low time period field diagnostic sick et al', 'faecal diarrhoea administration type crucial able detect vaccine virus field', 'effort mgb probe rapid discrimination vaccine old type field', 'total positive original type positive antigenic type n type n type n', 'prediction cpv specificity hi test mabs parrish carmichael nakamura al pcr rflp enzyme mboii sequence analysis desario et al', '', 'antigenic previous study desario al', 'old type dog population vaccine italy cpv pfizer inc ny usa tetradog chpl parvodog p merial italia p milan nobivac ® ceppi nobivac ® parvo c nobivac ® puppy cp intervet italia r l milan canigen ceppi l virbac r l milan italy', 'experimental type vaccine buonavoglia et al', 'commercial vaccine different separate', 'faecal w v phosphate saline pbs ph × g min', 'dna faecal ice schunck al uwatoko et al', 'ml pbs faecal', 'residual dna polymerase activity ineffective distilled water decaro al decaro et al', 'standard old type field vaccine vanguard cpv pfizer italia srl rome italy field faecal sample type decaro et al', 'order increase viral dna titre vaccine strain cell line', 'dna vaccine field real time able recognise al', 'cpv negative faecal suspension', 'dilution •', 'specific vaccine wild city account snp capsid protein gene original type responsible change ile thr residue capsid protein martella al press table', 'specific vaccine field fam vic', 'specificity sequence position real time pcr table', 'real time pcr cycler iq real time detection system bio rad milan italy', 'l template standard dna l iq tm supermix bio rad nm pb', 'different sample dilution standard dna', 'activation itaq dna polymerase • min step pcr denaturation • primer extension • min', 'increase fluorescent signal extension step reaction appropriate sequence detector software version', 'serial log dna type type cpv negative faecal suspension determine detectability linearity', 'vaccine virus dna respect field cpvs standard dna dna l template type', 'c triplicate plot log input dna copy number', 'specificity processing high low original type unrelated dna minute virus canine decaro al canid herpesvirus decaro al canine adenovirus type type decaro al sterile water', 'intra high intermediate low input standard old type negative faecal suspension', 'variation absolute copy number dilution decaro et al decaro et al', 'order determine ability vaccinal field dna dnas field various mgb probe absolute copy', 'dna parallel taqman able recognise old type antigenic al', 'exogenous dna nucleic acid ovine herpesvirus type decaro et al', 'real time pcr l reaction l master mix bio rad nm cpv rev nm probe cpv pb table l dna', 'thermal activation itaq dna polymerase • min denaturation • primer • c extension • min', 'detection probe dna', 'standard strong linear correlation fig', '', 'cross old type', 'fam fluorescence dna original type fluorescence dna', 'none fig', '', 'variation dynamic range type mgb probe', 'canine cross reactivity vic fluorescence sterile water', 'cvs intra assay old type', 'original type type fig', '', 'low high old type interference detection quantitation vaccine field sample dna cpv', 'cpv dna field parallel developed mgb probe taqman decaro et al', 'fig', 'log dynamic similar dna', 'contrast poor correlation vaccine ccid dna copy mgb probe table', 'diagnosis cpv infection faecal diarrhoea vaccination', 'fact live virus able replicate intestinal mucosa carmichael al buonavoglia et unnatural route administration subcutaneous shed low time period respect field previous work decaro al', 'circumstance detection nucleic acid false positive misdiagnosis disease enteric canine coronavirus canine virus salmonella spp etc', 'important rule vaccine disease due virulence vaccine old type virus', 'purpose characterisation cpv traditional inconclusive simultaneous infection type vaccine wild type virus hi mabs pcr rflp sequence analysis', 'pcr approach senda et al', 'address point advantage snps determine replacement leu position ala position old wild type table', 'specific wild mutation end nucleotide primer detrimental primer extension pcr amplification', 'experience sufficient prevent amplification old type virus vaccine v martella n decaro c personal observation', 'moreover vaccine wild type strategy able detect simultaneous presence', 'mgb probe rapid characterisation cpv decaro al decaro al discriminate old type type', 'vaccinated type novel mgb probe order assess true type field old type virus', 'correct discrimination help resolution diagnostic dilemma gastroenteric vaccination old virus', 'type available market', 'moment type vaccine', 'fact vaccine virus probe specific cpv field strain vaccine strain', 'additional assay able discriminate type type field cpvs order correct discrimination infected', 'conclusion test allow discrimination vaccine field diagnosis administration type worldwide']"
2589012924e1cde60527b4cd5da3613d13dfead1,pep group pep therapy high risk isolation pneumonia pre isolation risk exposure hcws pep exposure pre unprotected exposure risk infection east respiratory hcws high hcws unprotected lopinavir ritonavir respiratory syndrome safety pep severe pre south korea study efficacy syndrome coronavirus completion pep direct care exposure prophylaxis middle east non pep pneumonia patient post exposure therapy pep unprotected high adverse therapy airway suction attack rate cardiopulmonary resuscitation chicago il ci p consensus pep coronavirus infection coronavirus outbreak day last decrease risk dose mg efficacy pep efficacy ribavirin endotracheal intubation exposure incubation exposure patient group pep hcws cov hcws non healthcare severe hospital pep il usa incubation period infection pep korea hospital last exposure mg h nebulizer treatment non group outbreak south p ¼ patient pneumonia pep hcws pep healthcare pep infection pep middle pep protocol period disease preisolation pneumonia prevention infection prophylaxis pep referral hospital ribavirin lopinavir ritonavir pep sample size severe adverse small number spread infection therapy decrease therapy median therapy prevention type exposure abbvie inc absence current absence part addition comparator admission patient adverse completion adverse important adverse mild adverse possible aerosol procedure aerosolgenerating suction age pep anaemia leucopenia analysis due animal patient antiviral high application highflow appropriate personal,"['post exposure prophylaxis middle east respiratory syndrome coronavirus outbreak healthcare worker high risk exposure pre isolation pneumonia u r effective post exposure prophylaxis pep strategy spread infection', 'consensus pep middle east respiratory syndrome coronavirus infection', 'study efficacy ribavirin lopinavir ritonavir pep healthcare severe pre isolation pneumonia', 'safety pep', 'high risk exposure pre isolation pneumonia', 'hcws pep therapy pep group', 'pep therapy decrease risk infection', 'severe adverse therapy', 'consensus pep middle east respiratory syndrome coronavirus infection', 'study efficacy ribavirin lopinavir ritonavir pep healthcare severe pre isolation pneumonia', 'safety pep', 'high risk exposure pre isolation pneumonia', 'hcws pep therapy pep group', 'pep therapy decrease risk infection', 'severe adverse therapy', 'healthcare infection society', 'ltd', 'spread infection infection outbreak', 'healthcare high risk infection caring', 'laboratory east respiratory syndrome coronavirus outbreak south korea hcws cov healthcare', 'thirty hcws cov course treatment patient', 'post exposure prophylaxis pep therapy prevention infection', 'objective study assess efficacy pep therapy hcws severe pre isolation pneumonia', 'safety pep', 'sample pneumonia case study study population woman patient hospital pain', 'time admission patient pneumonia fever lasting', 'patient intensive care unit endotracheal intubation', 'diagnosis infection period hcws use appropriate personal protective equipment ppe', 'specific pathogen cov infection', 'real time reverse transcriptaseepolymerase chain reaction rrtepcr positive', 'patient cycle c protein gene open reading frame gene', 'patient rapid contact possible contact high risk high risk exposure', 'hcws highrisk exposure oral ribavirin viramid south korea lopinavir ritonavir kaletra abbvie inc north chicago il usa', 'pep protocol last unprotected exposure patient', 'pep therapy day last exposure incubation period disease', 'ribavirin dose mg mg h h', 'lopinavir ritonavir dose mg h', 'laboratory hcws pep group treatment initiation', 'hcws pep therapy underwent point sputum rrtepcr', 'detection unrecognized infection pep group enzyme immunosorbent assay elisa euroimmun lübeck germany detect immunoglobulin g igg completion pep therapy', 'control group selection super spread', 'retrospective comparative study', 'secondary referral hospital e tertiary referral hospital', 'hospital pre isolation pneumonia patient', 'pre isolation pneumonia infected', 'available preisolation pneumonia', 'c similar', 'hcws unprotected exposure pre isolation pneumonia', 'hcws high risk exposure', 'hcws hospital pep pep group', 'hcws pep non group', 'hcws non pep group development date exposure patient', 'incidence infection', 'south korea hospital contact survey exposure', 'data potential', 'epidemiological medical record review personal interview', 'infection rrtepcr', 'preisolation pneumonia patient pneumonia quarantine knowledge infection', 'high risk direct care inappropriate unprotected exposure pre isolation pneumonia', 'definition appropriate previous', 'absence part ppe unprotected exposure', 'aerosolgenerating suction application highflow instrument bronchoscopy endotracheal intubation tracheostomy nebulizer treatment sputum induction positive pressure ventilation manual ventilation cardiopulmonary resuscitation', 'several type exposure', 'duplicate', 'baseline non pep c exact categorical student u continuous', 'attack rate fisher exact test', 'categorical continuous mean standard deviation median interquartile', 'multivariate analysis due small sample size', 'confidential interval ci variable', 'p', 'p significant', 'pasw version spss inc chicago il usa statistical', 'pep group study efficacy pep infection unknown adverse possible', 'individual participation voluntary', 'informed consent pep therapy', 'study institutional review board respective hospital', 'hcws unprotected exposure pre isolation pneumonia participating', 'hcws definition high risk exposure figure', 'pep group hcws non pep group', 'baseline similar table median age pep group non group', 'none hcws high risk exposure worn respirator isolation gown facial shield', 'common type exposure direct care aerosol procedure patient airway suction nebulizer treatment', 'eighteen hcws direct care procedure', 'pep group pep group p', 'hcws infection', 'attack rate pep group pep group ci p ¼', 'instance infection pep group', 'hcws cardiopulmonary resuscitation airway suction', 'pep therapy significant factor ci p ¼ risk infection', 'pep group therapy median h range h unprotected exposure pre isolation pneumonia patient', 'hcws pep therapy median duration', 'pep therapy minor adverse', 'overall hcws pep group course therapy', 'common diarrhoea nausea stomatitis fever', 'twenty hcws pep group underwent laboratory', 'anaemia leucopenia therapy', 'hyperbilirubinaemia hcws', 'liver function normal', 'total bilirubin leucocyte completion pep therapy', 'rrtepcr hcws pep group completion pep protocol', 'test negative', 'serum unprotected high risk exposure negative antibody', 'preliminary study efficacy safety pep hcws unprotected high risk exposure severe pre isolation pneumonia', 'severe exposure infection group', 'pep therapy risk hcws unprotected high risk exposure', '', 'infection rate hcws fold average household transmission rate', 'main mode transmission respiratory hcws high risk infection', 'high risk exposure tracheal intubation appropriate ppe risk contamination', 'prophylactic antiviral high risk exposure various recommendation pep', 'pep available literature evidence animal patient', 'absence current pep therapy pep day last exposure incubation period disease', 'pep therapy several adverse mild', 'adverse completion therapy', 'hcws treatment due adverse', 'frequency severity duration reversibility adverse important prophylactic', 'regard pep safe choice prophylaxis exposure', 'several', 'retrospective study small number', 'inevitable selection bias', 'large outbreak south korea hospital pep hcws high risk exposure', 'selection pre isolation pneumonia severe similar c source exposure', 'addition comparator group focus degree exposure', 'self report determine exposure experience hcws', 'bias', 'method evaluate novel clinical trial setting', 'method feasible ethical context uncommon infectious disease outbreak', 'small number sample size date assess effectiveness pep therapy prevention infection', 'pep infection useful management', 'prospective clinical future']"
bd246a6d199cb961f7c4c3421d22324aface4ff4,bat bininda bininda et branch independent close indicate et al indicate branch lambda λ shi phylogenetic λ bat,"['lambda λ bat bininda et al', 'shi phylogenetic', 'close indicate branch independent', 'significant']"
729f663149bdb9441f3804fa903ba109a418f700,et al anti hiv hiv activity southern african anti viral firefly luciferase maregesi al luciferase reporter wang al al maregesi al wang µg ml african region popular use southern africa viral activity dna polymerase drug resistant medicinal plant positive control al al al sotoca al tshikalange binding plant caffeic acid hiv hiv ic µg ii pr jiang al luciferase activity phase ii resistant hiv unspecific binding use hiv al hela al hollman assay strain auld al b strain betulinic acid bioluminescent signal cell line cell viability chinsembu hedimbi chlorogenic acid colorimetric assay cos al cos et cytotoxic concentration dependent dna direct interaction due direct due unspecific elisa kit enzyme activity enzyme immunosorbent false due gail al generate drug half life hela tat hiv ii hiv rt iii b inhibition rt interaction firefly iso firefly life enzyme ltr promoter luciferase gene mcdougall al mode action nf κb plant iso pr activity prinsloo et promoter regulatory regulatory unlikely reporter bioluminescent reporter half signal due sotoca et strain iii strain rod tat luc tetrazolium colorimetric traditional use treatment hiv tshikalange al unlikely generate van wyk viol al viral dna vitro vivo vivo situation κb activation acid active acid caffeic active plant activity hiv,"['southern africa rich plant diversity flowering plant wyk', 'medicinal plant trade prominent today', 'world health organization african continent half traditional primary health care', 'industry full capacity', 'south africa example medicinal plant plant indigenous degree van wyk', 'southern african region', 'hiv', 'worldwide hiv', 'sub saharan hiv hiv', 'eastern southern africa home global population approximated infected hiv', 'anti retroviral therapy art effective treatment hiv', 'standard treatment suppress hiv replication cycle halt disease progression', 'antiretroviral therapy significant improving life hiv many resistance toxicity limited availability lack curative effect chinsembu hedimbi', 'potential hiv resistant anti retroviral arv treatment become concern clercq', 'drug resistant need development new world', 'open natural management hiv', 'electronic science direct central google scholar undertaken search medicinal anti viral southern africa', 'publication suitability plant active mode action primary literature', 'ethnobotanical african al uganda lamorde et al cameroon mbaveng al zimbabwe viol al chinsembu hedimbi zambia chinsembu management hiv hiv', 'inclusion traditional popular use infectious viral treatment similar hiv infection related popular use hiv activity vitro native southern african region activity acceptable', 'clinical relevant ic µg ml µm individual selection criterion study al butterweck nahrstedt cos al gertsch', 'traditional history use hiv new disease use popular hiv', 'many treat viral', 'investigation numerous plant hiv nature singh et al', 'screening medicinal opportunity discovery hiv toxicity side narayan al', 'active plant leaf material narayan et al', 'various laboratory plant variety', 'reverse transcriptase rt integrase protease pr activation viral infected activity indicator mtt luciferase activity', 'mtt reduction yellow bromide mtt mitochondrial active', 'active blue formazan cell viability cell proliferation cytotoxicity cos al shoemaker al', 'determine inhibition reduction viral infection various various anti viral activity table', 'rt viral genome viral dna polymerase domain rna dependent dna polymerase activity ribonuclease h rnase h domain component intermediary rna dna complex', 'enzyme dna dependent dna polymerase function available rt enzyme', 'numerous rt various thymidine triphosphate ttp rt polyadenylic acid oligodeoxythymidilic acid polya oligodt template primer presence absence test substance plant ali al al', 'various inhibition viral capture genxbio health science india chinnaiyan al hiv rt colourimetric enzyme immunosorbent serologic assay elisa kit roche germany chukwujekwu et al eldeen al kapewangolo et klos al tshikalange et al wang al recombinant rt enzyme merck germany kapewangolo et al', 'several assay', 'rt manganese divalent factor bolton al palladium iron assay responsible irreversible inhibition rt subsequent reduction virus proliferation filler lever', 'various present plant', 'inhibition rt crude plant consideration effect metal activity rt bessong obi', 'important metal plant order avoid false inhibitory stage', 'conjunction accessory viral integration viral dna chromosome nucleus host cell', 'integrase enzyme various xpress assay kit express international usa vitro model jiang al', 'recombinant e wang al evaluation processing activity bessong al', 'unspecific binding plant', 'pr viral structural functional form progeny obi', 'protease enzyme various fluorometric detection hiv pr activity hiv ii pr hiv fret fluorescence resonance energy transfer inc usa recombinant protease solution bachem table summary popular anti hiv', 'obi bolton et al chukwujekwu al eldeen al filler lever kapewangolo al tshikalange al wang al', 'integrase enzyme integration viral dna chromosome nucleus', 'xpress various', 'false due unspecific binding plant', 'obi jiang al al wang al protease pr protease enzyme viral structural functional form progeny', 'ii pr hiv fret fluorescence resonance energy transfer recombinant protease solution various', 'false due unspecific binding plant', 'obi harnett et al jiang al al wang al', 'assay enzyme immunosorbent assay detect quantify core protein', 'inhibition decrease viral antigen absorbance nm', 'antigen kit various', 'false due unspecific binding plant', 'klos et al', 'cell isolated hiv cell added plant', 'activity', 'recombinant virus transfection plasmid luciferase gene luciferase activity', 'rely inhibition single enzyme virus pseudovirion transfection', 'antioxidant activity result high mtt activity redox assay', 'free lead reduction mtt formazon product inaccurate', 'plant iso firefly luciferase reporter bioluminescent signal due direct interaction firefly luciferase reporter half life enzyme activity', 'firefly luciferase reporter false', 'auld al cos et al ngwira al prinsloo et al shoemaker al sotoca al wang al κb activation plasmid firefly luciferase gene hiv dependent nf κb activation tnfα', 'high expression luciferase activity nf κb activation canonical pathway', 'plant antiviral ltr promoter regulatory unlikely generate drug resistant hiv', 'plant iso firefly luciferase reporter bioluminescent signal due direct interaction firefly luciferase reporter half life enzyme activity', 'firefly luciferase reporter false', 'auld al sotoca et al tshikalange al hela tat luc hela tat luc plasmid reporter plasmid ltr luc', 'ltr cell line consequence high intracellular tat protein', 'ltr promoter regulatory unlikely generate drug resistant hiv', 'plant iso firefly luciferase reporter bioluminescent signal due direct interaction firefly luciferase reporter half life enzyme activity', 'auld al sotoca et al tshikalange al hela tet luc active nf κb inhibition tat inhibition hela tet discard nonspecific luciferase inhibitory activity', 'ltr promoter regulatory unlikely generate drug resistant hiv', 'eliminate nonspecific luciferase activity', 'switzerland', 'glycohydrolase eukaryotic host cell golgi apparatus responsible glycosylation', 'inhibition glycohydrolase infectivity hiv virion hiv glycosylated life cycle virus', 'glucosidase responsible glycosylation hiv harnett al al', 'escherichia recombinant pr detect inhibitory bacterial growth curve jiang al wang al', 'elisa kit enzyme immunosorbent assay available detect quantify core protein antigen assay kit beckman coulter miami fl usa klos et al cell', 'cell various different cell', 'wildtype reference al entry pbmcs leteane', 'utilised format infection format fusion gene stimulation vitro infection system human hela', 'infection hiv reporter gene quantifiable fashion beta galactosidase quantification inhibitory lubbe al', 'ngwira al prinsloo al wang al hela tat luc instance plasmid reporter plasmid ltr luc protein activation', 'ltr cell line consequence high intracellular tat protein tshikalange et al', 'isolated hiv htlv iiib lai culture supernatant hiv cell line cell viability cos et al', 'african green monkey kidney vero dang al cytotoxicity maregesi al maregesi et al', 'determine cell viability vitro little consideration possibility potential result high mtt false positive', 'stabilization luciferase gene many plant false positive al sotoca et al', 'cytotoxicity selectivity index si cytotoxic concentration cc effective inhibitory concentration therapeutic index ti cytotoxic concentration cc non cytotoxic concentration uninfected id', 'value indicative extract selective inhibition toxic virus et al', 'vitro important role anti hiv activity mindful false plant crude', 'lack absorption distribution metabolism excretion direct correlation vivo clinical scope application vitro agarwal al', 'inaccurate relate vitro protein inhibition situation screening botanical', 'hydrolysis phase ii transformation vivo system contribute incompatibility vitro vivo situation', 'hydrolysis formation non able induce specific biological response extent non extract', 'hydrolysis site conjugation result excretion conjugate urine bile day al', 'type flavonoid position nature sugar metabolism intestine large intestine absorption barrington al hollman', 'aglycone form phase ii methylation major impact activity ability body excrete barrington al hollman', 'phase ii representative original plant extract botanical preparation challenge vitro', 'apigenin galangin present low present systemic circulation phase ii biotransformation barrington chen et al hollman', 'quercetin antiviral specific absorption hydrolysis', 'quercetin glucoside small intestine rutinoside colon deglycosylation hollman', 'caffeic ferulic acid wellknown viral transformation spencer', 'chlorogenic acid anthocyanidin able withstand deglycosylation', 'important consider transformation conjugation', 'transformation absorption transformation liver human body affect extrapolation vitro vivo situation', 'adme many available useful traditional use activity', 'vitro vivo extrapolation complex information determine vivo situation botanical preparation numerous active', 'number medicinal anti hiv hedimbi cos et al singh et al', 'structural diversity adaptation ability various environmental development range defense various biological plant secondary huge source novel hiv hiv', 'fractionation crude platform discovery novel anti hiv', 'emergence drug resistant hiv arv treatment search novel effective', 'summary active table', 'anti hiv activity chloroquine genistein strictinin', 'chloroquine range antiviral endocytosis exocytosis viral addition ifn g tnf production tnf', 'activity human coronavirus ebov infection newborn mice clercq', 'strictinin green tea active influenza virus simplex hiv rt saha al genistein arenaviral hemorrhagic fever infection al', 'citrus limon lemon lackman smith al psidium guajava guava mao al ricinus communis castor oil et al zingiber officinalis ginger feng al mangifera indica mango cocos nucifera coconut food viral activity', 'specific activity microorganism', 'alkaloid many anti viral activity', 'major group secondary amaryllidaceae isoquinoline various structural van staden', 'lycorine narciclasine pretazettine family', 'narciclasine synthesis step bond formation pretazettine activity rna dependent dna polymerase various oncogenic enzyme fennell staden', 'important treat family crinine galanthamine central nervous system activity due resemblance morphine codeine staden', 'family amaryllidaceae novel treatment hiv research focus search anti viral', 'medicinal hiv medicinal new virus al', 'table summary southern africa present isolated activity possible mode action specific medicinal', 'distribution traditional use reflect distribution availability region', 'plant group helichrysum study popular use treat hiv hiv treatment infectious anti viral activity influenza chicken pox mode action', 'anti hiv activity similarity popular anti hiv anti viral activity elaeodendron croceum e transvaalensis e schlechterianum popular use hiv infectious leonurus l popular use hiv', 'similar hiv ethnobotanical documentation incomplete', 'activity treat hiv viral', 'information southern african region hiv treatment anti hiv activity several evaluation distinct', 'quercetin vernonia amygdilana flavonoid', 'terpenoid terpenoid combretum molle betulinic acid peltophorum africanum cardiac elaeodendrom croceum e schlechteranum phenolic gallic rosmarinic acid caffeic acid alepidea dicaffeoylquinic vernonia amygdilana di tricaffeoylquinic various helichrysum trigalloylquinic myrothamnus flabellifolius securidaca longipedunculata', 'sufficient evidence antiviral activity phenolic many medicinal plant al', 'dicaffeoylquinic dicaffeoyltartaric selective', 'date related dicaffeoyltartaric acid l chicoric acid mcdougall al', 'caffeoyl galloylquinic nonspecific anti hiv activity protein inhibit virus replication receptor', 'specific hi virus similar anti viral activity hsv type', 'galloyl inhibit vitro rt cellular dna particular dna polymerase mahmood et al', 'mcdougall al', 'argue activity hiv rt several active hiv enzyme', 'caffeoylquinic activity caffeic acid chlorogenic acid active show selective nature wide variety', 'chlorogenic acid quinic acid active reduced amount hbv dna viral et al potential use cqa treat viral infection', 'cqa numerous activity hsv thompson', 'active abundant anti hiv acid table inventory southern african region activity distribution traditional', 'plant tetrazolium colorimetric assay strain iii b strain rod', 'positive control', 'hoslunddiol euscaphic acid rt activity µg ml', 'maregesi al maregesi al mujovo al prakash staden extract', 'gail al ncube al viol al hypoxis sobolifera jacq', 'treat infectious tetrazolium colorimetric assay strain iii b strain rod', 'positive control', 'ethanolic extract cytotoxic si', 'cos al lamorde al maregesi al maregesi et next page g prinsloo et al', 'journal ethnopharmacology tetrazolium colorimetric assay strain iii b strain rod', 'positive control', 'acid toxic brine shrimp anacardic acid ginkgoic acid cytotoxic', 'maregesi al maregesi al', 'isolated', 'bergenin betulinic acid', '', 'acetyl pepstatin ap positive control', 'various betulinic acid caffeic acid forskolin', 'pr activity', 'pr alasbahi melzig chinsembu hedimbi kapewangolo al doxorubicin positive control', 'gail al kadu al rukunga al rhus chirindensis baker f', 'fresen', 'mahmood muazu kaita viol al rheumatism canavanine inhibitor nitric oxide synthase potential treatment septic shock condition advanced', 'inhibition rt', 'hiv ii pr activity mg ml', 'gail al harnett al van wyk albrecht elisa kit fluorometric detection hiv ii pr', '', 'maregesi al maregesi al maregesi al methanol stem bark extract ic µg ml next page g prinsloo et al', 'journal ethnopharmacology bioavailable stomach jejunum absorption small intestine large intestine farah et al', 'present low ferulic isoferulic p coumaric al vitro much', 'chlorogenic dihydroxycinammic acid anti beneficial', 'possible explanation pro oxidant activity form peroxidase h tyrosinase', 'toxic due oxidative stress unoxidised state glutathione ascorbic acid moridani et al', 'act pro quinone reactive oxygen effective defense pathogenic attack', 'addition caffeic acid mice level glutathione transferase gst due oxidant activity responsive element epre activation', 'many cinnamic potent p h quinone acceptor oxidoreductase clifford', 'dcqa dcta bis inhibit rt cell inhibition mcdougall al', 'mechanism phenolic act inhibit replication infection', 'related chlorogenic confirm anti hiv activity activity chiang mcdougall et al tamura al thompson al', 'traditional popular use many viral potent anti hiv activity vitro', 'poor nutrition inaccessibility health health spread inadequate control infection hiv coovadia et al', 'many traditional medicinal viral various active bessong et al', 'anti hiv activity isolated southern african anti hiv activity world', 'evident similar compound active plant various world identification progression vivo southern african region affordable safe', 'provide drug numerous plant clinical al', 'enough evidence various investigation active profile anti viral specific', 'systematic review liu yang beneficial herbal hiv infection inadequate evidence support use herbal infected', 'potential beneficial large rigorous al', 'southern african plant clinical trial', 'example indigenous southern namibia southeastern botswana wealth preclinical van wyk albrecht', 'phase study rddp bessong al ic µg ml water µg ml methanol rt ic µg ml water µg ml methanol significant side al', 'adaptive twostage double blind placebo study', 'study safety seropositive lymphocyte count', 'sutherlandia hiv viral load lymphocyte count similar total burden infection tuberculosis isoniazid preventive therapy ipt', 'study possible interaction evaluation safety consumption wilson', 'good activity chlorogenic vivo plant anti viral', 'clinical region stage majority hiv medicinal plant region', 'low number plant advanced research potential commercial market', 'herbal vivo commercial', 'paper evidence southern africa medicinal research isolation active vitro viral research validate', 'long term funding infrastructure many southern african region', 'screening literature seem common compound southern african many antiviral activity world anti hiv', 'presence plant anti hiv activity southern africa direct future focus development viral rapid development affordable anti hiv', 'vivo information anti hiv activity dependent available', 'current information southern african traditional use viral treatment hiv aim develop hiv urgent fast track vivo hiv clinical isolated effective affordable current treatment', 'gerhard prinsloo work progress manuscript', 'cynthia marokane postgraduate student collation information manuscript', 'renée street extensive experience medicinal plant research extensive background part hiv unit mrc content paper', 'responsible final editing proof paper']"
972701bc4b66493f6bed639cc4f4c3f2b09467fd,egg powder control group g egg g g first life group egg p g body gain et al kg sd al lux body weight cow milk duration diarrhea e antigen n p neonatal diarrhea powder n powder specific risk duration sd p specific egg al al cumulative incidence egg yolk faecal day farm turkey incidence diarrhea infectious agent life cow milk day powder calf powder control powder egg powder kg powder table result diarrhea sd average significant body significant risk spectrum egg active oral additional nonspecific additional treatment administration colostrum administration egg age commercial agent cumulative agent lout aim study al field al jensenius al kellner al lgsch al moon al murakami al nagy al sadowski amount previous analysis mann antibiotic liquid antibody different antibody spectrum antigen large antigen order antigen titer application specific attributable parameter average duration average first bartz al birth life birth weight body life body persisted bovine rota breed brown breed dependent brown trial burden production calf day calf first calf prophylaxis calf result challenge wiedemann chicken treatment clear reduction clinical diagnosis clinical diarrhea clinical state colostrum first colostrum important colostrum milk colostrum nipple commercial compound consistency score control infectious coronavirus e cryptosporidia faecal daily body,"['field trial farm turkey specific egg yolk prophylactic effect neonatal diarrhea', 'antibody spectrum egg powder suitable farm rotavirus', 'dosage g g g egg powder specific egg yolk whole egg first life significant risk duration body gain control group egg powder', 'significant body life', 'mortality risk control group egg powder calf result diarrhea', 'breed dependent', 'diarrhea e g', 'respiratory leading infectious infectious', 'great interest prophylaxis neonatal diarrhea', 'colostrum important role protective inoculation et al nagy al moon bunn', 'prophylactic use inhibit propagation diarrhea stabilization regeneration natural intestinal flora promising gedek', 'prophylactic measure active oral immunization newborn', 'application specific possible way control infectious diarrhea', 'serum colostrum milk snodgrass et al sadowski al murakami al al', 'specific chicken treatment bartz al jensenius al lgsch et al', 'layer antigen order specific yolk', 'simple extraction low modest burden production', 'efficacy oral administration egg specific immunized challenge wiedemann al al field al kellner al lux', 'field body gain incidence duration et al lux', 'field g g egg powder day calf first life', 'aim study dosage spectrum egg powder', 'state suitable spectrum field', 'study november farm turkey', 'farm dairy milk yield kg year cow', 'healthy g', 'respiratory diarrhea trial', 'order test response relationship newborn different', 'percentage first parity', 'control group egg powder', 'g g g egg powder specific neutralisation test minimal titer e antigen titer minimal drink day first life', 'frisian breed brown trial', 'newborn control group g g g', 'control group make group', 'first administration colostrum nipple drinking dams straw', 'colostrum first day life cow milk day', 'first life cow milk day cow milk meal week life', 'day fresh water hay available', 'age commercial compound', 'study al', 'infectious agent cumulative incidence diarrhea duration first sign diarrhea recovery body gain mortality trial', 'clinical diagnosis veterinarian knowledge experimental', 'diarrhea faecal consistency score condition', 'treatment diarrhea similar clinical state', 'necessary', 'faecal day prior treatment', 'identification infectious agent lout faecal lactovac hoechst veterin ti gmbh unterschleibheim germany', 'test identify bovine rota coronavirus e antigen', 'pbs ph positive extinction negative control', 'minimal difference extinction set', 'statistical analysis mann whitney test test', 'alpha', 'number control group egg powder control group', 'cumulative incidence diarrhea reduced egg powder control group', 'average duration diarrhea control group egg powder egg powder n p g egg powder n p g egg powder n p', 'group antibiotic liquid electrolyte treatment', 'control group result diarrhea p p g g g egg powder additional treatment calf', 'inspection different egg powder table', 'table incidence risk duration diarrhea relation different test period birth life percental proportion mortality', 'clinical diarrhea daily body weight first life fig', 'parameter', 'group sd average first life body weight powder', 'fio', '', 'body gain turkish diary first life', 'egg powder antibody different', 'egg powder', 'sd', 'weight body weight life', 'birth weight kg sd average', 'group kg sd powder sd p g egg powder kg sd p g egg powder kg sd p g egg powder table', 'regard day farm intestinal rotavirus', 'diarrheic rotavirus cryptosporidia faecal routine faecal day faecal', '', 'attributable parameter', 'study g g egg powder calf day', 'spite clear reduction egg powder amount previous et al lux significant risk duration diarrhea mortality body gain egg powder', 'significant body persisted control group egg powder', 'farm egg powder specific e antigen large proportion', 'g egg powder prevention neonatal diarrhea farm', 'yield egg powder egg calf prophylaxis period', 'different distribution specific egg powder', 'additional nonspecific egg']"
d2882f37917b6c8f2061da45bd1b58f467ac5cff,flu panel xpert flu qrt pcr influenza virus rt pcr analytical sensitivity viral load molecular poc pandemic virus real time time rt transport medium virus ml alternative antigenic analytical specificity available poc avian influenza detection influenza determination analytical inconsistent qrt molecular test nucleic acid pcr qrt poc molecular poc test primer probe respiratory panel sample preparation sd virus welcome alternative ± sd analytical reactivity antigenic poc antigenic rapid barcode reader care poc cepheid xpert clinical utm determination subtype determine analytical diagnosis influenza em standard emergency use freeze clinical genexpert system house real human influenza influenza molecular iquum system load virus nose throat panel available panel detect panel qrt panel test pcr detection pcr roche pcr specific poc antigenic poc qrt poc use point care probe xpert real poc reasonable sensitive roche almere sensitive qrt sensitivity similar similar qrt specific welcome subtype reasonable test detection throat swabs viral ml virus determination virus different aan den able subtype able timely acid isolation acid magna acid reagent acute respiratory addition viral addition virus additional confirmatory additional equipment additional laboratory administration emergency aka poc almere pandemic ampoule disposable analytical evaluation antigenic insensitivity antigenic match antigenic point antigenic purchase antigenic test apparatus laptop application clinical,"['background influenza antigenic point care poc individual reliable diagnosis influenza virus additional laboratory confirmation', 'molecular poc alternative', 'first influenza molecular poc test available cepheid xpert flu panel detect influenza virus subtype pandemic virus compare house real time rt pcr qrt pcr', 'study design clinical positive influenza virus influenza virus different viral different type subtype determine analytical reactivity sensitivity', 'panel pathogen negative different respiratory determine analytical specificity', 'sensitivity similar qrt pcr range viral ml', 'cycle threshold qrt pcr inconsistent qrt due probe xpert flu panel', 'analytical specificity', 'flu panel available poc molecular test detection influenza virus determination subtype reasonable sensitive qrt pcr specific welcome alternative antigenic poc', 'diagnosis influenza virus variety application clinical purpose', 'time virus isolation determine antigenic match influenza vaccine whilst point care poc antigenic rapid determination infection able timely implement therapy patient preventive spread outbreak', 'major drawback poc antigenic insensitivity hence unsuitability individual patient diagnosis additional confirmatory', 'poc particular fatal influenza virus', 'real time rt pcr qrt pcr rapid expensive equipment suited laboratory rna purification rt pcr reagent preparation', 'main bottle neck poc qrt pcr sample preparation', '', 'combine sample preparation single multiplex qrt pcr system assay hour', 'pandemic virus qrt pcr useful site triage rapid easy diagnosis office', 'commercial available poc qrt evaluation xpert flu panel poc test comparison house real time rt pcr qrt pcr influenza virus detection pandemic virus', 'flu panel generic detection type influenza virus matrix gene specific detection haemagglutinin gene pandemic virus', 'panel single use cartridge freeze rna extraction realtime rt pcr nucleic acid reagent squeeze ampoule disposable pipette kit', 'genexpert dx system cepheid sunnyval laptop computer barcode reader', 'manufacturer', 'briefly nucleic acid magna pure lc system magnapure total nucleic acid isolation kit roche almere', 'qrt pcr roche', 'primary qrt pcr clinical taqman master step pcr roche almere pandemic taqman ez rt pcr core step nieuwerkerk aan den ijssel', 'optimal comparison influenza virus step qrt pcr parallel xpert flu panel day', 'detailed information qrt pcr available request', 'determination analytical reactivity clinical nose throat swabs glucose lactalbumin viral transport medium different influenza viral inconsistent qrt pcr several influenza virus different quality control molecular influenza virus haemagglutinin external quality assessment eqa panel various virus transport medium table', 'determination analytical specificity respiratory panel negative table', 'determination analytical sensitivity qrt pcr cycle ct quantitative measure whereas determination exact viral load virus ml electron microscopy em standard human influenza puerto', 'xpert flu panel qrt pcr freeze thaw cycle', 'universal transport medium utm copan italia p italy medium xpert flu panel use transport medium performance transport clinical utm', 'table none respiratory panel influenza virus specimens illness positive xpert flu panel table', 'addition virus negative negative xpert flu panel', 'em standard viral load virus seasonal ± sd virus ml ± sd virus ml bilthoven ± sd virus ml', 'qrt pcr xpert flu panel matrix similar analytical sensitivity viral ml fig', 'table viral load subtype ct pcr', 'preliminary flu panel assay freeze nose throat swabs utm cartridge', 'none freeze clinical study reduced performance due clogging cartridge', 'significant xpert flu panel qrt original clinical utm fig', '', 'food drug administration emergency use authorization use cepheid xpert flu panel december iquum liat detection virus identification subtype clinical laboratory improvement perform moderate complexity hospital patient aka poc', 'poc use genexpert system available apparatus laptop barcode reader', 'iquum system system additional equipment', 'iquum system genexpert system useful rapid g', 'methicillin resistant staphylococcus aureus cerebrospinal fluid', 'rapid diagnosis respiratory illness filmarray respiratory panel sample preparation real time rt pcr detection variant acute respiratory hour', 'system clinical trial phase fda clearance', 'xpert flu panel test easy perform hour start result minute time', 'easy interpret clear positive negative information e g', 'information ct qrt pcr experience fig', '', 'validity test sample control probe', 'analytical evaluation potential xpert flu panel real poc molecular test', 'xpert flu panel detect human influenza variant analytical sensitivity similar qrt pcr low viral load', 'addition viral load limitation noticed avian influenza', 'important limitation urgent need molecular poc avian influenza', 'xpert flu panel test specific h gene virus able subtype virus positive matrix test xpert flu panel', 'repeatable inconsistent qrt xpert flu panel', 'primer probe pcr incon sistent', 'primer probe xpert flu panel cepheid impossible determine lack performance', 'drift influenza regular quick virus primer probe site dominant virus season', 'emergency use authorisation commercial influenza molecular problem emergency development validation season', 'molecular poc house qrt pcr detection identification influenza', 'contrast due utm freeze clinical', 'historical arrival large role poc', 'analytical sensitivity xpert flu panel analytical sensitivity antigenic purchase gen expert machine test euros cartridge neck antigenic test real poc use', 'xpert flu panel welcome alternative antigenic rapid large pcr emergency office', 'useful poc test avian influenza endemic xpert flu panel detection influenza determination relevant', 'conclusion xpert flu panel available poc molecular test detection influenza virus determination subtype reasonable sensitive qrt pcr specific welcome alternative antigenic poc', 'none', 'none', '']"
626bcea8ab6811ee19f946cb84a273601cfd7bcc,antibiotic resistance poc diagnostic antibiotic prescribing primary care bacterial infection human microbiota bacterial pathogen many different point care resistance gene acid amplification general practice incidence antibiotic nucleic acid antimicrobial resistance bacterial viral different antibiotic future antibiotic gene amplification geographical location gp practice location community national antibiotic presence antibiotic resistance gp respiratory tract spread antibiotic β lactamase antibiotic resistant detection antibiotic diagnostic device diagnostic many ethnic background gold standard new antibiotic note antibiotic particular geographical phenotypic detection resistance antibiotic resistance detection specific antibiotic time result travel ethnic viral bacterial viral infection actual choice advice gp amount unnecessary answer question antibiotic treatment available poc background antibiotic care difficult care general causative bacterial clinical sample cosmetic surgery decision making detect report detection gene detection mge detection test development rapid diagnostic antibiotic diagnostic development diagnostic innovator diversity antibiotic easy adaptation example nucleic exposure patient front line future resistance future science gene present gp clinical gps antibiotic gram negative impact human incidence specific information antibiotic information specific knowledge incidence knowledge national likely antibiotic many antibiotic mge antibiotic mobile genetic molecular detection nonlocal antibiotic normal human phenotypic analysis physical examination potential molecular practice many prescribing different provide advice question antibiotic rapid easy rapid phenotypic report specific,"['general front line healthcare provision pivotal role fight antibiotic resistance', 'respect antibiotic general unnecessary use reduced treatment side reduction global spread antibiotic', 'current gold standard antibiotic resistance detection slow h result implementation point care general goal antibiotic prescribing', 'antibiotic point care diagnostic trivial task publication', 'spread antibiotic resistance global problem global due antibiotic resistance', 'way defeat emergence antibiotic resistance accurate bacterial viral', 'problem accurate antibiotic prescribing relevant general', 'gps front line patient care primary care first point contact medical general public', 'rapid differentiation bacterial viral infection primary care difficult patient history physical examination value viral bacterial infection', 'diagnostic laboratory traditional gold standard pathogen isolation identification antibiotic resistance detection several gp practice', 'accurate evidence diagnosis antibiotic prescribing gps problematic', 'possible approach problem implement point care gp practice many different available infectious', 'poc bacterial viral pathogen present example inflammatory detect report specific pathogen case bacterial infection information presence antibiotic example nucleic acid amplification detect report specific pathogen presence antibiotic resistance example nucleic acid amplification', 'ability differentiate viral bacterial infection amount unnecessary viral', '', 'potential possible antibiotic resistance point care general', 'large diversity antibiotic resistance primary care development novel poc mutation downregulation pumps increase loss bacterial inactive bacterial diagnostic flexible format rapid easy adaptation new antibiotic knowledge incidence antibiotic resistance continuous epidemiological analysis incidence specific antibiotic resistance primary care target market area', 'goal connectivity different poc single gp practice local patient information system poc local geographical increased regional poc current spread future antibiotic resistance target region epidemiology antibiotic resistance due travel ethnic background carriage knowledge local incidence antibiotic resistance potential effect traveler colonization infection local gps influence impact human microbiota poc distinguish antibiotic present human microbiota detailed scientific information specific spread antibiotic resistance order provide advice antibiotic resistance gene nonpathogenic likely pathogenic antibiotic treatment information antibiotic prescribing knowledge national antibiotic prescribing note antibiotic prescribing different current future resistance', 'aware poc poc flexible rapid easy adaptation national antibiotic prescribing molecular phenotypic analysis possess particular potential molecular detection antibiotic resistance', 'gene promoter region sequencing idea expression specific antibiotic resistance', 'note protein dormant antibiotic resistance development rapid phenotypic detection test technique simple answer question antibiotic resistance many antibiotic resistance mobile genetic', 'note true inactive antibiotic resistant antibiotic resistance gp patient behavior', 'e g time result value understood poc diagnostic development gp general practitioner poc point care', 'part poc measurement nonspecific example reactive protein crp procalcitonin pct nonspecific bacterial pathogen resistant particular antibiotic', 'bacterial infection chance gps antibiotic suitable infection due lack information possible expression antibiotic resistance causative bacterial pathogen', 'bacterial infection useful gps able determine presence bacterial viral presence antibiotic', 'practice actual choice feasibility antibiotic resistance detection poc primary care difficult poc gps', 'article major antibiotic resistance poc table', 'material place part eu project poc diagnostic device use gps', 'type antibiotic resistance antibiotic resistance mechanisms primary care several availability use gps particular geographical location community', 'intrinsic', 'intrinsic resistance inherent characteristic insensitive particular example inherent resistance gram negative antibiotic due inability penetrate gram negative bacterial outer membrane', 'antimicrobial resistance relevant antimicrobial prescribing healthcare generate resistance resistant antibiotic susceptible', 'resistance different bacterial presence absence', 'transferable antibiotic resistance different mobile genetic example many different conjugation uptake naked dna transfection spread bacteriophage transfer transduction', 'antimicrobial resistance mge β lactam antibiotic hydrolyzing spectrum β esbl example klebsiella pneumoniae carbapenemase verona integron metallo β lactamase etc', 'gene many different example tem patient temoneira sulfhydryl variant shv β lactamase gene', 'antibiotic resistance nontransferable genetic genetic', 'example resistance region gyrase gyra gene bacterial resistance quinolone nalidixic acid', 'genetic downregulation upregulation efflux', 'many different resistance single isolate bacterium time multiresistant', 'particular respect general practice example community respiratory tract amoxicillin second third choice urinary tract nitrofurantoin phosphomycin trimethoprim ciprofloxacin', 'antibiotic hyper production plasmidal', '', 'diversity antimicrobial resistance unlikely feasible develop poc diagnostic detect different antibiotic scientific literature', 'approach antimicrobial resistance geographical location community', 'solution diagnostic access date epidemiological antibiotic target healthcare existence novel antimicrobial antimicrobial geographical', 'poc diagnostic many antibiotic detection knowledgeable enough significance different', 'relevant poc diagnostic provide advice gp dependent antibiotic resistant', 'advice gp treat patient gp decision', 'legal ethical', 'number poc diagnostic antibiotic resistance price diagnostic value cost ratio diagnostic', 'gps diagnostic many different antibiotic geographical location community', 'incidence antibiotic resistance gp geographic location time difficult future antibiotic resistance', 'example β resistance haemophilus influenzae respiratory tract primary care carriage expression transferable β lactamase', 'appear canada usa mexico scotland turkey', 'likely antibiotic resistance phenotype specific disease particular geographical location community gp empirical experience recent treatment', 'empirical knowledge national antibiotic resistance unnecessary', 'poc diagnostic bacterial future science group identification gp aware likely antibiotic particular bacterial pathogen', 'example bacterium moraxella catarrhalis upper respiratory tract respiratory tract obstructive pulmonary disease', 'bacterial pathogen carriage single unique β lactamase present different', 'epidemiological penicillin resistance carriage bro clinical poc diagnostic bro gene useful viable gps broad spectrum alternative erythromycin available prescription', 'course erythromycin resistance clinical incidence resistance low world', 'range antibiotic resistance gp practice fact', 'surgery elective cosmetic surgery high prevalence antibiotic resistance colonized nonlocal antibiotic resistant bacteria', 'nonlocal antibiotic various esbl new delhi', 'high ethnic minority antibiotic', 'question poc diagnostic travel ethnic background antibiotic resistance gp different geographical', 'specific collection travel community antibiotic resistance expensive diagnostic', 'important gps start unusual resistant standard general practice cryptic asymptomatic carriage unusual travel ethnic background antibiotic community setting important', 'scenario vertical transmission unrelated bacterial risk infection', 'turn time poc diagnostic healthcare market antibiotic resistance problem original', 'detection antibiotic resistance gene clinical sample mean causative bacterial pathogen illness resistance gene', 'true transferable present identical antibiotic resistance bacterial normal human microbiota patient', 'antibiotic resistance gene present clinical sample clinician sure antibiotic resistance gene present bacterial pathogen disease present harmless member patient microbiota', '', 'detection mge antibiotic resistance problem presence antibiotic resistance human microbiota able pathogenic', 'gp note recent exposure patient antibiotic resistance previous exposure patient human microbiota time', 'note antibiotic resistance poc diagnostic chance antibiotic resistance normal human microbiota nonpathogenic microorganisms patient increase false positive respect antibiotic sensitivity actual pathogen', 'many national treatment primary care', 'national institute health care excellence nice uk genoostchap nhg', 'essential poc diagnostic antibiotic resistance note antimicrobial antibiotic prescribing', 'poc diagnostic innovator different antibiotic resistance specific financial sense primary care available large access primary care', 'national antibiotic poc diagnostic time market generate profit new antibiotic resistance test fit regular cycle national guideline revision', 'course revision national actual choice poc diagnostic innovator consideration time poc development marketing', 'gp revision antibiotic prescribing due inclined antibiotic resistance diagnostic date', 'possible solution problem poc diagnostic problem develop adaptable ecosystem inter national new antibiotic', 'phenotypic analysis gold standard catch technique antibiotic resistance inability microorganism replicate presence minimum inhibitory concentration antibiotic', 'current phenotypic detection time result sensitivity general need laboratory testing nucleic acid amplification', 'majority available poc infectious disease nucleic amplification polymerase chain reaction pcr isothermal amplification', 'detection mge antibiotic resistance amplification conserved detection many transferable antibiotic resistance', 'antibiotic resistance due genetic standard nucleic acid amplification', 'present pathogenic bacterium example ciprofloxacin resistance quinolone resistance region detection gene information actual phenotypic antibiotic resistance', 'poc detect combination gene amplification example gene amplification microarray detection gene advantage gene amplification respect mutation antibiotic resistance', 'gene amplification gp clinical information antibiotic resistance base antibiotic prescribing decision', 'perceived value nucleic acid amplification diagnostic device gp', 'unanswered question availability antibiotic resistance antibiotic prescribing', 'gps case chance bacterial infection available poc diagnostic presence viral infection', 'undetected bacterial superinfection top viral infection', 'potential unanswered question gps antibiotic prescribing diagnostic device viral bacterial infection', 'gp clinical decision making patient physical examination type virus influenza virus coronavirus example type bacterium', 'introduction antibiotic resistance gps decision rational scientific testing', 'useful antibiotic resistance gene poc general task', 'choice limited diversity antibiotic resistance present general practice epidemiological information origin spread antibiotic resistance particular geographical particular available diagnostic many different antibiotic resistance', 'inaccuracy predicting future antibiotic resistance lack knowledge impact human microbiota antibiotic resistance carriage antibiotic treatment failure', 'future science group success failure implementation future antibiotic resistance general practice many interacting', 'behavioral decision making process individual general time result added value poc antibiotic resistance practice', '• general line defense antibiotic resistance', 'antibiotic prescribing example use point care amount unnecessary', '• choice antibiotic resistance diagnostic development problematic', '• antibiotic resistance general practice diverse', '• knowledge incidence specific antibiotic resistance order generate specific poc diagnostic relevant', '• scientific information specific incidence antibiotic resistance', '• poc diagnostic note antibiotic prescribing different future resistance', '• range incidence antibiotic resistance present community example cosmetic surgery local population', '• aware potential molecular detection antibiotic resistance', '• development rapid phenotypic detection test technique simple answer question antibiotic resistance antibiotic resistance', 'publication eu grant grant agreement']"
0df4acedd15922e72eb97cc24fcc7c77f866aa11,n protein anti n recombinant n antibody response cell lysate scov n n scfv stat phosphorylation room temperature n scfvs nucleocapsid protein phage elisa vero cell hcl ph heat inactivated monoclonal anti n antibody nucleotide sequence scfv library cov infection cross reactive h room inactivated vero mouse monoclonal reactive anti recombinant nucleocapsid strong antibody tris hcl actin antibody acute respiratory anti b anti cov anti phospho b actin blot analysis bone marrow bone metabolism buffer mm calf serum carbonate buffer co incubator common structural cross reactivity dmem fetal electro transfer fetal calf final volume gap separation genomic library homology scfv horseradish peroxidase incubation room inhibitor cocktail inhibitory effect intestinal epithelial lg recombinant library anti library mouse marrow stroma mm tris mouse heat n terminus nitrocellulose paper osteonecrosis convalescent page gel pathophysiological significance penalty gap phage scfv phage · phospho stat phosphorylation stat present study protease inhibitor protein blot protein n protein phage respiratory syndrome response mouse response viral scfv phage sds page separation penalty sequence analysis severe acute specific anti stat tyr structural motif transfer nitrocellulose tyr antibody viral nucleocapsid western blot · cfu absence presence absence various absorbance nm accordance physical acid incubation activity horseradish addition iptg addition phage,"['infection coronavirus strong n antibody response', 'pathophysiological significance anti n pathogenesis unknown', 'profile n scfv library heat inactivated vero cell lysate', 'specific anti n scfvs recombinant nucleocapsid protein reactivity phage elisa', 'sequence analysis isolated n scfv identical high homology scfv specific interleukin anti inflammatory cytokine bone marrow stroma', 'neutralization stat phosphorylation intestinal epithelial anti n scfv clone', 'outbreak severe acute respiratory syndrome spread', 'new type coronavirus causative agent', 'hematological strong antibody response viral nucleocapsid protein moderate antibody response viral spike protein viral envelop', 'addition phage peptide library anti cov serum peptide various viral nucleocapsid spike open reading', 'evidence spike anti cov block infection', 'protective effect virus infection non neutralizing virus nucleocapsid protein pathophysiological nucleocapsid anti n unknown', 'order gain understanding n library mouse heat inactivated vero cell lysate', 'panel anti n scfvs library', 'anti scfvs cross interleukin bone marrow stroma cytokine member interleukin cytokine family', 'expression purification scov n protein', 'full length nucleocapsid cdna pcr genomic library ndei ecori n terminus protein', 'expression induced mm iptg h escherichia coli strain', 'bacterial sonication cell centrifugation', 'nucleocapsid soluble fraction combination agarose chromatography qiagen size exclusion chromatography amersham', 'vero cell lysate', 'vero dmem fetal calf serum gibco co incubator', 'vero infected strain h mm ph mm kcl mm mgcl glycerol mm dtt mm pmsf protease inhibitor cocktail sigma', 'cell debris centrifugation virus cell lysate min inactivate live virus', 'heat cell lysate use', 'scfv library construction biopanning', 'scfv', 'noti sfii scfv pcantab phagemid vector amersham', 'library chemical transformation competent e', 'log phase helper phage amersham multiplicity infection moi ratio', 'pool scfv overnight culture polyethylene glycol precipitation nacl', 'ml pre buffer triton nan bsa non fat milk room temperature min process', 'antigen plate lg recombinant n protein ml carbonate buffer overnight', 'incubation room temperature h gentle bound scfv glycine hcl ph', 'min acid incubation room temperature eluant neutralized tris hcl ph', 'specificity phage phage elisa', 'phage elisa', 'phage elisa elisa plate carbonate buffer ph lg recombinant n protein', 'incubation scfv incubation horseradish peroxidase antibody amersham h activity horseradish peroxidase colorimetric method phenylenediamine h', 'color develop h room temperature absorbance nm lquant micro plate reader bio tek', 'nucleotide sequence analysis', 'nucleotide sequence dye terminator cycle beckman ceq dtcs kit manufacturer', 'capillary gel electrophoresis nucleotide sequence beckman sequencer beckman coulter', 'ncbi igblast multiple sequence alignment clustalw embl ebi server default blosum gap penalty gap extension penalty gap separation penalty maxdiv default end gap separation penalty', 'alignment accordance physical property amino acid', 'western blot analysis stat phosphorylation', 'dmem fetal calf serum u ml bovine insulin sigma co incubator', 'stat phosphorylation analysis grown confluence', 'fcs supplement h h peprotech ec min absence presence various individual anti n scfv · final volume', 'lysis buffer mm tris hcl ph sds mm sodium orthovanadate protease inhibitor cocktail use', 'lysate mg sds page gel electro transfer nitrocellulose paper', 'protein blot monoclonal anti phospho stat tyr antibody cell mouse monoclonal anti b actin antibody sigma h room temperature buffer mm tris hcl ph nan mm nacl mm cacl milk powder', 'alkaline phosphatase anti mouse ig secondary antibody zymed h room temperature immunoreactive nbt bcip manufacturer boehringer mannheim', 'recombinant nucleocapsid protein cov scov n cov genomic library pcr tag tag n terminus purification', 'expression recombinant n e dependent addition iptg', 'recombinant n protein molecular mass kda fig', '', 'recombinant n protein convalescent serum healthy subject fig', 'recombinant n protein native viral n protein', 'profile antibody response phage scfv library mouse heat inactivated vero cell lysate', 'evidenced western blot analysis recombinant nucleocapsid protein n response detectable first immunization strong antibody response boost', '', 'immunoreactive response mouse immunization fig', 'antibody response heat inactivated consistent previous finding inactivated high level antibody mice', 'construction phage scfv library anti n scfvs bio library · recombinant scov n protein n scfvs', 'strong scov n protein phage identical nucleotide sequence', 'surprise blast search anti n scfv ncbi database phage reactivity individual mice sera fold scov n protein purified recombinant n protein lg', 'strong immunoreactivity immunized mice humoral response mouse vero cell lysate antibody response cov infection', 'clone high sequence homology scfv accession', 'fig', '', 'order examine cross reactivity recombinant n protein phage elisa', 'scfv phage bound recombinant n protein recombinant fig', '', 'similar', 'biological effect anti n scfv tyrosine phosphorylation stat intestinal epithelial', 'stat phosphorylation test period', 'presence phage · cfu phosphorylation', 'contrast presence specific anti n scfvs inhibitory effect fig', '', 'induction auto viral infection human immunodeficiency virus human lymphotropic virus hepatitis virus enterovirus epstein barr virus', 'generation auto protein complex lupus glycan moiety human serum glycoprotein orosomucoid cov infection', 'severe acute respiratory syndrome strong antibody response', 'pathophysiological significance clinical relevance cross anti n antibody unknown', 'different lung thymus bone central nervous system', 'hematopoiesis bone metabolism production proinflammatory', 'regard interest note thrombocytopenia lymphopenia', 'inhibition stat phosphorylation', 'serum grown nm presence absence various anti n scfv phage · cfu final volume', 'total cell lysate sds page gel', 'electro transfer nitrocellulose paper protein blot mouse monoclonal anti phospho stat tyr antibody mouse monoclonal anti b actin antibody', 'representative separate similar', 'early phase infection', 'osteonecrosis convalescent', 'significant antibody inhibitory effect cross reactive anti n antibody early development limited role', 'hand cross reactivity n antibody n protein similar structural motif', 'possibility common structural protein important various biological presence n early infection cycle functional antagonist', 'scov n protein stimulate stat phosphorylation presence scov n protein stat phosphorylation', 'unlikely scov n protein share common structural motif stat receptor', 'administration steroid patient cause osteonecrosis convalescent osteonecrosis chronic steroid therapy', 'cumulative prednisolone dosage convalescent radiologic evidence osteonecrosis different osteonecrosis', 'present study cross reactive anti long term significance cross reactive anti antibody bone metabolism', 'marked increase proinflammatory cytokine', 'et al', 'phosphorylation stat vero', 'present study document antibody react', 'possibility cov infection cytokine', 'hence analysis sera anti cytokine particular ill pathogenesis']"
20c05a8e1616b61a78300ee5911bc70bd1c952d3,glucose transport corosolic acid banaba extract stimulatory activity transport stimulatory glucose uptake insulin glucose uptake assay antidiabetic activity b pgg activity banaba blood glucose insulin resistance water extract aand b cell model methanol extract transport activity acid insulin activity corosolic adipocyte differentiation banaba water cell line effective component extract banaba health beneficial insulin receptor penta galloyl responsible activity type diabetic able induce acid possess active tannin activity extract activity insulin adipogenesis activity antidiabetic anti antidiabetic hypoglycemic banaba banaba banaba glucose chen al comparison aand corosolic blood differentiation activity effective compound ellagitannin lagerstroemin extract corosolic extract effective extract insulin extract methanol extract responsible galloyl glucopyranose glucopyranose pgg glucose insulin inducing activity ir activation isolation identification jcl mice lagerstroemia speciosa lagerstroemin fig negative vehicle pgg effective pgg glucose pgg potent possess insulin potent efficacious potent lagerstroemin pure corosolic side effect ta jcl tannic acid tannin fraction transport adipogenic transport inducing transport stimulation vehicle control vivo antidiabetic water methanol way anova weight gain able combination able complete able stimulate absence glucose acid able acid acid acid activity acid concentration acid corosolic acid effective acid extract acid independent acid lagerstroemin acid pgg acid responsible acid ta acid use acid whole activation glucose activation insulin,"['speciosa lythraceae southeast asian tree banaba various treatment', 'popularity herbal medicine attract attention', 'numerous vivo antidiabetic activity banaba', 'different responsible activity', 'tumor corosolic isolated methanol extract banaba active compound', 'different cell model focus water soluble fraction extract discovery', 'ellagitannin lagerstroemin effective component banaba extract responsible activity', 'different approach glucose uptake functional screening method chen al', 'banaba water extract insulin glucose transport inducing activity', 'hplc fractionation glucose uptake assay banaba extract responsible activity corosolic acid', 'penta galloyl glucopyranose pgg potent gallotannin', 'comparison pgg glucose transport stimulatory activity lagerstroemin', 'chen al', 'pgg adipogenic addition glucose uptake', 'combination glucose uptake anti adipogenesis activity current insulin mimetic great therapeutic potential pgg', 'type developed epidemic', 'dramatic increase prevalence type rapid economic development last', 'type obesity', 'overweight obese', 'likely available high calorie food sedentary life style major obesity', 'obesity insulin resistance type', 'obesity weight gain way slow rate occurrence type', 'type insulin resistance defective insulin decreased insulin efficiency glucose transport blood key target muscle fat adipocyte', 'general obesity hyperglycemia turn insulin resistance', 'insulin resistance full blown type', 'obesity excessive adiposity visceral adiposity insulin resistance', 'antidiabetic hypoglycemic hyperglycemic blood glucose level', 'different gain promoting adipogenic', 'key hyperglycemia exacerbate condition obese type', 'beneficial short term optimal long term health type diabetic patient', 'desirable situation development new antidiabetic hypoglycemic anti hyperglycemic side effect weight gain adiposity', 'herbal useful treatment able combination ideal therapeutic', 'lagerstroemia speciosa fig', 'banaba tagalog language tropical plant many asia malaysia southern china', 'tree tall several shredded banaba used treatment disease', 'clear banaba grown different effective treatment', 'garcia research banaba hypoglycemic effect early', 'popular use banaba introduction japan', 'first publication scientific interest potential treatment', 'japan united banaba', 'lagerstroemia speciosa popular form health tea eastern asia united', 'kakuda et al', 'banaba antidiabetic activity water methanol plant', 'hereditary type diabetic kk ay ta jcl mice food water extract methanol extract effective blood glucose insulin', 'note total cholesterol mice plasma triglyceride level unchanged', 'second study research group food banaba water extract feed female obese ta jcl mice', 'obese banaba extract body weight control mice regular diet', 'change food intake', 'triglyceride content banaba extract mice', 'addition parametrial adipose tissue lighter', 'previous antidiabetic activity study effective component mechanism activity', 'vivo antidiabetic anti efficacy extract', 'group university ehrlich cell line bioassay fractionation screen isolated hplc banaba extract order effective antidiabetic component', 'corosolic acid acid effective compound methanol extract banaba glucose uptake assay fig', '', 'result caution tumor cell line study unusual unconventional cell line antidiabetic compound screening', 'result discrepancy banaba water extract methanol extract active antidiabetic anti obesity animal corosolic acid extract', 'potential line selection method publication corosolic acid whole activity banaba extract', 'cell model original tumor natural cell target insulin order allow isolation identification active improved methodology', 'hplc purification identified water extract banaba transport fat uptake assay', 'potent lagerstroemin fig', '', 'recent study group activation insulin receptor ir lagerstroemin fig', '', 'study able induce phosphorylation b subunit ir mm mechanism responsible ir activation', 'lagerstroemin bind insulin receptor', 'separate group several transporter translocation intracellular microsomal membrane plasma membrane muscle corosolic acid', 'result puzzling', 'major glucose transporter protein muscle responsive', 'corosolic acid possess insulin glucose transport stimulatory activity process translocation', 'membrane translocation mechanism corosolic acid independent ir pathway corosolic acid use pathway activity', 'group corosolic blood glucose insulin diabetic mice', 'group article corosolic blood glucose mark oral glucose tolerance test type diabetic', 'statistical difference group control group time point test', 'interest isolation identification antidiabetic natural investigation banaba cell model radioactive glucose uptake assay method identification potential antidiabetic', 'study water methanol banaba glucose transport stimulatory activity', 'addition activity extract concentration activity similar insulin suggesting activity extract insulin mechanism', 'adipocyte differentiation', 'methylisobutylxanthine dexamethasone insulin mdi differentiate sole influence mdi', 'result adipocyte differentiation activity mdi', 'glucose transport stimulation anti differentiation activity insulin insulin important role adipocyte differentiation component mdi mdi insulin', 'anti adipogenic adipogenic negative side effect insulin', 'order component responsible antidiabetic activity goal confirm corosolic acid responsible glucose transport stimulatory activity', 'material extract interested corosolic acid', 'surprise removing gelatin bovine serum albumin tannin extract able induce transport', 'glucose transport activity tannin component extract corosolic acid', 'tested pure corosolic acid able stimulate glucose transport cell model fig', '', 'exclude possibility corosolic acid activity corosolic acid insulin glucose transport stimulatory activity', 'banaba banaba different different chemical different experimental dried banaba', 'corosolic acid corosolic banaba extract product glucosol', 'glucose uptake assay glucosol glucose transport', 'activity dependent fig', '', 'corosolic acid insulin receptor glucose transport activity effect glucosol likely originate chemical extract corosolic acid', 'large diverse class polyphenolic', 'search active tannin fraction available tannic acid ta similar glucose transport stimulatory activity', 'main glucose core variable number galloyl ester', '', 'ta various health beneficial', 'constituent red wine blood glucose production key protein factor involved development cardiovascular disease', 'study ta potent efficacious ellagitannin lagerstroemin', 'ta chosen focus research active tannin fraction figure', 'absence glucose transport stimulatory activity corosolic acid', 'pure corosolic aqueous solution grown culture glucose transport procedure', 'mm insulin mm penta galloyl glucose pgg positive', 'treated water vehicle negative', 'experiment experiment', 'difference way anova statistical analysis negative vehicle control corosolic acid concentration', '', 'separated hplc active glucose uptake assay', 'study discovery penta galloyl glucopyranose pgg effective compound ta fig', '', 'occur nature', 'anomer active b form glucose transport stimulatory activity', 'corosolic acid lagerstroemin versus tannic acid pgg bioactive', 'ellagitannin study lagerstroemin transport stimulation', 'comparison aand b pgg exhibit activity concentration low mm ec mm', 'b pgg potent lagerstroemin glucose transport', 'aand b pgg possess adipogenesis inhibitory activity banaba extract ta', '', 'functional glucose transport adipogenic pgg glucose transport adipogenic', 'hyperglycemia adiposity desirable combination', 'lagerstroemin study glucose transport activity insulin', 'comparison aand b pgg insulin glucose transport inducing activity', '', 'glucose transport stimulatory activity glucosol', 'banaba extract house', '', 'regular glucose', '', 'result way anova', '', 'negative vehicle control', 'aand b pgg effective lagerstroemin table', 'pgg many health beneficial anti inflammation antivirus anti hiv anti antioxidant activity', 'tannin responsible insulin glucose transport stimulatory activity banaba extract', 'appear potent efficacious ir binding ir activation glucose transport induction', 'corosolic acid possess insulin glucose transport stimulatory activity', 'antidiabetic activity induced noninsulin indirect mechanism', 'effective component insulin glucose transport activity banaba extract effective tannin molecule extract', 'glucose uptake assay isolation able complete task', 'past banaba banaba', 'banaba interesting biomedical significant scientific attention', 'detailed cellular animal elucidate extract antidiabetic activity health beneficial adipogenesis activity', 'corosolic acid insulin nm activity b pgg']"
0c589675855cd6a533025c50fb319ecd269c2d0d,sg formation et al prrsv infection prrsv sgs sgs prrsv nf κb phosphorylation level prrsv replication canonical sgs inflammatory response prrsv inflammatory sg assembly alexa fluor formation sgs impairment sg donkey anti fluor donkey igg alexa lindquist et negative control perk inhibitor prrsv h stress response antibody specific endoplasmic reticulum formation perk formation prrsv hri specific infected prrsv inhibitor perk mock infected prrsv sg response prrsv rt qpcr sg marker stable formation translation initiation viral infection western blot white et anti mouse anti rabbit beta actin cytokine production genotype prrsv goat polyclonal h inoculum imagej software infection stress khaperskyy al mouse mab nc sirna onomoto al p comparison perk vehicle positive control post infection prrsv formation prrsv stable prrsv strain ratio total red prrsv reineke lloyd santa cruz sgs canonical stress kinase study prrsv swine industry tissue culture transient sg κb subunit actin expression activation phosphorylation administrative committee affect prrsv al lindquist al mengovirus al poliovirus al reineke alexa donkey anderson kedersha arsenite sa assembly sg beyotime nantong blot ratio bottom row bovine serum cell technology committee laboratory comparison mock composition prrsv confocal microscope consistent previous control nc control sa cruz biotechnology culture plate dapi blue detect prrsv detect sgs,"['stress mrna storage response various viral', 'porcine reproductive respiratory syndrome virus prrsv arterivirus swine industry worldwide late', 'study infection prrsv strain genotype prrsv stable formation robust sgs recruitment marker', 'treatment specific sirnas stress sg formation prrsv sg formation perk protein r endoplasmic reticulum kinase dependent mechanism', 'impairment sg assembly sg marker affect prrsv growth prrsv nf κb subunit phosphorylation inflammatory cytokine production', 'prrsv sg formation perk dependent pathway sgs prrsv inflammatory response', 'porcine reproductive respiratory syndrome prrs severe reproductive failure acute respiratory distress important swine industry lunney et al', 'causative agent prrs virus prrsv single positive sense rna virus arteriviridae family snijder et al', 'emergence late prrs important threat global swine industry difficult control vaccination meng neumann et al', 'virus host development effective control al', 'stress discrete cytoplasmic protein rna eukaryotic various heat shock starvation oxidation ultraviolet irradiation viral infection anderson kedersha', 'stress involved sg formation distinct rna dsrna dependent protein kinase pkr dsrna viral infection protein r endoplasmic reticulum kinase perk unfolded endoplasmic reticulum heme inhibitor kinase hri general control nonderepressible kinase amino acid starvation ultraviolet damage viral infection yamasaki anderson', 'activation phosphorylation alpha subunit eukaryotic initiation factor exchange', 'phosphorylation active ternary complex reversible inhibition translation initiation consequent polysome accumulation ribosomal preinitiation al', 'multiple rna binding gtpase protein protein internal antigen protein many sg assembly reineke lloyd', 'addition common sg sgs inactivation translation sg tourriere', 'many sg sg structure canonical sgs presence key translation initiation small ribosome subunit dinh al reineke lloyd', 'viral infection source stress several monitor effect host stress response modulate sg assembly', 'many inhibit sg accumulation human cell leukemia virus al rotavirus montero al influenza virus iav khaperskyy al mengovirus theiler murine encephalomyelitis virus borghese', 'contrast several respiratory syncytial virus rsv induce stable formation et al', 'transient sg formation infection virus poliovirus white et al coxsackievirus type fung al mammalian orthoreovirus mrv qin et al', 'evidence sg repress productive viral', 'propagation okonski samuel japanese encephalitis virus katoh al poliovirus white et al vesicular stomatitis virus vsv dinh al mengovirus borghese sgs', 'case iav mutant iav nonstructural protein wild type iav sgs retinoic acid inducible gene rig viral rna antiviral', 'inhibition sgs enhancement iav replication onomoto al', 'several benefit sg formation', 'example rsv replication level expression lindquist et al', 'prrsv replication cellular stress response unclear', 'study relationship prrsv sgs', 'prrsv stable formation robust sgs induction activation stress kinase perk', 'impairment sg assembly prrsv replication induced inflammatory production', 'monkey kidney cell line permissive prrsv infection dulbecco eagle medium dmem invitrogen carlsbad supplemented fetal bovine serum u ml penicillin µg ml streptomycin sulfate • incubator', 'prrsv strain genbank accession', 'isolated high fever china end pathogenic type north american prrsv study li al wang et al', 'prrsv', 'prrsv et al', 'briefly virus × pfu ml prrsv form layer fluid mm deep round flat tissue culture plate cm diameter', 'tissue culture plate clean bench cm shortwave nm ultraviolet light source h loss infectivity inability uv virus produce cytopathic effect monolayer', 'perk perk inhibitor dimethyl sulfoxide dmso imidazolo oxindole compound darmstadt germany', 'sodium arsenite sa sigma aldrich st louis mo usa', 'monkey hri catalog', 'invitrogen negative control sirna catalog', 'invitrogen final concentration nm lipofectamine reagent invitrogen manufacturer', 'sirna table', 'rabbit monoclonal cell technology usa', 'mouse mab beta actin medical biological japan', 'polyclonal rabbit polyclonal tiar goat polyclonal goat polyclonal santa cruz biotechnology santa cruz', 'rabbit mab nf κb phospho nf κb cell technology', 'mouse mab prrsv nucleocapsid n protein laboratory', 'alexa fluor donkey goat igg alexa fluor donkey anti rabbit igg alexa fluor donkey antirabbit igg alexa fluor donkey anti mouse igg alexa fluor donkey anti mouse igg santa cruz biotechnology inc horseradish peroxidase hrp goat anti rabbit hrp goat anti mouse hrp donkey anti goat medical biological', 'circular glass left grow confluence', 'indicated time treatment paraformaldehyde min methanol pre • min', 'permeabilized bovine serum albumin bsa phosphate saline pbs min incubation primary alexa fluor secondary ′ dapi beyotime nantong china pbs dilution min', 'fluorescent confocal microscope japan', 'cell addition lysis buffer sodium dodecyl sulfate sds dithiothreitol dtt mm tris hcl ph glycerine protease inhibitor pmsf', 'equal sodium dodecyl sulfate polyacrylamide gel electrophoresis sds page polyvinylidene difluoride pvdf membrane millipore billerica usa', 'appropriate specific', 'specific mab prrsv used analyze expression protein', 'beta actin anti beta actin mouse mab beyotime nantong china control', 'plaque luo et al', 'briefly confluent tissue culture h serial prrsv containing', 'ph w v bacto agar mixed × dmem mg neutral red', 'post infection', 'average plaque standard independent', 'virus pfu ml', 'total rna treated trizol reagent invitrogen manufacturer transcribed cdna oligo dt primer transcriptor first strand cdna synthesis kit roche mannheim germany manufacturer', 'cdna µl rt reaction mixture template sybr green qpcr city', 'abundance individual mrna assayed normalized dehydrogenase gapdh internal control', 'gene expression', 'table primer express software', 'prrsv multiplicity infection moi h', 'positive control sa h induce sgs', 'high sample', 'total number way analysis variance analyze experimental', 'independent mean ± standard deviation sd', 'statistical significance p value', 'animal hubei administrative committee laboratory number laboratory animal welfare administrative committee laboratory', 'investigate prrsv infection strain sg marker indirect immunofluorescence', 'formation sgs kinetic time prrsv infection', 'potent sg inducer sodium arsenite sa mock positive negative', 'monoclonal antibody specific prrsv n detect prrsv', 'sa obvious sgs infected consistent previous report et al', 'prrsv cytoplasmic sg marker post infection hpi occur hpi hpi', 'number prrsv sgs prrsv formation sgs hpi hpi figure', 'robust sg response prrsv h inoculation course prrsv infection', 'examine prrsv replication necessary sg formation ability prrsv induce sgs', 'end uv prrsv h stained n positive', 'figure second third treatment prrsv infection robust sg formation sg formation detectable inoculated uv prrsv figure top bottom', 'prrsv replication sg formation', 'previous vesicular stomatitis virus vsv sg marker contain bona fide sg eukaryotic initiation factor dinh et al', 'gain insight composition prrsv sgs determine prrsv sgs canonical sgs strain h', 'prrsv foci similar canonical sgs sa figure', 'hpi thereafter sgs prrsv infection', 'confirm prrsv sgs canonical sgs prrsv color immunofluorescence', 'canonical sgs contain translation initiation recruited prrsv sgs goat canonical sgs rabbit visualize prrsv sgs mouse n protein infected', 'early infection hpi foci observed figure third fourth', 'hpi amount foci high foci infected figure fifth bottom similar sgs figure second row', 'composition prrsv sgs canonical sgs', 'reason prrsv sgs late infection early study', 'identified stress perk hri sg sonenberg hinnebusch', 'phosphorylation level different time prrsv infection', 'figure increase phosphorylation h post inoculation consistent previous research huo al infection consistent appearance sgs', 'pathway prrsvinduced formation sgs', 'assess contribution individual stress kinase sg formation prrsv infection specific stress', 'compound analog potent activity hu conway jammi al henceforth perk potent perk inhibitor perk inactive dfg conformation region al', 'appreciable cytotoxicity µm mm µm perk figure comparison sgs prrsv sa', 'localization green red prrsv', 'mock infected prrsv', 'positive control uninfected mm sa h hpi antibody antibody alexa donkey goat igg alexa donkey anti rabbit igg', 'dapi blue', 'confocal microscope', 'sgs cytoplasm', 'b mock infected prrsv', 'positive control sa described', 'analyzed confocal microscopy', 'rabbit polyclonal antibody specific green detect sgs prrsv goat polyclonal antibody specific red detect sgs sa monoclonal antibody specific prrsv n blue detect prrsv', 'sgs cytoplasm', 'test effect induced sg formation perk vehicle h prrsv infection h inoculum h medium individual stress kinase inhibitor vehicle', 'stained n examine formation sgs', 'figure equivalent frequency sg formation prrsv infection vehicle', 'sg formation perk figure bottom row dmso', 'pkr sg formation response prrsv infection', 'hri specific available specific test prrsv sg formation', 'hri specific study able endogenous mrna negative control nc sirna figure', 'hri specific nc sirna prior prrsv infection', 'immunostained hpi examine presence sgs', 'significant induced sg formation knockdown depletion depletion hri formation prrsv sgs figure', 'confirm pathway sg induction prrsv infection relative specific stress', 'western blot assess', 'show figure infection prrsv strong increase phosphorylation level perk specific', 'treated similar absence prrsv infection', 'significant difference total various', 'support conclusion prrsv phosphorylation dependent perk', 'body evidence virus sgs sg important replication', 'cell indicated post infection expression western β actin expression control', 'representative western blot ratio total independent imagej software', 'p comparison mock infected', 'b pkr µm vehicle h', 'prrsv h inoculum replaced medium concentration vehicle', 'red prrsv green expression figure assess sg assembly', 'dapi blue', 'c µm perk inhibitor perk vehicle dmso h', 'prrsv h inoculum replaced medium concentration perk vehicle', 'described figure', 'assessment efficiency hri specific sirnas', 'sihri negative control nc h', 'continued figure mrna rt qpcr', 'e sihri nc h prrsv h red prrsv green figure', 'f infected prrsv pkr inhibitor perk inhibitor perk inhibitor sihri right described', 'cell expression western β actin expression control', 'representative western blot ratio total independent imagej software', 'p comparison mock infected', 'et al onomoto al reineke lloyd', 'assess sgs prrsv growth impair sg formation concomitant knockdown tiar', 'specific endogenous', 'knockdown efficiency realtime rt qpcr western blot figure', 'specific tiar prrsv infection sa treatment', 'sg assembly sg component', 'line previous study al concomitant depletion sis substantial sg sa figure', 'similar prrsvinfected sg prrsv figure bottom row', 'confirm efficient protein indirect immunofluorescence assay figure', 'tiar prrsv infection plaque assess', 'simultaneous depletion tiar significant difference prrsv replication control', 'sgs prominent influence prrsv replication', 'prrsv inflammatory response absence sgs previous sg component expression interleukin tumor necrosis factor athanasopoulos al mino al', 'interstitial pneumonia remarkable infection duan large number prrsv infection inflammatory cytokine production al', 'investigate sgs biological impact prrsv pro inflammatory tiar infection', 'mrna expression inflammatory real time rt qpcr', 'figure tnf α expression depletion negative control', 'nf κb important transcription factor proinflammatory cytokine production tak firestein prrsv infection nf κb pathway sgs participate prrsv nf κb activation', 'nf κb subunit phosphorylation nf κb activation phosphorylation level subunit', 'show figure prrsv induced phosphorylation level sirna', 'total level unchanged specific negative control', 'knowledge sgs recent', 'distinct sg formation following infection dna stable transient sg formation onomoto al', 'example rsv stable sg formation viral life cycle lindquist al lindquist et al poliovirus infection transient sg formation early phase infection sgs cleavage infection white et al', 'growth dna damage inducible phosphorylated form contribute sg formation hepatitis virus infected et al', 'contrast mengovirus borghese simplex virus khong jan influenza virus khaperskyy al restrict sg accumulation', 'present study prrsv formation h inoculation frequency sgs infection stress response', 'previous infection transmissible gastroenteritis coronavirus tgev mouse hepatitis coronavirus mhv order prrsv formation raaben al sola et al', 'common feature sgs future', 'mammalian serine threonine pkr hri perk stress various', 'abundant evidence several sg formation activation pkr activation berlanga al lindquist et al okonski samuel sg formation pkr activation iav khaperskyy al nile virus courtney et al', 'sg assembly formation sgs pkr deficiency hepatitis virus garaigorta al rsv lindquist et al', 'case kinase induction sgs qin et al', 'demonstrate inhibition perk pkr hri sg formation phosphorylation level prrsv perk responsible prrsv sg formation', 'previous research prrsv infection upregulated phosphorylation level perk huo al phosphorylation level correlated et al', 'knockdown pkr specific sirna significant effect prrsv phosphorylation wang al', 'pkr responsible phosphorylation subsequent sg formation consistent conclusion', 'endoplasmic reticulum er important organelle structure responsible protein synthesis berridge er stress translation initiation', 'translation arrest formation anderson anderson kedersha', 'previous study prrsv infection stress response turn perk subsequent phosphorylation et al', 'possible connection induction sgs prrsv infection stress response', 'viral replication controversial', 'sgs exhibit proviral antiviral different', 'example expression cleavage resistant sg formation poliovirus infection virus replication white et al', 'depletion enhanced vsv growth gene expression al', 'rsv sg formation facilitate viral replication lindquist et al', 'rsv prrsv stable sg formation rsv impairment sg formation influence replication prrsv', 'similar figure role sgs prrsv inflammatory', 'sitiar h infected prrsv', 'cytokine mrna real time rt qpcr hpi', 'p comparison nc sirna specific sirna prrsv infection', 'b', 'hpi phosphorylation western blotting', 'ratio total analyzed imagej software', 'mhv induce phosphorylation sg mhv replication benefit stress al', 'sgs transient dynamic cytoplasmic rna composition complex variable', 'many sgs affect assembly alter diverse', 'study involved pathway prrsv inflammatory response', 'prrsv impairment sg formation concomitant sg mrna α concomitant phosphorylation level nf κb subunit', 'interstitial pneumonia remarkable characteristic prrsv infection inflammatory response important role infection pathogenesis prrsv', 'inflammation sword host', 'impairment sg expression inflammatory extent sgs defense factor prrsv inflammatory response prrsv replication', 'limitation study study formation sgs prrsv infection', 'natural host vital detect relationship prrsv sgs primary porcine alveolar future study', 'addition genotype prrsv strain study', 'previous cytokine expression vary different genotype lee chen', 'sg expression genotype prrsv inflammatory study', 'summary present study prrsv infection stable formation perkdependent mechanism', 'impairment sg affect prrsv replication impairment enhance prrsv inflammatory response', 'sg formation inflammatory response prrsv infection er stress issue understanding pathogenesis immune regulation mechanism prrsv', 'yz sx research yz dw research yz sx paper']"
bcdceb50d70afda0d8615859b356484af61aab04,lamp reaction lamp method conventional pcr pcr reaction detection limit detection method target sequence high specificity independent target method specific rapid detection alternative approach approach detection detection alternative detection lamp dna extraction lamp detection ppv prv previous detection rapid simple rv prrsv sensitive rapid specific sensitive tgev rv transmissible gastroenteritis agarose goldview amplification lamp bst dna causative agent chen et circovirus type clinical lamp dermatitis nephropathy detection clinical detection virus diarrhea virus different dna dilution series dna polymerase dna ppv doc xr effective method electrophoresis w epidemic diarrhea et al gel doc initial stage involved virus isothermal amplification lamp pcr light goldview limit lamp method high mm dntps multisystemic syndrome nephropathy syndrome nucleic acid optimal temperature outer primer pedv tgev pmws porcine porcine circovirus porcine dermatitis porcine reproductive prv cdna reaction mixture reaction system reaction tube real time reproductive respiratory respiratory syndrome sensitive conventional sequence initial sequence stage series dna serum lamp stage independent study loop syndrome pdns syndrome pmws syndrome virus takara corp target gene temperature min temperature pcr time pcr time temperature ultraviolet light v agarose virus replication w v xr ultraviolet abattoir shanghai accelerated lamp acid amplification acid sequence addition real addition virus affected various agarose gel,"['background porcine circovirus type causative agent multisystemic syndrome pmws porcine dermatitis nephropathy syndrome pdns', 'heavy global agriculture recent', 'rapid detection important effective prophylaxis treatment pmws', 'isothermal amplification lamp detect study', 'distinct gene', 'gene genome sequence involved virus replication', 'time temperature min', 'analysis clinical lamp method sensitive', 'detection limit lamp conventional pcr', 'assay cross react porcine reproductive respiratory syndrome virus epidemic diarrhea virus transmissible gastroenteritis rotavirus', 'lamp system positive', 'lamp detection method specific sensitive rapid simple', 'previous detection alternative approach detection', 'porcine circovirus type non circular single dna virus family', 'virus widespread commercial swine population causative agent number multisystemic syndrome pmws porcine dermatitis nephropathy syndrome pdns', 'great industry', 'result necessary develop effective method prevent', 'present many detection virus conventional pcr', 'usefulness pcr presence pcr real biological', 'wide range organic inorganic phenolic amplification efficiency', 'pcr elisa common virus detection', 'hard definitive diagnosis elisa swine falsepositive analysis', 'addition real time pcr good method perform quantitative qualitative analysis', 'method high quality technical', 'rapid sensitive easy operate method examination', 'new technique isothermal amplification lamp nucleic high specificity sensitivity rapidity isothermal', 'method specific target sequence independent target sequence initial stage independent target sequence stage reaction', 'selectivity rapidity nucleic acid amplification', 'lamp loop', 'method valuable tool rapid diagnosis infectious hospital rapid detection pathogenic food', 'use lamp detecting chen et al', 'betaine', 'study loop different', 'previous detection alternative approach detection', 'lamp assay gene involved virus replication specific sensitive rapid simple detection method', 'optimized temperature assay basis temperature determination assay', 'optimal temperature reaction', 'bst dna polymerase temperature figure', 'optimal temperature pcr reaction reaction mixture', 'typical ladder pattern genomic dna figure', 'addition virus ntc template control', 'figure', 'amplified product length', 'homology gene', 'specificity product digestion haeiii', 'predictable product motif gel figure lane', 'comparative analysis sensitivity detection lamp method pcr dilution series dna', 'detection limit lamp reaction tube', 'detection limit pcr reaction tube', 'lamp sensitive conventional pcr figure figure', 'ten serum lamp method determine infected', 'clinical', 'study visual rapid detection method optimized lamp technique', 'conventional pcr analysis lamp method time low cost ease operation', 'mature lamp method specific amplified', 'suggest high specificity gene pcr nucleic acid sequence', 'lamp method high specificity target gene independent target sequence initial stage independent target sequence stage lamp reaction', 'pcr pair target gene', 'big difference previous study research loop part lamp reaction', 'gene high specificity detection virus', 'lamp reaction isothermal pcr thermal short time', 'study time whole lamp reaction h moreover lamp reaction require pretreatment expensive instrumentation', 'reaction rapid elisa real time pcr', 'reason easy use applicable', 'detection limit sensitive conventional pcr', 'sensitivity consistent virus', 'example swine transmissible gastroenteritis coronavirus avian influenza virus yellow head virus', 'initiated avoid false negative', 'lamp effective method detection clinical laboratory contamination serious reaction', 'detection clinical dna extraction', 'serum lamp reaction', 'sensitivity affected various clinical', 'time cost test many troublesome', 'important superior tolerance various lamp method possible small private thremmatology', 'rapid detection lamp chen et al', 'amplification method isothermal cap gene', 'study loop accelerated lamp reaction', 'betaine lamp reaction system increase speed', 'porcine sera dna extraction tolerance lamp biological superior detection', 'dna extraction step assay', 'lamp detection method specific sensitive rapid simple', 'previous detection alternative approach detection', 'viral institute animal science veterinary medicine shanghai agricultural', 'viral porcine parvovirus ppv prv porcine epidemic diarrhea virus pedv transmissible gastroenteritis tgev rotavirus rv porcine reproductive respiratory syndrome virus prrsv', 'viral conduct lamp', 'swine sera abattoir shanghai clinical detection lamp method', 'dna pure culture blood viral dna rna kit biomiga inc san diego', 'dna template optimum temperature', 'extraction rna pedv tgev rv prrsv kit', 'dna ppv prv cdna reverse transcription takara corp japan pedv tgev rv prrsv detect specificicty lamp method', 'decimal serial sterile distilled water', 'concentration dna', 'different dna determine detection limit dna', 'gene genbank accession', 'strain primerexplorer table', 'pcr reaction', 'length product bp', 'contrary previous loop lamp reaction', 'lamp total reaction mixture mm fip bip mm outer primer backward outer primer mm lf lb mm dntps betaine sigma mm tris hcl ph mm kcl mm nh mm mgso triton u bst dna polymerase large fragment new england usa', 'lamp reaction jingda digital thermostatic water bath jintan jingda apparatus factory china', 'pcr reaction volume μm mm dntps μm × pcr buffer u taq polymerase takara corp μl dna cdna', 'denaturation reaction system thermal cycling thermal cycler foster city final elongation min', 'lamp pcr electrophoresis w v agarose goldview', 'lamp reaction temperature min min', 'lamp agarose uv light gel doc xr ultraviolet light goldview', 'time temperature pcr reaction', 'specificity lamp detection method dna ppv prv cdna pedvd tgev rv prrsv sample reaction optimal', 'negative', 'haeiii confirm reaction specificity band shanghai co ltd', 'different optimized', 'figure sensitivity pcr detection', 'marker negative control dilution series dna', 'agarose goldview', 'time different dna conventional pcr', 'electrophoresis w v agarose gel doc xr ultraviolet light goldview', 'conventional pcr described', 'total serum presence', 'clinical infected', 'clinical lamp pcr reaction dna exaction optimized']"
5646a0eb649cd7e862225225aae1382f8de86f7d,virus inactivation complete feed swine feed ultraacid p inactivation pedv room temperature virus survival virus titer amount virus commercial feed fumaric acid inactivation pdcov initial virus salmonella spp salt sugar tcid ml weibull model μg ml acid booster da kemgest effective strategy feed addition feed effective feed salt linear model none effective pdcov survival pedv pdcov ph complete ph ph phosphoric acid strategy decrease survival pdcov swine testicular acid present activate da addition luprosil complete swine concentration effect concentration swine control diet coronavirus pdcov correlation ph current experiment decrease concentration delta coronavirus delta value determine addition different time disease virus double manufacturer effective pdcov effective virus experiment inactivation experiment recommended experimental unit feed additive feed double feed ml fever virus fit experimental fraction virus g min gastroenteritis virus inactivation log increase growth kemgest acid kinetic parameter log linear log tcid maintenance medium manufacturer concentration method crude model fit n curve n initial observation agreement organic inorganic porcine delta present ultraacid r linear response n storage room study determine swine fever total dietary transmissible gastroenteritis treatment n vial experimental virus pedv virus swine weibull distribution × g able survive absence ribonuclease acid citric acid combination acid effective acid fumaric acid inactivate,"['background feed potential route transmission porcine delta coronavirus pdcov', 'objective study determine addition commercial feed salt sugar swine feed effective strategy inactive pdcov', 'commercial feed ultraacid p activate da kemgest acid booster luprosil amasil salt sugar', 'recommended complete feed ml pdcov', 'experiment recommended feed', 'room temperature removal', 'virus solution swine testicular', 'feed additive', 'weibull log linear kinetic analyze virus survival', 'presence tail virus inactivation linear behavior hence weibull model inactivation due fit', 'recommended virus concentration log survival feed', 'concentration delta value ≤ amasil delta', 'feed phosphoric acid citric acid fumaric acid effective virus survival none inactivated virus post inoculation', 'commercial feed salt strategy decrease risk commercial feed pdcov survival complete feed storage room temperature', 'none virus', 'enteric gastrointestinal illness young transmissible gastroenteritis virus tgev porcine epidemic diarrhea virus pedv porcine delta coronavirus pdcov', 'transmissible gastroenteritis virus present united pedv pdcov', 'spread pedv swine rapid strict biosecurity prevent transmission respiratory reproductive syndrome virus ineffective complete feed route pedv transmission previous biosecurity', 'disease prevention essential understand feed handling risk transmission present feed', 'commercial swine feed various organic inorganic control bacterial mold growth increase growth performance nutrient digestibility control harmful animal gut', 'feed alternative use growth salmonella spp', '', 'nursery benefit addition addition increase growth rate', 'effective diarrhea mortality adequate growth nursery', 'study determine addition available feed sugar recommended effective survival', 'strain pdcov national veterinary laboratory nvsl', 'stock virus swine testicular', 'grown minimum essential medium earle l glutamine mediatech herndon va fetal bovine serum hyclone south logan ut μg ml gentamicin mediatech μg ml neomycin sulfate sigma st louis mo μg fungizone sigma μg ml streptomycin sigma', 'maintenance medium μg ml trypsin gibco life grand island ny', 'co appearance virus cytopathic infection', 'infected freeze thaw centrifugation × g min', 'supernatant aliquoted use', 'serial maintenance medium inoculation testicular microtiter ny usa μl dilution', 'inoculated co microscope appearance cpe', 'dilution cpe end point', 'virus tissue culture infectious dose tcid ml karber method', 'cgi enhance ground commercial starter feed experiment madison wi', 'feed contain animal', 'feed negative pdcov real time reverse transcription polymerase chain reaction rt pcr', 'minnesota valley new elm mn dry matter dm method extract method crude protein cp method crude fiber method ash method standard', 'chemical analysis dm ee cp crude ash basis', 'table', 'addition effect sodium chloride sucrose virus survival', 'second experiment pdcov survival recommended', 'forty g aliquot plastic scintillation additive', 'total dietary control', 'set recommended total dietary table', 'pdcov initial titer × tcid ml', 'control treatment feed additive', 'mixed vortex mixer room temperature', 'individual vial experimental unit vial degree virus inactivation', 'experiment recommended evaluated virus inactivation', 'different time virus inactivation early inoculation', 'determine amount virus inactivation time point virus vial ml beef glycine solution ph', '× g min', 'serial swine testicular virus titration', 'amount virus control log tcid ml', 'analyzed triplicate', 'fifty ml water g feed ml glass flask', 'feed suspension room temperature h magnetic stirrer', 'ph ph probe fisher scientific waltham min', 'final ph value average different time', 'average ph feed ± value compare ph addition', 'inactivation log tcid ml ginafit software freeware microsoft microsoft redmond wa', 'traditional log linear model bigelow esty characterize survival pdcov equation n amount virus treatment n initial virus titer k kinetic parameter day treatment time', 'kinetic parameter k decimal reduction time time initial virus titer log certain temperature weibull distribution function describe non linear inactivation different thermal non thermal processing', 'temperature resistance virus weibull distribution mafart al', 'equation virus titer treatment n initial virus titer δ time min logarithm decline virus titer n shape parameter', 'n value indication shape response curve', 'curve convex response n curve response n curve line linear model', 'treatment determine fit experimental adj', 'r number number model sum', 'effect different kinetic virus mixed model sas sas inst', 'inc cary nc effect time batch random', 'vial experimental unit', 'presence normal distribution univariate procedure sas sample location variability standard deviation test normality scale', 'statement sas calculate treatment model tukey test determine', 'study significance p', 'goodness model fit analyzed comparing adj', 'r linear weibull', 'adj', 'r linear model obtained weibull model weibull model fit experimental table', 'appearance resistant fraction virus able survive length experiment', 'residual survival long survival shape', 'nonlinear behavior virus survival delta weibull model', 'weibull prediction much inactivation virus survival', 'spite virus inactivation none effective virus', 'total amount virus inactivation period reduction control sample none effective pdcov survival', 'pdcov inactivation sucrose formic acid table', 'ultraacid p kemgest initial virus inactivation delta survival large fraction virus resistant treatment appearance n maximum inactivation degree log storage', 'addition luprosil booster chloride virus inactivation log reduction storage room temperature', 'ph complete feed addition ph complete feed addition luprosil da kemgest acid booster amasil', 'ph complete feed addition ultraacid p different complete feed', 'correlation ph diet addition pdcov delta', '', 'virus survive ph ph', 'organic inorganic swine control salmonella spp', '', 'knowledge evaluated impact available sodium sucrose survival pdcov swine feed', 'commercial added none effective decreasing survival pdcov manufacturer inactivation pdcov complete swine feed', 'contrast pedv similar concentration activate da kemgest inactivation pedv inactivation control diet', 'current experiment inactivation commercial available united industry focus specific active present pdcov', 'description order active commercial additive form phosphoric acid pka × present ultraacid p acid responsible inactivation pdcov', 'phosphoric acid inactivate salmonella spp', 'stainless steel available inactivation feed', 'inactivation pdcov presence acid booster active similar exception fumaric acid present kemgest', 'fumaric acid present ultraacid p effective pdcov', 'possible fumaric acid ultraacid p component inactivation', 'fumaric effective antimicrobial survivability salmonella spp', '', 'affect sensitivity deoxyriobonuclease virus capsid loss structural', 'rna rna sensitive ribonuclease ph ph', 'ph absence ribonuclease', 'clear pattern indication specific acid research depict acid combination inactivate virus', 'experiment inactivation pedv pdcov labile pedv environmental temperature storage general pedv', 'comparison inactivation pedv storage extent pdcov', '', 'correlation ph delta value virus inactivation recommended concentration feed survival enteric environment initial outbreak virus pedv number epidemiology geographic distribution pedv pdcov agreement current experiment', 'addition salt sugar control diet decrease delta pdcov', 'observation agreement inactivation pedv complete swine feed salt sugar inactivation pedv', 'observation agreement experiment suggest addition phosphate salt mix sausage manufacturing several swine food mouth disease virus classical swine fever virus swine vesicular disease virus african swine fever virus', 'feed effective strategy decrease concentration swine feed double manufacturer concentration effect', 'feed effective strategy decrease concentration swine feed double manufacturer concentration effect', 'observed inactivation pdcov demonstrate effectiveness pdcov transmission feed', 'none experiment effective inactivating pdcov', 'strategy research combination virus inactivation distribution single virus inactivation']"
65a9faf5b2ccdcb20822e4de4cdac5c77caf635e,corneal perforation dry eye epithelial defect calcareous degeneration calcium deposition persistent epithelial chronic gvhd ocular surface severe dry amniotic membrane artificial tear autologous serum corneal epithelial corneal epithelium corneal graft mg daily systemic condition acute calcareous amt tarsorrhaphy chronic ocular corneal calcification cyclosporine mg gland dysfunction lamellar keratectomy meibomian gland ocular inflammation perforation calcareous poor epithelialization severe kcs tear ointment aplastic anemia band keratopathy basement membrane bone marrow breakdown corneal calcareous corneal calcium corneal calcium phosphate calcium salt case tarsorrhaphy common complication corneal calcium corneal degeneration corneal infection corneal large daily mycophenolate daily systemic defect corneal defect stroma deposition case effect corneal epithelium spontaneous eye corneal eye persistent graft clear graft versus growth factor gvhd severe host disease immunologic reaction inflammatory reaction kcs corneal keratectomy amniotic large corneal limited effect long term marrow transplantation membrane transplantation mg day mm eye multilayer amt ointment day palpebral fissure paracentral area patient severe persistent corneal pulmonary edema recurrent corneal regraft amt severe meibomitis sicca kcs spontaneous tarsorrhaphy surgical treatment tarsorrhaphy amt tarsorrhaphy corneal tear film topical autologous transplantation amt type corneal versus host vision eye abnormal tear actual mechanism acute gvhd acute hepatitis acute respiratory addition amniotic addition meibomian addition reduction adhesion basal,"['keratoconjunctivitis sicca kcs common complication graft versus host disease gvhd epithelial defect', 'contrast recurrent calcareous degeneration perforation rare', 'woman chronic gvhd bone marrow transplantation aplastic anemia', 'severe kcs corneal calcium eye', 'keratoplasty corneal perforation poor epithelialization calcium deposition', 'lamellar keratectomy amniotic membrane transplantation amt calcareous degeneration subsequent recurrence corneal perforation', 'regraft amt tarsorrhaphy corneal graft clear', 'breakdown corneal epithelium spontaneous separation tarsorrhaphy', 'perforation exacerbation gvhd', 'regraft patient tarsorrhaphy amt', 'poor epithelialization regraft', 'corneal corneal perforation', 'corneal surgery patient chose undergo evisceration', 'case ocular enough lead corneal perforation calcareous degeneration recalcitrant medical surgical treatment', 'j formos assoc graft versus host disease major bone marrow transplantation bmt', 'chronic gvhd ocular oral mucosal liver', 'common complication sicca kcs epithelial defect corneal due tear production composition tear film', 'calcium con correspondence dr fung hu department national taiwan university hospital chung road taipei taiwan', 'e mail centration subsequent calcium salt precipitate cornea', 'calcium deposition cornea calcific band calcareous corneal degeneration', 'chronic ocular inflammation dry eye ocular surgical', 'contrast acute calcareous corneal degeneration gvhd', 'po yu chih hou wei chou lin figure', 'corneal epithelial defect calcium deposition', 'lamellar keratectomy amniotic membrane transplantation amt application topical preservative free artificial tear hour ciprofloxacin day day', 'acute calcareous degeneration', 'patient regular report case recurrent corneal perforation calcareous degeneration chronic gvhd', 'woman severe aplastic anemia allogenic july', 'procedure acute gvhd severe pulmonary edema systemic bacterial infection acute hepatitis jaundice', 'intensive medical treatment cyclosporine mg day mg day systemic condition', 'several cyclosporine mg daily mycophenolate mg daily systemic condition', 'severe kcs scleroderma skin liver dysfunction dry mouth chronic', 'vision clinic', 'initial examination vision os counting', 'eye mild superficial punctate keratitis eye large epithelial defect severe meibomitis', 'schirmer test mm eye mm eye', 'permanent punctal occlusion topical fluorometholone artificial tear ointment day epithelial defect eye', 'pressure therapeutic contact application several corneal calcium left eye april', 'follow', 'examination july corneal large corneal perforation paracentral area eye vision hand motion figure', 'emergency pen eye severe meibomitis calcium corneal perforation iris incarceration paracentral area arrow', 'neovascularization whole cornea', 'follow outpatient clinic', 'eye corneal perforation august', 'patient underwent regraft amt tarsorrhaphy', 'postoperative course smooth epithelialization complete week', 'corneal graft clear vision eye period', 'due spontaneous tarsorrhaphy corneal epithelial', 'patient due hospital severe acute respiratory syndrome', 'time clinic june calcium deposition corneal melting eye intensive use artificial tear ointment treatment figure', 'lamellar keratectomy therapeutic soft contact applied corneal progress', 'time pulmonary edema pneumonitis suspected sign gvhd exacerbation', 'intravenous methylprednisolone mg cyclosporine mg daily mycophenolate daily systemic condition', 'regraft corneal perforation', 'poor epithelialization treatment oral prednisolone mg daily topical autologous serum methylcellulose artificial tear ointment day', 'vision eye', 'patient surgical treatment tarsorrhaphy amt cosmetic', 'pathologic examination corneal graft dystrophic calcification inflammatory cell infiltration neovascularization edematous stroma', 'march corneal perforation dense corneal infiltration light perception vision', 'undergo pkp receive evisceration relief pain eye', 'gvhd immunologic reaction donor host skin gastrointestinal tract', 'gvhd lethal threaten vision', 'main ocular symptom gvhd secondary kcs result pre transplant total body irradiation chemotherapy', 'kcs damage immune process destroy meibomian conjunctiva cornea goblet lacrimal', 'kcs corneal sequelae punctate corneal erosion persistent corneal epithelial defect sterile infectious corneal ulcer', 'severe kcs persistent epithelial defect corneal stroma perforation', 'addition meibomian gland dysfunction corneal condition', 'ocular surface derive immunologic reaction treatment effective dry eye eye disease', 'immunosuppressant therapy satisfactory', 'case beneficial effect prednisolone dry eye', 'long term treatment prednisolone serious death', 'long term immunosuppression likelihood leukemic relapse', 'common type corneal calcification band keratopathy chronic ocular inflammation uveitis calcium metabolism retinal detachment surgery', 'histologic keratopathy calcium layer basement membrane corneal epithelium superficial layer stroma', 'type corneal calcification calcareous degeneration cornea persistent corneal epithelial defect dry eye stroma', 'histologic examination calcium corneal', 'corneal calcification infantile hypercalcemia vitamin intoxication iridocyclitis period patient severe dry eye persistent epithelial defect', 'precipitation calcium phosphate elevation level calcium phosphate ph elevation concentration evaporation', 'water production dry eye calcium deposit palpebral fissure due subsequent increase calcium salt concentration', 'actual mechanism calcium deposition understood', 'calcareous degeneration persistent epithelium defect stroma ph balance contribute calcification full thickness cornea', 'occurrence calcium deposition rapid extensive acute calcareous degeneration band keratopathy superficial', 'histopathologic patient calcium deep stroma corneal graft severe leukocytic infiltration short period time characteristic calcareous degeneration', 'several ophthalmologic development recurrence calcium deposition case dry eye persistent epithelial defect meibomian gland dysfunction chronic conjunctival inflammation', 'topical usage ciprofloxacin ph cornea calcium deposition case', 'ocular surface eye lid malfunction abnormal tear film trophic ulcer chronic ocular inflammation corneal infection epithelial delayed persistent epithelial defect stroma', 'amniotic membrane several growth inflammatory reaction suppress lymphocyte reaction', 'addition amniotic membrane basement membrane facilitate migration epithelial reinforce adhesion basal epithelium promote cell differentiation prevent cell apoptosis', 'previous applied persistent epithelial sterile ulceration descemetocele formation limbal stem cell transplantation chemical thermal injury epithelialization', 'patient amt se limited effect corneal ocular inflammatory reaction severe dry eye reactivation chronic gvhd severe blepharoconjunctivitis', 'multilayer amt choice reconstruct ocular surface gvhd patient tiny corneal perforation', 'patient severe corneal large perforation', 'multilayer amt biologic glue strength strong tectonic support case', 'massive alternative corneal tectonic stability vision recovery', 'autologous serum vitamin epidermal growth factor growth factor', 'necessary ocular surface environment physiology normal tear produc tion', 'severe dry eye response conventional treatment autologous serum tear treatment good alternative method', 'limited effect corneal epithelialization case', 'tarsorrhaphy evaporation palpebral fissure width', 'ocular cornea contact superior inferior lacrimal film redistribution epithelial', 'addition reduction lid movement tarsorrhaphy possible trauma epithelium blinking', 'half open eye corneal epithelium eye', 'continuous administration eye examination cornea', 'advantage tarsorrhaphy risk corneal infection respect bandage', 'tarsorrhaphy trichiasis adhesion premature pyogenic granuloma keloid formation manageable', 'reluctant undergo procedure cosmetic', 'case tarsorrhaphy help ocular surface', 'breakdown corneal epithelium spontaneous tarsorrhaphy relapse gvhd', 'case tarsorrhaphy beneficial treatment modality management persistent epithelial', 'conclusion rare case chronic gvhd recurrent corneal perforation calcareous degeneration due severe dry eye meibomian gland dysfunction reactivation gvhd', 'case integrity globe large corneal perforation', 'aggressive amt tarsorrhaphy systemic immunosuppressive topical autologous serum vision intractable', 'tarsorrhaphy role persistent epithelial', 'moni systemic condition aggressive ocular treatment important chronic severe dry eye']"
ad4f830c6a0985b878a66d4e797232ccba91aedc,c myc anti cancer myc mrna rnp complex tylophorine treatment protein expression myc cyclin cyclin cyclin cancer activity biotinylated tylophorine asp asp biotin x cell cycle mrna rnp myc protein protein tylophorine tylophorine carcinoma x sse cancer cell carcinoma cell cyclin mrna hyperphosphorylation prb mrna cyclin pull experiment supplemental table tylophorine dbq tylophorine protein warburg effect cellular target complex tylophorine expression tylophorine immunoblot analysis mrna myc myc tylophorine ribonucleoprotein complex rt pcr rt qpcr tylophorine fig tylophorine rnp asp tyr association c c jun common downstream cycle progression development therapeutic downstream effector drug resistant e g expression c h compound lys asp oncotarget tylophorine rna protein room temperature sds page semi rt supplemental figure temperature h thermo scientific treatment fig tumor suppressor tylophorine anti tylophorine biotin tylophorine exert tyr lys western blot accumulation c active form active prb activity tylophorine analysis antibody analysis fig analysis potential analyzed western body formation broad spectrum bt pull cancer tylophorine carcinoma supplemental cell treatment click it® clone id co immunoprecipitation complex c control gapdh control shrna cyclin expression cyclin fig cyclin promoter cyclin protein cyclin rnp cyclin tylophorine dbq fig dependent manner derivative dbq dibenzoquinoline derivative direct cellular downregulation cyclin drug development drug discovery,"['tylophorine anti cancer cellular unknown', 'biotinylated tylophorine derivative probe cellular target tylophorine', 'tylophorine recruitment mrna cyclin form ribonucleoprotein complex', 'tylophorine ribonucleoprotein complex polysomal mrna', 'carcinoma resistant tylophorine decreased formation ribonucleoprotein complex tylophorine', 'tylophorine myc hypophosphorylation rb suppression body formation warburg effect', 'gene expression gain c myc function downregulated c myc anti oncogenic', 'potent tylophorine derivative similar effect c myc protein xenograft', 'tylophorine exert anticancer activity protein ribonucleoprotein complex', 'transcriptional factor variety cellular activity cyclin cdk cyclin dependent kinase warburg effect cancer cell metabolism cellular mrnp processing', 'myc expression wide range human therapeutic target', 'rna protein human antigen r myc expression mirna risc rna complex c myc', 'possibility c myc rnp', 'cyclin cyclin cyclin cyclin human member cyclin family', 'regulation cell cycle progression transition phase', 'regulate transcription cycle cyclin', 'retinoblastoma tumor suppressor protein active cyclin', 'prb common downstream effector c myc', 'tumor suppressor protein prb several major', 'prb stable protein several cdks activity', 'active prb tumor suppressor cell cycle progression', 'active form prb transcriptional factor', 'prb hyperphosphorylation execute cell cycle regulatory', 'hyperphosphorylation prb late phase activation transcription e g cyclin', 'activation phosphorylation normal cell cycle progression phase', 'co ras gtpase protein protein cytoplasmic rna', 'complex thought regulate transport translation protein proliferation migration multiple cell terminal region c myc cyclin', 'c myc mrna cyclin mrna complex function specific rnp complex important cellular', 'natural successful promising resource drug discovery', 'elucidation cellular therapeutic natural identification valuable novel drug development subsequent molecular pharmacology mode action', 'tylophorine natural moraceae plant multiple biological g anticancer anti coronavirus anti inflammatory', 'tylophorine drug development therapeutic failed phase clinical due neurotoxicity', 'several action cancer tylophorine direct cellular target elucidated', 'particular fundamental broad spectrum drug resistant cancer cell inhibitory investigated', 'tylophorine compound molecular moiety direct cellular target', 'combination proteomic molecular mechanism cancer', 'mechanistic basis tylophorine anti cancer', 'cellular target tylophorine represent novel drug cancer therapeutic', 'non planar structure major phenanthrene indolizidine quinolizidine planarity rigidity indolizidine quinolizidine moiety tylophorine affect', 'synthesized potent tylophorine biological traditional pentacyclic tylophorine', 'angular dibenzoquinoline moiety tylophorine responsible direct target molecule', 'design synthesize tylophorine dibenzoquinoline fig', 'herein tylophorine probe direct interacting', 'tylophorine anti cancer cell activity ic carcinoma supplemental table', 'cell incubated vehicle control dimethyl sulfoxide dmso biotin x sse tylophorine prior addition streptavidin pull experiment', 'pulleddown complex sodium dodecyl sulfatepolyacrylamide gel electrophoresis sds page silver analyze tylophorine', 'total protein tylophorine biotin x sse fig', 'desorption ionization time flight maldi tof mass spectrometry ms', 'potential tylophorine mascot analysis fig', 'supplemental table specific interaction tylophorine western blot analysis fig', '', 'factor psf polyadenylate heterogeneous nuclear ribonucleoprotein hnrnpq tata binding factor isoform ribosomal protein ribosomal protein tylophorine biotin x sse dmso expression tylophorine carcinoma dmsotreated fig', '', 'pull ribosome tylophorine unexpected tylocrebrine inhibit translocation peptidyl trna tylocrebrine concentration high µm', 'tylophorine exert significant anti cancer seek specific anti cancer', 'tylophorine complex c myc cyclin biotinylated tylophorine normal progression phase', 'co immunoprecipitation antibody complex', 'complex presence tylophorine fig', '', 'associate co localize rna rich cytoplasmic association c myc cyclin mrna pcr analysis pull experiment tylophorine fig', '', 'direct weak interaction tylophorine', 'scheme synthesis tylophorine bt dibenzoquinoline derivative', 'b c pull experiment cell potential molecular', 'bt biotin x sse pull streptavidin', 'lane sample bt pull lane lysate bt pull lysate', 'indicated sds page gel b proteomic analysis potential', 'immunoblot mascot analysis potential tylophorine', 'e immunoblot analysis intracellular tylophorine total carcinoma cell tylophorine h downregulation cyclin upregulation c jun protein expression tylophorine treatment internal addition control gapdh', 'representative independent', 'oncotarget pull experiment recombinant protein fig', '', 'sedimentation fractionation c myc mrna cyclin co polysomal tylophorine treatment fig', 'colocalization vehicle fig', '', 'low abundance cyclin certain carcinoma cell', 'certain loss specific cyclin presence', 'investigation cyclin mrna co c myc mrna rnp complex fig', 'polysomal', '', 'cyclin mrnas biotinylated tylophorine fig', 'tylophorine rnp complex tylophorine', '', 'co immunoprecipitation cell lysate presence tylophorine immunoblot', 'b tylophorine myc rt pcr', 'recombinant protein biotinylated tylophorine', 'human affinity section pull experiment tylophorine', 'immunoblot analysis antibody human', 'polysome profile analysis sucrose gradient sedimentation protein western upper panel rna qrt pcr panel gradient localization c myc cyclin cyclin tylophorine rnp complex tylophorine µm effect tylophorine expression c myc pull', 'tylophorine treatment mrna myc cyclin', 'cyclin mrna tylophorine treatment cyclin level undetectable regardless tylophorine treatment fig', '', 'c myc cyclin protein tylophorine treatment fig', '', 'addition cyclin protein tylophorine cyclin detectable', '', 'used tamra label protein tylophorine treatment immunoprecipitation western blot detect interest', 'protein c myc tylophorine treatment protein fig', '', 'sirna resultant semi quantitative rt pcr effect mrna myc cyclin cyclin', 'relative expression respective internal loading control gapdh', 'b immunoblot tylophorine protein related rnp complex common downstream target prb', 'carcinoma tylophorine µm h semi quantitative rt pcr western blotting gene primer', 'protein c myc', 'specific antibody detected western blotting antibody', 'depletion carcinoma resistance tylophorine dbq', 'control shrna shrna puromycin', 'resultant analyzed western validation depletion measurement cell growth dbq', 'unpaired student test evaluate p value', 'e effect depletion association tylophorine rnp complex', 'pull tylophorine biotin x sse', 'immunoblot e semi rt qpcr detect protein mrna rnp complex', 'gene supplemental table', 'bt tylophorine', 'representative independent', '', 'oncotarget resistant tylophorine ic value tylophorine potent derivative dbq fig', '', 'fig', 'myc biotinylated tylophorine fig', '', 'tylophorine protein myc downstream anti cancer activity', 'myc cancerous tylophorine', 'tylophorine protein expression myc prb protein common downstream effector c myc tylophorine activity', 'prb active form tylophorine carcinoma protein expression unchanged fig', 'result protein upstream c myc tylophorine treatment phosphorylation prb fig', '', 'cyclin tylophorine arrest tylophorine', 'cyclin promoter region regulatory', 'cyclin fig', 'upper panel cyclin fig', 'panel downstream hyperphosphorylation prb upregulating cyclin expression tylophorine', '', 'overexpression c myc hyperphosphorylation downstream effector prb cyclin expression', 'expression ectopic overexpression c myc fig', 'target myc', 'hyperphosphorylation prb part increased fig', 'upstream effector prb feedback upregulated cyclin ectopic overexpression cyclin able resume hyperphosphorylation prb fig', '', 'c myc upregulate stabilize transcription subject sequestration tylophorine c myc mrna rnp complex translation', 'c myc hyperphosphorylation prb pathway independent', 'summary active prb hyperphosphorylated form overexpression carcinoma', 'hypophosphorylation prb important role anti cancer activity tylophorine', 'downstream pathway e', 'prb cyclin cyclin anti cancer activity tylophorine', 'demonstrate functional myc inhibition tylophorine cellular c myc warburg effect cancer metabolism formation p', 'tylophorine viable proliferation significant apoptosis', 'examined effect tylophorine treatment glutaminase type ldha lactate dehydrogenase c myc mediate cancer cell nutrient supply warburg effect protein expression tylophorine carcinoma', '', 'tylophorine protein expression fig', '', 'tylophorine warburg effect protein expression', 'gene involved cytoplasmic mrnp processing carcinoma constituent p', '', 'next examined treatment p body formation confocal immunofluorescent microscopy p p tylophorine treatment hela', '', 'oncotarget tylophorine growth wide variety drug sensitive drug resistant cancer cell c myc protein expression panel carcinoma cell cell treatment', 'blockade c myc protein expression individual carcinoma cell treatment tylophorine potent derivative dbq fibroblast cell', 'protein expression fig', 'myc mrna', '', 'gene expression analysis c myc downstream tylophorine dbq fig', 'validation rt qpcr fig', '', 'expression c myc mrna c myc e g cyclin cyclin mrna c myc e g fig', '', 'consistent observation c myc mrna myc protein tylophorinetreated negative regulation c myc effector', 'expression downregulated tylophorine dbq function c myc carcinogenesis figure', 'mouse tumor model human lung carcinoma xenografts tumor volume dose dependent manner', 'c myc protein mrna expression xenograft', 'myc protein dependent manner dbq vehicletreated', '', 'vivo anti tumor activity vitro anticancer fig', '', 'study tylophorine exert anti cancer c myc mrna cyclin rnp complex inhibiting protein translation mrna g c myc cyclin cyclin pathway fig', '', 'abnormal c myc cancer oncogenicity downregulation c tylophorine significant role anti cancer activity', 'therapeutic rnp explored strategy drug discovery', 'rnps rna protein ribosome enzyme telomerase hnrnp small nuclear rnps snrnps viral rnp interact', 'rnp multiple dynamic instability', 'rnps discovery development therapeutic challenge', 'several antiviral target viral rnp high potency exhibit significant potential development therapeutic', 'knowledge anti cancer agent rnp complex', 'first report rnp complex e c myc rnp complex tylophorine carcinoma anti cancer activity', 'pull biotinylated tylophorine association c myc mrna untreated carcinoma cell', 'myc cyclin observed tylophorinetreated carcinoma', '', 'polysomal colocalization c myc mrna mrna dmso carcinoma sedimentation fractionation fig', '', 'conclude tylophorine recruitment c myc mrna mrna rnp complex', 'hypothesis association c myc mrna polysomal vehicle carcinoma', 'myc mrna tylophorine carcinoma', '', 'mrna myc tylophorine treatment carcinoma reflect impairment mrna degradation due tylophorine treatment consistent dramatic decrease number p blockade cellular mrna degradation', 'cytoplasmic cycle p translational repress different', 'addition tylophorine treatment formation p', 'stress dmso table', '', 'oncotarget tylophorine carcinoma supplemental figure', 'tamra label protein tylophorine treatment tylophorine protein expression c myc', '', 'firm tylophorine rnp c myc polysomal', 'translation', 'detailed underlying', 'transport c myc cyclin cyclin translation', 'abrogation specific biological function induction cell cycle arrest phase', 'expression numerous tumor multiple', 'active abnormal transcriptional amplification oncogenicity', 'upregulation c myc tumor aggressiveness poor clinical outcome', 'conceivable inhibition c myc broad spectrum anti cancer activity drug resistant carcinoma', 'induction cell cycle addition myc mrna rnp complex oncotarget potential novel anti cancer drug target', 'blockade mrna transport tylophorine c myc mrna cyclin rnp complex anti cancer tylophorine conjunction accumulation c jun fig', '', 'tylophorine jun downregulation cyclin promoter activity phase anti cancer activity', 'c myc affect accumulation c jun induced tylophorine treatment increase expression cyclin prb supplemental figure fig', '', 'conclude elevation jun c myc mrna rnp complex produce anti cancer activity', '', 'tylophorine dbq described purity pahse hplc', 'scheme synthesis tylophorine purity reverse pahse figure nmr supplemental figure', 'compound overnight mixture nah tert butyl carbamate dmf compound', 'compound lialh ratio thf room temperature h compound', 'n boc amine h ch cl room temperature h compound', 'biotin x sse invitrogen compound n dmf room temperature h compound tylophorine tylophorine dibenzoquinoline derivative fig', 'measurement growth inhibition tylophorine tylophorine dbq ic', 'cell biotinylated tylophorine h oncotarget tylophorine streptavidin invitrogen h tylophorine bound laemmli buffer electrophoresis gradient sds page gel w h cm x cm amersham', 'protein interest gel digestion supplemental lc ms ms thermo scientific ltq xl mass spectrometer thermo scientific', 'addition western blot protein', 'tylophorine bound rnas trizol reagent invitrogen rt pcr associated', 'procedure', 'mrna expression semi rt qpcr gel pro analyzer program gene necessary', 'figure expression ∆∆ct method gapdh', 'primer pcr supplemental table', 'western antibody listed supplemental table', 'supplemental immunoprecipitation antibody proteintech group', 'transfected', 'purified anti flag affinity sigma aldrich', 'human protein flag n asp tyr lys asp asp asp tyr lys asp asp ile asp tyr lys asp asp asp asp lys c sigma aldrich', 'µg ml cycloheximide min harvest', 'total cell centrifugation min rpm', 'top sucrose gradient beckman rotor h rpm', 'bottom absorbance wavelength nm akta purifier ge healthcare amersham', 'rna protein trizol reagent invitrogen', 'protein expression expression western immunoblot analysis semi rt qpcr', 'methionine free dmem gibco life prior addition μm tylophorine μm click it® hpg l homopropargylglycine invitrogen incubation h click reaction μm tamra tetramethylrhodamine invitrogen click it® protein reaction buffer invitrogen', 'resultant cell immunoprecipitated proteintech group c myc cell technology anticyclin cyclin santa cruz biotechnology thermo scientific gar elmer overnight constant agitation prior incubation protein h specific immunoprecipitated protein analyzed western immunoblot analysis antibody', 'shrna plasmid origene pgfp c shlenti shrna origene fugene tm roche', 'h post transfection presence mg ml puromycin selection', 'addition lentivirus shrna clone id negative control shrna clone id sinica taiwan moi culture medium μg ml polybrene millipore', 'h post transduction presence mg ml puromycin selection', 'fugene tm roche transient transfection']"
e159298c6d214ba5e950ef1cda327cf5a88326b8,mask use public health isolation quarantine use public hong kong cough etiquette domestic travel health response influenza virus medical officer new south pandemic period part article virus transmission additional research alert period antiviral therapy authority understood available online british togo case control community level containment r cultural human early isolation effective urban general population health organization historical contemporary home isolation human influenza hygiene cough ill home ineffective impractical influenza pandemic influenza subtype kong public legal authority national community nonessential domestic nonpharmaceutical public novel human officer health pandemic alert pandemic influenza pandemic phase phase pandemic province alberta public gathering respiratory hygiene section b severity disease social distancing state new stop virus transmission general transmission pandemic use risk world health accompanied movement achievable objective acute respiratory addition study addition virus additional case additional information address example address influenza address public adjacent state advance respect advantage soap advice appendix advice early affected epidemiology affected state affected unspecified age school aggressive isolate aggressive quarantine air sydney alberta effort alberta home alberta provincial allow reopen allow time amplification transmission anchor sydney animal virus antibacterial handwashing antiviral illness antiviral population appear first appendix available appropriate financial area model army close army training article address article dealt,"['world health organization pandemic influenza limited vary transmission pattern pandemic phase illness severity extent', 'pandemic alert period isolation quarantine antiviral therapy', 'pandemic period focus spread population', 'ill home symptomatic isolation quarantine ineffective impractical', 'pandemic severe social distancing school', 'nonessential domestic travel', 'hand respiratory hygiene routine mask use risk household', 'additional research field essential update', 'legal authority understood advance respect cultural human', 'article second series scientific basis nonpharmaceutical public health world health organization contain transmission pandemic influenza novel human influenza subtype read conjunction guidance formal advice appendix available online', 'evidence base historical contemporary scientific', 'first part series transmission charac basis international spread', 'second part national community exposure susceptible virus', 'susceptible subsequent disease exposure achievable objective', 'exposure first wave chance virus specific vaccine available', 'addition virus virulent time ill subsequent', 'article address public communication infection control patient care', 'pandemic stop virus transmission impractical', 'canada medical officer health province alberta home isolation unspecified community diagnostic mild notify', 'medical officer many sign person house injustice diagnosis justified quarantine concealment evasion… discrimination health department', 'australian state new south compulsory reporting helpful identify first introduction community', 'number useful feasible', 'mild', 'compulsory home isolation assistance home', 'assess potential impact home reduction community', 'closed g military college early identification isolation stop virus transmission decrease attack community', 'report student army training corps university chicago similar fraternity formal contact', 'section frequent report illness ill simple influenza isolated home', 'section b close contact sick well several', 'usual', 'november total section rate tenth attack rate section', 'new section b daily inspection patient isolation epidemic', 'home boarding ill influenza', 'australian quarantine service review ship entry daily temperature immediate isolation prevent transmission number', 'several g canada british togo refer isolation modern terminology isolation quarantine', 'unclear imply home', 'ineffective impractical severe acute respiratory syndrome epidemic influenza success public recognition illness telephone medical advice early isolation potential health care', 'intercity', 'early isolation quarantine interrupted transmission serial interval peak infectivity presence mild possibility transmission successful', 'consultation influenza pandemic appear first army close', 'incidence rural consultation crowding peak incidence epidemic many', 'consultation northern opening summer played important role main epidemic phase', 'propensity influenza primary school', 'illness lead reopening', 'influenza epidemic israel significant respiratory medication age school', 'study report family', 'temporal relationship school incidence influenza general daily death rate time delay question', 'small island united single public school focal point spread influenza report period prompt closure school epidemic', 'school closure effective urban rural urban influenza chicago school holiday session', 'hartford new kept medical supervision death connecticut new london waterbury', 'universal influenza vaccination controversial use help potential effect transmission', 'example influenza small town tecumseh third illness rate nearby', 'japan influenza excess death entire population program', 'influenza respiratory viral hong kong epidemic determined basis review viral diagnostic laboratory', 'public health closing public gathering taxis public', 'high percentage public general social mixing', 'pandemic social distancing transmission research partial effectiveness unavailable', 'example british togo case traffic public', 'lomé october', 'edmonton canada isolation quarantine public public gathering business obvious impact epidemic', 'united comprehensive report pandemic closing effective urban effective rural group numerous', 'political state national government individual protect', 'delayed disease affected state interstate quarantine impoundment transcontinental train state western national state australian federal system', 'specific state new south first case sydney capital nsw state …and come adjacent state victoria new south interstate border prevent importation additional', 'first prohibition inbound land traffic quarantine detention first later', 'state anchor sydney harbor', 'sydney affected unspecified sydney', 'report quarantine interstate intrastate travel meager', 'report many small isolate complete reminiscent medieval plague enter town', 'railway towns', 'canadian pacific railway province manitoba epidemic canadian northern line', 'alberta provincial police major province alberta effort influenza prairie', 'inefficient spread disease', 'entire work', 'united infected', 'disease', 'explosive outbreak influenza pacific island new caledonia french territory', 'ship capital city australia normal seasonal winter influenza', 'illness spread nouméa southern portion colony part numerous celebration day july', 'spread isolated northern third island', 'travel measure major area', 'nouméa north quarantine departure time', 'recent quarantine unique influenza subtype rural thailand supplement antiviral population', 'model antiviral illness novel subtype basic reproduction number r r mean number secondary infected person susceptible population', 'prophylaxis closing movement area model probability containment r', 'additional case identification treatment', 'unsuccessful containment widescale spread month model', 'second modeling study case patient home susceptible neighborhoods disease containment r', 'population structure interaction early detection rural area', 'efficacy mask use transmission influenza', 'influenza pandemic mask use common required law many', 'skepticism medical officer health canada continued increase mask use public confidence measure efficacy way ridicule', 'healthcare protective evidence transmission railway carriage mask wearing railway public recommend', 'mask open air sydney unnecessary', 'united protective measure', 'report tucson early …isolation ill', 'epidemic', 'criticism money religious educational', 'allow reopen city worn place transaction necessary business … later public', 'universal compliance mask epidemic subsiding', 'hong kong public', 'influenza virus isolation multiple contribution mask use uncertain', 'case control hong kong public protection analysis', 'study doseresponse effect', 'methodologic g retrospective questionnaire design limit', 'hygiene cough etiquette mouth basis plausible effectiveness', 'part article influenza virus viable environmental transmissible', 'protective effect upper respiratory available online', 'likely viral small percentage due influenza', 'address influenza', 'addition study pakistan effect severe disease', 'institutional college military', 'antibacterial handwashing advantage soap water', 'hong kong case control study day telephone protective multivariate analysis', 'knowledge base use guidance nonpharmaceutical limited historical contemporary mathematical', 'guidance subject revision additional information', 'transmission pandemic strain pandemic way guidance national community level phase pandemic severity disease virulent strain justify extent transmission particular country community', 'animal virus human infection human exposure', 'pandemic alert period limited localized human human transmission aggressive isolate case quarantine accompanied movement consideration targeted antiviral therapy', 'likely feasible urban population', 'prediction mathematical novel human influenza virus subtype point rural southeast asia use public health pandemic address example strain new country multiple loci', 'transmission general population country phase pandemic period eventual worldwide spread inevitable public health response focus impact spread allow time vaccine development institution response', 'part article dealt international level community level part article effect true', 'time pandemic change public health response present difficult critical', 'field needed assess virus transmission g death', 'information pandemic pandemic subtype previous pandemic seasonal', 'pandemic period determine make informed public health response costly disruptive', 'evidence experience pandemic phase transmission general population aggressive quarantine first community good use health', 'phase ill home possible appropriate financial support work illness', 'social distance affected epidemiology transmission severity disease casefatality ratio risk', 'nonessential domestic travel large country unaffected domestic travel impractical', 'respiratory hygiene cough etiquette routine public health hand hygiene available amplification transmission', 'mask use public risk frequency exposure closeness contact infectious mask use public required', 'recommendation example mask use public transport', 'use risk scope review', 'disinfection household infectious worthwhile evidence efficacy widespread disinfection environment air', 'legal authority understood key pandemic cultural human', 'need urgent additional research transmission nonpharmaceutical public health', 'research epidemiologic virologic field effectiveness cost historical inquiry', 'research seasonal influenza research investment dedicated end', 'research effectiveness mask use cough etiquette prevented cost effectiveness public', 'research identify quarantine burdensome individual leaky effective', 'communicate essential public', 'real time meet future']"
0eed9647904ba87a841a177c12a0238faf5c2bd0,rt pcr multiplex rt rv infection pcr test flu season rvs influenza antigen detection influenza antigen rapid influenza single rv underwent multiplex community hospital community respiratory january april turnaround time acute respiratory adult community bacterial viral hematologic malignancy influenza adult influenza infection positive multiplex respiratory tract study period tertiary care test rvs time positive utilization multiplex bacterial culture care center clinical practice current utilization detection january detection kit detection rvs detection test diagnose influenza hmpv hrv hospital mortality hospital multiplex hospital p infection flu influenza pandemic kit seegene pcr adult pcr system period multiplex pneumonia rvs production rhinorrhea rate community rhinorrhea sore rsv hmpv rv detection rvs adult rvs hospital severe pneumonia sore throat system thermal test diagnose test test thermal cycler throat dyspnea unknown origin uri pneumonia viral coinfection vs p μl × acute appendicitis acute care acute cholangitis acute hepatitis acute infection additional multiplex adenovirus parainfluenza admission community admitted community adult acute adult age adult benign adult clinical adult effective adult familiar adult non adult pneumonia advent sensitive agarose g age male age underwent ang university anti influenza antimicrobial community antiviral severe antiviral unavailable anyplex ii appendicitis cellulitis appropriate time april electronic april january association mortality asymptomatic possible,"['pediatric respiratory important acute respiratory tract hospitalization acute care diagnostic', 'diagnostic evalua adult benign respiratory tract', 'advent sensitive molecular clinical variable rvs increasing frequency adult', 'importance rvs adult', 'emergence severe acute respiratory syndrome avian influenza pandemic influenza', 'future rv detection essential part diagnostic work adult acute respiratory tract', 'adult familiar rv detection', 'current utilization multiplex reverse transcription polymerase chain reaction rt pcr test rvs adult clinical practice', 'multiplex rt pcr test detection large number rvs sensitivity viral culture', 'utilization current multiplex rt pcr multiplex rt pcr utilization adult', 'study chung ang university hospital tertiary care hospital seoul republic korea', 'adult age underwent multiplex rt pcr january april electronic medical radiographs', 'demographic multiplex rt pcr presence respiratory clinical', 'upper respiratory infection uri presence ≥ respiratory cough sputum production rhinorrhea sore throat dyspnea', 'pneumonia presence new progressive infiltrate chest radiography production rhinorrhea sore throat dyspnea physician diagnosis pneumonia', 'nonrespiratory infection nri uri pneumonia', 'patient episode acute infection underwent multiplex rt pcr episode received test community infection', 'flu season january april january april', 'flu season weekly surveillance respiratory control prevention', 'study period nasopharyngeal flocked swab universal transport medium copan brescia italy', 'nasopharyngeal detection january december detection january april', 'nucleic viral gene spin viral dna rna extraction kit intron biotechnology', 'extracted synthesis premix seegene seoul korea geneamp pcr system thermal cycler foster city', 'detect influenza respiratory syncytial virus rsv human metapneumovirus hmpv human rhinovirus hrv pcr seeplex detection kit seegene manufacturer pcr system thermal cycler', 'agarose g ethidium bromide ml tri borate edta visualized ultraviolet light', 'pcr manufacturer', 'anyplex ii detection kit seegene detect fourteen dna manufacturer', 'briefly final volume μl μl cdna μl × primer μl solution μl × master mix real time pcr detection system bio rad', 'statistical spss version spss inc chicago il usa', 'continuous student test mann whitney u test', 'categorical square test fisher exact test', 'study period multiplex rt pcr respiratory adult', 'period rapid influenza antigen detection nasopharyngeal swab bacterial respiratory hospital', 'frequency multiplex rt pcr rapid influenza antigen detection bacterial', 'turnaround time positive multiplex rt pcr range', 'turnaround time positive', 'table', 'mean patient age male', 'common underlying disease chronic lung disease solid tumor hematologic malignancy chronic renal failure', 'multiplex rt pcr uri nri', 'majority multiplex rt pcr admitted community flu season', 'underwent multiplex rt pcr nri urinary tract gastroenteritis acute hepatitis febrile neutropenia meningitis mediastinitis pulmonary tuberculosis acute cholangitis escherichia coli bacteremia unknown origin enteric fever clostridium difficile infection acute appendicitis cellulitis cervical lymphadenitis hemorrhagic cystitis cerebrovascular seizure hyperventilation syndrome angina', 'nri multiplex rt pcr due presence fever unknown origin flu nonflu season', 'list table', 'rvs', 'influenza vs p human coronavirus vs p uri pneumonia', 'positivity different community hospital p', 'individual rv difference positivity community hospital', 'nri positive multiplex rt pcr adenovirus parainfluenza virus human enterovirus hrv rsv', 'underwent multiplex rt pcr pathogen type table', 'quarter rv infection bacterial infection', 'bacterial viral', 'pathogen', 'rv infection rvs influenza', 'single rv infection rv infection differ underlying hospital mortality rhinorrhea single rv infection flu season', 'pa rv bacterium rsv hematologic malignancy common infected single rv', 'hospital mortality bacterial viral coinfection rv infection single rv infection', 'multiplex rt pcr adult community respiratory tertiary care center flu season', 'test test late', 'rv positive rate community different hospital p', 'rvs identified quarter', 'half pneumonia rvs influenza', 'hospital multiplex rt pcr adult community respiratory flu season', 'test diagnose influenza adult', 'influenza pandemic use multiplex rt pcr diagnostic test influenza infection understandable', 'perception multiplex rt pcr similar predominance influenza rvs presence effective anti influenza', 'multiplex rt pcr test diagnose influenza flu season low sensitivity rapid influenza antigen detection', 'hospital multiplex rt pcr test rapid influenza antigen detection', 'outpatient hospital', 'understandable test available site rapid influenza antigen detection test', 'test national health insurance south expensive cost respiratory bacterial culture krw rapid influenza antigen detection test krw', 'infrequent routine pcr clinical laboratory day week hospital', 'turnaround time positive', 'forty appropriate time period introduction influenza', 'continuous threat influenza infection current utilization multiplex rt pcr improvement diagnostic sensitivity influenza decrease number thera py', 'study rv positivity rate community hospital', 'viral community hospital', 'recent study viral severe pneumonia intensive care unit admission community pneumonia healthcare similar positivity vs similar rv', 'rv previous healthcare antimicrobial community', 'hospital healthcare different similar explanation', 'frequent detection rvs hospital infection multiplex rt pcr limited community respiratory', 'test serious hospital respiratory unknown cause', 'study test hospital rv infection control turnaround time purpose', 'causal role rvs influenza adult effective treatment antiviral unavailable clinical practice', 'detection rvs influenza unnecessary adult non flu season fact multiplex rt pcr test sputum bacterial culture', 'clinical rvs influenza increased infection immunocompromised', 'antiviral severe pneumonia rvs influenza immunocompromised', 'study diagnosis influenza infection flu season rvs influenza pneumonia', 'half bacterial viral coinfection rvs influenza rsv hmpv hrv', 'group group single rv infection group rv infection', 'association mortality serious underlying hematologic malignancy impact bacterial group significance rvs influenza', 'clinical significance rsv hmpv hrv adult', 'study influenza adult pneumonia clinical impact rvs future clinical', 'study positive multiplex rt pcr test', 'clinical presentation rv infection pathogenic potential rv degree host immunity respiratory rv infection absent', 'asymptomatic possible explanation previous study', 'several', 'clinical management medical underwent multiplex rt pcr', 'study direct evidence clinical usefulness multiplex rt pcr test rvs', 'prior cost effectiveness multiplex rt pcr test', 'additional multiplex rt pcr test rvs south korea', 'second platform multiplex rt pcr study period multiplex rt pcr positivity', 'test', 'third clinical', 'unrecognized clinical analysis', 'fourth different', 'conclusion multiplex rt pcr test adult community respiratory season tertiary care center', 'test test', 'utilization multiplex rt pcr diagnose rvs hospital']"
eb2d3db69391b5c8f85c99b425c7c1a6d1e3f5ed,clinical immunology anti igg complement system veterinary clinical patient serum red blood immune response serum sample rheumatoid factor systemic lupus veterinary medicine lupus erythematosus rheumatoid arthritis serum protein basement membrane blood serum complement activity complement component fitc anti hemolytic complement human veterinary humoral immune mg ml normal healthy radial immunodiffusion calcium lactate cell mitogen cpm unstimulated et al gammaglobulin concentration igg serum immunoglobulin concentration indirect immunofluorescence lymphocyte transformation ml serum nitroblue tetrazolium non specific presence serum present time protein estimation rocket immunoelectrophoresis room temperature serum electrophoresis serum suppressor specific anti specific antiserum total serum transformation test ability host agglutinate weak agglutination patient anti iga antibody test antiserum immunoglobulin autoimmune hemolytic background cpm barbital tris barbitalsodium barbital blood group blood smear bovine canine buffer ph bullous pemphigoid cellular immune clinical stage clinique veterinaire concentration immunoglobulin concentration serum degree lysis dermatitis herpetiformis detection quantitation diagnosis autoimmune differential titer fetal calf fluorescein isothiocyanate fluorescent antibody gammaglobulin content group humoral guinea pig healthy homologous hemolytic anemia homologous fetal human medicine igg antiserum igg class igg sera immunitaire humorale immunoglobulin serum immunologie clinique immunology humoral immunosuppressive patient important factor ionic strength laboratory evaluation lactate buffer lazy leukocyte leukocyte syndrome level complement lymphocyte immunosuppressive man laboratory,"['laboratory applicable veterinary clinical immunology humoral immune response serum protein estimation complement cellular immune response phagocyte function function autoimmune antinuclear factor autoimmune hemolytic organ tissue', 'appropriate', 'key veterinary clinical immunology humoral immune response cellular immune response autoimmune une revue utilisi e immunologie vi ti rinaire resum couramment aisement immunologie clinique veterinaire sont trois detectant immunitaire humorale une estimation sur le complement', 'des immunitaire cellulaire fonction', 'detection tissus', 'le principe interpretation avec', 'immunologie clinique veterinaire immunitaire humorale cellulaire serologie barta clinical immunology laboratory evaluation immunologic competence autoimmunity', 'purpose detect ability host man animal respond antigenic stimulation source determine system', 'numerous category veterinary clinical immunology', 'large clinical humoral immune response cell immune response various cellular', 'large humoral immune b non specific serum g', 'complement conglutinin c intercellular g', '', 'clinical immunology human veterinary medicine fast rate recent', 'development improvement various laboratory diagnose immunologic instance appropriate laboratory', 'laboratory immunologic medicine', 'serologic discovery antibody capable specific reaction antigen', 'first serum', 'serologic century presence antibody body presence bacteria', 'various biological laboratory', 'numerous mycology detect antibody self diagnosis autoimmune', 'studied immune humoral stability specificity', 'basic various textbook', 'antibody activity specific action clinical immunology ability host antibody specificity', 'serum lead antibody formation', 'immunoprecipitation technique detection quantitation blood serum', 'absence detectable newborn adult various immunodeficiency origin', 'excess cancerous disease immunoglobulin myeloma', 'number non specific serum complement system connection clinical', 'complement system system serum activation act complement active split action cell', 'cell membrane damage destruction cell microorganism antibody important biological function complement system', 'limited knowledge complement complement component domestic various man laboratory complement system', 'third group humoral', 'intercellular group humoral action', 'numerous amplification inflammatory reaction', 'similar', 'connection cell immunity clinical diagnostic value present time', 'expensive detection quantitation specific simple pre', 'actometric estimation', 'simple refractometric estimation serum fast accurate test', 'many protometer', 'procedure total protein estimation producer instrument', 'study refractive longsworth', 'many total serum protein estimation', 'refractive index nomogram estimation fig', '', 'protein concentration g sufficient clinical', 'lowry method', 'precise estimation necessary clinical immunology cornwall', '', 'sensitivity range biuret method mg protein ml', 'sensitive method lowry et al', '', 'modification folin ciocalteau method detection tyrosine tryptophane ultraviolet absorption analysis', 'method warburg christian serum protein', 'amount protein dilution factor', 'optical density nm', 'normal healthy table', 'age important factor account newborn young table', 'normal healthy schalm et al', '', 'cow dog goat horse sheep', 'ml', 'serum close table', 'adult maximum normal', 'additional variation sex individual', 'hyperproteinemia various chronic infectious dehydration due extreme heat insufficient water supply due chronic nephritis multiple myeloma', 'ttypoproteinemia various origin glomerulonephritis renal amyloidosis chronic liver due insufficient albumin synthesis johne disease paratuberculosis due loss albumin protein enteropathy', 'gamma beta blood serum estimation important information status specific humoral immunity b', 'serum electrophoresis serum diagnosis many', 'percentage distribution serum albumin total serum protein concentration absolute concentration', 'electrophoresis underestimate high globulin region division', 'optimal equipment', 'sodium barbital tris barbital tris tricine serum electrophoresis', 'use prepared tris barbitalsodium barbital buffer ofph ionic strength good', 'buffer composition trizma tris g barbital sodium salt g barbituric acid g ml', 'serum electrophoresis special equipment available', 'simple hyper hypogammaglobulinemias', 'reaction turbidity zinc sulfate solution serum sample mcewan et al', '', 'solution mg znso litre water cox test ml solution ml test serum', 'agitation hr incubation absorbance nm spectrophotometer', 'absorbance reading milliliter standard curve serum gammaglobulin concentration', 'method correspond gammaglobulin concentration serum sera hemolysis', 'effect hemoglobin serum sample gammaglobulin level correction equation actual gammaglobulin content apparent gammaglobulin content mg ml absorbance serum dilution ×', 'low concentration', 'property utilized human bovine canine mink sera', 'glutaraldehyde merck', 'distilled water solution ml glutaraldehyde ml water dog calf gammaglobulin estimation', 'concentration proportional time fig', '', 'hr hypogammaglobulinemic', 'hypergammaglobulinemia coagulation rain', 'gammaglobulin concentration graphs literature', 'radial immunodiffusion mancini method single diffusion procedure serum sample presence immunoglobulin agarose gel specific antiserum immunoglobulin', 'prepared specific antiserum available test concentration igg iga igg', 'kit immunoglobulin concentration immunoglobulin concentration procedure description', 'precipitation radius serum sample fig', 'time radii mg ml serum sera', 'semilogarithmic paper fig', 'diagnostic radial immunodiffusion laboratory', 'high specificity antisera reproducible', 'technique accurate actual reading present serum', 'rocket immunoelectrophoresis new technique laurell', 'measure', 'method detail original laurell paper manual', 'method quantitation specific prepared antisera', 'principle antigen e g', 'serum constant diameter layer concentration specific antiserum immunoglobulin question', 'subject electrophoresis v cm hr line region optimal antibody', 'electrophoresis similar way immunoelectophoretic', 'unprecipitated protein', 'figure iga dog serum', 'igg center agarose plate line cigar shape fig', '', 'multiple length average width rocket cigar proportional concentration immunoglobulin serum', 'original barbitalsodium barbital calcium lactate buffer ph ionic strength agarose tricine calcium lactate buffer ph tris tricine mm calcium lactate sodium qiep iv buffer bio rad richmond', 'set immunoglobulin set', 'immunoglobulin estimation day', 'accuracy comparable radial immunodiffusion', 'immunoelectrophoresis combination electrophoretic agarose antibody electrophoresis perpendicular antibody gel', 'pattern fig', 'precipitating', 'area individual precipitate proportional antigen antibody ratio system planimetric measurement concentration', 'procedure detail review manual', 'specific anti immunoglobulin serum agarose second dimension electrophoresis estimation specific immunoglobulin content possible', 'antiserum case fig', 'igg', 'hypogammaglobulinemia normal immunoelectrophoresis noticeable immunoelectrophoresis', 'hypergammaglobulinemia gammaglobulin serum hypogammaglobulinemia ml serum', '', 'natural hypogammaglobulinemia newborns domestic', 'absolute postcolostral sera normal level gammaglobulin', 'gammaglobulin many physiologic pathologic', 'instance decrease beta gamma parturition', 'blood loss lead absolute', 'hypogammaglobulinemia many instance arabian absorption colostral', 'hand young immunodeficient hypogammaglobulinemic absorb high level colostral', 'igm class halflife igg class colostral igm blood circulation sooner', 'subnormal indicator immunodeficiency young igg normal due persistence colostral igg', 'igm last', 'radial immunodiffusion rocket immunoelectrophoresis zinc sulfate precipitation glutaraldehyde coagulation', 'infectious chronic particular lead hypergammaglobulinemias fig', '', 'high total protein instance present infected foot mouth disease virus infectious peritonitis aleutian disease', 'extraordinary increase total serum protein macroglobulinemia multiple myeloma', 'veterinary clinician hypogammaglobulinemia colostrum young infectious major concern', 'hypogammaglobulinemia young immunodeficiency failure passive transfer colostral', 'hypergammaglobulinemia concurrent infection myeloma autoimmune', 'poor prognosis', 'hand hypergammaglobulinemia infectious important defense feature infectious agent favorable feature', 'immunoglobulin colostrum milk', 'general level due age due variation quality reference', 'igg immunoglobulin concentration serum various', 'healthy whereas ml', 'hand chicken mg ml', 'igm iga mg ml dog iga horse pig ml', 'iga ml pig horse ml', 'complement system important system serum augment immune body', 'complement activated various antibody', 'level complement increased formation immune', 'complement system animal body physiological possible', 'complement man new year', 'total complement activity serum single complement diagnosis prognosis', 'determination total complement activity domestic variation optimal target red blood complement system optimal test', 'addition complement system number labile titer original complement storage blood serum sample', 'order reproducible storage', 'control sample set', 'recommend min room temperature time ice water bath temperature time serum sample blood collection', 'secondary white clot serum storage titer', 'horse cattle sera secondary', 'serum frozen dry ice bath noticeable exception swine serum complement laboratory storage several', 'swine serum', 'standard control sera decayed complement activity optimal hemolytic complement various domestic literature table', 'table lead detection hemolytic complement activity', 'important level identical storage serum constant red blood × ml optical density measurement optimal concentration red blood dose give detectable titer complement table standard temperature timing recommend temperature mammalian complement determination lysis min', 'tube microtiter plate', 'determination degree lysis tube microtiter plate determination', 'skilled laboratory worker degree lysis size cell volume color supernatant fluid sufficient clinical testing', 'accurate measurement spectrophotometer nm peak absorbance hemoglobulin', 'functional complement component excess question', 'commercial sheep complement system isolated guinea pig human sera available complement number domestic', 'herbivorous available system simple prepared system', 'immunochemical rocket immunoelectrophoresis specific antisera', 'presence complement component regardless function', 'human veterinary medicine present time', 'hemolytic complement ml serum healthy adult table', 'horse serum detectable level hemolytic complement optimal due quick conversion conglutination lysis blood', 'complement serum exceed hemolytic', 'bovine ruminant sera similar tendency sheep guinea pig rabbit', 'horse goat chicken sera low hemolytic active complement bactericidal activity', 'identical serum test', 'control standard serum reference sample frozen temperature small series sera clinical', 'fresh', 'defrosted', 'hypocomplementemia level healthy', 'physiological hypocomplementemia present newborn', 'level complement level adult', 'pathological hypocomplementemia complement component production function', 'clinical meaning complement normal healthy clear', 'individual complement system clinical veterinary medicine interpretation available', 'healthy', 'individual production function man clinical various', 'determination intercellular research clinical immunology', 'production humoral various immunity', 'premature review topic connection veterinary clinical immunology', 'clinical b', 'total white blood cell count differential count indicative cellular immunity', 'lymphopenia null', 'increased susceptibility lazy leukocyte syndrome cell', 'number immature white blood heavy use numerous tumorous', 'development human medicine', 'present time number', 'explain symptomatology measure vivo open question', 'neutrophil function', 'veterinary clinical immunology', 'mobilization body depot subcutaneous', 'capillary blood rain injection', 'peripheral hr', 'nitroblue tetrazolium superoxide anion insoluble purple formazan phagocytosis active polymorphonuclear cell', 'reduction measure superoxide anion generation', 'human medicine polymorphonuclear oxidative spectrophotometric measurement blood smear formazan blood smear', 'verterinary medicine test use clinical', 'test study bovine polymorphonuclear cell function', 'iodination test ability inorganic iodine trichloracetic acid precipitable form e protein bound', 'iodine suitable acceptor molecule tyrosine peroxide myeloperoxidase', 'system marked toxic activity', 'iodination procedure human', 'procedure determination iodine bound', 'various staphylococcus aureus listeria coli', 'laborious numerous', 'clinical domestic', 'extensive biochemical analysis antimicrobial mechanisms utilized veterinary clinical immunology', 'epinephrine stimulation increase peripheral blood lazy leukocyte syndrome man', 'nitroblue tetrazolium formazan healthy chronic granulomatous disease chgd', 'digestion ingestion index nitroblue tetrazolium normal healthy man laboratory bovine canine', 'index chgd severe chronic skin laboratory', 'similar chgd prior skin', 'preliminary phagocyte domestic description veterinary medicine', 'main different today various regulatory cytotoxic response hypersensitivity b immunoglobulin antibody null', 'normal immune response nonspecific specific transform replicate undergo blastogensis immunodeficient much degree stimulation', 'lymphocyte dysfunction lymphocyte immunosuppressive', 'vitro lymphocyte transformation test', 'time numerous test research clinical diagnosis immunodeficiency', 'many absolute normal abnormal available immunosuppression patient normal animal', 'topic human veterinary clinical immunology', 'principle patient blood preservative free heparin glass various serum patient healthy homologous fetal calf', 'incubation blastogenesis additional hr', 'washed amount determined scintillation counter', 'test quite complex numerous final result', 'complex meaningful evaluation immune status patient', '', 'blood heparin free syringe dish', 'calcium free necessary blood', 'recommend whole blood transformation clinical immunology suppression due serum suppressor number whole blood', 'autologous healthy homologous fetal calf serum', 'presence lymphocyte immunosuppressive patient sera distinguish mitogenesis suppression dysfunction se', 'concanavalin con broad cell mitogen phytohemagglutinin effector cell mitogen pokeweed mitogen pwm broad b cell mitogen', 'use optimal peak thymidine incorporation suboptimal mitogen response suboptimal', 'use specific bacterial viral small importance clinical immunology infection', 'hand use non specific functional status antigen respond', 'optimal timing maximal thymidine incorporation numerous', 'synthesis dna synthesis radiolabeled leucine', 'major speed low incidence contamination lack requirement serum', 'latter disadvantage modification detect presence serum suppressor', 'problem enumeration various domestic degree veterinary clinical immunology', 'suggest premature point discuss topic review', 'mean differentiation enumeration laboratory evaluation clinical', 'potential lymphocyte transformation test', 'test complex set various various useful', 'correct evaluation minute cpm unstimulated stimulation index cpm account', 'healthy range', 'mistake stimulation', 'reciprocal cpm cpm unstimulated cpm', 'stimulation stimulated background cpm', 'responsiveness numerous infectious lymphoreticular presence serum immunosuppressive patient serum response se mitogenicity due unidentified serum absence', 'preliminary infectious increase background cpm unstimulated recruitment cellular hematopoietic activity effector unspecified serum serum', 'developed serum response', 'specific target suppressor individual', 'viral chronic bacterial brucellosis response se regardless addition serum culture', 'lymphoproliferative enzootic leucosis substantial increase proliferation unstimulated infected blastogenesis healthy', 'preliminary lymphocyte transformation test clinical immunology incubation period infectious clinical stage lymphoproliferative infection fatal animal', 'hand responsiveness serum suppressor favorable short time elimination infection', 'autoimmune presence serum b presence rheumatoid factor c incomplete blood various', 'nuclear dna blood many systemic lupus erythematosus syndrome rheumatoid arthritis myositis', 'numerous determine specificity', 'fluorescent antibody test', 'many cryostat vero cell monkey kidney dog sera fig', '', 'test simple indirect immunofluorescent procedure', 'patient serum tissue cell tissue', 'incubation room temperature unbound protein cellular staining culture section igg fluorescein isothiocyanate', 'important factor specificity potency igg serum', 'pattern titer serum important', 'peripheral staining fig', 'typical active systemic lupus erythematosus sle', 'diffuse fig', 'remission sle rheumatoid arthritis', 'nucleolar present progessive systemic sclerosis', 'cell positive', 'positive rodent tissue', 'titer antibody laboratory', 'nuclear', 'peripheral cell number healthy laboratory', 'rheumatoid factor antibody ability react antigenic present fc portion immunoglobulin g igg molecule', 'serum rheumatoid arthritis', 'waaler co agglutination sheep arthritis', 'modification name test human veterinary diagnosis', 'test latex carrier immunoglobulin', 'rheumatoid factor', 'test rheumatoid factor prepared latex igg available use veterinary clinical immunology', 'domestic arthritis', 'topic', 'waaler test sheep rabbit dog hemolysin igg class various patient serum pre unsensitized sheep natural red blood', 'control unsensitized sheep natural carrier sheep serum', 'differential titer agglutination unsensitized sensitized sheep factor titer', 'fig', '', 'care transfer agglutinated microscopic slide agglutinate weak', 'differential titer positive rheumatoid factor', 'presence rheumatoid factor clinical pathognomic rheumatoid arthritis systemic lupus erythemotosus rheumatoid arthritis', 'hemolytic disease presence third component complement system patient red blood patient serum', 'incomplete agglutination', 'specific anti igg antiserum cell suspension', 'test presence various erythrocyte patient red blood serum numerous hemolytic', 'modification original antiglobulin coombs test diagnosis autoimmune', 'principle red blood blood edta ethylenediamine tetraacetate specific rabbit goat antiserum igg autoantibody', 'igg agglutination', 'suspension e', 'x', 'rabbit goat anti serum fold fold', 'degree agglutination glass microscope fig', '', 'critical point quality strength antiserum', 'care microscopic observation agglutinate weak', 'test presence detected patient serum blood group donor antibody', 'donor incomplete patient antibody anti igg serum direct test reveal presence incomplete', 'blood group determination cross necessity test hemolytic detectable antibody test veterinary medicine', 'special temperature regime blood sample detect cold secondary', 'cold able agglutinate complete antibody use anti igg sera', 'strength reaction strength antiserum concentration laboratory determine meaning various', 'prepared antisera laboratory healthy detectable agglutination hemolytic undetectable blood seldom', 'reciprocal dilution anti igg antiserum density blood', 'reagent contain prepared dog red blood negative anti igg sera give agglutination', 'autoimmune hemolytic anemia', 'hemolytic anemia anti igg serum agglutinate whereas drug hemolytic agglutinate', 'systemic lupus erythematosus anti igg antisera agglutination patient', 'hand presence cold anti agglutination patient blood', 'many mediated production patient tissue immune', 'renal skin direct immunofluorescence', 'donor healthy presence indirect immunofluorescence number autoimmune', 'direct procedure cryostat frozen tissue room temperature specific anti igg anti igm anti iga fluorescein isothiocyanate fitc stain', 'fluorescent microscope intensity pattern fig', '', 'indirect staining tissue section healthy patient serum rinsing specific fitc anti igg', 'anti igg antibody stain patient serum sample specific antibody tissue', '', 'adequate tissue optimal fluorescent antibody adequate flourescent microscopic equipment adequate good deal experience necessary satisfactory immunofluorescence study', 'detailed discussion interpretation scope overview', 'direct take account clinical stage development disease area sample collection control healthy animal', 'autoimmune glomerulonephritis due glomerular basement membrane common', 'glomerulonephritis immune complex granular epithelial side membrane', 'systemic lupus erythematosus linear granular direct antiglomerular', 'autoimmmune dermatologic direct immunoflorescent skin patient serum various skin', 'direct intercellular cement substance presence detectable indirect immunofluorescence typical pemphigus vulgaris', 'basement membrane dermal epidermal junction bullous pemphigoid disease basement membrane detectable', '', 'dermatitis herpetiformis intense basement membrane fitc anti iga fitc anti igg', 'skin basement fitc anti lgg systemic lupus erythematosus granular linear bullous pemphigoid disease', 'dermatitis herpetiformis systemic', 'direct indirect immunofluorescence dog skin diagnosis disease veterinary medicine', 'various body table', 'various sensitive ige man detect allergic igg', 'attempts isolate animal ige necessary specific antisera unsuccessful', 'prepared available detect ige detect type iv animal', 'type iv vivo intradermal administration various prepared', 'hypersensitivity ii iii immune special laboratory practical']"
833d88dda5c01de20c23c99d9e2c888b5b224846,anti hbv hbv activity dna replication hbv dna cinnamic acid acid fig activity cytotoxicity activity secretion chemical modification gene expression potent anti secretion hbsag ¼ mμ acute toxicity compound anti group cinnamoyl hbsag hbeag hbv gene hbv x ic ¼ luciferase reporter mμ si acid moiety activity caudatin activity hbv auriculatum bai bai shou c mhz cinnamoyl moiety co ltd compound caudatin compound single cytotoxicity compound drug resistance gibco iu good safety h c hbeag hbv hbeag secretion hbv hbv hbv promoter hbv unique hydroxyl group ic si iu ml male female mechanism action mg kg moiety anti non anti novel anti replication hbv replication ic secretion hbv si ¼ silica gel single dose toxicity mice unique antiviral ab foster abnormality body abnormality mice access water acetoxy group acid acid acid anhydrous acid ester acid food acid much acid presence acid quinic action hbv action luciferase active compound active derivative activity cinnamoyl activity comparing activity decrease activity fig activity hbsag activity host activity inhibited activity luciferase activity nitro activity ortho activity para activity plate activity series activity skeleton activity viral activity vivo additive good adefovir dipivoxil administration abnormality administration committee adv entecavir ae c ae standard aesar j affect hbv,"['hepatitis b virus hbv infection global health problem severe liver failure fibrosis cirrhosis hepatocellular carcinoma hcc', 'hbv lifelong', 'immunization therapy effective measure new succumb infection sequence due vaccine failure', 'interferona polyethylene glycol interferon anti hbv application low rate serious side myalgia nausea headache etc', '', 'nucleoside adefovir dipivoxil adv entecavir telbivudine ldt tenofovir df tdf fda hbv treatment', 'drug resistance high recurrence important clinical issue single target', 'new viral suppression virologic clearance drug resistance fascinating', 'novel hbv unique antiviral target mechanism', 'natural simple functionalgroup many novel anti hbv unique antiviral', 'example helioxanthin shrub taiwania unique hbv promoter activity viral gene expression replication', 'chemical modification active derivative fig', '', 'oxymatrine fig', 'anti hbv activity host heat stress cognate expression', 'previous study alisma potent anti hbv activity series high activity fig', 'chemical modification', 'search potential anti hbv study fig', 'cynanchum auriculatum bai shou chinese activity secretion hbsag hbv dna replication ic si ¼ mm si ¼', 'caudatin prospective anti hcc drug mechanism cell proliferation cell apoptosis', 'caudatin novel agent chemical modification', 'cinnamic acid much attention biology medicine antiviral antiatherogenic antitumor antituberculosis antioxidant antibacterial', 'example cinnamic acid fig', 'hiv pseudovirus cholesteryl cimmamic acid fig', 'anti poliovirus type activity', 'caffeic acid acid fig', 'chlorogenic acid ester acid quinic acid fig', 'potent anti hbv activity vivo vitro molecular cinnamic acid moiety potent anti hbv activity', 'cinnamic acid food additive good safety', 'molecular synergistic activity', 'combination caudatin cinnamic novel anti hbv anticipated anti hbv activity decrease cytotoxicity', 'herein chemical modification hbv inhibitory molecular hybridization', 'active compound mechanism action hbv x acute toxicity mice', 'reaction cinnamic presence n n dicyclohexylcarbodiimide dcc dmap scheme', 'exception compound caudatin acid presence diisopropyl azodicarboxylate diad triphenylphosphine tpp scheme', 'introduction fluorine useful physical metabolic disposition drug various fluorinated cinnamic react caudatin', 'table identified spectroscopic h ms', 'comparison caudatin mono cinnamoyl', 'caudatin anti hbv activity secretion hbsag hbeag hbv dna replication hepg', 'activity cytotoxicity table', 'derivative effective inhibiting hbsag hbeag secretion hbv dna replication caudatin ic si', 'methyl group cinnamoyl moiety anti hbv activity comparing compound caudatin', 'introduction formyl group moiety compound anti hbv activity secretion hbsag hbeag hbv dna replication cytotoxicity hydroxyl group cinnamoyl activity cytotoxicity compound', 'activity cytotoxicity compound hydroxy cinnamoyl alkoxyl etoe eoch oe', 'cinnamoyl caudatin activity secretion hbsag ic ¼ mμ si hbeag ic ¼ mμ si dna replication ic ¼ mμ si', 'anti hbv activity cytotoxicity caudatin acetoxy group cinnamic acid moiety', 'introduction halogen anti hbv activity', 'fluorine cytotoxicity cc ¼ mμ cc mμ increase', 'cf group potent activity hbsag secretion hbv dna replication weaker hbeag secretion co existence cf anti hbv activity', 'anti hbv activity nitro group cinnamoyl group cytotoxicity', 'moiety anti hbv activity caudatin', 'vs alkoxy vs vs f vs cl vs br vs meta activity para', 'contrary activity ortho para trifluoromethyl nitro vs group', 'small steric clash electron density hydrogen capacity different activity caudatin', 'due good activity cinnamoyl moiety caudatin', 'anti hbv activity', 'free hydroxyl group essential anti hbv activity skeleton crucial role anti hbv activity', 'elucidate mechanism action luciferase reporter gene determine hbv x enii', 'result compound mμ luciferase reporter fig', 'viability h', 'compound transcript activity hbv promoter xp hbv enhancer eni control', 'hbv control important replication hbv', 'xp transcription small kb mrna sequence hbv x protein hbx important role hbv transcription replication', 'hbv element crucial effect overall liver specific regulation hbv gene expression', 'compound anti hbv activity hbv', 'minimal xp sequence end eni compound influence xp eni region', 'compound effect region', 'analogs suppress hbv replication hbv polymerase premature dna chain affect hbv gene expression', 'compound anti hbv hbv gene expression hbv dna polymerase different', 'safety compound acute toxicity mice', 'healthy mice compound single dose mg kg', 'survival abnormality mice administration abnormality body table mice observation period', 'compound good safety vivo value mg oral route', 'summary design synthesis series non anti hbv cinnamic caudatin', 'potent anti hbv activity inhibited hbv dna replication preliminary mechanism study compound antivirus hbv hbv', 'low cytotoxicity acute toxicity compound novel non anti hbv drug candidate unique', 'nuclear magnetic resonance nmr spectra bruker h c mhz h c mhz chemical tms internal standard bruker germany ms vg manchester uk api qstar pulsar ab foster city usa mass chromatography cc silica gel mesh qingdao makall group ltd qingdao china', 'thin layer chromatography tlc silica gel', 'caudatin c auriculatum bai shou wu purity', 'cinnamic alfa aesar j k scientific ltd organic analytical reagent grade tianjin chemical reagent co ltd solution mmol dmap proper cinnamic acid anhydrous ch cl ml hz promoter core x nt nt eni enii upstream luciferase gene', 'hepg reporter vector dish lipofectamineô manufacturer', 'hepg constant amount vector firefly luciferase basic control phrl cmv vector renilla luciferase internal control', 'h transfection', 'compound medium similar antiviral assay', 'represent average ae standard deviation', 'transcriptional activity luciferase activity plate luminometer analytical luciferase reporter system promega', 'hep g medium gibco fetal calf serum gibco mg ml gibco iu ml penicillin gibco iu ml streptomycin gibco c moist co', 'week fresh medium day', 'male female chengdu dashuo biotechnology co ltd chengdu china animal certificate', 'license', 'scxk chuan', 'male female', 'compound single dose blank group volume physiological saline mg kg', 'free access water food stainless room temperature ae c light dark cycle', 'mouse survival body recorded posttreatment', 'protocol city laboratory animal administration committee care use laboratory']"
bd5105c9b33818fbf0292a52805405aa6576c41e,et al complex type cell surface high mannose p dol protein glycosylation endoplasmic reticulum olofsson al serafini cessi g protein plasma membrane schwarz datema intracellular transport n methyl infectious virus inhibition protein l deoxynojirimycin sindbis virus influenza virus man p san juan see section amino acid campadelli fiume cell free cessi et ct mannosidase gdp man glycoprotein processing golgi mannosidase mutant cell plague virus potent inhibitor terminal glycosylation udp glcnac virus formation al al cell line fiume serafini fowl plague gdp dgic gibson al host cell hybrid type mannosidase ii methyl l n glycosylation olden et surface expression al olofsson datema al env protein glcnac transferase glucosidase ii ii fig methyl deoxynojirimycin mode action personal communication presence tunicamycin processing n proteolytic cleavage schmidt et synthesis lipid cell culture datema et gic p inhibition glycosylation johnson spear man dol membrane fraction n complex rat liver roizman furlong romero et synthesis n transfer protein al romero al see chemical synthesis chick embryo cleavage ha different different dol formation dol p dolichol diphosphate dolichol pathway furlong roizman galactosyl transferase glc p immune response polypeptide chain ric r synthesis complex temperature sensitive uridine diphosphate viral membrane virus specific active site al hsieh bernacki korytnyk,"['increase number biological role last use f glycosylation', 'review discuss', 'context discussion structure biosynthesis section', 'discussion intracellular traffic biosynthesis role', 'glycosylation pre lipid carrier dolichol diphosphate', 'dolichol pathway section', 'rise non underglycosylated', 'transfer protein mature', 'inhibition glycosidase rise immature section', 'biological numerous', 'certain lysosomal', 'schwarz datema olden et al olden et al kornfeld von figura hasilik', 'review biological infected section useful delineate several membrane biological role protein glycosylation', 'turn elucidation viral development exert antiviral section', '', 'structure oligosaccharide viral structure covalent linkage oligosaccharide backbone kornfeld montreuil sharon lis', 'first class asparagine n n n acetylglucosamine amide nitrogen asparagine', 'second class n acetylgalactosamine serine threonine fig', '', 'latter mucin type abundant mucin', 'invariant chain inner', '', 'inner sugar rise wide variety', 'derive common biosynthetic precursor see', '', 'high mannose mannose n acetylglucosamine termini heptasaccharide fig', '', 'ii complex type mannosyl ii fig', 'number outer', 'outer trisaccharide', 'substitution pattern lead bi tri tetra penta antennary complex type', 'addition innermost glcnac residue asparagine residue', 'example triantennary structure fig', '', 'iii hybrid type present oligo mannosidic complextype', '', 'certain embryonic poly lactosamine oligosaccharide e', 'complex type lactosamine et al', 'poly lactosamine large muramatsu et al jfirnefelt et al', 'viral embryonic etchison al', '', 'carbohydrate heterogeneous structure', 'core iva fig', 'simple', '', 'viral simplex virus olofsson al olofsson al mouse hepatitis virus corona virus niemann klenk al vaccinia virus shida', 'present viral viral contain glycoprotein gicnac asn mouse hepatitis virus niemann klenk al', 'structure major', 'niemann et al', 'final several specific structural mind viral different dependent cell type virus', 'complex type hybrid degree degree sialylation glycosidic peripheral lis kornfeld', 'extent variation structure oligosaccharides viral', 'necessary sufficient condition glycosylation occurrence asparagine tripeptide sequence asn x ser thr marshall kornfeld', 'additional requirement exposure tripeptide sequence special secondary structure accessibility peptide transferase', 'x x ser thr amino acid proline forbidden unfavourable conformation discussion montreuil', 'role polypeptide structure biosynthesis individual glycosylation site particular protein specific see', 'specific polypeptide glycolysation', 'x ser ala x ala thr thr val pro thr takayashu al acceptor core galnac residue hydroxy amino ser thr', 'proposal baenziger', 'accessibility hydroxy amino acid enzyme order structural chain short characteristic amino acid sequence critical galnac residue kessler et al mellis baenziger', 'biosynthesis n oligosaccharides transfer sugar residue sugar donor hydroxyl group acceptor substrate sharon lis kornfeld', 'sugar nucleotide isoprenoid alcohol table', 'sugar galactosyl', 'glycosyl specific acceptor substrate anomeric linkage', 'fig', 'different transferase ii beyer al schachter', 'general hypothesis different enzyme synthesis glycosidic linkage linkage enzyme hypothesis cf', 'roseman', 'subject detail kornfeld ivatt schwarz datema kornfeld', 'biosynthesis n l highmannose membrane bound lipid dolichol diphosphate transfer protein nascent polypeptide chain processing protein oligosaccharide generate complex type hybridtype high mannose et al schachter kornfeld', 'pathway immediate precursor protein glycosylation dolichol fig', '', 'membrane bound rough endoplasmic reticulum lennarz', 'transfer gicnac p udp glcnac donor man gdp man man dol glc udp gic glc p dol glcnac udp gicnac galnac udp galnac gal udp gal fuc gdp fuc neuac cmp neuac note biosynthesis sugar sharon lis', 'staneloni al parodi leloir', 'glucosylation lipid oligosaccharide efficient transfer protein et al staneloni al trimble et al peripheral mannose man p dol transfer protein spiro al', 'example man dol formation intact protein chapman al chapman al turco rearick et al', 'transfer protein high mannose e quesada allue viral', 'schwarz datema', 'transfer protein glucose glucosidase glucosidase ii fig', 'endoplasmic reticulum kornfeld', 'reaction important role post translational fate', 'example deglucosylation necessary efficient movement apparatus see section', 'endoplasmic reticulum exit endoplasmic reticulum mannose trimming endoplasmic reticulum give kabcenell atkinson', 'high mannose endoplasmic reticulum prevent extensive mannose parodi et al', 'golgi bound mannosidase number mannose rise various highmannose mature', 'processing complex hybrid type golgi apparatus', 'removal final non core mannose', 'structure ii fig', 'prior addition acetylglucosamine gicnac transferase fig', 'beyer al schachter kornfeld', 'intermediate fig', 'precursor hybrid type addition glcnac fl mannose glcnac transferase iii core mannosidase ii', 'compound action ct mannosidase ii fig', 'substrate glcnac transferase ii iii fucosyl transferase transfer fuc asn glcnac', 'fucosyl transferase absolute requirement r gicnac gicnac asn fig', '', 'initial pathway', 'text', '', 'fig', '', 'mannose completion high mannose mature glycoprotein', 'r', 'branch', 'fucogyl transferase glcnac glcnac transferase addition gal galactosyl transferase glcnac branch schachter beyer al', 'simple biantennary complex type oligosaccharide stepwise addition sialic acid example fig', '', 'pathway branch specificity galactosyl e', 'glycosyl branch contrast branch orientation montreuil', 'galactosylation branch become biantennary oligosaccharide structure ii fig', 'poor substrate glcnactransferase iv triantennary et al narasimhan al blanken et al joziasse et al joziasse et al', 'sequential action glycosyl high substrate specificity competition common substrate ultimate structure complex type', '', 'extent processing', 'particular cell structure genetic control sharon lis', 'addition relative metabolic control', 'metabolic state host cell different sindbis virus glycoprotein l grown atkinson', 'glucose starvation energy depeletion affect formation lipid kaluza turco baumann jahreis spiro al griffin al effect dependent cell type cell density', 'example formation accumulation protein', 'clear cellular machinery produce wide variety different extent processing polypeptide chain cellular processing', 'primary structure polypeptide chain important determinant carbohydrate structure viral individual glycosylation selectivity high mannose complex type klenk hsieh et al hsieh al savvidon al hsieh mayne al pollack atkinson', 'physical accessibility fact extent processing virus site accessible processdd complex type al', 'intracellular pathway biosynthesis viral final rindler al pfeiffer al see', 'addition certain glycosyl particular golgi rothman goldberg tartakoff vassali schachter al gabel bergman dunphy rothman', 'passage golgi system distinct cis enter golgi medial golgi', 'sequential processing n different kornfeld', 'example galactosyl transferase berger strous berger region glcnac transferase dunphy al medial region', 'final structure oligosaccharide competition specific glycosyl compartmental organization golgi stack certain glycosyl distinct', 'question extensive compartmentalisation glycosylation pathway sugar available glycosyl', 'example cmp cytoplasm van den eijnden luminal side golgi kornfeld', 'rat liver golgi cmp neuac golgi membrane translocation equimolar exchange cmp et al capasso hirschberg', 'similar golgi sugar udp gal gdp fuc', 'degradation nucleoside diphosphatase thiamine pyrophosphatase golgi enzyme brendan fleischer translocation antiport', 'similar translocation endoplasmic reticulum lipid synthesis investigation', 'udp glcnac membrane endoplasmic reticulum perez hirschberg', 'transfer gicnac dolichol cytoplasmic endoplasmic reticulum cf', 'kornfeld discussion mechanism translocation udp glcnac', 'dolichol luminal face luminal face endoplasmic reticulum lipid oligosaccharide donor protein glycosylation bergman kuehl', 'udp glc gdp man known', 'interest vitamin deficiency accumulation rosso al synthesis require man p dol', 'retinol retinol mannosylphosphate protein glycosylation bernard al example translocation mechanism man frot coutaz al proposal wide acceptance stoll al', 'involvement dolichol', 'addition galnac udp galnac polypeptide formation successive individual oligosaccharide', 'peptide signal addition understood', 'biosynthesis golgi concomitant processing n kim al ko raghupathy hanover al', 'accord monensin', 'simplex virus presence monensin devoid johnson spear', 'galnac transferase bhk immature viral complex type initial residue cessi et al', 'possible initial galnac cis golgi remainder assembly oglycosyl place medial region golgi addition terminal', 'oligosaccharide synthesis galnac gal density gradient centrifugation terminal cis elhammer kornfeld roth', 'core galnac cis golgi peripheral galnac', 'structural variability glycosyl similar processing n', 'glycosyl transferase specificity sugar acceptor e', 'enzyme type glycosidic linkage roseman', 'information sequence monosaccharide final oligosaccharide genome specific sugar suitable acceptor subsequent transferase', 'addition compartmental organization golgi', 'evident introduction new glycosyl transferase early biosynthesis oligosaccharides formation acceptor subsequent', 'virus enzyme structure', 'blood group activity submaxillary mucin detail cf', 'beyer al review', 'biosynthesis characterized', 'scheme assembly fig', '', 'final structure porcine submaxillary mucin part figure', 'galnac r thr final structure oligosaccharlde fig', '', 'scheme group reactive oligosaccharide porcine submaxillary mucin', 'pathway formation indicated series thin', 'thick glycosyl transferase kinetic intracellular important structure', 'bar denote forbidden text', 'figure drawn roseman ivatt', 'figure evident biosynthetic dead end', 'inaccessible processing isolated subfraction mucin', 'addition galnac sialyl transferase galactosyl transferase acceptor gainac', 'fact neuac galnac reaction acceptable galactosyl transferase reaction b reaction dead end product neuac galnac protein', 'appearance dead end competition', 'several evidence majority way produce structure roseman', 'evidence kinetic relative preferred enzymic indicated broad', 'figure clear none', 'reaction vitro submaxillary gland glycosyl et al fact mucin carlson ivatt', 'ii several non optimal substrate', 'example disaccharide gal galnac ser thr substrate trisaccharide b fucosyl transferase', 'reaction f poor substrate sialyl transferase reaction h occur', 'circumstantial evidence glycosyl formation pentasaccharide specific order', 'peptide importance glycosylation glycosylation place different intracellular number structure final', 'virtue antiviral antibacterial datema', 'lipid dependent transfer sugar sugar phosphate glycosylation envelope bacterial peptidoglycan synthesis', 'subsequent action biological glycosylation large extent use virus', 'fact many biosynthesis virus infected model', 'viral protein glycosylation', 'several cell free et al', 'none purified form contrast sadler et al action use crude cell reaction', '', 'virus', 'ultimate substrate dolichol pathway protein acceptor virus product', 'antiviral glycosylation therefore consequence special particular viral high rate viral glycoprotein biosynthesis schwarz datema', 'way preferential antiviral effect specific host cell protein glycosylation', 'extensive discussion see section', 'section mode action sugar tunicamycin', 'dolichol cycle glycoconjugate synthesis briefly', 'glucosamine gicn inhibit synthesis lipid schwarz datema rasmussen', 'action', 'sugar specific pathway', 'sugar protein glycosylation metabolic schwarz datema', 'exert inhibition dolichol cycle sugar notable exception glucosamine', 'metabolism sugar different different anticellular antiviral thereof dependent', 'glycolytic pathway scholtissek', 'several table', 'metabolic profile proportion type dependent', 'nucleotide infected sugar certain decreased viral rna protein synthesis scholtissek keppler et al', 'protein nucleotide pool imbalance discussion related scholtissek', 'inhibition protein glycosylation dglc formation gdp dglc schmidt et al', 'gdp dgic udp dglc dglc schmidt et al', 'result dglc analog glucose', 'yeast chick embryo udp gdp datema', 'yeast mammalian', 'formation decrease pool size physiological nucleotide man udp glcnac schmidt al schwarz al datema al diminuation pool size udp glc observed lead inhibition protein glycosylation schwarz datema koch et al', 'guanosine diphosphate uridine diphosphate datema schwarz datema al datema al inhibit certain pathway', 'several guanosine diphosphate dglc contribute inhibition glycosylation uridine diphosphate', 'mannose anti influenza virus glucose al schmidt et al', 'antiviral fact inhibition viral protein glycosylation due block assembly datema schwarz', 'chemical synthesis udp dgic gdp dgic possible study detail mechanism inhibition protein glycosylation table', 'cell free formation glc p dol man p dol glcnac e pp endogenous dol p exogenous sugar gdp dgic dol p dglc p dol mcdowell al letoublon et al', 'lipid inhibitory cycle dglc dglc l p udp dgic gdp dglc acid dglc dglc p dol udp dglc gdp dglc dglc p dol glcnac udp gicnac gicn gicn intact occurrence', 'presence gdp dgic datema schwarz mcdowell al due interference trisaccharide lipid formation reaction b fig', '', 'gdp dgic trisaccharide dead end assembly', '', 'similar situation', '', 'fact small lipid dglc protein', 'gdp dgic alternative substrate mannosyl man', 'resistance inhibition glycosylation dglc increased pool gdp man relative gdp dgic dglc resistant bhk cell line schwarz et al', 'decrease pool size gdp man imp dehydrogenase tiazofurin phenolic acid formation lipid sokoloski sartorelli', 'dolichol diphosphate tri', 'formation gdp man fig', '', 'likely inhibition mannosyl transferase inhibition lipid intact', 'inhibition protein glycosylation due inhibition synthesis lipid', 'clear inhibition inhibit free incorporation man gdp man lipid', 'inhibit synthesis glc p dol man p dol dolichol diphosphate cell free', 'dolichol phosphate datema et al', 'surprising formation gic p dol man p dol', 'inhibition glc p dol formation decreased pool size udp gic', 'pool gdp man udp glcnac dol p inhibit transfer glc man dol p lipid', 'energy charge decrease man dol formation incubation', 'way dilemma e', 'source inhibition man p dol lipid oligosaccharide formation blocked formation retinol phosphate mannose gdp man exogenous retinol phosphate rat liver', 'evidence p prove role retinol phosphate formation man p dol', 'inhibition formation retinolphosphate mannose lead inhibition man p dol formation', 'mode action', 'udp dglc synthesis glc p dol therefore glucosylation mang glcnac pp dol', 'enzyme dolichol phosphate udp glc glucosyl transferase datema al mcdowell al none uridine diphosphate alternative substrate enzyme table', 'fact algal chick hamster group udp gic crucial activity glucosyl transferase group man man essential mannosyl transferase schwarz datema mcdowell al datema et al', 'inhibition gic p dol formation uridine diphosphate dglc contribute inhibition protein glycosylation chick sugar', 'reason major block sugar involvement gic p dol', 'reason large pool gic p dol', 'incorporation dglc p dol glc man fig', 'cell free inhibition glycosylation intact', 'dglc presence influenza virus replication viral small lipid protein schwarz datema', 'glycosylation viral hemagglutinin datema al synthesis require man p dol fig', '', 'glucose analog glucosamine glcn cause several metabolic atp scholtissek decrease rate glycolysis inhibition protein glycosylation induction system formation excessive udp glcnac udp galnac schwarz datema koch al al', 'related glucosamine cytotoxic antiviral', 'uridylate inhibition rna synthesis inhibition virus replication', 'glucose inhibition viral rna synthesis scholtissek glucosamine antiviral effect inhibition protein glycosylation due interference oligosaccharidelipid schwarz', 'inhibition lipid assembly glucosamine reversible amino sugar koch et al', 'datema schwarz rise underglycosylated concentration drug horisberger al', 'location block oligosaccharide concentrationdependent different different', 'inhibition lipid synthesis glcn addition local anaesthetic lidocaine procaine', 'membrane active cytotoxicity amino sugar due modification membrane ultrastructure friedman skehan effect rapid inhibition protein glycosylation al', 'clear membrane reversible inhibition protein glycosylation study ultrastructural lead inhibition protein glycosylation al', 'gicn inhibit oligosaccharide lipid synthesis crude cell free membrane fraction gicn', 'level product high pan elbein', 'oligosaccharidelipid gdp man man dol gic p dol present glcn', 'fact date evidence available prime target glcn inhibition dolichol pathway', 'reason multitude biological amines structure activity relationship amino antiviral', 'p biosynthesis lipid free orderly sequential addition mannose minor certain', 'lipid mannosamine pan elbein', 'heptasaccharide lipid conventional intermediate dolichol pathway structure fig', 'structure similar identical mansglcnac z intermediate processing pathway ii fig', '', 'sugar nucleotide mannosamine amine metabolism', 'interest furthermore observation presence mannosamine', 'synthesis lipid result additional evidence lipid intact', 'question context truncated certain certain example concomitant decrease rate intracellular transport', 'amino biological protein glycosylation', 'see section', 'specific inhibition tein processing formation dolichol', 'inhibition lipid formation inhibition glucosidase compound romero et al', 'tunicamycin ii fig', 'family tamura', 'characterized tamura co uracil cl aminodeoxy dialdose tunicamine anomeric carbon gicnac amino group chain fatty', 'mixture structure fatty acid', 'total synthesis tunicamycin suami et al', 'tunicamycin udp gicnac analog thereof uridine diphosphate ester polyprenol phosphate elbein', 'first step dolichol pathway udp glcnac dol p gicnac pp doi ump tkacz lampen takatsuki et al lehle tanner', 'tunicamycin potent specific glcnac pp dol elbein lipid formation animal plant fungal', 'specificity course ii absolute inhibited high antibiotic', 'addition tunicamycin treatment increase udp glcnac pool alter ultra structure endoplasmic reticulum nuclear al', 'antiviral anticellular cytotoxic due inhibition protein glycosylation', 'interest tunicamycin inhibit formation udp glcnac gicnac pp dol similar transfer gicnac lehle tanner carrasco vazquez', 'fact action tunicamycin streptovirudin p transferase k tunicamycin x reversible difficulty high substrate et al heifetz et al', 'major tunicamycin different biological', 'example amount inhibit protein glycosylation et al', 'homologue fattyacid side chain active glycosylation', 'drug high selective toxicity duksin al seiberg duksin', 'activity penetration plasma membrane membrane endoplasmic reticulum glcnac p transferase duksin', 'close relative streptovirudin et al therapeutic effect trypanosoma resp', 'influenza', 'drug toxic example impair postnatal development cerebellum al', 'several cell free diumycin showdomycin bacitracin tsushimycin', 'action review see', 'dolichol phosphate schwarz datema hemming', 'virus', 'experimental free certain schwarz datema elbein', 'several sugar simple fuorinated biosynthesis pathway', 'antiviral investigated bernacki korytnyk schwarz datema reutter bauer', 'synthetic sugar nucleoside portion diphosphate bridge little attention eukaryotic prokaryotic shibaev', 'little anything structural base ribosemoiety interaction glycosyl bernacki korytnyk', 'exert inhibition intact sugar plasma membrane inhibit terminal glycosylation golgi membrane', 'udp glucose analog iii fig', 'former property glycosylation viral al', 'inhibitor virus specific contrary synthetic approach novel glycosylation', 'metabolism formation fluorouridine mammalian literature therein', 'hepatoma free metabolic pattern fudp analogous udp', 'addition fudp gic fudp gicnac formation gic p dol', 'galactosamine § fudp gicn holstege al lipid saccharide formation formation gicn p dol fraudulent sugar formation physiological dolichol al', 'underline potential nucleoside analogs glycosylation', 'bis amidinohydrazone derivative ih benz f structure fig', 'selective activity et al glycosylation uninfected sindbis virus paramyxovirus serafini cessi campadelli fiume', 'drug attachment high mannose', 'example virus specific glycosylation inhibitor', 'subsequent genetic virus specific block mutant resistant drug tognon', 'mode action drug sugar nucleotide metabolism theaipid', 'hsv number metabolism', '§for metabolic decker keppler et al', 'potential chemotherapeutic fig', 'marcellomycin cell differentiation inhibit protein glycosylation formation dolichol morin sartorelli', 'block pathway glycosylation inhibitor atropine alarcon et al', 'amino acid analog antagonist l glutamine inhibit protein glycosylation conversion fructose glucosamine greene pratt', 'hand threonine analog fl hydroxynorvaline glycosylation acceptor asn residue hortin boime', 'likely transfer dolichol protein fl hydroxynorvaline thr tripeptide sequence asn x thr hortin noime docherty aronson', 'cellfree system glycosylation protein synthesis dl threo fl fluoroasparagine asn glycosylation incorporation analog protein hortin et al', 'amino acid hydroxynorvaline dl threo fluoro asparagine therefore prevent protein glycosylation lipid', 'extension work free system hexapeptide epoxyethylglycine ala val ome structure iii fig', 'oligosaccharide transferase bause', 'inhibition active catalysis suicide mechanism', 'transfer dolichol diphosphate protein see section', 'extent different different different particular pollack atkinson', 'consequence processing particular protein ¶ different time life different pathway generation diversity structure time', 'turn different particular side chain different life section', 'inhibition glycoprotein processing immature', 'early depend activity inhibition glycoprotein processing', 'different intracellular section disruption intracellular traffic example inhibition processing', 'glycosyl potential processing', 'section address processing', 'glycosidase', 'briefly', 'mutant cell interfere glycoprotein processing', 'review stanley', 'viral intracellular transport cell ¶the processing pathway valid membrane viral envelope belong', 'lysosomal subject processing particular described', 'review kornfeld kornfeld', 'secretory pathway equip oligosaccharide', 'glycosidase endoplasmic reticulum golgi system elbein', 'structural point view see nojirimycin n methyl l deoxynojirimycin manno l deoxynojirimycin b indolizidine castanospermine', 'substance chemical synthesis myo inositol covalent inhibitor lotz legler', 'reaction bromoconduritol yeast ct glucosidase histidine', 'reaction epoxide active site dehydrobromination inhibitor legler lotz legler', 'bromoconduritol glucose rat liver glucosidase preparation', 'hence presence bromoconduritol last glucose datema et al', 'intact inhibited synthesis n complex type oligosaccharide high composition glclmant gglcnac', 'inhibited synthesis complex type release innermost glucose residue precursor complex type hybrid type highmannose al', 'drug glucosidase ii cell free system intact glc residue glc presence bromoconduritol cf', 'fig', '', 'nigerose competitive inhibitor enzyme active site glucose', 'bromoconduritol therefore release glucose group catalytic site enzyme', 'bromoconduritol release glc glcmanxglcnac r datema al substrate bromoconduritol enzyme', 'result complete glucose necessary mannosetrimming composition x fig', 'et al', 'intact fact glucose', 'antibiotic et al', 'nature inouye al analog nitrogen atom pyranose ring', 'nojirimycin mammalian origin potent inhibitor latter niwa reese', 'amino sugar competitive inhibitor', 'synthesis biantennary complex type n oligosaccharide processing', 'n methyl l deoxynojirimycin cas castanospermine manno l deoxynojirimycin ii glcnac man x gal • neuac', 'mdn cas intact accumulation', 'intact sglcnac', 'small intestinal sucrase hanozet lysosomal glucosidase human liver', 'source enzyme whole human liver homogenate hydrolysis glucose affect release fl glucose al', 'mammalian fl', 'microsomal glucosidase preparation rat liver substrate nojirimycin glucose release', 'calf liver source enzyme hydrolysis inhibition hettkamp et al', 'nojirimycin potent inhibitor processing glucosidase', 'intact mm drastic change electrophoretic mobility igd igm hybridoma', 'treated presence nojirimycin n glucosamine al', 'nojirimycin glucosidaseinhibitor', 'influenza fowl plague virus chick embryo incorporation', 'hence nojirimycin specific inhibitor processing', 'demonstrate necessary determine mode action assess usefulness inhibitor', '', 'reduction inouye al isolated several bacillus tree', 'several truscheit al see ganem therein', 'parent compound potent inhibitor several intestinal sucrase maltase isomaltase glucoamylase schmidt et al', 'contrary nojirimycin weak inhibitor fl mammalian origin niwa al legler jfilich', 'nojirimycin l deoxynojirimycin competitive small intestinal sucrase', 'enzyme hanozet et al active center enzyme form transition state catalysis', 'potent inhibitor trimming', 'inhibition glucosidase glucosidase ii saunier al', 'reverse hold liver inhibition glucosidase tam whereas drug glucosidase ii extent hettkamp et al', 'inhibition glucosidase calf pancreas et al release glucose gi mangglcnac rat liver microsomal preparation', 'intact synthesis n complex type et al gross et high mannose composition romero et al', 'mixture glucose', 'intact action glucosidase ii', 'biological inhibition part general inhibition synthesis lipid specific inhibition intestinal epithelial et al', 'intestinal inhibition inhibitor medium g l', 'role carbohydrate light multiple sugar analog romero et al', 'methylation murai et al', 'presence methyl group important biological', 'certain deoxynojirimycin inhibit synthesis lipid al', 'inhibition n methyl l deoxynojirimycin romero al', 'second n methyl l deoxynojirimycin potent inhibitor glucosidase cell free et al hettkamp al saunier b jelinek unpublished work', 'intact synthesis n complex type high mannose composition romero et al romero', 'direct comparison deoxynojirimycin glycoprotein biosynthesis intestinal epithelial culture mm n derivative necessary inhibit synthesis complex type effect', 'presence n methyl l deoxynojirimycin glucose et al', 'hence intact n methyl l deoxynojirimycin complex type synthesis action glucosidase', '', 'isolated castanospermum australe hohenschutz et al l', 'chemical synthesis glucose granem', 'cause severe gastrointestinal irritation death hohenschutz al', 'vivo castanospermine neutral acidic ct brain kidney spleen unchanged fl galactosidase fl n acetylhexosaminidase saul et al', 'castanospermine potent inhibitor fl glucosidase fl glucocerebrosidase lysosomal glucosidase', 'inhibition fl glucosidase mixed type castanospermine enzyme reversible', 'castanospermine high mannose glucose pan al', 'fact biological castanospermine n methyl l deoxynojirimycin similar', 'example viral stable presence drug proteolytic cleavage polyprotein precursor sindbis virus drug virus bhk section', 'human hepatoma secretion certain g cqantitrypsin ceruloplasmin drug secretion iii sasak et al', 'similar differential effect secretion', 'decrease activity culture fungus inhibition secretion due secretion active enzyme elbein al', 'castanospermine receptor uptake mannose et al possible explanation', 'pyrrolidine alkaloid analog fructofuranose', 'isolated derris elliptica welter et al sericeus al', 'chemical synthesis card hitz', 'dmdp potent inhibitor fl et card hitz', 'concentration inhibition g flglucosidase et al', 'inhibition competitive dependent ph manner form dmdp active inhibitor card hitz', 'influenza virus mdck addition dmdp synthesis n complex type', 'analysis presence high mannose composition dmdp glucosidase al', 'intestinal epithelial culture dmdp synthesis complex type mixture high mannose type', 'small increase relative untreated', 'primary complex type synthesis inhibition al', 'difference mode action dmdp influenza mdck uninfected intestinal epithelial unclear elucidated', '', 'indolizidine alkaloid swainsona et al locoweed stragalus lentiginosus molyneux octonia legurninicola schneider et al', 'chemical synthesis glucose ali al fleet al', 'cell free system swainsonine reversible active site inhibitor lysosomal mannosidase al', 'golgi ct mannosidase ii tulsiani al reaction reversible lysosomal enzyme inhibition competitive tm tulsiani et al', 'swaisonine activity golgi mannosidase ii contrary expectation increase tissue lysosomal mannosidase tulsiani touster tulsiani et al', 'swainsonine agent responsible disease livestock lysosomal ct mannosidosis e g', 'pleomorphic accumulation free certain neurological et al al molyneux', 'quantitative analysis urine locoweed sheep method detect disease early al', 'addition phenocopy genetic mannosidosis swainsonine fungus metarhizium anisopliae act immunomodulator vivo kino al see section', 'latter effect due compound glycoprotein processing', 'intact inhibited synthesis complex type et al hybrid type tulsiani touster', 'mode action free system drug biosynthesis complex type golgi mannosidase ii tu lsiani al fig', '', 'presence swainsonine viral hybrid complextype particle release see section', 'secretion antitrypsin gross et al fibronectin arumugham tanzer antichymotrypsin transferrin complement lodish kong igd igm drug', 'fact human hepatoma intracellular transport secretion transferrin ceruloplasmin rantitrypsin secretion yeo al discussion phenomenon', 'line cell surface expression fms et al erb b schmidt et oncogene section histocompatibility hla b c hla dr al insulin insulin growth factor al normal', 'swainsonine receptor uptake degradation arumugham tanzer', 'inhibition receptor uptake mannose permanent occupation receptor mannose membrane presence swainsonine chung al', 'explanation similar uptake system processing inhibited castanospermine', 'dmm analog product present lonchocarpus sericeus lonchocarpus costaricensis isolated al', 'synthesized several schedel see ganem therein', 'fl reaction product mannose inhibition marked inhibition legler jiilich', 'cellfree system yeast dmm enzyme mangglcnac effect mannosidase action jelinek al', 'competitive inhibitor rat liver golgi ct mannosidase sensitive drug inhibition dmm lysosomal mannosidase inhibit rough endoplasmic reticulum soluble mannosidase bischoff kornfeld', 'observation analog mannosidase inhibitor reaction similar cationic reaction intermediate lalrgerie et al fuhrmann et al', 'intact synthesis n complextype accumulation composition manv gglcnac high proportion mangglcnac fuhrmann al al romero al romero', 'hence intact golgi mannosidase activity', 'n methyl l deoxynojirimycin inhibitor glucosidase', 'hand potent inhibitor golgi mannosidase intact form bosch et al', 'inhibition golgi mannosidase activity synthesis high mannose secretion igd igm hybridoma et al acid glycoprotein rantitrypsin primary gross al cell surface expression human class histocompatibility burke', 'specific', 'example human hepatoma intracellulary cathepsin fraction cathepsin fold segregation maturation nauerth', 'biosynthesis lipid influenza chick embryo inhibition mu mdck high inhibition mannose incorporation al', 'nauerth al showing dmm inhibition incorporation tricholoroacetic acid insoluble material need caution biological inhibition golgi mannosidase', 'analogue furanose sugar benzyl ct mannopyranoside fleet al', 'effective inhibitor jack bean mannosidase swainsonine palamarczyk fleet al', 'lysosomal mannosidase high concentration dim palamarczyk et al', 'inhibition competitive nitrophenyl mannopyranoside substrate fleet palamarczyk et al', 'pyrrolidine alkaloid dmdp form unprotonated nitrogen furanose active inhibitor card hitz palamarczyk et al', 'intact inhibited synthesis complex type', 'high mannose composition addition small proportion material endo h sensitive resistant jack bean mannosidase', 'material hybrid type', 'hence intact dim mannosidase effective swainsonine synthesis n complex et al free', 'fl glucopyranosylmethyl p nitrophenyltriazene fl galactopyranosylmethylp nitro phenyltriazene mannopyranosylmethyl p nitrophenyltriazene inactivate lysosomal fl glucosidase fl galactosidase van al ct mannosidase docherty et al', 'suicide irreversible active site', 'presence mm mannopyranosylmethyl p nitrophenyltriazene glycoprotein high complex type', 'mannosidase triazene', 'removal drug normal cq acid glycoprotein synthesis hr due synthesis', 'analysis high mannose treated glucosidase nmethyl l deoxynojirimycin castanospermine dmdp mannose action processing mannosidase', 'action endoplasmic reticulum ct mannosidase golgi mannosidase com action', 'similar effect presence golgi mannosidase inhibitor complex type fuhrmann al al romero al romero', 'removal mannose presence due rough endoplasmic reticulum ct mannosidase activity bischoff romero et al', 'inhibition early step n oligosaccharides action glucosidase part particular glycoprotein cellular system study', 'see section kornfeld', 'hand inhibition glycoprotein transport secretion processing late step golgi mannosidase ii swainsonine', 'role processing section', 'fact cellular g', 'l deoxymannojirimycin unrelated inhibition processing example inhibition glycoprotein oligosaccharide synthesis cautious approach use', 'summary trimming valuable role n mode action understood', 'purification affinity chromatography processing et al schweden et al', 'ah sepharose purify calf liver mannosidase capable schweden et al', 'existence endoplasmic reticulum ct mannosidase bischoff et al', 'enzyme responsible trimming', 'useful determination intact structural', 'example sulfation influenza virus swainsonine influenza mdck absent castanospermine', 'sulfation previous action acetylglucosaminyl transferase merkle et al', 'similar requirement fucosyl transferase lfucose ct innermost n acetylglucosamine complex type influenza virus', 'presence glucosidase dmdp schwarz elbein presence golgi inhibitor fucose hybrid swainsonine schwarz elbein', 'number sugar interfere terminal glycosylation certain bernacki korytnyk schwarz datema reutter bauer corfield schauer see al', 'analogs sugar example neuac block terminal glycosylation', 'bernacki korytnyk', 'new list sugar nucleotide glycero galacto octapyranosyl uridine methoxycarbonyi glycero ct galacto octapyranosyl inosine kijima suda et al', 'competitive inosine analog specific inhibitor sialyl transfer catalyzed murine', 'biological terminal glycosylation section', 'study role number', 'attachment glycoprotein processing mutant cell enzymes glycosylation chemical enzymatic deglycosylation useful investigate oligosaccharides viral', 'clear discussion n specific synthesis available viral', 'role glycosylation numerous biological tunicamycin extent deoxyglucose', 'several datema elbein olden et al olden et al kornfeld von figura hasilik attempt repeat', 'concentrate glycoprotein processing virus', 'interference protein glycosylation diverse biological cell type glycoprotein investigation', 'nevertheless', 'viral role protein conformation metabolic stability viral proteolytic processing polyprotein viral intracellular traffic antigenicity infection', 'note', 'biological activity interference glycosylation et al', 'reaction protein recognition cell adhesion baenziger', 'part', 'envelope cell membrane mechanism wiley', 'viral surface number common cellular membrane cellular different subcellular cellular transport rothman wickner lodish', 'addition amino acid share number common fig', '', 'membrane anchor sequence hydrophobic amino c terminus', 'ample evidence membrane anchoring', 'specific amino acid sequence hydrophobic stretch', 'hydrophobic threoine fatty', 'c terminus small hydrophilic sequence cytoplasmic site membrane core virus particle', 'size wiley dipeptide el glycoprotein virus undecapeptide hemagglutinin fowl plaque virus lamino stretch glycoprotein virus', 'hydrophilic play role virus garoff et viral fig', '', 'stretch amino n terminal part signal leader sequence secretory membrane bound', 'amino terminal extension uncharged amino', 'leader peptide specific sequence requirement membrane translocation nascent chain reticulum', 'process compartimentalization detail wickner lodish walter et al perara et al', 'secretory endoplasmic reticulum viral membrane anchored membrane hydrophobic c terminal sequence', 'signal peptide nascent chain signal peptidase influenza exception terminal anchor membrane signal sequence murphy webster', 'amino acid oligosaccharide attachment membrane fusion activity viral', '', 'envelope rna kornfeld initial membrane vesicular stomatitis virus atkinson lee', 'absence glycosylation sequestration nascent viral glycoprotein cytoplasm reticulum garoff schwarz', 'mechanism intracellular transport viral site host cell mechanism responsible rothman understood see section', 'rna plasma membrane certain polarized epithelial influenza parainfluenza apical surface vesicular stomatitis virus certain c type basolateral surface rodriguez boulan al morrison ward', 'specificity maturation site glycoprotein roth al glycosylation roth al green et al', 'rna intracellular membrane golgi endoplasmic reticulum reticulum', 'present viral necessary direct protein different intracellular', 'intracellular transport example different viral membrane transport selective see example kabat', 'covalent glycosylation glycoprotein processing', 'guan al review olden et al', 'known theory applicable secretory interaction glycoprotein endogenous carbohydrate protein lectin step intracellular transport olden et al olden et al', 'postulate glycosylation influence nascent polypeptide exert intracellular transport gibson al see section', 'useful postulate explain number glycosylation', 'protein conformation g basis susceptibility degradative proteolysis non protein olden et al schwarz datema bienkowski accurate proteolytic processing precursor klenk rott aggregation viral impair effective intracellular transport gibson al', 'decrease proportion envelope glyco protein membrane virus bud inhibitor', 'scenario viral glycoprotein', 'idiosyncrasy viral discussion individual viral', 'influenza membrane ha neuraminidase fig', 'murphy webster', 'third membrane protein lamb et al', 'ha major cell surface antigen antigenic variation membrane fusion receptor murphy webster', 'ha single polypeptide chain', 'trypsin trypsin endoprotease host cell', 'disulfide bridge klenk rott murphy webster', 'carboxypeptidase enzyme activity c terminal arg case fowl plague cterminal basic peptide garten garten klenk', 'cleavage change n terminus c terminus', 'amino hydrophobic amino fusion membrane fusion activity necessary infectious cell entry example skehel waterfield skehel al huang al white et al white et al', 'infectivity cleavage ha intact fusion peptide', 'hemagglutinin spike virus membrane noncovalent', 'ha monomer globular region receptor site ha stem fusion', 'sequence ha hong strain potential n glycosylation klenk al site', 'high mannose complex type', 'lateral surface molecule cover', 'surface area', 'ha', 'different e', 'different virus oligosaccharides addition strain dependent structure klenk', 'hand structural analysis individual particular glycosylation certain ha ha rostock strain fowl plague virus attachment site unique set al', 'virus certain dimensional structure glycoprotein', 'analysis ha cellular et al keil al al', 'suggested variation attachment variation structure role antigenic variation ha', 'example certain', 'interaction antibody underlying polypeptide distal antigenic skehel al alexander elder', 'immune reactivity antisera ha endoglycosidase f oligosaccharide side immune response alexander elder', 'inhibition protein glycosylation dglc glcn fman tunicamycin chick embryo influenza virus fowl plague virus inhibition production infectious virus datema', 'explanation result extensive degradation ha prior transport plasma membrane schwarz et al', 'inclusion medium tunicamycin protease inhibitor extent degradation ha', 'dimensional structure ha hong kong number potential chymotryptic tryptic cleavage', 'degradation unglycosylated ha cell inaccurate cleavage ha dglc decrease metabolic stability ha schwarz klenk klenk rott', 'deoxyglucose treatment contrast tunicamycin treatment result unglycosylated ha nakamura part metabolic stability ha tunicamycin dglc', 'study nonglycosylated number fowl plague virus h presence tunicamycin', 'problem proteolytic sensitivity ha quantitative', 'inhibitor infected noncleavable bosch et al bosch al uncleaved stable absence protease rott', 'mdbk influenza wsn hon non cleavable ha ha molecule cell system', 'cleavability part primary structure ha bosch et al', 'virus particle production tunicamycin', 'spike glycoproteindeficient ha degraded release virus', 'rapid harvest procedure protease inhibitor intact ha', 'undegraded surface glycosylation necessary formation ha', 'migration uncleaved ha plasma membrane appearance cell surface intracellular synthesis basak', 'result ha rough indication glycosylation membrane insertion membrane glycoprotein', 'unglycosylated ha migrate smooth membrane fraction membrane normal molecule stable see', 'cleavage ha membrane fraction glycosylation cleavage metabolic stability ha', 'elimination peptide amino acid carboxypeptidase unglycosylated ha survived degradative proteolysis', 'availability study fate ha mature', 'contrast tunicamycin dglc glycosylation inhibit glycosylation', 'deoxymannojirimycin section inhibit glycosylation result glycosylation addition inhibition processing', 'possibility', 'influenza virus ha obligatory step glycoprotein processing ha occur cell surface datema al', 'fowl plague virus preponderance complex type viral mannose trimming klenk', 'glucosidase inhibitor castanospermine influenza virus noncleavable see formation virus pan et al', 'virus castanospermine major oligosaccharide structure scheme e', 'glucose trimming', 'presence glc', 'glc ctl analysis deoxynojirimycin cleavable influenza virus ha virus n burke et al', 'drug inhibition glucose cell surface expression ha release virus', 'innermost glucose residue bromoconduritol viral ha structure x complex type formation', 'effect cell surface expression ha virus release virus cleavable ha', 'inhibition glycosylation inhibition prevent cell surface expression noncleavable ha', 'equipment non cleavable ha high mannose addition castanospermine bromoconduritol sufficient allow virus production ha cell surface expression indistinguishable untreated infected', 'n methyldeoxynojirimycin glucose complex type formation inhibit viral protein synthesis lipid synthesis stability viral al', 'fowl plague virus formation chick embryo n methyl deoxynojirimycin infectious virus oligosaccharide structure', 'mannose trimming', 'cleavage ha membrane fraction place rate control et al tt addition elimination basic peptide n methyldeoxynojirimycin', 'ha x stable', 'presence bromoconduritol intracellular viral ha', 'plague virus ha due rate intracellular transport rate cleavage ha datema et al', 'bromoconduritol nomethyl deoxynojirimycin similar biological', 'glc manx x unstable reach cell surface release infectious virus datema et al', 'respect ha virus formation reminiscent', 'explanation ha stable infected independent oligosaccharide composition ha stable ha suceptible degradative proteolysis bromoconduritol', 'biological glucosidase ii n methyl deoxynojirimycin deoxynojirimycin glucosidase sindbis virus rous sarcoma virus bromoconduritol fowl plague virus specific action drug', 'bromoconduritol n methyl deoxynojirimycin tunicamycin growth human embryo unpublished tunicamycin inhibition cell division concentration antiviral nomethyl deoxynojirimycin deoxynojirimycin cytotoxicity drug', 'castanospermine cytotoxic pan al', 'interest inhibitor glucosidase ii study effect pathogenic influenza', 'interesting question pathway ha conformation stable', 'number man ttfor number exit endoplasmic reticulum glucose trimming kornfeld', 'nosidase available resolve question', 'late processing step swainsonine mannosidase ii complex type hybrid type plague virus formation', 'ct mannosidase dim inhibit formation influenza virus influenza non cleavable ha elbein al palamarczyk et al', 'virus ct mannosidase', 'none glycoprotein processing', 'castanospermine n methyl deoxynojirimycin', 'complete inhibition inhibiting glucosidase mannosidase example castanospermine deoxymannojirimycin', 'summary glycosylation table', 'vesicular stomatitis virus vsv influenza virus negative strand rna', 'vsv important human pathogen extensive use glycoprotein research', 'usefulness part immense host range part fact glycoprotein g protein major glycoprotein infected', 'g protein n glycosylation protein complex type anchor amino carboxyterminal amino viral core fig', '', 'g protein emerson', 'vsv san juan strain tunicamycin inhibited infectious virus production leavitt al gibson al', 'g protein reach cell surface', 'extracted isolated free g protein gibson al', 'impairment transport non g rough smooth membrane cell morrison al', 'strain n glycosylation temperature dependence', 'virus release infectious g protein gibson al', 'latter infected form', 'g orsay strain denaturated guanidine hydrochloride temperature sensitivity reaggregation renaturation dialysis salt', 'g different amino acid different glycosylation', 'nascent glycoprotein present protein endoplasmic reticulum determine polypeptide san juan strain stringent requirement proper folding g essential intracellular migration morrison al gibson al gibson al', 'man dol synthesis section', 'thy l e man p dol vsv g protein', 'processed kornfeld complex type g wild type thy', '', 'viable question large precursor evolutionary speaking', 'mutant cell line san juan temperature sensitive', 'g protein', 'formation biantennary complex type oligosaccharide processing', 'clone mutant cell line cho deficient glcnac transferase gottlieb al', 'alternative pathway pathway prevalent mouse lymphoma cell line deficient synthesis man p dol chapman al', 'ii glcnac c man', 'r datema et al', 'vsv san juan tm tem c perature sensitive b dn cs inhibited temperature sensitive dmm', 'inhibited swainsonine e', 'tunicamycin dn deoxynojirimycin cs castanospermine dmm deoxymannojirimycin mutant cho cell line deficient glcnactransferase gottlieb al', 'bvirus production inhibited infectious', 'ctransport g protein cell surface', 'dtransport g protein surface inhibited temperature sensitivity related', 'text', 'mutant cell line guanidine hydrochloride dialysis san juan g protein orsay g protein temperature gibson al', 'large required prevent aggregation certain sensitive san juan g protein advent processing san juan g protein proper conformation glucose et al', 'contrast non g san juan g san juan presence castanospermine deoxynojirimycin surface', 'vsv san juan production g protein glc participate virus budding', 'virus production temperature vsv production g protein sensitive structure', 'presence swainsonine infectious kang', 'g protein case hybrid type fig', '', 'summary table', 'sindbis virus relative semliki virus sfv study glycoprotein biosynthesis animal', 'belong alpha togavirus family simple positive strand rna', 'viral nucleocapsid lipid bilayer', 'matrix protein influenza absent fig', '', 'viral structural series proteolytic initial translation subgenomic mrna', 'cleavage protein translation signal sequence transmembrane translocation nascent protein', 'proteolytic cleavage anchored membrane', 'translation signal sequence second glycoprotein e synthesis vsv san juan temperature sensitive virus mutant cho cell line initial glycosylation stage fig', 'due defect gicnac transferase vectorial transfer glycoprotein membrane anchor', 'carboxy terminus e l cytoplasmic site membrane fig', '', 'e l pe endoplasmic reticulum endoplasmic reticulum golgi system plasma membrane el form complex golgi enzyme burke bell strauss schmidt schlessinger al tabas kornfeld bonatti cancedda ziemiecki al', 'proteolytic cleavage pe essential virus budding', 'small glycoprotein amino sindbis virus associated el heterodimer sfv', 'e l sinbis virus n glycosylation strauss', 'virus grown bhk embryo complex type el', 'e chain el complex high mannose chain al', 'particular glycosylation site complex type high mannose large extent folding polypeptide chain high mannose accessible processing et al hsieh al hsieh', 'location complex type n glycosylation alpha et al interference complex type formation interesting problem', 'sindbis virus bhk glucose inhibited deoxynojirimycin n methyl deoxynojirimycin castanospermine bromoconduritol cleavage protein migrate cell surface', 'requirement cleavage virus formation release virus inhibitor romero al', '', 'cell surface', 'sindbis intraceuuler compartment reminiscent vsv g protein al', 'pez high mannose conformation resistant cleavage golgi protease', 'sfv glycoprotein sindbis virus undergoes conformational rearrangement maturation protein et al', 'conformation change glucose conformation susceptible tryptic protease', 'glucose mannose deoxymannojirimycin cleavage mcdowell personal communication', 'interference protein conformation glucosidase inhibitor understandable virus formation deoxynojirimycin temperature sensitive', 'summary see table', 'mouse hepatitis virus mhv family large positive strand rna', 'viral envelope corona microscope glycoprotein cf', 'fig', '', 'many typical rna virus membrane glycoprotein membrane transported plasma membrane', 'glycoprotein mhv unique viral membrane glycoprotein membrane plasma membrane acylated niemann klenk et al niemann al armstrong et al et al', 'matrix protein influenza vsv', 'possible budding internal membrane internal synthesis', 'el accumulate perinuclear residue viral perturbation apparatus ionophore monensin tartakoff glycosylation el virus endoplasmic reticulum infected niemann al', 'mhv contrast counterpart cell surface', 'smooth membrane fraction tunicamycin repp al', 'virus tunicamycin al niemann klenk rottier infectious', 'underlines role viral infectivity', 'addition intracellular transport inhibition glycosylation susceptibility protein proteolysis et al', 'formation virus presence n castanospermine repp et al', 'glucosylated high mannose appearance cell surface non intra cellular membrane fraction', 'glucosidase delay intracellular transport concomitant inhibition synthesis degradation extent occur tunicamycin parallel repp al', 'formation presence n methyl deoxynojirimycin virus particle formation evident glucosidase inhibitor formation el', 'glucose mannose effect intracellular transport virus formation repp et al', 'result reminiscent virus crucial role glucose maturation viral membrane', 'summary see table', 'role glycosylation env several connection correct proteolytic processing h', 'niemann personal communication', 'effect tunicamycin mdn n methyldeoxynojirimycin cs castanospermine dim', 'bnot due precursor intracellular site cleavage', 'cnon infectious virus', 'dheterogenous cleavage molecular weight', 'lack effect virus cell fusion infectious virus formation', 'indirect immunofluorescence h niemann personal communication', 'polyprotein intracellular migration incorporation', 'different different retroviral', 'highlight confine discussion comparison avian retrovirus rous sarcoma virus rsv mammalian retrovirus friend mink cell focus murine leukemia virus mulv processing', 'glycosylation necessary correct proteolytic processing stable incorporation', 'tunicamycin devoid env', 'schwarz al diggelman stohrer hunter pinter al', 'metabolic env mulv', 'rsv protein cleaved bosch et al mulv counterpart cell surface pinter al', 'work al several monoclonal agaist mulv env protein non form whereas env protein', 'glycosylation conformational change protein effective intracellular transport correct proteolysis', 'glycosylation nmethyl deoxynojirimycin bromoconduritol swainsonine analysis correct proteolytic cleavage env protein ruppin strain rsv', 'addition ¶ ¶ infectious medium normal et al', 'contrast necessary transport env protein mulv cell surface proteolytic cleavage infected cell deoxynojirimycin', 'drug treatment lead incorporation env protein extracellular virus formation pinter al', 'requirement proteolytic cleavage env protein reminiscent sindbis virus system', '', 'interest observation protein presence deoxynojirimycin complex type oligosaccharide et al ¶ ¶the env mulv complex type', '', 'possible glucosidase deoxynojirimycin potent inhibitor n methyl deoxynojirimycin romero et al unlikely high drug', 'possibility mulv env protein part non high mannose mechanism cf', 'p', 'investigation mulv system mannosidase inhibitor particular interest', 'oncogene', 'v fms mcdonough strain feline sarcoma virus sm fesv v erb b avian erythroblastosis virus regard oligosaccharide essential role transformation', 'sm fesv cell castanospermine n methyldeoxynojirimycin serum dependence growth hadwiger al poor growth soft agar transformation', 'glycosylation product electrophoretic mobility protein', 'protein protein kinase activity cytoplasmic domain membrane protein gag fusion protein release gag protein', 'cell surface expression fms oncogene product inhibition clear cf', 'hadwiger al al', 'quantitative transport glycoprotein cell surface glucosidase inhibitor issue intracellular transport cell surface function extraceullular domain hadwiger al growth factor receptor altered essential loss state', 'swainsonine effect sm fesv aev transformed hadwiger al al schmidt et al', 'hand v erb b deoxynojirimycin pyrrolidine able maintain state schmidt et contrast fms', 'cell surface expression turnover oncogene product aev system glucose unaltered', 'erb b consequence dissimilar', 'important determine identical effect system', '', 'respect general membrane dna resemble rna', 'section', 'biosynthesis n host cell large dna fiume serafini cessi initial glycosylation asn translational event endoplasmic reticulum', 'dna section poxvirus', 'fatty acylation occur number rna virus membrane herpes simplex virus glycoprotein johnson spear', 'generation proteolytic cleavage polyprotein characteristic property several virus dna virus glycoprotein', 'poxviridae hepadnaviridae contain dna structural', 'envelope process maturation golgi complex payne kristensson payne', 'inner lamellae nuclear membrane cell surface extracellular fluid roizman furlong roizman', 'due lack suitable permissive cell little known morphological hepadnavirus multiplication', 'recent review howard', 'dna encode membrane', 'likely part infectious process vivo dna potential glycosylation', 'role glycosylation replication simplex virus hsv important realize hsv buds nuclear envelope plasma membrane ii hsv equipped n iii genetic capacity rna', 'hsv several distinct large number gene unknown biological possible hsv non structural', 'hsv vivo reside long time little viral protein synthesis glycosylation review hill', 'rapid cytolytic infection hsv cultured detailed infectious cycle', 'infection viral envelope cell svennerholm personal communication fuller spear', 'hsv type oral facial genital al', 'penetration hsv fusion process cell surface spear', 'adsorption penetration', 'fusion nuclear membrane viral dna nucleus transcription dna replication place roizman furlong roizman', 'several virus cytoplasm dna nucleus occurs roizman furlong roizman', 'virus inner membrane nuclear lamella roizman furlong roizman', 'massive transport viral cytoplasmic little known transport mechanism', 'viral addition plasma membrane spear', 'contain proportion processed', 'high mannose membrane bound complete processing n prerequisite transport nuclear membrane compton courtney', 'fact large proportion hsv carl ohydrate deficient post courtney', 'several viral egress cytoplasm cell surface roizman furlong spear', 'active role morphological biochemical hsv infection permissive roizman furlong roizman', 'r da et al', 'spear morse et al reuchan al para al marsden et roizman al buckmaster al spear mcgeoch et al swain al ackermann al richman al golgi apparatus monensin ionophore golgi intracellular traffic johnson spear', 'hsv distinct', 'hsv biological construction viable intertypic halliburton', 'distinct gb gc gd ge gg', 'hsv spear', 'genetic fig', 'loci map position', 'moreover particular glycoprotein exhibit considerable biological antigenic acid', 'spite specific antigenic recognizable monoclonal type specificity dependent glycoprotein norrild dowbenko laskey spear', 'summary table', 'hsv n complex type high rnannose type high mannose fuller spear svennerholm b jeansson vahlne lycke e olofsson al olofsson al baucke spear spear noble et al serafini cessi al olofsson al buckmaster johnson spear little et al', 'helix pomatia lectin', 'glycoprotein infected cell', 'glycoprotein b glycosylated end product high mannose et al serafini cessi campadelli fiume campadelli al', 'lectin affinity gel filtration analysis complex type bi triantennary campadelli fiume serafini cessi', 'hsv available', 'cell glycosylation machinery indicate host cell involved n glycosylation campadelli campadelli fiume serafini cessi serafini cessi et al', 'different kinetic galactosyl transfer infected uninfected hsv infection oligosaccharide structure', 'hsv addition n courtney olofsson al olofsson al olofsson al norrild pedersen spear serafini cessi et al', 'glycoprotein affinity specific lectin helix pomatia hpa olofsson al olofsson al addition terminal neuac neuac gal dall olio al johnson spear olofsson et al', 'infected tunicamycin synthesis absence n olofsson al', 'glycosyl glycoprotein gc hpa', 'hpa single glycoprotein olofsson', 'host cell content hpa hsv infection due biosynthesis gc olofsson al b', 'hsv glycosyl biosynthesis proportion hpa olofsson jeansson preparation glycosyl dependent cell type infection', 'small arranged multi', 'many small', 'organization much respiratory syncytial virus glycoprotein levine wertz et ball et al', 'several indirect evidence olofsson al peptide acid essential acquisition gc', 'recent large tunicamycin pronase resistant hpa binding olofsson al fact several small similar size structure', 'several n glycosylation block production infectious hsv', 'tunicamycin infectious virus factor factor pizer al k tz al k tz al courtney et al', 'dramatic decrease infectious number hsv production intact infectivity courtney al pizer al katz et al', 'hsv presence deoxyglucose tunicamycin permissive tthe suffix distinguish', 'infectious virus untreated attachment function hsv absence n et al svennerholm et al', 'l iand ability hsv penetrate plasma membrane inhibition n formation', 'synthesis transport intraceuular localization virus proper function viral cell attachment component dependent presence', 'contrast fusion activity hsv absence n person', 'glycosylation antiviral deoxyglucose successful treatment keratitis et al', 'study duration genital hsv deoxyglucose treatment giuntoli', 'significance study duration treated treated untreated genital hsv', 'reason similar vehicle study giuntoli duration genital', 'clear potential glycosylation treatment genital', 'show effect deoxyglucose hydroxynorvaline course animal et al kern al shannon al gordon al effect glycosylation human genital', 'reason lack effect deoxyglucose', 'drug potent enough tunicamycin alternative light p', 'possible animal active metabolite gdp dgic see section', 'fate individual viral infected tunicamycin', 'date gc gb gd respect inhibition glycosylation', 'cell surface gb presence tunicamycin norrild al', 'analogy protein section unglycosylated form gb transported plasma membrane intracellular', 'contrast gc presence tunicamycin plasma membrane antigenic activity extent absence norrild glorioso al spear', 'gc considerable amount aggregation proteolytic degradation gc n olofsson al johnson spear olofsson al dall olio et al', 'unglycosylated gd cell surface type dependent glorioso al norrild', 'adsorption penetration process hsv glycoprotein personal communication fuller spear noble et al', 'gc important role virus absorption protein adsorption hsv permissive monoclonal gc specific spear svennerholm personal communication', 'gc negative hsv ability infect permissive glycoprotein ability initiate attachment', 'inhibition monoclonal likely gd ge attachment fuller spear', 'concept hsv glycopro attachment process gc negative hsv wild type personal communication', 'present viral attachment present envelope hsv', 'assumption gc major importance attachment protein accordance antigenic various treated norrild pedersen glorioso et al', 'penetration hsv fusion', 'syncytia formation gb gd fusogenic noble al manservigi al little et al', 'gb essential penetration hsv temperature sensitive gb negative non permissive temperature ability permissive al little et al sarmiento et al', 'role gd penetration', 'presence tunicamycin plasma membrane norrild pedersen glorioso al nucleus', 'probable explanation lack infectivity hsv presence tunicamycin gb ability infect', 'deoxynojirimycin bromoconduritol mannodeoxynojirimycin swainsonine hsv', 'rna early processing glucosidase fate viral membrane infectious virus formation interference late mannosidase formation infectious virus', 'role processing hsv release cell deficient glycosyl', 'bhk cell ric r glcnac transferase ric r defective golgi addition peripheral et al narasimhan et al', 'ric r percent glcnac transferase activity normal ric r glcnac galactosyl transferase normal bhk al', 'gc deficient hsv grown ric k electrophoretical pronase high mannose complextype fiume al campadelli fiume serafini cessi serafii cessi et al', 'ric r similar pronounced effect campadelli fiume serafini cessi serafini cessi et al', 'appearance hsv elecrophoretical mobility n glycosyl complete fraction fiume serafini cessi serafini cessi et al', 'addition impaired', 'different biological effect partial inhibition processing n', 'first time lag appearance intracellular infectious virus mutant cell fiume al campadelli fiume serafini cessi serafini cessi et al', 'infectious virus mutant cell normal bhk post infection difference hr post infection serafini cessi et al', 'second egress virus mutant cell normal campadelli fiume al serafini cessi et al', 'effective release infectious hsv dependent n campdelli fiume serafini cessi', 'course swainsonine', 'block egress infectious hsv presence monensin spear', 'monensin clear block due absence due direct block golgi intracellular transport cf', 'discussion mouse hepatitis virus p', 'glycosylation table', 'table gel bind fc position immunoglobulin igg baucke spear spear gc l receptor factor complement system friedman al', 'necessary replication virus cell culture proven hsv host', 'part regulation immune response review egwang befus hsv', 'activity gc sensitive sialidase treatment carbohydrate part responsible gc smiley friedman', 'activity relevance pathogenicity potential target glycosylation', 'glycosylation hsv uninfected rna', 'bis amidino hydrazone derivative see section p step transfer lipid oligosaccharide serafini cessi campadelli fiume', 'benzhydrazone pronounced effect viral infectivity', 'explanation available benzhydrazone glycosylation', 'see', 'b bromovinyldeoxyuridin bvdu inhibitor hsv dna synthesis electrophoretic mobility bovine virus al', 'similar effect hsv siegel et al', 'reason active herpesvirus infected order exert inhibitory dna replication protein glycosylation al', 'phosphorylation uninfected due suitable', 'due broad specificity herpesvirus thymidine infected clercq', 'hsv l bvdu glycosylation', 'synthesis lipid full size olofsson et al', 'clear effect thymidine kinase dependent', 'second galactose incorporation', 'effect dependent thymidine kinase expression major increase electrophoretic mobility gc viral', 'bvdu infected synthesis', 'bvdu synthesis olofsson al', 'gc major hpa terminal galnac wga terminal neuac gal olofsson et al', 'bvdu treatment hsv amount hpa amount wga binding', 'case compatible inhibition galactose addition', 'inhibitory terminal synthesis likely glycosylation minor importance prominent activity cell culture compound', 'possible specific inhibition discussed section', 'bvdu transfer clear', 'action glycosylation human detail', 'electrophoretical cytomegalovirus varizella zoster virus epstein barr virus ebv consequence tunicamycin treatment presence n edson thorley lawson morgan al montalvo', 'addition presence high considerable presence human', 'similar bovine misra et al', 'detailed picture inhibition formation n infectious cycle ebv hutt fletcher et al', 'presence tunicamycin intact ebv infectivity', 'result much result hsv system table spivack et al svennerholm et al', 'hsv permissive normal untreated virus ability virus penetrate plasma membrane consequence tunicamycin treatment hutt al', 'ebv suggest fusion ebv hsv', 'hsv glycoprotein b viral penetration sarmiento et al', 'sequence glycoprotein part similar sequence hsv glycoprotein pellet et al baer et al', 'tunicamycin sensitivity hsv penetration immunological cross reactivity similar e', 'part penetration hsv hutt', 'acid immunological cross mammilitis virus varicella zoster virus norrild al shirki et al', 'reasonable assume similar dependent proper expression biological', 'true infectivity glycosylation', 'effect glycosylation dna', 'poxvirus vaccinia virus replication deoxyglucose glucosamine payne kristensson', 'vaccinia virus infectious intraceuular vaccinia extracellular appleyard et al', 'likely extracellular form dissimination vivo infection payne', 'glucosamine deoxyglucose moderate decrease infectivity infectious intracellular virus number intracellular physical payne kristensson', 'reduction infectivity decreased incorporation radio molecular weight essential infectivity kristensson', 'production infectious hand treatment mm', 'electron microscopy indicated acquisition intracellular structure necessary formation extracellular deoxyglucose kristensson', 'possible glycosylation potential arrest replication poxvirus', 'due lack suitable permissive cell culture effect glycosylation b virus available', 'cho hepatitis b virus hbsag gene prevented addition n polypeptide pizer et al', 'hbsag aggregate membrane empty virus possible information effect glycosylation release hepatitis b', 'presence tunicamycin hbsag', 'glycosylation hbsag requirement release hepatitis b', 'envelope dependent replication cell culture pertinent discuss possible glycosylation', 'transcription human adenovirus type membrane glycoprotein apparent molecular weight walter maizel ishibasi maizel', 'replication glycoprotein plasma membrane storch maizel chin maizel al', 'molecular organization similar glycophorin hla persson al', 'high degree homology hla dr heavy chain', 'gene adenovirus growth cell culture glycoprotein role strategy infection natural host chatterjee maizel', 'section maturation affected processing n level mannosidase ii example swainsonine', 'many complex type viral past stage', 'biological role terminal glycosylation viral', 'biological function section production infectious virus part life cyle virus example fate virus vivo', 'section hsieh et al', 'sindbis virus grown mosquito high mannose terminal sialyl galactosyl', 'grown sindbis virus much blood mice cell virus hirsch normal set complex type section', 'analysis system clearance vivo complement dependent alternative complement sialic acid al', 'analysis sindbis virus vivo role terminal glycosylation viral', 'likely terminal glycosylation n oligosaccharides synthesis viral future importance viral spread pathogenesis', 'evidence non viral support notion', 'example surface involved recognition associated tumor invasion metastasis example hutchis beek', 'b murine melanoma swainsonine pulmonary colonization v', 'injection inhibited al', 'experimental pulmonary metastatis cell sialyl transferase inhibitor suda et al see', 'swainsonine toxic high et vivo wihout overt toxicity kino al', 'immunodeficient swainsonine capacity antibody inhibited growth sarcoma lung metastasis melanoma kino al', 'last interference processing n tumor deoxymannojirimycin tumor susceptibility lysis role n complextype recognition', 'note possible p', 'terminal glycosylation antiviral worth account carbohydrate plasma membrane protein moiety tauber al', 'short terminal serum plasma membrane reglycosylation host terminal glycosylation serum', 'addition antiviral virus toxicity', 'virus specific glycosyltransferase argument nucleotide translocation cf', 'capasso hirschberg virus infected activation virus analogous formation viral dna polymerase activation viral thymidine kinase cf', 'clercq', 'bvdu dna synthesis galactosylation n olofsson al', 'effect infected tk deficient strain p', 'bvdu specific glycosylation inhibitor l n bvdu galactosylation potential nucleoside glycosylation', 'lack specific precluded assessment role diverse biological', 'mutant cell line defective udp gal udp galnac kingsley et al', 'cellline study viral', 'interference formation certain hsv special interest', 'detail section hsv glycoprotein contain unusual lectin binding', 'glycosyl affinity pomatia lectin hpa terminal galnac affinity peanut lectin pna main specificity gal ill galnac specific lectin vicia villosa hsv olofsson al olofsson jeansson preparation', 'viral amount surface binding', 'appearance correlated certain differentiation lymphoid consequence different functional', 'carbohydrate cell surface recognition essential induction immune response gahmberg andersson conzelmann et al sharon nakamura al al kimura al pink', 'due lectin cross carbohydrate various speculate task hsv way immune response', 'specific inhibitor oligosaccharide synthesis role primary secondary anti hsv immune response', 'terminal n glycosylation evident biological looked cell culture', 'context mutant deficient hpa glycoprotein gc multiply wild type clinical gc deficient consecutive laboratory', 'fact biological significance hpa binding virus host organism level virus host cell level']"
90c1ab8b02263998f809915b0629da5aa1cbc47a,tympanic thermometer home use thermometer home home thermometer hospital thermometer thermometer hospital absolute difference predictive value difference temperature health care value ci ≥ °c body temperature nurse home nurse thermometer parent nurse plot difference reference standard temperature nurse temperature parent ± °c fever sensitivity mean absolute nurse hospital scatter plot significant amount child temperature ci negative ci specificity current study hospital use negative predictive parent thermometer positive predictive sensitivity ci specificity positive thermometer ± correlation coefficient figure scatter home tympanic hospital tympanic human error intraclass correlation model tympanic nurse model parent home standard study standard tympanic study tympanic temperature tympanic tympanic temperature use figure use nurse °c significant °c ≥ amount nurse ci table comparison parent consistent different diagnostic accuracy diego thermometer difference nurse difference parent difference ± febrile afebrile great caution ideal technique inc san measurement body nurse tympanic objective study operator tympanic pulmonary artery rectal temperature sample size san diego sheet paper similar febrile temperature thermometer temperature ≥ temporal artery thermometer absolute thermometer fever thermometer nurse thermometer significant thermometer °c use thermometer °c °c abbreviations°c pa ability inner absolute similar accuracy health accuracy thermometer accuracy tympanic accurate measurement actual reading acute respiratory admission temperature advice give afebrile nurse,"['background common measure tympanic', 'objective study assess diagnostic accuracy', 'temperature tympanic thermometer home use home thermometer', 'reference standard temperature nurse model tympanic thermometer hospital thermometer', 'difference ≥ °c significant', 'fever temperature ≥ °c', 'mean absolute difference parent nurse home thermometer ± °c ≥ °c', 'mean absolute difference parent home thermometer nurse hospital thermometer ± °c ≥ °c', 'home thermometer fever sensitivity ci specificity positive predictive value ci negative predictive value ci', 'different tympanic absolute difference ± °c', 'fever sensitivity ci specificity positive predictive value ci negative predictive value home thermometer', 'intraclass correlation coefficient consistency body temperature', 'tympanic thermometer home use significant amount reference standard tympanic thermometer majority time detect quarter time', 'tympanic interpreted great caution', 'health care home determine child medical assessment', 'health care admission temperature report', 'true patient temperature normal range indicative bacterial infection', 'health care commercial tympanic', 'easy use minimize risk nosocomial infection', 'tympanic available home use cost', 'tympanic home use health care', 'primary objective study diagnostic accuracy tympanic thermometer home use', 'health research board university study consent form', 'rectal standard', 'nurse model tympanic thermometer standard study rectal pa febrile temperature opposite true steady state', 'general pediatric clinic emergency department inpatient hospital eligible study', 'afebrile nurse available preference fever', 'study communicate english exclusion', 'informed consent parent child practical parent instruction sheet thermoscan thermoscan inc san diego thermometer home thermometer', 'measure child temperature understood', 'sheet paper', 'sheet paper research child temperature thermometer', 'nurse child temperature corecheck alaris inc san diego thermometer hospital thermometer', 'new probe cover', 'mean absolute difference nurse thermometer', 'febrile', 'temperature nurse hospital thermometer fever', 'percentage °c significant difference', 'parent nurse similar home thermometer possible accuracy thermometer', 'nurse parent home thermometer nurse hospital thermometer reference standard study', 'parent nurse nurse consistent different inaccurate human error', 'hand nurse inconsistent different instrument human error problem', 'central tendency intraclass correlation coefficient', 'bland altman method plotted average', 'possible calculate sample size standard deviation', 'sample size', 'sixty participate study', 'median', 'majority fever febrile time study', '', 'table', 'mean absolute difference temperature parent temperature nurse home thermometer ± °c figure', 'difference similar febrile afebrile', 'reading parent', 'fever sensitivity ci specificity positive predictive value ci negative predictive value ci table', 'mean absolute difference nurse home thermometer hospital thermometer ± °c', 'reading hospital thermometer', 'agreement presence fever case reading °c °c table', 'fever sensitivity ci specificity positive predictive value ci negative predictive value ci table', 'parent home thermometer hospital thermometer absolute difference ± °c ≥ °c', 'intraclass correlation coefficient', 'variation consistent different', 'comparison parent nurse home tympanic thermometer figure comparison parent nurse home tympanic thermometer common report child body temperature tympanic thermometer home use', 'study reliability tympanic consistency health care method', 'current study obtained instrument mean significant amount', 'absolute similar febrile afebrile', 'reference standard tympanic temperature nurse model thermometer parent °c definition fever', 'parent tympanic thermometer reliable', 'fact previous subjective assessment child fever sensitivity similar sensitivity current study tympanic thermometer', 'nurse home tympanic thermometer hospital tympanic thermometer absolute difference °c significant amount', 'clear degree discrepancy operator tympanic true difference tympanic thermometer', 'nurse thermometer child temperature thermometer °c thermometer', 'skilled operator tympanic thermometer home use reliable likely detect actual reading', 'chief limitation study nurse hospital tympanic thermometer accurate', 'tympanic accurate measurement body temperature', 'standard axillary rectal temperature', 'operator cooperative patient body temperature tympanic pulmonary artery esophageal temperature rectal axillary', 'tympanic temperature hospital tympanic thermometer available reference standard study', 'incorrect technique', 'high tympanic thermometer thermometer room temperature fact parent reading nurse possibility ideal technique', 'limitation temperature', 'evidence low tympanic rapid succession placement thermometer local possible waited possible read hospital setting time practice', 'possible knew evaluation performance', 'possible tympanic thermometer differ study population', 'clear advice give thermometer', 'ability inner city read mercury glass thermometer poor previous', 'electronic thermometer read inexpensive mercury thermometer', 'current study tympanic thermometer significant amount nurse', 'ease use tympanic', 'clear infrared temporal artery thermometer', 'study temporal artery temperature parent nurse ≥ °c sensitive specific rectal temperature ≥ °c agreement plot difference temperature parent thermometer home use figure scatter plot difference temperature parent thermometer home use versus thermometer °c °c', 'agreement current study possible', 'recent outbreak severe acute respiratory syndrome rapid measurement body temperature health care important tool indicate board staff work', 'important determine accuracy health care body temperature', 'study tympanic ther mometer significant amount nurse tympanic thermometer', 'consistent gradient direction gradient difficult interpret', 'gradient nurse tympanic thermometer home use model tympanic thermometer significant time', 'difficult conclude poor performance human error element instrument error', 'fact comparison reference standard tympanic temperature scatter plot difference temperature parent thermometer home use nurse thermometer hospital use figure scatter plot difference temperature parent thermometer home use nurse thermometer hospital use nurse hospital thermometer home thermometer much parent ideal technique', 'case interpret tympanic thermometer great caution', 'detect majority absolute', 'clinical picture useful piece information', 'abbreviations°c pa pulmonary artery scatter plot difference temperature nurse thermometer home use thermometer hospital use figure scatter plot difference temperature nurse thermometer home use thermometer hospital use']"
d4f6cfb312bae60aa35168d4a775bdb90c4bc39c,ili sari air pollution sunshine duration mean concentration meteorological air time series acute respiratory ifi positive logistic regression second part ifi pcr indoor pollution prevalence rvi respiratory infection respiratory viral severe acute association ili b p city porto information criterion meteorological pollution model ifi p q part study positive ifi presence home prevalence respiratory regression model relative humidity respiratory tract respiratory virus absolute humidity adenovirus frequency adult population air ci arima p autoregressive moving average temperature climate significant common respiratory dampness mold demographic clinical determine number duration relative el niño emergency room er respiratory evaluate association first part frequency ili g kg hospital respiratory hospital stay humidity mean icu admission ifi positivity ifi test ili severe illness ili infection sari influenza adenovirus influenza virus mean temperature median duration mold growth morbidity mortality moving average multivariate logistic multivariate time number emergency number ili pollution adult pollution ili pollution meteorological pollution respiratory porto alegre positive pcr present study prevalence meteorological rainfall sunshine relevance climate research team risk respiratory rsv influenza sari evaluate sari meteorological sari relevance series analysis significant morbidity significant underlying standardized questionnaire study period subtropical climate survival transmission temperature sunshine use air virus survival year study absolute g access patient,"['background respiratory viral common respiratory', 'prevalence respiratory', 'meteorological air pollution likely play role', 'determine number emergency illness ili severe acute respiratory infection sari evaluate association ili sari rvi prevalence meteorological air pollution city porto brazil november october', 'respiratory meteorological air', 'subset nasopharyngeal analyzed ifi test', 'time series analysis', 'illness', 'thirty positive ifi ifi pcr positive', 'multivariate logistic regression model ifi positivity absolute humidity air presence home', 'sunshine duration frequency ili', 'sari temperature sunshine duration relative humidity mean concentration', 'er respiratory rvi', 'meteorological air pollution ili sari relevance climate significant underlying prevalence rvi', 'air pollution illness meteorology respiratory viral severe acute respiratory', 'cite paper silva al', 'respiratory viral meteorological pollution respiratory emergency room', 'influenza respiratory', 'respiratory tract common infection majority significant morbidity mortality', 'emergency frontline risk respiratory infection acute nature', 'prevalence respiratory viral infection rvi unexplored relevant concern', 'rvi severe elderly respiratory cardiac disease', 'winter many', 'etiology respiratory undetermined', 'study pulmonary overall prevalence respiratory respiratory tract influenza virus common', 'er prevalence rvi', 'study hospital respiratory hospital respiratory', 'seasonality certain acute respiratory tract infection meteorological', 'study temperature correlated respiratory syncytial virus rsv influenza adenovirus frequency rhinovirus relative humidity rh', 'climatic interaction host pathogen environment probability exposure susceptibility infection', 'addition experimental air lung immune inflammatory risk respiratory', 'large impact respiratory virus morbidity important understand meteorological air respiratory virus', 'determine number emergency room illness ili severe acute respiratory infection sari evaluate association ili sari frequency respiratory virus prevalence meteorological pollution adult population subtropical climate', 'present study symptomatic respiratory er hospital alegre year october', 'second part respiratory prevalence rvi part october', 'year study climate air pollution', 'study hcpa city porto southern brazil', 'hcpa general tertiary care university hospital year', 'population metropolitan area', 'porto alegre humid subtropical climate hallmark great variability classification cfa k€ oppen geiger', 'committee access patient', 'study informed consent participate', 'first part clinical daily research team', 'respiratory coryza nasal obstruction dyspnea chest pain dysphonia fever onset time study', 'fever', 'demographic clinical laboratorial standardized questionnaire sex age race smoking status admission duration presence vital temperature heart rate respiratory rate peripheral oxygen saturation digital oximeter breath radiological hospital stay intensive care unit icu admission hospitalization death discharge', 'second part symptoms nasopharyngeal', 'day daily shift morning afternoon inclusion', 'interviewed member research team standardized questionnaire addition first part family income influenza previous antibiotic use occupational exposure flu family presence family history respiratory disease air home work home', 'total throat sari throat shortness breath difficulty breathing', 'nasopharyngeal standard protocol second part study', 'indirect immunofluorescence ifi respiratory daily meteorological temperature maximum average minimum in°c relative absolute g kg humidity rainfall sunshine duration number sunshine day climate laboratory federal university rio grande sul', 'mean concentration', 'methodology laboratory concentration last', 'city porto alegre probable pollutant responsible matter lm dynamic diameter pm', 'number ae standard deviation sd median interquartile range iqr', 'categorical chi square test correction exact test', 'continuous test wilcoxon test', 'nominal confidence', 'p value significant', 'analysis spss statistical package social il usa free statistical software r', 'time series analysis linear model glm examine association ili air pollution meteorological logistic regression', 'autoregressive moving average arima model ili sari', 'pollution meteorological explanatory', 'second part study ifi pcr', 'volatility model variance error autoregressive conditional heteroscedasticity arch arima modeling framework', 'arima ili sari', 'arima p q useful time series non stationary common box', 'arima p q autoregressive moving average', 'sg identification order average box', 'need differentiation sari graphical analysis time series autocorrelation unit root dickey fuller reject hypothesis non stationarity ili sari', 'second moment seasonality ili sari autocorrelation partial autocorrelation', 'variable selection p q ili sari approach backward', 'information criterion aic penalize number schwarz information criterion sic bayesian information criterion bic select', 'sample size literature review', 'prevalence rvi significance level total confidence interval amplitude second part study', 'study period respiratory', 'common cough fever dyspnea pain coryza', 'median duration admission', 'total hospitalized icu admission', 'ili', 'overall mortality rate study', 'demographic clinical population table', 'selection inclusion participate', 'virological investigation year second', 'age sex race sample er period', 'median duration unsatisfactory ifi positive pcr', 'negative ifi positive pcr', 'positive ifi pcr result positive', 'pcr concordant', 'patient adenovirus ifi influenza pcr', 'case ifi piv type pcr piv', 'positive negative table', 'figure virus percent positive ifi month', 'table environmental study', 'figure observed sari', 'daily number ili sari meteorological', 'autocorrelation previous lags variable average temperature rainfall sunshine duration relative humidity mean concentration humidity', 'number ili sari july august', 'period mean ae tmax ae sunshine duration ae sun day winter', 'median entire year mm iqr mm', 'addition absolute humidity ae g kg mean concentration lm period annual', 'table logistic regression model ifi pcr', 'included logistic regression ifi logistic regression pcr climate year study', 'ifi positivity ah ci use air ci presence home ci', 'hand pcr positivity use air ci average temperature ci mean concentration', 'multivariate time series sari table', 'sunshine duration independent covariate frequency ili', 'b coefficient parameter negative ili frequency sunshine duration', 'model sari significant mean temperature b p sunshine duration b p rh b p mean concentration p', 'acute rvis responsible significant morbidity mortality', 'common respiratory syndrome ili', 'severe presentation sari rvs', 'study relationship ili sari meteorological air pollution multivariate time series', 'ili sunshine duration', 'addition sari mean temperature sunshine duration rh concentration', 'seasonal infectious atmospheric prevalence virulence pathogen behavior host', 'sunshine duration winter', 'temperature rsv influenza adenovirus frequency', 'positive correlation temperature sari', 'possible explanation degree celsius rise temperature risk premature death acute morbidity respiratory rest population', 'second evidence temperature air pollution ground level ozone amplify adverse poor air quality', 'evidence account concentration sari', 'decrease air pollution prevalence sari', 'third hypothesis explain relationship related el niño southern oscillation enso phenomenon', 'enso episodes reverse cold', 'southern region brazil phenomenon elevated spring period', 'previous el niño increased severe influenza', 'severe acute respiratory infection rh study', 'previous rh survival virus influenza influenza b rsv piv', 'use indoor winter dry air desiccation mucosa epithelial damage mucociliary clearance host susceptibility rvis', 'tropical climate rh activity influenza', 'observation variation viral stability different rh', 'stability influenza rh rh minimum mid range rh', 'multivariate logistic regression model ifi positive ah protect factor rvi', 'recent study ah correlate influenza virus survival transmission', 'rh ah actual water vapor content air irrespective temperature prominent low indoor outdoor', 'humidification survival transmissibility influenza', 'air pollution adverse health', 'acute respiratory cardiovascular hospital mortality', 'available exposure risk rvi potential unexplored', 'sari decrease mean concentration', 'fact rainfall period rain', 'hand effect indoor pollution', 'last indoor pollution health problem time chemical biological', 'indoor pollution wood presence home', 'ifi positive live residence mold growth', 'dampness important indoor pollution respiratory', 'home dampness mold growth dust reduced ventilation indoor', 'cough upper respiratory dampness mold metaanalysis', 'prevalence cough home ifi positive', 'air conditioning related ifi test study', 'air use hospital cardiovascular chronic obstructive pulmonary disease pneumonia high exposed outdoor', 'majority virus transmission indoor air humidity airborne virus survival transmission', 'hot humid transmission air transmission', 'prevalence rv previous', 'length ifi positive', 'consistent knowledge virus identification prompt initiation therapy unnecessary use length hospital stay', 'present study', 'data single center catchment population vaccination coverage', 'second important note investigation group severe disease', 'individual air implausible separate air individual', 'short study period limitation', 'molecular study number limited sensitivity ifi method', 'analyze relationship rv meteorological pollution adult population', 'conclusion adult er respiratory rv', 'meteorological air pollution ili sari relevance climate significant underlying rvi temperate region', 'additional confirm time series', 'fundo fipe hcpa fapergs']"
93387fc895bc5dea56fd858fff48fd3ffe454e65,et al spike protein amino acid cell culture chicken trachea coronavirus spike heparan sulfate avian coronavirus ibv strain protein receptor beaudette spike cavanagh al infectious bronchitis promkuntod et sequence diversity sialic acid spike histochemistry cleavage site different ibv high sequence ibv beaudette ibv infection protective immune respiratory disease respiratory tract role spike strain beaudette tropism ibv vaccine strain wickramasinghe al wickramasinghe et cell tropism cross protection culture ibv host cell host protease host range host tissue ibv field ibv spike many different n terminal outcome infection protein avian quail coronavirus reproductive tract sjaak al terminal domain tissue tropism trachea fig tropism pathogenesis al al al woo attachment protein binding trachea cam fig chicken kidney collisson al dc sign determinant ibv furin cleavage furin dependent gastrointestinal disease heparin sulfate host attachment host factor immune response jackwood et l sign madu et overview literature pathogenicity ibv primary chicken promkuntod al receptor domain recombinant beaudette recombinant ibv recombinant ibvs selective pressure sequence identity sign l sulfate site tropism pathogenicity unidentified host various ibv virus ibv winter et abd el acid dependent acid identity acid sequence additional cleavage address role al et al fig al mckinley al recombinant al toro al yang amino terminus,"['avian gammacoronavirus infectious bronchitis virus ibv coronavirus chicken', 'ibv contagious disease respiratory tract strain reproductive urogenital tract', 'control ibv field many different protection due diversity', 'diversity due amino acid variation domain major viral attachment protein spike', 'last much effort undertaken address role avian coronavirus spike various cycle', 'various developed contribution virus cell culture organ vivo tropism pathogenesis', 'review overview literature avian coronavirus spike particular focus recent recombinant soluble spike protein chicken', 'aim current understanding avian coronavirus spike contribution host tissue role therapeutic protective', 'avian belong genus gammacoronavirus order', 'avian major health subsequent economic several bird gallus gallus', 'genus gammacoronavirus cetacean et al woo et al', 'addition avian genera gammacoronavirus deltacoronavirus wild bird et al woo al woo al pathogenesis host range unknown', 'review focus avian particular role spike outcome infection', 'avian infectious bronchitis virus ibv infectious bronchitis', 'date important gammacoronavirus prototype', 'ibv coronavirus hawn', 'spike protein protein e membrane protein nucleocapsid protein n', 'genomic replication protein rna genome ribonucleocapsid structural generate virus particle', 'virus major adhesion molecule spike protein detail section', 'much effort undertaken address role spike various virus life cycle outcome infection vivo respect tropism pathogenesis', 'various different ibv infection', 'review overview literature recent spike protein avian current understanding spike contribution host tissue role therapeutic protective', 'disease infectious bronchitis collection ibv genotype serotype protectotype sjaak al', 'classical subtype respiratory disease ibv massachusetts van roekel united fabricant', 'respiratory disease severity', 'respiratory disease dyspnea serous nasal discharge cavanagh gelb', 'infection epithelium upper respiratory tract nasal cavity trachea loss ciliary activity degeneration desquamation loss', 'addition hyperemia inflammation fig', 'presence heterophilic', '', 'ibv respiratory tract cause aerosacculitis al', 'normal state extensive hyperplasia al nakamura al purcell mcferran', 'respiratory tract virus host viremia epithelial renal itakura condron marshall ciliated epithelium oviduct crinion al jordan', 'virus renal failure urate obstruction due tubular necrosis mononuclear inflammation chen itakura oviductal necrosis malformation abnormal egg production inability chousalkar', 'severity disease various ibv subtype mortality', 'minor pathological due ibv infection', 'virus infect glandular epithelial proventriculus yu et lymphoid cecal al', 'result significant clinical gastrointestinal disease', 'ibv infect harderian gland toro al toro al van ginkel al immune response', 'ibv al', 'avian various poultry', 'ibv ibv fig', '', 'histological immunohistochemical trachea mock ibv layer', 'day old spf layer pbs mock various time infection', 'mock upper chicken dpi trachea small mucoid material multifocal hyperemia mucosa', 'b hematoxylin eosin h e anti ibv mab immunohistochemistry right section trachea mock dpi dpi dpi chicken', 'trachea chicken dpi intact epithelial lining minimal hyperemia epithelial mucus epithelial marked intracytoplasmic presence antigen', 'dpi trachea normal architecture due desquamation ciliated epithelium replacement hyperplastic squamous non epithelium infiltration large marked hyperemia superficial layer presence necrotic', 'epithelial heterophilic abundant mucoid material', 'epithelial antigen', 'mock chicken trachea', 'scale high sequence similarity ibv vaccine et al sun al much divergent different virus cavanagh', 'example turkey coronavirus tcov divergent spike gene contrast respiratory disease ibv gastrointestinal disease gallopavo', 'edematous frothy content result severe enteritis cavanagh guy maurel al', 'quail coronavirus high spike sequence identity tcov enteritis subsequent diarrhea growth young coturmix coturmix al', 'guinea numida meleagris guinea acute pancreatitis liais et al', 'respiratory kidney colchicus cavanagh al respiratory disease pancreatitis livia qian et al', 'wild avian clinical respective chu et al', 'laboratory inability ibv field continuous cell', 'several vivo addition vivo available', 'ibv intra chicken', 'virus epithelial membrane cam fig', 'chicken embryo', 'infectious virus allantois fluid', 'morphological cam embryo growth retardation al', 'addition organ tracheal organ darbyshire et al', 'read parameter infection system ciliostasis cook et al', 'oviduct organ study ibv tropism reproductive tract', 'ibv field isolated primary chicken embryo kidney cek gillette', 'adaptation', 'study ibv laboratory cell culture ibv strain beaudette beaudette hudson', 'contrast ibv field infect baby hamster kidney monkey kidney fig', 'madu al et al', 'beaudette serial virulent massachusetts strain chicken beaudette hudson', 'consequence adaptation beaudette ability infect pathogenic al', 'cell culture ibv strain beaudette primary choice backbone development recombinant et al fang al youn et al', 'recombinant system attenuated vaccine strain', 'recombinant excellent dissect contribution viral various infection cycle', 'evaluation much cumbersome wild type ibv multiple genome present disease', 'study role spike protein virus recombinant soluble spike become practical', 'protein histochemistry different various chicken al', 'elucidation specific host attachment ibv infection following', 'spike coronavirus structural characteristic club petal nm virion surface appearance microscopy', 'spike protein transmembrane glycoprotein molecular mass kda glycosylation', 'nterminal signal peptide binns al endoplasmatic reticulum er extensive terminal n glycosylation cavanagh', 'thirty potential n glycosylation ibv spike protein et al mass kda', 'glycosylation er form delmas laude lewicki gallagher', 'protein avian host cell protease basic pentapeptide motif rrfrr amino size cavanagh et al', 'ibv protein cleavage recognition site minor amino acid correlate serotype pathogenicity tropism', 'n terminal subunit part large ectodomain oligomeric protein', 'c terminal subunit part narrow stalk short transmembrane endodomain', 'coronavirus spike protein class viral fusion variable domain host cell receptor domain virion cellular et al', 'receptor ibv promkuntod al various domain', 'membrane fusion unit repeat interact form coil structure stalk putative fusion peptide', 'endocytosis conformational triggered exposure acidic ph al fusion viral envelope cellular membrane', 'contrast contribute infection ibv see section', 'domain involved host cell receptor interplay avidity specificity virus attachment al', 'contrast virus alpha different many different gammacoronavirus ibv jackwood sjaak al', 'main antigenic viral protein neutralization cavanagh al kant et al koch al mockett al high sequence diversity domain serotypical variation', 'amino acid sequence identity different variation domain average britton cavanagh', 'phylogenetic tree various ibv reference', 'relationship amongst avian coronavirus spike', 'correlation amino acid sequence identity level cross protection ibv serotype share amino acid identity share amino acid identity cavanagh', 'similar limited cross protection high level cross protection much homology sjaak al', 'monoclonal conformation dependent antigenic immunodominant region terminal region koch al al lenstra et al', 'neutralizing antigenic locate hypervariable cavanagh al cavanagh al moore et al hvrs antigenicity serotypical variation', 'nucleotide sequence part subunit spike oie', 'diagnostic ibv hypervariable amino terminus region', 'result great genetic variability ibv definitive nomenclature genetic classification system', 'high sequence diversity domain hypervariable amino terminus particular cavanagh et al jackwood thought result accumulation selection', 'average rate synonymous site year hanada al', 'reason high sequence diversity spike unknown', 'phylogenetic analysis amino acid spike protein avian', 'muscle default', 'unrooted maximum likelihood tree mega fit substitution model lg g complete deletion', 'bootstrap', 'selective pressure high virus high viral subpopulation diversity', 'intrahost selection specific ibv immune response affinity host microenvironmental organ et al', 'emergence new ibv high basic reproductive number wit et al', 'wide spread use live vaccine subsequent selective pressure neutralizing adaptation virus escape immunity hence result evolutionary jackwood et al', 'next genetic recombination creation new genetic different parental', 'occurrence recombination many recombination hot recombination breakpoint incidence', 'hot upstream spike gene thor al', 'last hot spot special interest protein viral tropism', 'hence recombination gene new new new', 'time double cross event ibv unknown avian coronavirus infection single host emergence tcov jackwood et al', 'ibv pathogen ibv ibv gamma fig', '', 'different ibv relevant', 'recombinant ibv beaudette qx attachment spike histochemistry wickramasinghe al trachea chicken', 'virulent massachusetts strain sensitive infection', 'avidity vaccine strain trachea lung et al', 'beaudette obvious binding chicken trachea wickramasinghe et al promkuntod', 'nephropathogenic show appreciable trachea kidney qx strain reproductive tract tropism mild patchy oviduct', 'scale c schematic representation ability trimeric spike set ability ibv available literature nd', 'peafowl partridge blue teal pigeon mallard duck graylag goose cavanagh pheasant cavanagh al guineafowl cavanagh liais various wild bird al', 'molecular', 'poultry chicken avian turkey quail guinea circella et al liais al al', 'tcov originate recombination ibv gene unknown jackwood et al', 'ibv full similar similarity gene', 'extensive genetic variation gene north american european tcovs fig', 'maurel al creation different jackwood al', 'genome guinea genome common ancestor current separate evolutionary path liais et al', 'quail coronavirus amino identity certain tcov identity ibv', 'genome quail coronavirus quail coronavirus guineafowl turkey coronavirus', 'poultry pigeon partridge divergent ibv reference', '', 'unknown ibv host range various bird number uncharacterized ibv', 'spike high sequence diversity ibv', 'crucial role outcome infection', 'overview literature avian coronavirus spike role tropism pathogenicity', 'effect sequence diversity ibv recombinant spike histochemistry wickramasinghe al fig', '', 'avidity recombinant trimeric massachusetts beaudette pathogenicity wickramasinghe et al', 'trimeric soluble nephropathogenic qx reproductive tract appreciable trachea fig', 'relevant kidney oviduct fig', '', 'ibv qx oviduct', 'overview various trimeric spike infectivity particular tissue ibv strain fig', '', 'human fc tail avidity trimeric chicken trachea limited extend ability bind fig', '', 'line dimeric qx oviduct al ibv permissive tracheal epithelial primary chicken kidney shahwan al', 'dimeric beaudette bound chicken et al trimeric beaudette sufficient binding trachea fig', 'wickramasinghe al cam fig', 'promkuntod et al', 'amount protein wickramasinghe et al', 'clear multimerization state spike', '', 'recombinant trimeric dimeric ibv', 'recombinant frame trimerization strep tag human fc tail chicken trachea', 'similar protein dimeric trimeric concentration mg ml trimeric avidity dimeric', 'contrast dimeric limited binding trachea trimeric binding', 'scale similar spike histochemistry contribution spike', 'n terminal amino c terminal domain fig', 'bound acid dependent manner promkuntod et al', 'beaudette amino critical promkuntod al', 'ibv gammacoronavirus rbd', 'likely important binding domain avian', 'contribution outside clear beaudette spike promkuntod et al', 'beaudette sufficient binding chicken trachea fig', 'cam fig', '', 'extension part spike ectodomain fig', 'cam promkuntod et al', 'extension complete ectodomain increased affinity profile chicken trachea fig', 'determine avidity specificity virus attachment', 'ibv spike glycoprotein determinant cell tropism host cell tropism beaudette section review protein', 'ectodomain spike beaudette beaudette viral background recombinant ibvs casais al cell tropism ibv', 'recombinant beaudette ability progeny virus primary chicken kidney cef infection replication beaudette casais et al', 'recombinant beaudette gene beaudette retained ability grow vero et al infection cell culture sequence beaudette', 'n terminal domain spike terminal domain chicken trachea', 'ntd sufficient attachment chicken receptor domain promkuntod al b recombinant beaudette soluble recombinant chicken trachea', 'beaudette spike cell ectodomain extension ectodomain avidity cam promkuntod et al', 'scale contradictory cause host range beaudette', 'major putative additional cleavage protein host host attachment section review', 'addition particular drive cell cell fusion activity infectivity beaudette', 'additional host downstream cell culture tropism beaudette', 'domain important binding domain vitro tropism ibv role protein clear', 'exchange spike protein beaudette virulent ibv viral beaudette genome apathogenic recombinant et al hodgson al poor replication trachea hodgson et al', 'addition replacement domain beaudette vaccine strain nonpathogenic virus tracheal till day al indicating recombinant virus ability replicate respiratory tract', 'conclude spike protein vivo tropism clinical organ cell recombinant parent', 'spike pathogenicity ibv', 'elucidation contribution tissue tropism pathogenesis vivo intrahost variation', 'viral acid distinct predominant vaccine trachea gallardo et al mckinley al harderian reproductive tract gallardo et al', 'different al ndegwa et al selection ibv specific immune et al toro et al', 'nonstructural replicase contribute fitness pathogenicity ibv vivo', 'recombinant ibv structural region virulent replicase nonvirulent beaudette armesto al show clinical inoculation tracheas ciliary activity contrast', 'virus viral rna trachea recombinant', 'interest elucidate virus replicate inoculation site determine lack pathogenicity due fitness', 'evidence role replicase pathogenicity study genome virulent avirulent arkdpi ibv ammayappan et al', 'next spike amino acid', 'region immune regulatory role determine viral replication rate', 'host response infection fitness virus', 'replicase region sole determinant ibv pathogenicity replicase gene infected identical vaccine correlation pathotype mondal cardona', 'coronavirus spike protein host factor subsequent fusion virus host cellular first virus life cycle', 'main host factor ibv attachment sialic acid', 'addition specific heparan sulfate cellular furin play role beaudette infection vitro', 'knowledge host ibv infection regard possible existence protein receptor available', 'interaction spike protein specific attachment responsible host tissue tropism', 'hence distribution critical outcome infection vivo', 'sialic receptor determinant ibv abd el rahman al winter et winter et al', 'sialic specific susceptibility ibv infection desialylation neuraminidase infection', 'lab wickramasinghe al et al shahwan al recombinant vivo trachea lung intestine kidney sialic fig', '', 'particular glycan array ibv glycan wickramasinghe et al', 'abd el rahman al', 'observed variation tissue tropism different ibv difference preference specific sialic', 'respect particular sialic acid glycan ibv qx', 'much sialic unidentified host factor specific sialic array', 'et al', 'binding recombinant dimeric different pathogenicity sialic comparable trimeric different', 'attachment protein different', 'example trimeric protein oviduct broiler layer', 'remarkable attachment factor expression', 'several host surface sialic attachment factor', 'sialic acid affect tropism pathogenicity virus', 'murine betacoronavirus mhv attachment sialic affect cell tropism neurovirulence kazi et al', 'respiratory coronavirus transmissible gastroenteritis virus cellular protein receptor ability latter sialic acid enterotropism krempl al schultze et al', 'ibv express receptor enzyme winter et contrast avian influenza virus certain', 'compensate binding affinity spike ha attachment protein avian influenza wickramasinghe al host attachment', 'none functional protein receptor', 'many alpha specific protein restrict host tissue infection', 'several porcine feline canine certain human utilize aminopeptidase n apn receptor protein protein receptor usage variable', 'murine coronavirus receptor human alphacoronavirus betacoronavirus use betacoronavirus raj', 'miguel et al', 'role apn ibv entry chu et al', 'feline functional receptor ibv', 'surface protein receptor determine tropism ibv elucidated', 'overexpression human c type dc sign l sign nonpermissive cell infection ibv sialic acid independent manner al', 'similar second co mentioned protein human', '', 'sialic acid dependent broiler layer', 'spike histochemistry recombinant described wickramasinghe et al broiler b layer broiler', 'binding trachea neuraminidase vibrio cholerae vcna pre spike specific glycan sialec', 'high binding avidity oviduct layer broiler oviduct', 'scale marzi al yang al al hofmann et al feline fipv regan whittaker fecov regan al', 'dc sign l sign nonepithelial dendritic endothelial role chicken human dc sign l sign ibv pathogenesis vivo hence speculative', 'next potential contribution domain section host tropism cell culture ibv strain beaudette additional cell surface receptor heparan sulfate madu et al', 'receptor many different thorp murine coronavirus mhv mutant host range al', 'upon passage cell culture ibv beaudette madu al acquisition heparan sulfate binding use heparin sulfate alternative attachment entry receptor', 'putative heparin sulfate site beaudette second furin cleavage site domain madu et al', 'madu et al', 'infectivity beaudette presence soluble heparin cell heparan sulfate heparin sulfate role attachment entry factor beaudette', 'heparan sulfate sequence rrkr sequence prrr heparan sulfate binding site crucial entry infectious', 'spike histochemistry assay site required attachment beaudette spike susceptible chicken et al fig', '', 'host protease perlman', 'furin dependent cleavage ibv spike occur virus assembly cavanagh correlate pathogenicity ibv strain', 'additional furin cleavage site subunit beaudette involved furin dependent entry syncytium formation vitro', 'observation productiveness ibv beaudette infection cellular furin expression tay al', 'novel xxxr cleavage site ibv spike position additional cleavage site beaudette cleavage unidentified host protease', 'host protease tropism ibv strain beaudette entry furin dependent vero unidentified protease chicken kidney winter personal communication', 'spike protein humoral cellular immune ibv cavanagh', 'presence protection ibv cavanagh al collisson al ignjatovic galli', 'cytotoxic critical disease collisson al ctl present spike protein collisson al liu et al', 'several different generate', 'protective immune live viral recombinant ibvs', 'many available poultry infectious bronchitis field live type sjaak al experimental investigation', 'overview context spike protein role protection', 'live ibv serial ibv isolate first ibv', '', 'beaudette spike chorioallantoic membrane tissue', 'spike histochemistry recombinant wild type beaudette spike beau proposed heparan sulfate site shrkhs aa sequence sprrrs beau presence mg ml heparin application beau treatment neuraminidase vibrio cholerae vcna promkuntod et al', 'heparan sequence beaudette spike blocked heparin cam dependent sialic', 'scale ibv', 'attenuation adaptation virulent field isolate chicken embryos aim virulence ability sufficient immune challenge virus', 'virus spike region replicase ammayappan al mondal cardona', 'impossible predict genetic sequence ibv strain potent effective immune response', 'addition use live residual pathogenicity vaccine backpassage et al mckinley al oie', 'live ibv golden standard protect ibv immune high', 'delivery spike dna viral variable protective immunity cavanagh', 'dna vaccine immunization multiple structural ibv increase level humoral cellular individual al yang et al', 'contrast vector poultry field transport present avian newcastle disease virus fowl pox virus virus disease virus vaccine ibv', 'delivery spike attenuated mycoplasma gallisepticum vaccine strain shil et al recombinant al partial protection homologous ibv', 'vector addition immune related clinical viral rna al shi al wang al zeshan al', 'dna plasmid viral vector particular sequence domain account amino acid mutation ability confer protection challenge al', 'domain protein contribute protection heterologous ibv challenge toro et al', 'promising viral vector live', 'ability protect challenge vivo light role spike attenuation induction protective immune', 'vaccination recombinant ibv beaudette virulent hodgson al armesto al importance homologous spike protective immune', 'presence domain ibv vaccine strain beaudette bone sufficient morbidity virulent wei et al', 'recombinant virus ibv specific similar live vaccine histopathological', 'recombinant ibvs contrast vector comparable protection live', 'future research recombinant likely focus quantification protective immune ability protection multiple', 'summarized current knowledge avian coronavirus spike', 'addressed fundamental spike overview experimental role entry cell culture tissue tropism pathogenesis protection vivo', 'fundamental spike avian resemble many', 'serotype diversity sequence diversity unique ibv', 'spike poultry turkey', 'ibv respiratory pathogen chicken turkey cause gastrointestinal disease', 'pathogenesis tropism many bird clear different ibv', 'n terminal domain spike protein receptor domain', 'domain prototype massachusetts sufficient attachment chicken', 'preference avidity trimeric chicken tropism pathogenicity vivo', 'recombinant dimeric respect sialic surface attach', 'host organ specific expression sialic unidentified host putative protein receptor host protease contribute tropism various ibv', 'spike protein main determinant ibv tropism cell culture', 'tropism ibv beaudette several heparan sulfate site second furin cleavage site fusion synergistic interaction', 'limited information available actual role spike virus preference vivo clear spike sole contributor ibv pathogenicity viral replicase outcome disease', 'nucleocapsid protein important induction protective immune', 'selective pressure extensive vaccination intrahost selection adaptive evolution avian mutation recombination', 'due many different ibv limited cross protection vaccination control infectious bronchitis poultry industry big challenge']"
43913d3de280bbe325e4e0a8f9e6e50dbfd342b3,viral respiratory infl ammation aeroallergen sensitisation respiratory tract early life asthma exacerbation development asthma identifi ed allergic asthma allergic infl allergic sensitisation asthma age hrv aeroallergen rsv infection sensitisation hrv fi gure interferon γ respiratory infection respiratory virus risk factor year life diagnosis asthma due hrv eff ect eventual development family history hrv c hrv infection identifi cation respiratory asthma respiratory early risk asthma specifi c admission hospital airway infl asthma respiratory asthma viral asthmatic healthy bronchial epithelial coast study detection respiratory epithelial cell fi rst history asthma hrv development hrv rsv infection asthma innate immune major cause non allergic persistent asthma rst year rsv bronchiolitis tissue culture acute care allergic disease antiviral activity association rsv association viral asthma bronchiolitis asthma major asthma non bronchial hyper cause asthma cause morbidity cell interferon damage epithelium defi cient disease progression ect asthma eff ective emergency department episode due expression disease expression persistent factor diagnosis fi life function impairment high risk hrv related hrv replication hrvs cause human rhinovirus hyper reactivity increase risk infection allergic infection early interferon α interferon β interferon λ iu ml large number lent support life due life hrv life subsequent little evidence lung function many asthma many gene,"['viral respiratory tract common imited', 'asthma viral respiratory tract eff ect expression disease loss control', 'new evidence early life due human major risk factor diagnosis asthma age', 'asthma major cause morbidity acute care result death', 'viral respiratory tract human asthma', 'evidence defi antiviral activity integrity epithelial barrier severe viral respiratory increase risk exacerbation', 'view ect respiratory many eff risk rst step treatment', 'viral respiratory tract eff important fi gure', 'early life many associated respiratory', 'many respiratory syncytial virus rsv human rhinovirus hrv metapneumovirus parainfl uenza cor onavirus', 'respiratory diminish age early life mark', 'contrary early life subsequent respiratory morbidity hygiene hypothesis respiratory early life protective eventual development allergic asthma proposal lent support low prevalence day care', 'hypothesis frequent challenge stimulation individual protective immunity ie immunity', 'recent exposure nonpathogenic important exposure pathogenic healthy immune development risk allergic', 'respiratory viral severe adverse outcomes asthma viral respiratory asthma exacerbation', 'association viral respiratory', 'respiratory disease progression eventual severity disease clear', 'review discuss role viral respiratory early life contribute asthma', 'viral respiratory', 'association respiratory early life attempt potential relation eventual development asthma', 'relation studied respiratory due hrv', 'many asthma rapid small infl ammation respiratory compromise', 'third initial episode due bronchiolitis recurrent', 'association speculation rsv bronchiolitis infancy initiate development asthma', 'association rsv infection cient cause admission hospital eventual development asthma', 'identifi ed treatment hospital rsv bronchiolitis disease progression old', 'healthy similar age sex', 'old family history asthma bronchiolitis high family history asthma bronchiolitis none', 'study severe rsv family history asthma increase individual developing asthma', 'medline relevant search viral respiratory asthma jan', 'completeness personal', 'fi widespread idea genetic family history environmental rsv infection determine expression disease asthma', 'geneenvironment idea lent support large epidemiological study tennessee usa time year rsv prevalence peak rate', 'birth respect peak winter bronchiolitis season high risk', 'fi risk severe viral bronchiolitis likely', 'several viral wheezing contribute development asthma', 'prospective birth cohort association wheezing due infection early life subsequent expression persistent asthma child school', 'association rsv infection asthma', 'example longitudinal tucson respiratory study rsv respiratory tract child age subsequent childhood age', 'thomsen association admission hospital due rsv infection development asthma twin registry denmark', 'severe rsv asthma genetic predisposition rsv bronchiolitis asthma', 'hrvs cause common cold viral respiratory tract upper airway tract', 'several hrv bronchiolitis respiratory compromise severe admission hospital', 'hrvs important role asthma common viral respiratory infection early life', 'many part hrvs play development asthma', 'molecular available detect hrv respiratory', 'sensitive specifi c use non invasive plastic bag', 'second pcr small virus culture', 'third hrv viral load large viral symptomatic infection likelihood asthma exacerbation small viral', 'diff many hrv possible discussed ability new wheezing', 'study identify role respiratory development lemanske cohort high risk asthma', 'parent asthma allergic disease', 'childhood coast study', 'nasal lavage rst year lifeat age symptomatic respiratory infection', 'next nasal lavage child symptomatic respiratory', 'age frequency persistent', 'age study', 'study design fi gure able determine respiratory early life eventual development asthma', 'clinician fashion basis fulfi several clinical diagnosis asthma physician frequent albuterol controller medication step plan oral prednisone use asthma exacerbation', 'basis prestudy asthma age', 'fi coast study respiratory nasal', 'viral cause', 'hrv rsv', 'ed asthma intermittent asthma mild persistent asthma moderate persistent asthma', 'information detection respiratory virus jackson able risk illness due hrv rsv fi life diagnosis asthma life', 'risk asthma age child episode due hrv rsv infection age year life', 'asthma diagnosis age rsv infection fi life ci', 'fi rst life due asthma age', 'additional risk individual fi gure', 'jackson relation allergic sensitisation hrv development asthma coast study cohort table', 'aeroallergen sensitisation fi rst year life sensitisation risk asthma age', 'frequency asthma sensitisation hrv', 'aeroallergen sensitisation increase risk infant fi rst year life', 'third year life hrv eff ect asthma risk aeroallergen sensitisation', 'evidence aeroallergen sensitisation age association hrv development age', 'early life respiratory dominant risk factor diagnosis asthma age', 'kusel risk doubled age sensitisation common', 'risk respiratory time', 'eff ect allergic sensitisation respiratory infection risk asthma', 'respiratory infection allergic sensitisation independent risk eff ect synergistic', 'virus related respiratory tract initial clinical expression persistent many asthma', 'hrv confi virus question hrvs cause asthma', 'hrv widespread general population unlikely', 'several severe hrv related asthma', 'hrv aeroallergen sensitisation hrv aeroallergen sensitisation aeroallergen sensitisation hrv aeroallergen sensitisation third year life hrv aeroallergen sensitisation hrv aeroallergen sensitisation aeroallergen sensitisation hrv aeroallergen sensitisation', 'hrv human rhinovirus', 'permission jackson', 'table contribution rhinovirus aeroallergen sensitisation risk age dysfunctional antiviral immune cient production', 'second environmental tobacco smoke exposure promote severe hrv related asthma', 'third specifi c viral asthma', 'exclusive', 'extent association viral development much interest hrv development asthma', 'area research identifi cation essential inform understanding recurrent asthma viral respiratory', 'interplay host risk sensitisation area much research', 'asthma major cause morbidity asthma', 'major research place understanding many identifi cation infectious frequency viral respiratory asthma exacerbation host dependent risk synergistic role respiratory state', 'respiratory major cause asthma', 'bacterial asthma little evidence support theory', 'development pcr technology cause respiratory cult support growth', 'recent evidence hrvs main asthma respiratory infection asthma respiratory hrv', 'advent pcr technology number respiratory sensitive specifi', 'johnston age asthma', 'assessed', 'onset respiratory tract infection asthma respiratory tract viral', 'viral respiratory tract association asthma', 'due hrv', 'similar viral respiratory tract hrv', 'development application pcr assessment precise identifi cation respiratory asthma exacerbation research role contribution hrv', 'association pivotal virus forefront asthma research', 'asthma exacerbation respiratory', 'understand infection provoke asthma', 'interaction host infectious agent complex many gene environment gure', 'additional several respiratory infl uenza rsv identifi ed identifi ed', 'identifi cation large number hrv', 'diff er growth tissue culture inhibition specifi c antisera classifi hrv b basis genetic analysis', 'ed additional', 'identifi ed hrv group', 'several identifi ed respiratory group standard tissue culture application ↑hyper responsiveness molecular', 'analysis number full length c unique cellular', 'development tissue culture enable defi nitive information hrv c group', 'clinical importance new hrv c subject study', 'treatment hospital report systemic infection hrv c hrv epidemiology complex community season', 'prevailing season', 'view complex epidemiological large number diff erent long term population determine virulence hrv c', 'virulent identifi ed door preventive eff vaccination risk', 'little evidence asthma healthy', 'prospective study cold transmission ed partner asthma', 'extended duration illness severity respiratory', 'fi response infection frequency infection er', 'olenec nasal week group relation infection illness presence allergic sensitisation', 'infection upper respiratory tract duration severity allergic asthma non allergic asthma', 'viral likely cause loss asthma control allergic asthma non allergic asthma', 'nonallergic asthma twice rate asymptomatic infection', 'fi allergic asthma severe illness non allergic asthma infection respiratory', 'possibility abnormal antiviral activity several virus cytokine peripheral blood mononuclear', 'interferon γ viral', 'evidence mononuclear cell production interferon α interferon γ asthma hrv interferon γ pulmonary function', 'sputum response ratio interferon γ mrna mild rapid clearance virus', 'addition diff sputum evidence epithelial cell interferon asthma', 'wark bronchial epithelial culture asthma', 'relevant individual susceptibility infection primary site hrv infection airway', 'replication interferon β bronchial epithelial asthmatic fi gure', 'addition interferon β bronchial epithelial cell asthmatic virus replication', 'contoli co interferon λ bronchoalveolar asthmatic', 'inoculation fall lung function ie expiratory volume second proportional interferon λ generation fi gure', 'asthma defective antiviral reduced generation', 'conclusion unable confi rm epithelial cell interferon defi cient asthma', 'moreover hrv identifi ed diff asthma', 'many diff severity individual investigation', 'additional resolve diff', 'airway infl ammation pulmonary physiology respiratory understood', 'address message assessed infection asthmatic healthy', 'innoculation hrv similar illness respiratory lung function impairment bronchial hyper reactivity airway infl ammation asthmatic healthy', 'asthmatic healthy load respiratory bronchial hyper reactivity total function impairment neutrophilic eosinophilic airway infl ammation', 'virological clinical defi cient interferon γ', 'generation possible link risk factor allergic sensitisation susceptibility hrv infection', 'consistent fi clinical allergy viral risk acute', 'example presence viral respiratory tract relation patient atopic status asthma episode', 'distinct seasonal pattern percentage september november', 'hrv predominant respiratory virus admitted wheezing vs', 'serum ige healthy geometric iu ml vs iu ml aeroallergen test panel', 'allergic sensitisation important risk factor hrv infection ige dependent development cold', 'additional allergic risk virus asthma', 'johnston instrumental september northern hemisphere novel host environmental asthma', 'canada sharp emergency department asthma predictable year year', 'air pollution aff ect asthma', 'test hypothesis asthma school year viral respiratory emergency department community severe asthma acute care', 'emergency respiratory virus identifi ed pcr detection respiratory ed', 'detection respiratory high prevalence virus time year', 'school term high stress environment', 'conclude viral infection immediate trigger asthma exacerbation likely act cause september epidemic', 'clinical several explain respiratory allergic infl ammation cause wheezing', 'viral allergic infl ammation damage epithelium exacerbate morbidity', 'hand viral function epithelium lead absorption wall increase allergic infl ammation', 'hand hrv replication vitro epithelium undamaged epithelium induced damage epithelium viral replication lead severe clinical illness', 'notion exposure toxic eg tobacco smoke nitrogen dioxide risk viral wheeze', 'epithelium healthy distinct increased goblet laboratory evidence hrv replication', 'recent mechanistic evidence antagonistic relation allergic infl ammation antiviral immunity', 'example allergic infl ammation inhibit innate immune interferon c', 'gill cross engagement ige peripheral blood dendritic major contributor innate immune host defence inhibition virus interferon α secretion', 'dendritic key role allergic sensitisation development naive secrete ige production eosinophilic infl ammation', 'hrv infection allergic infl ammation epithelial secrete thymic stromal lymphopoietin cytokine act various dendritic diff erentiation allergic infl ammation', 'innate immune early life overproduction key suboptimum antiviral risk respiratory structure promote asthma', 'elaborate set hypothesis immunoinfl ammatory aeroallergen exposure respiratory defi severe asthma', 'time emergency treatment acute asthma exacerbation', 'postnasal blood acute convalescent period leucocyte phenotypic fl cytometry', 'respiratory virus hrv accounting', 'whereas monocyte dendritic cell upregulated expression chemokine receptor potential provoke infl ammation lung', 'upregulated expression high affi nity receptor ige concomitant gene expression signature phenotype', 'virus infection mice fi specifi c innate antiviral response dendritic natural killer pathogenesis virus wheeze asthma', 'allergic disease risk factor cold enable respiratory virus interact epithelium start asthma exacerbation', 'determination interactive insight provoked respiratory eff ective treatment', 'strong reproducible respiratory important development exacerbation asthma', 'past appreciation complexity association antiviral possibility hrv important process', 'many infl ammation arise respiratory airway dysfunction many gene', 'important step asthma pathogenesis eff ective']"
6ffde4d3288f780a7fdf52afbf21c7539a8b3ee7,lymph node node cell antigen concentration immune response day culture et al ten cell antibody synthesis antigenic stimulation humoral immune anti abortusovis antibody response cell culture culture medium bacterial dissemination fetal calf concentration ten day day milk pbs sheep lymph antigenic boost calf serum horse serum inactivated abortusovis node vitro secondary antibody vitro antigenic vivo lymph vivo unprimed anti salmonella antibody production concentration cell elisaspot elisa heat inactivated ig isotype induction antibody node culture presence fcs room temperature unprimed lymph vitro antibody abortusovis cell al pardon alkaline phosphatase antibody day bacterial concentration bacterium cell berthon et blue dye boost vitro bovine milk cell fcs cell sfc culture duration culture elisa dye exclusion fcs hs gibco h gibco heat high antigen igm igg lymphoid tissue min room pardon et pbs min phosphate saline plateau phase primary antibody primary immune response anti second week serum horse specific antibody stock suspension tap water tenth day trypan blue tween milk unprimed sheep vitro culture abortusovis al abortusovis antibody abortusovis elisaspot abortusovis igm adult horse antibody adsorption antibody elisaspot antibody presence antibody secretion antigen cell antigen microtiter assay vitro bacterial colonization berthon al calf adult cell concentration cell final cell igm cell induction cell viability,"['vitro culture induce salmonella antibody synthesis lymph node immunized unprimed culture presence heat', 'humoral immune specific antibody elisaspot secreted culture elisa', 'optimal secondary antibody response fetal calf serum horse serum antigen concentration ten cell', 'kind antigenic stimulation induction numerous antibody adsorption', 'maximal rate sheep put culture', 'kinetic antibody production lymph node phase sixth twelfth day culture plateau phase day', 'igm end', 'twelfth day antigenic stimulation igm isotype high antigen concentration cell concentration ten cell', 'anti salmonella igm specific lipopolysaccharide lps cell wall fraction bacterial', 'kinetic primary antibody vitro lamb lymph node defined', 'immune igm', 'anti salmonella igg tenth day culture', 'vitro induction antibody synthesis vivo unprimed sheep lymph node', 'methodology achievement detailed lymph node understanding bacterial dissemination lymphoid tissue', 'apc antigen cell fcs fetal calf serum hs horse serum ig lps author', 'ssdi e berthon al', 'veterinary lmmunology lmrnunopathology normal lamb serum pbs phosphate saline sfc spot', 'facultative intracellular brucella listeria major pathogenic domestic animal', 'pathogenesis step bacterial dissemination inoculation site liver spleen lymph', 'bacterial colonization lymph node inoculation area experimental subcutaneous pardon bacterial dissemination', 'host defense cellular humoral immune', 'immune lymph fundamental role control infectious process', 'lymphocyte late tenth day infection al responsible granuloma formation guilloteau et al', 'cell transfer protective efficient spleen anti brucella immunity mice plommet', 'antibody production b infection first evidence bacterial contamination', 'agglutinin opsonin specific lymphoid tissue bacterial colonization lymph pardon plommet plommet', 'suitable size development surgical trnka al al sheep represent model role lymph bacterial dissemination inoculation site', 'establishment experimental model infection salmonella abortusovis serotype specific sheep abortion mortality newborn et al opportunity study pathogenesis pattern natural host', 'mice experimental inoculation abortusovis infection similar salmonella typhimurium administration et al', 'intensity bacterial dissemination lymph bacterial strain virulence fontaine et expression host genetic resistance plant glynn hormaeche brien hormaeche maskell al', 'previous work intravenous subcutaneous inoculation sheep vaccinal strain abortusovis al pardon blood specific humoral immune response elisa animal susceptibility disease bacterial infection level spleen', 'bacterial infected abortusovis antibody blood v', 'gautier unpublished', 'understand bacterial dissemination lymph detail host phagocytic finlay falkow play antigen cell apc function node induction antibody synthesis vivo unprimed sheep', 'report vitro assay sheep lymph node culture abortusovis bacteria', 'vitro antibody synthesis antigenic stimulation anti abortusovis antibody elisaspot titration antigen specific culture elisa', 'comparison elisaspot elisa cellular level detailed approach ovine humoral immune response', 'vitro secondary antibody response different culture vivo lymph node du sud flock laboratory infectious pathology immunology', 'bacteria live vaccinal strain abortusovis al pardon et al month', 'unprimed lymph node france study vitro primary humoral immune response', 'sheep cell prescapular mediastinal precrural iliac hepatic lymph', 'represent mean individual standard sem', 'bacterial vaccinal abortusovis strain al pardon et inoculated sheep source antigen vitro lymph node cell immunoenzymatic elisaspot pardon et al', 'briefly ° c inoculated mice tryptic soy agar phosphate saline saline ph', 'bacterial', 'purity viable serial', 'antigenic leucocyte bacterial heat treatment h al', 'use saline x g °c min', 'appropriate culture medium see', 'step microtiter bacterial °c h overnight phenol saline min saline', 'stock suspension concentration appropriate dilution phenol saline °c', 'lymph node cell technique isolation sheep peripheral blood mononuclear', 'lymph mem gibco heat normal lamb serum nls u penicillin sigma mg ml streptomycin sigma nls mem', 'lymphoid small mem', 'cellular gauze remove cell ficoll gradient histopaque sigma', 'centrifugation min room temperature lymph node histopaque mem interface nls mem × g ° c rain', 'cell viability trypan blue dye exclusion test cell final concentration x viable ml culture medium', 'culture medium gibco heat inacti fetal calf serum fcs gibco heat inactivated horse serum hs gibco h mm l glutamine gibco h mm sodium pyruvate gibco h serva rpmi hs rpmi', 'lymph node cell vitro antigenic stimulation technique berthon et different heat inactivated abortusovis lipopolysaccharide salmonella abortusequi phenol extract sigma culture medium', 'lps antigen identical lps abortusovis le minor', 'antigenic boost vitro tissue culture flow lymph node cell suspension × ml heat bacterial × × bacteria', 'ten lymph node cell final final volume ml', 'medium serum fetal calf adult horse', 'control addition antigen ml culture medium', 'first sample ml fresh culture medium ml', 'time lymph node cell survival viable trypan blue dye exclusion test', 'duration culture lymph node culture', 'elisaspot microtiter flat nunc inactivated abortusovis', 'enumeration antibody elisas pot test necessary homogeneous regular coating antigen microtiter technique different elisa technique salmonella typhi kantele', 'microtiter ml aqueous solution overnight °c logtenberg et al', 'wash phosphate saline pbs ph stock bacterial suspension saline x bacteria overnight c pbs protein adhesiveness bovine milk pbs min room temperature wash pbs', 'elisaspot sheep lymph node vitro', 'culture cell berthon et al', 'briefly lymph node several fcs free', 'cell viability trypan blue dye exclusion several prepared fcs rpmi', 'negative b strain brucella abortus gramnegative bacterium antigenic cross reactivity diaz bosseray heat formol gift dr g dubray inra laboratory infectious pathology immunology nouz iuy france', 'h', 'b immunoenzymatic technique alkaline phosphatase conjugate holt bianchi al', 'present assay overnight incubation °c rabbit dako z pbs tween merck milk tweenmilk pbs', 'second incubation °c h alkaline phosphatase swine ig rabbit ig dako tween milk pbs', 'enzymatic activity substrate phosphate sigma agarose sigma holt rate ml overnight room temperature dark blue', 'alkaline phosphatase activity ml sodium hydroxide solution reading', 'olympus magnification', 'several several lymph node cell', 'different proportional leucocyte concentration', 'cell culture culture duration decimal logarithm spot cell sfc lymph node culture', 'anti abortusovis lymph node cell culture different elisa', 'whole specific ig isotype vitro', 'elisa microtiter', 'ml × dilution saline stock suspension abortusovis elisaspot', 'dry overnight tap water wash bacterial min ml cold v v acetone water solution', 'nonspecific binding bovine milk pbs min room temperature', 'lps fraction immobilized antigen microtiter nunc ml mg ml stock solution lps v v pbs glycerol mixture carbonate buffer ph', 'overnight incubation tap water pbs bovine milk', 'pbs culture supernatant unknown ml serial milk pbs h', 'positive specific serum hyperimmunized sheep reference sample test', 'negative ml fresh lymph node cell culture medium', 'whole anti salmonella peroxidase rabbit ig sheep igg h l nordic tween milk pbs min c ig isotype appropriate monoclonal beh sheep igm beh ascitic dr k j', 'beh csiro division animal health mcmaster laboratory glebe australia', 'min incubation ° monoclonal antibody detected peroxidase goat ig mouse igg h l rad', 'tween milk pbs °c', 'tap water tween saline', 'peroxidase activity boehringer substrate solution bernard et al', 'optical serial elisa logistic', 'underwent conversion linear determination sample dilution point inflexion logistic', 'antibody', 'antibody equivalent logarithm base sample dilution point inflexion elisa logistic curve', 'regard vitro induction secondary antibody response vivo lymph node vitro heat inactivated abortusovis cell table', 'day culture day day day', 'survival hs lps', 'antigenic boost vitro cell recovery control', 'survival presence concentration table vivo sensitized lymph node vitro heat inactivated abortusovis ten cell lipopolysaccharide', 'cell presence fetal calf serum horse serum', 'sample maximum antibody response logm maximal number spot scf culture mean sem n day culture peak immune response cell culture recovery day percentage culture mean sem fetal calf serum horse serum abortusovis cell second week culture', 'stimulation vitro ml mitogenic effect fraction lymph node', 'concentration cytotoxic concentration similar', 'similar range cell induction primary antibody response lymph node cell abortusovis leucocyte presence fcs table', 'lymph node immunized vitro salmonella', 'b table specific antibody abortusovis elisaspot technique', 'humoral immune response lymph node underwent antigenic boost vitro whole lps stimulation table', 'concentration antigen early weak response peak fourth day culture magnitude ten sfc', 'sfc day', 'profile magnitude sfc boost similar antigen concentration', 'b', 'vitro antigenic stimulation bacterium cell induction antibody synthesis fourth day culture', 'maximal sfc num table', 'control primed antigenic stimulation', 'time b abortus b antigen elisaspot sfc specific anti', 'parallel elisaspot technique enumeration specific antibody lymph cell determine abortusovis culture', '', 'technique fourteenth day antigenic stimulation cell fcs observed whereas sfc kind serum', 'b', 'kinetic fcs culture duration day plateau phase', 'vitro antibody hs', 'weak immune response fcs day maximal antibody titre ml concentration equal antibody day', 'antibody unstimulated lymph node cell culture', 'secreted inactivated bacteria effect antigen concentration response', '', 'immune antibody observed bacterial concentration', 'maximal day antigen ten cell fcs hs', 'serum cell antibody day day day identical sfc day presence bacterium cell sixth day culture presence ten cell', 'low bacterial concentration ten leucocyte day appearance sfc detection culture', 'antigen concentration cell interval lag', 'large amount antibody decrease antibody elisa', 'optimal vitro culture fcs hs antigen concentration order ten cell', 'ig anti abortusovis vivo lymph node cell fig', 'igm ten cell maximal igg antibody synthesis presence ten cell', 'humoral specificity kinetic identical inactivated whole', '', 'anti igg synthesis anti abortusovis production day lag magnitude', 'weak late response anti day culture bacterium cell', 'lymph node cell small early anti humoral response lps stimulation', 'immune igm igg antibody', 'igm identical whole anti abortusovis day antibody day', 'lps igm igm whole salmonella', 'day culture elisa fixed whole bacteria', 'vitro antibody synthesis primary immune response figure elisa vivo unprimed lymph node vitro antigen concentration heat leucocyte presence fcs', 'similar cell hs', 'kind humoral response igm eighth day culture', 'whole bacteria kinetic characterized peak day', 'secondary antibody response anti igm abortusovis igm', 'anti abortusovis whole second week culture tenth day', 'kind elisa technique antibody synthesis leucocyte antigenic stimulation', 'study new assay vitro antibody synthesis specific bacterial node unprimed lambs sheep intravenous route general antigenic sensitization lymph month present lymphoid et al', 'culture pig vitro viral al', 'sera available author laboratory elisa sera fetal calf adult horse devoid antibody cross', 'hence fcs ig free low mitogenic sheep leucocyte', 'vivo unprimed sheep lymph node serum culture medium supplement great difference cell culture', 'kind antigen stimulation vitro', 'cell concentration salmonella cell', 'abortusovis cell antigen concentration stock suspension salmonella', 'similar former bacterial concentration', 'culture report differ pig blood bacterial membrane pleuropneumoniae borthwick et al', 'case vitro carried form antigenic pulse h clear cytotoxic effect', 'culture lymph node inactivated abortusovis presence whole', 'month', 'inactivated salmonella exert cytotoxic effect sheep', 'vitro antigenic boost vivo lps study effect component cell wall gramnegative immune response sheep living whole', 'cytotoxic sheep', 'range ml mitogenic effect culture duration', 'vivo lymph node vitro boost induced weak short immune antibody response lack polyclonal activation salmonella specific b', 'vitro antigenic boost inactivated whole vivo sheep lymph node expression antibody response elisaspot elisa', 'secondary humoral immune response abortusovis specific low background control', 'identical elisaspot antibody presence fcs hs', 'vitro culture node presence fcs able secrete cellular level hs', 'antibody production vitro immunization', 'spontaneous antibody secretion vivo lymph node culture antigen', 'presence antigen concentration ten cell sfc fourth sixth day culture antibody culture day day', 'day enumeration antibody titration antibody berthon et al', 'berthon al', 'veterinary lrnmunology lmmunopathology vitro bacterial cell sfc lag elisaspot elisa culture antigen', 'detection related', 'reason antigen concentration ten cell good expression sfc great antibody adsorption chosen', 'kinetic vitro ascending stage day day plateau phase day', 'kinetic isolated immunized typhi vaccine kantele sheep mutant strain typhimurium al step narrow peak immunization', 'antigenic stimulation step long lasting humoral immune response', 'nature antigen presence lps wall nixdorff', 'secondary antibody sheep lymph node cell igm igg', 'similar ig vivo experimental infection sheep salmonella al', 'comparison antibody secretion weak late response respective biological igg levieux', 'second week cell igm antibody presence high antigen concentration cell igg low concentration ten cell', 'ig isotype expression different culture case igg antigen', 'elisaspot ig', 'anti abortusovis igm lps specific response anti abortusovis igg specific bacterial', 'agreement mice brown hormaeche', 'methodology study vitro primary immune lymph node cell', 'high antigen concentration cell culture cell culture secretion antibody', 'kinetic antibody production lymph node similar vivo', 'main difference humoral immune level ig isotype expression', 'unprimed lymph node secreted synthesized igm igg', 'anti salmonella igm anti lps', 'achievement primary antibody immunogenic negative antigen origin culture', 'thymus dependent dendritic real effective apc able stimulate resting primary immune response comparison apc bujdoso al', 'report first time induction antibody synthesis specific salmonella vivo unprimed lymph node', 'assay vitro antigenic stimulation sheep antibody detection elisaspot elisa detailed humoral immune response', 'immune reaction vivo identical vivo', 'culture partial reproduction physiological vivo', 'vitro rise lymph node immune relation expression host genetic resistance disease', 'bacterial dissemination lymphoid tissue']"
5eba29203084de16f501b71b64873f5c96ce55f2,kanni salem salem black water buffalo pprv infection pprv replication virus replication buffalo pbmc h gene barbari tellicherry inflammatory cytokine mrna expression pprv h qrt pcr basal expression type ifn differential susceptibility goat buffalo goat pbmc imiquimod pprv innate immune pbmc pprv poly c pprv goat susceptibility pprv c imiquimod gene expression ifna ifnc tellicherry kanni tnfa ifnc aldrich st amino acid barbari g buffalo differential cytokine mrna figure b g barbari g g genetic host human ifna ifna production lineage iv louis mo mg ml pbmc h pro inflammatory real time resistance pprv role ifna sigma aldrich st louis tlr ligand viral replication virus yield analysis nucleotide animal university association differential barbari figure biophotometer eppendorf black figure blood mononuclear bonferroni test buffalo downstream buffalo fold buffalo pprv clinical disease cm pprv complete gene confirm role contagious viral ct nt cytokine expression cytokine production difference ct different goat disease sheep effect prominent engagement pprv engagement synthetic expression immunomodulatory expression pprv expression tnfa fold change fold figure full length gapdh actin gene immune gene mrna gene specific goat gene goat plague goat water h mrna host genetic ifn production ifna mrna ifna pprv ifna treatment ifnc pbmc imiquimod treatment immune system,"['ovine goat plague important contagious viral disease sheep peste virus pprv', 'susceptibility plague different water exist', 'host innate immune system molecular surveillance toll', 'investigated role tlr differential susceptibility goat water buffalo pprv', 'replication peripheral blood mononuclear pbmc indian domestic water buffalo downstream correlation susceptibility vs resistance', 'susceptible goat tellichery innate immune increased viral basal expression', 'stimulation pbmc synthetic proinflammatory immunosuppressive interleukin il pprv resistant kanni salem black water transcriptional level pbmc', 'water buffalo ifn comparison transcriptional translational', 'pre treatment vero human ifna reduction pprv replication role ifna pprv replication', 'treatment antagonist reduction ifna pprv replication role', 'single nucleotide polymorphism analysis goat show nucleotide susceptibility vs resistance pprv', 'host genetic susceptibility genetic host', 'peste ppr ovine rinderpest goat plague acute contagious viral disease peste pprv family paramyxoviridae', 'disease high fever ocular necrotic ulcerative inflammation intestinal tract', 'pprv infection great economic productivity sheep subsequent global eradication rinderpest', 'example economic cost indian year', 'pprv replication seroconversion large', 'solitary report clinical pprv water buffalo later', 'ppr sudan sheep', 'ppr serious disease susceptibility sheep goat sheep', 'outbreaks sheep suffer high morbidity', 'strain specific virulence pprv breed different respond infection virus', 'speciesspecific disease occurrence foot mouth disease sheep severe infection virus', 'epizootic haemorrhagic disease virus cattle sheep suffer disease', 'recognised avian influenza virus aiv severe disease rapid death infection pathogenic aiv', 'reason specificity unclear present', 'natural susceptibility pprv several host virus derived', 'factor presence distribution specific viral lymphocyte activation molecule pprv morbilli canine distemper virus', 'host immune differential susceptibility explored detail ruminant', 'toll type transmembrane cell innate immune system pathogen molecular', 'intracellular tlr sense viral nucleic double stranded rna single rna cpg dna', 'imiquimod poly standard induce leading production inflammatory type immune cell maturation', 'tlr various water buffalo differential immune', 'cell specific location basal expression mrna natural pamp load tissue host resistance', 'addition differential expression ligand downstream cytokine role innate disease resistance', 'example mastitis important inflammatory disease udder prevalent jersey', 'temporal duration immune tumor necrosis factor tnfa ifnc intramammary inoculation pathogenic e', 'india indigenous', 'barbari common breed goat meat milk production northern india', 'tellicherry kanni salem black indigenous southern india', 'barbari southern india mortality', 'severe outbreak ppr tellicherry breed mortality', 'pprv infection subclinical kanni salem black', 'native water buffalo india resistant pprv', 'anecdotal evidence field differential resistance goat water buffalo available experimental evidence observed susceptibility', 'differential susceptibility various indian goat native water buffalo pprv innate immune resistance', 'infection peripheral blood mononuclear water buffalo differential viral replication inflammatory cytokine profile ifna ifnc tnfa differential activation', 'analysis single polymorphisms snps complete gene', 'relative basal expression naive pbmc quantitative real time rt pcr qrt pcr individual breed n', 'kanni salem black basal significant difference tellicherry figure', 'understand contribution virus replication goat mean tissue culture dose tcid pprv virus load h post infection pi qrt pcr specific pprv h gene tcid', 'pbmc barbari tellicherry pprv replication kanni salem black figure similar', 'significant reduction virus yield log kanni salem black pbmc barbari tellicherry', 'pre stimulation pbmc tlr poly imiquimod reduction pprv replication', 'difference ct h gene mrna unstimulated poly c pbmc figure', 'case pre stimulation imiquimod difference ct tellicherry salem black figure', 'comparison viral load pprv h gene mrna infective viral imiquimod treatment significant reduction viral load kanni salem black tellicherry', 'tcid poly pbmc h mrna expression different figure', 'order investigate specific disease outcome permissiveness goat buffalo pbmc pprv replication vitro', 'water buffalo fold replication pprv goat pbmc', 'log difference virus yield evident buffalo goat pbmc pprv infection figure b', 'understand mechanistic basis differential permissiveness virus replication different goat vs water buffalo downstream effector', 'pbmc poly c imiquimod pprv analyzed expression tnfa ifnc ifna mrna figure', 'upregulation inflammatory goat kanni salem black treatment c imiquimod pprv', 'effect prominent case pprv pbmc ifna ifnc kanni salem black barbari figure', 'significant tellicherry inflammatory cytokine mrna', 'consistent immunosuppressive cytokine barbari figure', 'mrna expression salem black poly c imiquimod figure b', 'cytokine elisa tnfa figure ifna figure ifnc figure', 'cytokine similar mrna expression qrt pcr figure c', 'pprv pbmc kanni salem black production ifna ifnc', 'poly c imiquimod production ifna kanni salem black engagement pprv', 'determine induction pro inflammatory water buffalo respective pbmc pprv', 'mrna buffalo pbmc ifnc goat pbmcs', 'ifna activation buffalo fold figure', 'confirm observation ifna protein culture define association differential pprv replication ifna expression ability viral replication human recombinant ifna', 'mean ct value pprv h gene expression vero ifna treatment', 'pre treatment vero pprv h gene expression', 'dose ifna ng ml replication fold figure', 'confirm role ifna induction pprv goat buffalo pbmcs predetermined optimum concentration mg ml antagonist prior imiquimod treatment pprv infection', 'ifna mrna irs treatment pbmc imiquimod pprv figure b', 'confirm role ifna virus replication medium cm pprv pre treat pbmc virus infection figure', 'percent inhibition virus replication cm buffalo pbmc goat pbmc figure', 'determine differential ifn pro inflammatory cytokine production kanni salem vs barbari tellicherry dependent single nucleotide tlr complete gene sequence', 'gene pcr full length gene goat sequence genbank template accession', 'barbari tellicherry kanni goat genbank accession', 'nucleotide goat', 'sequence analysis nucleotide region nucleotide untranslated region', 'nucleotide salem c c g barbari g barbari g g amino acid', 'synonymous amino acid different goat', 'addition barbari salem g g barbari g g', 'eradication focus pprv potential virus eradication', 'single serotype pprv availability efficacious live vaccine sensitive diagnostic economic impact disease ability new geographical attractive target', 'ppr india sheep lineage iv virus massive outbreak northern india lineage iv virus', 'live specific lineage iv pprv india', 'susceptible pprv sheep contract clinical disease', 'mortality lambs susceptibility african european', 'differential susceptibility goat india', 'host genetic particular major histocompatibility complex mhc susceptibility disease', 'virus recognition genetic interaction virus host', 'particular non genetic host tlr pathogen recognition hamper innate immune activation', 'visna infection sheep dependent susceptibility disease individual susceptibility breed specific', 'related morbillivirus snps tlr myeloid differentiation primary response gene immune human', 'single double rna', 'key viral infection dsrna stage life cycle', 'immune plasmacytoid dendritic substantial type ifns response viral rna', 'study basal pbmcs pprv resistant goat salem black', 'engagement synthetic poly imiquimod suppression pprv infectious virus yield pbmc', 'role recognition rna goat pbmc role cytosolic rna retinoic acidinducible gene rigi melanoma differentiation study', 'complete abrogation viral gene expression stimulation c rigi protein r pkr', 'expression pprv clinical disease level virus replication clearance innate adaptive', 'cell surface receptor pprv slam', 'virus replication pbmc water permissive pprv infection', 'level multi cycle virus replication', 'pprv replication water buffalo pbmc type ifn production virus infection', 'pprv replication human ifna pre vero cm virus low role type ifn virus replication', 'human ifna suppress replication bovine viral diarrhea virus bovine parainfluenza virus', 'pivotal role induction modulation immunological', 'tlr lead activation nuclear factor kapp light chain enhancer b nfkb interferon regulatory factor irf switch expression specific panel pro inflammatory activation normal', 'activation tlr production release type ifns', 'engagement synthetic lead cytokine expression similar pprv infection weak production goat pbmc', 'inflammatory cytokine repertoire expression tnfa ifna ifnc mrna protein', 'tlr engagement pprv infection inflammatory cytokine production canonical nfkb pathway type ifn production activation irfs', 'stimulation synthetic rna production tnfa ifnc pbmc', 'ifnc pbmc engagement respective', 'ifnc production nk secreted tlr dcs', 'buffalos mrna protein type ifn role virus replication buffalo', 'ifna production critical antagonist ifna production imiquimod pprv goat buffalo pbmc', 'effect prominent buffalo pbmc ifna production pprv replication efficiency', 'consistent inflammatory cytokine environment pprv infection expression immunomodulatory cytokine high pprv susceptible goat tellicherry', 'key regulatory cytokine immunosuppressive uncontrolled inflammatory response', 'addition maturation antigen proliferation differentiation dependent suppression antiviral', 'immunosuppressive drug immunosuppression expression', 'experimental immunosuppression goat dexamethasone challenge virulent pprv immunosuppressed viremia extensive severe disease advancement significant decrease number high antigen load various mortality rate', 'basal expression kanni salem inflammatory cytokine expression immunomodulatory enhanced antiviral state susceptibility pprv infection', 'buffalo type ifn response infection resistance pprv', 'goat gene long open reading frame amino', 'nucleotide sequence homology relationship ruminant', 'indian goat total polymorphic present region', 'toll receptor tir domain sequence conserved crucial role tlr downstream', 'study sequence analysis nucleotide region nucleotide', 'synonymous difficult correlation specific snp susceptibility pprv goat', 'repeat different', 'unable demonstrate positive association differential susceptibility pprv goat gene immune relationship susceptibility pprv infection genetic host', 'gene different polymorphic synonymous snp leucine rich', 'presence snp lrr buffalo gene responsible pamp snp differential sensing pprv', 'correlate snp buffalo differential response buffalo pbmc pprv', 'qrt pcr sybr green chemistry', 'fold change mrna expression imiquimod pprv stimulation mock cytokine mrna expression calibrator', 'replication goat buffalo pbmc h h presence medium cm pprv', 'expression viral hemagglutinin h mrna percentage inhibition viral replication presence cm control pbmc pprv role basal expression infection study', 'addition tlr intracellular role', 'conclusion basal innate antiviral immune infection resistance pprv infection kanni salem barbari tellicherry', 'type ifn infection water virus replication virus clearance', 'lrr prediction goat lrrs buffalo lrrs', 'difference lrr critical factor goat buffalo', 'future immunogenetic immune response pprv', 'animal committee veterinary animal university india', 'healthy month old barbari tellicherry kanni salem black sex similar research station nadu veterinary animal university india', 'pprv record disease course study', 'pbmc tlr mrna expression analysis pprv infection tlr pbmc breed', 'live pprv strain department veterinary microbiology veterinary college india', 'imiquimod mg ml polyionosinic polycytidylic acid synthetic analog dsrna poly c mg ml invivogen san diego free water', 'e toxate kit limulusam ebocyte lysate sigma aldrich st louis mo free', 'blood jugular vein sterile ethylene diamine tetra acetic acid edta vacutainer dickenson cambridge uk pbmc isolation', 'briefly blood equal paisley uk medium antibiotic antimycotic solution ml histopaque specific gravity sigma aldrich st louis mo min', 'mononuclear interface min', 'viability trypan blue dye exclusion method', 'pbmc predetermined poly', 'h cytokine transcript analysis', 'separate experiment tlr ligand tcid pprv', 'virus un pbmc h pi sybr green quantitative real time reverse transcription polymerase chain reaction qrt pcr specific pprv h gene', 'infective virus pbmc vero tcid ml', 'total rna pbmcs tri reagent solution sigma aldrich st louis mo permanufacturer', 'rna concentration purity biophotometer eppendorf hamburg germany', 'mg total rna reverse oligo dt high capacity archive kit carlsbad', 'basal expression pbmc gene specific taqman', 'qrt pcr triplicate cycle min real time pcr system carlsbad', 'cytokine gene expression green qrt pcr gene specific carlsbad available request', 'unstimulated pbmc control', 'ct ct nt ct mean sample ct nt mean house control group gapdh actin treatment target gene gapdh actin slope', 'slope serial respective ct pcr efficiency slope', '', 'expression fold change respective basal endogenous control gene ct antigen capture tnfa abdserotec kidlington uk ifna mabtech sweden ifnc cusabio biotech china determine cytokine culture tlr ligand pbmc', 'elisa manufacturer elisa reader epoch micro volume spectrophotometer system biotek winooski vt nm', 'mock cell culture supernatant control', 'tnfa ifnc corrected optical density tlr ligand infected culture mock', 'ifna experimental', 'blood barbari tellicherry kanni salem black genomic dna blood dna isolation kit biobasic usa', 'concentration dna biophotometer eppendorf germany', 'full length gene available pcr big dye terminator cycle', 'kb contig bp open reading frame', 'sequence animal multiple nucleotide lasergene software dnastar madison wi', 'heterozygous different individual chromatogram chromas lite technelysium queensland australia', 'polymorphic amino acid position change', 'statistical analysis graphpad prism software', 'ct fold induced cytokine mrna expression pprv h gene yield tcid determination way bonferroni test multiple', 'elisa pprv h gene ifna treatment way bonferroni test multiple', 'different p value']"
0d8784d230453109b9340461f2692f0f2d048927,figure b western blot cell lysate nodule formation cp loop bone nodule palmitoylation interaction antiviral activity bone formation immune activity molecular mass wild type absence presence anti flag role palmitoylation b western gene expression ifitm family low molecular sigma aldrich acid sequence blot co co immunoprecipitation figure c flag agarose palmitoylation domain role spalmitoylation study palmitoylation absence lane addition palmitoylation agarose gel amino acid antigen gene band position chemical reporter class antigen correct membrane cysteine cp cysteine palmitoylation differentiation medium expression plasmid expression vector hcl ph high low immunoprecipitation wild inhibitor palmitoylation interaction osteoblast lysate immunoprecipitation necessary interaction palmitic acid palmitoylation bone panel figure sds page specific interaction translational modification tris hcl able interact absence cell absence figure acid cysteine acid inhibitor activity formation activity virus amino terminal b cell b ref band upper blot analysis cell expression cmv neo complex expression complex formation contribution interaction cys mutant cysteine cys cysteine ii cysteine osteoblast cysteine thioester cytoplasmic cp dissociation complex domain cp domain necessary e coli e expression effect palmitoylation expression interferon expression relevant figure figure flag peptide flag primary formation complex functional mechanism g min ge healthcare h l hydroxylamine treatment igg h immune system important bone infection internalization,"['interferon transmembrane family important target activity virus infection', 'protein translational modification fatty cysteine palmitoylation crucial role antiviral activity', 'cysteine transmembrane domain cytoplasmic cp loop', 'mammalian ifitm family palmitoylation significant', 'ifitm family protein protein form order complex osteoblast expression relevant', 'study role spalmitoylation interaction interaction key process gene expression', 'reporter acid inhibitor palmitoylation acid palmitoylated addition', 'cysteine cp loop', 'immunoprecipitation western blot interaction presence', 'mutant palmitoylation site domain interaction', 'palmitoylation interaction', 'bone nodule formation presence bone formation factor', 'experiment morphological aberration bone nodule', 'palmitoylation formation', 'citation tsukamoto li x morita h minowa aizawa et al', 'role palmitoylation interaction osteoblast', 'plos', 'interferon transmembrane ifitm protein family fragilis family part family double transmembrane α cytoplasmic cp loop extracellular ec amino terminal polypeptide figure', 'ifitm', 'recent genomic research ifitm', 'diverse biological cell maturation gastrulation cell cell adhesion antiviral activity bone formation detailed unknown present', 'particular target intensive activity virus infection internalization', 'dr yount co antiviral activity dependent palmitoylation protein', 'palmitoylation post translational modification fatty palmitic certain cysteine thioester linkage figure', 'modification protein unique membrane immunoreactivity amino acid sequence alignment', 'black', 'red sequence top bottom', 'unique gray', 'second transmembrane extracellular cytoplasmic loop ec', 'tm sosui', 'terminal region blue', 'schematic illustration protein palmitoylation', 'palmitic cysteine thioester linkage', 'palmitoylation depalmitoylation protein', 'study hydroxylamine nh oh linkage', 'acid sequence identity similarity summarized', 'doi protein protein interaction', 'palmitoylated membrane proximal domain cp loop figure', 'addition palmitoylation cell membrane antiviral activity', 'moreover manner intracellular localization', 'resent study murine cysteine palmitoylation antiviral activity protein stability', 'ifitm family role spalmitoylation significant', 'bril protein', 'ifitm family unique', 'expression ifitm family expression region upstream gene regulatory', 'expression osteoblast ifitm ii', 'amino acid sequence similarity amino acid sequence dissimilar similarity share similarity figure c', 'addition aspartate rich domain c terminal region calcium binding figure', 'iii role bone formation expression mineralization bone formation process osteoblast', 'previous expression bone', 'knockout', 'gene small hairpin rna bone nodule formation overexpression gene increase calcium uptake bone nodule formation', 'iv role immune activity recent protein form prostaglandin receptor negative regulator fprp complex', 'complex interferon bone marrow stromal cell antigen interferon inducible protein irgm protein tetratricopeptide class antigen gene', 'involved bone formation immune system activity', 'study palmitoylation role interaction osteoblast', 'plasmid dna mouse presence chemical reporter acid inhibitor palmitoylation acid', 'biochemical wild type', 'spalmitoylation site prepared cysteine cys', 'chemical reporter', 'interaction immunoprecipitation loss interaction presence', 'result', 'palmitoylation domain necessary interaction', 'hand cp loop involved interaction', 'interaction important relevant gene expression role palmitoylation interaction regulate immune activity osteoblast', 'possible interaction mechanism effect palmitoylation bone nodule formation', 'mammalian cell expression plasmid type flag inserting cmv neo expression vector takara bio shiga japan', 'dna', 'prepared quikchange site mutagenesis kit stratagene la jolla', 'plasmid cys constructed inserting cmv neo expression vector', 'e expression plasmid vector gene novagen madison wi expression vector', 'primer reverse primer amplify gene entire plasmid vector mammalian cell expression', 'underlined ndei xhoi cleavage site', 'quikchange site mutagenesis kit', 'sense anti sense sigma aldrich st louis mo', 'cell bank rcb', 'culture transfection protein expression', 'necessary acid wako japan sigma aldrich dimethyl sulfoxide dmso wako differentiation medium dmso', 'wild type mutant e recombinant expression system', 'e expression plasmid grown lb medium μg ml ampicillin', 'hour induction mm isopropyl β dthiogalactopyranoside iptg centrifugation × g min', 'mm tris hcl ph french press tokyo japan mpa ×', 'crude membrane fraction ultracentrifugation × g min', 'fraction n dodecyl β dmaltopyranoside ddm dojindo lab kumamoto japan tris hcl ph nacl imidazole', 'ultracentrifugation supernatant ni agarose resin qiagen germany', 'resin chromatography column mm imidazole mm tris hcl ph nacl ddm', 'ddm collected elution buffer imidazole', 'sample appropriate buffer solution ge healthcare uk ltd amersham place england', 'experimental previous', 'briefly total osteoblast total protein extraction kit institute inc newark', 'cell lysate anti flag agarose aldrich h recover ng μl × flag peptide sigma saline gel h total sds page epagel tokyo japan western blot', 'polyclonal antibody amino terminal peptide sequence tsypredprapssrc anti flag monoclonal antibody sigma aldrich primary', 'hrp goat anti rabbit igg h l francisco mouse igg h l sigma aldrich secondary flag primary', 'chemiluminescent reaction merck millipore billerica', 'cell lysate osteoblast incubated anti flag agarose gel purified flag', 'azide peg tamra click chemistry scottsdale az reference previous manufacturer guide', 'sds page laser excitation fluorescence tamra long path filter typhoon fla ge healthcare', 'osteoblast density mm α eagle medium α mem sigma v v fetal bovine serum fbs nichirei japan', 'next day differentiation medium mm glycerophosphate μg ml sodium final osteoblast differentiation', 'necessary μm dmso dmso differentiation medium final', 'co', 'red sigma aldrich', 'standard staining procedure', '', 'palmitoylation plasmid dna absence presence palmitoylation figure', 'cell lysate total protein use sds page western blot', 'e coli absence cell lysate', 'figure b western osteoblast e', 'osteoblast single band molecular mass marker lane absence', 'presence lane band position absence lane', 'high low molecular mass absence presence', 'palmitoylation reversible reaction strong reductant hydroxylamine', 'hydroxylamine treatment lane band position presence lane', 'prokaryote e coli translational modification palmitoylation occur', 'hence band position lane', 'case palmitoylation induce change mobility electrophoresis present', 'direct observation palmitoylation chemical reporter figure', 'osteoblast plasmid presence label protein', 'extraction purification cell lysate ligated tamra cu azidealkyne cycloaddition method', 'gel fluorescence image lane figure', 'flag tag influence modification chemical labeling', 'addition hydroxylamine treatment lane fluorescence weak dissociation mechanism dissociation palmitic acid reduction lane figure', 'native osteoblast', 'addition high low molecular mass western blot analysis depalmitoylated', 'introduction cysteine palmitoylation', 'cp loop figure', 'mammalian family figure', 'modification site prepared cysteine cys', 'osteoblast plasmid absence cell lysate', 'figure b western blot expression', 'cys low molecular mass form', 'result involved palmitoylation', 'addition figure strong weak fluorescence mutant absence presence hydroxylamine mutant', 'rest cysteine mutant cys mutant palmitoylation', 'cysteine', 'addition palmitoylation domain major effect mobility gel panel figure figure', 'hereafter high low molecular mass', 'western blot analysis mutant mutant cys mutant', 'previous', 'family transmembrane domain', 'interaction important immune activity formation complex expression interferon irgm mhc class antigen gene', 'investigate effect palmitoylation interaction immunoprecipitation assay', 'osteoblast transfected cultured absence presence', 'cell lysate anti flag agarose gel', 'gel several', 'eluted addition flag peptide', 'conserved orange', 'panel correspond residual number', 'calculation probability total mammalian encyclopedia database', 'sequence alignment clustalw', 'sequence logos weblogo', 'b western blot wild type cysteine osteoblast', 'detection antibody primary antibody', 'upper arrow spalmitoylated', 'lane cys lane', 'experiment', 'doi step', 'figure western blot co immunoprecipitation fkbp flag', 'band upper panel', 'cell lysate immunoprecipitation', 'palmitoylated absence lane presence see lane', 'immunoprecipitation single band appeared absence lane interaction', 'presence band corresponding lane', 'palmitoylation interaction', 'investigated relationship spalmitoylation interaction', 'osteoblast cultured', 'immunoprecipitation way', 'figure b western blot co immunoprecipitation wild type', 'figure c control experiment cell lysate immunoprecipitation', 'previous section band upper immunoprecipitation anti flag agarose gel', 'panel figure b single observed mutant', 'result wild type mutant interact whereas', 'tendency trend palmitoylation domain cys panel figure c', 'palmitoylation interaction previous section figure figure palmitoylation site able interact', 'palmitoylation necessary interaction', 'introduction previous formation', 'investigated influence spalmitoylation bone nodule formation native', 'figure time dependent nodule formation absence presence figure b', 'figure c trial effect dmso solvent nodule formation', 'nodule red calcium', 'figure area experimental time', 'absence figure mineralization initiation cell differentiation day', 'hand presence figure nodule day', 'halftime maximum mineralization presence absence figure', 'addition', 'figure e view nodule day', 'presence panel b whereas absence large cluster', 'palmitoylation bone nodule formation osteoblast', 'study palmitoylation osteoblast', 'share sequence similarity figure cysteine cp loop', 'hand similarity cysteine domain cysteine cp loop', 'account high conservation ifitm palmitoylation case', 'palmitoylation palmitoylation crucial correct membrane resistance viral infection internalization figure detail', 'recent study palmitoylation important membrane', 'know role spalmitoylation membrane present proper antibody immunohistochemistry much time search considerable number', 'dr co domain cp loop anti flag primary', 'existence protein palmitoylation', 'western blot co immunoprecipitation wild type flag osteoblast absence presence', 'control verify existence immunoprecipitation show immunoprecipitation', 'experiment', 'b western blot co immunoprecipitation wild type cysteine osteoblast', 'band flag molecular mass flag relative', 'experiment figure b verify present cell lysate immunoprecipitation', 'experiment', 'functional mechanism previous', 'ii correct membrane iii antiviral activity influenza virus', 'functional mechanism present previous', 'cysteine ii', 'palmitoylation interact', 'dissociation complex formation complex relevant gene expression', 'formation unknown iii important bone formation present present interactive protein', 'hand partner palmitoylation significant contribution interaction', 'oligomer cell physiological function', 'contain relevant modification ability interact', 'present study palmitoylation domain necessary interaction', 'speculate face interaction surface interact palmitic acid cysteine figure b detail', 'investigation involved spalmitoylation contribute interaction', 'speculate loop domain contribution interaction', 'previous heterologous fibroblast direct cell receptor protein hydroxysteroid dehydrogenase', 'palmitoylation low molecular mass form figure b ref', 'figure b ref', 'fibroblast palmitoylation insufficient', 'native osteoblast nonspecific', 'consideration palmitoylation specific interaction osteoblast', 'role palmitoylation immune activity present previous', 'specific interaction necessary form complex', 'member tetraspanin membrane family component b cell coreceptor complex b cell immune', 'complex partner protein complex osteoblastspecific expression interferon mhc class antigen gene', 'spalmitoylation specific interaction complex induced gene expression associated complex', 'respect speculate immune system activity interaction immune activity', 'addition palmitoylation nodule formation morphology time mineralization figure', 'difficult conclude present lack palmitoylation diffusion bone panel b figure palmitoylated presence', 'inhibitor palmitoylation many metabolic', 'difficult interpret long term incubation presence', 'case key role palmitoylation bone formation', 'figure possible mechanism interaction role osteoblast cell function comparison', 'case figure', 'ii', 'palmitoylation correct membrane iii', 'spalmitoylation crucial resistance influenza virus', 'spalmitoylation significant decrease antiviral activity', 'hand figure b case', 'cysteine ii', 'able interact', 'interaction palmitic acid cysteine interaction surface', 'palmitoylation interaction', 'present little known role palmitoylation localization membrane', 'palmitoylation localization case membrane', 'loss interaction relocalization association iii', 'spalmitoylated complex dissociation complex expression relevant', '', 'unknown present illustrated figure b important bone mineralization osteoblast', 'lack palmitoylation interaction complex formation gene expression', 'addition bone nodule formation', 'note role spalmitoylation formation', 'indicated palmitoylation regulation immune activity formation', 'conclusion palmitoylation role interaction', 'immune activity mineralization osteoblast palmitoylation', 'general functional role palmitoylation different protein', 'many depalmitoylation cycle constitutive', 'present difficult address palmitoylation constitutive osteoblast', 'underway']"
7d286a7255cf820dba6ea89a13764045161ddbea,neck domain dc signr repeat unit dc sign residue position sign dc domain dc gel filtration position repeat repeat position crystal structure leucine position leucine residue stability neck terminal repeat acid repeat arginine residue differential calorimetry domain repeat fragment repeat full extracellular methionine position methionine residue nacl mm number repeat position arginine present position side chain stable repeat adjacent crd arginine position circular dichroism cl ph domain stable form stable glutamic acid high mannose mm tris natural neck ph mm phenylalanine residue residue present structure neck tris cl bridge glutamic carbohydrate recognition coiled coil denaturation temperature extracellular fragment extracellular portion helical structure heptad pattern loss stability mm cacl mm nacl portion neck portion receptor presence glutamine presence repeat repeat domain room temperature salt bridge signr neck structure stability tetrameric coil uniform neck unit adjacent version neck acid residue adhesion nonintegrin affinity chromatography assess effect bglii digestion buffer nacl c terminal calorimetry circular cell adhesion cell specific chromatography sepharose coil arginine coil structure contrast dc crd fig dendritic cell dichroism presence different sugar dna sequence domain gel domain leucine domain methionine end repeat expression vector extracellular sign filtration analysis filtration calorimetry final repeat formation sign full repeat generate dna glutamine position,"['human dendritic cell specific intercellular adhesion nonintegrin dc sign sinusoidal endothelial cell receptor dc signr l sign related sugar binding', 'dc sign pathogen endocytic receptor cell adhesion molecule dc signr pathogen function', 'addition sugar recognition sequence adjacent neck coil tetramerization acid repeat', 'series model uniform repeat gel filtration differential calorimetry circular dichroism', 'repeat stable first position heptad pattern hydrophobic coil arginine residue surface coil bridge glutamic acid residue polypeptide chain', 'dc signr stable repeat carbohydrate recognition', 'contrast stable repeat membrane dc sign', 'presence formation repeat carbohydrate recognition dc sign', 'neck sign dc contribute different sugar different', 'sugar immune system way distinguish host', 'work subtle related way interact display similar', 'human dc sign dendritic cell specific intercellular adhesion nonintegrin dual role adhesion receptor receptor', 'cell adhesion function ability receptor lewis x trisaccharide surface', 'receptor bear high mannose rich lewis x epitope', 'dual binding specificity part accommodation high mannose site type carbohydrate recognition domain crd portion receptor', 'contrast related human receptor dc signr high mannose interact viral', 'receptor l sign expression sinusoidal endothelial lymph specific cell', 'dc sign dc similar overall organization multivalent viral cell', 'terminal cell surface neck multiple acid repeat', '', 'information sign dc interest site underlie ability human immunodeficiency virus hiv nile virus infect', 'recent quantum evidence arrangement different', 'dc sign single form full repeat partial repeat unit polymorphisms gene dc signr result number neck variation susceptibility infection', 'facilitate analysis oligomer formation dc sign dc signr strategy purification neck addition sequence cterminus neck domain point crd fig', '', 'neck domain cluster histidine purification resin', 'approach neck domain receptor function oligomerization domain form membrane anchor crd', 'structure repeat domain dc signr unusual crystal form unit cell single repeat unit context fragment repeat', 'repeat unit short n terminal nonhelical region proline residue coiled coil region', 'heptad pattern leucine isoleucine valine helical region coiledcoil neck domain tetramer', 'similar organization neck dc sign dc signr differ important', 'instance neck domain dc much stable thermal denaturation neck domain dc sign', '', 'way individual repeat structure stability neck domain', 'force extracellular sign dc signr consistent presence acid repeat structure', 'detailed structural information neck domain dc sign available', 'goal present sign dc signr order understand sequence different polymorphic signr', 'analysis key organization extracellular', 'different crystal terminal portion dc signr limited', 'similar sign alternative approach confirm presence little influence formation sign', 'ability domain interact full extracellular portion receptor', 'significant stabilize additional formation full extracellular portion receptor mixed neck domain full extracellular fragment', 'neck domain extracellular fragment dc sign mixed allowed renature fractionation protein mannose sepharose affinity column column edta', 'neck domain bind sepharose represent purification mixed full extracellular fragment fig', '', 'fact different random fashion consistent interpretation formation sign independent neck domain', 'information', 'n terminal extracellular sign dc signr consist short region acid repeat half repeat unit divergent repeat', 'previous dc signr nonrepeat region terminus partial repeat unit end change stability neck domain denaturation temperature differential calorimetry', 'similar truncation neck domain dc sign fragment tetramer room temperature denaturation temperature calorimetry close value full length neck domain', 'dc sign dc signr stability full repeat terminus neck domain', 'divergent sequence terminal repeat unit dc signr adjacent crd fig', '', 'crystal structure neck domain reveal contribution variant density average repeat unit c terminal repeat unit repeat', 'structure crd dc signr portion neck terminal repeat unit splayed apart', 'key feature terminal repeat unit phenylalanine residue position', 'unit position valine residue part heptad hydrophobic characteristic coil', 'valine side chain able pack coil phenylalanine side chain large', 'variation final repeat unit special part neck domain positioning broad spacing', 'unusual terminal repeat unit key point variation dc sign dc signr position repeat residue heptad pattern primary structure helix crystal structure', 'repeat visible crystal structure dc signr neck domain repeat position leucine residue core coil fig', '', 'leucine residue present repeat sign', 'assess effect residue position structure stability neck domain domain repeat leucine residue position', 'gel filtration version neck domain stable tetramer room temperature position natural fragment neck domain dc signr repeat tetramer fig', '', 'analysis differential scanning calorimetry uniform neck domain stable equivalent portion natural dc signr neck domain thermal denaturation temperature natural neck domain fig', '', 'reason stability natural neck domain presence destabilizing c terminal repeat unit', 'addition uniform neck domain residue position residue glutamine glutamic acid several repeat natural neck domain', 'crystal structure neck domain arginine residue bundle bridge glutamic acid side chain position fig', '', 'salt bridge hydrogen bond stability repeat', 'prototype sequence neck repeat unit high stability present position coil arginine present position salt bridge bundle', 'addition stability minor sign dc signr number polymorphic signr', 'compare multiple repeat unit leucine position arginine position', 'stability neck domain gel filtration analysis single peak repeat repeat monomer fig', '', 'similar stability differential calorimetry transition absent version repeat', '', 'high tetramer formation possible tetramer fragment repeat', 'version evidence tetramer formation gel filtration calorimetry', 'fig', 'repeat conformation crystal structure', 'number repeat ratio', 'small helical pitch coil', 'formation bundle similar effect', 'slight decrease intensity cd signal repeat unit neck repeat consistent gel filtration coiledcoil tetramer equilibrium monomeric structure concentration gel filtration cd analysis', 'molar good quality spectra formation estimate effect partial dissociation fragment repeat', 'contrast fragment repeat significant loss helical structure ratio consistent conclusion fragment form stable', 'stable coiled coil structure presence repeat', 'leucine residue present position repeat sign position glutamine residue repeat methionine residue present repeat unit', 'assess effect variation position structure stability neck domain repeat glutamine methionine position repeat unit', 'contrast homogeneous neck domain leucine position repeat unit identical neck domain glutamine present position repeat unit fail form stable', 'room temperature allglutamine version neck domain gel filtration fig', '', 'neck domain yield clear denaturation transition differential calorimetry consistent absence stable', 'circular dichroism analysis presence helical structure molar ellipticity neck domain leucine position', '', 'glutamine version neck domain comparable leucine neck domain', 'glutamine version static dichroism experiment stable observed filtration experiment', 'analog neck domain methionine position repeat unit defined denaturation peak calorimetry diminished helical content fig', '', 'case ratio molar ellipticity helix formation formation domain', 'oligomeric state gel filtration gel filtration calorimetry circular dichroism presence glutamine position neck domain repeat unit compatible formation tetrameric coil repeat unit sequence conformation repeat unit leucine position glutamine form stable', 'contrast methionine residue position conformation', 'final unusual feature dc sign neck domain tryptophan residue position fourth repeat unit', 'substitution little effect behavior neck fact substitution first portion neck domain dc signr arginine residue position portion sign removal tryptophan residue detectable effect stability neck domain', 'dc sign subject rapid genetic change', 'acid repeat domain present', 'divergent homologous mice', 'key amino neck comparison dc sign dc signr potential functional genetic fig', '', 'distinct structural dc signr presence leucine residue position last repeat presence unusual phenylalanine residue position repeat unit adjacent crd variation number repeat', 'contrast dc sign diversity stable repeat position arginine position membrane repeat terminal end glutamine position', 'methionine residue present position repeat neck domain', 'conservation spite variation number repeat specific different functional', 'crystal structure neck domain dc signr average different present', 'repeat residue position vary position', 'full extracellular portion dc signr', 'possible methionine position repeat natural neck domain dc sign mixture position different repeat strategy spectroscopy calorimetry gel filtration variation structure repeat position', 'combination information repeat position arginine position form stable tetrameric', 'arginine residue position loss salt bridge glutamic acid residue position destabilization introduction alternative position destabilizing', 'summary sign dc signr figure presence leucine residue position arginine residue position high proportion repeat', 'appropriate stability coil', 'loss stability presence glutamine residue position surprising favorable hydrogen glutamine trimeric glutamine side chain interior tetrameric coil', 'circular dichroism presence glutamine compatible coiled coil structure signal loss stability dissociated time', 'significant residue position coil disruption proline', 'loss hydrophobic significance context destabilization', 'contrast presence methionine residue position significant disruption structure neck domain steric linear side chain coil', 'loss stability potential disruption helical structure presence methionine residue middle repeat unit neck domain dc sign resistant crystallization', 'dc signr key emerge leucine position arginine position', 'presence phenylalanine residue position repeat unit adjacent crd neck domain stable tetrameric coil', 'arrangement stable repeat domain dc signr necessary neck domain tetrameric final repeat presence phenylalanine residue', 'suggest presence formation stable present common genetic human population', 'minimal length neck domain stable presence repeat', 'stable structure coil dc exact orientation flexible unusual repeat unit adjacent crd', 'contrast dc signr repeat proximal end neck domain dc sign leucine position', 'presence stable repeat dc sign neck domain membrane presence repeat disruptive methionine position repeat unit middle neck domain possibility cterminal portion neck domain time extracellular domain able different sugar recent', 'high affinity multivalent multivalency appropriate orientation sugar arrangement cluster dc sign bind range', 'dos al', 'sign dc signr local', 'example dc sign parasite recognition x epitope bound dc sign dc signr', 'difficult differential binding high mannose case nile virus dc signr dc sign interaction individual', 'likely different various glycan distinct', 'extracellular human sign dc signr escherichia coli purification affinity chromatography sepharose', 'wild type chromatography anion exchange chromatography', 'case site insertion expression vector neck polypeptide ribosome termination phage gene protein', 'uniform neck domain repeat position cdna dc signr neck', 'synthetic sequence n unit sequence c unit create dna sequence block repeat identical amino acid terminal tag fig', '', 'various construct partial digestion bglii digestion bamhi', 'generate repeat', 'expression vector wild type neck', 'similar strategy generate dna sequence repeat position synthetic sign cdna end repeat unit end repeat unit fig', '', 'bglii partial digestion strategy expand number repeat', 'creation neck domain methionine position synthetic generate dna fragment repeat', '', 'partial bglii digestion number repeat', 'analytical affinity chromatography sepharose buffer nacl mm tris cl ph mm cacl elution buffer nacl mm tris cl ph mm edta', 'sds polyacrylamide gel electrophoresis buffer system laemmli', 'gel filtration analysis cm superdex column mm nacl mm tris cl ph mm edta', 'cytochrome c å bovine erythrocyte carbonic anhydrase å bovine serum albumin å yeast alcohol dehydrogenase å b amylase å e å thyroglobulin å', 'protein ninhydrin assay alkaline hydrolysis', 'differential calorimetry mm nacl mm cacl vacuum sample loop nano iii calorimeter calorimetry corporation', 'equilibration gas', '', 'protein native neck give', 'different protein fold', 'mm nacl mm tris cl ph mm cacl', 'analysis chirascan spectropolarimeter sec nm', 'fold range', 'test concentration range ratio gel filtration undergo dissociation version repeat position']"
fe90da34ca7b4f7fd6711bd870cb2163b8fd4ef4,ion torrent bat guano bacterial phyla rrna gene fresh guano present study leschenaultii guano r leschenaultii composite guano different bacterial bacterial genera guano bacterial phyla e bacterial guano core microbiome e coli et al extension °c genera e guano different guano microbiome individual variation pathogenic potential potential bacterial present bat query coverage supplementary figure abundance abundance bacterial diversity bacterial present cgs sample community dna coverage ≥ culture study denaturation °c dna isolation fasta file frugivorous bat good quality ground surface human pathogenic inc usa inter individual microbiome different pathogen database pcr amplification risk group rousettus leschenaultii sequence similarity single fasta staphylococcus aureus total bacterial total viable unique bacterial abundance bacterial alpha diversity amplification rrna analysis ncbi attempt core bacterial community bacterial count bacterial identification bacterial ion bacterial pathogen bacterial rrna bat microbiome blast analysis buffer mmol carrier pathogenic cause infection cause various ceiling soil cfus gram corynebacterium diphtheriae culture approach direct contact dna extraction dna purification e g ecology package escherichia coli final extension full length gene ion gene positive general bacterial guano abundance guano pathogenic guano study guano sufficient gut microbial human bacterial human health human pathogen ibea gene identification ion initial denaturation insight microbial invitrogen inc l polymerase,"['crucial proper functioning ecosystem', 'various important ecosystem environment', 'carrier pathogenic possible role potential carrier pathogenic', 'culture approach multiple bacteriological identified rousettus frugivorous bat majority family putative', 'next pathogenic potential component microbiome e', 'escherichia presence virulent many e', 'depth bacterial community analysis high throughput gene high inter individual variation studied guano', 'diversity bacterial guano representative', 'search human pathogenic identity small proportion wellknown human', 'present study bat potential bacterial advice study effect probable mode transmission', 'previous bacterial identification bat guano intestinal content immense scope additional bacterial', 'serious study bat guano', 'important various potential role zoonosis zoonosis', 'metagenomic rrna gene characterize gut microbial different', 'report al', 'herbivory dietary strategy active diverse microbiota carnivore inactive', 'carrillo araujo et al', 'diet primary factor define gut microbiome', 'previous study considerable similarity microbial insectivorous dietary overlap different', 'addition diet guano abundance bacterial', 'approach veikkolainen al', 'presence important human bacterial pathogen bartonella mayotimonensis', 'microbial comprehensive aspect host microbe relationship possibility putative bacterial', 'study identification general bacterial potential bacterial present rousettus leschenaultii guano', 'pathogenic potential virulence isolated microbiome e', 'escherichia coli', 'rrna gene ion torrent pgm bacterial presence putative human', 'study human interference wildlife irreparable loss ecosystem severe human health', 'bat guano collection', 'fresh bat guano robber maharashtra india', 'collection inside cave guano dropping', 'way total fresh guano guano sufficient quantity free study', 'bat identification', 'sequence analysis cytochrome b cytb gene total extracted dna guano collected fecal single bat', 'rousettus leschenaultii predominant bat', 'collected guano single bat', 'total viable identification', 'total viable count bat guano ranged × × cfus gram guano different bacterial', 'bacterial rrna gene blast analysis ncbi', 'total bacterial guano bacterial environment total identified entire list provided supplementary table', 'similarity', 'rrna gene analyzed genus level distribution', 'maximum bacterial genera e', 'luria hiveg agar la zobell marine agar zma genera arret kirshbum agar ak genera isolation agar str genera', 'la efficient unique bacterial genus zma ak str fig', '', 'total supplementary figure different genera fig', 'bacterial phyla e', 'proteobacteria actinobacteria bat guano', 'bacterial genera enterococcus', 'unique bacterial genera e', 'aquitalea cedecea pontoea stream water sample bacterial genera e', 'staphylococcus bcs ceiling soil sample supplementary figure', 'literature survey bacterial', 'taxonomic affiliation majority phylum proteobacteria guano abundance pathogenic', 'hence detailed literature survey bacterial r leschenaultii guano pathogenic potential', 'risk pathogen', 'survey risk group table bacterial association different opportunistic', 'cause infection virulence', 'study total', 'common component healthy gut many virulent pathotype', 'hence e coli pathogenic potential identification virulence table', 'assessment ibea hlya gene positive indicative extraintestinal pathogenic e gene positive indicative enteroaggregative e', 'isolate enterotoxigenic e heat stable enterotoxin b estii gene', 'e coli hemorrhagic ehec scientific shiga toxin ii stx gene gene', 'positive ibea', 'none e coli enteroinvasive eiec pathotype ipah negative', 'comparison previous avian pathogenic prevalence ibea gene study previous', 'e isolated human vagina neonatal meningitis similar prevalence ibea gene', 'present study prevalence gene similar previous study diarrheal', 'comparable frequency virulent', 'ion torrent sequence analysis', 'depth overview total bacterial leschenaultii guano rrna gene ion torrent pgm', 'quantitative insight microbial ecology package', 'presence different bacterial phyla bat guano huge uncultivated bacterial present bat guano fig', '', 'abundance abundance abundance', 'cave ground surface soil cgs sample abundance proteobacteria', 'huge inter individual variation bacterial', 'various diversity cgs diverse sample fresh guano bacterial diversity supplementary', 'computation core microbiome ion torrent fresh guano presence bacterial phyla e', 'proteobacteria division different', 'supplementary figure', 'bat guano microbiome comparison', 'previous bat microbiome present bat guano microbiome study', 'accomplish fastq sra sequence archive ncbi quality analyzed qiime pipeline', 'analysis bat microbiome different composition relative proportion bacterial', 'phyla e', 'chlamydiae proteobacteria veikkolainen et al', 'study location finland bat daubentonii', 'contrary study al', 'location india bat available present study location bat leschenaultii bacterial phyla actinobacteria', '', 'attempt core bacterial microbiome taxonomic level bacterial phyla supplementary figure', 'sample cgs present study composite guano al', 'study guano hence comparison', 'beta diversity analysis jaccard distance cgs composite guano different bacterial different rest fresh guano', '', 'pathogen identification ion torrent', 'presence potential bacterial culture study assess ion torrent presence', 'hence ion torrent available human pathogen database', 'analysis sequence identity cutoff ≥ query coverage identity crucial integral part healthy ecosystem many pollination', 'ecological bio bat guano rich source crop production gardening', 'human health', 'draculin desmoteplase glycoprotein vampire bat saliva natural anti coagulant trial medication treat patient ischaemic stroke', 'blood damage hence prove life saver', 'grandness aspect gut microbial addressed', 'present study identify bacterial present rousettus frugivorous bat culture approach identification thousand hundred different bacterial', 'majority first time', 'full length rrna gene identity', 'ion torrent rrna gene information general bacterial specific emphasis total present bat guano', 'observation bacterial count r leschenaultii guano range × × cfus gram count e', '× guano myotis sp', 'fresh guano old dried pellet reason', 'bacterial count intestinal different cfus main sample individual variation due host body size specificity geographical location', 'bacteriological bacterial', 'bacterial', 'contrast different bacteriological able different bacterial phyla genera different importance traditional approach microbial exploration', 'fact presence unique bacterial', 'single genus', 'staphylococcus bcs', 'possibility bcs guano bacterial bat guano autochthonous community', 'rock staphylococcus manganese mobilization basalt high abundance bcs', 'guano bacterial genera cw cgs guano care', 'next generation microbial community various', 'metagenomic understanding structure system', 'ion torrent guano proteobacteria abundance abundance', 'previous huge variation gut bacterial similar human', 'major reason host specificity individual diet health physiological state', 'guano microbiome composite guano cave floor hence information available host', 'addition multiple guano bat rousettus leschenaultii frugivorous bat robber', 'alpha diversity rarefaction analysis significant microbial enrichment cgs sample process bacterial diversity', 'disintegration process various physical environmental', 'biogeochemical crucial organic inorganic microorganism ph due release nutritional growth diverse', 'enrichment bacterial guano', 'soil increase microbial load', 'comparison composite guano composite guano dissimilar microbial composition fresh guano bacterial guano different fresh guano', 'speculate different guano host duration process physicochemical different development microbial', 'taxonomic able detect bacterial phyla phyla composite guano', 'true core microbiome different phyla actinobacteria candidate division fresh guano r leschenaultii presence phyla', 'bacterial phyla able recover food material huge diet gastrointestinal tract', 'comparison ion torrent culture finding major bacterial phyla e', 'actinobacteria stable nature bacterial phyla bat gut environment', 'abundance ion torrent sequence relative proportion obtained culture actinobacteria cultivable employed', 'due stringent growth culture', 'absence microbiome presence culture individual', 'comparison present study microbiome study number bacterial phyla fresh guano study prime reason', 'attempt core microbiome different microbiome phyla e', 'proteobacteria present', 'recent microbiome strong influence host phylogeny dietary pattern physiology geography microbial', 'reservoir human bacterial important pathogen dissemination', 'bacterial', 'escherichia coli risk group staphylococcus aureus risk group ii', 'bacterial cause various human', 'johnsonii cause fish infection staphylococcus lentus cause mastitis involved sepsis urinary tract compromised', 'present study majority family enterobacteriaceae escherichia commensal gut inhabitant opportunistic rg ii pathogen', 'high percent expec eaggec pathotype r leschenaultii guano serious health concern', 'shiga toxin strain severe outbreak germany', 'e r leschenaultii guano pathogenic', 'presence virulence', 'cabal et al', 'virulence gene profile cattle swine broiler', 'presence gene', 'post diarrhea common problem piggery major reason epec etec different virulence labile stable stb', 'healthy dairy carry virulent lt e dung', 'prime epec eiec remain healthy', 'hence virulence appropriate combination virulent cause infection available', 'presence host pathogen', 'possibility additional virulence successful infection', 'light presence various coli essential discuss pathogenic', 'discussion indicate abundance bacterial', 'isolated member genus escherichia escherichia fergusonii relative e many', 'diarrhea etc', 'cause bacteremia diabetic patient', 'genera e g', 'enterobacter asburiae enterobacter enterobacter cloacae e', 'enterococcus hirae various immunocompromised', 'e faecalis common human clinical', 'citrobacter koseri citrobacter freundii opportunistic neonatal neonatal meningitis due high mortality rate', 'serratia common nosocomial urinary tract', 'gram positive guano', 'main genus staphylococcus', 'staphylococcus aureus organism staphylococcus nepalensis staphylococcus lentus cause various', 'threat sheep nearby', 'potential bacterial ion torrent human pathogen database', 'database human pathogenic virulence factor database bacterial creation', 'ion torrent length bp use region identification maximum coverage diversity', 'addition sequence high query coverage ≥ high similarity value search database analysis', 'hence possibility presence', 'ion torrent clostridium', 'p aeruginosa gram negative pathogen responsible several nosocomial opportunistic', 'bacterial enterica shigella flexneri gastroenteritis food shigellosis', 'direct contact fecal oral route', 'hence consumption food bat guano', 'scientific doi e', 'streptococcus pneumoniae enterococcus faecalis staphylococcus aureus streptococcal pneumonia meningitis bacteremia infectious neonatal septicemia', 'important observation presence mycobacterium tuberculosis corynebacterium diphtheriae', 'mycobacterium tuberculosis airborne disease spread droplet nuclei', 'corynebacterium diphtheriae causative agent diphtheria skin contact', 'proper caution cave site', 'bartonella henselae causative cat scratch disease accidental bite', 'infected', 'affiliated brucella melitensis pathogenic brucella', 'sheep hence contact infected', 'hence zoonotic direct contact aerosol inhalation food', 'conclusion present study gram r leschenaultii guano different bacterial pathogenic', 'core microbiome bacterial phyla culture study', 'large inter individual variation microbiome composition guano individual specificity', 'virulence gene e presence many virulent', 'study culture study r leschenaultii bat guano cultivable bacterial diversity potential human pathogenic', 'advised wild life huge loss environment health', 'site sample collection', 'guano basalt rock structure western state india', 'collection ground surface colony', 'individual guano', 'total guano °c transportation laboratory processing', 'guano sufficient quantity bacterial isolation', 'guano study e g', 'cave water cw stream side cave ceiling soil bcs ground guano ground surface soil cgs', 'sample processing', 'half quantity ml water mixed', 'supernatant dilution different la incubation', 'post incubation observed total colony cfus', 'total viable number cfus dilution factor volume supernatant inoculum', 'random sample sub respective medium', 'post incubation full colony te tris ethylenediamine tetra acetate buffer ph use dna isolation', 'guano sample total bacterial community dna extraction ion torrent', 'bacterial dna isolation identification', 'bacterial identification dna pure purelink ® pro dna purification kit invitrogen inc usa', 'pcr amplification rrna gene pcr buffer mmol l polymerase bangalore genei gtttgatcctggctcag r', 'pcr initial denaturation °c min min °c denaturation °c extension °c final extension °c °c', 'pcr gel positive', 'positive peg nacl polyethylene glycol nacl', 'abi dna analyzer usa', 'full length sequence bacterial rrna gene internal r', 'chromaspro blast analysis ncbi', 'blast sequence similarity ≥ query coverage ≥', 'identification bacterial', 'bacterial risk pathogen present study', 'html', 'table different pathotype e', 'dna e coli pathotype e', 'pcr pcr buffer mmol l polymerase thermo scientific inc usa respective', 'pcr initial denaturation °c min min °c denaturation different extension °c final extension °c °c', 'bat guano community dna extraction pcr amplification rrna gene', 'total community dna bat guano stool dna isolation kit qiagen ion torrent analysis', 'dna nanodrop nanodrop thermo scientific usa pcr amplification region rrna hi fidelity gold invitrogen inc usa eubacterial universal r', 'pcr agencourt ampure xp dna purification beckman coulter usa end repair', 'blunt substrate sample specific barcode adapter ligation reaction manufacturer', 'size distribution molar bioanalyzer agilent', 'concentration dna concentration equimolar ratio pooled pm', 'pooled ion sphere emulsion pcr ionxpress kit iononetouch system', 'next template positive isps iononetouch es system', 'isps chip ion torrent personal genome machine life', 'ion torrent analysis', 'barcode specific fastq mothur pipeline fasta quality file', 'quality size bp homo polymer max', 'ambiguity max average quality score', 'way able good quality', 'single fasta file quantitative insight microbial ecology package', 'briefly otus open reference approach sequence similarity cutoff', 'representative sequence otu possible taxonomic rank rdp classifier silva database reference', 'order assess relationship depth discovery new otus rarefaction analysis', 'diversity alpha diversity simpson', 'core otus cgs sample core otu otu present', 'microbiome sra sequence ncbi fastq format compare present bat guano microbiome microbiome', 'total', 'al', 'veikkolainen et al', '', 'quality mothur pipeline good quality sequence length ambiguity comparison', 'good quality single fasta file qiime pipeline', 'closed reference approach reference pick different different region rrna gene', 'pathogen identification ion torrent', 'bacterial pathogen database search bacterial ion torrent', 'rrna gene guano cgs single fasta file mentioned database sequence similarity algorithm', 'sequence hit', 'blast query coverage ≥ maximum identity maximum score value e value', 'number hit ≥ identity calculated proportion bacterial', 'statistical analysis', 'statistical analysis graphpad prism venn diagram venny', 'heat mev software']"
fef7a8f796c4068d359d7b65f03ddba1841d1738,development computational gene expression recode database cellular concentration computational prediction database information efficiency cellular eukaryotic antizyme format annotation information utilize mrna efficiency novel database postgresql database protein synthesis ribosomal frameshifting rna secondary selenocysteine insertion sequence responsible standard genetic transcriptional slippage translational bypassing translational recoding user registration version database able identify absolute transcription access detailed accordance growth accurate annotation active full additional specialized address issue affect recognition allow incorporation amino g amino share annotate mrnas annotation annotation annotation format annotation human annotation number annotation software annotation standard antizyme mrna antizyme oazs antizyme production archaea organism arfa oaf article describe automatic identification autoregulatory circuit availability dataset available database available sequence available term available web bacterial dnax bacterial eukaryotic bacterial insertion bacterial release balance independent batch importation bench upto benefit gene biosynthesis insertion body sequence bypassing stopgo certain group circuit biosynthesis code ribosomal codon organism codon readthrough codon redefinition complementary rna complex search complex stem computational identification computer oaf concentration product concentration turn considerable diversity considerable progress constant ratio context frequency data gene database arfa database batch database expand database figure database last database php database population database rapid database search database user dataset recode date information definition recodeml describe incarnation describe non,"['term describe non standard genetic code ribosomal stop codon readthrough selenocysteine insertion translational bypassing', 'small proportion protein synthesis accurate annotation annotation standard', 'order address issue service field data gene annotation software recode database', 'updated version database', 'access detailed information utilize translational recoding complex search visualization sequence', 'present database information utilize expression factor increase previous version database', 'available term translational recoding utilization standard protein synthesis ribosomal codon redefinition translational bypassing stopgo', 'error e g', 'error mistranslation particular codon organism fitness survival', 'propensity error evolution formation particular sequence context frequency error', 'discriminate promiscuous translational translational noise term recoding', 'position mrna event place site', 'sequence responsible efficiency stimulatory minimal sequence fragment place natural efficiency e', 'relative level standard site cassette', 'benefit gene expression number', 'gene expression part sensor particular cellular', 'prominent ribosomal bacterial release factor eukaryotic antizyme', 'ribosomal frameshifting production active full length protein', 'mrna efficiency cellular concentration product autoregulatory circuit biosynthesis', 'antizyme mrna efficiency cellular concentration turn antizyme', 'mechanism maintenance antizyme production support appropriate', 'diversification protein single gene', 'illustrative example bacterial dnax mrna different protein n terminal part single open reading frame orf mrna', 'constant ratio dnax stoichiometric balance', 'balance independent absolute transcription translational initiation mrna', 'many responsible ratio protein gag pro pol single mrna', 'rna mechanism translation downstream orfs polycistronic rnas leaky reinitiation iress production subgenomic rnas global regulation switch translation replication genomic rna', 'way incorporation standard amino g', 'amino share termination prominent example selenocysteine uga', 'information diverse variety recent', 'variety diverse sequence', 'example primary trna relative ribosome affect recognition release site', 'hand many recoding form rna secondary simple stem complex stem loops rna', 'rna ribosomal complementary rna nascent peptide ribosome exit tunnel', 'selenocysteine insertion require presence additional specialized machinery selenocysteine specific translation several selenocysteine biosynthesis insertion pathway', 'recent stimulatory modulation molecular provide', 'considerable progress development computational prediction identification annotation', 'hurdle much fact standard genetic readout considerable diversity sequence responsible', 'diversity considerable', 'extreme example orthologous different gene expression goal', 'example dnax ribosomal employed transcriptional slippage thermus thermophilus', 'similar situation bacterial insertion sequence certain group transcriptional slippage orfa orfb many ribosomal frameshifting purpose', 'diversity wide spectrum unrelated sequence design uniform model intractable', 'recent development computational identification particular specific particular homologous', 'facilitated availability dataset recode database', 'facilitate development computational prediction body sequence bench upto date information efficient recode database population annotation', 'article describe incarnation database', 'major new location previous new web design enhanced visualization stimulatory uniform recodeml format annotation number many size database last update', 'local postgresql database php web interface', 'schema postgresql database figure', 'database information individual stimulatory original literature', 'order facilitate uniform annotation format annotation', 'document type definition recodeml available web site extensibility allow incorporation new annotation', 'database batch importation recodeml database rapid population new', 'database', 'archaea organism type recoding', 'key search field', 'regular', 'output database search list short format organism name kingdom genus type event status figure example sequence annotation human gene diagram stimulatory rna secondary structure logo', 'utilizes identification computer oaf able identify annotate mrnas bacterial eukaryotic antizyme oazs', 'significant source serendipitous experimental systematic large similar', 'large proportion new semi', 'ease manual population special form available database user registration', 'user registration database', 'novel database arfa oaf new selenoprotein new viral frameshift japanese encephalitis group', 'database expand accordance growth available sequence information annotation', 'plan automatic identification nucleotide', 'field number extract relevant literature number novel database', 'encourage field submit', 'willing provide help potential new']"
7f37181b66f15b8ca2d62b6943d9a6f92e843a66,hong kong life cycle tropical medicine clinician scientist medical officer patrick manson vector borne western medicine college medicine fresh water kong college liver abscess medical education medicine chinese missionary hospital pathology dr acute respiratory alimentary tract baptist missionary blood elephantiasis british garrison chair professor chang chow chinese western clinical service completion life compound microscope cycle many dairy farm david manson endemic haemoptysis exercise dietary fatty liver febrile case firm foundation foundation manson health organization heavy exercise human blood importance vector infected human infectious disease local chinese lymphatic filariasis manson amoy manson clinician manson many manson medicine manson reputation manson small manson tropical many tropical medical practice medical society medicine manson memorial hospital modern tropical mosquito house mr li nocturnal periodicity personal example point disease professor pathology public health research infectious respiratory syndrome room temperature severe acute syndrome coronavirus time mosquito traditional chinese transmission vector trocar cannula tropical room university hong vector control world health aberdeen scotland aberdeenshire scotland able make able memorize abscess absence abscess fatal abscess liver absence many absence supervision abundant blood acceptance western account operating accurate decisive accurate surgeon active microfilariae adaptive attitude address society adult bancrofti adventurous patient affordable pregnant affordable supply africa mr age h,"['patrick manson clinician scientist china many tropical infectious vector peculiar warm climate person person transmission', 'nocturnal periodicity microfilariae blood elephantiasis', 'microfilariae undergo metamorphosis mosquito vector completion life cycle', 'demonstrated linkage lung endemic haemoptysis eggs', 'miracidium eggs fresh water tropical life cycle many', 'vector hypothesis vector control cornerstone world health organization elimination control lymphatic filariasis dracunculiasis malaria', 'china memorial hospital hong kong college medicine chinese forerunner university hong kong medical society medical service education', 'kong dairy farm hygienic milk affordable pregnant', 'manson clinician initial involvement colonialistic british empire asia work understanding exotic', 'research', 'clinical service perception chinese western medicine', 'laid medical education hong kong', 'trace manson white indisputable founder modern tropical medicine', 'patrick manson small market town aberdeen scotland', 'mother livingstone distant relative great explorer christian missionary africa mr david livingstone', 'manson mock scandinavian pirate norwegian descent dull curious child', 'presbyterian christian family good memory able memorize church age', 'noted interest carpentry', 'minor incident career dissection ferocious cat tapeworm', 'initial enthusiasm apprenticeship ironsmith age', 'power physique spinal curvature right arm paresis', 'invalid give engineering blessing disguise biological science', 'personal experience illness disability decision medicine caring profession', 'manson medicine university', 'medical curriculum age young graduation spend year', 'worked assistant medical officer lunatic asylum durham time postmortem psychiatric medicine thesis', 'thesis severity brain pathology diameter aneurismal internal carotid artery similar situation cirrhotic portal vein due portal hypertension', 'inexperienced medical graduate medical officer takao formosa manson elder brother shanghai medical officer post service formosa', 'sailed cape good hope madagascar takao present day formosa', 'official daily duty inspect port treat keep meteorological record', 'chinese local missionary hospital wide variety leprosy postgraduate training supervision', 'research tool combination clinical skill hand good record', 'pride fishing nose hypertonic saline', 'european tropical much meat wine fatty liver prescription heavy exercise dietary discretion', 'disappointed death young chinese patient heart failure next day treatment', 'patient treatment traditional chinese doctor', 'many similar beriberi result vitamin deficiency many', 'confident humbler wiser', 'manson small community local local', 'time island state unrest due japanese chinese control', 'manson good upright native chinese similar character buy chinese', 'british amoy', 'manson community entrance amoy harbour port much inland trading city chang chow', 'official duty medical officer local imperial maritime local chinese baptist missionary society hospital dispensary chinese', 'supervision mentorship daily work david manson missionary', 'white man hot humid', 'narrow irregular filthy excreta', 'machinery sanitation amoy excreta', 'extreme poverty rice sweet vegetable fish', 'area endemic dengue fever leprosy', 'estimation survey leprosy', 'cholera outbreak amoy population', 'brother david manson amoy', 'absence supervision training specialist competent clinician able make brilliant diagnosis useful treatment', 'competence anatomy clinical medicine febrile case persistent point disease chest laryngeal irritation cause suspect aneurysm aortic arch', 'attended missionary hospital', 'ton tissue elephantiasis chloroform anaesthesia support blood', 'many job limbs', 'financial burden superstition demon possession', 'instance man huge tumour suicide arsenic excessive dose poison gastric irritation early emesis poison', 'manson mind', 'successful operation manson reputation gradual acceptance western medicine local chinese', 'elephantiasis many due renal ureteric bladder surgical', 'modest good carpenter indifferent surgeon', 'manson accurate surgeon tackle liver abscess fatal era organ', 'famous clinical quote febrile case point disease nature suspect abscess liver', 'manson trocar cannula single blind exploration treatment liver abscess', 'trocar cannula local ironsmith amoy stylet drainage tube exploration hidden liver abscess absence many surgical figure', 'adventurous patient accurate decisive personality clinical practice recreation', 'manson reputation snipe shot tiger', 'ignorance superstition distrust spread western medicine china', 'western si fan powder life death chinese western', 'western chinese chinese', 'manson traditional chinese history pulse tongue full view open street', 'account operating theater street wide glass', 'whole process patient anaesthesia painlessness surgical procedure removal recovery anaesthesia open patrick manson tropical public', 'sharp observation humanistic concern adaptive attitude success western medicine', 'seasoned clinician scientist manson understood prevention cure', 'smallpox vaccination amoy incidence mortality smallpox', 'public vaccinator chang chow', 'many native house practice', 'fervent evangelist baptist missionary hospital manson medical practice spiritual work', 'manson continued practice european population', 'returned london', 'henrietta isabella thurburn', 'time eye surgery', 'personality meticulous surgical conscientious surgeon touch eye till specialist skill london', 'information tropical disappointed information scarce', 'work timothy lewis british museum library microscopic nematode worm filaria sanguinis hominis filaria nocturna wuchereris bancrofti chylous urine blood indian patient', 'struck manson many elephantiasis', 'manson amoy wife compound microscope', 'new compound microscope manson microfilariae abundant blood figure', 'observation active microfilariae unchanged blood body temperature sheath tropical room temperature', 'alimentary tract female culex quinquefasciatus human blood', 'microfilariae underwent unsheathing metamorphosis alimentary tract thoracic', 'thomas bancroft infected human biting', 'manson adult bancrofti uterus elephantiasis', 'complete life cycle filariasis illustrates human tohuman transmission vector', 'landmark discovery role host life cycle transmission vector borne meticulous painstaking research', 'small mosquito house fine mosquito proof gauze', 'put gardener sleep mosquito house', 'light inside house door night', 'next morning infected human blood gauze', 'tobacco smoke labelled glass', 'microscope', 'chinese blood elephantiasis indication ill±health recurrent fever oedema', 'infected incidence infection elderly', 'manson astute clinician scientist nocturnal periodicity microfilariaemia', 'number blood number midnight human time mosquito biting activity', 'eye research gazette journal linnean society london zoology', 'paper society critic work genius likely faroff china everyone aware drank much whisky', 'time mosquito hypothesis', 'manson exflagellation blood malarial parasitic agent male gametocyte long time figure', 'ronald ross important piece research india', 'figure', 'put water ciliated tropical room temperature', 'manson fluke paragonimus westermanii distoma ringeri postmortem examination patient endemic haemoptysis large sputum', 'lung fluke intermediate host fresh water completion life cycle', 'hypothesis nakagawa', 'fresh water snail theory schistosomiasis', 'manson many important tropical discovery filaria demarquaii mansonella loa loa mansonella bothriocephalus mansoni spirometra diphyllobothrium mansoni dermatophytic fungus trichophyton concentricum tinea', 'identification human basis current management prevention', 'kkw ky memorial hospital', 'manson presidential address society lack education research tropical medicine unable differentiate fever', 'due wastage quinine non malarial fever', 'philosophy judicious use important present era antimicrobial resistance', 'clinical tropical fatty liver heavy exercise dietary food alcoholic portal important knowledge medical society', 'heavy engagement medical education withdraw medical practice', 'inauguration hong kong college medicine chinese mr hung chang prime minister dynasty china tongue cancer tientsin november', 'manson prolonged bout gout board', 'manson li sublingual abscess', 'mr li impressed knowledge skill manson', 'mr li patron hong kong college medicine chinese till death', 'college hku', 'firm foundation manson slow development research infectious', 'hku chair pathology dr chung yik wang infectious tuberculosis syphilis', 'second world war chair professor pathology dr pao chang hou relationship primary cholangiocarcinoma liver clonorchis sinensis infection', 'inaugural speech chair professor pathology dr emphasized fatality infectious disease due', 'establishment department microbiology research microbiology', 'dr founding chair microbiology pseudomallei pseudomallei cause major outbreak amongst ocean park hong kong', 'successful control tropical kong direction infectious disease research infectious', 'top global significance human immunodeficiency virus influenza virus severe acute respiratory syndrome coronavirus', 'associated patient care public health policy', 'source severe acute respiratory syndrome coronavirus human natural reservoir chinese horseshoe', 'similar key role animal tropical major role genesis infectious', 'hku search novel human', 'medical school medical system education mainland participation hku shenzhen hospital hospital guangdong province', 'life hong difficult british garrison provided medicine', 'annual death rate british garrison many related infection figure', 'sanitation public health prevention dire situation manson dairy farm pokfulam district hygienic affordable supply milk dairy pregnant', 'first batch ayrshire aberdeenshire scotland pasture guineagrass bare hill side farm queensland', 'improvement nutritional status vital health susceptibility infection', 'strong dreadnought', 'pay price honesty conviction resignation post tropical dock seaman hospital', 'time convinced necessity tropical medicine manson london school tropical medicine hygiene', 'age h round trip school week teaching', 'similar eminent continuous interest future keen effective control infectious', 'groundwork manson solid foundation many clinical epidemiological modern tropical medicine', 'global control eradication dracunculiasis infectious vectorborne', 'control arthropod vector borne chemical biological contact human', 'example control reduction mosquito population patrick manson tropical ky yuen environmental prevention mosquito±human contact bed', 'alternative biological control investigation insecticide resistance ecological side use bacterial endosymbiont wolbachia inhibit replication plasmodium entomopathogenic', 'life cycle basis control schistosomiasis china snails excreta', 'incidence paragonimiasis education chemotherapy control vector population reduction human±arthropod practicable sustainable', 'importance vector borne', 'many yellow virus', 'problem vector borne disease climate change', 'geographical range arthropod borne recent altitude', 'example chikungunya virus tropical italy', 'many vector example new', 'great personal example clinician scientist teacher manson', 'great physician surgeon microbiologist discoverer', 'long period stay significant risk health safety', 'personal example excellence clinical service medical education microbial research', 'scientific importance vector control interrupt life cycle many tropical disease title tropical medicine', 'year world health organization global campaign lymphatic filariasis possible firm foundation manson', 'contribution china', 'dr yat sen sun imprisonment secret dynasty london', 'effort sun china feudal dynasty', 'pursuit science medicine manson medicine', 'microscope', 'see finger discovery', 'grateful dr samson wong university hong hong kong review', '']"
5796fdc80a85b6e634a279c57711356055b65880,author funder available author cc nd copyright holder display preprint funder medrxiv holder preprint international license license available license display medrxiv license nd international preprint perpetuity doi medrxiv medrxiv preprint public disclosure disease control index secondary case patient exposure virus female family household transmission important disease index patient infection china information age male family male female number age peer copyright school closure secondary age secondary number transmission important workplace hygiene admission regular age age age consistent age group age much age source age table analysis secondary appendix table article background assembly compact available download background february basic information bias transmissibility care next case index china daily china detailed china workplace chinese local city provincial closure duration closure time compact environment consistent report control household control transmission coronavirus infection daily city demographic potential detailed information deviation distribution disclosure chinese disclosure information disclosure january disclosure record distribution figure distribution secondary doi preprint download manuscript duration education environment virus estimation household evaluation transmission example disclosure fact male family fact family male family primary family travel february novel female male female transmission first article first school group special health china health male home wuhan household contact household information household patient household public husband wife,"['first article background february novel coronavirus infection china', 'risk uncharacterized', 'reproduction infection major', 'household transmission important information age', 'estimation household transmission important disease control household contact', 'prone transmit particular age group special control transmission', 'study transmission virus', 'infection china daily city provincial health china detailed information individual demographic potential exposure virus', 'public disclosure january february', 'typical example disclosure', 'cc nd international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint household public disclosure record index secondary', 'index patient case patient person home wuhan province household', 'secondary exposure virus family', 'illness index secondary age', 'matrix age table', 'case index patient age consistent report february', 'secondary number age much index', 'generation', 'mid age source household', 'analysis secondary number age age', 'cc nd international license available author funder medrxiv license display preprint perpetuity', 'copyright holder preprint', 'doi preprint figure', 'distribution secondary age', 'male family primary family', 'table proportion male female transmission household information husband wife sister female male wife husband', 'mean serial', 'time onset case patient onset household patient standard deviation distribution figure', 'information transmission pairs index light mild time home', '', 'cc nd international license available author funder medrxiv license display preprint perpetuity', 'copyright holder preprint', 'doi medrxiv preprint public disclosure chinese local health male index major source virus', 'important disease control', 'first school closure time', 'assembly compact environment virus exposure', 'evaluation transmission particular interest school closure duration education', 'public disclosure information age', 'local primary postpone admission regular operation local secondary', 'second workplace hygiene particular important next phase disease control', 'bias transmissibility male female family fact male family travel work female family male transmissibility female', 'travel china workplace hygiene serious care next month', '', 'cc nd international license available author funder medrxiv license display preprint perpetuity', 'copyright holder preprint', 'doi medrxiv preprint appendix table', 'basic information index secondary', 'available download manuscript', '', 'cc nd international license available author funder medrxiv license display preprint perpetuity', 'peer copyright holder preprint', 'doi medrxiv preprint']"
7107f088cbed45d8a06a026276ccf4d602d50f10,spinal cord cns resident viral antigen white matter resident microglia supplementary figure day postinfection brain spinal pbs tx acute inflammation chronic inflammatory innate immune ∘ c axonal loss chronic inflammation egfp fluorescence gray white infected mice long time peak inflammation recombinant strain room temperature adaptive immune control mock fluorescence microscopy gray matter hepatitis virus hrs postinfection immune system infect cns inflammation day inflammatory demyelination isogenic spike matter white mhv infection mhv jhm microglia present microglia specific mouse hepatitis myelin loss myelin sheath neonatal microglial pbs triton pen strep peripheral immune specific medium spike gene spike protein strain mhv strain spike strain strain tx pbs virus mhv ×g min absence peripheral affymetrix microarray alzheimer disease amyotrophic lateral anti rabbit antibody pbs antigen detection antigen positive antigen white astrocyte monolayer astrocyte specific astrocytespecific medium camera image cell culture cell lysate centrifugation ×g clinical developmental cns inflammation cns inflammatory column anterior common antigen cord day cord section culture hrs culture supernatant culture system current vivo cytoplasm microglia demyelinating plaque demyelination axonal demyelination virus detection limit developmental immunology direct cns dmem fbs egfp gene egfp viral figure supplementary foci demyelination free mice fresh astrocyte g ml gene egfp gene host goat anti goat serum,"['microglia resident macrophage central nervous system cns', 'quiescent unable perform effector antigen presentation activated injury infection represent line defence cns', 'previous neurotropic mouse hepatitis virus mhv meningoencephalitis myelitis subsequent axonal loss demyelination virus model human neurological disease multiple sclerosis ms', 'current mhv infection pronounced activation acute inflammation characteristic cellular morphology expression microglia specific ionized adaptor molecule macrophage microglia specific novel calcium membrane phagocytosis', 'chronic inflammation day postinfection microglia present demyelination', 'ex spinal cord slice culture neonatal microglial culture direct microglial infection', 'infect activate acute inflammation turn chronic inflammation stage phagocytosis myelin sheath chronic inflammatory demyelination', 'constitute total glial specific neuroanatomical region cns', 'glial morphology gene expression pattern function', 'neuron conventional glial neuroectodermal microglia haematopoietic origin act primary pathogen infection injury peripheral', 'several distinguish cell body communicate glial', 'infectious traumatic phagocytotic nature', 'many proinflammatory oxygen nitric contribute clearance', 'unwarranted microglial cell activation pathological lead several neuroinflammatory nervous system', 'innate immune response cns major pathogenic number neuroinflammatory clinical developmental immunology prominent leukocytic immune', 'neuroinflammation many neurodegenerative alzheimer disease ad parkinson disease pd amyotrophic lateral sclerosis multiple sclerosis ms', 'ad pd neurodegenerative disease neuroinflammatory major chronic inflammatory cns heterogeneous chronic clinical course', 'ms autoimmune inflammatory disease exposure environmental cell tolerance myelin', 'demyelination complex process precise mechanisms pathology unclear inflammatory demyelination adaptive immune myelin sheaths', 'pathogenic role myelin specific strong association susceptibility ms major histocompatibility complex mhc class ii', 'recognition potential importance pathogenesis demyelination', 'contribution innate immune ms pathogenesis attention several role various innate immune ms pathogenesis particular potential anti inflammatory proinflammatory function microglial physical interaction myelin', 'long time present chronic inflammatory plaque myelin dead sick neuron ms recognition cns resident immune role health substantial role function regulatory demyelination', 'ms studied experimental autoimmune encephalitis eae theiler murine encephalomyelitis tmev mouse hepatitis virus mhv neuroinflammation', 'immune response play important eae tmev neurotropic strain mouse hepatitis virus mhv mhv jhm pathogenesis ms', 'intracranial c', 'infection neurotropic acute meningoencephalitis hepatitis major pathologic process supplementary figure available online', 'natural recombinant mhv targeted rna recombination differential pathological several mechanisms demyelination concomitant axonal loss', 'outcome degree mhv disease dependent several age strain mouse strain route virus inoculation', 'related pathogenic', 'hepatotropic e e g jhm isolate jhm g hepatotropic neurotropic', 'viral titer peak postinfection p', '', 'infectious virus first time mice begin demyelination clinical chronic hind limb paralysis', 'mhv jhm cause inflammatory demyelination brain spinal cord whereas vasculitis', 'primary mhv demyelination neuronal preserved', 'axonal damage large part immune mhvinfected mice demyelination', 'concurrent axonal loss demyelination protein recombinant strain infected mouse spinal cord', 'evidence neurovirulent jhm mhv induced demyelination', 'clearance infectious virus cytolytic cytokine pathologic', 'demyelination jhminfected lymphocyte deficient rag − − mice', 'demyelination transfer immunocompetent − − mice', 'depletion transfer model demyelination', 'intact adaptive immune system promote demyelination jhm mhv infection', 'contrary demyelination adult immunocompromised mice b', 'depletion acute stage infection demyelination', 'isogenic spike protein hostattachment protein recombinant strain disease mice small population', 'mechanism demyelination part due myelin direct axonal injury conventional', 'current infection mhv infect cns resident microglia mechanism microglial activation induction chronic demyelination', 'use experimental institutional animal care use committee indian institute science education research kolkata indian institute science india', 'animal cpcsea india', 'isogenic recombinant strain spike gene host attachment protein spike gene gene rna recombination previous', 'recombinant strain green fluorescence protein easy detection viral particle egfp fluorescence', 'engineer recombinant vector entire end genome construction recombinant', 'isogenic spike protein', 'strain spike background strain spike background', 'egfp gene genome place nonessential gene', 'order gene egfp gene introduction sali site intergenic sequence gene noti site bp upstream stop codon gene quick change site mutagenesis kit stratagene la jolla', 'silent nucleotide', 'sequence egfp vector clontech palo alto sali inserted place sali fragment', 'plasmid non sequence egfp open reading frame entire gene rest bp gene', 'previous jhm strain interruption orf alter neurovirulence vivo replication vitro', 'recombination select mhv stable efficient expression gene egfp facilitate vivo detection virus mouse cns viral entry spread tissue culture', 'similar wild type virus tissue culture mouse cns', 'similar encephalitis demyelination virus recombinant attenuated virulence', 'week old ten free mice jackson laboratory india ld dose strain pfu', 'daily disease', 'mock cell comparable dilution', 'period peak inflammation postinfection routine histopathological analysis frozen', 'rest day postinfection routine paraffin histopathological analysis', 'cervical thoracic lumbar spinal cord dorsal posterior column anterior column anterior separate spinal cord level', 'histopathology', 'postinfection brain spinal cord mock mice', 'routine paraffin brain spinal cord', 'micron thin routine cns pathology frozen pfa sucrose solution sucrose solution cryomatrix thermo shandon', 'ten micron thin frozen tissue immunofluorescence', 'paraffin tissue hematoxylin eosin h determine inflammation luxol fast blue lfb detect loss myelin sheath', 'read manner', 'analysis', 'serial brain spinal cord avidin biotinimmunoperoxidase technique vector substrate dilution wako richmond va usa dilution lca leukocyte common antigen bd pharmingen wako richmond va usa dako carpinteria dilution monoclonal antibody nucleocapsid protein n mhv jhm monoclonal antibody clone julian leibowitz primary', 'control infected mice', 'spinal cord pbs room temperature chamber min room temperature mg ml nabh pbs autofluorescence incubated h room temperature glycine pbs nonspecific cross pbs pbs triton tx pbs tx goat serum gs', 'overnight ∘ c dilution rabbit antibody pbs tx gs incubated secondary antiserum pbs gs hrs ∘ c humidified chamber', 'viral antigen egfp fluorescein isothiocyanate channel', 'control parallel preimmune rabbit sera infected mice secondary', 'tissue pbs tx pbs visualized fluorescence microscopy uplanapo objective iris diaphragm limit contribution plane fluorescence filter suitable green fluorescence fluorescence', 'hamamatsu charge device camera image pro image analysis software spring md usa', 'chronic inflammatory stage infection', 'presence microglia chronic demyelinating plaque ultrastructural level perfused pfa spinal mock fixed overnight glutaraldehyde', 'transmission microscopy tem postfixed osmium tetroxide flatembedded poly epoxy resin', 'half micrometer lesional epicenter toluidine blue light microscopy', 'ultrathin tem representative foci demyelination toluidine semithin mesh copper uranyl acetate bismuth subnitrate jeol jem', 'culture', 'week old mhv free sterile pbs', 'spinal cord washed pbs penicillin streptomycin pen strep', 'spinal cord mould micron thick vibratome leica microtome', 'pbs pen strep', 'plate slice', 'l dmem fbs pen strep l glutamine incubated', 'hrs explantation pfu half low serum medium hr pbs unbound medium infected culture hrs', 'hrs hrs hrs postinfection antibody egfp fluorescence detect viral antigen', 'briefly different postinfection pbs pfa', 'postfixed triton goat serum hr rt overnight incubation antibody', 'next day antibody solution fresh antibody ∘ additional hrs', 'antibody goat anti rabbit igg hrs', 'labelled unbound fluorescent antibody vectashield vector dapi observed zeiss confocal microscope', 'software carl zeiss', 'brain', 'primary mixed glia day day newborn mice', 'briefly removal brain incubated rocking water bath ∘ min salt solution hbss gibco presence g ml dnasei sigma trypsin sigma', 'dissociated fetal calf serum fcs wash centrifugation ×g min', 'pellet hbss micron nylon mesh second wash centrifugation ×g min', 'astrocytespecific medium dulbecco essential medium penicillin streptomycin mm l glutamine fcs day co incubator ∘ hrs nonadherent fresh astrocyte specific medium', 'adherent specific medium', 'culture', 'establishment mixed glia culture feeding significant microglial growth top astrocyte monolayer', 'microglia population', 'adherent astrocyte monolayer orbital incubator shaker rpm min ∘ c', 'agitation suspended culture medium centrifuged ×g min ∘ c cell pellet fresh astrocytespecific medium final concentration × ml well slide primary cell culture nunc ml', 'min adherent adherent fresh astrocyte specific medium infected medium change', 'different cell culture primary cell specific determine presence purity major glial cell', 'chemicon nutrient medium jackson immunoresearch', 'polyclonal rabbit antiglial fibrillary acidic protein gfap dako goat anti rabbit molecular jackson immunoresearch secondary', 'double label immunofluorescence microscopy nutrient medium', 'primary clinical developmental immunology room temperature min', 'secondary', 'surfacelabelled paraformaldehyde pbs pbs tx pbs triton x min pbs tx gs pbs triton x normal goat', 'astrocytic marker gfap pbs tx appropriate secondary antibody pbs g ml stock min', 'vectashield vector fluorescence microscopy olympus planapo objective numerical aperture', 'hamamatsu orca ccd camera image software', 'day neonatal microglial multiplicity infection moi mock noninfected cell lysate', 'viral adsorption hr fresh virus', 'hrs infection microscopy egfp fluorescence', '', 'growth curve', 'confluent undiluted diluted culture supernatant microglia hr ∘ c adsorption tris buffer saline dmem fbs agarose', 'postinfection culture plaque count', 'confirm cns inflammation brain spinal cord day peak inflammation day demyelination mice h e lfb', 'meningitis supplementary figure encephalomyelitis accumulation inflammatory cell perivascular supplementary supplementary figure ready information figure', '', 'inflammatory cell brain day postinfection leukocyte common antigen lca macrophage microglial marker pan cell marker', 'majority inflammatory immunoreactive lca supplementary figure supplementary figure supplementary figure', 'nonspecific background available quantification difficult', 'inflamed brain spinal cord', 'demyelination lfb early day supplementary figure peak day postinfection supplementary figure', 'lfb spinal cord section myelin loss supplementary figure', 'demyelination', 'cns inflammation mixed population inflammatory population', 'infection acute inflammation', 'neurotropic infect different neural cell evidence neurotropic infect activity due infection neural cell', 'order determine tropism cns resident microglia fourweek old mhv free mice jackson laboratory', 'mice peak inflammation day spinal cord cryostat sectioning', 'viral antigen fluorescence microscopy', 'identification cns resident microglia specific marker microglia', 'immunofluorescence gray white matter double fluorescence immunofluorescence dual labelling egfp viral antigen positive positive microglia present white matter infected mice figure', 'white matter microglia', 'control mock spinal cord section double fluorescent', 'previous time postinfection viral antigen spread gray matter white matter mice', 'phenomenon prevalent spinal cord mice gray white matter white matter', 'immunostained section viral antigen gray white matter day postinfection figure', 'day viral antigen detection level day postinfection viral antigen detection limit', 'determine microglia trajectory viral spread debris demyelinating plaque', 'microglial accumulation plaque emphasis sheath', 'accumulation demyelination plaque chronic phase inflammation ultrastructural level semithin micron infected mice day infection', 'semithin toluidine blue', 'control mock spinal cord evaluate background fixation postfixation supplementary figure', 'spinal significant myelin loss accumulation phagocytotic microglia supplementary', 'representative foci demyelination semithin ultrathin bed tem', 'high resolution tem accumulation large number microglia basement membrane characteristic supplementary figure', 'multiple myelin cytoplasm microglia plaque supplementary figure', 'microglial accumulation control mock high resolution tem supple figure', '', 'vivo colocalization viral antigen positive infect microglia resident intracranial ic inoculation blood brain barrier blood infection', 'cns resident infection activated morphological analysis number enlarged', 'resident infection', 'control explant antibody vitro culture system due perturbation culture system', 'image egfp viral antigen green microglia dapi blue demonstrate presence viral antigen cell cytoplasm microglia', 'due thickness clarity', 'infection explant absence peripheral immune cns resident', 'syncytia', 'order determine infect microglial vitro neural neonatal microglial multiplicity infection moi mock noninfected cell lysate', 'cell suspension conventional shake method ± positive staining figure', 'gfap astrocyte marker positive isolated microglia culture', 'hrs infection microscopy egfp fluorescence', 'hrs fluorescence infected culture hrs fluorescence appear presence viral antigen', 'hrs postinfection stressed morphology hrs postinfection large syncytia formation figure characteristic rna characteristic parental strain strain mhv', 'nucleus syncytia obvious figure', 'vitro experiment infect primary isolated culture syncytia primary', 'demonstrate virus microglia culture supernatant routine plaque assay', 'routine plaque detection limit', 'discrete syncytia infected titer ml', 'understand cellular mechanism demyelination strain mhv prior detailed pathogenesis recombinant mhv strain strain strain ndm isogenic spike gene host attachment spike glycoprotein', 'capable hepatitis encephalitis meningitis', 'ability subsequent demyelination axonal loss', 'infection demyelination spinal cord day postinfection peak inflammation', 'contrast produce demyelination axonopathic spinal cord white matter', 'inability induce demyelination due part lack transport viral antigen subsequent inflammatory reaction white matter', 'vivo vitro ability interneuronal spread', 'demyelination axonal degeneration macrophage myelin intact', 'spike glycoprotein spread viral antigen white matter axonal transport specific subsequent demyelination', 'plausible explanation mhv intra gray matter white matter viral astrocyte spike protein local oligodendroglial dystrophy inflammation', 'viral antigen white matter inflammatory response microglial activation', 'activated due intrinsic nature chemotaxis recruit site inflammation strip myelin demyelination', 'current vivo hypothesis infect cns resident microglia', 'migration activation numerous white matter acute inflammation retention chronic inflammatory plaque reinforce hypothesis cns resident microglia region local cns injury', 'ultrastructural morphology multiple plaque substantiate cns resident microglia mediate myelin mediate demyelination', 'spread colocalization gray matter cns resident microglia', 'haematogenous propagation peripheral cns widespread distribution spinal cord gray white matter track', 'delay complete development demyelination partial resolution encephalitis inflammation previous', 'ex colocalization positive microglia infect cns resident microglia absence peripheral immune', 'vitro neonatal microglia demonstrate infection cell cell contact', 'current vivo vitro culture recruitment cns resident microglial pool peripheral monocyte', 'current understanding innate immune mechanism cns resident microglia activation maturation phagocytotic activity', 'affymetrix microarray mrna expression expression inflammatory chemokine inflammatory', 'mhv infection spinal cord increased expression mock cns', 'chronic infection day postinfection microglia present demyelination inflammatory active', 'putative microglia inflammatory local cns microenvironment viral replication ifn gamma production acute phase infection', 'ifn maturation activation engulfment myelin sheath demyelination', 'affymetrix microarray confirmation', 'viral infection cns inflammatory nature meningeal perivascular parenchymal peripheral infection inflammation proceed cns resident glial activation peripheral immune infection hiv infection prion', 'perspective speculate underlying mechanism chronic myelin loss ms persistence myelin tolerance persistence cns resident microglia mediate demyelination myelin', 'innate immune function long time role microglia chronic inflammation new episode field glial biology neuroinflammatory', 'concept chronic inflammation acute inflammation relevant context cns neurodegenerative alzheimer disease amyotrophic lateral sclerosis parkinson disease huntington disease', 'neurodegenerative prominent mechanism inflammation cns resident microglia', 'activation cns resident microglia context chronic neuroinflammation underlying mechanism neurodegeneration', 'prime intrinsic cns resident immune system major focus cellular neuroimmunology therefore neuroinflammation', 'long time absence conventional major role neurotropic mhv demyelination mechanism infection route infection long time', 'current microglial tropism isogenic demyelinating strain mhv infect activate cns resident microglia microglia help demyelination debris', 'neuroinflammatory helpful understanding direct cns cellular injury demyelination intact adaptive immune system', 'understanding role direct cns resident microglial infection activation light pathogenesis cns inflammatory disease infectious cns', 'vision cnsresident driven neuroinflammatory neuropathological avenue explore contribution chronic neuroinflammatory cns']"
b9eaf7c97ff51c43bbcf3ed0605c2a040fe8c588,antiviral activity ml ste ste treatment µg ml relocation hnrnp viral adsorption activity ste dependent translation kinase phosphorylation activation kinase ste viral cytoplasmic relocation post adsorption supplementary fig hnrnp translocation ste activation ste h treatment group cap dependent genomic rna hnrnp relocation nucleus cytoplasm ste fig ste infected viral rna × pfu adsorption post analysis condition dose dependent effect ste h analysis h p hnrnp nucleus hydrogen peroxide infected mice initiation factor kinase activation plaque formation presence µg progeny virus ste antiviral study ste survival mice viral protease addition ste adsorption condition adsorption period adsorption phase antioxidant power aqueous extract centrifugation × cleavage condition different ste dmem fbs effect kinase enteroviral translation fisher scientific h °c heterogeneous nuclear hnrnp cytoplasm infectious virus nuclear ribonucleoprotein p vs percentage cytoplasmic peroxide treatment pfu ml phosphorylation fig possible ste presence ste present study protease pro redox state renilla luciferase ros generation serum free state host ste mg ste phosphorylation thermo fisher titer virus translation initiation translocation hnrnp treated ste treatment ste treatment µg viral attachment virus ste waltham usa water treatment µg ste × g ability ste activity st animal care animal study antioxidative capacity antioxidative mechanism antiviral drug antiviral effect bicistronic reporter,"['aqueous extract schizonepeta ste antiviral activity', 'ste replication evident ability diminish plaque formation cytopathic effect inhibit synthesis viral rna protein', 'singledose ste treatment survival mice', 'ste multiple enteroviral infection', 'treatment ste viral attachment entry cleavage eukaryotic translation initiation factor g protease pro virus reactive oxygen formation relocation heterogeneous nuclear ribonucleoprotein hnrnp nucleus cytoplasm', 'decline hyperphosphorylation kinase', 'plausible ste induced kinase activation subsequent hnrnp relocation membrane trafficking', 'ste health food candidate antiviral drug protection', 'enterovirus non positive sense single rna virus family major hand foot mouth disease young old', 'person person direct contact saliva nasal mucus stool blister', '', 'infected herpangina rash mouth hand body', 'severe xx xx xxxx open scientific aseptic meningitis encephalitis polio', 'central nervous system cns pulmonary edema pulmonary hemorrhage lung collapse', 'severe neural sequelae', 'large recent', 'fatal taiwan', 'caused', 'antiviral drug available infection', 'development specific drug clinical', 'rna genome large precursor polypeptide viral protease viral structural nonstructural', 'viral attachment receptor virus clathrin uncoated release genomic rna', 'cellular message rna viral genomic rna cap structure end recruit ribosome initiate protein translation', 'untranslated region utr internal ribosomal entry site translation', 'heterogeneous nuclear ribonucleoprotein member itafs synthesis viral genome protein', 'infection relocation hnrnp cytoplasm viral replication', 'viral protease pro eukaryotic initiation factor protein pabp essential cap dependent translation', 'hydrolytic switch cap dependent translation dependent translation', 'translation machinery viral', 'evidence redox state host important viral pathogenesis', 'susceptibility virus enterovirus coronavirus redox state host', 'viral infection', 'instance glutathione resveratrol inhibit influenza infection cell animal model', 'treatment synthetic n acetyl cysteine natural epigallocatechin gallate egcg gallocatechin gallate gcg replication', 'antiviral capacity tea antioxidant ability', 'redox state host important determinant viral susceptibility antioxidative capacity herbal extract antiviral activity', 'schizonepeta', 'st jie china annual plant family labiatae', 'east asia fresh stem leaf st several food herbal tea beneficial medicinal cuisine herbal remedy', 'st sun use', 'st number bioactive supplementary table', 'st treat common cold dermatitis skin rash inflammatory', 'antiviral activity st st formulation yinqiao decoction effective reduction hemagglutinin titer virus lung tissue influenza virus mice', 'previous enteroviral activity st extract controversial', 'hsu et al', 'ethanolic extract clinical screen activity taiwanese folk medicinal', 'contrast lin al', 'aqueous extract st activity antipyretic toxin traditional chinese', 'present study demonstrate activity ste', 'ste cytopathic effect plaque formation genomic rna replication', 'survival mice', 'ste generation hnrnp translocation cleavage eukaryotic translation initiation factor kinase phosphorylation', 'ste antiviral activity action number', 'ste replication', 'plaque screen anti enteroviral activity herbal extract', 'rd pfu different brcr agarose µg ml ste', 'ste plaque formation brcr strain plaque formation fig', 'vero supplementary fig', '', 'cytotoxic effect rd μg ml supplementary fig', 'vero μg ml supplementary fig', '', 'validate antiviral effect ste rd strain quantified level genomic rna', 'level upon treatment µg ml ste fig', '', 'dose dependent decrease expression viral rna dependent rna polymerase pol viral protease pro', 'expression infected presence µg ml ste', 'expression infected µg ml ste fig', '', 'reduction rna significant decrease progeny virus', 'intracellular extracellular viral ste infected control treatment group fig', '', 'ste activity', 'study mechanism antiviral activity ste time addition study stage ste infection', 'ste different brcr infection fig', 'immunoblotting', 'expression indicative viral replication', 'fig', 'treatment ste prior adsorption condition suppress replication', 'ste treatment viral adsorption period condition diminished replication', 'addition ste viral adsorption period replication condition', 'ste present viral adsorption post adsorption condition replication', 'ste viral viral adsorption post adsorption', 'synergy antiviral', 'antiviral activity ste viral adsorption period ste unavailable attachment surface receptor', 'test possibility mixed virus ste water excess ste centrifugal filtration infectious virus', 'infectious virus ste treatment group ± × pfu ml water treatment group ± × pfu ml fig', '', 'ste subsequent attachment cellular receptor', 'activity ste', 'rd pfu h overlaid agarose fbs µg ml ste', 'h crystal violet solution', 'representative cell', 'b rd brcr absence presence µg ml ste level genomic copy quantitative reverse transcription pcr level β actin', 'relative untreated', '± separate', 'p vs treatment', 'brcr presence ste', 'cellular protein h p subject western blotting actin', '', 'representative experiment', 'rd c µg ml ste', 'extracellular intracellular viral h p titer determination', '± separate', 'p vs treatment', 'ste antiviral activity post viral adsorption phase', 'switch cap dependent dependent translation course replication', 'study ste process bicistronic reporter fig', 'transfected hour ste', 'firefly luciferase activity renilla luciferase activity rluc ratio uninfected p', 'ste treatment post adsorption phase inhibited increase fig', '', 'ratio firefly renilla luciferase relative preponderance dependent translation', 'ste cap dependent translation', 'validate ste treatment termination host translation level translation initiation factor target enteroviral', 'rd treated ste fig', '', 'infection complete cleavage condition', 'pre treatment ste viral adsorption condition affect process', 'presence ste viral adsorption phase cleavage condition', 'addition ste post adsorption cleavage condition', 'inclusion ste adsorption post adsorption inhibited degradation condition', '', 'µg ste h virus h analysis condition', 'virus presence µg ml ste h cultured h analysis condition', 'virus treated ste h analysis condition', 'virus presence µg ml ste h treated ste h analysis condition', 'b expression β actin aforementioned western blotting', '', 'representative experiment', 'c interaction ste viral infectivity', 'viral preparation µg ste water °c reaction mix amicon filter retentate viral titer', 'sd separate', 'p vs water treatment group', 'ste cap dependent translation maintenance active', 'plausible ste dependent translation', 'factor hnrnp cytoplasm utr facilitate translation', 'possibility ste treatment relocation hnrnp', 'rd expression vector hnrnp transfected effect ste treatment', 'fig', 'nuclei mock', 'infection relocation hnrnp nucleus cytoplasm', 'treatment µg ml ste change hnrnp distribution', 'high throughput quantify percentage cytoplasmic relocation gfp hnrnp', 'percentage mock ±', 'ste treatment significant reduction cytoplasmic gfp positive', 'percentage cytoplasmic gfp positive infected ± treatment µg ml ste fig', '', 'ste dependent translation inhibition hnrnp relocation', 'ste activation kinase', 'kinase regulate hnrnp translocation', 'possible ste hnrnp translocation modulation', 'test possibility rd strain infected µg ste phosphorylated kinase erk', 'infection cause biphasic activation kinase', 'modest increase kinase phosphorylation min p', 'second phase phosphorylation h p intensity kinase phosphorylation h p', 'fig', '', 'ste treatment phosphorylation fig', '', 'contrary infection induce phosphorylation erk h viral adsorption', 'ste treatment erk phosphorylation', 'essential role kinase activation infection inhibitory effect kinase inhibitor expression fig', 'middle panel', 'level dose dependent manner', 'moreover production progeny virus', 'intracellular extracellular progeny virus µm dmso fig', '', 'infection kinase ste activation', 'treatment rescue cleavage fig', 'middle panel cleavage independent kinase activation', 'study possibility pathway cytoplasmic relocation hnrnp effect hnrnp distribution', 'fig', 'percentage cytoplasmic relocation hnrnp brcr dose dependent manner', 'cytoplasmic hnrnp translocation kinase pathway', 'ste phosphorylation antioxidative mechanism', 'hydrogen peroxide kinase phosphorylation infection oxidative stress', 'possibility ros ste', 'study hypothesis antioxidative activity ste', 'antioxidative capacity ste ferric antioxidant power frap trolox equivalent gram ste', 'study antioxidative infection ros generation fluorescent dcfda cellrox deep red reagent determine ros generation', 'ros brcr infected fig', 'supplementary fig', '', 'ste significant reduction generation', 'study ste activation kinase', 'rd h effect ste phosphorylation kinase', 'hydrogen peroxide treatment dose dependent increase kinase phosphorylation rd', 'target protein kinase membrane trafficking important synthesis virus assembly', 'infection rd induced phosphorylation fig', 'lane vs', 'treatment phosphorylation fig', 'lane', 'validate kinase pathway phosphorylation effect kinase inhibitor phosphorylation', 'phosphorylation presence fig', '', 'kinase phosphorylation', 'probable ste phosphorylation suppressive effect kinase', 'study ste treatment mice infection ste mg kg survival clinical', 'survival rate ste infected mice water infected mice', '', 'ste infected mice milder water', 'percentage mice water treatment group limb ste treatment group fig', '', 'paralyzed present study ste protection vitro vivo', 'antiviral number different', 'viral attachment host cleavage cytoplasmic translocation hnrnp', 'cytoplasmic relocation hnrnp kinase activation', 'ste act scavenge ros inhibit kinase phosphorylation', 'addition target molecule kinase', 'phosphorylation ste', 'ste powerful antiviral activity', 'effective drug available treatment', 'controversial antiviral effect ste', 'plaque assay herbal ste protection brcr', 'ste cpe genomic rna progeny virus', 'difference vitro antiviral activity ste difference extraction', 'hsu et al', 'combination organic extraction lin al', 'boiling water purpose', 'difference extraction nature amount active', 'ste clinical survival mice', 'ste antiviral activity vitro vivo', 'mechanistic ste infection time addition assay', 'ste viral adsorption post adsorption', 'treatment virus ste amount infectious virus fig', '', 'unavailable infection', 'probable ste virion attachment virion receptor', 'glycyrrhiza uralensis ganoderma lucidum block adsorption enterovirus', 'major tenuifolia briq possible natural present ste similar manner', 'ste virion', 'number ability ste inhibit infection post adsorption stage', 'ste suppression host cell translation viral translation', 'viral protease necessary translation host cell mrna', 'possible ste protease', 'rosmarinic acid bioactive ste inhibit cysteine protease', 'possible exclusive explanation ste translation viral rna level protease', 'initiation viral rna translation itafs host initiation', 'member itafs hnrnp stem loop ii enteroviral translation replication', 'infection translocation hnrnp nucleus cytoplasm fig', 'activity', 'similar observation poliovirus infected', 'ability ste suppress cytoplasmic relocation hnrnp reduced enteroviral translation replication', 'apigenin prevent interaction rna hnrnp', 'glycosidic derivative apigenin hnrnp cytoplasm', 'arsenite treatment oxidative stress cytoplasmic relocation hnrnp', 'hydrogen peroxide treatment rd translocation nucleus cytoplasm supplementary fig', '', 'infection mitochondrial dysfunction nadph oxidase activation generation', 'increase ros subsequent hnrnp relocation', 'ste block hnrnp translocation', 'consistent notion ste strong antioxidant capacity', 'ste ros generation', 'supplementary fig', '', 'possible ros ste translocation', 'participation mapk', 'activation kinase replication', 'inhibition kinase enteroviral translation fig', '', 'likely kinase important infection', 'consistent kinase cascade regulation subcellular distribution hnrnp', 'activation kinase sufficient promote relocation hnrnp', 'pharmacological inhibition kinase translocation process fig', '', 'ste activation kinase fig', '', 'mechanism action ste elusive', 'activator kinase', 'hydrogen peroxide treatment kinase phosphorylation figure', 'ste clinical mice', 'sevenday old icr mice pfu', 'day single dose ste mg kg n water ml kg n daily', 'survival rate clinical ste b water c daily', 'clinical weakness loss paralysis limb paralysis limb death', 'presence ste fig', '', 'antioxidant treatment activation', 'possible ste activation kinase', 'addition ste expression involved metabolism', 'instance ste expression inducible nitric oxide synthase', 'oral administration ste hepatic expression catalase superoxide dismutase glutathione peroxidase mouse model inflammation', 'ste activation kinase hnrnp relocation antioxidative mechanism', 'target kinase important infection', 'protein egfr complex egf protein α oncogenic variant crk', 'confocal microscopic study co localization α adaptin clathrin clathrin', 'expression egfr transferrin', 'involved ligand endocytosis', 'recent phosphorylation biochemical activity', 'phosphorylation ligand endocytosis', 'phosphorylated kinase location phosphorylation site functional role endocytic process', 'essential role infection', 'extent enteroviral infection', 'result essentiality endocytosis infectious entry process', 'membrane essential replication', 'robust increase phosphorylation mid late phase life cycle role replication', 'agreement enterovirus endocytic machinery transfer cholesterol membrane culture medium replication rna replication processing', 'antiviral activity ste part ability inhibit kinase phosphorylation', 'propose model antiviral activity ste supplementary fig', '', 'scheme ste act number viral infection', 'ste suppress adsorption internalization cleavage activation cytoplasmic relocation hnrnp post translational modification', 'ste various bioactive antiviral', 'genogroup', 'virus vero rd', 'mouse strain infectious clone', 'infectious clone plasmid mlui', 'vitro transcription megascript transcription kit thermo fisher scientific waltham usa', 'rd overnight', 'microgram viral rna rd cell lipofectamine thermo fisher scientific waltham usa manufacturer', 'h incubation virus freeze thaw', 'virus rd animal study', '× rd cm culture dish °c co incubator', 'pbs dmem fbs', 'h infection virus supernatant', 'ste preparation', 'ste authenticated sun pharmaceutical co ltd taipei taiwan', 'herbarium chang gung university taoyuan taiwan', 'powder distilled water constant shaking room temperature period h insoluble substance centrifugation × g min subsequent centrifugation × g min °c', 'aqueous extract st filter', 'drug culture medium use', 'viral plaque plaque antiviral activity', 'titer virus plaque rd', 'viral supernatant serum free medium ten manner', 'monolayer confluence diluted viral viral titer form plaque unit ml', 'plaque reduction pfu virus h °c', 'removal unabsorbed virus agarose medium serum different ste', 'control group mock ste', 'plaque size number assessment antiviral activity ste', 'multiplicity infection', '', 'serum free medium', 'h viral absorption dmem fbs different ste infected', 'total rna hour post infection p', '', 'total rna mini kit sijhih district new taipei city taiwan manufacturer', 'relative copy number', 'sds page western blot analysis', 'protein subject sds page western blot analysis', 'study supplementary table', 'infectivity reduction assay', 'brcr × pfu ml ml mg ml ste h ice', 'medium unadsorbed virus amicon ultra centrifugal filter unit membrane merck millipore darmstadt germany ste centrifugation × g °c min', 'viral ml serum free dmem', 'titer virus', 'ferric antioxidant power frap assay', 'antioxidant power ste formation ferrous tripyridyltriazine', 'method ability antioxidant ferric tripyridyltriazine complex ferrous form absorption maximum nm', 'formation cell permeable fluorogenic red reagent h', 'method ability intracellular leuco dye fluorescent form dye laden amenable cytometric analysis', 'bicistronic reporter detection activity', 'bicistronic plasmid gift dr shin ru shih chang gang university', 'bicistronic mrna expression renilla luciferase rluc cytomegalovirus cmv promoter expression firefly luciferase fluc', 'plasmid dna µg rd µl lipofectamine manufacturer', 'twelve transfection un infected × hour', 'hour indicated final ste', 'h cell enzyme dual luciferase reporter system promega madison usa glomax single tube promega madison usa manufacturer', 'heterogeneous nuclear ribonucleoprotein hnrnp translocation assay', 'plasmid pgfp hnrnp green fluorescent protein gfp hnrnp protein', 'rd µg pgfp hnrnp plasmid lipofectamine', 'h post transfection × pfu brcr h °c', 'virus adsorption dmem fbs different ste infected h °c', 'mock formalin min cell hoechst thermo fisher scientific inc waltham usa pbs room temperature', 'cell analyzer ge healthcare life', 'region nucleus blue fluorescent region', 'translocation hnrnp nucleus cytoplasm increase intensity green fluorescence cytoplasm nucleus', 'percentage hnrnp relocation random', 'confocal microscopic study rd mm glass bottom culture dish poly lysine mattek corporation', 'zeiss lsm system carl zeiss microimaging gmbh germany', 'animal study', 'specific pathogen free day old icr mice laboratory animal center college medicine national cheng kung university tainan taiwan × pfu dmem', 'infected mice single dose water ste mg daily intraperiteronal injection form day infection', 'infected daily clinical survival', '', 'animal care present study accordance national guide', 'institutional animal care use committee national cheng kung university iacuc', '', '± sd', 'statistical graphpad prism software graphpad software inc san diego california usa', 'unpaired student test compare mean', 'log rank test compare survival mice drug water group', 'p value significant']"
189b6018d5c5a6c07a3a7f33911d9302bbc3f2c0,edible vaccine • edible immune response coat protein mucosal immune plant plant administration injection almv coat b lymphoid b virus cell epitope edible effective edible part er er expression foreign expression gene feasibility oral generation generation hepatitis b immune system mosaic virus part plant plant generation plant vaccine production edible purification plant safety plant soluble protein total soluble traditional vaccine viral genome virus vaccine ability assemble ability plant accumulation epitope accumulation plant action digestive active tissue acute watery addition cell addition plant additional advantage additional safety address several advantage expression advantage raw advent modern adverse side affiliate cornell agent transgenic agricultural genetic agrobacterium transformation albumin human alfalfa mosaic allergen specific allergy treatment almv expression alteration suit alternative produce alternative way animal dna animal pathogen animal system animal western antibiotic resistance antigen accumulation antigen animal antigen contact antigen expression antigen production antigen transgenic antigenic epitope antigenic stimulation antigens present application international aqueous possess artificial seed assay elisa assemble different attainable transgenic attempt produce availability storage avoid cumbersome avoid degradation avoid infection avoid maladministration b tobacco bacterium diarrhea banana choice bananas high biology new biotechnological stable bite sized breakdown edible candidate hiv cedar pollen cell production center antigenic chain storage choice general,"['advent modern molecular biology new production', 'pathogenic expression gene protein surrogate organism', 'last decade green surrogate production organism human hb sag', 'immune response', 'addition cell production plant important part normal human diet', 'significant new safe effective oral', 'introduction desired encoded primary condition development edible', 'process transformation transgenic', 'selection important epitope region pathogen interest key success potential edible', 'edible vaccine development low expression foreign transgenic', 'expression total soluble protein tsp render edible vaccine immunogenic', 'selection strong plant specific super expression key factor determine success edible', 'transformation tobacco great efficient genetic transformation expression foreign', 'foreign major ornamental medicinal', 'various foreign serum albumin human interferon human murine igg iga', 'recent several various', 'edible part plant parenteral route intramuscular intravenous injection isolation purification plant tissue', 'edible part plant vaccine raw experimental possible denaturation avoid cumbersome purification', 'agrobacterium transformation method choice general method method transformation existence', 'foreign use strong organ specific plant protein endoplasmic reticulum er er er retention translation start site context alteration suit expression prokaryotic plant', 'production edible desirable select plant raw avoid degradation cooking', 'tomato banana choice', 'expression gene genome material form express gene short period fig', '', 'additional advantage expression product high level attainable transgenic', 'sense single plant rna effective alternative produce vaccine', 'technique epitope interest plant virus coat protein gene', 'infection susceptible non gm plant intracellular production accumulation epitope', 'epitope sequence viral genome integrated plant genome hence generation', 'recombinant cowpea mosaic virus elicit protective immunity mink express antigenic epitope mink enteritis virus', 'recombinant alfalfa mosaic virus almv expression significant hiv integration respective sequence almv coat protein', 'extra virion surface virus assembly', 'recombinant almv coat protein ability assemble different hiv', 'ability plant multicomponent', 'transient viral expression transgenic time foreign gene viral genome time transformation antigen production wide host range plant use multiple plant', 'single antigen animal western enzyme immunosorbent assay elisa', 'mucosal digestive respiratory urinoproductive active tissue body', 'mucosal immune system first line defense effective site vaccination', 'nasal oral effective mucosal', 'goal oral vaccine stimulate mucosal humoral immunity', 'edible undergo mastication degradation plant intestine due action digestive', 'peyer source iga plasma potential populate mucosal tissue mucosal immune effector site', 'breakdown edible vaccine peyer lymphoid intestine germinal center antigenic stimulation', 'site penetration intestinal epithelium', 'antigen contact', 'express major histocompatibility complex mucous b lymphoid', 'b lymphoid diffuse mucosal lymphoid tissue differentiate plasma secrete iga class', 'iga epithelial antigens present figure', '• edible effective delivery vehicle immunization immune response', '• edible vaccine elicit mucosal immunity traditional', '• edible effective availability storage preparation production transportation', 'biotechnological stable room temperature traditional vaccine chain storage preserve', 'transgenic moisture content oil aqueous possess storage', 'cost low special manufacture', 'edible vaccine mass level comparison animal system', '• edible require administration injection traditional', 'medical risk contamination low', 'feasibility oral administration injection advantage', '• plant source new numerous', 'multicomponent second generation several', '• edible safety traditional vaccine possibility infectious', '• separation purification plant pathogenic contamination animal', '• possibility development immunotolerance vaccine protein peptide', '• consistency dosage form plant plant generation generation', '• protein content plant plant generation generation', '• ripeness present form', '• standardization plant material product', '• stability vaccine plant plant', '• food raw e g potato cooked denature protein present', '• variable edible vaccine major problem', 'vaccine time tomato last long temperature', 'avoid infection microbial spoilage', '• concern edible vaccine vaccine fruit normal fruit avoid maladministration vaccine tolerance', '• glycosylation pattern different', 'first report production edible vaccine surface protein tobacco total leaf protein level form patent application international patent cooperation treaty', 'number various table', 'acute watery diarrhea enterotoxigenic escherichia coli vibrio cholerae small intestine enterotoxin attempt produce edible vaccine heat labile enterotoxin lt b tobacco', 'transgenic grown mason thompson institute plant research affiliate cornell university', 'transgenic enterotoxin strong immune', 'edible vaccine immune response', 'bite sized raw potato part toxin e bacterium diarrhea', 'ten transgenic fold serum immunization fold intestinal', 'serious adverse side table', 'ideal candidate hiv antigen transgenic protein edible immune thermal process', 'bananas high rate success russia', 'vector', 'advantage raw pure form', 'research use vector third world edible tropical suitable', 'egyptian maize hepatitis b virus vaccine', 'team hania el itriby director agricultural genetic engineering research institute gm maize hbsag response hepatitis b virus vaccine table', 'predominant cell epitope japanese cedar pollen rice seed mucosal immune system development immune response allergen specific cell', 'specific ige production release histamine mast inflammatory pollinosis', 'feasibility oral immunotherapy agent transgenic cell epitope allergy treatment table', 'seed expression system foreign protein production substantial recombinant seed natural storage organ starch protein oil seedling growth', 'artificial seed remarkable contrast', 'plant free animal pathogen', 'plant dna interact animal dna plant viral mammalian', 'safety plant similar traditional', 'present concern use gm research important field', 'gm pollen compatible related biodiversity', 'order address several containment', 'exploitation different male sterility suicide infertility', 'alternative way problem engineering dna cpdna sexual progeny pollen', 'additional safety feature gm addition plant', 'important recognize medicinal regulated pharmaceutical', 'majority antigen accumulation plant order total soluble protein recent integration value', 'latter value land industrial plant vaccine production order square', 'enable vaccine field grown crop safety plant transient antigen expression', 'point public concern gm presence antibiotic resistance selective marker transgenic', 'generate gm nuclear cpdna integration carry']"
7a7ace6dcceb13de9cb1f1ec2504fd3ecdbc8eb8,et al innate immune virus infection cytosolic dna type interferon sun et immune response al sun cgas dependent cgas pathway dna sensor ifnb production rna dna type ifn innate immunity al al dna rna infection al ishikawa et zhang al ablasser al al clementz al yu cgas activation chen al clementz al deficient mice dna hybrid dub activity falck pedersen hbv polymerase host cell host defense host innate ifn production immune evasion initiate innate kshv infection kshv viral lam falck pattern recognition positive sense response virus role dna second messenger sense rna vaccinia virus viral cgas viral dna viral immune viral infection viral replication yu et able cleave activation ifnb adaptor protein aguirre al akt kinase al figure al gentili antiviral response cell surface cgamp production cgamp second cgas autophagy cgas deficient cgas dna cgas important cgas sting cleavage degradation deletion mutant denv infection dependent ifnb dependent manner dependent response diner al dna binding dna cgas dna exhibit dna ifnb dna ishikawa dna virus gentili et host response identification viral ifnb induction ifnb promoter independent viral induction type infection host infection virus interferon production lau et li et liu et lxcxe necessary many dna mechanism inhibition nitta et non structural,"['virus infection host concerted innate immune response type interferon pro inflammatory enable elimination pathogen', 'intracellular interferon pathway response virus infection host defense range dna rna', 'review cgas modulate pathway', 'utilized viral cgas sting', 'flip side host thwart viral immune escape', 'balance host immune control viral immune evasion pivotal viral pathogenesis discuss virus host context cgas innate pathway', 'innate immunity rapid line host defense microbial', 'host initiate innate immune recognition pathogen pathogen molecular host damage molecular diverse pattern recognition', 'viral virus infection signal produce type interferon multiple synthesis many antiviral', 'antiviral growth apoptosis inhibit cellular protein translation', 'immune site viral infection order control spread virus adaptive immune response virus infection', 'prrs antiviral requirement cytokine dependent autocrine paracrine stimulation', 'pattern recognition germ line present cell surface specific cellular last', 'prrs microbial', 'molecular essential pathogen survival nucleic lps bacterial flagellin yeast zymosan', 'prrs play significant role first host defense', 'prrs important rapid efficient innate immune response', 'prrs oligomerization leucine rich nlrs retinoic acid absent melanoma cytosolic dna brubaker et al medzhitov takeuchi al figure', 'context virus infection pamp viral genome viral nucleic replication cycle host cell single rna dna', 'cytosolic dna prrs consensus intracellular detection pathogen dna critical initiating innate immune', 'downstream kinase transcriptional important cytosolic mita eris mpys upstream', 'subsequent work cascade critical dna multiple dna', 'important molecule cytoplasmic dna innate immune jin al sun et al zhong al', 'loss cytosolic dna ifnb production', 'deficient mice great susceptibility simplex virus infection dependent cytosolic dna ishikawa et al', 'many dna date', 'dna dependent activator ifn regulatory first cytosolic dna sensor', 'important ifnb production takaoka al', 'dai deficient normal response cytosolic dna stimulation possibility redundancy cytosolic dnasensing al', 'dna sensor role dna dendritic', 'depletion reduction ifnb production poly da dt poly dg dc hsv influenza zhang al', 'animal functional role innate immune', 'direct indirect method dna rna polymerase iii b form dna rna polymerase iii rig induction interferon et al chiu et al', 'dna sensor', 'vaccinia virus vacv dna recruit ifnb induction', 'small interfering rna reduced vacv dna ifnb unterholzner', 'innate immunity many viral modulated viral replication', 'example nuclear viral dna sensor important signaling induction et morrone et al al', 'degraded infection proteasome dependent manner protein degradation diner al al', 'infection virus restriction factor viral replication gene expression', 'accumulate cytoplasm ansari al li et al', 'serve nuclear cytosolic sensor dna', 'addition human cytomegalovirus hcmv trigger tegument protein response li et al', 'play role inflammasome schematic different pattern recognition prr', 'tlrs cell surface present endosomal', 'tlrs utilize myeloid differentiation primary response gene tir domain interferon trif adaptor protein recruit downstream production inflammatory type interferon ifn', 'family melanoma differentiation gene laboratory physiology specific rna', 'rlrs signal adaptor protein mavs cardif visa mitochondria trigger production type', 'nlrs cytosolic prrs contain domain nbd lrr region terminal effector caspase activation recruitment domain card pyrin domain pyd', 'several nlr large complex inflammasome asc procaspase inflammasome induction number different', 'nlr family protein cytosolic dsdna', 'similar stimulation procaspase asc induce', 'herpesvirus kshv infection al', 'ifix new molecule herpesvirus replication detect viral dna nucleus cytoplasm foreign dna hin domain sequence non specific manner', 'many human pyhin important immunity diner al', 'additional cyclic gmp amp cgamp synthase cgas detail dna pk play role dna trigger innate immune et al kim al kondo al al zhang al', 'many dna dna host cell', 'possible type specificity different', 'example fibroblast endothelial dendritic', 'future question novel mechanisms elucidate regulatory innate immunity', 'endoplasmic reticulum resident membrane protein mitochondria mitochondria terminal transmembrane al', 'response cytosolic dna dimerizes perinuclear region key activation downstream et al saitoh al sun et al', 'relocalization subsequent phosphorylation liu et al', 'induction type ifn', 'dna function direct cytosolic dna sensor', 'physiological dna coordination dna abe et al', 'undergo different ubiquitination phosphorylation', 'ubiquitin ligase mediate ubiquitination lysine facilitate dimerization tsuchida et al', 'function ligase capable ubiquitin', 'study mutation ubiquitination mutation additional diminish ubiquitination', 'interact important interaction sendai virus sev infection zhang al', 'ubiquitin ligase ubiquitination degradation', 'lysine target site ubiquitination degradation viral infection al', 'ligase polyubiquitination residue sting', 'attenuate sting ubiquitination ubiquitination positive regulation', 'regulate innate immune temporal fashion qin et al', 'addition ubiquitination', 'kinase serine dna cgamp stimulation activation', 'negative feedback loop play control activation', 'hand phosphorylate residue liu', 'dichotomy different additional clarify regulation', 'role cgas autophagy', 'interaction cgas autophagy regulator cgamp synthesis ifn induction infection autophagy', 'interaction event activation immune stimulation', 'akt kinase phosphorylate cgas suppress activity', 'infection akt kinase cgamp ifn b production concomitant increase replication', 'akt dependent response vaccinia virus infection al seo et al', 'cgas pathway cgas cytosolic dna sensor production cgamp atp gtp dna binding', 'cgamp second messenger type ifn production ablasser al gao al sun al figure', 'capacity dna cgas important role type interferon kshv sun et al', 'cgas deficient mouse respond virus infection cgas deficient mice viral susceptibility vaccinia virus murine gammaherpesvirus wild type mice ablasser al al', 'cgas nuclear human contribute stabilization al', 'cgas cooperate sense nuclear herpesviral dna initiate innate signaling', 'cgas important viral dna exhibit important host immunity certain positive sense rna life cycle', 'cgas knockout mice susceptible infection nile virus wnv positive sense single rna virus', 'likely cgas absent basal transcript certain antiviral vulnerable certain rna wnv al', 'recent study rna dna hybrid able cgas lead cgamp production mankan al', 'dna component rna dna hybrid essential cgamp production', 'additional animal address cgas role rna dna hybrid', 'note deficient mice susceptibility virus e g vesicular stomatitis virus vsv infection deficient mount strong innate immune response rna sev ishikawa et al', 'utr flavivirus hepatitis virus hcv dependent response al fact dsrna mimic poly c abe al', 'co immunoprecipitation rna sensor rig rlr protein', 'fact deficiency host response stimuli infection virus encephalomyocarditis virus emcv ishikawa barber', 'undergo perinuclear translocation rna virus infection cytosolic rna stimulation distinct functional model cytosolic dna ishikawa et al', 'conclusion cgas serve restriction virus infection distinct role dna virus precise delineated', 'study sting fusion viral target rna independent event', 'study cationic translocation perinuclear interferon production holm et al', 'innate response virus dependent tlrs rlrs', 'extra protection additional danger signal infection dna', 'number counteract cgas pathway', 'table different viral cgas sting', 'different dna circumvent cgas activation discussed', 'gregory al jacobs damania et al herpesvirus evasion cgas pathway infancy', 'dna virus activate sting vivo vitro experimental activator cgas pathway', 'deficiency mice lethal susceptibility infection due successful type interferon response', 'kalamvoki roizman critical cellular innate immunity necessary replication certain cell', 'wt virus hela deletion mutant degradation', 'consistent replication knockdown important optimal virus replication circumstance', 'human embryonic lung sun al clementz al chen al infection wt deletion depletion increased replication wt deletion', 'cell type context dependent', 'kshv infection activate cgas pathway', 'cgas endothelial ifnb production primary infection reactivation latency kshv viral gene transcription viral genome copy number control endothelial', 'cgas screen kshv open reading multiple kshv viral cgas dependent ifnb promoter activation ifnb protein production', 'kshv viral interferon regulatory factor cgas dependent ifnb induction', 'interact prevent binding', 'inhibition phosphorylation overall inhibition dna pathway', 'context kshv infection induction', 'kshv study wu et al', 'study kicgas kshv inhibitor cgas abundant gammaherpesvirus specific tegument protein inhibit cytosolic dna cgas enzymatic activity mechanism cgas dna binding', 'infection deletion mutant phosphorylation wt loss virus host innate immune', 'similar inhibitory effect related monkey rhadinovirus rrv epstein barr virus ebv cgas mechanism al', 'addition cytoplasmic latency nuclear antigen lana interact cgas cgas dependent reactivation kshv latency zhang al', 'gene type interferon production response activation', 'deletion virus dependent innate immune response potential role sun et al', 'overall multiple cgas different successful evasion host innate immunity', 'identification viral evade new', 'hepadnaviridae hepatitis b virus hbv polymerase protein ifnb promoter activation liu et al', 'dissection reverse transcriptase rt rnase h rh domain hbv polymerase protein sufficient suppress', 'hbv polymerase attenuated polyubiquitination function protein al', 'human papillomavirus hpv ubiquitous dna tumor virus', 'recent study link hpv cgas pathway', 'hpv potent inhibitor dna antiviral response', 'lxcxe necessary cgas activation', 'absence significant induction type interferon lau et al', 'study adenovirus function antagonist', 'block activity', 'lxcxe necessary dna lau et al', 'agreement study critical type interferon induction response lam falck pedersen', 'lam falck pedersen evidence suppression cgas dependent activation hr post adenovirus infection', 'viral replication lack cgas hela hr hr lam falck pedersen', 'block activation ifnb adenovirus replicate affected upstream cgas dependent look et al', 'antagonist step interfere innate immune response adenoviral evasion antiviral response', 'fact role cgas dna rna many cgas dependent manner rna viral pathway', 'restrict virus infection independent type interferon', 'example type ifn dengue virus denv infection al', 'non structural protein yellow fever virus colocalize interact block rig dependent', 'bioinformatic denv hcv display certain homology ishikawa et al', 'result initial study complex overexpressed endogenous', 'interaction observation affect endogenous protein oligomerization al nitta et al', 'group different mechanism inhibition', 'paper hcv colocalization interaction al paper colocalization mitochondrial impaired mavs interaction nitta et al', 'irrespective mechanism viral mimic optimal pathway protein protein', 'distinct activation', 'discovery denv non structural antagonist type ifn production rodriguez madoz et al', 'mechanism inhibition ability bind aguirre al yu et al', 'cleavage degradation denv infection', 'inactive able cleave previous protease activity type ifn inhibition', 'target human sequence murine aguirre al yu et al', 'able cleave murine block ifnb production murine susceptible denv aguirre et al yu et al', 'coronaviridae human coronavirus hcov inhibitor type ifn production', 'membrane plp domain protein interacted er sun et al', 'dimerization interaction', 'addition polyubiquitination deubiquitinase dub activity', 'insufficient polyubiquitination ability disrupt dub activity clementz et al sun et al', 'protein porcine epidemic diarrhea virus pedv interact repress polyubiquitination et al', 'dub activity pedv inhibition', 'difference human porcine clarification', 'cov suppress type ifnb production', 'cov protease inhibit activation chen al clementz al sun et al', 'transmembrane domain plpro co rig', 'similar hcov plpro affected dimerization polyubiquitination function papain protease domain family chen al clementz al sun et al', 'host viral immune evasion', 'example adjacent', 'host cell limit cell cell spread', 'cgamp second messenger independent viral', 'cgamp induced stingdependent antiviral et al gentili et al', 'distinct transfer independent viral nucleic novel mode host virus', 'cgamp initiate innate immune need cgas activation efficient host response viral infection bridgeman al gentili et al', 'cgamp bystander independent virus infection ablasser al specific host strategy utilized virus infection cell', 'induction second messenger cgamp important translation host g ifnb cgamp neighboring lieu ifnb elicit innate immune', 'summary host various robust immune time modulate escape host innate immune system', 'lot uncovered respect cgas function many different immune evasion dna indicative importance pathway viral', 'rna dna similar inhibit function distinct cleavage degradation', 'positive sense rna negative sense rna', 'future identification viral group informative', 'inhibition remain', 'rna dna exhibit acute lytic infection lifelong persistent latent host target cgas immune response likely important lytic latent viral lifecycle', 'conclusion understanding battle virus human host benefit prevention treatment viral', 'due space able cite topic', 'thank damania lab helpful', 'b', 'nih', 'b', 'leukemia lymphoma society scholar wellcome fund investigator pathogenesis infectious disease']"
